data_2uz5_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2uz5 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp . . . . . 0 N--CA 1.456 -0.168 0 CA-C-O 120.755 0.312 . . . . 3.1499999999999999 110.222 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -57.79 -52.04 67.09 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.101 -0.499 . . . . 1.27 110.145 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -66.64 -34.39 77.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.864 -0.607 . . . . 2.5699999999999998 109.936 178.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -55.79 -32.61 63.64 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.089 -0.708 . . . . 2.1400000000000001 109.089 178.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.497 ' HA ' ' HG2' ' A' ' 11' ' ' LYS . 41.5 m-20 -75.7 -38.37 58.71 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.201 -0.909 . . . . 1.3999999999999999 110.509 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -56.39 -39.6 73.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.878 -0.601 . . . . 3.2400000000000002 111.571 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.2 m -78.33 -47.83 23.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 112.604 0.594 . . . . 1.9199999999999999 112.604 -178.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.497 ' HG2' ' HA ' ' A' ' 8' ' ' ASN . 22.1 ptmt -63.55 -33.99 76.81 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.602 0.223 . . . . 2.1499999999999999 111.602 -179.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.86 -52.98 5.54 Favored Glycine 0 C--N 1.33 0.231 0 C-N-CA 120.75 -0.738 . . . . 0.33000000000000002 112.461 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -57.66 -26.27 61.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.969 0.414 . . . . 2.3900000000000001 110.346 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.17 -40.67 37.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.814 -0.63 . . . . 0.92000000000000004 110.529 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -58.69 -48.92 79.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.076 -0.511 . . . . 0.27000000000000002 110.278 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.542 ' HA ' ' HB3' ' A' ' 19' ' ' ASN . 4.2 pp -67.0 -34.52 77.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.32 -0.4 . . . . 1.3100000000000001 110.714 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.444 ' N ' HD13 ' A' ' 16' ' ' LEU . 18.5 m -57.72 -49.65 75.85 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.246 -0.434 . . . . 1.1599999999999999 110.209 179.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -73.72 -32.01 63.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.86 -0.609 . . . . 2.4700000000000002 110.074 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.542 ' HB3' ' HA ' ' A' ' 16' ' ' LEU . 0.5 OUTLIER -54.29 -33.14 58.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.467 -0.788 . . . . 0.22 111.521 -179.915 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -46.66 -19.75 0.1 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.041 -0.527 . . . . 2.8799999999999999 112.163 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.679 ' N ' HD21 ' A' ' 21' ' ' ASN . 0.8 OUTLIER -68.03 -33.52 74.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.638 -0.256 . . . . 0.40000000000000002 111.594 -178.789 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.436 ' O ' HG21 ' A' ' 25' ' ' VAL . 67.7 mttm -52.05 119.03 13.32 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.551 -0.295 . . . . 1.9299999999999999 110.511 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -57.73 146.41 85.51 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.231 1.954 . . . . 1.0600000000000001 112.222 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.05 3.16 79.87 Favored Glycine 0 CA--C 1.522 0.471 0 C-N-CA 120.869 -0.682 . . . . 0.40999999999999998 114.16 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.545 HG23 ' HH ' ' A' ' 102' ' ' TYR . 35.6 t -56.8 110.71 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 117.65 0.725 . . . . 1.6000000000000001 110.435 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.9 p -126.12 127.58 71.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.898 -0.592 . . . . 1.6599999999999999 111.126 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.1 p -83.09 143.08 12.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.073 -0.512 . . . . 1.5600000000000001 111.021 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.487 ' HB3' ' HD2' ' A' ' 29' ' ' PRO . 69.3 mt -103.86 168.56 8.46 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.102 -0.499 . . . . 1.0800000000000001 110.806 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.487 ' HD2' ' HB3' ' A' ' 28' ' ' LEU . 78.4 Cg_exo -51.48 -33.45 47.39 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 121.943 1.762 . . . . 0.65000000000000002 111.754 178.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.5 m -84.49 -11.95 55.16 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.046 -0.524 . . . . 1.75 111.195 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.04 14.16 27.25 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.507 -0.854 . . . . 0.34999999999999998 114.258 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.486 ' HB2' HD13 ' A' ' 28' ' ' LEU . 6.5 mp -83.08 134.77 35.0 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.068 0.766 . . . . 2.0 113.068 -178.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -116.6 143.65 45.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.191 -0.913 . . . . 2.3199999999999998 108.542 177.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.477 ' HB3' HG23 ' A' ' 101' ' ' ILE . 30.7 p90 -160.27 175.56 12.72 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.37 0.507 . . . . 0.92000000000000004 112.37 -178.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -120.54 116.86 26.21 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.38 -0.827 . . . . 2.6800000000000002 109.331 178.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.6 t -78.1 125.34 37.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 113.475 0.917 . . . . 0.77000000000000002 113.475 -177.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 63.3 mt -101.21 -60.83 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.289 -0.869 . . . . 1.46 109.109 177.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -134.77 100.06 4.5 Favored 'General case' 0 CA--C 1.527 0.072 0 CA-C-N 115.799 -0.637 . . . . 1.05 109.673 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.565 ' HB3' ' HE1' ' A' ' 99' ' ' TRP . 59.9 p -103.18 145.62 29.66 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.113 0.482 . . . . 2.02 112.161 -178.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 94.82 -126.54 8.76 Favored Glycine 0 C--N 1.333 0.384 0 CA-C-N 115.599 -0.728 . . . . 1.0900000000000001 113.146 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 16.9 m-80 70.08 -83.07 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.559 0.577 . . . . 1.7 112.559 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.11 167.36 30.37 Favored Glycine 0 CA--C 1.521 0.429 0 N-CA-C 115.289 0.875 . . . . 0.40000000000000002 115.289 -177.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.528 ' O ' ' HB3' ' A' ' 44' ' ' LYS . 2.5 t -91.81 176.88 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 114.365 -0.917 . . . . 2.0299999999999998 109.592 178.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.693 ' HG2' ' HA ' ' A' ' 94' ' ' PRO . 0.0 OUTLIER 165.46 157.64 0.09 OUTLIER Pre-proline 0 N--CA 1.475 0.781 0 CA-C-O 121.357 0.599 . . . . 2.7400000000000002 112.35 -179.878 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.592 ' HD2' ' HB2' ' A' ' 49' ' ' ASP . 1.2 Cg_endo -84.65 173.35 8.47 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 125.076 3.851 . . . . 0.34000000000000002 113.882 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 48' ' ' SER . . . -67.99 -171.97 6.34 Favored Glycine 0 C--O 1.222 -0.625 0 CA-C-N 114.947 -1.024 . . . . 0.38 111.664 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.499 ' O ' HG11 ' A' ' 79' ' ' VAL . 23.0 pttm -41.33 -13.46 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 113.921 1.082 . . . . 2.9399999999999999 113.921 -177.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.487 ' N ' ' O ' ' A' ' 46' ' ' GLY . 80.9 p -86.25 7.52 24.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.549 0.69 . . . . 1.8999999999999999 109.364 177.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.592 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 0.0 OUTLIER -71.79 149.17 45.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.666 -1.152 . . . . 1.73 112.183 -179.255 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 58.8 m -126.67 119.39 26.88 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 109.055 -0.72 . . . . 0.92000000000000004 109.055 178.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.507 HG13 ' HA ' ' A' ' 133' ' ' VAL . 33.1 m -132.45 156.28 42.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 112.671 0.619 . . . . 1.22 112.671 -178.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 96.6 m -111.93 121.14 44.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.06 -0.973 . . . . 1.05 108.973 178.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.468 HG11 ' HA ' ' A' ' 130' ' ' LEU . 2.6 m -142.57 -179.66 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.328 0.585 . . . . 1.05 112.012 -178.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.487 ' HB3' ' HG2' ' A' ' 69' ' ' GLU . 28.6 mt-10 -131.38 132.75 44.64 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.267 -0.879 . . . . 2.3999999999999999 109.426 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -143.82 158.11 43.91 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.793 0.806 . . . . 0.93999999999999995 112.229 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 82.5 m -126.0 113.63 17.39 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.133 -1.394 . . . . 1.0600000000000001 108.532 178.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.413 ' O ' HG22 ' A' ' 64' ' ' VAL . . . -108.93 147.26 16.72 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 119.78 -1.2 . . . . 0.14000000000000001 112.72 -178.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.01 147.45 32.64 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.852 0.358 . . . . 2.6899999999999999 110.199 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.461 HD22 HD23 ' A' ' 124' ' ' LEU . 13.2 mt -84.95 157.78 20.72 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.003 -0.544 . . . . 1.77 110.233 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.503 ' HB ' ' O ' ' A' ' 123' ' ' THR . 10.2 tp -57.16 -10.93 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.347 0.594 . . . . 1.3700000000000001 109.709 178.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.441 ' H ' ' C ' ' A' ' 59' ' ' LEU . 24.7 t70 -67.4 -11.53 57.98 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.373 -0.83 . . . . 2.0099999999999998 111.007 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.13 -0.34 75.41 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.483 -0.865 . . . . 0.45000000000000001 113.578 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.3 t -122.89 138.93 54.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 117.37 0.585 . . . . 1.99 111.712 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.413 HG22 ' O ' ' A' ' 57' ' ' GLY . 7.5 p -62.99 133.99 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 115.825 -0.625 . . . . 1.0700000000000001 110.064 179.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.643 ' HD1' ' H ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -97.99 -25.61 14.91 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.067 -0.515 . . . . 0.25 111.147 -179.848 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.643 ' H ' ' HD1' ' A' ' 65' ' ' PHE . 19.1 t70 -176.51 131.17 0.21 Allowed 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 120.733 0.302 . . . . 0.29999999999999999 110.889 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 70.8 p -128.35 126.52 40.87 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.293 -0.412 . . . . 1.8100000000000001 110.531 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.574 HG23 ' HB2' ' A' ' 75' ' ' ALA . 81.1 p -81.83 -21.59 37.53 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.767 0.318 . . . . 0.93000000000000005 111.235 -179.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.487 ' HG2' ' HB3' ' A' ' 54' ' ' GLU . 41.2 mt-10 -75.08 -47.76 27.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.284 -0.416 . . . . 2.1099999999999999 111.226 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm -63.01 -36.87 84.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.43 . . . . 3.79 111.166 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 41.6 m -59.07 -22.89 61.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.312 -0.404 . . . . 2.1200000000000001 110.719 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 92.05 4.75 66.61 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.808 -0.711 . . . . 0.80000000000000004 112.355 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -126.5 116.95 22.98 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.454 0.127 . . . . 3.52 110.771 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.46 159.01 11.5 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.139 1.893 . . . . 0.76000000000000001 111.923 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.574 ' HB2' HG23 ' A' ' 68' ' ' THR . . . -94.78 124.62 38.92 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.355 -0.384 . . . . 0.76000000000000001 110.475 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 48.4 m -127.44 111.95 14.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.838 0.352 . . . . 1.98 111.446 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -158.67 163.78 36.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.091 -0.504 . . . . 0.44 110.904 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.527 ' HG3' ' HB2' ' A' ' 81' ' ' GLN . 0.4 OUTLIER -95.28 148.33 22.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.379 0.609 . . . . 1.8 110.503 178.931 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.505 ' HB ' ' HB3' ' A' ' 90' ' ' LEU . 0.6 OUTLIER -59.29 -28.38 39.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 114.93 -1.032 . . . . 1.79 113.262 -178.431 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.508 ' HB3' ' NE2' ' A' ' 78' ' ' GLN . 46.7 t -85.44 -2.42 58.09 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.78 0.659 . . . . 1.6100000000000001 112.78 -178.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.527 ' HB2' ' HG3' ' A' ' 78' ' ' GLN . 5.3 tp-100 -96.93 5.85 49.74 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.534 0.568 . . . . 2.4199999999999999 112.534 -179.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.6 m -112.77 -178.15 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 N-CA-C 112.361 0.504 . . . . 1.1799999999999999 112.361 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.497 ' O ' HG21 ' A' ' 87' ' ' THR . 28.1 pt -56.88 155.37 15.48 Favored Pre-proline 0 N--CA 1.464 0.273 0 CA-C-N 116.0 -0.546 . . . . 1.5900000000000001 112.017 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -44.33 -60.43 0.81 Allowed 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.074 2.516 . . . . 1.01 113.597 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.4 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -49.12 -49.08 31.14 Favored Glycine 0 CA--C 1.522 0.529 0 C-N-CA 120.493 -0.86 . . . . 0.35999999999999999 112.721 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . 0.443 ' HB2' HG13 ' A' ' 83' ' ' ILE . 0.7 OUTLIER -61.81 -43.87 97.99 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.248 0.462 . . . . 0.98999999999999999 112.248 -179.003 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.497 HG21 ' O ' ' A' ' 83' ' ' ILE . 53.7 p -56.12 -34.49 66.11 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.7 0.286 . . . . 1.8899999999999999 111.395 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -70.27 -51.46 30.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.404 -0.362 . . . . 1.4299999999999999 111.835 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.45 ' HB1' HD23 ' A' ' 32' ' ' LEU . . . -65.78 -52.24 52.48 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 112.418 0.525 . . . . 0.33000000000000002 112.418 -178.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.505 ' HB3' ' HB ' ' A' ' 79' ' ' VAL . 4.1 mm? -56.97 -26.91 60.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.424 -0.353 . . . . 1.1599999999999999 111.615 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.444 ' HG3' ' N ' ' A' ' 47' ' ' LYS . 53.2 tt0 -67.7 -23.47 65.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.789 0.328 . . . . 2.23 111.182 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.44 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 88.8 mt -100.75 -8.04 23.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.298 -0.41 . . . . 2.0899999999999999 111.526 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.457 ' SD ' HD11 ' A' ' 90' ' ' LEU . 62.1 mtt -76.41 110.78 12.37 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 116.748 -0.205 . . . . 2.2799999999999998 111.281 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.693 ' HA ' ' HG2' ' A' ' 44' ' ' LYS . 67.4 Cg_endo -84.93 147.45 10.54 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.837 2.358 . . . . 0.72999999999999998 112.771 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.471 ' HA ' ' HG ' ' A' ' 130' ' ' LEU . . . -45.8 131.02 9.46 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.288 -0.415 . . . . 1.21 112.06 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 88.99 -11.94 67.65 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.845 -0.693 . . . . 0.34000000000000002 113.613 179.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.486 ' HB3' ' HG2' ' A' ' 94' ' ' PRO . 96.6 p -67.75 -175.92 0.59 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.963 0.411 . . . . 1.8899999999999999 111.284 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 17.6 m -161.54 97.75 1.1 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.899 -0.592 . . . . 0.88 110.81 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.565 ' HE1' ' HB3' ' A' ' 39' ' ' SER . 43.9 m0 -119.93 152.11 37.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.082 0.468 . . . . 0.67000000000000004 111.563 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -122.25 108.27 13.09 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.459 -0.941 . . . . 1.53 108.459 177.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.477 HG23 ' HB3' ' A' ' 34' ' ' TYR . 31.5 pt -106.4 141.7 21.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 113.217 0.821 . . . . 0.72999999999999998 113.217 -177.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.545 ' HH ' HG23 ' A' ' 25' ' ' VAL . 0.6 OUTLIER -125.53 103.97 8.16 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.578 -1.192 . . . . 0.91000000000000003 108.368 178.309 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 4.1 t -106.2 110.79 64.24 Favored Pre-proline 0 C--N 1.33 -0.262 0 N-CA-C 113.114 0.783 . . . . 1.1399999999999999 113.114 -177.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.473 ' HG2' HD11 ' A' ' 107' ' ' LEU . 17.7 Cg_endo -61.96 152.19 76.66 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.308 2.006 . . . . 0.68000000000000005 111.131 177.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -47.12 -42.14 18.7 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.834 0.679 . . . . 2.3700000000000001 112.834 -178.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -57.4 -9.36 4.51 Favored Glycine 0 CA--C 1.521 0.452 0 C-N-CA 121.043 -0.598 . . . . 0.40000000000000002 113.882 -178.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.473 HD11 ' HG2' ' A' ' 104' ' ' PRO . 9.2 mp -113.4 -7.71 13.46 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.138 0.422 . . . . 2.9300000000000002 112.138 -178.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.439 0 CA-C-N 116.692 -0.231 . . . . 1.3799999999999999 110.63 179.777 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo . . . . . 0 C--O 1.231 0.142 0 CA-C-O 120.959 0.316 . . . . 1.0900000000000001 111.51 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.572 HG22 HD11 ' A' ' 124' ' ' LEU . 57.4 mt -90.84 115.21 29.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.791 -0.64 . . . . 1.8799999999999999 110.015 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -44.18 157.41 0.17 Allowed Glycine 0 C--N 1.334 0.463 0 CA-C-N 116.153 -0.476 . . . . 0.56000000000000005 113.13 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -63.64 131.65 32.29 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.274 1.983 . . . . 0.84999999999999998 111.643 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 49.3 34.18 6.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.262 -0.426 . . . . 1.1200000000000001 110.356 -178.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -116.29 129.17 56.13 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.203 -0.453 . . . . 1.8200000000000001 111.358 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.503 ' O ' ' HB ' ' A' ' 60' ' ' ILE . 77.5 m -93.07 127.27 38.54 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.722 -0.844 . . . . 1.0900000000000001 108.722 178.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.572 HD11 HG22 ' A' ' 118' ' ' ILE . 7.4 mp -115.22 157.84 23.14 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.27 0.557 . . . . 2.1000000000000001 112.399 -178.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.413 HD13 ' N ' ' A' ' 125' ' ' ILE . 4.8 mp -114.86 139.35 41.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.255 -0.884 . . . . 1.0600000000000001 109.502 178.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -131.13 131.79 44.36 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.099 0.476 . . . . 0.28999999999999998 111.544 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.569 ' HB3' ' HZ3' ' A' ' 127' ' ' LYS . 3.3 mmmp? -110.45 103.78 12.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.514 -0.766 . . . . 2.77 109.18 178.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.4 mp -103.94 118.7 51.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.163 0.506 . . . . 1.5600000000000001 112.242 -178.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -113.35 98.34 7.04 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.41 -0.959 . . . . 0.29999999999999999 108.41 177.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.471 ' HG ' ' HA ' ' A' ' 95' ' ' ALA . 21.9 tp -82.74 123.18 29.07 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.552 -0.749 . . . . 2.0299999999999998 111.683 -178.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 55.8 mt -89.81 -55.99 5.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.799 -0.637 . . . . 1.8899999999999999 110.785 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.446 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 60.5 p -163.64 165.04 23.78 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.072 0.463 . . . . 1.75 111.628 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.507 ' HA ' HG13 ' A' ' 51' ' ' VAL . 2.5 p -108.95 131.53 59.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.715 -0.675 . . . . 2.1299999999999999 111.418 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 5.8 tttp 34.37 64.96 0.35 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.012 -0.54 . . . . 3.5600000000000001 111.574 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm 62.03 42.86 9.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.897 -0.592 . . . . 3.6699999999999999 111.229 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 90.0 p 47.82 64.42 1.63 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.752 -0.658 . . . . 1.6000000000000001 111.413 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 43.4 t . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.21 -0.9 . . . . 2.7799999999999998 110.865 179.994 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp . . . . . 0 N--CA 1.456 -0.139 0 CA-C-O 120.772 0.32 . . . . 3.1499999999999999 110.358 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -57.53 -51.42 69.53 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.085 -0.507 . . . . 1.27 110.265 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -67.22 -35.14 78.95 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.927 -0.579 . . . . 2.5699999999999998 110.215 179.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -55.78 -32.47 63.49 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 109.386 -0.598 . . . . 2.1400000000000001 109.386 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.544 ' HB3' ' HG2' ' A' ' 122' ' ' GLU . 19.0 m-20 -75.66 -39.13 58.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.491 -0.777 . . . . 1.3999999999999999 110.38 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.425 ' HD2' ' O ' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -56.79 -40.84 76.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.9 -0.591 . . . . 3.2400000000000002 111.331 179.816 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.416 HG22 ' N ' ' A' ' 11' ' ' LYS . 19.6 m -74.15 -48.23 38.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 112.169 0.433 . . . . 1.9199999999999999 112.169 -179.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.611 ' HZ2' ' HB3' ' A' ' 11' ' ' LYS . 0.2 OUTLIER -64.07 -29.91 71.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.776 0.322 . . . . 2.1499999999999999 111.029 -179.683 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.69 -48.33 8.99 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 121.051 -0.595 . . . . 0.33000000000000002 112.176 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -59.01 -30.15 67.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.035 0.445 . . . . 2.3900000000000001 110.377 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.88 -41.33 37.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.794 -0.639 . . . . 0.92000000000000004 111.118 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -56.02 -52.71 63.26 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 120.768 0.318 . . . . 0.27000000000000002 110.288 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.456 ' HA ' ' HB3' ' A' ' 19' ' ' ASN . 4.0 pp -63.71 -35.51 80.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.083 -0.508 . . . . 1.3100000000000001 110.446 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.4 m -57.33 -48.53 78.72 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.066 -0.516 . . . . 1.1599999999999999 110.343 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -73.22 -31.82 64.38 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.948 -0.569 . . . . 2.4700000000000002 109.876 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.485 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 0.9 OUTLIER -56.03 -30.43 61.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.368 -0.833 . . . . 0.22 111.817 -179.883 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -43.22 -19.99 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.244 0.461 . . . . 2.8799999999999999 112.244 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.668 ' N ' HD21 ' A' ' 21' ' ' ASN . 0.8 OUTLIER -68.6 -34.03 75.08 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.462 0.542 . . . . 0.40000000000000002 112.462 -178.627 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.485 ' HG2' ' O ' ' A' ' 19' ' ' ASN . 38.3 mmtt -46.7 119.46 5.58 Favored Pre-proline 0 N--CA 1.463 0.198 0 CA-C-O 120.527 0.203 . . . . 1.9299999999999999 110.899 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.432 ' HD2' ' HE2' ' A' ' 35' ' ' LYS . 40.5 Cg_exo -57.0 135.6 71.79 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.006 1.804 . . . . 1.0600000000000001 112.049 179.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.31 3.24 78.92 Favored Glycine 0 CA--C 1.52 0.362 0 C-N-CA 120.755 -0.736 . . . . 0.40999999999999998 113.949 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.458 HG21 ' O ' ' A' ' 22' ' ' LYS . 8.9 t -52.05 111.57 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 117.606 0.703 . . . . 1.6000000000000001 110.218 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.1 p -127.46 133.69 67.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.891 -0.595 . . . . 1.6599999999999999 111.078 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.6 p -85.77 141.91 13.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.953 -0.567 . . . . 1.5600000000000001 110.968 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.564 HD11 ' HB2' ' A' ' 32' ' ' LEU . 64.5 mt -99.66 166.61 12.53 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 1.0800000000000001 110.782 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.417 ' HD2' ' HB3' ' A' ' 28' ' ' LEU . 52.4 Cg_exo -53.14 -30.57 50.95 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 121.908 1.739 . . . . 0.65000000000000002 111.513 178.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 39.8 t -86.02 -12.74 49.48 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.014 -0.539 . . . . 1.75 111.031 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.05 14.42 24.64 Favored Glycine 0 C--N 1.334 0.436 0 C-N-CA 120.464 -0.874 . . . . 0.34999999999999998 114.313 178.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.564 ' HB2' HD11 ' A' ' 28' ' ' LEU . 6.6 mp -85.11 139.26 31.85 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.098 0.777 . . . . 2.0 113.098 -179.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -116.01 144.18 44.45 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.918 -1.037 . . . . 2.3199999999999998 108.438 177.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.547 ' HB3' HG23 ' A' ' 101' ' ' ILE . 15.5 p90 -160.29 175.37 12.93 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.898 0.703 . . . . 0.92000000000000004 112.898 -178.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.432 ' HE2' ' HD2' ' A' ' 23' ' ' PRO . 24.5 tttm -121.93 116.77 24.96 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.006 -0.997 . . . . 2.6800000000000002 109.413 178.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.7 t -77.87 126.17 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 113.188 0.81 . . . . 0.77000000000000002 113.188 -178.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.415 HD13 HG23 ' A' ' 98' ' ' THR . 83.5 mt -101.9 -65.69 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.562 -0.745 . . . . 1.46 110.733 178.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -148.39 80.63 1.46 Allowed 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 120.845 0.355 . . . . 1.05 111.002 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.526 ' HB2' ' NE1' ' A' ' 99' ' ' TRP . 38.9 t -106.96 146.14 31.43 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.254 -0.43 . . . . 2.02 111.968 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 99.27 100.38 2.25 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.834 -0.698 . . . . 1.0900000000000001 113.135 178.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -177.93 -57.39 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 120.671 0.272 . . . . 1.7 111.617 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.27 165.47 31.45 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.833 -0.699 . . . . 0.40000000000000002 114.073 -178.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.561 ' O ' ' HB3' ' A' ' 44' ' ' LYS . 2.7 t -90.5 175.34 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 123.324 0.65 . . . . 2.0299999999999998 109.733 179.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.561 ' HB3' ' O ' ' A' ' 43' ' ' VAL . 18.5 ptmt 164.65 156.87 0.07 OUTLIER Pre-proline 0 N--CA 1.47 0.557 0 CA-C-O 121.475 0.655 . . . . 2.7400000000000002 112.324 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.449 ' HD2' ' CB ' ' A' ' 49' ' ' ASP . 2.1 Cg_endo -84.43 174.25 8.04 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 124.908 3.739 . . . . 0.34000000000000002 113.21 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.51 ' O ' ' N ' ' A' ' 48' ' ' SER . . . -67.47 -172.03 5.72 Favored Glycine 0 C--O 1.225 -0.42 0 CA-C-N 115.326 -0.852 . . . . 0.38 111.356 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.537 ' HG2' ' HB2' ' A' ' 91' ' ' GLN . 33.9 mtmm -41.26 -13.18 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 113.499 0.926 . . . . 2.9399999999999999 113.499 -177.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.51 ' N ' ' O ' ' A' ' 46' ' ' GLY . 47.2 t -85.75 7.08 25.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.085 0.469 . . . . 1.8999999999999999 110.313 178.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.449 ' CB ' ' HD2' ' A' ' 45' ' ' PRO . 3.5 p30 -77.34 150.32 35.19 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.568 -0.742 . . . . 1.73 112.048 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 86.1 m -126.47 119.25 26.74 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.657 -0.868 . . . . 0.92000000000000004 108.657 178.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.501 HG11 ' HA ' ' A' ' 133' ' ' VAL . 12.2 m -124.34 158.47 31.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.443 0.534 . . . . 1.22 112.443 -178.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 83.7 m -112.65 120.89 43.09 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.748 -0.834 . . . . 1.05 108.748 178.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.641 HG12 HD21 ' A' ' 130' ' ' LEU . 12.3 m -141.9 179.85 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.393 0.616 . . . . 1.05 112.043 -178.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -127.09 132.34 50.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.149 -0.932 . . . . 2.3999999999999999 109.236 178.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -146.49 161.1 41.17 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.614 0.721 . . . . 0.93999999999999995 112.184 -179.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 57.9 m -126.99 112.34 15.13 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.621 -1.172 . . . . 1.0600000000000001 108.677 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.43 ' O ' HG22 ' A' ' 64' ' ' VAL . . . -111.41 146.25 17.78 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.045 -1.074 . . . . 0.14000000000000001 112.986 -178.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.48 ' NE ' HD11 ' A' ' 125' ' ' ILE . 3.2 ppt_? -148.03 148.4 30.65 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.817 0.342 . . . . 2.6899999999999999 110.17 179.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.408 ' C ' ' H ' ' A' ' 61' ' ' ASP . 19.3 mt -77.51 160.87 28.34 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.102 -0.499 . . . . 1.77 109.991 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.494 ' HB ' ' O ' ' A' ' 123' ' ' THR . 8.0 tp -59.1 -11.43 2.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.211 -0.662 . . . . 1.3700000000000001 109.211 178.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.408 ' H ' ' C ' ' A' ' 59' ' ' LEU . 8.1 m-20 -65.69 -11.31 44.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.081 -0.963 . . . . 2.0099999999999998 110.774 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.46 -0.85 78.34 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.665 -0.779 . . . . 0.45000000000000001 113.531 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.8 t -118.53 138.45 52.52 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 117.227 0.514 . . . . 1.99 111.579 -178.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.43 HG22 ' O ' ' A' ' 57' ' ' GLY . 6.0 p -64.2 133.15 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 115.822 -0.626 . . . . 1.0700000000000001 110.147 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.587 ' HD1' ' N ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -97.49 -22.53 16.5 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.09 -0.505 . . . . 0.25 110.739 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.587 ' N ' ' HD1' ' A' ' 65' ' ' PHE . 19.8 t70 -175.68 130.15 0.26 Allowed 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.262 -0.426 . . . . 0.29999999999999999 110.649 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 70.2 p -126.61 123.99 38.9 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.28 -0.418 . . . . 1.8100000000000001 110.721 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 70.8 p -90.55 -41.05 11.6 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.381 -0.372 . . . . 0.93000000000000005 111.002 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -70.87 -35.6 72.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 2.1099999999999999 111.147 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.9 tmtm? -63.03 -51.49 66.57 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.365 -0.379 . . . . 3.79 110.857 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 77.1 p -58.63 -19.56 40.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.29 -0.414 . . . . 2.1200000000000001 111.099 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.09 10.36 58.61 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.799 -0.715 . . . . 0.80000000000000004 112.437 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.644 ' HB3' ' HZ2' ' A' ' 73' ' ' LYS . 8.0 mtpm? -115.53 116.68 41.18 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.535 0.167 . . . . 3.52 110.678 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -58.88 144.97 98.44 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.274 1.983 . . . . 0.76000000000000001 112.085 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -94.6 124.25 38.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.206 -0.452 . . . . 0.76000000000000001 111.038 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.2 t -126.18 120.18 29.42 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.33 -0.395 . . . . 1.98 110.767 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -158.04 169.13 25.25 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.263 0.554 . . . . 0.44 111.863 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.604 HE21 ' N ' ' A' ' 79' ' ' VAL . 3.9 tp60 -87.96 145.29 26.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.32 -0.854 . . . . 1.8 109.168 178.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.604 ' N ' HE21 ' A' ' 78' ' ' GLN . 26.1 m -79.71 -27.42 12.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 113.111 0.782 . . . . 1.79 113.111 -177.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.598 ' H ' HE21 ' A' ' 78' ' ' GLN . 80.3 p -85.84 -2.08 57.89 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 111.743 0.275 . . . . 1.6100000000000001 111.743 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.411 ' NE2' ' HG2' ' A' ' 78' ' ' GLN . 1.2 mp0 -93.88 5.88 50.22 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.546 0.573 . . . . 2.4199999999999999 112.546 -178.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.6 -175.04 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 N-CA-C 112.244 0.461 . . . . 1.1799999999999999 112.244 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.499 HG13 ' H ' ' A' ' 86' ' ' TRP . 34.3 pt -56.32 158.17 8.09 Favored Pre-proline 0 N--CA 1.462 0.17 0 CA-C-N 115.962 -0.563 . . . . 1.5900000000000001 112.212 -179.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.453 ' HD2' ' HB ' ' A' ' 83' ' ' ILE . 6.2 Cg_endo -48.71 -50.28 12.87 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.868 2.379 . . . . 1.01 112.553 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.443 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -57.86 -49.11 77.43 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.671 -0.776 . . . . 0.35999999999999999 113.411 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . 0.499 ' H ' HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -62.51 -53.39 55.41 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.518 0.562 . . . . 0.98999999999999999 112.518 -178.457 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.0 t -52.9 -33.38 50.1 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.739 0.274 . . . . 1.8899999999999999 111.739 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -68.99 -50.71 46.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.528 -0.305 . . . . 1.4299999999999999 111.726 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.466 ' HB1' HD23 ' A' ' 32' ' ' LEU . . . -64.16 -45.46 88.34 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.932 0.345 . . . . 0.33000000000000002 111.932 -179.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.455 HD11 ' SD ' ' A' ' 93' ' ' MET . 4.3 mm? -56.59 -30.43 63.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.387 -0.369 . . . . 1.1599999999999999 111.483 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.537 ' HB2' ' HG2' ' A' ' 47' ' ' LYS . 7.8 tt0 -64.82 -23.93 67.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.404 -0.362 . . . . 2.23 111.15 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.407 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 9.1 mp -95.79 -7.84 36.0 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.145 -0.48 . . . . 2.0899999999999999 111.582 -179.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.48 ' HE2' HD11 ' A' ' 128' ' ' ILE . 60.4 mtt -88.79 107.79 19.48 Favored Pre-proline 0 N--CA 1.452 -0.344 0 CA-C-N 116.719 -0.219 . . . . 2.2799999999999998 111.517 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.414 ' HA ' ' CD ' ' A' ' 44' ' ' LYS . 95.7 Cg_endo -79.86 145.27 17.73 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.651 2.234 . . . . 0.72999999999999998 111.817 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.461 ' HB3' ' HA ' ' A' ' 132' ' ' SER . . . -46.94 127.27 9.89 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 120.649 0.262 . . . . 1.21 110.973 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 96.71 -5.39 64.24 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 120.689 -0.767 . . . . 0.34000000000000002 112.997 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.418 ' OG ' ' N ' ' A' ' 98' ' ' THR . 11.2 t -74.78 177.8 5.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.837 0.351 . . . . 1.8899999999999999 111.117 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.418 ' N ' ' OG ' ' A' ' 97' ' ' SER . 18.8 m -151.38 92.86 1.83 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.045 -0.525 . . . . 0.88 110.444 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.526 ' NE1' ' HB2' ' A' ' 39' ' ' SER . 24.2 m0 -116.6 149.18 40.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.171 0.51 . . . . 0.67000000000000004 111.867 -179.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -120.99 108.03 13.37 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.758 -1.201 . . . . 1.53 107.758 176.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.547 HG23 ' HB3' ' A' ' 34' ' ' TYR . 46.2 pt -107.6 139.44 29.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 113.112 0.782 . . . . 0.72999999999999998 113.112 -177.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.444 ' O ' ' HD3' ' A' ' 104' ' ' PRO . 0.1 OUTLIER -117.89 103.9 10.41 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.734 -1.21 . . . . 0.91000000000000003 107.734 177.294 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 39.6 t -97.84 105.53 27.85 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 113.39 0.885 . . . . 1.1399999999999999 113.39 -176.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.481 ' HA ' HG21 ' A' ' 123' ' ' THR . 33.4 Cg_exo -59.84 151.17 73.03 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.344 2.029 . . . . 0.68000000000000005 111.392 177.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.5 p -48.31 -43.13 32.78 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 111.969 0.359 . . . . 2.3700000000000001 111.969 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -57.21 -8.85 3.7 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 114.328 0.491 . . . . 0.40000000000000002 114.328 -178.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.57 -25.66 28.52 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.542 0.571 . . . . 2.9300000000000002 112.542 -178.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.357 0 C-N-CA 121.033 -0.267 . . . . 1.3799999999999999 111.288 -179.626 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo . . . . . 0 C--O 1.231 0.174 0 CA-C-O 120.802 0.251 . . . . 1.0900000000000001 111.882 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.535 HG13 HD23 ' A' ' 124' ' ' LEU . 3.4 mp -91.88 131.19 39.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 1.8799999999999999 109.993 178.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -47.95 153.9 1.62 Allowed Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.934 -0.651 . . . . 0.56000000000000005 112.515 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.433 ' O ' ' HG3' ' A' ' 122' ' ' GLU . 29.1 Cg_endo -62.44 130.28 29.55 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.102 1.868 . . . . 0.84999999999999998 111.655 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 47.63 35.13 4.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.959 -0.564 . . . . 1.1200000000000001 110.24 -179.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.544 ' HG2' ' HB3' ' A' ' 8' ' ' ASN . 43.1 mt-10 -115.23 132.55 56.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.831 -0.622 . . . . 1.8200000000000001 111.279 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.494 ' O ' ' HB ' ' A' ' 60' ' ' ILE . 87.6 m -95.11 127.53 41.23 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.929 -0.767 . . . . 1.0900000000000001 108.929 178.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.535 HD23 HG13 ' A' ' 118' ' ' ILE . 6.5 mp -116.72 157.81 24.86 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.197 0.522 . . . . 2.1000000000000001 112.092 -178.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.48 HD11 ' NE ' ' A' ' 58' ' ' ARG . 4.5 mp -114.21 142.87 25.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.438 -0.801 . . . . 1.0600000000000001 109.617 178.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -135.35 132.26 37.41 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.089 0.471 . . . . 0.28999999999999998 111.717 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 24.4 tptm -108.67 103.55 12.67 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.565 -0.902 . . . . 2.77 108.565 178.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.48 HD11 ' HE2' ' A' ' 93' ' ' MET . 9.1 mt -102.76 122.38 55.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 113.007 0.743 . . . . 1.5600000000000001 113.007 -177.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -116.89 100.31 7.68 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.378 -0.971 . . . . 0.29999999999999999 108.378 177.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.641 HD21 HG12 ' A' ' 53' ' ' VAL . 0.2 OUTLIER -77.95 121.32 24.02 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.926 -0.579 . . . . 2.0299999999999998 111.545 -178.042 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 48.3 mm -93.47 -57.45 4.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.018 -0.537 . . . . 1.8899999999999999 110.092 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.461 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 59.8 p -164.67 163.11 21.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.108 -0.496 . . . . 1.75 111.449 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.501 ' HA ' HG11 ' A' ' 51' ' ' VAL . 11.0 p -107.74 135.14 47.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.691 -0.686 . . . . 2.1299999999999999 110.094 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.44 ' C ' ' H ' ' A' ' 136' ' ' SER . 58.9 pttt 38.5 -149.07 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 O-C-N 123.243 0.339 . . . . 3.5600000000000001 111.234 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.403 ' HD2' ' N ' ' A' ' 135' ' ' LYS . 1.0 OUTLIER -78.21 13.48 1.47 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.058 0.456 . . . . 3.6699999999999999 110.261 179.133 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.44 ' H ' ' C ' ' A' ' 134' ' ' LYS . 47.2 t 65.43 67.03 0.51 Allowed 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.487 -0.778 . . . . 1.6000000000000001 110.925 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.41 ' H ' ' HE3' ' A' ' 134' ' ' LYS . 35.8 m . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.213 -0.899 . . . . 2.7799999999999998 110.863 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? . . . . . 0 N--CA 1.455 -0.178 0 CA-C-O 120.815 0.341 . . . . 3.1499999999999999 110.367 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -55.5 -51.68 66.19 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.014 -0.539 . . . . 1.27 110.169 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -67.38 -36.52 81.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.842 -0.617 . . . . 2.5699999999999998 109.93 179.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -56.34 -32.8 65.04 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.119 -0.697 . . . . 2.1400000000000001 109.119 178.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.476 ' HA ' ' HG2' ' A' ' 11' ' ' LYS . 50.3 m-20 -72.72 -38.51 67.44 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.276 -0.875 . . . . 1.3999999999999999 110.63 179.334 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -56.31 -37.83 70.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.008 -0.542 . . . . 3.2400000000000002 111.595 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.9 t -77.69 -52.54 16.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 112.047 0.388 . . . . 1.9199999999999999 112.047 -179.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.482 ' HE2' HG13 ' A' ' 60' ' ' ILE . 21.3 ptmt -61.13 -29.72 69.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.544 -0.298 . . . . 2.1499999999999999 111.683 -179.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.26 -52.88 5.9 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.569 -0.824 . . . . 0.33000000000000002 112.005 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -63.98 -26.59 68.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.968 0.413 . . . . 2.3900000000000001 110.406 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.0 -39.31 50.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.958 -0.565 . . . . 0.92000000000000004 110.53 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -59.13 -51.03 71.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.992 -0.549 . . . . 0.27000000000000002 110.324 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.498 ' HA ' ' HB3' ' A' ' 19' ' ' ASN . 4.2 pp -64.9 -34.44 78.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.309 -0.405 . . . . 1.3100000000000001 110.577 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.2 m -57.5 -48.8 78.28 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.211 -0.449 . . . . 1.1599999999999999 110.201 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -73.2 -32.05 64.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.81 -0.632 . . . . 2.4700000000000002 109.986 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.498 ' HB3' ' HA ' ' A' ' 16' ' ' LEU . 0.8 OUTLIER -57.58 -27.39 62.66 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.53 -0.759 . . . . 0.22 111.317 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.1 mttm -46.71 -19.85 0.11 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.302 -0.408 . . . . 2.8799999999999999 111.884 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.699 ' N ' HD21 ' A' ' 21' ' ' ASN . 0.7 OUTLIER -68.58 -30.26 68.98 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.469 0.544 . . . . 0.40000000000000002 112.469 -178.491 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.487 ' HG2' ' O ' ' A' ' 19' ' ' ASN . 18.6 mmtp -53.75 118.76 16.01 Favored Pre-proline 0 N--CA 1.464 0.246 0 C-N-CA 121.245 -0.182 . . . . 1.9299999999999999 110.766 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.28 140.73 95.48 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.343 2.029 . . . . 1.0600000000000001 112.523 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.91 3.84 79.47 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.743 -0.742 . . . . 0.40999999999999998 114.318 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.495 HG23 ' HH ' ' A' ' 102' ' ' TYR . 7.0 t -52.4 112.21 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 117.602 0.701 . . . . 1.6000000000000001 110.667 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -118.93 131.03 72.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.904 -0.589 . . . . 1.6599999999999999 111.669 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.2 t -89.27 132.85 32.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.777 -0.647 . . . . 1.5600000000000001 110.49 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.536 HD11 ' HB2' ' A' ' 32' ' ' LEU . 66.1 mt -94.71 163.48 22.36 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.406 -0.361 . . . . 1.0800000000000001 110.925 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -51.81 -30.66 39.05 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.25 1.967 . . . . 0.65000000000000002 112.019 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.8 m -85.49 -13.28 49.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.114 -0.494 . . . . 1.75 111.36 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.637 ' HA2' HD23 ' A' ' 107' ' ' LEU . . . 104.84 15.79 19.21 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.134 -1.031 . . . . 0.34999999999999998 113.874 179.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.536 ' HB2' HD11 ' A' ' 28' ' ' LEU . 2.4 mp -83.34 138.74 33.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.373 0.606 . . . . 2.0 112.243 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -119.22 138.93 52.64 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.158 -0.928 . . . . 2.3199999999999998 108.623 177.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.49 ' HB3' HG23 ' A' ' 101' ' ' ILE . 16.8 p90 -160.61 175.52 12.59 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.206 0.527 . . . . 0.92000000000000004 112.301 -178.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -121.45 117.08 25.98 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.37 -0.832 . . . . 2.6800000000000002 109.591 178.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 67.8 t -73.49 125.97 33.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 113.473 0.916 . . . . 0.77000000000000002 113.473 -178.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 63.2 mt -103.63 -66.7 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.434 -0.803 . . . . 1.46 110.049 178.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 37.7 t30 -130.96 91.92 3.13 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 116.337 -0.392 . . . . 1.05 110.164 178.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.696 ' HB3' ' HE1' ' A' ' 99' ' ' TRP . 96.3 p -105.41 144.83 31.64 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.204 0.446 . . . . 2.02 112.204 -178.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.498 ' HA3' ' HG3' ' A' ' 94' ' ' PRO . . . 80.44 98.55 0.33 Allowed Glycine 0 C--N 1.332 0.351 0 CA-C-N 115.823 -0.626 . . . . 1.0900000000000001 113.141 178.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -151.48 -82.29 0.1 Allowed 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 111.75 0.278 . . . . 1.7 111.75 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.47 -178.83 42.56 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 121.142 -0.551 . . . . 0.40000000000000002 114.098 -178.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.468 ' O ' ' HB3' ' A' ' 44' ' ' LYS . 0.2 OUTLIER -90.32 177.73 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 123.667 0.787 . . . . 2.0299999999999998 110.439 178.937 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.517 ' HB3' HG13 ' A' ' 133' ' ' VAL . 0.0 OUTLIER 165.92 155.24 0.09 OUTLIER Pre-proline 0 N--CA 1.47 0.545 0 CA-C-O 121.668 0.747 . . . . 2.7400000000000002 112.419 -179.681 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.443 ' HD2' ' CB ' ' A' ' 49' ' ' ASP . 2.3 Cg_endo -85.72 173.39 7.28 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 125.102 3.868 . . . . 0.34000000000000002 113.39 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.493 ' O ' ' N ' ' A' ' 48' ' ' SER . . . -68.1 -172.57 6.85 Favored Glycine 0 C--O 1.225 -0.461 0 CA-C-N 115.109 -0.95 . . . . 0.38 111.453 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.484 ' O ' HG11 ' A' ' 79' ' ' VAL . 55.8 mttp -41.71 -13.22 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 113.603 0.964 . . . . 2.9399999999999999 113.603 -178.058 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.493 ' N ' ' O ' ' A' ' 46' ' ' GLY . 39.2 t -86.45 6.92 28.04 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.065 0.46 . . . . 1.8999999999999999 110.625 178.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.443 ' CB ' ' HD2' ' A' ' 45' ' ' PRO . 3.1 p30 -76.63 155.88 33.13 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.776 -0.647 . . . . 1.73 111.487 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.548 ' HB ' ' HG2' ' A' ' 134' ' ' LYS . 33.1 m -125.07 122.27 36.74 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.347 -0.983 . . . . 0.92000000000000004 108.347 178.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.406 HG13 ' HA ' ' A' ' 133' ' ' VAL . 34.0 m -126.78 151.34 33.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 112.826 0.676 . . . . 1.22 112.826 -177.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 95.5 m -114.1 120.96 42.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.05 -0.977 . . . . 1.05 109.152 178.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.445 HG11 ' HA ' ' A' ' 130' ' ' LEU . 3.1 m -142.13 176.88 3.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.149 0.5 . . . . 1.05 111.742 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -126.15 132.03 51.92 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.462 -0.79 . . . . 2.3999999999999999 108.969 178.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -145.56 165.37 28.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.606 0.717 . . . . 0.93999999999999995 112.125 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 88.5 m -130.02 113.47 14.6 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.606 -1.179 . . . . 1.0600000000000001 108.491 178.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -110.62 144.32 17.15 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 119.838 -1.173 . . . . 0.14000000000000001 113.065 -178.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.521 ' NH2' ' HA3' ' A' ' 62' ' ' GLY . 0.1 OUTLIER -147.47 146.83 29.67 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.794 0.331 . . . . 2.6899999999999999 110.192 179.037 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.439 ' HA ' ' HG ' ' A' ' 124' ' ' LEU . 9.8 mt -80.14 157.67 26.55 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.196 -0.456 . . . . 1.77 110.327 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.487 ' HB ' ' O ' ' A' ' 123' ' ' THR . 9.7 tp -59.1 -10.93 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.41 -0.589 . . . . 1.3700000000000001 109.41 178.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.416 ' H ' ' C ' ' A' ' 59' ' ' LEU . 21.3 t70 -66.39 -9.76 36.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.281 -0.872 . . . . 2.0099999999999998 110.673 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.521 ' HA3' ' NH2' ' A' ' 58' ' ' ARG . . . 90.98 -0.23 75.73 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.516 -0.85 . . . . 0.45000000000000001 113.317 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.5 t -121.51 138.71 54.18 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 117.357 0.578 . . . . 1.99 111.702 -178.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.3 p -66.86 133.34 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-N 115.654 -0.703 . . . . 1.0700000000000001 109.979 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.672 ' HD1' ' H ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -97.93 -27.25 14.35 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.271 -0.422 . . . . 0.25 111.523 -179.74 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.672 ' H ' ' HD1' ' A' ' 65' ' ' PHE . 25.0 t70 -177.25 130.74 0.17 Allowed 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 116.709 -0.223 . . . . 0.29999999999999999 110.564 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 68.0 m -134.61 124.51 25.52 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.791 0.329 . . . . 1.8100000000000001 111.12 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 80.9 p -86.14 -12.99 48.47 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.072 0.463 . . . . 0.93000000000000005 110.391 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.89 -48.28 25.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.705 -0.68 . . . . 2.1099999999999999 111.303 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -64.57 -37.86 89.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.111 -0.495 . . . . 3.79 111.418 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 62.9 p -60.23 -14.58 18.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.47 -0.332 . . . . 2.1200000000000001 111.405 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.92 8.02 88.05 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.779 -0.724 . . . . 0.80000000000000004 112.624 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -123.44 118.35 27.6 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 120.268 0.08 . . . . 3.52 110.874 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.62 150.05 45.82 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.42 2.08 . . . . 0.76000000000000001 112.447 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -94.76 126.65 40.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 0.76000000000000001 111.344 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 78.7 m -118.51 115.72 25.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.388 -0.369 . . . . 1.98 110.901 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -150.58 148.66 28.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.309 -0.405 . . . . 0.44 111.396 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.497 HE21 ' H ' ' A' ' 80' ' ' SER . 0.0 OUTLIER -81.78 141.77 33.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.819 -0.628 . . . . 1.8 110.107 179.364 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.494 HG21 ' HB2' ' A' ' 90' ' ' LEU . 2.6 p -64.26 -24.95 36.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.273 -0.421 . . . . 1.79 112.126 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.497 ' H ' HE21 ' A' ' 78' ' ' GLN . 47.3 t -90.93 -9.72 45.1 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.718 0.266 . . . . 1.6100000000000001 111.718 -179.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -91.99 5.8 48.77 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.991 0.367 . . . . 2.4199999999999999 111.991 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 10.5 m -116.24 -178.46 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 112.279 0.474 . . . . 1.1799999999999999 112.279 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.495 ' O ' HG21 ' A' ' 87' ' ' THR . 24.8 pt -56.6 155.87 13.29 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 115.915 -0.584 . . . . 1.5900000000000001 112.035 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -48.16 -60.24 0.95 Allowed 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.211 2.607 . . . . 1.01 113.168 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.487 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -44.39 -48.82 8.5 Favored Glycine 0 CA--C 1.522 0.497 0 C-N-CA 120.596 -0.812 . . . . 0.35999999999999999 112.17 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 1.1 m0 -62.44 -36.63 83.02 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.014 0.375 . . . . 0.98999999999999999 112.014 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.495 HG21 ' O ' ' A' ' 83' ' ' ILE . 30.5 p -58.7 -40.21 83.0 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 121.03 -0.268 . . . . 1.8899999999999999 111.609 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -70.46 -51.67 27.54 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.494 0.553 . . . . 1.4299999999999999 112.494 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.79 -52.41 51.05 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.381 0.511 . . . . 0.33000000000000002 112.381 -178.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.526 HD11 ' SD ' ' A' ' 93' ' ' MET . 4.2 mm? -57.6 -25.72 60.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.334 -0.394 . . . . 1.1599999999999999 111.779 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 21.5 tm0? -81.58 -19.36 42.14 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.754 0.279 . . . . 2.23 111.754 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 98.2 mt -90.25 -22.16 21.76 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.77 0.285 . . . . 2.0899999999999999 111.77 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.526 ' SD ' HD11 ' A' ' 90' ' ' LEU . 15.4 ptp -81.75 121.01 79.11 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-O 120.555 0.217 . . . . 2.2799999999999998 111.511 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.498 ' HG3' ' HA3' ' A' ' 40' ' ' GLY . 92.8 Cg_endo -80.4 147.51 18.04 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.767 2.312 . . . . 0.72999999999999998 111.791 179.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.458 ' HB3' ' HA ' ' A' ' 132' ' ' SER . . . -45.79 126.46 7.12 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.707 0.289 . . . . 1.21 111.151 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 97.84 -2.38 60.14 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 120.82 -0.705 . . . . 0.34000000000000002 113.024 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.414 ' OG ' ' HB2' ' A' ' 93' ' ' MET . 83.0 p -79.42 -174.47 4.24 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.934 0.397 . . . . 1.8899999999999999 111.563 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.5 m -159.89 105.79 1.59 Allowed 'General case' 0 C--O 1.231 0.085 0 CA-C-N 116.029 -0.532 . . . . 0.88 111.001 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.696 ' HE1' ' HB3' ' A' ' 39' ' ' SER . 40.0 m0 -126.9 149.37 49.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.04 0.448 . . . . 0.67000000000000004 111.781 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -117.8 107.91 14.71 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 107.847 -1.168 . . . . 1.53 107.847 177.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.49 HG23 ' HB3' ' A' ' 34' ' ' TYR . 43.3 pt -109.35 140.05 29.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 113.515 0.932 . . . . 0.72999999999999998 113.515 -177.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.495 ' HH ' HG23 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -116.41 103.57 10.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.76 -1.109 . . . . 0.91000000000000003 108.031 177.542 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.465 HG21 HD21 ' A' ' 32' ' ' LEU . 9.6 t -102.53 102.74 27.67 Favored Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 113.191 0.812 . . . . 1.1399999999999999 113.191 -177.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -62.0 151.73 79.67 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.101 1.868 . . . . 0.68000000000000005 110.774 177.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -48.34 -42.5 31.54 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 111.883 0.327 . . . . 2.3700000000000001 111.883 -179.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -57.27 -10.07 5.06 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.982 -0.628 . . . . 0.40000000000000002 113.315 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.637 HD23 ' HA2' ' A' ' 31' ' ' GLY . 0.2 OUTLIER -103.6 -15.89 15.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.766 0.317 . . . . 2.9300000000000002 111.504 -179.575 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.503 -0.317 . . . . 1.3799999999999999 111.173 -179.787 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo . . . . . 0 C--O 1.231 0.153 0 CA-C-O 121.038 0.349 . . . . 1.0900000000000001 111.573 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.612 HG22 HD11 ' A' ' 124' ' ' LEU . 92.8 mt -90.75 124.18 43.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.753 -0.658 . . . . 1.8799999999999999 110.261 179.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -48.56 156.59 1.21 Allowed Glycine 0 C--N 1.331 0.304 0 CA-C-N 116.097 -0.501 . . . . 0.56000000000000005 113.048 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -62.05 131.43 34.72 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.373 2.048 . . . . 0.84999999999999998 111.653 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 50.14 34.41 8.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.272 -0.422 . . . . 1.1200000000000001 110.259 -178.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -115.91 127.11 54.74 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.341 -0.39 . . . . 1.8200000000000001 111.738 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.487 ' O ' ' HB ' ' A' ' 60' ' ' ILE . 97.3 m -90.72 128.63 36.73 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.376 -0.972 . . . . 1.0900000000000001 108.376 177.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.612 HD11 HG22 ' A' ' 118' ' ' ILE . 0.1 OUTLIER -113.35 156.45 23.39 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.829 0.677 . . . . 2.1000000000000001 112.829 -177.577 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 5.1 mp -114.78 138.41 45.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 114.973 -1.012 . . . . 1.0600000000000001 109.228 177.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.411 ' CE1' HD23 ' A' ' 124' ' ' LEU . 68.7 m-85 -131.51 132.47 44.22 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.95 0.405 . . . . 0.28999999999999998 111.893 -178.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -109.12 103.62 12.66 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.521 -0.918 . . . . 2.77 108.521 178.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 19.6 mt -104.11 122.92 57.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 112.974 0.731 . . . . 1.5600000000000001 112.974 -177.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -118.43 99.29 6.73 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.508 -0.923 . . . . 0.29999999999999999 108.508 177.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.445 ' HA ' HG11 ' A' ' 53' ' ' VAL . 20.2 tp -79.56 120.24 23.64 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.889 -0.596 . . . . 2.0299999999999998 111.365 -178.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 50.1 mm -89.75 -56.45 5.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.895 -0.593 . . . . 1.8899999999999999 110.561 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.458 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 2.1 m -161.11 165.4 29.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.203 -0.453 . . . . 1.75 110.802 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.517 HG13 ' HB3' ' A' ' 44' ' ' LYS . 7.2 p -111.66 121.38 64.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.048 -0.524 . . . . 2.1299999999999999 111.663 -179.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.548 ' HG2' ' HB ' ' A' ' 50' ' ' THR . 34.0 mtpt 43.42 65.72 0.93 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.908 -0.587 . . . . 3.5600000000000001 111.097 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 95.5 mttt 59.53 30.84 20.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.904 -0.589 . . . . 3.6699999999999999 111.09 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 42.0 t 55.86 65.2 1.51 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.884 -0.598 . . . . 1.6000000000000001 111.096 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 58.7 m . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.211 -0.9 . . . . 2.7799999999999998 110.871 179.97 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--O 1.233 0.208 0 CA-C-O 121.063 0.459 . . . . 3.1499999999999999 109.936 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.37 -41.74 98.86 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.718 -0.674 . . . . 1.27 110.428 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -74.83 -31.5 61.69 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.261 -0.427 . . . . 2.5699999999999998 110.419 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.441 ' HG3' ' HE3' ' A' ' 11' ' ' LYS . 9.6 tp10 -55.93 -40.75 73.59 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.767 -0.457 . . . . 2.1400000000000001 109.767 179.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.517 ' HA ' ' HG2' ' A' ' 11' ' ' LYS . 25.7 p30 -78.64 -29.28 45.71 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.193 -0.458 . . . . 1.3999999999999999 110.44 179.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 121' ' ' ASN . 64.5 tttp -61.16 -39.57 90.6 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.104 -0.498 . . . . 3.2400000000000002 111.125 178.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.454 HG22 ' N ' ' A' ' 11' ' ' LYS . 27.4 m -77.46 -50.63 19.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 112.462 0.541 . . . . 1.9199999999999999 112.462 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.517 ' HG2' ' HA ' ' A' ' 8' ' ' ASN . 19.5 ptpt -64.95 -26.63 68.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.626 0.25 . . . . 2.1499999999999999 111.359 -179.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -75.05 -53.74 6.06 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.648 -0.787 . . . . 0.33000000000000002 112.206 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -63.52 -24.98 68.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.052 0.453 . . . . 2.3900000000000001 110.384 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.96 -42.38 33.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.795 -0.638 . . . . 0.92000000000000004 110.915 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -57.46 -48.47 79.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.202 -0.454 . . . . 0.27000000000000002 110.578 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.519 ' HA ' ' HB3' ' A' ' 19' ' ' ASN . 4.3 pp -67.64 -35.88 79.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.295 -0.411 . . . . 1.3100000000000001 110.74 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.408 ' O ' ' HD3' ' A' ' 20' ' ' LYS . 12.1 m -57.57 -48.34 79.63 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.114 0.483 . . . . 1.1599999999999999 109.854 178.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -72.28 -31.79 66.05 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.821 -0.627 . . . . 2.4700000000000002 109.809 178.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.525 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 0.8 OUTLIER -58.41 -27.09 63.98 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.744 -0.662 . . . . 0.22 111.378 179.902 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.408 ' HD3' ' O ' ' A' ' 17' ' ' THR . 55.3 mtpt -46.02 -20.0 0.08 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.423 -0.353 . . . . 2.8799999999999999 111.659 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.706 ' N ' HD21 ' A' ' 21' ' ' ASN . 0.7 OUTLIER -70.6 -33.16 70.74 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.346 0.499 . . . . 0.40000000000000002 112.346 -179.218 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.525 ' HG2' ' O ' ' A' ' 19' ' ' ASN . 44.3 mmtt -43.09 118.25 2.42 Favored Pre-proline 0 N--CA 1.467 0.377 0 CA-C-N 116.77 -0.196 . . . . 1.9299999999999999 111.373 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.448 ' HD2' ' HE2' ' A' ' 35' ' ' LYS . 18.8 Cg_endo -58.0 133.2 54.15 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.607 2.205 . . . . 1.0600000000000001 112.44 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.69 1.58 85.26 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.754 -0.736 . . . . 0.40999999999999998 113.177 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 34' ' ' TYR . 7.4 p -60.3 114.48 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 121.205 0.526 . . . . 1.6000000000000001 110.519 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.1 p -128.06 141.14 47.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.763 -0.653 . . . . 1.6599999999999999 111.291 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.5 p -89.51 140.59 15.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.13 -0.486 . . . . 1.5600000000000001 111.032 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.558 HD11 ' HB2' ' A' ' 32' ' ' LEU . 73.7 mt -96.92 167.61 11.75 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.036 -0.529 . . . . 1.0800000000000001 110.845 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.451 ' HD2' ' HB3' ' A' ' 28' ' ' LEU . 71.8 Cg_exo -52.25 -31.28 45.67 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 121.878 1.719 . . . . 0.65000000000000002 111.388 178.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.1 m -86.38 -11.83 50.92 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.842 -0.617 . . . . 1.75 111.142 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.28 13.32 28.95 Favored Glycine 0 CA--C 1.521 0.446 0 C-N-CA 120.483 -0.865 . . . . 0.34999999999999998 114.885 178.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.558 ' HB2' HD11 ' A' ' 28' ' ' LEU . 4.0 mp -83.44 134.86 34.85 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 117.882 0.841 . . . . 2.0 112.762 -178.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -114.4 140.69 48.47 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.065 -1.087 . . . . 2.3199999999999998 108.065 177.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.558 ' HB3' HG23 ' A' ' 101' ' ' ILE . 36.9 p90 -155.16 176.03 13.07 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 113.206 0.817 . . . . 0.92000000000000004 113.206 -177.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.448 ' HE2' ' HD2' ' A' ' 23' ' ' PRO . 33.8 tttm -120.75 116.89 26.12 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.012 -0.995 . . . . 2.6800000000000002 109.2 178.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.504 HG12 ' HE1' ' A' ' 99' ' ' TRP . 36.2 t -73.27 126.59 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 113.346 0.869 . . . . 0.77000000000000002 113.346 -177.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.51 HD13 HG21 ' A' ' 98' ' ' THR . 72.6 mt -104.6 -64.1 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 115.436 -0.802 . . . . 1.46 110.672 178.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.412 ' O ' ' HA ' ' A' ' 97' ' ' SER . 9.7 t30 -151.26 78.6 1.28 Allowed 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.653 0.263 . . . . 1.05 110.819 179.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.456 ' HB3' ' NE1' ' A' ' 99' ' ' TRP . 79.3 p -106.45 146.13 30.92 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.964 0.411 . . . . 2.02 112.076 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.434 ' H ' ' HG ' ' A' ' 97' ' ' SER . . . 97.55 99.71 2.03 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 121.025 -0.607 . . . . 1.0900000000000001 113.026 179.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -176.48 -62.1 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 111.776 0.287 . . . . 1.7 111.776 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.07 160.97 28.84 Favored Glycine 0 CA--C 1.518 0.281 0 C-N-CA 120.843 -0.694 . . . . 0.40000000000000002 113.858 -179.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.498 ' O ' ' HB3' ' A' ' 44' ' ' LYS . 0.2 OUTLIER -90.71 175.85 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 123.215 0.606 . . . . 2.0299999999999998 110.516 179.152 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.58 ' HD3' ' HA ' ' A' ' 94' ' ' PRO . 10.0 ptmm? 163.71 156.29 0.06 OUTLIER Pre-proline 0 N--CA 1.471 0.61 0 CA-C-O 121.427 0.632 . . . . 2.7400000000000002 111.933 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.422 ' HD2' ' HB2' ' A' ' 49' ' ' ASP . 7.2 Cg_exo -74.57 173.11 14.87 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 124.485 3.457 . . . . 0.34000000000000002 113.202 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 48' ' ' SER . . . -67.5 -172.56 6.06 Favored Glycine 0 C--O 1.224 -0.497 0 N-CA-C 110.895 -0.882 . . . . 0.38 110.895 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.414 ' O ' ' HB2' ' A' ' 80' ' ' SER . 24.2 pttm -41.61 -13.2 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.388 0.884 . . . . 2.9399999999999999 113.388 -178.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.522 ' N ' ' O ' ' A' ' 46' ' ' GLY . 60.4 m -86.12 7.74 23.62 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 121.036 0.446 . . . . 1.8999999999999999 110.376 178.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.422 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 3.3 p30 -77.84 160.2 28.47 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.656 -0.702 . . . . 1.73 111.611 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.521 ' HB ' ' HG3' ' A' ' 134' ' ' LYS . 48.3 m -126.34 119.5 27.49 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.814 -0.81 . . . . 0.92000000000000004 108.814 178.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.44 HG11 ' HA ' ' A' ' 133' ' ' VAL . 26.5 m -130.07 150.73 34.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.156 0.503 . . . . 1.22 112.319 -178.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 53.3 m -111.74 121.15 44.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.477 -0.783 . . . . 1.05 109.299 178.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.498 HG11 ' HA ' ' A' ' 130' ' ' LEU . 3.4 m -137.83 177.8 5.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.154 0.502 . . . . 1.05 111.772 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -126.55 132.9 51.24 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.441 -0.8 . . . . 2.3999999999999999 109.77 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -144.69 159.63 42.52 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.682 0.753 . . . . 0.93999999999999995 112.161 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 62.9 m -124.71 112.09 16.33 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.42 -1.263 . . . . 1.0600000000000001 108.412 178.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -110.63 141.38 16.35 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 119.813 -1.184 . . . . 0.14000000000000001 113.173 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.437 ' NE ' HD11 ' A' ' 125' ' ' ILE . 2.5 ppt_? -147.36 146.35 29.62 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.786 0.327 . . . . 2.6899999999999999 110.197 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.46 HD22 HD13 ' A' ' 124' ' ' LEU . 0.1 OUTLIER -73.31 163.48 28.02 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.038 -0.528 . . . . 1.77 110.38 -179.863 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.485 ' HB ' ' O ' ' A' ' 123' ' ' THR . 9.0 tp -59.4 -11.01 2.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.357 0.598 . . . . 1.3700000000000001 109.499 178.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.427 ' H ' ' C ' ' A' ' 59' ' ' LEU . 7.4 m-20 -71.73 -12.48 61.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.321 -0.854 . . . . 2.0099999999999998 110.979 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.413 ' HA3' HH11 ' A' ' 58' ' ' ARG . . . 90.02 -0.88 79.64 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.604 -0.808 . . . . 0.45000000000000001 112.921 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.3 m -110.18 128.46 55.49 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 120.92 0.391 . . . . 1.99 111.21 -178.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.1 p -61.0 130.7 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 115.968 -0.56 . . . . 1.0700000000000001 110.099 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.596 ' HD1' ' N ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -97.45 -21.92 16.87 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.976 -0.556 . . . . 0.25 110.912 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.596 ' N ' ' HD1' ' A' ' 65' ' ' PHE . 16.2 t70 -175.82 129.5 0.25 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.164 -0.471 . . . . 0.29999999999999999 110.559 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 30.2 p -132.21 122.28 24.99 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.279 -0.419 . . . . 1.8100000000000001 110.516 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.675 HG22 ' HB2' ' A' ' 75' ' ' ALA . 69.4 p -79.12 -29.17 43.06 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.426 -0.352 . . . . 0.93000000000000005 111.184 -179.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -69.74 -30.98 68.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.463 -0.335 . . . . 2.1099999999999999 110.922 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -71.26 -42.13 69.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 3.79 110.995 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 53.6 p -59.72 -18.93 46.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.908 0.385 . . . . 2.1200000000000001 110.947 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 92.55 2.74 67.33 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.918 -0.658 . . . . 0.80000000000000004 112.604 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -125.98 140.58 37.18 Favored Pre-proline 0 N--CA 1.453 -0.303 0 CA-C-O 120.929 0.395 . . . . 3.52 110.786 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -71.25 160.1 49.91 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.422 2.082 . . . . 0.76000000000000001 112.193 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.675 ' HB2' HG22 ' A' ' 68' ' ' THR . . . -93.63 124.82 37.88 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 116.13 -0.486 . . . . 0.76000000000000001 110.86 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.2 t -126.34 118.29 24.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.007 0.432 . . . . 1.98 110.946 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -157.63 154.28 28.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.118 -0.492 . . . . 0.44 111.578 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.538 HE21 ' H ' ' A' ' 80' ' ' SER . 0.0 OUTLIER -81.31 130.21 34.94 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.926 -0.768 . . . . 1.8 108.926 178.69 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.403 ' O ' HG23 ' A' ' 87' ' ' THR . 12.0 m -64.14 -6.5 2.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 112.851 0.686 . . . . 1.79 112.851 -178.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.538 ' H ' HE21 ' A' ' 78' ' ' GLN . 40.8 t -96.54 -14.0 22.58 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.503 0.557 . . . . 1.6100000000000001 112.503 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.495 HE21 ' HB2' ' A' ' 78' ' ' GLN . 50.6 mt-30 -97.43 5.76 49.24 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.839 0.681 . . . . 2.4199999999999999 112.839 -178.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 6.1 m -99.36 178.32 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.992 -0.283 . . . . 1.1799999999999999 111.744 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.476 HG13 ' HB2' ' A' ' 86' ' ' TRP . 26.8 pt -56.16 155.92 11.67 Favored Pre-proline 0 CA--C 1.531 0.225 0 CA-C-N 116.379 -0.373 . . . . 1.5900000000000001 111.646 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -45.75 -59.92 1.03 Allowed 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.191 2.594 . . . . 1.01 113.049 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.47 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -49.51 -49.08 33.81 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 120.701 -0.761 . . . . 0.35999999999999999 112.719 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . 0.476 ' HB2' HG13 ' A' ' 83' ' ' ILE . 0.6 OUTLIER -61.19 -46.5 90.21 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.325 0.491 . . . . 0.98999999999999999 112.325 -179.015 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.431 HG21 ' O ' ' A' ' 83' ' ' ILE . 71.6 p -54.92 -36.44 65.24 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 111.791 0.293 . . . . 1.8899999999999999 111.791 -179.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -70.46 -50.27 39.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.547 -0.297 . . . . 1.4299999999999999 111.654 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.473 ' HB1' HD21 ' A' ' 32' ' ' LEU . . . -63.5 -52.14 62.54 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.486 -0.324 . . . . 0.33000000000000002 111.852 -179.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -57.4 -30.02 64.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.16 -0.473 . . . . 1.1599999999999999 111.827 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -69.84 -17.81 63.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.444 -0.344 . . . . 2.23 111.391 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 89.5 mt -101.6 -7.52 22.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.293 -0.412 . . . . 2.0899999999999999 111.7 -179.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.432 ' O ' ' HD3' ' A' ' 44' ' ' LYS . 90.6 mtp -91.59 107.37 21.61 Favored Pre-proline 0 C--N 1.33 -0.26 0 N-CA-C 111.76 0.282 . . . . 2.2799999999999998 111.76 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.58 ' HA ' ' HD3' ' A' ' 44' ' ' LYS . 38.8 Cg_endo -69.44 142.71 50.1 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.032 1.822 . . . . 0.72999999999999998 110.799 178.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.474 ' HB3' ' HA ' ' A' ' 132' ' ' SER . . . -45.82 126.66 7.35 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.78 0.324 . . . . 1.21 111.511 -179.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 101.32 -2.75 54.27 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.636 -0.792 . . . . 0.34000000000000002 113.229 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.434 ' HG ' ' H ' ' A' ' 40' ' ' GLY . 74.9 m -76.35 -177.54 4.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.048 0.451 . . . . 1.8899999999999999 111.847 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.51 HG21 HD13 ' A' ' 37' ' ' ILE . 9.7 m -155.26 98.68 2.01 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.67 -0.696 . . . . 0.88 110.55 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.504 ' HE1' HG12 ' A' ' 36' ' ' VAL . 20.6 m0 -121.79 149.31 43.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.138 0.494 . . . . 0.67000000000000004 111.581 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -115.28 107.63 15.51 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.156 -1.053 . . . . 1.53 108.156 177.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.558 HG23 ' HB3' ' A' ' 34' ' ' TYR . 48.7 pt -110.14 145.94 16.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 113.339 0.866 . . . . 0.72999999999999998 113.339 -177.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -127.31 103.69 7.53 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.694 -1.139 . . . . 0.91000000000000003 108.099 178.138 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.452 HG21 HD22 ' A' ' 32' ' ' LEU . 2.4 t -104.7 98.88 16.11 Favored Pre-proline 0 CA--C 1.53 0.205 0 N-CA-C 113.448 0.907 . . . . 1.1399999999999999 113.448 -176.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.595 ' HD2' HD21 ' A' ' 107' ' ' LEU . 12.4 Cg_endo -58.6 151.92 59.29 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.0 1.8 . . . . 0.68000000000000005 110.507 177.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -47.73 -38.9 16.35 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.273 0.471 . . . . 2.3700000000000001 112.273 -178.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -57.29 -9.35 4.32 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.985 -0.626 . . . . 0.40000000000000002 113.288 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.595 HD21 ' HD2' ' A' ' 104' ' ' PRO . 6.5 mp -110.41 -13.85 14.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.668 0.27 . . . . 2.9300000000000002 111.52 -178.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.55 -0.296 . . . . 1.3799999999999999 111.061 -179.67 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo . . . . . 0 C--O 1.232 0.186 0 CA-C-O 120.748 0.228 . . . . 1.0900000000000001 111.976 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.588 HD13 HD12 ' A' ' 124' ' ' LEU . 26.0 mm -90.65 125.16 43.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.482 . . . . 1.8799999999999999 110.567 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -44.81 155.33 0.35 Allowed Glycine 0 C--N 1.334 0.435 0 CA-C-N 115.724 -0.671 . . . . 0.56000000000000005 113.554 -179.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -60.82 132.75 44.05 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.444 2.096 . . . . 0.84999999999999998 111.437 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.423 ' HB2' ' OD1' ' A' ' 8' ' ' ASN . 1.4 m-80 47.71 35.73 4.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.231 -0.44 . . . . 1.1200000000000001 109.925 -178.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.457 ' HG3' HG23 ' A' ' 60' ' ' ILE . 41.1 tt0 -114.7 128.84 56.53 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.051 -0.522 . . . . 1.8200000000000001 111.394 -179.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.485 ' O ' ' HB ' ' A' ' 60' ' ' ILE . 87.4 m -95.44 129.58 42.55 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.184 -0.673 . . . . 1.0900000000000001 109.184 178.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.588 HD12 HD13 ' A' ' 118' ' ' ILE . 0.1 OUTLIER -120.33 159.9 24.1 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.104 0.478 . . . . 2.1000000000000001 111.956 -178.266 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.437 HD11 ' NE ' ' A' ' 58' ' ' ARG . 4.5 mp -114.6 143.44 24.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.657 -0.701 . . . . 1.0600000000000001 109.977 178.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -133.17 132.3 41.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.953 0.406 . . . . 0.28999999999999998 111.541 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 10.3 tmtt? -111.36 103.56 11.94 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.558 -0.904 . . . . 2.77 108.558 178.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 20.8 mt -102.68 122.92 55.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.91 0.707 . . . . 1.5600000000000001 112.91 -177.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -118.7 99.75 6.98 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.891 -0.781 . . . . 0.29999999999999999 108.891 177.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.498 ' HA ' HG11 ' A' ' 53' ' ' VAL . 0.7 OUTLIER -78.48 124.84 28.58 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.157 -0.474 . . . . 2.0299999999999998 111.558 -178.615 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 43.6 mm -94.06 -57.07 4.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.753 -0.658 . . . . 1.8899999999999999 110.735 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.474 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 4.3 m -163.68 166.07 22.62 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.951 0.405 . . . . 1.75 111.491 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.449 HG13 ' HB3' ' A' ' 44' ' ' LYS . 7.3 p -107.63 124.33 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 115.945 -0.57 . . . . 2.1299999999999999 111.012 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.521 ' HG3' ' HB ' ' A' ' 50' ' ' THR . 0.7 OUTLIER 33.36 73.16 0.07 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.057 -0.52 . . . . 3.5600000000000001 111.792 -179.5 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 95.4 mttt 60.48 29.91 19.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.863 -0.608 . . . . 3.6699999999999999 111.57 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.409 ' HB2' ' HB3' ' A' ' 132' ' ' SER . 46.9 t 55.41 67.78 0.96 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.055 -0.521 . . . . 1.6000000000000001 111.083 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 66.2 m . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.345 -0.836 . . . . 2.7799999999999998 110.889 179.964 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 23.3 tptm . . . . . 0 N--CA 1.455 -0.216 0 CA-C-O 120.79 0.329 . . . . 3.1499999999999999 110.242 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -58.11 -52.0 67.36 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.092 -0.504 . . . . 1.27 109.977 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -64.85 -36.42 84.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.979 -0.555 . . . . 2.5699999999999998 110.008 178.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -55.88 -33.13 64.32 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.89 -0.781 . . . . 2.1400000000000001 108.89 178.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.482 ' HA ' ' HG2' ' A' ' 11' ' ' LYS . 53.2 m-20 -72.34 -38.24 68.65 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.165 -0.925 . . . . 1.3999999999999999 110.428 179.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.476 ' HZ2' ' HB3' ' A' ' 9' ' ' LYS . 4.2 ttpm? -57.27 -35.64 70.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.977 -0.556 . . . . 3.2400000000000002 111.212 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.9 t -76.35 -52.61 17.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 111.959 0.355 . . . . 1.9199999999999999 111.959 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.482 ' HG2' ' HA ' ' A' ' 8' ' ' ASN . 19.0 ptpt -58.59 -33.35 69.89 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.668 0.27 . . . . 2.1499999999999999 111.314 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.448 ' O ' ' HG ' ' A' ' 16' ' ' LEU . . . -76.39 -53.2 5.67 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.719 -0.753 . . . . 0.33000000000000002 112.329 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -61.08 -30.75 70.52 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.837 0.351 . . . . 2.3900000000000001 110.839 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.23 -32.09 55.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.319 -0.401 . . . . 0.92000000000000004 110.458 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -63.99 -54.53 32.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.938 -0.573 . . . . 0.27000000000000002 110.66 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.72 ' HA ' ' HB3' ' A' ' 19' ' ' ASN . 0.6 OUTLIER -65.59 -32.5 74.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.28 -0.418 . . . . 1.3100000000000001 111.152 -179.724 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.439 ' N ' HD11 ' A' ' 16' ' ' LEU . 8.3 m -57.2 -48.54 78.52 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.606 -0.516 . . . . 1.1599999999999999 109.606 179.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -74.16 -31.85 62.87 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.93 -0.577 . . . . 2.4700000000000002 110.065 178.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.72 ' HB3' ' HA ' ' A' ' 16' ' ' LEU . 0.3 OUTLIER -57.12 -28.38 62.65 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.305 -0.861 . . . . 0.22 112.133 -179.523 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -48.04 -18.58 0.2 Allowed 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 112.32 0.489 . . . . 2.8799999999999999 112.32 -179.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.678 ' N ' HD21 ' A' ' 21' ' ' ASN . 0.8 OUTLIER -67.67 -33.11 74.27 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.88 0.326 . . . . 0.40000000000000002 111.88 -178.713 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.467 ' HD2' ' OD1' ' A' ' 19' ' ' ASN . 68.1 mttm -54.04 119.48 19.74 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.716 -0.22 . . . . 1.9299999999999999 111.022 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -56.8 145.56 82.77 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.246 1.964 . . . . 1.0600000000000001 112.374 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.71 3.11 81.0 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.735 -0.745 . . . . 0.40999999999999998 113.921 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.0 t -58.65 109.48 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 117.517 0.659 . . . . 1.6000000000000001 110.637 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.5 p -130.35 128.56 64.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.908 -0.587 . . . . 1.6599999999999999 111.089 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.2 p -82.69 137.24 21.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.184 -0.462 . . . . 1.5600000000000001 110.866 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.511 HD13 ' HB2' ' A' ' 32' ' ' LEU . 61.2 mt -95.52 166.88 13.76 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.102 -0.499 . . . . 1.0800000000000001 110.713 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.417 ' HD2' ' HB3' ' A' ' 28' ' ' LEU . 53.2 Cg_exo -53.53 -30.93 56.61 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 121.889 1.726 . . . . 0.65000000000000002 111.53 178.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.436 ' HG ' ' HA3' ' A' ' 85' ' ' GLY . 28.0 t -85.43 -10.96 55.49 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.057 -0.519 . . . . 1.75 110.953 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.83 13.98 28.19 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 120.425 -0.893 . . . . 0.34999999999999998 114.645 178.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.511 ' HB2' HD13 ' A' ' 28' ' ' LEU . 5.8 mp -85.61 136.98 33.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 117.747 0.774 . . . . 2.0 112.951 -179.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -119.01 139.9 50.92 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.118 -0.946 . . . . 2.3199999999999998 108.49 177.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.579 ' HB3' HG23 ' A' ' 101' ' ' ILE . 41.0 p90 -155.04 176.39 12.6 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.794 0.664 . . . . 0.92000000000000004 112.794 -178.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.418 ' HE2' ' HB3' ' A' ' 22' ' ' LYS . 23.4 ttmt -120.78 117.36 27.24 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.974 -1.012 . . . . 2.6800000000000002 109.583 179.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 51.6 t -74.52 125.61 34.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 113.297 0.851 . . . . 0.77000000000000002 113.297 -177.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 54.9 mt -107.22 -66.82 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.288 -0.869 . . . . 1.46 109.92 178.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.411 ' C ' ' ND2' ' A' ' 38' ' ' ASN . 0.7 OUTLIER -134.77 85.14 2.16 Favored 'General case' 0 C--O 1.226 -0.143 0 CA-C-N 116.022 -0.536 . . . . 1.05 109.754 178.927 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.579 ' HB2' ' HE1' ' A' ' 99' ' ' TRP . 47.0 t -106.47 145.16 32.14 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.376 0.51 . . . . 2.02 112.376 -179.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.481 ' H ' ' HG ' ' A' ' 97' ' ' SER . . . 80.1 109.19 0.27 Allowed Glycine 0 C--N 1.333 0.366 0 CA-C-N 115.665 -0.698 . . . . 1.0900000000000001 113.936 178.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -177.75 -62.28 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 111.644 0.239 . . . . 1.7 111.644 178.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.2 168.98 34.28 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 120.63 -0.795 . . . . 0.40000000000000002 113.763 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.551 ' O ' ' HB3' ' A' ' 44' ' ' LYS . 7.9 p -90.72 176.88 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 123.208 0.603 . . . . 2.0299999999999998 109.959 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.551 ' HB3' ' O ' ' A' ' 43' ' ' VAL . 19.4 ptmt 164.94 156.2 0.07 OUTLIER Pre-proline 0 N--CA 1.469 0.519 0 CA-C-O 121.602 0.715 . . . . 2.7400000000000002 112.86 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.451 ' HD2' ' CB ' ' A' ' 49' ' ' ASP . 1.2 Cg_endo -85.18 173.48 7.81 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 125.169 3.913 . . . . 0.34000000000000002 113.097 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.508 ' O ' ' N ' ' A' ' 48' ' ' SER . . . -67.99 -172.18 6.46 Favored Glycine 0 C--O 1.225 -0.43 0 CA-C-N 115.393 -0.821 . . . . 0.38 111.383 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -41.41 -13.5 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 113.448 0.907 . . . . 2.9399999999999999 113.448 -178.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.508 ' N ' ' O ' ' A' ' 46' ' ' GLY . 84.5 p -85.84 7.28 24.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.094 0.473 . . . . 1.8999999999999999 110.282 178.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.52 ' HB2' HG22 ' A' ' 133' ' ' VAL . 3.2 p30 -76.64 140.88 41.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.459 -0.791 . . . . 1.73 111.857 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 62.8 m -113.45 119.4 37.47 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.615 -0.883 . . . . 0.92000000000000004 108.615 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.449 HG13 ' HB ' ' A' ' 133' ' ' VAL . 16.9 m -124.28 154.54 31.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 113.051 0.76 . . . . 1.22 113.051 -177.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 87.4 m -114.52 120.8 41.47 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.026 -0.988 . . . . 1.05 108.638 178.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.515 HG11 ' HA ' ' A' ' 130' ' ' LEU . 4.4 m -142.97 -179.71 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.296 0.57 . . . . 1.05 111.991 -178.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.513 ' HB3' ' HG2' ' A' ' 69' ' ' GLU . 28.3 mt-10 -129.55 132.79 46.92 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.114 -0.948 . . . . 2.3999999999999999 109.455 178.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -146.48 160.86 41.55 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.703 0.763 . . . . 0.93999999999999995 112.203 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 62.1 m -128.31 112.85 14.9 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.358 -1.292 . . . . 1.0600000000000001 108.428 178.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.412 ' O ' HG22 ' A' ' 64' ' ' VAL . . . -110.0 147.14 17.22 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.008 -1.091 . . . . 0.14000000000000001 113.021 -178.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.473 ' NE ' HD11 ' A' ' 125' ' ' ILE . 1.8 ppt_? -147.91 148.05 30.39 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.888 0.375 . . . . 2.6899999999999999 110.122 179.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.418 ' C ' ' H ' ' A' ' 61' ' ' ASP . 23.4 mt -77.55 162.18 27.31 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.981 -0.554 . . . . 1.77 110.102 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.509 ' HB ' ' O ' ' A' ' 123' ' ' THR . 6.9 tp -59.18 -10.75 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.365 0.603 . . . . 1.3700000000000001 109.458 178.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.418 ' H ' ' C ' ' A' ' 59' ' ' LEU . 9.4 m-20 -67.65 -12.61 60.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.312 -0.858 . . . . 2.0099999999999998 110.721 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.42 ' HA3' HH11 ' A' ' 58' ' ' ARG . . . 90.55 -0.94 78.19 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.594 -0.812 . . . . 0.45000000000000001 113.238 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 71.6 p -115.84 134.35 55.09 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 117.088 0.444 . . . . 1.99 111.458 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.412 HG22 ' O ' ' A' ' 57' ' ' GLY . 6.7 p -62.71 132.43 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-N 115.951 -0.568 . . . . 1.0700000000000001 110.044 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.577 ' HD1' ' H ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -97.65 -22.35 16.52 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.083 -0.508 . . . . 0.25 110.99 -179.95 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.577 ' H ' ' HD1' ' A' ' 65' ' ' PHE . 24.9 t70 -175.91 130.05 0.24 Allowed 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 116.323 -0.399 . . . . 0.29999999999999999 110.995 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.7 p -125.55 124.36 41.11 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.103 -0.499 . . . . 1.8100000000000001 110.544 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.544 HG22 ' HB3' ' A' ' 75' ' ' ALA . 69.8 p -83.26 -25.33 31.72 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 120.848 0.356 . . . . 0.93000000000000005 111.032 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.513 ' HG2' ' HB3' ' A' ' 54' ' ' GLU . 38.1 mt-10 -75.09 -39.32 60.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 2.1099999999999999 110.98 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -63.54 -44.86 92.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 3.79 110.639 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 54.7 m -58.25 -21.4 48.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.258 -0.428 . . . . 2.1200000000000001 110.556 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 90.46 7.5 67.08 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.808 -0.71 . . . . 0.80000000000000004 112.311 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -125.99 117.01 23.98 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.355 0.122 . . . . 3.52 110.937 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -55.47 157.19 15.51 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.314 2.01 . . . . 0.76000000000000001 112.107 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.544 ' HB3' HG22 ' A' ' 68' ' ' THR . . . -94.72 123.99 38.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.346 -0.388 . . . . 0.76000000000000001 110.622 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.6 t -125.89 118.48 25.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.786 0.327 . . . . 1.98 111.189 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -158.47 163.49 37.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.11 0.481 . . . . 0.44 111.865 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.469 ' NE2' ' O ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -83.04 137.8 33.98 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.524 -0.762 . . . . 1.8 109.03 178.608 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.416 ' O ' HG23 ' A' ' 87' ' ' THR . 21.6 m -69.26 -20.07 24.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 113.587 0.958 . . . . 1.79 113.587 -177.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.461 ' HB3' ' OE1' ' A' ' 78' ' ' GLN . 33.2 t -95.3 -2.56 49.1 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.955 0.354 . . . . 1.6100000000000001 111.955 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.42 ' NE2' ' HB3' ' A' ' 78' ' ' GLN . 23.4 mt-30 -96.17 5.58 50.74 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.895 0.331 . . . . 2.4199999999999999 111.895 -179.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.455 ' HB ' HD12 ' A' ' 83' ' ' ILE . 3.1 m -107.38 -175.66 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 111.662 0.245 . . . . 1.1799999999999999 111.662 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.628 ' H ' HD12 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -56.45 147.73 47.72 Favored Pre-proline 0 N--CA 1.463 0.191 0 CA-C-N 116.507 -0.315 . . . . 1.5900000000000001 111.711 -179.468 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo -42.25 -54.12 3.23 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.19 2.594 . . . . 1.01 113.365 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.484 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -51.87 -49.21 49.05 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.517 -0.849 . . . . 0.35999999999999999 112.7 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . 0.407 ' HB2' HG12 ' A' ' 83' ' ' ILE . 0.5 OUTLIER -60.9 -47.7 85.18 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.693 0.257 . . . . 0.98999999999999999 111.693 -179.348 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 79' ' ' VAL . 30.9 p -53.52 -33.73 55.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.766 0.317 . . . . 1.8899999999999999 111.598 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -70.61 -51.41 28.35 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.161 0.43 . . . . 1.4299999999999999 112.161 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.447 ' HB1' HD23 ' A' ' 32' ' ' LEU . . . -68.01 -48.49 65.57 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.483 0.549 . . . . 0.33000000000000002 112.483 -178.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -55.19 -30.99 61.04 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.021 0.378 . . . . 1.1599999999999999 112.021 -179.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -65.68 -21.15 66.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.595 -0.275 . . . . 2.23 111.574 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.439 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 10.6 mp -96.41 -22.13 17.34 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.382 0.512 . . . . 2.0899999999999999 112.382 -178.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.511 ' HE1' ' HB2' ' A' ' 99' ' ' TRP . 22.2 ttm -71.41 108.73 4.22 Favored Pre-proline 0 CA--C 1.532 0.278 0 N-CA-C 111.472 0.175 . . . . 2.2799999999999998 111.472 -179.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.442 ' HD2' ' OG ' ' A' ' 97' ' ' SER . 6.1 Cg_exo -75.67 144.89 28.64 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.751 2.301 . . . . 0.72999999999999998 111.889 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.469 ' HA ' ' HG ' ' A' ' 130' ' ' LEU . . . -48.31 127.57 13.06 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.472 -0.331 . . . . 1.21 111.437 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 94.39 2.57 63.63 Favored Glycine 0 CA--C 1.521 0.422 0 C-N-CA 120.701 -0.762 . . . . 0.34000000000000002 113.446 179.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.481 ' HG ' ' H ' ' A' ' 40' ' ' GLY . 69.6 m -89.92 -174.59 4.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.885 0.374 . . . . 1.8899999999999999 111.609 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.7 m -152.3 112.78 4.11 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.066 -0.515 . . . . 0.88 110.773 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.579 ' HE1' ' HB2' ' A' ' 39' ' ' SER . 14.8 m0 -132.25 149.77 52.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.052 0.453 . . . . 0.67000000000000004 111.759 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -123.73 108.54 12.64 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.367 -0.975 . . . . 1.53 108.367 177.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.579 HG23 ' HB3' ' A' ' 34' ' ' TYR . 24.7 pt -107.68 139.68 28.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 112.974 0.731 . . . . 0.72999999999999998 112.974 -177.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -120.34 103.99 9.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.951 -1.022 . . . . 0.91000000000000003 108.262 178.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.3 t -109.12 102.43 48.9 Favored Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 113.764 1.024 . . . . 1.1399999999999999 113.764 -176.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.573 ' HG2' HD21 ' A' ' 107' ' ' LEU . 12.3 Cg_endo -59.62 150.94 73.3 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 121.872 1.715 . . . . 0.68000000000000005 110.037 176.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -47.56 -31.74 4.72 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.512 0.56 . . . . 2.3700000000000001 112.512 -178.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -57.09 -13.47 9.14 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.877 -0.677 . . . . 0.40000000000000002 114.084 -178.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.573 HD21 ' HG2' ' A' ' 104' ' ' PRO . 3.0 mm? -114.57 -5.55 12.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 117.193 0.496 . . . . 2.9300000000000002 111.763 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.412 0 CA-C-N 116.513 -0.312 . . . . 1.3799999999999999 110.385 179.658 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.911 0.296 . . . . 1.0900000000000001 111.679 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.5 HG21 HD11 ' A' ' 124' ' ' LEU . 5.1 mp -91.55 120.06 39.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.77 -0.65 . . . . 1.8799999999999999 110.082 179.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -46.13 157.6 0.4 Allowed Glycine 0 C--N 1.333 0.416 0 CA-C-N 116.083 -0.508 . . . . 0.56000000000000005 113.308 -179.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.428 ' O ' ' HG3' ' A' ' 122' ' ' GLU . 26.5 Cg_endo -62.07 131.33 34.22 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.486 2.124 . . . . 0.84999999999999998 111.826 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 47.22 34.57 3.13 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.03 -0.532 . . . . 1.1200000000000001 110.371 -178.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.428 ' HG3' ' O ' ' A' ' 120' ' ' PRO . 37.0 mt-10 -115.64 122.92 47.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.34 -0.391 . . . . 1.8200000000000001 111.528 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.509 ' O ' ' HB ' ' A' ' 60' ' ' ILE . 91.2 m -89.17 127.9 35.76 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.782 -0.822 . . . . 1.0900000000000001 108.782 178.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.5 HD11 HG21 ' A' ' 118' ' ' ILE . 6.3 mp -114.42 155.82 25.63 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.217 0.532 . . . . 2.1000000000000001 112.268 -177.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.473 HD11 ' NE ' ' A' ' 58' ' ' ARG . 4.6 mp -113.9 132.88 61.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.306 -0.861 . . . . 1.0600000000000001 109.716 178.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -125.39 131.82 52.88 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.975 0.417 . . . . 0.28999999999999998 111.423 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -110.0 102.94 11.64 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.482 -0.933 . . . . 2.77 108.482 178.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.429 HD11 ' N ' ' A' ' 128' ' ' ILE . 5.0 mp -105.71 118.65 53.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 112.429 0.529 . . . . 1.5600000000000001 112.429 -177.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -109.18 99.32 8.62 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.282 -1.007 . . . . 0.29999999999999999 108.282 177.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.515 ' HA ' HG11 ' A' ' 53' ' ' VAL . 26.2 tp -79.3 114.9 18.61 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.86 -0.609 . . . . 2.0299999999999998 111.511 -178.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 67.8 mt -84.18 -56.73 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 CA-C-N 115.884 -0.598 . . . . 1.8899999999999999 110.288 179.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.458 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 11.3 p -164.27 165.15 22.14 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.246 -0.433 . . . . 1.75 111.409 179.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.52 HG22 ' HB2' ' A' ' 49' ' ' ASP . 7.2 p -117.04 122.24 69.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.902 -0.59 . . . . 2.1299999999999999 111.064 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.414 ' C ' ' O ' ' A' ' 133' ' ' VAL . 11.3 mttm 32.99 79.19 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.233 -0.44 . . . . 3.5600000000000001 111.344 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 15.6 pttm 51.86 30.7 7.38 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.783 -0.644 . . . . 3.6699999999999999 111.629 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 33.8 t 50.61 44.52 27.38 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.587 -0.733 . . . . 1.6000000000000001 111.096 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 42.3 t . . . . . 0 C--O 1.248 0.979 0 CA-C-O 118.24 -0.886 . . . . 2.7799999999999998 111.04 -179.734 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 59.9 mmtt . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.843 0.354 . . . . 3.1499999999999999 110.598 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -58.39 -48.67 79.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.975 -0.557 . . . . 1.27 110.7 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -75.14 -31.9 61.19 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.275 -0.42 . . . . 2.5699999999999998 110.916 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -56.78 -41.74 78.21 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.683 -0.488 . . . . 2.1400000000000001 109.683 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.494 ' HA ' ' HG2' ' A' ' 11' ' ' LYS . 23.7 p30 -78.97 -29.2 43.77 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.734 -0.666 . . . . 1.3999999999999999 111.415 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 121' ' ' ASN . 66.7 tttm -56.16 -44.12 78.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.005 0.431 . . . . 3.2400000000000002 110.741 179.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.4 HG21 ' N ' ' A' ' 11' ' ' LYS . 5.4 m -78.1 -44.97 27.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.915 -0.584 . . . . 1.9199999999999999 112.446 -179.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.494 ' HG2' ' HA ' ' A' ' 8' ' ' ASN . 17.9 ptmt -59.16 -33.57 71.07 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.703 0.287 . . . . 2.1499999999999999 111.429 -179.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.407 ' O ' ' HG ' ' A' ' 16' ' ' LEU . . . -76.34 -53.01 5.78 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.833 -0.699 . . . . 0.33000000000000002 112.202 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.525 ' HA ' HD13 ' A' ' 16' ' ' LEU . 47.8 mt-10 -59.21 -25.38 63.93 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.931 0.396 . . . . 2.3900000000000001 110.591 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.15 -37.61 45.55 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.061 -0.518 . . . . 0.92000000000000004 110.584 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -61.78 -51.91 66.37 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.165 -0.471 . . . . 0.27000000000000002 110.828 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.675 ' HA ' ' HB3' ' A' ' 19' ' ' ASN . 0.6 OUTLIER -67.84 -32.66 73.35 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.717 -0.393 . . . . 1.3100000000000001 111.143 -179.72 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.455 ' N ' HD11 ' A' ' 16' ' ' LEU . 6.2 m -57.65 -46.09 84.66 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.494 -0.558 . . . . 1.1599999999999999 109.494 178.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -74.27 -31.96 62.73 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.753 -0.658 . . . . 2.4700000000000002 109.856 178.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.675 ' HB3' ' HA ' ' A' ' 16' ' ' LEU . 0.6 OUTLIER -60.15 -26.36 66.23 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.436 -0.802 . . . . 0.22 112.532 -179.384 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -48.91 -19.46 0.39 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.764 0.316 . . . . 2.8799999999999999 111.689 -179.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.714 ' N ' HD21 ' A' ' 21' ' ' ASN . 0.7 OUTLIER -69.12 -34.71 75.48 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.135 0.42 . . . . 0.40000000000000002 112.135 -179.229 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.489 ' HG2' ' O ' ' A' ' 19' ' ' ASN . 18.7 mmtp -46.02 127.87 7.19 Favored Pre-proline 0 N--CA 1.465 0.298 0 CA-C-O 120.661 0.267 . . . . 1.9299999999999999 111.266 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -57.89 137.12 79.38 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.336 2.024 . . . . 1.0600000000000001 112.192 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.94 0.83 83.03 Favored Glycine 0 CA--C 1.52 0.374 0 C-N-CA 120.771 -0.728 . . . . 0.40999999999999998 113.955 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.432 HG21 ' O ' ' A' ' 22' ' ' LYS . 24.1 t -56.21 103.98 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.125 0 CA-C-N 117.541 0.67 . . . . 1.6000000000000001 110.17 179.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.6 p -126.49 135.68 63.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.611 -0.722 . . . . 1.6599999999999999 111.138 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 7.6 p -87.05 141.77 13.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.261 -0.427 . . . . 1.5600000000000001 111.157 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.443 HD11 ' HB2' ' A' ' 32' ' ' LEU . 55.5 mt -101.29 166.06 13.02 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.099 -0.5 . . . . 1.0800000000000001 110.804 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -53.79 -30.58 57.74 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 121.914 1.743 . . . . 0.65000000000000002 111.455 178.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.43 ' O ' HD11 ' A' ' 107' ' ' LEU . 38.8 t -83.85 -12.85 54.95 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.862 -0.608 . . . . 1.75 110.871 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.43 14.18 26.44 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 120.485 -0.864 . . . . 0.34999999999999998 114.291 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.463 HD23 ' HB1' ' A' ' 89' ' ' ALA . 6.6 mp -85.89 137.51 32.7 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 113.64 0.978 . . . . 2.0 113.64 -178.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.5 mp0 -118.4 142.7 47.28 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.985 -1.117 . . . . 2.3199999999999998 107.985 177.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.564 ' HB3' HG23 ' A' ' 101' ' ' ILE . 34.8 p90 -158.79 175.69 13.28 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.278 0.844 . . . . 0.92000000000000004 113.278 -178.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -121.58 117.46 26.8 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 114.901 -1.045 . . . . 2.6800000000000002 109.606 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.6 t -81.92 126.77 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 113.216 0.821 . . . . 0.77000000000000002 113.216 -178.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.437 HD11 HG21 ' A' ' 98' ' ' THR . 81.4 mt -101.73 -64.14 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 115.658 -0.701 . . . . 1.46 110.761 178.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -141.35 86.08 2.0 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.826 0.346 . . . . 1.05 110.931 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.656 ' HB2' ' HE1' ' A' ' 99' ' ' TRP . 39.5 t -106.82 146.06 31.38 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.315 -0.402 . . . . 2.02 112.047 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 93.41 85.19 1.59 Allowed Glycine 0 C--N 1.334 0.422 0 C-N-CA 121.05 -0.595 . . . . 1.0900000000000001 113.224 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -153.28 -71.75 0.14 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.693 0.282 . . . . 1.7 111.612 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.26 166.67 32.24 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 121.052 -0.594 . . . . 0.40000000000000002 114.376 -178.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.465 ' O ' ' HB3' ' A' ' 44' ' ' LYS . 2.6 t -90.45 176.18 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 123.516 0.726 . . . . 2.0299999999999998 109.905 179.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.465 ' HB3' ' O ' ' A' ' 43' ' ' VAL . 2.2 pptp? 165.72 156.06 0.09 OUTLIER Pre-proline 0 N--CA 1.47 0.552 0 CA-C-O 121.464 0.65 . . . . 2.7400000000000002 111.952 -179.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.488 ' HD2' ' HB2' ' A' ' 49' ' ' ASP . 3.1 Cg_exo -76.56 172.47 16.16 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 124.602 3.535 . . . . 0.34000000000000002 113.624 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.493 ' O ' ' N ' ' A' ' 48' ' ' SER . . . -67.76 -173.12 6.76 Favored Glycine 0 C--O 1.223 -0.568 0 CA-C-N 115.17 -0.923 . . . . 0.38 110.944 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.461 ' HG2' ' HB2' ' A' ' 91' ' ' GLN . 53.7 mtmt -42.14 -14.05 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.56 0.948 . . . . 2.9399999999999999 113.56 -177.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.493 ' N ' ' O ' ' A' ' 46' ' ' GLY . 45.1 t -86.52 7.69 25.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.137 0.494 . . . . 1.8999999999999999 110.256 178.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.488 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 3.0 p30 -76.18 162.96 27.54 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.515 -0.766 . . . . 1.73 111.368 -179.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 60.0 m -123.85 122.93 39.3 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.598 -0.89 . . . . 0.92000000000000004 108.598 178.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.426 HG11 HG21 ' A' ' 133' ' ' VAL . 2.3 m -122.85 141.08 44.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.285 0.564 . . . . 1.22 112.491 -177.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 66.3 m -113.07 120.08 40.1 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.228 -1.027 . . . . 1.05 108.228 177.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.521 HG11 ' HA ' ' A' ' 130' ' ' LEU . 4.8 m -144.97 177.56 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.231 0.538 . . . . 1.05 111.686 -178.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -125.22 131.86 53.08 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.642 -0.873 . . . . 2.3999999999999999 108.642 178.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -143.78 158.2 43.85 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.701 0.762 . . . . 0.93999999999999995 112.381 -179.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 59.4 m -122.71 112.44 17.94 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.312 -1.313 . . . . 1.0600000000000001 108.577 178.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -109.82 145.77 16.98 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 119.953 -1.118 . . . . 0.14000000000000001 112.7 -178.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.476 ' NE ' HD11 ' A' ' 125' ' ' ILE . 4.9 ppt_? -148.09 146.97 29.04 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.048 0.452 . . . . 2.6899999999999999 110.431 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.468 ' C ' ' H ' ' A' ' 61' ' ' ASP . 46.3 tp -76.1 160.36 29.84 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.759 -0.655 . . . . 1.77 109.809 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.518 ' HB ' ' O ' ' A' ' 123' ' ' THR . 9.5 tp -56.34 -10.68 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.251 0.548 . . . . 1.3700000000000001 109.879 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.468 ' H ' ' C ' ' A' ' 59' ' ' LEU . 20.4 t70 -66.02 -12.4 54.88 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.454 -0.794 . . . . 2.0099999999999998 110.861 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.82 -0.77 77.14 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.577 -0.821 . . . . 0.45000000000000001 113.315 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.4 t -118.65 142.33 47.75 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.053 0.454 . . . . 1.99 111.214 -179.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.0 p -65.96 133.71 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 115.827 -0.624 . . . . 1.0700000000000001 110.17 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.59 ' HD1' ' N ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -97.43 -22.79 16.39 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.988 -0.551 . . . . 0.25 110.497 179.719 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.59 ' N ' ' HD1' ' A' ' 65' ' ' PHE . 25.4 t70 -176.95 131.7 0.18 Allowed 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.922 -0.581 . . . . 0.29999999999999999 110.532 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 63.3 p -129.52 123.53 31.67 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.449 -0.342 . . . . 1.8100000000000001 110.966 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.51 HG23 ' HB3' ' A' ' 75' ' ' ALA . 59.7 p -78.65 -14.35 59.35 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.898 0.38 . . . . 0.93000000000000005 110.905 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -75.38 -51.83 12.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.048 -0.524 . . . . 2.1099999999999999 110.604 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.9 ttpm? -61.04 -36.8 80.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.044 -0.525 . . . . 3.79 110.911 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 41.2 m -57.91 -20.03 34.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.206 -0.452 . . . . 2.1200000000000001 110.744 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.29 4.88 90.03 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.831 -0.699 . . . . 0.80000000000000004 112.013 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -126.18 117.38 23.6 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.457 0.17 . . . . 3.52 110.931 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -52.99 156.66 9.34 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.395 2.063 . . . . 0.76000000000000001 112.046 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.51 ' HB3' HG23 ' A' ' 68' ' ' THR . . . -94.21 124.62 38.34 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.42 -0.355 . . . . 0.76000000000000001 110.601 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.1 t -127.79 118.09 23.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.162 0.506 . . . . 1.98 111.428 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -158.36 167.12 30.58 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.674 -0.694 . . . . 0.44 110.896 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.594 ' NE2' ' HB3' ' A' ' 80' ' ' SER . 5.7 tt0 -85.5 146.0 27.14 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.3 -0.63 . . . . 1.8 109.3 178.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 32.9 m -68.44 -26.51 33.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 113.032 0.753 . . . . 1.79 113.032 -178.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.594 ' HB3' ' NE2' ' A' ' 78' ' ' GLN . 33.4 t -95.53 -3.77 45.98 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 111.937 0.347 . . . . 1.6100000000000001 111.937 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 -84.87 5.65 27.96 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.733 0.272 . . . . 2.4199999999999999 111.733 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 1.7 m -112.06 -172.55 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.6 -0.273 . . . . 1.1799999999999999 111.553 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.504 HG13 ' HB2' ' A' ' 86' ' ' TRP . 29.2 pt -55.99 154.4 14.68 Favored Pre-proline 0 CA--C 1.528 0.13 0 CA-C-N 116.472 -0.331 . . . . 1.5900000000000001 111.629 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -48.01 -53.67 6.33 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.651 2.234 . . . . 1.01 112.91 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -52.93 -49.69 53.9 Favored Glycine 0 CA--C 1.521 0.458 0 C-N-CA 120.802 -0.713 . . . . 0.35999999999999999 113.112 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . 0.504 ' HB2' HG13 ' A' ' 83' ' ' ILE . 0.4 OUTLIER -59.49 -45.57 91.31 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.842 0.312 . . . . 0.98999999999999999 111.842 -179.069 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 98.4 m -55.66 -37.49 68.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.442 -0.345 . . . . 1.8899999999999999 111.689 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.64 -49.98 64.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.491 -0.322 . . . . 1.4299999999999999 111.745 -179.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.463 ' HB1' HD23 ' A' ' 32' ' ' LEU . . . -64.39 -49.24 72.36 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.009 0.374 . . . . 0.33000000000000002 112.009 -179.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -57.24 -26.72 61.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.423 -0.353 . . . . 1.1599999999999999 111.72 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.664 HE21 ' HA ' ' A' ' 91' ' ' GLN . 0.0 OUTLIER -66.43 -24.55 66.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.836 0.35 . . . . 2.23 110.976 -179.89 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.404 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 4.2 mm? -93.59 -7.51 43.85 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.168 -0.469 . . . . 2.0899999999999999 111.134 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 69.3 mtp -88.32 108.44 22.15 Favored Pre-proline 0 CA--C 1.531 0.222 0 CA-C-N 116.47 -0.332 . . . . 2.2799999999999998 111.891 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' A' ' 92' ' ' LEU . 99.0 Cg_endo -79.91 147.07 18.84 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.403 2.068 . . . . 0.72999999999999998 110.582 178.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.45 ' HB3' ' HA ' ' A' ' 132' ' ' SER . . . -45.58 126.59 6.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.779 0.323 . . . . 1.21 111.65 -179.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 97.66 -7.8 63.53 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 120.549 -0.834 . . . . 0.34000000000000002 113.281 178.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 33.5 t -69.82 174.83 4.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.876 0.37 . . . . 1.8899999999999999 111.264 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.437 HG21 HD11 ' A' ' 37' ' ' ILE . 24.5 m -147.31 90.82 1.91 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.987 -0.552 . . . . 0.88 110.471 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.656 ' HE1' ' HB2' ' A' ' 39' ' ' SER . 23.5 m0 -112.11 149.41 32.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.266 0.555 . . . . 0.67000000000000004 112.189 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -119.59 107.78 13.69 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.311 -0.996 . . . . 1.53 108.311 177.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.564 HG23 ' HB3' ' A' ' 34' ' ' TYR . 48.7 pt -111.07 146.27 16.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 113.221 0.822 . . . . 0.72999999999999998 113.221 -177.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -130.98 103.76 6.73 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.657 -1.156 . . . . 0.91000000000000003 108.145 178.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 4.7 t -105.39 99.75 22.33 Favored Pre-proline 0 C--N 1.33 -0.265 0 N-CA-C 113.709 1.003 . . . . 1.1399999999999999 113.709 -176.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.583 ' HG2' HD21 ' A' ' 107' ' ' LEU . 11.6 Cg_endo -58.73 151.15 65.78 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 121.701 1.601 . . . . 0.68000000000000005 109.814 176.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -47.49 -31.87 4.67 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.544 0.572 . . . . 2.3700000000000001 112.544 -178.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -56.97 -13.9 9.38 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.667 -0.778 . . . . 0.40000000000000002 113.949 -178.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.583 HD21 ' HG2' ' A' ' 104' ' ' PRO . 2.8 mm? -115.19 -5.87 12.42 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 117.09 0.445 . . . . 2.9300000000000002 111.788 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.421 0 CA-C-N 116.551 -0.295 . . . . 1.3799999999999999 110.621 179.954 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo . . . . . 0 C--O 1.231 0.155 0 CA-C-O 120.913 0.297 . . . . 1.0900000000000001 111.92 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.43 HG12 HD12 ' A' ' 124' ' ' LEU . 97.9 mt -91.07 124.65 43.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.993 -0.549 . . . . 1.8799999999999999 110.273 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -45.55 155.21 0.5 Allowed Glycine 0 CA--C 1.522 0.481 0 CA-C-N 115.981 -0.554 . . . . 0.56000000000000005 113.469 -179.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -62.11 131.02 32.73 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.282 1.988 . . . . 0.84999999999999998 111.466 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.458 ' O ' ' HA ' ' A' ' 9' ' ' LYS . 1.8 m-80 47.92 35.32 4.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.073 0.463 . . . . 1.1200000000000001 110.097 -178.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.432 ' HB3' HD13 ' A' ' 59' ' ' LEU . 11.3 mt-10 -115.6 135.39 54.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.044 -0.526 . . . . 1.8200000000000001 110.904 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.518 ' O ' ' HB ' ' A' ' 60' ' ' ILE . 92.6 m -95.7 129.36 42.94 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.568 -0.53 . . . . 1.0900000000000001 109.568 179.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.435 ' HG ' ' HA ' ' A' ' 59' ' ' LEU . 0.2 OUTLIER -117.45 150.48 38.84 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.168 0.509 . . . . 2.1000000000000001 111.53 -178.593 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.476 HD11 ' NE ' ' A' ' 58' ' ' ARG . 4.1 mp -113.48 140.56 33.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.567 -0.742 . . . . 1.0600000000000001 110.08 179.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -131.82 132.09 43.42 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.09 -0.505 . . . . 0.28999999999999998 111.179 -179.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -109.71 103.8 12.68 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.171 -0.677 . . . . 2.77 109.171 178.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 15.6 mt -102.81 122.58 55.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 112.634 0.605 . . . . 1.5600000000000001 112.634 -177.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -118.26 100.09 7.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.243 -0.889 . . . . 0.29999999999999999 108.74 178.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.521 ' HA ' HG11 ' A' ' 53' ' ' VAL . 0.8 OUTLIER -78.93 124.38 28.19 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.14 -0.482 . . . . 2.0299999999999998 111.92 -178.047 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 35.3 mm -94.25 -50.52 11.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.642 -0.708 . . . . 1.8899999999999999 110.09 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.45 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 51.9 p -164.5 165.12 21.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.922 -0.581 . . . . 1.75 110.244 179.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.493 HG22 HD23 ' A' ' 130' ' ' LEU . 96.8 t -130.72 117.86 40.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.803 0.335 . . . . 2.1299999999999999 111.302 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 5.5 tmtp? 51.03 62.39 2.74 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.933 -0.576 . . . . 3.5600000000000001 110.711 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 68.9 mttm 59.05 43.65 17.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.811 -0.631 . . . . 3.6699999999999999 110.35 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 86.8 p 50.55 31.88 6.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.431 -0.804 . . . . 1.6000000000000001 111.037 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 45.1 t . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.216 -0.897 . . . . 2.7799999999999998 110.847 -179.873 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 62.7 tttp . . . . . 0 N--CA 1.455 -0.185 0 N-CA-C 109.622 -0.51 . . . . 3.1499999999999999 109.622 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.472 ' HA ' ' ND2' ' A' ' 8' ' ' ASN . . . -57.65 -52.28 66.06 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.757 -0.656 . . . . 1.27 110.115 179.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -64.41 -36.15 83.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.784 -0.644 . . . . 2.5699999999999998 109.484 178.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.492 ' HG2' ' HZ3' ' A' ' 11' ' ' LYS . 31.4 tt0 -55.68 -33.46 64.15 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.8 -0.815 . . . . 2.1400000000000001 108.8 178.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.479 ' HA ' ' HG2' ' A' ' 11' ' ' LYS . 19.3 m-20 -69.1 -39.44 78.97 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 115.572 -0.74 . . . . 1.3999999999999999 109.961 179.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -56.7 -32.4 65.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.709 -0.678 . . . . 3.2400000000000002 111.037 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.8 t -78.03 -52.87 15.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.374 -0.375 . . . . 1.9199999999999999 111.895 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.492 ' HZ3' ' HG2' ' A' ' 7' ' ' GLU . 10.2 ptpp? -63.18 -26.06 68.63 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.895 0.379 . . . . 2.1499999999999999 110.59 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.405 ' O ' ' HG ' ' A' ' 16' ' ' LEU . . . -75.76 -50.33 8.06 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.841 -0.695 . . . . 0.33000000000000002 111.667 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.405 ' HA ' HD12 ' A' ' 16' ' ' LEU . 12.8 pt-20 -66.41 -27.56 67.94 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.873 0.368 . . . . 2.3900000000000001 110.188 179.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.02 -34.19 61.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.096 -0.502 . . . . 0.92000000000000004 110.491 179.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -63.75 -55.81 20.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.753 -0.658 . . . . 0.27000000000000002 110.573 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.676 ' HA ' ' HB3' ' A' ' 19' ' ' ASN . 0.4 OUTLIER -64.16 -31.79 73.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.228 -0.442 . . . . 1.3100000000000001 111.04 179.968 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.5 m -56.56 -47.65 79.01 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.607 -0.516 . . . . 1.1599999999999999 109.607 179.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -73.61 -32.19 63.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.825 -0.625 . . . . 2.4700000000000002 109.865 178.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.676 ' HB3' ' HA ' ' A' ' 16' ' ' LEU . 0.7 OUTLIER -59.09 -25.58 63.92 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.635 -0.711 . . . . 0.22 111.573 179.869 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -46.89 -20.21 0.13 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.536 -0.302 . . . . 2.8799999999999999 111.605 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.709 ' N ' HD21 ' A' ' 21' ' ' ASN . 0.7 OUTLIER -68.67 -37.12 79.37 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.436 -0.347 . . . . 0.40000000000000002 110.991 -179.482 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -50.53 118.83 10.2 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.067 -0.515 . . . . 1.9299999999999999 110.251 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -57.06 147.06 77.48 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.33 2.02 . . . . 1.0600000000000001 112.649 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.02 3.46 79.58 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.869 -0.681 . . . . 0.40999999999999998 113.967 179.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 38.1 t -55.09 106.43 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 117.563 0.681 . . . . 1.6000000000000001 110.681 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.6 p -130.76 126.73 60.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.868 -0.605 . . . . 1.6599999999999999 111.133 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.8 p -80.16 142.47 13.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.05 -0.523 . . . . 1.5600000000000001 110.77 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.559 HD13 ' HB2' ' A' ' 32' ' ' LEU . 63.0 mt -101.73 167.85 9.95 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.476 -0.329 . . . . 1.0800000000000001 110.673 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.436 ' HD2' ' HB3' ' A' ' 28' ' ' LEU . 71.4 Cg_exo -51.49 -31.95 41.3 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 121.923 1.748 . . . . 0.65000000000000002 111.742 178.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.463 ' O ' HD21 ' A' ' 107' ' ' LEU . 30.3 t -86.44 -11.21 52.49 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.231 -0.44 . . . . 1.75 110.87 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.04 14.91 23.43 Favored Glycine 0 C--N 1.335 0.474 0 C-N-CA 120.563 -0.827 . . . . 0.34999999999999998 114.298 178.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.559 ' HB2' HD13 ' A' ' 28' ' ' LEU . 6.8 mp -84.33 134.65 34.49 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.364 0.876 . . . . 2.0 113.364 -178.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.6 mp0 -114.28 142.54 46.17 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.082 -1.081 . . . . 2.3199999999999998 108.082 177.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.411 ' CB ' HG21 ' A' ' 101' ' ' ILE . 27.8 p90 -158.97 175.18 13.87 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 113.173 0.805 . . . . 0.92000000000000004 113.173 -178.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -122.48 117.3 25.61 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 114.768 -1.105 . . . . 2.6800000000000002 109.536 179.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 66.6 t -77.3 126.25 37.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 113.424 0.898 . . . . 0.77000000000000002 113.424 -178.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 78.0 mt -101.3 -65.99 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 115.408 -0.815 . . . . 1.46 109.872 178.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -129.84 95.54 3.99 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 116.394 -0.366 . . . . 1.05 110.094 178.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.65 ' HB3' ' HE1' ' A' ' 99' ' ' TRP . 68.2 p -105.15 145.88 29.97 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.262 0.467 . . . . 2.02 112.262 -178.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.92 103.18 0.07 OUTLIER Glycine 0 C--N 1.332 0.36 0 CA-C-N 115.686 -0.688 . . . . 1.0900000000000001 113.168 179.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 54.6 m-80 -152.52 -82.56 0.09 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.691 0.282 . . . . 1.7 111.15 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.13 174.2 38.49 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 121.191 -0.528 . . . . 0.40000000000000002 113.743 -179.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.611 ' O ' ' HB3' ' A' ' 44' ' ' LYS . 33.8 m -82.42 176.4 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 C-N-CA 123.401 0.68 . . . . 2.0299999999999998 110.409 179.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.611 ' HB3' ' O ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER 165.1 156.54 0.08 OUTLIER Pre-proline 0 N--CA 1.471 0.591 0 CA-C-O 121.47 0.653 . . . . 2.7400000000000002 112.33 -179.236 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.517 ' HD2' ' HB2' ' A' ' 49' ' ' ASP . 1.8 Cg_endo -85.36 173.47 7.63 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 125.082 3.854 . . . . 0.34000000000000002 113.367 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' A' ' 48' ' ' SER . . . -68.28 -172.34 6.94 Favored Glycine 0 C--O 1.223 -0.572 0 CA-C-N 115.216 -0.902 . . . . 0.38 111.451 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -41.64 -13.48 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.763 1.023 . . . . 2.9399999999999999 113.763 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 46' ' ' GLY . 50.5 m -86.16 7.51 24.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.46 0.647 . . . . 1.8999999999999999 109.851 178.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.517 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 1.8 t70 -74.84 162.15 28.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.887 -1.051 . . . . 1.73 112.326 -179.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 90.3 m -125.56 133.85 52.16 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 108.752 -0.833 . . . . 0.92000000000000004 108.752 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.519 HG13 HG23 ' A' ' 133' ' ' VAL . 30.1 m -131.74 140.37 48.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 112.807 0.669 . . . . 1.22 112.807 -178.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 89.4 m -112.98 119.86 39.39 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.083 -1.08 . . . . 1.05 108.083 177.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.516 HG11 ' HA ' ' A' ' 130' ' ' LEU . 5.0 m -146.4 -179.17 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.229 0.538 . . . . 1.05 111.943 -178.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -130.04 132.13 46.09 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.37 -0.832 . . . . 2.3999999999999999 108.977 178.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -147.18 167.11 25.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.757 0.789 . . . . 0.93999999999999995 112.412 -178.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 58.3 m -131.19 113.99 14.55 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.384 -1.28 . . . . 1.0600000000000001 108.728 178.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.4 ' O ' HG21 ' A' ' 64' ' ' VAL . . . -109.53 147.53 17.03 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 119.989 -1.1 . . . . 0.14000000000000001 112.452 -178.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.34 145.93 31.4 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.046 0.451 . . . . 2.6899999999999999 110.429 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.406 ' HA ' ' HG ' ' A' ' 124' ' ' LEU . 6.9 mt -79.9 153.39 29.04 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.688 -0.687 . . . . 1.77 110.255 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.485 ' HB ' ' O ' ' A' ' 123' ' ' THR . 0.4 OUTLIER -55.64 -14.35 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.401 0.619 . . . . 1.3700000000000001 109.411 178.936 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -65.11 -10.87 34.07 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.266 -0.879 . . . . 2.0099999999999998 110.93 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.02 0.03 75.14 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.547 -0.835 . . . . 0.45000000000000001 113.837 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.0 t -121.64 131.53 54.15 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 117.646 0.723 . . . . 1.99 111.865 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.4 HG21 ' O ' ' A' ' 57' ' ' GLY . 3.9 p -61.68 134.35 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-N 115.709 -0.678 . . . . 1.0700000000000001 110.049 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.688 ' HD1' ' H ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -97.66 -27.36 14.4 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.097 -0.501 . . . . 0.25 111.565 -179.882 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.688 ' H ' ' HD1' ' A' ' 65' ' ' PHE . 13.9 t70 -176.83 129.96 0.18 Allowed 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 120.619 0.247 . . . . 0.29999999999999999 110.54 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 57.6 p -129.18 117.46 20.8 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.455 -0.339 . . . . 1.8100000000000001 110.736 179.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.624 HG22 ' HB2' ' A' ' 75' ' ' ALA . 65.3 p -74.83 -12.35 60.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.065 0.459 . . . . 0.93000000000000005 110.449 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -75.73 -46.91 28.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.632 -0.713 . . . . 2.1099999999999999 111.25 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -71.18 -36.46 71.97 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.028 -0.533 . . . . 3.79 111.751 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 54.5 p -59.61 -12.62 7.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.788 0.327 . . . . 2.1200000000000001 111.296 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 75.01 8.47 83.06 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.795 -0.717 . . . . 0.80000000000000004 112.415 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -122.97 117.75 28.4 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.572 0.225 . . . . 3.52 110.875 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.09 153.18 16.54 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.667 2.245 . . . . 0.76000000000000001 112.6 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.624 ' HB2' HG22 ' A' ' 68' ' ' THR . . . -96.58 124.74 40.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.022 -0.535 . . . . 0.76000000000000001 110.448 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.8 t -130.44 118.19 20.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.089 0.471 . . . . 1.98 111.297 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -158.54 161.82 37.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.022 -0.535 . . . . 0.44 111.108 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.455 HE21 ' H ' ' A' ' 80' ' ' SER . 0.0 OUTLIER -81.66 146.5 30.01 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.12 -0.491 . . . . 1.8 109.965 179.143 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 87' ' ' THR . 20.0 m -66.54 -30.88 51.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 112.771 0.656 . . . . 1.79 112.771 -178.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.455 ' H ' HE21 ' A' ' 78' ' ' GLN . 46.8 t -95.76 -6.39 39.82 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 112.438 0.533 . . . . 1.6100000000000001 112.438 -178.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -84.92 5.66 28.13 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 111.89 0.33 . . . . 2.4199999999999999 111.89 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.7 m -110.41 -173.37 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 111.749 0.277 . . . . 1.1799999999999999 111.749 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 45.4 pt -56.03 156.43 10.25 Favored Pre-proline 0 CA--C 1.53 0.2 0 CA-C-N 116.428 -0.351 . . . . 1.5900000000000001 111.631 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -46.07 -59.56 1.16 Allowed 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.858 2.372 . . . . 1.01 113.262 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.436 ' O ' HD12 ' A' ' 32' ' ' LEU . . . -50.9 -49.46 41.87 Favored Glycine 0 CA--C 1.521 0.454 0 C-N-CA 120.858 -0.686 . . . . 0.35999999999999999 113.114 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -61.72 -38.51 88.17 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.915 0.339 . . . . 0.98999999999999999 111.915 -178.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 79' ' ' VAL . 50.6 m -61.02 -35.55 77.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.721 0.296 . . . . 1.8899999999999999 111.35 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -70.38 -42.64 71.46 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.279 -0.418 . . . . 1.4299999999999999 111.798 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.441 ' HB1' HD23 ' A' ' 32' ' ' LEU . . . -75.51 -51.99 11.68 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.429 0.529 . . . . 0.33000000000000002 112.429 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -54.93 -39.35 68.76 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.432 0.53 . . . . 1.1599999999999999 112.432 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -67.23 -9.59 41.95 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.667 0.27 . . . . 2.23 111.443 -179.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 83.2 mt -103.42 -7.88 20.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.433 -0.349 . . . . 2.0899999999999999 111.019 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.587 ' HE3' HD11 ' A' ' 128' ' ' ILE . 68.0 mtt -85.95 110.07 27.61 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.315 -0.402 . . . . 2.2799999999999998 111.641 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.522 ' HG2' ' HB3' ' A' ' 97' ' ' SER . 74.3 Cg_endo -74.67 147.28 35.22 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.35 2.033 . . . . 0.72999999999999998 111.477 179.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.474 ' HB3' ' HA ' ' A' ' 132' ' ' SER . . . -50.02 126.72 15.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.505 -0.316 . . . . 1.21 111.594 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 94.97 -8.84 70.43 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 120.717 -0.754 . . . . 0.34000000000000002 113.148 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.522 ' HB3' ' HG2' ' A' ' 94' ' ' PRO . 98.4 p -70.57 -176.52 1.29 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.926 0.393 . . . . 1.8899999999999999 111.417 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 24.3 m -159.03 97.44 1.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.762 -0.654 . . . . 0.88 110.605 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.65 ' HE1' ' HB3' ' A' ' 39' ' ' SER . 34.9 m0 -115.11 149.06 38.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.233 0.54 . . . . 0.67000000000000004 111.717 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.402 ' O ' ' HB2' ' A' ' 34' ' ' TYR . 27.0 tt0 -115.16 107.23 15.04 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.827 -1.175 . . . . 1.53 107.827 177.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.411 HG21 ' CB ' ' A' ' 34' ' ' TYR . 13.8 pt -114.58 140.57 34.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 113.602 0.964 . . . . 0.72999999999999998 113.602 -177.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -120.58 104.33 9.86 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.959 -1.126 . . . . 0.91000000000000003 107.959 177.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.549 HG12 HD11 ' A' ' 107' ' ' LEU . 52.9 t -93.35 98.23 2.37 Favored Pre-proline 0 C--N 1.329 -0.284 0 N-CA-C 113.563 0.949 . . . . 1.1399999999999999 113.563 -177.101 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.437 ' HG2' ' HG ' ' A' ' 107' ' ' LEU . 6.9 Cg_endo -53.08 150.94 22.69 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.267 1.978 . . . . 0.68000000000000005 111.407 177.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.5 p -48.02 -43.36 29.94 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.293 0.479 . . . . 2.3700000000000001 112.293 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -57.32 -9.14 4.14 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 115.384 0.914 . . . . 0.40000000000000002 115.384 -177.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.549 HD11 HG12 ' A' ' 103' ' ' VAL . 46.3 mt -91.64 -19.27 22.86 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 118.244 1.022 . . . . 2.9300000000000002 112.937 -178.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.31 0 C-N-CA 120.761 -0.376 . . . . 1.3799999999999999 111.769 -179.473 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_exo . . . . . 0 N--CA 1.465 -0.173 0 N-CA-C 111.093 -0.387 . . . . 1.0900000000000001 111.093 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.577 HG22 HD11 ' A' ' 124' ' ' LEU . 94.8 mt -92.37 134.03 31.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.5 -0.773 . . . . 1.8799999999999999 109.944 178.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -48.55 146.69 5.53 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.526 -0.845 . . . . 0.56000000000000005 112.244 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -54.78 130.54 40.98 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.265 1.976 . . . . 0.84999999999999998 111.861 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 42.75 35.16 0.66 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.033 -0.531 . . . . 1.1200000000000001 110.65 -179.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -116.54 142.86 46.33 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.826 -0.625 . . . . 1.8200000000000001 111.074 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.491 HG22 HD21 ' A' ' 16' ' ' LEU . 92.7 m -95.66 129.53 42.83 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.548 -0.538 . . . . 1.0900000000000001 109.548 178.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.577 HD11 HG22 ' A' ' 118' ' ' ILE . 0.1 OUTLIER -113.93 154.55 27.37 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.358 0.599 . . . . 2.1000000000000001 112.279 -177.992 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.5 mp -113.92 140.75 32.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.174 -0.921 . . . . 1.0600000000000001 109.585 178.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.4 ' CE1' HD23 ' A' ' 124' ' ' LEU . 82.2 m-85 -135.47 131.97 36.78 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.024 0.44 . . . . 0.28999999999999998 111.445 -179.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.547 ' HB3' ' HZ3' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -114.4 102.8 10.44 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.189 -1.041 . . . . 2.77 108.189 177.87 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.587 HD11 ' HE3' ' A' ' 93' ' ' MET . 12.2 mt -103.73 130.58 53.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 112.684 0.624 . . . . 1.5600000000000001 112.684 -177.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -117.88 101.01 7.95 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.129 -0.941 . . . . 0.29999999999999999 108.919 178.221 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.516 ' HA ' HG11 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -78.5 123.29 26.9 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.119 0.485 . . . . 2.0299999999999998 111.814 -178.274 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 58.6 mt -93.39 -53.13 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 115.518 -0.765 . . . . 1.8899999999999999 110.92 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.474 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 60.7 p -164.53 165.57 21.12 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.055 0.455 . . . . 1.75 111.259 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.519 HG23 HG13 ' A' ' 51' ' ' VAL . 2.1 t -111.84 126.09 69.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.642 -0.708 . . . . 2.1299999999999999 110.772 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 18.2 tttt 44.52 57.38 4.47 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.93 -0.577 . . . . 3.5600000000000001 110.917 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm 60.85 34.5 19.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.572 -0.74 . . . . 3.6699999999999999 111.336 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.421 ' HB2' ' HB2' ' A' ' 132' ' ' SER . 39.0 t 55.42 64.27 1.82 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.852 -0.613 . . . . 1.6000000000000001 111.205 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 53.6 m . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.3 -0.857 . . . . 2.7799999999999998 110.821 179.762 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 28.9 tptp . . . . . 0 CA--C 1.521 -0.146 0 N-CA-C 109.89 -0.411 . . . . 3.1499999999999999 109.89 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -58.97 -52.43 65.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.875 -0.602 . . . . 1.27 110.127 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -63.96 -35.23 80.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.725 -0.671 . . . . 2.5699999999999998 110.218 179.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -55.92 -32.58 63.9 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.334 -0.617 . . . . 2.1400000000000001 109.334 178.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 13.7 m-20 -74.07 -37.46 64.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.445 -0.798 . . . . 1.3999999999999999 110.826 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 52.6 tptt -63.9 -38.51 91.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 3.2400000000000002 111.64 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.1 m -71.58 -48.44 52.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 C-N-CA 121.189 -0.204 . . . . 1.9199999999999999 111.514 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.426 ' HG3' HG23 ' A' ' 60' ' ' ILE . 18.1 ptpt -68.81 -25.71 64.82 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.835 0.35 . . . . 2.1499999999999999 110.486 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.62 -53.26 8.63 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 121.066 -0.588 . . . . 0.33000000000000002 112.143 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.41 ' HA ' HD13 ' A' ' 16' ' ' LEU . 43.8 tt0 -62.13 -27.89 69.25 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.096 0.474 . . . . 2.3900000000000001 110.313 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.13 -30.63 49.43 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.951 -0.568 . . . . 0.92000000000000004 110.423 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -65.94 -52.73 47.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.752 -0.658 . . . . 0.27000000000000002 110.612 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.644 ' HA ' ' HB3' ' A' ' 19' ' ' ASN . 0.4 OUTLIER -67.62 -32.06 72.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.268 -0.424 . . . . 1.3100000000000001 111.078 179.91 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.2 m -56.67 -47.58 79.5 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 109.748 -0.464 . . . . 1.1599999999999999 109.748 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -73.05 -32.52 65.1 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.859 -0.61 . . . . 2.4700000000000002 109.812 178.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.644 ' HB3' ' HA ' ' A' ' 16' ' ' LEU . 0.6 OUTLIER -59.46 -25.01 64.03 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.439 -0.8 . . . . 0.22 111.582 179.829 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -49.97 -20.35 0.91 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.518 -0.31 . . . . 2.8799999999999999 111.722 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.733 ' N ' HD21 ' A' ' 21' ' ' ASN . 0.7 OUTLIER -68.96 -33.13 73.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.378 -0.374 . . . . 0.40000000000000002 111.53 -178.98 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.447 ' O ' HG21 ' A' ' 25' ' ' VAL . 12.6 mptt -48.35 118.69 6.97 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 116.188 -0.46 . . . . 1.9299999999999999 110.906 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.441 ' O ' ' HG2' ' A' ' 35' ' ' LYS . 32.1 Cg_exo -57.52 139.18 89.38 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.316 2.011 . . . . 1.0600000000000001 112.651 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.83 3.39 80.27 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 120.863 -0.684 . . . . 0.40999999999999998 114.025 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.578 HG23 ' HH ' ' A' ' 102' ' ' TYR . 4.0 t -53.52 117.67 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.175 0 CA-C-N 117.425 0.613 . . . . 1.6000000000000001 110.826 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 33' ' ' GLN . 4.3 p -129.87 128.16 64.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.064 -0.516 . . . . 1.6599999999999999 111.061 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.3 p -85.69 141.97 13.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.459 . . . . 1.5600000000000001 111.078 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.514 HD13 ' HB2' ' A' ' 32' ' ' LEU . 41.5 mt -104.1 165.34 13.57 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.011 -0.541 . . . . 1.0800000000000001 110.609 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.431 ' HD2' ' HB3' ' A' ' 28' ' ' LEU . 72.2 Cg_exo -50.48 -38.34 53.64 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.179 1.919 . . . . 0.65000000000000002 112.26 179.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.527 ' HB3' HD22 ' A' ' 107' ' ' LEU . 7.3 m -80.76 -9.59 59.79 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.2 -0.454 . . . . 1.75 111.368 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.3 14.52 27.99 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.331 -0.938 . . . . 0.34999999999999998 113.48 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.514 ' HB2' HD13 ' A' ' 28' ' ' LEU . 0.4 OUTLIER -83.11 134.86 34.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.45 0.643 . . . . 2.0 112.168 -179.28 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.411 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 47.4 mt-30 -123.34 143.0 50.38 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.984 -1.007 . . . . 2.3199999999999998 108.636 178.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.492 ' HB3' HG23 ' A' ' 101' ' ' ILE . 48.3 p90 -157.83 175.39 13.93 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.809 0.67 . . . . 0.92000000000000004 112.809 -178.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.441 ' HG2' ' O ' ' A' ' 23' ' ' PRO . 3.5 tmmm? -122.2 118.94 29.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.001 -0.999 . . . . 2.6800000000000002 109.321 178.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.619 HG12 ' HE1' ' A' ' 99' ' ' TRP . 48.5 t -71.93 125.61 30.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 113.279 0.844 . . . . 0.77000000000000002 113.279 -177.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.3 mp -98.81 -66.24 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.319 -0.855 . . . . 1.46 110.11 178.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.487 ' ND2' HD22 ' A' ' 41' ' ' ASN . 7.3 t30 -144.89 90.51 2.06 Favored 'General case' 0 CA--C 1.527 0.062 0 CA-C-N 116.471 -0.332 . . . . 1.05 110.166 179.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.601 ' HB3' ' HE1' ' A' ' 99' ' ' TRP . 94.9 p -105.32 145.98 30.0 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.932 0.396 . . . . 2.02 112.006 -178.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 91.59 94.4 1.33 Allowed Glycine 0 C--N 1.332 0.352 0 CA-C-N 115.854 -0.612 . . . . 1.0900000000000001 112.764 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.487 HD22 ' ND2' ' A' ' 38' ' ' ASN . 35.4 m-80 -150.93 -81.89 0.1 Allowed 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 111.776 0.287 . . . . 1.7 111.776 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.09 178.53 42.01 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 121.088 -0.577 . . . . 0.40000000000000002 114.161 -178.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.611 ' O ' ' HB3' ' A' ' 44' ' ' LYS . 27.3 m -90.32 176.89 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 123.729 0.812 . . . . 2.0299999999999998 110.33 179.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.611 ' HB3' ' O ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER 165.08 156.6 0.08 OUTLIER Pre-proline 0 N--CA 1.472 0.668 0 CA-C-O 121.486 0.66 . . . . 2.7400000000000002 112.172 -179.61 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 44' ' ' LYS . 2.8 Cg_exo -77.72 173.52 14.0 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 124.752 3.634 . . . . 0.34000000000000002 112.955 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.492 ' O ' ' N ' ' A' ' 48' ' ' SER . . . -67.54 -172.84 6.28 Favored Glycine 0 N--CA 1.448 -0.5 0 CA-C-N 115.368 -0.833 . . . . 0.38 111.037 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.421 ' HE3' ' NE2' ' A' ' 91' ' ' GLN . 9.2 ptpp? -41.88 -13.88 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.707 1.003 . . . . 2.9399999999999999 113.707 -177.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 46' ' ' GLY . 84.5 p -86.54 7.37 26.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.065 0.459 . . . . 1.8999999999999999 110.522 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -72.08 156.14 39.52 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.71 -0.677 . . . . 1.73 111.993 -179.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 26.0 m -126.67 119.72 27.69 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 108.481 -0.933 . . . . 0.92000000000000004 108.481 178.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.518 HG23 HD23 ' A' ' 130' ' ' LEU . 14.3 m -128.67 158.4 41.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.222 0.534 . . . . 1.22 112.326 -178.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 94.2 m -113.78 120.8 42.05 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.337 -0.847 . . . . 1.05 109.115 178.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.626 HG13 HD21 ' A' ' 130' ' ' LEU . 6.1 m -139.4 170.11 16.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.137 0.494 . . . . 1.05 111.6 -178.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -124.05 132.31 53.66 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.375 -0.83 . . . . 2.3999999999999999 109.128 178.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 14.7 p90 -144.05 164.6 30.17 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.683 0.754 . . . . 0.93999999999999995 112.491 -178.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.543 HG21 ' HG ' ' A' ' 67' ' ' SER . 37.9 m -123.56 113.39 18.64 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.426 -1.261 . . . . 1.0600000000000001 108.565 178.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -110.02 143.81 16.79 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 119.684 -1.246 . . . . 0.14000000000000001 112.677 -178.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.457 ' NH2' ' HA3' ' A' ' 62' ' ' GLY . 0.5 OUTLIER -147.62 147.0 29.57 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.004 0.431 . . . . 2.6899999999999999 110.589 179.552 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.434 ' HA ' ' HG ' ' A' ' 124' ' ' LEU . 3.8 mt -78.83 158.03 28.24 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.858 -0.61 . . . . 1.77 110.254 179.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.455 ' HB ' ' O ' ' A' ' 123' ' ' THR . 0.4 OUTLIER -58.16 -14.21 3.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 108.957 -0.757 . . . . 1.3700000000000001 108.957 178.64 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -63.64 -12.48 34.05 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.14 -0.936 . . . . 2.0099999999999998 110.837 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.457 ' HA3' ' NH2' ' A' ' 58' ' ' ARG . . . 91.15 -0.31 75.31 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 120.634 -0.793 . . . . 0.45000000000000001 113.673 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.3 t -119.85 132.46 55.58 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 117.374 0.587 . . . . 1.99 111.507 -178.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.2 p -61.18 134.7 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 115.807 -0.633 . . . . 1.0700000000000001 109.906 179.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.647 ' HD1' ' H ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -97.5 -26.54 14.79 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.241 -0.436 . . . . 0.25 111.266 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.647 ' H ' ' HD1' ' A' ' 65' ' ' PHE . 16.3 t70 -176.33 129.98 0.21 Allowed 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 120.809 0.338 . . . . 0.29999999999999999 111.085 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.543 ' HG ' HG21 ' A' ' 56' ' ' THR . 62.4 m -123.79 123.89 41.48 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.235 -0.439 . . . . 1.8100000000000001 110.452 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.611 HG22 ' HB3' ' A' ' 75' ' ' ALA . 33.7 p -70.56 -8.41 51.2 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.94 0.4 . . . . 0.93000000000000005 110.652 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -75.39 -46.85 30.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.861 -0.609 . . . . 2.1099999999999999 110.794 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -61.94 -38.7 89.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.981 -0.554 . . . . 3.79 111.304 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 14.2 m -60.73 -13.54 15.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.143 0.496 . . . . 2.1200000000000001 110.182 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 73.8 3.54 63.92 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.69 -0.687 . . . . 0.80000000000000004 112.351 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -127.21 124.68 23.85 Favored Pre-proline 0 C--N 1.33 -0.262 0 C-N-CA 121.325 -0.15 . . . . 3.52 111.071 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -53.75 162.68 3.45 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.284 1.989 . . . . 0.76000000000000001 111.517 179.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.611 ' HB3' HG22 ' A' ' 68' ' ' THR . . . -93.94 124.31 37.86 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.446 -0.343 . . . . 0.76000000000000001 110.812 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 27.5 m -123.87 116.22 22.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.751 0.31 . . . . 1.98 111.079 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -158.72 159.46 35.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 0.44 111.34 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.541 HE21 ' H ' ' A' ' 80' ' ' SER . 0.0 OUTLIER -81.48 143.74 31.85 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 108.983 -0.747 . . . . 1.8 108.983 178.317 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.8 m -70.83 -14.4 17.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 113.008 0.744 . . . . 1.79 113.008 -178.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.543 ' HA ' ' HG1' ' A' ' 87' ' ' THR . 66.0 m -95.49 -19.18 20.05 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.197 0.443 . . . . 1.6100000000000001 112.197 -179.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.408 ' HG2' ' HB3' ' A' ' 78' ' ' GLN . 78.2 mm-40 -79.62 6.26 11.06 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.412 0.523 . . . . 2.4199999999999999 112.412 -179.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.4 m -111.25 -175.7 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 112.685 0.624 . . . . 1.1799999999999999 112.685 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.432 ' HB ' ' HD2' ' A' ' 84' ' ' PRO . 42.4 pt -56.12 160.45 4.75 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 115.836 -0.62 . . . . 1.5900000000000001 112.595 -179.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.454 ' O ' HG23 ' A' ' 87' ' ' THR . 78.1 Cg_exo -47.86 -60.75 0.76 Allowed 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 123.102 2.535 . . . . 1.01 114.204 -178.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.554 ' H ' ' CD1' ' A' ' 107' ' ' LEU . . . -53.17 -48.3 59.28 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.759 -0.734 . . . . 0.35999999999999999 113.386 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -54.81 -47.95 73.38 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.798 0.666 . . . . 0.98999999999999999 112.798 -178.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.543 ' HG1' ' HA ' ' A' ' 80' ' ' SER . 11.6 t -62.68 -33.87 75.97 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.713 -0.395 . . . . 1.8899999999999999 111.779 -179.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.465 ' O ' ' HG2' ' A' ' 91' ' ' GLN . 18.3 mm-40 -70.79 -40.85 72.3 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.924 0.342 . . . . 1.4299999999999999 111.924 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.439 ' HB1' HD11 ' A' ' 32' ' ' LEU . . . -75.84 -49.45 17.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.871 0.367 . . . . 0.33000000000000002 111.585 -179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.45 HD11 ' SD ' ' A' ' 93' ' ' MET . 3.5 mm? -55.87 -41.33 74.24 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.888 -0.596 . . . . 1.1599999999999999 112.06 -179.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.465 ' HG2' ' O ' ' A' ' 88' ' ' GLU . 3.2 pt20 -65.41 -3.76 4.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.635 -0.257 . . . . 2.23 111.636 -179.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 94.7 mt -104.97 -29.61 10.35 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.713 0.264 . . . . 2.0899999999999999 111.713 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.45 ' SD ' HD11 ' A' ' 90' ' ' LEU . 24.0 ptp -81.91 111.05 23.5 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-O 120.615 0.245 . . . . 2.2799999999999998 111.537 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.87 147.18 61.59 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.227 1.952 . . . . 0.72999999999999998 111.45 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.496 ' HB3' ' HA ' ' A' ' 132' ' ' SER . . . -46.35 127.15 8.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.469 -0.332 . . . . 1.21 111.115 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 103.56 -7.61 50.6 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.896 -0.669 . . . . 0.34000000000000002 112.717 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 66.4 m -79.94 -175.47 4.96 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.845 0.355 . . . . 1.8899999999999999 111.39 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 14.1 m -156.75 104.09 2.12 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.032 -0.531 . . . . 0.88 111.083 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.619 ' HE1' HG12 ' A' ' 36' ' ' VAL . 30.5 m0 -125.15 149.23 48.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.252 -0.431 . . . . 0.67000000000000004 111.058 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 100' ' ' GLU . 12.6 pt-20 -119.05 108.52 14.82 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.556 -0.905 . . . . 1.53 108.556 177.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.492 HG23 ' HB3' ' A' ' 34' ' ' TYR . 37.3 pt -108.17 139.67 29.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 112.963 0.727 . . . . 0.72999999999999998 112.963 -177.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.578 ' HH ' HG23 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -113.95 103.91 11.63 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.783 -1.192 . . . . 0.91000000000000003 107.783 177.886 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.408 ' HA ' ' HD2' ' A' ' 104' ' ' PRO . 40.7 t -94.57 102.04 7.98 Favored Pre-proline 0 C--N 1.329 -0.296 0 N-CA-C 113.78 1.03 . . . . 1.1399999999999999 113.78 -176.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.433 ' HA ' HG21 ' A' ' 123' ' ' THR . 9.3 Cg_endo -56.07 149.89 50.75 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.192 1.928 . . . . 0.68000000000000005 111.085 177.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.4 p -49.11 -43.26 41.23 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.247 0.462 . . . . 2.3700000000000001 112.247 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -56.24 -8.42 2.45 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 115.19 0.836 . . . . 0.40000000000000002 115.19 -177.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.554 ' CD1' ' H ' ' A' ' 85' ' ' GLY . 1.1 tm? -82.25 -31.75 30.02 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 117.863 0.831 . . . . 2.9300000000000002 112.748 -178.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.42 ' HB1' ' HB ' ' A' ' 83' ' ' ILE . . . . . . . . 0 C--N 1.326 -0.451 0 C-N-CA 120.375 -0.53 . . . . 1.3799999999999999 112.382 -178.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo . . . . . 0 C--O 1.231 0.17 0 CA-C-O 120.876 0.282 . . . . 1.0900000000000001 112.019 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.528 HG21 HD11 ' A' ' 124' ' ' LEU . 92.6 mt -91.45 135.66 26.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.069 -0.514 . . . . 1.8799999999999999 110.322 179.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -46.97 148.3 2.88 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.748 -0.739 . . . . 0.56000000000000005 112.087 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -56.05 130.03 38.09 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.119 1.88 . . . . 0.84999999999999998 111.986 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 41.49 35.45 0.45 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.792 -0.64 . . . . 1.1200000000000001 110.878 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -116.89 145.86 43.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.881 -0.6 . . . . 1.8200000000000001 111.258 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.455 ' O ' ' HB ' ' A' ' 60' ' ' ILE . 90.6 m -95.2 134.04 38.39 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.646 -0.501 . . . . 1.0900000000000001 109.646 179.004 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.528 HD11 HG21 ' A' ' 118' ' ' ILE . 0.1 OUTLIER -120.55 156.54 31.36 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.342 0.592 . . . . 2.1000000000000001 112.46 -178.249 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.405 HD11 ' N ' ' A' ' 125' ' ' ILE . 4.4 mp -113.85 148.17 16.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.128 -0.942 . . . . 1.0600000000000001 109.467 178.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -139.96 132.28 28.34 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.166 0.508 . . . . 0.28999999999999998 111.761 -179.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.2 tmtp? -110.91 104.04 12.6 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.575 -0.898 . . . . 2.77 108.575 178.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.479 HD13 ' N ' ' A' ' 128' ' ' ILE . 4.1 mp -102.12 127.19 55.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.377 0.608 . . . . 1.5600000000000001 112.582 -177.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -118.38 99.97 7.18 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.036 -0.984 . . . . 0.29999999999999999 108.492 177.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.626 HD21 HG13 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -77.94 120.95 23.52 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.122 -0.49 . . . . 2.0299999999999998 111.135 -178.39 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 49.7 mm -94.9 -56.22 5.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.852 -0.613 . . . . 1.8899999999999999 110.946 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.496 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 89.8 p -163.4 164.66 24.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.003 0.43 . . . . 1.75 111.351 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.473 ' HA ' HG11 ' A' ' 51' ' ' VAL . 7.1 p -107.93 127.24 64.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.904 -0.589 . . . . 2.1299999999999999 111.054 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 12.8 tttp 45.34 -149.22 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.255 -0.43 . . . . 3.5600000000000001 110.785 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -64.65 -5.4 5.6 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.226 -0.443 . . . . 3.6699999999999999 110.979 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 32.9 t 65.42 82.6 0.18 Allowed 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.935 -0.575 . . . . 1.6000000000000001 110.953 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 81.6 p . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.17 -0.919 . . . . 2.7799999999999998 111.387 179.885 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp . . . . . 0 N--CA 1.455 -0.213 0 CA-C-O 120.791 0.329 . . . . 3.1499999999999999 110.464 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -56.58 -51.94 66.7 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 116.145 -0.479 . . . . 1.27 110.386 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -67.59 -33.37 74.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.837 -0.62 . . . . 2.5699999999999998 110.226 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.423 ' O ' ' HG2' ' A' ' 11' ' ' LYS . 41.3 tt0 -55.58 -33.53 64.0 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 109.096 -0.705 . . . . 2.1400000000000001 109.096 178.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.466 ' HA ' ' HE2' ' A' ' 11' ' ' LYS . 10.1 m-20 -75.54 -38.42 59.31 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.371 -0.831 . . . . 1.3999999999999999 110.286 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -56.24 -38.82 71.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.75 -0.659 . . . . 3.2400000000000002 111.605 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.403 HG22 ' N ' ' A' ' 11' ' ' LYS . 18.6 m -78.33 -49.81 20.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 112.639 0.607 . . . . 1.9199999999999999 112.639 -178.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.466 ' HE2' ' HA ' ' A' ' 8' ' ' ASN . 61.1 pttt -66.94 -26.25 66.75 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 120.861 -0.336 . . . . 2.1499999999999999 111.445 -179.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.413 ' O ' ' HG ' ' A' ' 16' ' ' LEU . . . -76.41 -53.43 5.56 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.734 -0.746 . . . . 0.33000000000000002 112.313 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.418 ' HA ' HD13 ' A' ' 16' ' ' LEU . 20.4 tp10 -61.86 -28.21 69.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.096 0.474 . . . . 2.3900000000000001 110.604 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.3 -36.46 46.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.839 -0.619 . . . . 0.92000000000000004 110.747 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -59.82 -53.71 54.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.076 -0.511 . . . . 0.27000000000000002 110.617 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.666 ' HA ' ' HB3' ' A' ' 19' ' ' ASN . 0.4 OUTLIER -66.59 -33.77 76.4 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.737 -0.385 . . . . 1.3100000000000001 111.101 -179.784 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.1 m -57.43 -45.96 84.08 Favored 'General case' 0 N--CA 1.456 -0.125 0 N-CA-C 109.622 -0.51 . . . . 1.1599999999999999 109.622 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -74.35 -32.38 62.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.91 -0.586 . . . . 2.4700000000000002 109.9 178.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.666 ' HB3' ' HA ' ' A' ' 16' ' ' LEU . 0.4 OUTLIER -57.58 -26.46 61.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.514 -0.767 . . . . 0.22 111.497 -179.822 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -49.19 -19.2 0.43 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.169 -0.469 . . . . 2.8799999999999999 111.824 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.711 ' N ' HD21 ' A' ' 21' ' ' ASN . 0.8 OUTLIER -68.46 -31.87 71.47 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.192 0.441 . . . . 0.40000000000000002 112.192 -178.482 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' A' ' 19' ' ' ASN . 27.2 mmtm -52.97 119.21 15.66 Favored Pre-proline 0 CA--C 1.531 0.237 0 C-N-CA 121.322 -0.151 . . . . 1.9299999999999999 110.619 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -57.86 143.64 95.34 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.189 1.926 . . . . 1.0600000000000001 112.278 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.75 2.94 81.08 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.858 -0.687 . . . . 0.40999999999999998 113.705 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.421 HG21 ' O ' ' A' ' 22' ' ' LYS . 5.9 t -59.73 120.86 6.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 117.167 0.483 . . . . 1.6000000000000001 110.481 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.3 p -130.17 133.32 64.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 1.6599999999999999 111.204 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.5 p -92.37 137.04 23.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.145 -0.479 . . . . 1.5600000000000001 110.745 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.466 ' HB2' ' HB2' ' A' ' 32' ' ' LEU . 35.1 mt -100.94 162.94 19.05 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 1.0800000000000001 110.751 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -53.26 -30.72 52.82 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.176 1.917 . . . . 0.65000000000000002 112.309 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.445 ' HB2' ' HG3' ' A' ' 88' ' ' GLU . 30.9 t -84.32 -10.08 57.91 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.175 -0.466 . . . . 1.75 111.551 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.27 15.49 25.48 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.367 -0.92 . . . . 0.34999999999999998 112.595 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.508 HD22 ' HA3' ' A' ' 85' ' ' GLY . 2.6 mm? -80.86 133.54 35.6 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.222 0.535 . . . . 2.0 112.05 -178.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -126.07 138.27 53.69 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.329 -0.85 . . . . 2.3199999999999998 109.175 178.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.46 ' HB3' HG23 ' A' ' 101' ' ' ILE . 38.6 p90 -160.84 174.81 13.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.269 0.557 . . . . 0.92000000000000004 112.361 -178.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -121.71 117.51 26.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.198 -0.91 . . . . 2.6800000000000002 109.3 178.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 86.9 t -72.56 125.53 31.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 113.081 0.771 . . . . 0.77000000000000002 113.081 -178.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 64.6 mt -102.3 -64.2 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.387 -0.824 . . . . 1.46 110.125 178.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.493 ' ND2' HD22 ' A' ' 41' ' ' ASN . 9.7 t30 -139.46 89.49 2.34 Favored 'General case' 0 CA--C 1.528 0.099 0 CA-C-N 116.37 -0.377 . . . . 1.05 110.192 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.755 ' HB2' ' HE1' ' A' ' 99' ' ' TRP . 31.9 t -105.37 146.2 29.75 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 112.334 0.494 . . . . 2.02 112.334 -178.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 87.31 95.65 0.9 Allowed Glycine 0 C--N 1.332 0.341 0 CA-C-N 115.684 -0.689 . . . . 1.0900000000000001 112.936 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.493 HD22 ' ND2' ' A' ' 38' ' ' ASN . 43.3 m-80 -150.72 -83.65 0.09 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 111.675 0.25 . . . . 1.7 111.675 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.51 178.01 41.05 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 121.061 -0.59 . . . . 0.40000000000000002 114.285 -178.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.578 ' O ' ' HB3' ' A' ' 44' ' ' LYS . 9.3 p -90.68 178.38 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 123.666 0.786 . . . . 2.0299999999999998 109.688 178.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.578 ' HB3' ' O ' ' A' ' 43' ' ' VAL . 12.6 pttm 165.95 157.66 0.1 OUTLIER Pre-proline 0 N--CA 1.47 0.55 0 CA-C-O 121.482 0.658 . . . . 2.7400000000000002 112.628 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.611 ' HD2' ' HB2' ' A' ' 49' ' ' ASP . 1.3 Cg_endo -85.03 173.79 7.75 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 125.061 3.841 . . . . 0.34000000000000002 113.767 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.462 ' O ' ' N ' ' A' ' 48' ' ' SER . . . -68.05 -171.66 6.22 Favored Glycine 0 C--O 1.221 -0.714 0 CA-C-N 114.984 -1.007 . . . . 0.38 111.741 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.574 ' HG3' HE21 ' A' ' 91' ' ' GLN . 54.8 mtpt -41.22 -15.74 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.875 1.065 . . . . 2.9399999999999999 113.875 -177.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.462 ' N ' ' O ' ' A' ' 46' ' ' GLY . 51.0 m -85.89 7.83 22.58 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.522 0.677 . . . . 1.8999999999999999 109.677 178.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.611 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 0.0 OUTLIER -69.33 151.03 46.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.796 -1.093 . . . . 1.73 112.329 -179.073 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 48.4 m -126.86 119.74 27.52 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.71 -0.677 . . . . 0.92000000000000004 109.257 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.578 HG13 ' HA ' ' A' ' 133' ' ' VAL . 34.9 m -133.24 154.98 40.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.26 0.553 . . . . 1.22 112.24 -178.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 90.3 m -111.12 121.24 44.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.339 -0.846 . . . . 1.05 109.148 178.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.472 HG11 ' HA ' ' A' ' 130' ' ' LEU . 4.2 m -141.28 -179.62 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.06 0.457 . . . . 1.05 111.833 -178.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -135.11 133.06 38.84 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.635 -0.712 . . . . 2.3999999999999999 109.384 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -143.63 158.38 43.71 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.731 0.777 . . . . 0.93999999999999995 112.124 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 63.2 m -125.37 113.26 17.32 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.353 -1.294 . . . . 1.0600000000000001 108.582 178.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.402 ' O ' HG22 ' A' ' 64' ' ' VAL . . . -109.69 145.15 16.85 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 119.914 -1.136 . . . . 0.14000000000000001 112.756 -178.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.503 HH11 HD11 ' A' ' 125' ' ' ILE . 0.1 OUTLIER -148.07 146.48 28.86 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 120.891 0.377 . . . . 2.6899999999999999 110.193 179.325 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.447 ' HA ' ' HG ' ' A' ' 124' ' ' LEU . 5.7 mt -76.27 156.64 33.29 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.989 -0.55 . . . . 1.77 109.744 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.439 HG23 ' HG3' ' A' ' 11' ' ' LYS . 0.4 OUTLIER -58.09 -11.17 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.199 -0.667 . . . . 1.3700000000000001 109.199 179.021 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.432 ' H ' ' C ' ' A' ' 59' ' ' LEU . 19.5 t70 -65.0 -11.58 40.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.357 -0.838 . . . . 2.0099999999999998 110.722 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.456 ' HA3' ' NH2' ' A' ' 58' ' ' ARG . . . 90.81 -0.72 77.08 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.544 -0.836 . . . . 0.45000000000000001 113.511 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 40.7 p -118.94 128.36 54.35 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 117.277 0.538 . . . . 1.99 111.381 -178.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.402 HG22 ' O ' ' A' ' 57' ' ' GLY . 6.5 p -60.71 134.9 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 115.936 -0.574 . . . . 1.0700000000000001 109.807 179.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.632 ' HD1' ' H ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -97.31 -26.24 14.97 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.185 -0.462 . . . . 0.25 110.888 -179.554 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.632 ' H ' ' HD1' ' A' ' 65' ' ' PHE . 21.4 t70 -177.29 134.46 0.18 Allowed 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.438 -0.346 . . . . 0.29999999999999999 110.744 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 40.4 t -131.14 122.58 26.89 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.322 -0.399 . . . . 1.8100000000000001 110.451 179.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.676 HG23 ' HB2' ' A' ' 75' ' ' ALA . 47.9 p -71.62 -17.88 62.24 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.007 0.432 . . . . 0.93000000000000005 110.382 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -75.14 -45.58 39.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.916 -0.583 . . . . 2.1099999999999999 110.508 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -62.55 -41.74 99.09 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.861 -0.609 . . . . 3.79 111.114 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 21.6 m -58.38 -17.63 21.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.315 -0.402 . . . . 2.1200000000000001 110.662 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.42 3.61 88.43 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.821 -0.704 . . . . 0.80000000000000004 112.46 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.597 ' HB3' ' HZ2' ' A' ' 73' ' ' LYS . 8.6 mtpm? -126.38 117.68 23.22 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.347 0.118 . . . . 3.52 111.039 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.43 163.38 3.67 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.476 2.117 . . . . 0.76000000000000001 112.228 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.676 ' HB2' HG23 ' A' ' 68' ' ' THR . . . -96.33 124.72 40.43 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.207 -0.451 . . . . 0.76000000000000001 110.511 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 61.8 m -124.79 111.44 15.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.922 0.391 . . . . 1.98 111.262 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -158.5 163.29 37.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.894 -0.594 . . . . 0.44 110.564 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.635 ' HG3' ' HB2' ' A' ' 81' ' ' GLN . 1.5 pt20 -89.7 147.49 23.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.385 0.612 . . . . 1.8 109.989 178.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 27.5 m -57.61 -23.36 19.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 N-CA-C 114.039 1.125 . . . . 1.79 114.039 -177.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 91.8 p -95.35 -2.55 48.94 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.515 0.561 . . . . 1.6100000000000001 112.515 -178.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.635 ' HB2' ' HG3' ' A' ' 78' ' ' GLN . 6.6 tt0 -83.22 5.32 23.33 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.751 0.278 . . . . 2.4199999999999999 111.751 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -112.87 -178.86 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.912 0.386 . . . . 1.1799999999999999 111.977 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.559 HG13 ' H ' ' A' ' 86' ' ' TRP . 25.6 pt -56.1 154.46 15.02 Favored Pre-proline 0 C--O 1.231 0.102 0 CA-C-N 115.951 -0.568 . . . . 1.5900000000000001 111.741 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -47.81 -44.67 26.32 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.483 2.122 . . . . 1.01 112.414 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.508 ' HA3' HD22 ' A' ' 32' ' ' LEU . . . -61.19 -49.26 79.95 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 120.622 -0.799 . . . . 0.35999999999999999 113.024 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . 0.559 ' H ' HG13 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -63.03 -53.1 59.18 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.894 0.331 . . . . 0.98999999999999999 111.894 -178.985 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.0 t -53.93 -34.23 59.02 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.006 0.373 . . . . 1.8899999999999999 112.006 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.445 ' HG3' ' HB2' ' A' ' 30' ' ' SER . 0.6 OUTLIER -66.09 -51.09 61.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.6 -0.273 . . . . 1.4299999999999999 111.076 -179.829 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.404 ' HB1' ' HG ' ' A' ' 32' ' ' LEU . . . -65.07 -44.41 89.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.512 -0.313 . . . . 0.33000000000000002 111.549 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.5 HD12 ' HE1' ' A' ' 93' ' ' MET . 3.8 mm? -57.42 -29.85 64.49 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.252 -0.431 . . . . 1.1599999999999999 111.354 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.574 HE21 ' HG3' ' A' ' 47' ' ' LYS . 29.6 tt0 -62.24 -23.67 66.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.271 -0.422 . . . . 2.23 111.233 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 8.3 mp -93.2 -7.66 44.62 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.153 0.427 . . . . 2.0899999999999999 112.153 -178.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.5 ' HE1' HD12 ' A' ' 90' ' ' LEU . 2.9 ttm -92.21 107.81 26.01 Favored Pre-proline 0 C--N 1.33 -0.253 0 C-N-CA 120.99 -0.284 . . . . 2.2799999999999998 111.512 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -75.19 146.77 32.39 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.232 1.954 . . . . 0.72999999999999998 110.496 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.463 ' HB3' ' HA ' ' A' ' 132' ' ' SER . . . -45.81 124.96 5.67 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.917 -0.313 . . . . 1.21 111.363 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 102.38 -9.49 55.97 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 120.518 -0.848 . . . . 0.34000000000000002 113.328 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 31.2 t -72.74 175.0 6.85 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 117.005 0.403 . . . . 1.8899999999999999 111.193 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.3 m -146.46 96.35 2.75 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.94 -0.573 . . . . 0.88 110.473 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.755 ' HE1' ' HB2' ' A' ' 39' ' ' SER . 30.8 m0 -119.57 149.79 41.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.192 0.52 . . . . 0.67000000000000004 111.961 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.406 ' HB3' ' HD3' ' A' ' 127' ' ' LYS . 8.9 pt-20 -119.46 107.99 14.0 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.966 -1.124 . . . . 1.53 107.966 177.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.46 HG23 ' HB3' ' A' ' 34' ' ' TYR . 41.8 pt -108.14 142.75 20.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 113.53 0.937 . . . . 0.72999999999999998 113.53 -177.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -123.45 103.63 8.58 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.498 -1.228 . . . . 0.91000000000000003 108.228 177.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.2 t -107.55 96.89 17.63 Favored Pre-proline 0 C--N 1.329 -0.307 0 N-CA-C 113.219 0.822 . . . . 1.1399999999999999 113.219 -176.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.529 ' HG2' HD21 ' A' ' 107' ' ' LEU . 9.5 Cg_endo -54.5 149.68 37.84 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 121.861 1.708 . . . . 0.68000000000000005 110.484 177.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.5 p -48.63 -27.8 3.07 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.873 0.694 . . . . 2.3700000000000001 112.873 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -60.22 -10.46 15.76 Favored Glycine 0 CA--C 1.521 0.441 0 C-N-CA 120.799 -0.715 . . . . 0.40000000000000002 113.754 -179.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.529 HD21 ' HG2' ' A' ' 104' ' ' PRO . 3.0 mm? -114.66 -0.94 13.45 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.242 0.46 . . . . 2.9300000000000002 112.242 -178.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.496 ' HB1' HD13 ' A' ' 83' ' ' ILE . . . . . . . . 0 C--N 1.327 -0.399 0 N-CA-C 110.34 -0.244 . . . . 1.3799999999999999 110.34 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo . . . . . 0 N--CA 1.464 -0.22 0 N-CA-C 110.83 -0.489 . . . . 1.0900000000000001 110.83 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.607 HG21 HD11 ' A' ' 124' ' ' LEU . 93.2 mt -90.09 135.57 26.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.311 -0.859 . . . . 1.8799999999999999 110.031 179.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -42.88 152.0 0.3 Allowed Glycine 0 CA--C 1.52 0.386 0 C-N-CA 121.247 -0.501 . . . . 0.56000000000000005 113.101 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -60.33 130.88 35.78 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.436 2.091 . . . . 0.84999999999999998 111.71 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 43.73 34.89 0.92 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.161 -0.472 . . . . 1.1200000000000001 110.081 -178.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -115.72 136.37 53.13 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.914 -0.584 . . . . 1.8200000000000001 111.495 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.436 HG22 HD21 ' A' ' 16' ' ' LEU . 96.7 m -95.53 134.08 38.81 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.02 -0.733 . . . . 1.0900000000000001 109.02 178.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.607 HD11 HG21 ' A' ' 118' ' ' ILE . 0.1 OUTLIER -121.5 154.79 36.16 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.31 0.576 . . . . 2.1000000000000001 112.413 -178.085 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.503 HD11 HH11 ' A' ' 58' ' ' ARG . 4.4 mp -113.81 141.22 30.62 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 CA-C-N 115.237 -0.892 . . . . 1.0600000000000001 109.387 178.307 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -133.83 132.06 39.97 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.173 0.511 . . . . 0.28999999999999998 111.809 -179.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.406 ' HD3' ' HB3' ' A' ' 100' ' ' GLU . 42.6 mmtm -107.21 103.55 12.95 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.811 -0.811 . . . . 2.77 108.811 178.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 36.2 mt -102.68 119.03 50.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.047 0.451 . . . . 1.5600000000000001 112.075 -178.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -114.99 99.97 7.85 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.655 -0.702 . . . . 0.29999999999999999 109.327 178.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.472 ' HA ' HG11 ' A' ' 53' ' ' VAL . 0.6 OUTLIER -79.31 123.28 27.31 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.002 -0.545 . . . . 2.0299999999999998 111.06 -178.838 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 48.3 mm -93.43 -56.77 4.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.067 -0.515 . . . . 1.8899999999999999 111.012 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.463 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 13.6 m -163.45 165.23 24.03 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.976 0.417 . . . . 1.75 111.622 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.578 ' HA ' HG13 ' A' ' 51' ' ' VAL . 2.7 p -107.93 129.92 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 115.734 -0.666 . . . . 2.1299999999999999 110.441 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.436 ' HG2' HG23 ' A' ' 133' ' ' VAL . 17.3 ptmt 34.55 55.25 0.67 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.036 0.446 . . . . 3.5600000000000001 111.316 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm 61.62 42.94 10.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.764 -0.653 . . . . 3.6699999999999999 110.929 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 43.5 t 52.5 61.14 3.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.78 -0.646 . . . . 1.6000000000000001 110.993 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 71.2 m . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.2 -0.905 . . . . 2.7799999999999998 111.139 -179.689 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 61.0 tttm . . . . . 0 N--CA 1.455 -0.179 0 CA-C-O 120.877 0.37 . . . . 3.1499999999999999 110.116 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.72 -52.52 62.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.739 -0.664 . . . . 1.27 110.179 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.402 ' O ' HG21 ' A' ' 10' ' ' VAL . 20.9 m-20 -67.4 -36.3 81.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.62 -0.718 . . . . 2.5699999999999998 110.293 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -55.76 -32.99 63.91 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 109.335 -0.617 . . . . 2.1400000000000001 109.335 178.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.526 ' HA ' ' HE2' ' A' ' 11' ' ' LYS . 21.4 m-20 -72.78 -38.84 67.14 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.494 -0.775 . . . . 1.3999999999999999 110.471 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 8.3 tmtm? -59.8 -31.45 69.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.097 -0.501 . . . . 3.2400000000000002 111.353 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.402 HG21 ' O ' ' A' ' 6' ' ' ASP . 11.8 t -77.81 -53.48 14.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 111.895 0.331 . . . . 1.9199999999999999 111.895 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.526 ' HE2' ' HA ' ' A' ' 8' ' ' ASN . 58.9 pttt -66.1 -27.21 67.89 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.943 0.401 . . . . 2.1499999999999999 110.523 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.95 -45.07 12.51 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.789 -0.72 . . . . 0.33000000000000002 111.8 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -68.07 -34.4 76.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.697 0.284 . . . . 2.3900000000000001 110.767 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.47 -42.46 64.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.92000000000000004 111.342 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -58.38 -56.28 24.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.541 -0.299 . . . . 0.27000000000000002 110.496 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.523 ' HA ' ' HB3' ' A' ' 19' ' ' ASN . 4.1 pp -60.01 -33.06 71.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.262 -0.426 . . . . 1.3100000000000001 110.482 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.8 m -58.09 -48.56 79.81 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.989 -0.551 . . . . 1.1599999999999999 110.204 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -73.69 -32.01 63.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.934 -0.575 . . . . 2.4700000000000002 110.034 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.523 ' HB3' ' HA ' ' A' ' 16' ' ' LEU . 0.4 OUTLIER -53.69 -32.45 51.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.408 -0.815 . . . . 0.22 111.478 179.934 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.575 ' HE2' HE22 ' A' ' 33' ' ' GLN . 35.6 mmtp -44.02 -20.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.996 -0.547 . . . . 2.8799999999999999 112.332 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.647 ' N ' HD21 ' A' ' 21' ' ' ASN . 0.8 OUTLIER -68.49 -33.05 73.46 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.983 0.364 . . . . 0.40000000000000002 111.983 -178.751 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.434 ' HD2' ' OD1' ' A' ' 19' ' ' ASN . 67.3 mttm -54.14 119.11 18.12 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.686 -0.234 . . . . 1.9299999999999999 110.988 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.46 142.73 95.33 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.449 2.099 . . . . 1.0600000000000001 112.258 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.14 -1.63 86.56 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.769 -0.729 . . . . 0.40999999999999998 113.249 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' A' ' 34' ' ' TYR . 3.7 p -61.26 110.53 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 121.21 0.529 . . . . 1.6000000000000001 110.58 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.0 p -130.04 130.94 66.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.838 -0.619 . . . . 1.6599999999999999 111.508 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 9.7 p -82.89 138.38 19.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 1.5600000000000001 110.861 179.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.517 HD13 ' HB2' ' A' ' 32' ' ' LEU . 55.3 mt -96.22 167.45 12.37 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.255 -0.429 . . . . 1.0800000000000001 110.704 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.455 ' HD2' ' HB3' ' A' ' 28' ' ' LEU . 75.0 Cg_exo -51.06 -30.97 33.36 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.129 1.886 . . . . 0.65000000000000002 112.265 179.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 31.9 m -89.25 -9.41 50.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.265 -0.425 . . . . 1.75 111.782 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.58 15.68 22.15 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.388 -0.91 . . . . 0.34999999999999998 113.627 178.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.517 ' HB2' HD13 ' A' ' 28' ' ' LEU . 2.7 mm? -83.02 134.27 35.05 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.008 0.432 . . . . 2.0 111.92 -179.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.575 HE22 ' HE2' ' A' ' 20' ' ' LYS . 46.1 mt-30 -125.23 139.02 54.09 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.282 -0.636 . . . . 2.3199999999999998 109.282 178.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.58 ' HB3' HG23 ' A' ' 101' ' ' ILE . 28.8 p90 -151.17 175.72 11.88 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.788 0.662 . . . . 0.92000000000000004 112.788 -178.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -121.09 117.06 26.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.226 -0.897 . . . . 2.6800000000000002 109.175 178.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.5 t -72.66 126.66 33.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 113.299 0.852 . . . . 0.77000000000000002 113.299 -177.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.486 HD11 HG23 ' A' ' 98' ' ' THR . 76.8 mt -107.42 -66.75 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 115.401 -0.818 . . . . 1.46 110.131 178.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -142.59 82.86 1.79 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.19 -0.459 . . . . 1.05 110.157 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.433 ' OG ' ' NE1' ' A' ' 99' ' ' TRP . 17.8 m -106.03 146.38 30.18 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 112.515 0.561 . . . . 2.02 112.515 -178.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 92.43 83.65 1.5 Allowed Glycine 0 C--N 1.334 0.455 0 CA-C-N 115.755 -0.657 . . . . 1.0900000000000001 113.038 178.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -150.61 -72.77 0.17 Allowed 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 111.681 0.252 . . . . 1.7 111.681 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.12 172.29 36.45 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 121.072 -0.585 . . . . 0.40000000000000002 114.298 -178.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.473 HG13 ' H ' ' A' ' 44' ' ' LYS . 2.0 t -90.47 175.99 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 123.474 0.71 . . . . 2.0299999999999998 110.022 179.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.473 ' H ' HG13 ' A' ' 43' ' ' VAL . 2.1 pptp? 164.96 156.53 0.07 OUTLIER Pre-proline 0 N--CA 1.472 0.657 0 CA-C-O 121.503 0.668 . . . . 2.7400000000000002 112.028 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 44' ' ' LYS . 1.2 Cg_endo -83.84 172.54 9.88 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 124.823 3.682 . . . . 0.34000000000000002 113.692 -179.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 48' ' ' SER . . . -67.98 -172.93 6.92 Favored Glycine 0 C--O 1.223 -0.565 0 CA-C-N 115.096 -0.956 . . . . 0.38 111.237 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -41.63 -13.98 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.825 1.046 . . . . 2.9399999999999999 113.825 -177.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.487 ' N ' ' O ' ' A' ' 46' ' ' GLY . 55.6 m -86.32 7.24 26.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.268 0.556 . . . . 1.8999999999999999 110.092 178.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.441 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 3.0 p30 -74.79 166.23 23.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.267 -0.879 . . . . 1.73 111.676 -179.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 91.7 m -126.07 121.26 32.43 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 108.691 -0.855 . . . . 0.92000000000000004 108.691 178.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.562 HG11 HG21 ' A' ' 133' ' ' VAL . 6.4 m -122.92 142.63 38.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 112.97 0.73 . . . . 1.22 112.97 -177.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 39.3 m -115.35 119.79 37.45 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.067 -1.086 . . . . 1.05 108.067 177.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.535 HG11 ' HA ' ' A' ' 130' ' ' LEU . 2.7 m -146.34 178.78 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.26 0.552 . . . . 1.05 111.961 -177.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -128.78 132.45 47.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.291 -0.868 . . . . 2.3999999999999999 109.107 178.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -146.13 159.28 43.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.584 0.707 . . . . 0.93999999999999995 112.345 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 57.0 m -121.84 112.89 18.9 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.483 -1.235 . . . . 1.0600000000000001 108.223 178.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.403 ' O ' HG22 ' A' ' 64' ' ' VAL . . . -110.66 143.54 17.02 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 119.664 -1.255 . . . . 0.14000000000000001 113.236 -178.113 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.517 ' O ' HD11 ' A' ' 124' ' ' LEU . 0.1 OUTLIER -148.43 145.61 28.07 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.566 -0.317 . . . . 2.6899999999999999 110.176 179.266 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.531 HD21 HD12 ' A' ' 124' ' ' LEU . 2.3 mt -74.9 154.02 38.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.978 -0.555 . . . . 1.77 110.586 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.469 ' HB ' ' O ' ' A' ' 123' ' ' THR . 0.4 OUTLIER -56.55 -11.94 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.362 0.601 . . . . 1.3700000000000001 109.621 179.001 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.439 ' H ' ' C ' ' A' ' 59' ' ' LEU . 21.4 t70 -71.11 -10.01 59.03 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.434 -0.803 . . . . 2.0099999999999998 110.816 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.7 0.18 75.92 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.597 -0.811 . . . . 0.45000000000000001 113.629 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 61.4 p -113.3 121.43 44.38 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 117.339 0.57 . . . . 1.99 111.724 -178.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.403 HG22 ' O ' ' A' ' 57' ' ' GLY . 5.9 p -60.61 132.4 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-N 115.889 -0.596 . . . . 1.0700000000000001 109.819 179.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.694 ' HD1' ' H ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -97.79 -28.07 14.03 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.333 -0.394 . . . . 0.25 111.908 -179.4 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.694 ' H ' ' HD1' ' A' ' 65' ' ' PHE . 15.1 t70 -177.64 131.49 0.16 Allowed 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.606 0.241 . . . . 0.29999999999999999 110.821 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.6 m -131.41 116.84 18.05 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.879 0.371 . . . . 1.8100000000000001 110.487 178.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 80.4 p -74.84 -29.59 61.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.478 . . . . 0.93000000000000005 111.323 -179.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -70.18 -39.45 75.26 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.199 -0.455 . . . . 2.1099999999999999 110.654 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -71.02 -37.95 72.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.226 -0.443 . . . . 3.79 111.042 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 33.8 m -57.11 -22.75 42.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.233 -0.44 . . . . 2.1200000000000001 110.794 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 95.21 2.15 62.33 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.869 -0.681 . . . . 0.80000000000000004 112.618 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.559 ' HZ3' ' HB2' ' A' ' 73' ' ' LYS . 3.6 ttmp? -126.35 118.03 23.28 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.638 0.219 . . . . 3.52 111.111 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -52.65 150.25 22.39 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.62 2.213 . . . . 0.76000000000000001 112.125 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -94.73 125.02 39.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.39 -0.368 . . . . 0.76000000000000001 110.811 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.7 t -123.85 113.97 19.24 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.952 0.406 . . . . 1.98 111.428 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -159.03 154.65 26.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.021 -0.536 . . . . 0.44 111.121 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.553 ' NE2' ' HB3' ' A' ' 80' ' ' SER . 0.0 OUTLIER -84.5 148.84 26.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.35 0.595 . . . . 1.8 109.871 178.487 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.5 m -68.79 -25.78 31.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 113.925 1.084 . . . . 1.79 113.925 -177.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.553 ' HB3' ' NE2' ' A' ' 78' ' ' GLN . 37.7 t -86.17 -2.35 58.27 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.616 0.599 . . . . 1.6100000000000001 112.616 -178.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -95.33 5.56 51.35 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.274 0.472 . . . . 2.4199999999999999 112.274 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 1.7 m -113.63 -173.17 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 112.334 0.494 . . . . 1.1799999999999999 112.334 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.537 HG13 ' H ' ' A' ' 86' ' ' TRP . 42.2 pt -56.14 158.95 6.52 Favored Pre-proline 0 CA--C 1.53 0.201 0 CA-C-N 115.906 -0.588 . . . . 1.5900000000000001 112.268 -179.127 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -51.38 -47.37 26.36 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.894 2.396 . . . . 1.01 113.043 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.466 ' HA3' HD22 ' A' ' 32' ' ' LEU . . . -59.85 -48.66 84.97 Favored Glycine 0 CA--C 1.521 0.407 0 C-N-CA 120.524 -0.846 . . . . 0.35999999999999999 112.953 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . 0.537 ' H ' HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -64.06 -44.72 91.56 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.651 0.611 . . . . 0.98999999999999999 112.651 -178.695 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.0 t -60.25 -37.14 79.46 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.072 0.397 . . . . 1.8899999999999999 112.072 -178.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.421 ' O ' ' HG2' ' A' ' 91' ' ' GLN . 10.3 tp10 -70.75 -40.2 72.85 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.008 0.373 . . . . 1.4299999999999999 112.008 -179.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.09 -52.46 10.11 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.013 0.375 . . . . 0.33000000000000002 112.013 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.563 HD13 HD12 ' A' ' 128' ' ' ILE . 4.6 mm? -57.38 -34.69 69.11 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.778 0.658 . . . . 1.1599999999999999 112.778 -178.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.421 ' HG2' ' O ' ' A' ' 88' ' ' GLU . 18.1 pt20 -65.55 -4.79 6.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.635 0.255 . . . . 2.23 111.653 -179.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 82.6 mt -108.22 -7.85 15.89 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.564 -0.289 . . . . 2.0899999999999999 111.207 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.461 ' HE2' ' N ' ' A' ' 99' ' ' TRP . 13.8 ttt -78.08 112.93 28.97 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.417 -0.356 . . . . 2.2799999999999998 111.102 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.464 ' HA ' ' HG2' ' A' ' 44' ' ' LYS . 4.5 Cg_exo -77.04 142.37 21.85 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.761 2.307 . . . . 0.72999999999999998 111.84 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.464 ' HB3' ' HA ' ' A' ' 132' ' ' SER . . . -50.41 128.28 19.46 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.372 -0.377 . . . . 1.21 111.499 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 92.25 2.27 68.56 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.689 -0.767 . . . . 0.34000000000000002 113.292 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.4 ' HB3' ' HA ' ' A' ' 39' ' ' SER . 19.8 m -92.85 -179.72 5.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.094 0.473 . . . . 1.8899999999999999 111.776 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.486 HG23 HD11 ' A' ' 37' ' ' ILE . 3.9 m -144.63 120.4 10.55 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.658 -0.701 . . . . 0.88 110.084 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.461 ' N ' ' HE2' ' A' ' 93' ' ' MET . 4.9 m0 -132.36 150.65 52.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.23 0.538 . . . . 0.67000000000000004 112.264 -178.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -122.46 106.85 11.4 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.715 -1.217 . . . . 1.53 107.715 177.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.58 HG23 ' HB3' ' A' ' 34' ' ' TYR . 41.0 pt -109.44 139.28 33.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 112.923 0.712 . . . . 0.72999999999999998 112.923 -177.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -122.72 103.33 8.59 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.826 -1.079 . . . . 0.91000000000000003 108.214 178.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.7 t -107.3 97.08 17.49 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 112.501 0.556 . . . . 1.1399999999999999 112.501 -177.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.598 ' HA ' ' HA ' ' A' ' 123' ' ' THR . 9.9 Cg_endo -54.12 149.06 37.28 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 121.621 1.547 . . . . 0.68000000000000005 110.528 177.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.3 m -48.15 -29.49 3.72 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.489 0.551 . . . . 2.3700000000000001 112.489 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -56.64 -9.79 3.87 Favored Glycine 0 CA--C 1.521 0.444 0 C-N-CA 121.016 -0.611 . . . . 0.40000000000000002 113.992 -178.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.479 HD21 ' HG2' ' A' ' 104' ' ' PRO . 3.4 mm? -110.6 1.98 18.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 117.251 0.526 . . . . 2.9300000000000002 111.897 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.466 ' HB1' HD11 ' A' ' 83' ' ' ILE . . . . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.715 -0.22 . . . . 1.3799999999999999 111.586 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.502 ' HB2' HD13 ' A' ' 118' ' ' ILE . 49.6 Cg_exo . . . . . 0 C--O 1.231 0.144 0 CA-C-O 120.995 0.331 . . . . 1.0900000000000001 111.453 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.502 HD13 ' HB2' ' A' ' 117' ' ' PRO . 4.0 mp -92.53 135.65 26.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.753 -0.658 . . . . 1.8799999999999999 110.212 178.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -42.64 149.53 0.46 Allowed Glycine 0 C--N 1.335 0.493 0 C-N-CA 120.917 -0.658 . . . . 0.56000000000000005 112.489 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -55.73 131.31 45.31 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.263 1.976 . . . . 0.84999999999999998 112.282 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 42.99 37.68 1.2 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.311 -0.404 . . . . 1.1200000000000001 110.862 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.443 ' OE1' HD23 ' A' ' 59' ' ' LEU . 30.8 tt0 -114.09 144.28 43.4 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.012 -0.54 . . . . 1.8200000000000001 111.957 -179.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.598 ' HA ' ' HA ' ' A' ' 104' ' ' PRO . 70.0 m -97.0 129.3 44.49 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.369 -0.604 . . . . 1.0900000000000001 109.369 178.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.531 HD12 HD21 ' A' ' 59' ' ' LEU . 1.4 mm? -115.53 152.43 33.02 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.121 0.486 . . . . 2.1000000000000001 111.838 -178.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.8 mp -114.3 136.36 51.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.557 -0.747 . . . . 1.0600000000000001 110.02 178.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -133.53 131.7 40.07 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.275 -0.42 . . . . 0.28999999999999998 111.397 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -108.43 102.38 11.49 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.862 -1.162 . . . . 2.77 107.862 177.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.563 HD12 HD13 ' A' ' 90' ' ' LEU . 18.2 mt -102.83 126.56 57.03 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 CA-C-O 121.238 0.542 . . . . 1.5600000000000001 112.148 -177.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . 0.458 ' O ' ' HB ' ' A' ' 53' ' ' VAL . 1.3 t-160 -118.56 98.37 6.21 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.227 -0.897 . . . . 0.29999999999999999 109.297 178.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.535 ' HA ' HG11 ' A' ' 53' ' ' VAL . 17.3 tp -80.25 113.61 18.54 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.187 -0.46 . . . . 2.0299999999999998 111.113 -178.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 34.3 mm -81.98 -50.29 16.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.786 -0.643 . . . . 1.8899999999999999 110.782 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.464 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 5.3 m -163.4 165.22 24.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 1.75 110.358 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.562 HG21 HG11 ' A' ' 51' ' ' VAL . 91.7 t -129.16 135.77 61.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.01 -0.541 . . . . 2.1299999999999999 110.589 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.521 ' HE2' ' HB2' ' A' ' 137' ' ' SER . 21.4 ptmt 40.74 49.8 2.87 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.878 -0.601 . . . . 3.5600000000000001 111.277 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt 63.77 41.21 7.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.345 -0.843 . . . . 3.6699999999999999 111.507 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 33.9 t 48.03 32.61 2.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.71 -0.677 . . . . 1.6000000000000001 111.477 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.521 ' HB2' ' HE2' ' A' ' 134' ' ' LYS . 69.8 m . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.213 -0.898 . . . . 2.7799999999999998 110.894 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 76.2 t80 . . . . . 0 N--CA 1.485 1.276 0 CA-C-O 120.791 0.329 . . . . 3.73 110.806 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.474 ' HA ' ' HB3' ' A' ' 5' ' ' ALA . 8.0 p30 -70.11 -20.54 63.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.228 -0.442 . . . . 2.0800000000000001 110.976 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -57.51 -39.73 77.14 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.622 -0.51 . . . . 3.7599999999999998 109.622 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -79.43 -36.12 39.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.685 -0.689 . . . . 3.1499999999999999 110.222 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.474 ' HB3' ' HA ' ' A' ' 2' ' ' ASN . . . -57.79 -52.04 67.09 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.101 -0.499 . . . . 1.27 110.145 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -66.64 -34.39 77.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.864 -0.607 . . . . 2.5699999999999998 109.936 178.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -55.79 -32.61 63.64 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.089 -0.708 . . . . 2.1400000000000001 109.089 178.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.497 ' HA ' ' HG2' ' A' ' 11' ' ' LYS . 41.5 m-20 -75.7 -38.37 58.71 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.201 -0.909 . . . . 1.3999999999999999 110.509 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -56.39 -39.6 73.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.878 -0.601 . . . . 3.2400000000000002 111.571 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.2 m -78.33 -47.83 23.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 112.604 0.594 . . . . 1.9199999999999999 112.604 -178.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.497 ' HG2' ' HA ' ' A' ' 8' ' ' ASN . 22.1 ptmt -63.55 -33.99 76.81 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.602 0.223 . . . . 2.1499999999999999 111.602 -179.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.86 -52.98 5.54 Favored Glycine 0 C--N 1.33 0.231 0 C-N-CA 120.75 -0.738 . . . . 0.33000000000000002 112.461 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -57.66 -26.27 61.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.969 0.414 . . . . 2.3900000000000001 110.346 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.17 -40.67 37.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.814 -0.63 . . . . 0.92000000000000004 110.529 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -58.69 -48.92 79.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.076 -0.511 . . . . 0.27000000000000002 110.278 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.542 ' HA ' ' HB3' ' A' ' 19' ' ' ASN . 4.2 pp -67.0 -34.52 77.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.32 -0.4 . . . . 1.3100000000000001 110.714 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.444 ' N ' HD13 ' A' ' 16' ' ' LEU . 18.5 m -57.72 -49.65 75.85 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.246 -0.434 . . . . 1.1599999999999999 110.209 179.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -73.72 -32.01 63.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.86 -0.609 . . . . 2.4700000000000002 110.074 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.542 ' HB3' ' HA ' ' A' ' 16' ' ' LEU . 0.5 OUTLIER -54.29 -33.14 58.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.467 -0.788 . . . . 0.22 111.521 -179.915 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -46.66 -19.75 0.1 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.041 -0.527 . . . . 2.8799999999999999 112.163 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.679 ' N ' HD21 ' A' ' 21' ' ' ASN . 0.8 OUTLIER -68.03 -33.52 74.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.638 -0.256 . . . . 0.40000000000000002 111.594 -178.789 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.436 ' O ' HG21 ' A' ' 25' ' ' VAL . 67.7 mttm -52.05 119.03 13.32 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.551 -0.295 . . . . 1.9299999999999999 110.511 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -57.73 146.41 85.51 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.231 1.954 . . . . 1.0600000000000001 112.222 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.05 3.16 79.87 Favored Glycine 0 CA--C 1.522 0.471 0 C-N-CA 120.869 -0.682 . . . . 0.40999999999999998 114.16 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.545 HG23 ' HH ' ' A' ' 102' ' ' TYR . 35.6 t -56.8 110.71 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 117.65 0.725 . . . . 1.6000000000000001 110.435 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.9 p -126.12 127.58 71.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.898 -0.592 . . . . 1.6599999999999999 111.126 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.1 p -83.09 143.08 12.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.073 -0.512 . . . . 1.5600000000000001 111.021 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.487 ' HB3' ' HD2' ' A' ' 29' ' ' PRO . 69.3 mt -103.86 168.56 8.46 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.102 -0.499 . . . . 1.0800000000000001 110.806 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.487 ' HD2' ' HB3' ' A' ' 28' ' ' LEU . 78.4 Cg_exo -51.48 -33.45 47.39 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 121.943 1.762 . . . . 0.65000000000000002 111.754 178.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.5 m -84.49 -11.95 55.16 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.046 -0.524 . . . . 1.75 111.195 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.04 14.16 27.25 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.507 -0.854 . . . . 0.34999999999999998 114.258 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.486 ' HB2' HD13 ' A' ' 28' ' ' LEU . 6.5 mp -83.08 134.77 35.0 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.068 0.766 . . . . 2.0 113.068 -178.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -116.6 143.65 45.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.191 -0.913 . . . . 2.3199999999999998 108.542 177.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.477 ' HB3' HG23 ' A' ' 101' ' ' ILE . 30.7 p90 -160.27 175.56 12.72 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.37 0.507 . . . . 0.92000000000000004 112.37 -178.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -120.54 116.86 26.21 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.38 -0.827 . . . . 2.6800000000000002 109.331 178.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.6 t -78.1 125.34 37.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 113.475 0.917 . . . . 0.77000000000000002 113.475 -177.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 63.3 mt -101.21 -60.83 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.289 -0.869 . . . . 1.46 109.109 177.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -134.77 100.06 4.5 Favored 'General case' 0 CA--C 1.527 0.072 0 CA-C-N 115.799 -0.637 . . . . 1.05 109.673 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.565 ' HB3' ' HE1' ' A' ' 99' ' ' TRP . 59.9 p -103.18 145.62 29.66 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.113 0.482 . . . . 2.02 112.161 -178.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 94.82 -126.54 8.76 Favored Glycine 0 C--N 1.333 0.384 0 CA-C-N 115.599 -0.728 . . . . 1.0900000000000001 113.146 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 16.9 m-80 70.08 -83.07 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.559 0.577 . . . . 1.7 112.559 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.11 167.36 30.37 Favored Glycine 0 CA--C 1.521 0.429 0 N-CA-C 115.289 0.875 . . . . 0.40000000000000002 115.289 -177.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.528 ' O ' ' HB3' ' A' ' 44' ' ' LYS . 2.5 t -91.81 176.88 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 114.365 -0.917 . . . . 2.0299999999999998 109.592 178.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.693 ' HG2' ' HA ' ' A' ' 94' ' ' PRO . 0.0 OUTLIER 165.46 157.64 0.09 OUTLIER Pre-proline 0 N--CA 1.475 0.781 0 CA-C-O 121.357 0.599 . . . . 2.7400000000000002 112.35 -179.878 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.592 ' HD2' ' HB2' ' A' ' 49' ' ' ASP . 1.2 Cg_endo -84.65 173.35 8.47 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 125.076 3.851 . . . . 0.34000000000000002 113.882 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 48' ' ' SER . . . -67.99 -171.97 6.34 Favored Glycine 0 C--O 1.222 -0.625 0 CA-C-N 114.947 -1.024 . . . . 0.38 111.664 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.499 ' O ' HG11 ' A' ' 79' ' ' VAL . 23.0 pttm -41.33 -13.46 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 113.921 1.082 . . . . 2.9399999999999999 113.921 -177.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.487 ' N ' ' O ' ' A' ' 46' ' ' GLY . 80.9 p -86.25 7.52 24.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.549 0.69 . . . . 1.8999999999999999 109.364 177.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.592 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 0.0 OUTLIER -71.79 149.17 45.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.666 -1.152 . . . . 1.73 112.183 -179.255 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 58.8 m -126.67 119.39 26.88 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 109.055 -0.72 . . . . 0.92000000000000004 109.055 178.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.507 HG13 ' HA ' ' A' ' 133' ' ' VAL . 33.1 m -132.45 156.28 42.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 112.671 0.619 . . . . 1.22 112.671 -178.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 96.6 m -111.93 121.14 44.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.06 -0.973 . . . . 1.05 108.973 178.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.468 HG11 ' HA ' ' A' ' 130' ' ' LEU . 2.6 m -142.57 -179.66 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.328 0.585 . . . . 1.05 112.012 -178.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.487 ' HB3' ' HG2' ' A' ' 69' ' ' GLU . 28.6 mt-10 -131.38 132.75 44.64 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.267 -0.879 . . . . 2.3999999999999999 109.426 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -143.82 158.11 43.91 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.793 0.806 . . . . 0.93999999999999995 112.229 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 82.5 m -126.0 113.63 17.39 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.133 -1.394 . . . . 1.0600000000000001 108.532 178.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.413 ' O ' HG22 ' A' ' 64' ' ' VAL . . . -108.93 147.26 16.72 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 119.78 -1.2 . . . . 0.14000000000000001 112.72 -178.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.01 147.45 32.64 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.852 0.358 . . . . 2.6899999999999999 110.199 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.461 HD22 HD23 ' A' ' 124' ' ' LEU . 13.2 mt -84.95 157.78 20.72 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.003 -0.544 . . . . 1.77 110.233 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.503 ' HB ' ' O ' ' A' ' 123' ' ' THR . 10.2 tp -57.16 -10.93 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.347 0.594 . . . . 1.3700000000000001 109.709 178.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.441 ' H ' ' C ' ' A' ' 59' ' ' LEU . 24.7 t70 -67.4 -11.53 57.98 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.373 -0.83 . . . . 2.0099999999999998 111.007 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.13 -0.34 75.41 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.483 -0.865 . . . . 0.45000000000000001 113.578 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.3 t -122.89 138.93 54.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 117.37 0.585 . . . . 1.99 111.712 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.413 HG22 ' O ' ' A' ' 57' ' ' GLY . 7.5 p -62.99 133.99 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 115.825 -0.625 . . . . 1.0700000000000001 110.064 179.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.643 ' HD1' ' H ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -97.99 -25.61 14.91 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.067 -0.515 . . . . 0.25 111.147 -179.848 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.643 ' H ' ' HD1' ' A' ' 65' ' ' PHE . 19.1 t70 -176.51 131.17 0.21 Allowed 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 120.733 0.302 . . . . 0.29999999999999999 110.889 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 70.8 p -128.35 126.52 40.87 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.293 -0.412 . . . . 1.8100000000000001 110.531 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.574 HG23 ' HB2' ' A' ' 75' ' ' ALA . 81.1 p -81.83 -21.59 37.53 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.767 0.318 . . . . 0.93000000000000005 111.235 -179.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.487 ' HG2' ' HB3' ' A' ' 54' ' ' GLU . 41.2 mt-10 -75.08 -47.76 27.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.284 -0.416 . . . . 2.1099999999999999 111.226 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm -63.01 -36.87 84.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.43 . . . . 3.79 111.166 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 41.6 m -59.07 -22.89 61.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.312 -0.404 . . . . 2.1200000000000001 110.719 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 92.05 4.75 66.61 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.808 -0.711 . . . . 0.80000000000000004 112.355 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -126.5 116.95 22.98 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.454 0.127 . . . . 3.52 110.771 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.46 159.01 11.5 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.139 1.893 . . . . 0.76000000000000001 111.923 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.574 ' HB2' HG23 ' A' ' 68' ' ' THR . . . -94.78 124.62 38.92 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.355 -0.384 . . . . 0.76000000000000001 110.475 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 48.4 m -127.44 111.95 14.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.838 0.352 . . . . 1.98 111.446 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -158.67 163.78 36.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.091 -0.504 . . . . 0.44 110.904 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.527 ' HG3' ' HB2' ' A' ' 81' ' ' GLN . 0.4 OUTLIER -95.28 148.33 22.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.379 0.609 . . . . 1.8 110.503 178.931 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.505 ' HB ' ' HB3' ' A' ' 90' ' ' LEU . 0.6 OUTLIER -59.29 -28.38 39.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 114.93 -1.032 . . . . 1.79 113.262 -178.431 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.508 ' HB3' ' NE2' ' A' ' 78' ' ' GLN . 46.7 t -85.44 -2.42 58.09 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.78 0.659 . . . . 1.6100000000000001 112.78 -178.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.527 ' HB2' ' HG3' ' A' ' 78' ' ' GLN . 5.3 tp-100 -96.93 5.85 49.74 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.534 0.568 . . . . 2.4199999999999999 112.534 -179.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.6 m -112.77 -178.15 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 N-CA-C 112.361 0.504 . . . . 1.1799999999999999 112.361 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.497 ' O ' HG21 ' A' ' 87' ' ' THR . 28.1 pt -56.88 155.37 15.48 Favored Pre-proline 0 N--CA 1.464 0.273 0 CA-C-N 116.0 -0.546 . . . . 1.5900000000000001 112.017 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -44.33 -60.43 0.81 Allowed 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.074 2.516 . . . . 1.01 113.597 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.4 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -49.12 -49.08 31.14 Favored Glycine 0 CA--C 1.522 0.529 0 C-N-CA 120.493 -0.86 . . . . 0.35999999999999999 112.721 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . 0.443 ' HB2' HG13 ' A' ' 83' ' ' ILE . 0.7 OUTLIER -61.81 -43.87 97.99 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.248 0.462 . . . . 0.98999999999999999 112.248 -179.003 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.497 HG21 ' O ' ' A' ' 83' ' ' ILE . 53.7 p -56.12 -34.49 66.11 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.7 0.286 . . . . 1.8899999999999999 111.395 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -70.27 -51.46 30.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.404 -0.362 . . . . 1.4299999999999999 111.835 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.45 ' HB1' HD23 ' A' ' 32' ' ' LEU . . . -65.78 -52.24 52.48 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 112.418 0.525 . . . . 0.33000000000000002 112.418 -178.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.505 ' HB3' ' HB ' ' A' ' 79' ' ' VAL . 4.1 mm? -56.97 -26.91 60.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.424 -0.353 . . . . 1.1599999999999999 111.615 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.444 ' HG3' ' N ' ' A' ' 47' ' ' LYS . 53.2 tt0 -67.7 -23.47 65.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.789 0.328 . . . . 2.23 111.182 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.44 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 88.8 mt -100.75 -8.04 23.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.298 -0.41 . . . . 2.0899999999999999 111.526 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.457 ' SD ' HD11 ' A' ' 90' ' ' LEU . 62.1 mtt -76.41 110.78 12.37 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 116.748 -0.205 . . . . 2.2799999999999998 111.281 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.693 ' HA ' ' HG2' ' A' ' 44' ' ' LYS . 67.4 Cg_endo -84.93 147.45 10.54 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.837 2.358 . . . . 0.72999999999999998 112.771 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.471 ' HA ' ' HG ' ' A' ' 130' ' ' LEU . . . -45.8 131.02 9.46 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.288 -0.415 . . . . 1.21 112.06 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 88.99 -11.94 67.65 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.845 -0.693 . . . . 0.34000000000000002 113.613 179.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.486 ' HB3' ' HG2' ' A' ' 94' ' ' PRO . 96.6 p -67.75 -175.92 0.59 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.963 0.411 . . . . 1.8899999999999999 111.284 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 17.6 m -161.54 97.75 1.1 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.899 -0.592 . . . . 0.88 110.81 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.565 ' HE1' ' HB3' ' A' ' 39' ' ' SER . 43.9 m0 -119.93 152.11 37.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.082 0.468 . . . . 0.67000000000000004 111.563 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -122.25 108.27 13.09 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.459 -0.941 . . . . 1.53 108.459 177.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.477 HG23 ' HB3' ' A' ' 34' ' ' TYR . 31.5 pt -106.4 141.7 21.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 113.217 0.821 . . . . 0.72999999999999998 113.217 -177.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.545 ' HH ' HG23 ' A' ' 25' ' ' VAL . 0.6 OUTLIER -125.53 103.97 8.16 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.578 -1.192 . . . . 0.91000000000000003 108.368 178.309 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 4.1 t -106.2 110.79 64.24 Favored Pre-proline 0 C--N 1.33 -0.262 0 N-CA-C 113.114 0.783 . . . . 1.1399999999999999 113.114 -177.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.473 ' HG2' HD11 ' A' ' 107' ' ' LEU . 17.7 Cg_endo -61.96 152.19 76.66 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.308 2.006 . . . . 0.68000000000000005 111.131 177.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.428 ' HB2' ' N ' ' A' ' 111' ' ' PRO . 0.3 OUTLIER -47.12 -42.14 18.7 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.834 0.679 . . . . 2.3700000000000001 112.834 -178.69 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -57.4 -9.36 4.51 Favored Glycine 0 CA--C 1.521 0.452 0 C-N-CA 121.043 -0.598 . . . . 0.40000000000000002 113.882 -178.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.473 HD11 ' HG2' ' A' ' 104' ' ' PRO . 9.2 mp -113.4 -7.71 13.46 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.138 0.422 . . . . 2.9300000000000002 112.138 -178.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -109.93 -104.31 0.37 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.692 -0.231 . . . . 1.3799999999999999 110.63 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -91.73 -13.93 30.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.991 0.424 . . . . 1.6000000000000001 110.409 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 102.87 144.54 14.3 Favored Glycine 0 CA--C 1.523 0.533 0 CA-C-N 115.829 -0.623 . . . . 2.3399999999999999 113.577 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.428 ' N ' ' HB2' ' A' ' 105' ' ' SER . 17.3 Cg_endo -57.99 -7.05 3.11 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 123.702 2.935 . . . . 1.9299999999999999 112.835 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.563 ' C ' ' H ' ' A' ' 114' ' ' VAL . 88.5 mtt180 -75.64 171.4 14.38 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.807 0.337 . . . . 3.8799999999999999 110.365 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 54.5 m -63.25 14.24 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.138 -0.483 . . . . 2.0800000000000001 112.22 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.563 ' H ' ' C ' ' A' ' 112' ' ' ARG . 2.9 t -103.28 19.28 3.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.117 0.484 . . . . 3.4199999999999999 110.353 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -66.11 104.16 0.99 Allowed Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.801 -0.636 . . . . 1.0900000000000001 112.426 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.98 -113.25 0.01 OUTLIER Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.977 -0.63 . . . . 0.89000000000000001 112.479 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.7 -34.87 96.07 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.16 1.907 . . . . 1.0900000000000001 111.51 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.572 HG22 HD11 ' A' ' 124' ' ' LEU . 57.4 mt -90.84 115.21 29.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.791 -0.64 . . . . 1.8799999999999999 110.015 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -44.18 157.41 0.17 Allowed Glycine 0 C--N 1.334 0.463 0 CA-C-N 116.153 -0.476 . . . . 0.56000000000000005 113.13 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -63.64 131.65 32.29 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.274 1.983 . . . . 0.84999999999999998 111.643 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 49.3 34.18 6.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.262 -0.426 . . . . 1.1200000000000001 110.356 -178.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -116.29 129.17 56.13 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.203 -0.453 . . . . 1.8200000000000001 111.358 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.503 ' O ' ' HB ' ' A' ' 60' ' ' ILE . 77.5 m -93.07 127.27 38.54 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.722 -0.844 . . . . 1.0900000000000001 108.722 178.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.572 HD11 HG22 ' A' ' 118' ' ' ILE . 7.4 mp -115.22 157.84 23.14 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.27 0.557 . . . . 2.1000000000000001 112.399 -178.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.413 HD13 ' N ' ' A' ' 125' ' ' ILE . 4.8 mp -114.86 139.35 41.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.255 -0.884 . . . . 1.0600000000000001 109.502 178.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -131.13 131.79 44.36 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.099 0.476 . . . . 0.28999999999999998 111.544 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.569 ' HB3' ' HZ3' ' A' ' 127' ' ' LYS . 3.3 mmmp? -110.45 103.78 12.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.514 -0.766 . . . . 2.77 109.18 178.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.4 mp -103.94 118.7 51.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.163 0.506 . . . . 1.5600000000000001 112.242 -178.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -113.35 98.34 7.04 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.41 -0.959 . . . . 0.29999999999999999 108.41 177.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.471 ' HG ' ' HA ' ' A' ' 95' ' ' ALA . 21.9 tp -82.74 123.18 29.07 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.552 -0.749 . . . . 2.0299999999999998 111.683 -178.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 55.8 mt -89.81 -55.99 5.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.799 -0.637 . . . . 1.8899999999999999 110.785 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.446 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 60.5 p -163.64 165.04 23.78 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.072 0.463 . . . . 1.75 111.628 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.507 ' HA ' HG13 ' A' ' 51' ' ' VAL . 2.5 p -108.95 131.53 59.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.715 -0.675 . . . . 2.1299999999999999 111.418 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 5.8 tttp 34.37 64.96 0.35 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.012 -0.54 . . . . 3.5600000000000001 111.574 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm 62.03 42.86 9.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.897 -0.592 . . . . 3.6699999999999999 111.229 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 90.0 p 47.82 64.42 1.63 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.752 -0.658 . . . . 1.6000000000000001 111.413 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 43.4 t . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.21 -0.9 . . . . 2.7799999999999998 110.865 179.994 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.733 0.302 . . . . 3.73 110.96 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -66.37 -18.84 65.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 2.0800000000000001 111.2 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -58.06 -41.13 82.67 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.592 -0.521 . . . . 3.7599999999999998 109.592 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -79.83 -35.06 38.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.72 -0.673 . . . . 3.1499999999999999 110.358 179.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -57.53 -51.42 69.53 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.085 -0.507 . . . . 1.27 110.265 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -67.22 -35.14 78.95 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.927 -0.579 . . . . 2.5699999999999998 110.215 179.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -55.78 -32.47 63.49 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 109.386 -0.598 . . . . 2.1400000000000001 109.386 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.544 ' HB3' ' HG2' ' A' ' 122' ' ' GLU . 19.0 m-20 -75.66 -39.13 58.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.491 -0.777 . . . . 1.3999999999999999 110.38 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.425 ' HD2' ' O ' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -56.79 -40.84 76.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.9 -0.591 . . . . 3.2400000000000002 111.331 179.816 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.416 HG22 ' N ' ' A' ' 11' ' ' LYS . 19.6 m -74.15 -48.23 38.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 112.169 0.433 . . . . 1.9199999999999999 112.169 -179.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.611 ' HZ2' ' HB3' ' A' ' 11' ' ' LYS . 0.2 OUTLIER -64.07 -29.91 71.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.776 0.322 . . . . 2.1499999999999999 111.029 -179.683 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.69 -48.33 8.99 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 121.051 -0.595 . . . . 0.33000000000000002 112.176 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -59.01 -30.15 67.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.035 0.445 . . . . 2.3900000000000001 110.377 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.88 -41.33 37.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.794 -0.639 . . . . 0.92000000000000004 111.118 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -56.02 -52.71 63.26 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 120.768 0.318 . . . . 0.27000000000000002 110.288 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.456 ' HA ' ' HB3' ' A' ' 19' ' ' ASN . 4.0 pp -63.71 -35.51 80.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.083 -0.508 . . . . 1.3100000000000001 110.446 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.4 m -57.33 -48.53 78.72 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.066 -0.516 . . . . 1.1599999999999999 110.343 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -73.22 -31.82 64.38 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.948 -0.569 . . . . 2.4700000000000002 109.876 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.485 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 0.9 OUTLIER -56.03 -30.43 61.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.368 -0.833 . . . . 0.22 111.817 -179.883 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -43.22 -19.99 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.244 0.461 . . . . 2.8799999999999999 112.244 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.668 ' N ' HD21 ' A' ' 21' ' ' ASN . 0.8 OUTLIER -68.6 -34.03 75.08 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.462 0.542 . . . . 0.40000000000000002 112.462 -178.627 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.485 ' HG2' ' O ' ' A' ' 19' ' ' ASN . 38.3 mmtt -46.7 119.46 5.58 Favored Pre-proline 0 N--CA 1.463 0.198 0 CA-C-O 120.527 0.203 . . . . 1.9299999999999999 110.899 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.432 ' HD2' ' HE2' ' A' ' 35' ' ' LYS . 40.5 Cg_exo -57.0 135.6 71.79 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.006 1.804 . . . . 1.0600000000000001 112.049 179.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.31 3.24 78.92 Favored Glycine 0 CA--C 1.52 0.362 0 C-N-CA 120.755 -0.736 . . . . 0.40999999999999998 113.949 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.458 HG21 ' O ' ' A' ' 22' ' ' LYS . 8.9 t -52.05 111.57 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 117.606 0.703 . . . . 1.6000000000000001 110.218 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.1 p -127.46 133.69 67.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.891 -0.595 . . . . 1.6599999999999999 111.078 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.6 p -85.77 141.91 13.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.953 -0.567 . . . . 1.5600000000000001 110.968 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.564 HD11 ' HB2' ' A' ' 32' ' ' LEU . 64.5 mt -99.66 166.61 12.53 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 1.0800000000000001 110.782 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.417 ' HD2' ' HB3' ' A' ' 28' ' ' LEU . 52.4 Cg_exo -53.14 -30.57 50.95 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 121.908 1.739 . . . . 0.65000000000000002 111.513 178.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 39.8 t -86.02 -12.74 49.48 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.014 -0.539 . . . . 1.75 111.031 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.05 14.42 24.64 Favored Glycine 0 C--N 1.334 0.436 0 C-N-CA 120.464 -0.874 . . . . 0.34999999999999998 114.313 178.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.564 ' HB2' HD11 ' A' ' 28' ' ' LEU . 6.6 mp -85.11 139.26 31.85 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.098 0.777 . . . . 2.0 113.098 -179.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -116.01 144.18 44.45 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.918 -1.037 . . . . 2.3199999999999998 108.438 177.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.547 ' HB3' HG23 ' A' ' 101' ' ' ILE . 15.5 p90 -160.29 175.37 12.93 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.898 0.703 . . . . 0.92000000000000004 112.898 -178.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.432 ' HE2' ' HD2' ' A' ' 23' ' ' PRO . 24.5 tttm -121.93 116.77 24.96 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.006 -0.997 . . . . 2.6800000000000002 109.413 178.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.7 t -77.87 126.17 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 113.188 0.81 . . . . 0.77000000000000002 113.188 -178.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.415 HD13 HG23 ' A' ' 98' ' ' THR . 83.5 mt -101.9 -65.69 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.562 -0.745 . . . . 1.46 110.733 178.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -148.39 80.63 1.46 Allowed 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 120.845 0.355 . . . . 1.05 111.002 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.526 ' HB2' ' NE1' ' A' ' 99' ' ' TRP . 38.9 t -106.96 146.14 31.43 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.254 -0.43 . . . . 2.02 111.968 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 99.27 100.38 2.25 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.834 -0.698 . . . . 1.0900000000000001 113.135 178.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -177.93 -57.39 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 120.671 0.272 . . . . 1.7 111.617 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.27 165.47 31.45 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.833 -0.699 . . . . 0.40000000000000002 114.073 -178.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.561 ' O ' ' HB3' ' A' ' 44' ' ' LYS . 2.7 t -90.5 175.34 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 123.324 0.65 . . . . 2.0299999999999998 109.733 179.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.561 ' HB3' ' O ' ' A' ' 43' ' ' VAL . 18.5 ptmt 164.65 156.87 0.07 OUTLIER Pre-proline 0 N--CA 1.47 0.557 0 CA-C-O 121.475 0.655 . . . . 2.7400000000000002 112.324 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.449 ' HD2' ' CB ' ' A' ' 49' ' ' ASP . 2.1 Cg_endo -84.43 174.25 8.04 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 124.908 3.739 . . . . 0.34000000000000002 113.21 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.51 ' O ' ' N ' ' A' ' 48' ' ' SER . . . -67.47 -172.03 5.72 Favored Glycine 0 C--O 1.225 -0.42 0 CA-C-N 115.326 -0.852 . . . . 0.38 111.356 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.537 ' HG2' ' HB2' ' A' ' 91' ' ' GLN . 33.9 mtmm -41.26 -13.18 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 113.499 0.926 . . . . 2.9399999999999999 113.499 -177.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.51 ' N ' ' O ' ' A' ' 46' ' ' GLY . 47.2 t -85.75 7.08 25.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.085 0.469 . . . . 1.8999999999999999 110.313 178.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.449 ' CB ' ' HD2' ' A' ' 45' ' ' PRO . 3.5 p30 -77.34 150.32 35.19 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.568 -0.742 . . . . 1.73 112.048 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 86.1 m -126.47 119.25 26.74 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.657 -0.868 . . . . 0.92000000000000004 108.657 178.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.501 HG11 ' HA ' ' A' ' 133' ' ' VAL . 12.2 m -124.34 158.47 31.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.443 0.534 . . . . 1.22 112.443 -178.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 83.7 m -112.65 120.89 43.09 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.748 -0.834 . . . . 1.05 108.748 178.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.641 HG12 HD21 ' A' ' 130' ' ' LEU . 12.3 m -141.9 179.85 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.393 0.616 . . . . 1.05 112.043 -178.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -127.09 132.34 50.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.149 -0.932 . . . . 2.3999999999999999 109.236 178.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -146.49 161.1 41.17 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.614 0.721 . . . . 0.93999999999999995 112.184 -179.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 57.9 m -126.99 112.34 15.13 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.621 -1.172 . . . . 1.0600000000000001 108.677 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.43 ' O ' HG22 ' A' ' 64' ' ' VAL . . . -111.41 146.25 17.78 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.045 -1.074 . . . . 0.14000000000000001 112.986 -178.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.48 ' NE ' HD11 ' A' ' 125' ' ' ILE . 3.2 ppt_? -148.03 148.4 30.65 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.817 0.342 . . . . 2.6899999999999999 110.17 179.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.408 ' C ' ' H ' ' A' ' 61' ' ' ASP . 19.3 mt -77.51 160.87 28.34 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.102 -0.499 . . . . 1.77 109.991 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.494 ' HB ' ' O ' ' A' ' 123' ' ' THR . 8.0 tp -59.1 -11.43 2.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.211 -0.662 . . . . 1.3700000000000001 109.211 178.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.408 ' H ' ' C ' ' A' ' 59' ' ' LEU . 8.1 m-20 -65.69 -11.31 44.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.081 -0.963 . . . . 2.0099999999999998 110.774 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.46 -0.85 78.34 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.665 -0.779 . . . . 0.45000000000000001 113.531 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.8 t -118.53 138.45 52.52 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 117.227 0.514 . . . . 1.99 111.579 -178.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.43 HG22 ' O ' ' A' ' 57' ' ' GLY . 6.0 p -64.2 133.15 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 115.822 -0.626 . . . . 1.0700000000000001 110.147 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.587 ' HD1' ' N ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -97.49 -22.53 16.5 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.09 -0.505 . . . . 0.25 110.739 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.587 ' N ' ' HD1' ' A' ' 65' ' ' PHE . 19.8 t70 -175.68 130.15 0.26 Allowed 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.262 -0.426 . . . . 0.29999999999999999 110.649 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 70.2 p -126.61 123.99 38.9 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.28 -0.418 . . . . 1.8100000000000001 110.721 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 70.8 p -90.55 -41.05 11.6 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.381 -0.372 . . . . 0.93000000000000005 111.002 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -70.87 -35.6 72.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 2.1099999999999999 111.147 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.9 tmtm? -63.03 -51.49 66.57 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.365 -0.379 . . . . 3.79 110.857 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 77.1 p -58.63 -19.56 40.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.29 -0.414 . . . . 2.1200000000000001 111.099 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.09 10.36 58.61 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.799 -0.715 . . . . 0.80000000000000004 112.437 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.644 ' HB3' ' HZ2' ' A' ' 73' ' ' LYS . 8.0 mtpm? -115.53 116.68 41.18 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.535 0.167 . . . . 3.52 110.678 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -58.88 144.97 98.44 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.274 1.983 . . . . 0.76000000000000001 112.085 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -94.6 124.25 38.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.206 -0.452 . . . . 0.76000000000000001 111.038 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.2 t -126.18 120.18 29.42 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.33 -0.395 . . . . 1.98 110.767 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -158.04 169.13 25.25 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.263 0.554 . . . . 0.44 111.863 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.604 HE21 ' N ' ' A' ' 79' ' ' VAL . 3.9 tp60 -87.96 145.29 26.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.32 -0.854 . . . . 1.8 109.168 178.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.604 ' N ' HE21 ' A' ' 78' ' ' GLN . 26.1 m -79.71 -27.42 12.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 113.111 0.782 . . . . 1.79 113.111 -177.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.598 ' H ' HE21 ' A' ' 78' ' ' GLN . 80.3 p -85.84 -2.08 57.89 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 111.743 0.275 . . . . 1.6100000000000001 111.743 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.411 ' NE2' ' HG2' ' A' ' 78' ' ' GLN . 1.2 mp0 -93.88 5.88 50.22 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.546 0.573 . . . . 2.4199999999999999 112.546 -178.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.6 -175.04 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 N-CA-C 112.244 0.461 . . . . 1.1799999999999999 112.244 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.499 HG13 ' H ' ' A' ' 86' ' ' TRP . 34.3 pt -56.32 158.17 8.09 Favored Pre-proline 0 N--CA 1.462 0.17 0 CA-C-N 115.962 -0.563 . . . . 1.5900000000000001 112.212 -179.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.453 ' HD2' ' HB ' ' A' ' 83' ' ' ILE . 6.2 Cg_endo -48.71 -50.28 12.87 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.868 2.379 . . . . 1.01 112.553 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.443 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -57.86 -49.11 77.43 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.671 -0.776 . . . . 0.35999999999999999 113.411 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . 0.499 ' H ' HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -62.51 -53.39 55.41 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.518 0.562 . . . . 0.98999999999999999 112.518 -178.457 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.0 t -52.9 -33.38 50.1 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.739 0.274 . . . . 1.8899999999999999 111.739 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -68.99 -50.71 46.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.528 -0.305 . . . . 1.4299999999999999 111.726 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.466 ' HB1' HD23 ' A' ' 32' ' ' LEU . . . -64.16 -45.46 88.34 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.932 0.345 . . . . 0.33000000000000002 111.932 -179.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.455 HD11 ' SD ' ' A' ' 93' ' ' MET . 4.3 mm? -56.59 -30.43 63.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.387 -0.369 . . . . 1.1599999999999999 111.483 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.537 ' HB2' ' HG2' ' A' ' 47' ' ' LYS . 7.8 tt0 -64.82 -23.93 67.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.404 -0.362 . . . . 2.23 111.15 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.407 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 9.1 mp -95.79 -7.84 36.0 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.145 -0.48 . . . . 2.0899999999999999 111.582 -179.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.48 ' HE2' HD11 ' A' ' 128' ' ' ILE . 60.4 mtt -88.79 107.79 19.48 Favored Pre-proline 0 N--CA 1.452 -0.344 0 CA-C-N 116.719 -0.219 . . . . 2.2799999999999998 111.517 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.414 ' HA ' ' CD ' ' A' ' 44' ' ' LYS . 95.7 Cg_endo -79.86 145.27 17.73 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.651 2.234 . . . . 0.72999999999999998 111.817 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.461 ' HB3' ' HA ' ' A' ' 132' ' ' SER . . . -46.94 127.27 9.89 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 120.649 0.262 . . . . 1.21 110.973 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 96.71 -5.39 64.24 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 120.689 -0.767 . . . . 0.34000000000000002 112.997 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.418 ' OG ' ' N ' ' A' ' 98' ' ' THR . 11.2 t -74.78 177.8 5.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.837 0.351 . . . . 1.8899999999999999 111.117 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.418 ' N ' ' OG ' ' A' ' 97' ' ' SER . 18.8 m -151.38 92.86 1.83 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.045 -0.525 . . . . 0.88 110.444 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.526 ' NE1' ' HB2' ' A' ' 39' ' ' SER . 24.2 m0 -116.6 149.18 40.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.171 0.51 . . . . 0.67000000000000004 111.867 -179.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -120.99 108.03 13.37 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.758 -1.201 . . . . 1.53 107.758 176.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.547 HG23 ' HB3' ' A' ' 34' ' ' TYR . 46.2 pt -107.6 139.44 29.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 113.112 0.782 . . . . 0.72999999999999998 113.112 -177.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.444 ' O ' ' HD3' ' A' ' 104' ' ' PRO . 0.1 OUTLIER -117.89 103.9 10.41 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.734 -1.21 . . . . 0.91000000000000003 107.734 177.294 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 39.6 t -97.84 105.53 27.85 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 113.39 0.885 . . . . 1.1399999999999999 113.39 -176.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.481 ' HA ' HG21 ' A' ' 123' ' ' THR . 33.4 Cg_exo -59.84 151.17 73.03 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.344 2.029 . . . . 0.68000000000000005 111.392 177.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.543 ' HB2' ' HA2' ' A' ' 110' ' ' GLY . 2.5 p -48.31 -43.13 32.78 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 111.969 0.359 . . . . 2.3700000000000001 111.969 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -57.21 -8.85 3.7 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 114.328 0.491 . . . . 0.40000000000000002 114.328 -178.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.57 -25.66 28.52 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.542 0.571 . . . . 2.9300000000000002 112.542 -178.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -127.73 -125.11 0.23 Allowed 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 121.033 -0.267 . . . . 1.3799999999999999 111.288 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.456 ' HB2' ' H ' ' A' ' 116' ' ' GLY . 47.2 m-85 -89.51 4.63 48.62 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 121.133 0.492 . . . . 1.6000000000000001 110.408 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.543 ' HA2' ' HB2' ' A' ' 105' ' ' SER . . . -37.5 -78.48 0.05 OUTLIER Glycine 0 CA--C 1.525 0.712 0 CA-C-N 115.134 -0.939 . . . . 2.3399999999999999 114.983 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.406 ' HA ' ' OD1' ' A' ' 121' ' ' ASN . 12.0 Cg_endo -56.19 -12.75 8.22 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.252 2.634 . . . . 1.9299999999999999 113.405 -178.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.47 ' C ' ' H ' ' A' ' 114' ' ' VAL . 3.3 mmp_? -82.39 139.75 33.87 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.888 -0.412 . . . . 3.8799999999999999 109.888 178.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 36.1 t -62.18 -4.51 1.77 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.105 0.479 . . . . 2.0800000000000001 110.607 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.47 ' H ' ' C ' ' A' ' 112' ' ' ARG . 6.4 t -111.09 55.21 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.453 -0.794 . . . . 3.4199999999999999 110.577 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -53.48 115.9 5.27 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.803 -0.713 . . . . 1.0900000000000001 112.651 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.456 ' H ' ' HB2' ' A' ' 109' ' ' TYR . . . -71.44 -125.51 0.06 OUTLIER Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.769 -0.729 . . . . 0.89000000000000001 112.142 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.54 -35.94 98.01 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.008 1.806 . . . . 1.0900000000000001 111.882 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.535 HG13 HD23 ' A' ' 124' ' ' LEU . 3.4 mp -91.88 131.19 39.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 1.8799999999999999 109.993 178.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -47.95 153.9 1.62 Allowed Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.934 -0.651 . . . . 0.56000000000000005 112.515 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.433 ' O ' ' HG3' ' A' ' 122' ' ' GLU . 29.1 Cg_endo -62.44 130.28 29.55 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.102 1.868 . . . . 0.84999999999999998 111.655 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.406 ' OD1' ' HA ' ' A' ' 111' ' ' PRO . 3.1 m-80 47.63 35.13 4.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.959 -0.564 . . . . 1.1200000000000001 110.24 -179.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.544 ' HG2' ' HB3' ' A' ' 8' ' ' ASN . 43.1 mt-10 -115.23 132.55 56.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.831 -0.622 . . . . 1.8200000000000001 111.279 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.494 ' O ' ' HB ' ' A' ' 60' ' ' ILE . 87.6 m -95.11 127.53 41.23 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.929 -0.767 . . . . 1.0900000000000001 108.929 178.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.535 HD23 HG13 ' A' ' 118' ' ' ILE . 6.5 mp -116.72 157.81 24.86 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.197 0.522 . . . . 2.1000000000000001 112.092 -178.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.48 HD11 ' NE ' ' A' ' 58' ' ' ARG . 4.5 mp -114.21 142.87 25.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.438 -0.801 . . . . 1.0600000000000001 109.617 178.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -135.35 132.26 37.41 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.089 0.471 . . . . 0.28999999999999998 111.717 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 24.4 tptm -108.67 103.55 12.67 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.565 -0.902 . . . . 2.77 108.565 178.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.48 HD11 ' HE2' ' A' ' 93' ' ' MET . 9.1 mt -102.76 122.38 55.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 113.007 0.743 . . . . 1.5600000000000001 113.007 -177.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -116.89 100.31 7.68 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.378 -0.971 . . . . 0.29999999999999999 108.378 177.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.641 HD21 HG12 ' A' ' 53' ' ' VAL . 0.2 OUTLIER -77.95 121.32 24.02 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.926 -0.579 . . . . 2.0299999999999998 111.545 -178.042 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 48.3 mm -93.47 -57.45 4.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.018 -0.537 . . . . 1.8899999999999999 110.092 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.461 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 59.8 p -164.67 163.11 21.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.108 -0.496 . . . . 1.75 111.449 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.501 ' HA ' HG11 ' A' ' 51' ' ' VAL . 11.0 p -107.74 135.14 47.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.691 -0.686 . . . . 2.1299999999999999 110.094 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.44 ' C ' ' H ' ' A' ' 136' ' ' SER . 58.9 pttt 38.5 -149.07 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 O-C-N 123.243 0.339 . . . . 3.5600000000000001 111.234 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.403 ' HD2' ' N ' ' A' ' 135' ' ' LYS . 1.0 OUTLIER -78.21 13.48 1.47 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.058 0.456 . . . . 3.6699999999999999 110.261 179.133 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.44 ' H ' ' C ' ' A' ' 134' ' ' LYS . 47.2 t 65.43 67.03 0.51 Allowed 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.487 -0.778 . . . . 1.6000000000000001 110.925 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.41 ' H ' ' HE3' ' A' ' 134' ' ' LYS . 35.8 m . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.213 -0.899 . . . . 2.7799999999999998 110.863 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 120.847 0.356 . . . . 3.73 110.889 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -68.47 -18.61 64.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.105 -0.498 . . . . 2.0800000000000001 111.103 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.58 ' HZ2' ' HB3' ' A' ' 3' ' ' LYS . 8.2 mtpm? -57.45 -40.86 79.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.21 0.528 . . . . 3.7599999999999998 109.823 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -79.98 -37.17 34.89 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.633 -0.712 . . . . 3.1499999999999999 110.367 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -55.5 -51.68 66.19 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.014 -0.539 . . . . 1.27 110.169 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -67.38 -36.52 81.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.842 -0.617 . . . . 2.5699999999999998 109.93 179.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -56.34 -32.8 65.04 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.119 -0.697 . . . . 2.1400000000000001 109.119 178.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.476 ' HA ' ' HG2' ' A' ' 11' ' ' LYS . 50.3 m-20 -72.72 -38.51 67.44 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.276 -0.875 . . . . 1.3999999999999999 110.63 179.334 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -56.31 -37.83 70.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.008 -0.542 . . . . 3.2400000000000002 111.595 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.9 t -77.69 -52.54 16.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 112.047 0.388 . . . . 1.9199999999999999 112.047 -179.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.482 ' HE2' HG13 ' A' ' 60' ' ' ILE . 21.3 ptmt -61.13 -29.72 69.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.544 -0.298 . . . . 2.1499999999999999 111.683 -179.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.26 -52.88 5.9 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.569 -0.824 . . . . 0.33000000000000002 112.005 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -63.98 -26.59 68.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.968 0.413 . . . . 2.3900000000000001 110.406 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.0 -39.31 50.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.958 -0.565 . . . . 0.92000000000000004 110.53 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -59.13 -51.03 71.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.992 -0.549 . . . . 0.27000000000000002 110.324 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.498 ' HA ' ' HB3' ' A' ' 19' ' ' ASN . 4.2 pp -64.9 -34.44 78.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.309 -0.405 . . . . 1.3100000000000001 110.577 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.2 m -57.5 -48.8 78.28 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.211 -0.449 . . . . 1.1599999999999999 110.201 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -73.2 -32.05 64.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.81 -0.632 . . . . 2.4700000000000002 109.986 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.498 ' HB3' ' HA ' ' A' ' 16' ' ' LEU . 0.8 OUTLIER -57.58 -27.39 62.66 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.53 -0.759 . . . . 0.22 111.317 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.1 mttm -46.71 -19.85 0.11 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.302 -0.408 . . . . 2.8799999999999999 111.884 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.699 ' N ' HD21 ' A' ' 21' ' ' ASN . 0.7 OUTLIER -68.58 -30.26 68.98 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.469 0.544 . . . . 0.40000000000000002 112.469 -178.491 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.487 ' HG2' ' O ' ' A' ' 19' ' ' ASN . 18.6 mmtp -53.75 118.76 16.01 Favored Pre-proline 0 N--CA 1.464 0.246 0 C-N-CA 121.245 -0.182 . . . . 1.9299999999999999 110.766 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.28 140.73 95.48 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.343 2.029 . . . . 1.0600000000000001 112.523 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.91 3.84 79.47 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.743 -0.742 . . . . 0.40999999999999998 114.318 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.495 HG23 ' HH ' ' A' ' 102' ' ' TYR . 7.0 t -52.4 112.21 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 117.602 0.701 . . . . 1.6000000000000001 110.667 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -118.93 131.03 72.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.904 -0.589 . . . . 1.6599999999999999 111.669 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.2 t -89.27 132.85 32.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.777 -0.647 . . . . 1.5600000000000001 110.49 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.536 HD11 ' HB2' ' A' ' 32' ' ' LEU . 66.1 mt -94.71 163.48 22.36 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.406 -0.361 . . . . 1.0800000000000001 110.925 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -51.81 -30.66 39.05 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.25 1.967 . . . . 0.65000000000000002 112.019 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.8 m -85.49 -13.28 49.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.114 -0.494 . . . . 1.75 111.36 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.637 ' HA2' HD23 ' A' ' 107' ' ' LEU . . . 104.84 15.79 19.21 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.134 -1.031 . . . . 0.34999999999999998 113.874 179.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.536 ' HB2' HD11 ' A' ' 28' ' ' LEU . 2.4 mp -83.34 138.74 33.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.373 0.606 . . . . 2.0 112.243 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -119.22 138.93 52.64 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.158 -0.928 . . . . 2.3199999999999998 108.623 177.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.49 ' HB3' HG23 ' A' ' 101' ' ' ILE . 16.8 p90 -160.61 175.52 12.59 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.206 0.527 . . . . 0.92000000000000004 112.301 -178.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -121.45 117.08 25.98 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.37 -0.832 . . . . 2.6800000000000002 109.591 178.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 67.8 t -73.49 125.97 33.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 113.473 0.916 . . . . 0.77000000000000002 113.473 -178.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 63.2 mt -103.63 -66.7 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.434 -0.803 . . . . 1.46 110.049 178.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 37.7 t30 -130.96 91.92 3.13 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 116.337 -0.392 . . . . 1.05 110.164 178.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.696 ' HB3' ' HE1' ' A' ' 99' ' ' TRP . 96.3 p -105.41 144.83 31.64 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.204 0.446 . . . . 2.02 112.204 -178.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.498 ' HA3' ' HG3' ' A' ' 94' ' ' PRO . . . 80.44 98.55 0.33 Allowed Glycine 0 C--N 1.332 0.351 0 CA-C-N 115.823 -0.626 . . . . 1.0900000000000001 113.141 178.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -151.48 -82.29 0.1 Allowed 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 111.75 0.278 . . . . 1.7 111.75 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.47 -178.83 42.56 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 121.142 -0.551 . . . . 0.40000000000000002 114.098 -178.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.468 ' O ' ' HB3' ' A' ' 44' ' ' LYS . 0.2 OUTLIER -90.32 177.73 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 123.667 0.787 . . . . 2.0299999999999998 110.439 178.937 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.517 ' HB3' HG13 ' A' ' 133' ' ' VAL . 0.0 OUTLIER 165.92 155.24 0.09 OUTLIER Pre-proline 0 N--CA 1.47 0.545 0 CA-C-O 121.668 0.747 . . . . 2.7400000000000002 112.419 -179.681 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.443 ' HD2' ' CB ' ' A' ' 49' ' ' ASP . 2.3 Cg_endo -85.72 173.39 7.28 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 125.102 3.868 . . . . 0.34000000000000002 113.39 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.493 ' O ' ' N ' ' A' ' 48' ' ' SER . . . -68.1 -172.57 6.85 Favored Glycine 0 C--O 1.225 -0.461 0 CA-C-N 115.109 -0.95 . . . . 0.38 111.453 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.484 ' O ' HG11 ' A' ' 79' ' ' VAL . 55.8 mttp -41.71 -13.22 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 113.603 0.964 . . . . 2.9399999999999999 113.603 -178.058 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.493 ' N ' ' O ' ' A' ' 46' ' ' GLY . 39.2 t -86.45 6.92 28.04 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.065 0.46 . . . . 1.8999999999999999 110.625 178.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.443 ' CB ' ' HD2' ' A' ' 45' ' ' PRO . 3.1 p30 -76.63 155.88 33.13 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.776 -0.647 . . . . 1.73 111.487 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.548 ' HB ' ' HG2' ' A' ' 134' ' ' LYS . 33.1 m -125.07 122.27 36.74 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.347 -0.983 . . . . 0.92000000000000004 108.347 178.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.406 HG13 ' HA ' ' A' ' 133' ' ' VAL . 34.0 m -126.78 151.34 33.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 112.826 0.676 . . . . 1.22 112.826 -177.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 95.5 m -114.1 120.96 42.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.05 -0.977 . . . . 1.05 109.152 178.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.445 HG11 ' HA ' ' A' ' 130' ' ' LEU . 3.1 m -142.13 176.88 3.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.149 0.5 . . . . 1.05 111.742 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -126.15 132.03 51.92 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.462 -0.79 . . . . 2.3999999999999999 108.969 178.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -145.56 165.37 28.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.606 0.717 . . . . 0.93999999999999995 112.125 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 88.5 m -130.02 113.47 14.6 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.606 -1.179 . . . . 1.0600000000000001 108.491 178.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -110.62 144.32 17.15 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 119.838 -1.173 . . . . 0.14000000000000001 113.065 -178.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.521 ' NH2' ' HA3' ' A' ' 62' ' ' GLY . 0.1 OUTLIER -147.47 146.83 29.67 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.794 0.331 . . . . 2.6899999999999999 110.192 179.037 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.439 ' HA ' ' HG ' ' A' ' 124' ' ' LEU . 9.8 mt -80.14 157.67 26.55 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.196 -0.456 . . . . 1.77 110.327 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.487 ' HB ' ' O ' ' A' ' 123' ' ' THR . 9.7 tp -59.1 -10.93 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.41 -0.589 . . . . 1.3700000000000001 109.41 178.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.416 ' H ' ' C ' ' A' ' 59' ' ' LEU . 21.3 t70 -66.39 -9.76 36.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.281 -0.872 . . . . 2.0099999999999998 110.673 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.521 ' HA3' ' NH2' ' A' ' 58' ' ' ARG . . . 90.98 -0.23 75.73 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.516 -0.85 . . . . 0.45000000000000001 113.317 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.5 t -121.51 138.71 54.18 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 117.357 0.578 . . . . 1.99 111.702 -178.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.3 p -66.86 133.34 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-N 115.654 -0.703 . . . . 1.0700000000000001 109.979 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.672 ' HD1' ' H ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -97.93 -27.25 14.35 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.271 -0.422 . . . . 0.25 111.523 -179.74 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.672 ' H ' ' HD1' ' A' ' 65' ' ' PHE . 25.0 t70 -177.25 130.74 0.17 Allowed 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 116.709 -0.223 . . . . 0.29999999999999999 110.564 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 68.0 m -134.61 124.51 25.52 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.791 0.329 . . . . 1.8100000000000001 111.12 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 80.9 p -86.14 -12.99 48.47 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.072 0.463 . . . . 0.93000000000000005 110.391 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.89 -48.28 25.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.705 -0.68 . . . . 2.1099999999999999 111.303 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -64.57 -37.86 89.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.111 -0.495 . . . . 3.79 111.418 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 62.9 p -60.23 -14.58 18.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.47 -0.332 . . . . 2.1200000000000001 111.405 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.92 8.02 88.05 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.779 -0.724 . . . . 0.80000000000000004 112.624 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -123.44 118.35 27.6 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 120.268 0.08 . . . . 3.52 110.874 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.62 150.05 45.82 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.42 2.08 . . . . 0.76000000000000001 112.447 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -94.76 126.65 40.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 0.76000000000000001 111.344 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 78.7 m -118.51 115.72 25.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.388 -0.369 . . . . 1.98 110.901 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -150.58 148.66 28.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.309 -0.405 . . . . 0.44 111.396 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.497 HE21 ' H ' ' A' ' 80' ' ' SER . 0.0 OUTLIER -81.78 141.77 33.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.819 -0.628 . . . . 1.8 110.107 179.364 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.494 HG21 ' HB2' ' A' ' 90' ' ' LEU . 2.6 p -64.26 -24.95 36.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.273 -0.421 . . . . 1.79 112.126 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.497 ' H ' HE21 ' A' ' 78' ' ' GLN . 47.3 t -90.93 -9.72 45.1 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.718 0.266 . . . . 1.6100000000000001 111.718 -179.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -91.99 5.8 48.77 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.991 0.367 . . . . 2.4199999999999999 111.991 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 10.5 m -116.24 -178.46 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 112.279 0.474 . . . . 1.1799999999999999 112.279 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.495 ' O ' HG21 ' A' ' 87' ' ' THR . 24.8 pt -56.6 155.87 13.29 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 115.915 -0.584 . . . . 1.5900000000000001 112.035 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -48.16 -60.24 0.95 Allowed 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.211 2.607 . . . . 1.01 113.168 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.487 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -44.39 -48.82 8.5 Favored Glycine 0 CA--C 1.522 0.497 0 C-N-CA 120.596 -0.812 . . . . 0.35999999999999999 112.17 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 1.1 m0 -62.44 -36.63 83.02 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.014 0.375 . . . . 0.98999999999999999 112.014 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.495 HG21 ' O ' ' A' ' 83' ' ' ILE . 30.5 p -58.7 -40.21 83.0 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 121.03 -0.268 . . . . 1.8899999999999999 111.609 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -70.46 -51.67 27.54 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.494 0.553 . . . . 1.4299999999999999 112.494 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.79 -52.41 51.05 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.381 0.511 . . . . 0.33000000000000002 112.381 -178.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.526 HD11 ' SD ' ' A' ' 93' ' ' MET . 4.2 mm? -57.6 -25.72 60.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.334 -0.394 . . . . 1.1599999999999999 111.779 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 21.5 tm0? -81.58 -19.36 42.14 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.754 0.279 . . . . 2.23 111.754 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 98.2 mt -90.25 -22.16 21.76 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.77 0.285 . . . . 2.0899999999999999 111.77 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.526 ' SD ' HD11 ' A' ' 90' ' ' LEU . 15.4 ptp -81.75 121.01 79.11 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-O 120.555 0.217 . . . . 2.2799999999999998 111.511 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.498 ' HG3' ' HA3' ' A' ' 40' ' ' GLY . 92.8 Cg_endo -80.4 147.51 18.04 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.767 2.312 . . . . 0.72999999999999998 111.791 179.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.458 ' HB3' ' HA ' ' A' ' 132' ' ' SER . . . -45.79 126.46 7.12 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.707 0.289 . . . . 1.21 111.151 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 97.84 -2.38 60.14 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 120.82 -0.705 . . . . 0.34000000000000002 113.024 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.414 ' OG ' ' HB2' ' A' ' 93' ' ' MET . 83.0 p -79.42 -174.47 4.24 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.934 0.397 . . . . 1.8899999999999999 111.563 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.5 m -159.89 105.79 1.59 Allowed 'General case' 0 C--O 1.231 0.085 0 CA-C-N 116.029 -0.532 . . . . 0.88 111.001 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.696 ' HE1' ' HB3' ' A' ' 39' ' ' SER . 40.0 m0 -126.9 149.37 49.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.04 0.448 . . . . 0.67000000000000004 111.781 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -117.8 107.91 14.71 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 107.847 -1.168 . . . . 1.53 107.847 177.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.49 HG23 ' HB3' ' A' ' 34' ' ' TYR . 43.3 pt -109.35 140.05 29.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 113.515 0.932 . . . . 0.72999999999999998 113.515 -177.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.495 ' HH ' HG23 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -116.41 103.57 10.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.76 -1.109 . . . . 0.91000000000000003 108.031 177.542 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.465 HG21 HD21 ' A' ' 32' ' ' LEU . 9.6 t -102.53 102.74 27.67 Favored Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 113.191 0.812 . . . . 1.1399999999999999 113.191 -177.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -62.0 151.73 79.67 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.101 1.868 . . . . 0.68000000000000005 110.774 177.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -48.34 -42.5 31.54 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 111.883 0.327 . . . . 2.3700000000000001 111.883 -179.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -57.27 -10.07 5.06 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.982 -0.628 . . . . 0.40000000000000002 113.315 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.637 HD23 ' HA2' ' A' ' 31' ' ' GLY . 0.2 OUTLIER -103.6 -15.89 15.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.766 0.317 . . . . 2.9300000000000002 111.504 -179.575 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -109.19 -104.17 0.37 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.503 -0.317 . . . . 1.3799999999999999 111.173 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -89.42 -17.43 28.78 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.836 0.35 . . . . 1.6000000000000001 110.73 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 102.76 151.52 23.38 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.949 -0.644 . . . . 2.3399999999999999 114.332 178.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.62 -6.52 3.31 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.846 3.031 . . . . 1.9299999999999999 113.262 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.578 ' C ' ' H ' ' A' ' 114' ' ' VAL . 99.3 mtt180 -74.87 170.61 15.59 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.799 0.333 . . . . 3.8799999999999999 110.88 -178.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 78.4 p -63.0 11.85 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.947 -0.57 . . . . 2.0800000000000001 112.0 -179.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.578 ' H ' ' C ' ' A' ' 112' ' ' ARG . 30.0 m -102.53 19.51 3.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.902 0.382 . . . . 3.4199999999999999 110.692 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -62.42 103.91 0.68 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.906 -0.664 . . . . 1.0900000000000001 112.13 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.22 -110.0 0.01 OUTLIER Glycine 0 CA--C 1.52 0.39 0 C-N-CA 120.862 -0.685 . . . . 0.89000000000000001 112.4 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -62.95 -34.93 69.42 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.138 1.892 . . . . 1.0900000000000001 111.573 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.612 HG22 HD11 ' A' ' 124' ' ' LEU . 92.8 mt -90.75 124.18 43.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.753 -0.658 . . . . 1.8799999999999999 110.261 179.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -48.56 156.59 1.21 Allowed Glycine 0 C--N 1.331 0.304 0 CA-C-N 116.097 -0.501 . . . . 0.56000000000000005 113.048 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -62.05 131.43 34.72 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.373 2.048 . . . . 0.84999999999999998 111.653 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 50.14 34.41 8.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.272 -0.422 . . . . 1.1200000000000001 110.259 -178.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -115.91 127.11 54.74 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.341 -0.39 . . . . 1.8200000000000001 111.738 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.487 ' O ' ' HB ' ' A' ' 60' ' ' ILE . 97.3 m -90.72 128.63 36.73 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.376 -0.972 . . . . 1.0900000000000001 108.376 177.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.612 HD11 HG22 ' A' ' 118' ' ' ILE . 0.1 OUTLIER -113.35 156.45 23.39 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.829 0.677 . . . . 2.1000000000000001 112.829 -177.577 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 5.1 mp -114.78 138.41 45.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 114.973 -1.012 . . . . 1.0600000000000001 109.228 177.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.411 ' CE1' HD23 ' A' ' 124' ' ' LEU . 68.7 m-85 -131.51 132.47 44.22 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.95 0.405 . . . . 0.28999999999999998 111.893 -178.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -109.12 103.62 12.66 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.521 -0.918 . . . . 2.77 108.521 178.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 19.6 mt -104.11 122.92 57.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 112.974 0.731 . . . . 1.5600000000000001 112.974 -177.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -118.43 99.29 6.73 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.508 -0.923 . . . . 0.29999999999999999 108.508 177.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.445 ' HA ' HG11 ' A' ' 53' ' ' VAL . 20.2 tp -79.56 120.24 23.64 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.889 -0.596 . . . . 2.0299999999999998 111.365 -178.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 50.1 mm -89.75 -56.45 5.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.895 -0.593 . . . . 1.8899999999999999 110.561 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.458 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 2.1 m -161.11 165.4 29.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.203 -0.453 . . . . 1.75 110.802 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.517 HG13 ' HB3' ' A' ' 44' ' ' LYS . 7.2 p -111.66 121.38 64.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.048 -0.524 . . . . 2.1299999999999999 111.663 -179.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.548 ' HG2' ' HB ' ' A' ' 50' ' ' THR . 34.0 mtpt 43.42 65.72 0.93 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.908 -0.587 . . . . 3.5600000000000001 111.097 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 95.5 mttt 59.53 30.84 20.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.904 -0.589 . . . . 3.6699999999999999 111.09 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 42.0 t 55.86 65.2 1.51 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.884 -0.598 . . . . 1.6000000000000001 111.096 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 58.7 m . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.211 -0.9 . . . . 2.7799999999999998 110.871 179.97 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.81 0.338 . . . . 3.73 110.921 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.499 ' HA ' ' HB3' ' A' ' 5' ' ' ALA . 6.6 p30 -69.26 -22.6 63.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.433 . . . . 2.0800000000000001 111.136 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.518 ' HD3' ' H ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -61.85 -38.96 90.16 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.232 -0.655 . . . . 3.7599999999999998 109.232 178.773 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.458 ' N ' ' HG2' ' A' ' 3' ' ' LYS . 88.4 tttt -80.0 -34.97 38.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.463 -0.79 . . . . 3.1499999999999999 109.936 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.499 ' HB3' ' HA ' ' A' ' 2' ' ' ASN . . . -62.37 -41.74 98.86 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.718 -0.674 . . . . 1.27 110.428 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -74.83 -31.5 61.69 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.261 -0.427 . . . . 2.5699999999999998 110.419 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.441 ' HG3' ' HE3' ' A' ' 11' ' ' LYS . 9.6 tp10 -55.93 -40.75 73.59 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.767 -0.457 . . . . 2.1400000000000001 109.767 179.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.517 ' HA ' ' HG2' ' A' ' 11' ' ' LYS . 25.7 p30 -78.64 -29.28 45.71 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.193 -0.458 . . . . 1.3999999999999999 110.44 179.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 121' ' ' ASN . 64.5 tttp -61.16 -39.57 90.6 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.104 -0.498 . . . . 3.2400000000000002 111.125 178.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.454 HG22 ' N ' ' A' ' 11' ' ' LYS . 27.4 m -77.46 -50.63 19.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 112.462 0.541 . . . . 1.9199999999999999 112.462 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.517 ' HG2' ' HA ' ' A' ' 8' ' ' ASN . 19.5 ptpt -64.95 -26.63 68.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.626 0.25 . . . . 2.1499999999999999 111.359 -179.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -75.05 -53.74 6.06 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.648 -0.787 . . . . 0.33000000000000002 112.206 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -63.52 -24.98 68.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.052 0.453 . . . . 2.3900000000000001 110.384 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.96 -42.38 33.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.795 -0.638 . . . . 0.92000000000000004 110.915 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -57.46 -48.47 79.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.202 -0.454 . . . . 0.27000000000000002 110.578 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.519 ' HA ' ' HB3' ' A' ' 19' ' ' ASN . 4.3 pp -67.64 -35.88 79.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.295 -0.411 . . . . 1.3100000000000001 110.74 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.408 ' O ' ' HD3' ' A' ' 20' ' ' LYS . 12.1 m -57.57 -48.34 79.63 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.114 0.483 . . . . 1.1599999999999999 109.854 178.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -72.28 -31.79 66.05 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.821 -0.627 . . . . 2.4700000000000002 109.809 178.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.525 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 0.8 OUTLIER -58.41 -27.09 63.98 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.744 -0.662 . . . . 0.22 111.378 179.902 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.408 ' HD3' ' O ' ' A' ' 17' ' ' THR . 55.3 mtpt -46.02 -20.0 0.08 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.423 -0.353 . . . . 2.8799999999999999 111.659 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.706 ' N ' HD21 ' A' ' 21' ' ' ASN . 0.7 OUTLIER -70.6 -33.16 70.74 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.346 0.499 . . . . 0.40000000000000002 112.346 -179.218 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.525 ' HG2' ' O ' ' A' ' 19' ' ' ASN . 44.3 mmtt -43.09 118.25 2.42 Favored Pre-proline 0 N--CA 1.467 0.377 0 CA-C-N 116.77 -0.196 . . . . 1.9299999999999999 111.373 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.448 ' HD2' ' HE2' ' A' ' 35' ' ' LYS . 18.8 Cg_endo -58.0 133.2 54.15 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.607 2.205 . . . . 1.0600000000000001 112.44 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.69 1.58 85.26 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.754 -0.736 . . . . 0.40999999999999998 113.177 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 34' ' ' TYR . 7.4 p -60.3 114.48 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 121.205 0.526 . . . . 1.6000000000000001 110.519 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.1 p -128.06 141.14 47.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.763 -0.653 . . . . 1.6599999999999999 111.291 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.5 p -89.51 140.59 15.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.13 -0.486 . . . . 1.5600000000000001 111.032 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.558 HD11 ' HB2' ' A' ' 32' ' ' LEU . 73.7 mt -96.92 167.61 11.75 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.036 -0.529 . . . . 1.0800000000000001 110.845 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.451 ' HD2' ' HB3' ' A' ' 28' ' ' LEU . 71.8 Cg_exo -52.25 -31.28 45.67 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 121.878 1.719 . . . . 0.65000000000000002 111.388 178.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.1 m -86.38 -11.83 50.92 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.842 -0.617 . . . . 1.75 111.142 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.28 13.32 28.95 Favored Glycine 0 CA--C 1.521 0.446 0 C-N-CA 120.483 -0.865 . . . . 0.34999999999999998 114.885 178.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.558 ' HB2' HD11 ' A' ' 28' ' ' LEU . 4.0 mp -83.44 134.86 34.85 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 117.882 0.841 . . . . 2.0 112.762 -178.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -114.4 140.69 48.47 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.065 -1.087 . . . . 2.3199999999999998 108.065 177.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.558 ' HB3' HG23 ' A' ' 101' ' ' ILE . 36.9 p90 -155.16 176.03 13.07 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 113.206 0.817 . . . . 0.92000000000000004 113.206 -177.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.448 ' HE2' ' HD2' ' A' ' 23' ' ' PRO . 33.8 tttm -120.75 116.89 26.12 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.012 -0.995 . . . . 2.6800000000000002 109.2 178.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.504 HG12 ' HE1' ' A' ' 99' ' ' TRP . 36.2 t -73.27 126.59 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 113.346 0.869 . . . . 0.77000000000000002 113.346 -177.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.51 HD13 HG21 ' A' ' 98' ' ' THR . 72.6 mt -104.6 -64.1 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 115.436 -0.802 . . . . 1.46 110.672 178.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.412 ' O ' ' HA ' ' A' ' 97' ' ' SER . 9.7 t30 -151.26 78.6 1.28 Allowed 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.653 0.263 . . . . 1.05 110.819 179.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.456 ' HB3' ' NE1' ' A' ' 99' ' ' TRP . 79.3 p -106.45 146.13 30.92 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.964 0.411 . . . . 2.02 112.076 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.434 ' H ' ' HG ' ' A' ' 97' ' ' SER . . . 97.55 99.71 2.03 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 121.025 -0.607 . . . . 1.0900000000000001 113.026 179.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -176.48 -62.1 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 111.776 0.287 . . . . 1.7 111.776 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.07 160.97 28.84 Favored Glycine 0 CA--C 1.518 0.281 0 C-N-CA 120.843 -0.694 . . . . 0.40000000000000002 113.858 -179.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.498 ' O ' ' HB3' ' A' ' 44' ' ' LYS . 0.2 OUTLIER -90.71 175.85 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 123.215 0.606 . . . . 2.0299999999999998 110.516 179.152 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.58 ' HD3' ' HA ' ' A' ' 94' ' ' PRO . 10.0 ptmm? 163.71 156.29 0.06 OUTLIER Pre-proline 0 N--CA 1.471 0.61 0 CA-C-O 121.427 0.632 . . . . 2.7400000000000002 111.933 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.422 ' HD2' ' HB2' ' A' ' 49' ' ' ASP . 7.2 Cg_exo -74.57 173.11 14.87 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 124.485 3.457 . . . . 0.34000000000000002 113.202 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 48' ' ' SER . . . -67.5 -172.56 6.06 Favored Glycine 0 C--O 1.224 -0.497 0 N-CA-C 110.895 -0.882 . . . . 0.38 110.895 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.414 ' O ' ' HB2' ' A' ' 80' ' ' SER . 24.2 pttm -41.61 -13.2 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.388 0.884 . . . . 2.9399999999999999 113.388 -178.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.522 ' N ' ' O ' ' A' ' 46' ' ' GLY . 60.4 m -86.12 7.74 23.62 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 121.036 0.446 . . . . 1.8999999999999999 110.376 178.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.422 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 3.3 p30 -77.84 160.2 28.47 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.656 -0.702 . . . . 1.73 111.611 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.521 ' HB ' ' HG3' ' A' ' 134' ' ' LYS . 48.3 m -126.34 119.5 27.49 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.814 -0.81 . . . . 0.92000000000000004 108.814 178.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.44 HG11 ' HA ' ' A' ' 133' ' ' VAL . 26.5 m -130.07 150.73 34.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.156 0.503 . . . . 1.22 112.319 -178.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 53.3 m -111.74 121.15 44.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.477 -0.783 . . . . 1.05 109.299 178.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.498 HG11 ' HA ' ' A' ' 130' ' ' LEU . 3.4 m -137.83 177.8 5.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.154 0.502 . . . . 1.05 111.772 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -126.55 132.9 51.24 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.441 -0.8 . . . . 2.3999999999999999 109.77 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -144.69 159.63 42.52 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.682 0.753 . . . . 0.93999999999999995 112.161 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 62.9 m -124.71 112.09 16.33 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.42 -1.263 . . . . 1.0600000000000001 108.412 178.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -110.63 141.38 16.35 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 119.813 -1.184 . . . . 0.14000000000000001 113.173 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.437 ' NE ' HD11 ' A' ' 125' ' ' ILE . 2.5 ppt_? -147.36 146.35 29.62 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.786 0.327 . . . . 2.6899999999999999 110.197 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.46 HD22 HD13 ' A' ' 124' ' ' LEU . 0.1 OUTLIER -73.31 163.48 28.02 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.038 -0.528 . . . . 1.77 110.38 -179.863 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.485 ' HB ' ' O ' ' A' ' 123' ' ' THR . 9.0 tp -59.4 -11.01 2.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.357 0.598 . . . . 1.3700000000000001 109.499 178.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.427 ' H ' ' C ' ' A' ' 59' ' ' LEU . 7.4 m-20 -71.73 -12.48 61.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.321 -0.854 . . . . 2.0099999999999998 110.979 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.413 ' HA3' HH11 ' A' ' 58' ' ' ARG . . . 90.02 -0.88 79.64 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.604 -0.808 . . . . 0.45000000000000001 112.921 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.3 m -110.18 128.46 55.49 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 120.92 0.391 . . . . 1.99 111.21 -178.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.1 p -61.0 130.7 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 115.968 -0.56 . . . . 1.0700000000000001 110.099 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.596 ' HD1' ' N ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -97.45 -21.92 16.87 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.976 -0.556 . . . . 0.25 110.912 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.596 ' N ' ' HD1' ' A' ' 65' ' ' PHE . 16.2 t70 -175.82 129.5 0.25 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.164 -0.471 . . . . 0.29999999999999999 110.559 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 30.2 p -132.21 122.28 24.99 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.279 -0.419 . . . . 1.8100000000000001 110.516 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.675 HG22 ' HB2' ' A' ' 75' ' ' ALA . 69.4 p -79.12 -29.17 43.06 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.426 -0.352 . . . . 0.93000000000000005 111.184 -179.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -69.74 -30.98 68.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.463 -0.335 . . . . 2.1099999999999999 110.922 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -71.26 -42.13 69.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 3.79 110.995 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 53.6 p -59.72 -18.93 46.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.908 0.385 . . . . 2.1200000000000001 110.947 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 92.55 2.74 67.33 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.918 -0.658 . . . . 0.80000000000000004 112.604 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -125.98 140.58 37.18 Favored Pre-proline 0 N--CA 1.453 -0.303 0 CA-C-O 120.929 0.395 . . . . 3.52 110.786 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -71.25 160.1 49.91 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.422 2.082 . . . . 0.76000000000000001 112.193 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.675 ' HB2' HG22 ' A' ' 68' ' ' THR . . . -93.63 124.82 37.88 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 116.13 -0.486 . . . . 0.76000000000000001 110.86 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.2 t -126.34 118.29 24.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.007 0.432 . . . . 1.98 110.946 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -157.63 154.28 28.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.118 -0.492 . . . . 0.44 111.578 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.538 HE21 ' H ' ' A' ' 80' ' ' SER . 0.0 OUTLIER -81.31 130.21 34.94 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.926 -0.768 . . . . 1.8 108.926 178.69 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.403 ' O ' HG23 ' A' ' 87' ' ' THR . 12.0 m -64.14 -6.5 2.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 112.851 0.686 . . . . 1.79 112.851 -178.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.538 ' H ' HE21 ' A' ' 78' ' ' GLN . 40.8 t -96.54 -14.0 22.58 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.503 0.557 . . . . 1.6100000000000001 112.503 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.495 HE21 ' HB2' ' A' ' 78' ' ' GLN . 50.6 mt-30 -97.43 5.76 49.24 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.839 0.681 . . . . 2.4199999999999999 112.839 -178.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 6.1 m -99.36 178.32 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.992 -0.283 . . . . 1.1799999999999999 111.744 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.476 HG13 ' HB2' ' A' ' 86' ' ' TRP . 26.8 pt -56.16 155.92 11.67 Favored Pre-proline 0 CA--C 1.531 0.225 0 CA-C-N 116.379 -0.373 . . . . 1.5900000000000001 111.646 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -45.75 -59.92 1.03 Allowed 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.191 2.594 . . . . 1.01 113.049 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.47 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -49.51 -49.08 33.81 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 120.701 -0.761 . . . . 0.35999999999999999 112.719 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . 0.476 ' HB2' HG13 ' A' ' 83' ' ' ILE . 0.6 OUTLIER -61.19 -46.5 90.21 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.325 0.491 . . . . 0.98999999999999999 112.325 -179.015 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.431 HG21 ' O ' ' A' ' 83' ' ' ILE . 71.6 p -54.92 -36.44 65.24 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 111.791 0.293 . . . . 1.8899999999999999 111.791 -179.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -70.46 -50.27 39.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.547 -0.297 . . . . 1.4299999999999999 111.654 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.473 ' HB1' HD21 ' A' ' 32' ' ' LEU . . . -63.5 -52.14 62.54 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.486 -0.324 . . . . 0.33000000000000002 111.852 -179.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -57.4 -30.02 64.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.16 -0.473 . . . . 1.1599999999999999 111.827 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -69.84 -17.81 63.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.444 -0.344 . . . . 2.23 111.391 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 89.5 mt -101.6 -7.52 22.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.293 -0.412 . . . . 2.0899999999999999 111.7 -179.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.432 ' O ' ' HD3' ' A' ' 44' ' ' LYS . 90.6 mtp -91.59 107.37 21.61 Favored Pre-proline 0 C--N 1.33 -0.26 0 N-CA-C 111.76 0.282 . . . . 2.2799999999999998 111.76 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.58 ' HA ' ' HD3' ' A' ' 44' ' ' LYS . 38.8 Cg_endo -69.44 142.71 50.1 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.032 1.822 . . . . 0.72999999999999998 110.799 178.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.474 ' HB3' ' HA ' ' A' ' 132' ' ' SER . . . -45.82 126.66 7.35 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.78 0.324 . . . . 1.21 111.511 -179.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 101.32 -2.75 54.27 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.636 -0.792 . . . . 0.34000000000000002 113.229 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.434 ' HG ' ' H ' ' A' ' 40' ' ' GLY . 74.9 m -76.35 -177.54 4.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.048 0.451 . . . . 1.8899999999999999 111.847 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.51 HG21 HD13 ' A' ' 37' ' ' ILE . 9.7 m -155.26 98.68 2.01 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.67 -0.696 . . . . 0.88 110.55 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.504 ' HE1' HG12 ' A' ' 36' ' ' VAL . 20.6 m0 -121.79 149.31 43.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.138 0.494 . . . . 0.67000000000000004 111.581 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -115.28 107.63 15.51 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.156 -1.053 . . . . 1.53 108.156 177.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.558 HG23 ' HB3' ' A' ' 34' ' ' TYR . 48.7 pt -110.14 145.94 16.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 113.339 0.866 . . . . 0.72999999999999998 113.339 -177.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -127.31 103.69 7.53 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.694 -1.139 . . . . 0.91000000000000003 108.099 178.138 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.452 HG21 HD22 ' A' ' 32' ' ' LEU . 2.4 t -104.7 98.88 16.11 Favored Pre-proline 0 CA--C 1.53 0.205 0 N-CA-C 113.448 0.907 . . . . 1.1399999999999999 113.448 -176.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.595 ' HD2' HD21 ' A' ' 107' ' ' LEU . 12.4 Cg_endo -58.6 151.92 59.29 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.0 1.8 . . . . 0.68000000000000005 110.507 177.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -47.73 -38.9 16.35 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.273 0.471 . . . . 2.3700000000000001 112.273 -178.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -57.29 -9.35 4.32 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.985 -0.626 . . . . 0.40000000000000002 113.288 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.595 HD21 ' HD2' ' A' ' 104' ' ' PRO . 6.5 mp -110.41 -13.85 14.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.668 0.27 . . . . 2.9300000000000002 111.52 -178.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -109.18 -104.1 0.37 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.55 -0.296 . . . . 1.3799999999999999 111.061 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -89.64 -17.08 29.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.768 0.318 . . . . 1.6000000000000001 111.026 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 107.64 145.02 11.68 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.889 -0.672 . . . . 2.3399999999999999 113.869 178.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.405 ' HA ' ' H ' ' A' ' 121' ' ' ASN . 28.1 Cg_endo -61.45 -8.55 10.98 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 123.579 2.852 . . . . 1.9299999999999999 113.299 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.574 ' C ' ' H ' ' A' ' 114' ' ' VAL . 84.3 mtm180 -75.95 171.21 14.82 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.879 0.371 . . . . 3.8799999999999999 110.969 -178.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 42.9 t -55.71 -0.6 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.861 -0.609 . . . . 2.0800000000000001 111.774 -179.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.574 ' H ' ' C ' ' A' ' 112' ' ' ARG . 2.8 t -91.91 19.47 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.181 0.515 . . . . 3.4199999999999999 110.226 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -62.59 112.06 4.58 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.794 -0.639 . . . . 1.0900000000000001 112.151 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -68.71 -113.93 0.02 OUTLIER Glycine 0 CA--C 1.521 0.438 0 C-N-CA 120.99 -0.624 . . . . 0.89000000000000001 112.743 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.6 -34.69 51.05 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.241 1.961 . . . . 1.0900000000000001 111.976 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.588 HD13 HD12 ' A' ' 124' ' ' LEU . 26.0 mm -90.65 125.16 43.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.482 . . . . 1.8799999999999999 110.567 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -44.81 155.33 0.35 Allowed Glycine 0 C--N 1.334 0.435 0 CA-C-N 115.724 -0.671 . . . . 0.56000000000000005 113.554 -179.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -60.82 132.75 44.05 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.444 2.096 . . . . 0.84999999999999998 111.437 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.423 ' HB2' ' OD1' ' A' ' 8' ' ' ASN . 1.4 m-80 47.71 35.73 4.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.231 -0.44 . . . . 1.1200000000000001 109.925 -178.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.457 ' HG3' HG23 ' A' ' 60' ' ' ILE . 41.1 tt0 -114.7 128.84 56.53 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.051 -0.522 . . . . 1.8200000000000001 111.394 -179.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.485 ' O ' ' HB ' ' A' ' 60' ' ' ILE . 87.4 m -95.44 129.58 42.55 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.184 -0.673 . . . . 1.0900000000000001 109.184 178.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.588 HD12 HD13 ' A' ' 118' ' ' ILE . 0.1 OUTLIER -120.33 159.9 24.1 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.104 0.478 . . . . 2.1000000000000001 111.956 -178.266 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.437 HD11 ' NE ' ' A' ' 58' ' ' ARG . 4.5 mp -114.6 143.44 24.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.657 -0.701 . . . . 1.0600000000000001 109.977 178.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -133.17 132.3 41.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.953 0.406 . . . . 0.28999999999999998 111.541 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 10.3 tmtt? -111.36 103.56 11.94 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.558 -0.904 . . . . 2.77 108.558 178.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 20.8 mt -102.68 122.92 55.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.91 0.707 . . . . 1.5600000000000001 112.91 -177.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -118.7 99.75 6.98 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.891 -0.781 . . . . 0.29999999999999999 108.891 177.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.498 ' HA ' HG11 ' A' ' 53' ' ' VAL . 0.7 OUTLIER -78.48 124.84 28.58 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.157 -0.474 . . . . 2.0299999999999998 111.558 -178.615 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 43.6 mm -94.06 -57.07 4.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.753 -0.658 . . . . 1.8899999999999999 110.735 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.474 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 4.3 m -163.68 166.07 22.62 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.951 0.405 . . . . 1.75 111.491 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.449 HG13 ' HB3' ' A' ' 44' ' ' LYS . 7.3 p -107.63 124.33 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 115.945 -0.57 . . . . 2.1299999999999999 111.012 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.521 ' HG3' ' HB ' ' A' ' 50' ' ' THR . 0.7 OUTLIER 33.36 73.16 0.07 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.057 -0.52 . . . . 3.5600000000000001 111.792 -179.5 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 95.4 mttt 60.48 29.91 19.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.863 -0.608 . . . . 3.6699999999999999 111.57 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.409 ' HB2' ' HB3' ' A' ' 132' ' ' SER . 46.9 t 55.41 67.78 0.96 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.055 -0.521 . . . . 1.6000000000000001 111.083 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 66.2 m . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.345 -0.836 . . . . 2.7799999999999998 110.889 179.964 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.593 0.235 . . . . 3.73 110.883 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -60.59 -35.36 75.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.554 -0.294 . . . . 2.0800000000000001 111.077 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -54.76 -37.93 66.59 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.274 -0.639 . . . . 3.7599999999999998 109.274 178.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -79.68 -34.97 39.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.433 -0.803 . . . . 3.1499999999999999 110.242 179.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -58.11 -52.0 67.36 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.092 -0.504 . . . . 1.27 109.977 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -64.85 -36.42 84.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.979 -0.555 . . . . 2.5699999999999998 110.008 178.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -55.88 -33.13 64.32 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.89 -0.781 . . . . 2.1400000000000001 108.89 178.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.482 ' HA ' ' HG2' ' A' ' 11' ' ' LYS . 53.2 m-20 -72.34 -38.24 68.65 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.165 -0.925 . . . . 1.3999999999999999 110.428 179.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.476 ' HZ2' ' HB3' ' A' ' 9' ' ' LYS . 4.2 ttpm? -57.27 -35.64 70.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.977 -0.556 . . . . 3.2400000000000002 111.212 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.9 t -76.35 -52.61 17.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 111.959 0.355 . . . . 1.9199999999999999 111.959 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.482 ' HG2' ' HA ' ' A' ' 8' ' ' ASN . 19.0 ptpt -58.59 -33.35 69.89 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.668 0.27 . . . . 2.1499999999999999 111.314 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.448 ' O ' ' HG ' ' A' ' 16' ' ' LEU . . . -76.39 -53.2 5.67 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.719 -0.753 . . . . 0.33000000000000002 112.329 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -61.08 -30.75 70.52 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.837 0.351 . . . . 2.3900000000000001 110.839 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.23 -32.09 55.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.319 -0.401 . . . . 0.92000000000000004 110.458 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -63.99 -54.53 32.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.938 -0.573 . . . . 0.27000000000000002 110.66 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.72 ' HA ' ' HB3' ' A' ' 19' ' ' ASN . 0.6 OUTLIER -65.59 -32.5 74.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.28 -0.418 . . . . 1.3100000000000001 111.152 -179.724 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.439 ' N ' HD11 ' A' ' 16' ' ' LEU . 8.3 m -57.2 -48.54 78.52 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.606 -0.516 . . . . 1.1599999999999999 109.606 179.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -74.16 -31.85 62.87 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.93 -0.577 . . . . 2.4700000000000002 110.065 178.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.72 ' HB3' ' HA ' ' A' ' 16' ' ' LEU . 0.3 OUTLIER -57.12 -28.38 62.65 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.305 -0.861 . . . . 0.22 112.133 -179.523 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -48.04 -18.58 0.2 Allowed 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 112.32 0.489 . . . . 2.8799999999999999 112.32 -179.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.678 ' N ' HD21 ' A' ' 21' ' ' ASN . 0.8 OUTLIER -67.67 -33.11 74.27 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.88 0.326 . . . . 0.40000000000000002 111.88 -178.713 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.467 ' HD2' ' OD1' ' A' ' 19' ' ' ASN . 68.1 mttm -54.04 119.48 19.74 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.716 -0.22 . . . . 1.9299999999999999 111.022 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -56.8 145.56 82.77 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.246 1.964 . . . . 1.0600000000000001 112.374 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.71 3.11 81.0 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.735 -0.745 . . . . 0.40999999999999998 113.921 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.0 t -58.65 109.48 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 117.517 0.659 . . . . 1.6000000000000001 110.637 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.5 p -130.35 128.56 64.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.908 -0.587 . . . . 1.6599999999999999 111.089 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.2 p -82.69 137.24 21.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.184 -0.462 . . . . 1.5600000000000001 110.866 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.511 HD13 ' HB2' ' A' ' 32' ' ' LEU . 61.2 mt -95.52 166.88 13.76 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.102 -0.499 . . . . 1.0800000000000001 110.713 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.417 ' HD2' ' HB3' ' A' ' 28' ' ' LEU . 53.2 Cg_exo -53.53 -30.93 56.61 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 121.889 1.726 . . . . 0.65000000000000002 111.53 178.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.436 ' HG ' ' HA3' ' A' ' 85' ' ' GLY . 28.0 t -85.43 -10.96 55.49 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.057 -0.519 . . . . 1.75 110.953 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.83 13.98 28.19 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 120.425 -0.893 . . . . 0.34999999999999998 114.645 178.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.511 ' HB2' HD13 ' A' ' 28' ' ' LEU . 5.8 mp -85.61 136.98 33.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 117.747 0.774 . . . . 2.0 112.951 -179.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -119.01 139.9 50.92 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.118 -0.946 . . . . 2.3199999999999998 108.49 177.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.579 ' HB3' HG23 ' A' ' 101' ' ' ILE . 41.0 p90 -155.04 176.39 12.6 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.794 0.664 . . . . 0.92000000000000004 112.794 -178.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.418 ' HE2' ' HB3' ' A' ' 22' ' ' LYS . 23.4 ttmt -120.78 117.36 27.24 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.974 -1.012 . . . . 2.6800000000000002 109.583 179.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 51.6 t -74.52 125.61 34.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 113.297 0.851 . . . . 0.77000000000000002 113.297 -177.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 54.9 mt -107.22 -66.82 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.288 -0.869 . . . . 1.46 109.92 178.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.411 ' C ' ' ND2' ' A' ' 38' ' ' ASN . 0.7 OUTLIER -134.77 85.14 2.16 Favored 'General case' 0 C--O 1.226 -0.143 0 CA-C-N 116.022 -0.536 . . . . 1.05 109.754 178.927 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.579 ' HB2' ' HE1' ' A' ' 99' ' ' TRP . 47.0 t -106.47 145.16 32.14 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.376 0.51 . . . . 2.02 112.376 -179.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.481 ' H ' ' HG ' ' A' ' 97' ' ' SER . . . 80.1 109.19 0.27 Allowed Glycine 0 C--N 1.333 0.366 0 CA-C-N 115.665 -0.698 . . . . 1.0900000000000001 113.936 178.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -177.75 -62.28 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 111.644 0.239 . . . . 1.7 111.644 178.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.2 168.98 34.28 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 120.63 -0.795 . . . . 0.40000000000000002 113.763 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.551 ' O ' ' HB3' ' A' ' 44' ' ' LYS . 7.9 p -90.72 176.88 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 123.208 0.603 . . . . 2.0299999999999998 109.959 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.551 ' HB3' ' O ' ' A' ' 43' ' ' VAL . 19.4 ptmt 164.94 156.2 0.07 OUTLIER Pre-proline 0 N--CA 1.469 0.519 0 CA-C-O 121.602 0.715 . . . . 2.7400000000000002 112.86 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.451 ' HD2' ' CB ' ' A' ' 49' ' ' ASP . 1.2 Cg_endo -85.18 173.48 7.81 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 125.169 3.913 . . . . 0.34000000000000002 113.097 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.508 ' O ' ' N ' ' A' ' 48' ' ' SER . . . -67.99 -172.18 6.46 Favored Glycine 0 C--O 1.225 -0.43 0 CA-C-N 115.393 -0.821 . . . . 0.38 111.383 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -41.41 -13.5 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 113.448 0.907 . . . . 2.9399999999999999 113.448 -178.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.508 ' N ' ' O ' ' A' ' 46' ' ' GLY . 84.5 p -85.84 7.28 24.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.094 0.473 . . . . 1.8999999999999999 110.282 178.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.52 ' HB2' HG22 ' A' ' 133' ' ' VAL . 3.2 p30 -76.64 140.88 41.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.459 -0.791 . . . . 1.73 111.857 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 62.8 m -113.45 119.4 37.47 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.615 -0.883 . . . . 0.92000000000000004 108.615 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.449 HG13 ' HB ' ' A' ' 133' ' ' VAL . 16.9 m -124.28 154.54 31.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 113.051 0.76 . . . . 1.22 113.051 -177.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 87.4 m -114.52 120.8 41.47 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.026 -0.988 . . . . 1.05 108.638 178.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.515 HG11 ' HA ' ' A' ' 130' ' ' LEU . 4.4 m -142.97 -179.71 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.296 0.57 . . . . 1.05 111.991 -178.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.513 ' HB3' ' HG2' ' A' ' 69' ' ' GLU . 28.3 mt-10 -129.55 132.79 46.92 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.114 -0.948 . . . . 2.3999999999999999 109.455 178.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -146.48 160.86 41.55 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.703 0.763 . . . . 0.93999999999999995 112.203 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 62.1 m -128.31 112.85 14.9 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.358 -1.292 . . . . 1.0600000000000001 108.428 178.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.412 ' O ' HG22 ' A' ' 64' ' ' VAL . . . -110.0 147.14 17.22 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.008 -1.091 . . . . 0.14000000000000001 113.021 -178.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.473 ' NE ' HD11 ' A' ' 125' ' ' ILE . 1.8 ppt_? -147.91 148.05 30.39 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.888 0.375 . . . . 2.6899999999999999 110.122 179.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.418 ' C ' ' H ' ' A' ' 61' ' ' ASP . 23.4 mt -77.55 162.18 27.31 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.981 -0.554 . . . . 1.77 110.102 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.509 ' HB ' ' O ' ' A' ' 123' ' ' THR . 6.9 tp -59.18 -10.75 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.365 0.603 . . . . 1.3700000000000001 109.458 178.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.418 ' H ' ' C ' ' A' ' 59' ' ' LEU . 9.4 m-20 -67.65 -12.61 60.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.312 -0.858 . . . . 2.0099999999999998 110.721 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.42 ' HA3' HH11 ' A' ' 58' ' ' ARG . . . 90.55 -0.94 78.19 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.594 -0.812 . . . . 0.45000000000000001 113.238 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 71.6 p -115.84 134.35 55.09 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 117.088 0.444 . . . . 1.99 111.458 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.412 HG22 ' O ' ' A' ' 57' ' ' GLY . 6.7 p -62.71 132.43 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-N 115.951 -0.568 . . . . 1.0700000000000001 110.044 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.577 ' HD1' ' H ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -97.65 -22.35 16.52 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.083 -0.508 . . . . 0.25 110.99 -179.95 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.577 ' H ' ' HD1' ' A' ' 65' ' ' PHE . 24.9 t70 -175.91 130.05 0.24 Allowed 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 116.323 -0.399 . . . . 0.29999999999999999 110.995 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.7 p -125.55 124.36 41.11 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.103 -0.499 . . . . 1.8100000000000001 110.544 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.544 HG22 ' HB3' ' A' ' 75' ' ' ALA . 69.8 p -83.26 -25.33 31.72 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 120.848 0.356 . . . . 0.93000000000000005 111.032 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.513 ' HG2' ' HB3' ' A' ' 54' ' ' GLU . 38.1 mt-10 -75.09 -39.32 60.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 2.1099999999999999 110.98 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -63.54 -44.86 92.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 3.79 110.639 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 54.7 m -58.25 -21.4 48.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.258 -0.428 . . . . 2.1200000000000001 110.556 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 90.46 7.5 67.08 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.808 -0.71 . . . . 0.80000000000000004 112.311 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -125.99 117.01 23.98 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.355 0.122 . . . . 3.52 110.937 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -55.47 157.19 15.51 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.314 2.01 . . . . 0.76000000000000001 112.107 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.544 ' HB3' HG22 ' A' ' 68' ' ' THR . . . -94.72 123.99 38.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.346 -0.388 . . . . 0.76000000000000001 110.622 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.6 t -125.89 118.48 25.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.786 0.327 . . . . 1.98 111.189 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -158.47 163.49 37.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.11 0.481 . . . . 0.44 111.865 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.469 ' NE2' ' O ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -83.04 137.8 33.98 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.524 -0.762 . . . . 1.8 109.03 178.608 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.416 ' O ' HG23 ' A' ' 87' ' ' THR . 21.6 m -69.26 -20.07 24.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 113.587 0.958 . . . . 1.79 113.587 -177.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.461 ' HB3' ' OE1' ' A' ' 78' ' ' GLN . 33.2 t -95.3 -2.56 49.1 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.955 0.354 . . . . 1.6100000000000001 111.955 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.42 ' NE2' ' HB3' ' A' ' 78' ' ' GLN . 23.4 mt-30 -96.17 5.58 50.74 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.895 0.331 . . . . 2.4199999999999999 111.895 -179.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.455 ' HB ' HD12 ' A' ' 83' ' ' ILE . 3.1 m -107.38 -175.66 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 111.662 0.245 . . . . 1.1799999999999999 111.662 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.628 ' H ' HD12 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -56.45 147.73 47.72 Favored Pre-proline 0 N--CA 1.463 0.191 0 CA-C-N 116.507 -0.315 . . . . 1.5900000000000001 111.711 -179.468 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo -42.25 -54.12 3.23 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.19 2.594 . . . . 1.01 113.365 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.484 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -51.87 -49.21 49.05 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.517 -0.849 . . . . 0.35999999999999999 112.7 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . 0.407 ' HB2' HG12 ' A' ' 83' ' ' ILE . 0.5 OUTLIER -60.9 -47.7 85.18 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.693 0.257 . . . . 0.98999999999999999 111.693 -179.348 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 79' ' ' VAL . 30.9 p -53.52 -33.73 55.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.766 0.317 . . . . 1.8899999999999999 111.598 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -70.61 -51.41 28.35 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.161 0.43 . . . . 1.4299999999999999 112.161 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.447 ' HB1' HD23 ' A' ' 32' ' ' LEU . . . -68.01 -48.49 65.57 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.483 0.549 . . . . 0.33000000000000002 112.483 -178.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -55.19 -30.99 61.04 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.021 0.378 . . . . 1.1599999999999999 112.021 -179.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -65.68 -21.15 66.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.595 -0.275 . . . . 2.23 111.574 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.439 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 10.6 mp -96.41 -22.13 17.34 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.382 0.512 . . . . 2.0899999999999999 112.382 -178.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.511 ' HE1' ' HB2' ' A' ' 99' ' ' TRP . 22.2 ttm -71.41 108.73 4.22 Favored Pre-proline 0 CA--C 1.532 0.278 0 N-CA-C 111.472 0.175 . . . . 2.2799999999999998 111.472 -179.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.442 ' HD2' ' OG ' ' A' ' 97' ' ' SER . 6.1 Cg_exo -75.67 144.89 28.64 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.751 2.301 . . . . 0.72999999999999998 111.889 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.469 ' HA ' ' HG ' ' A' ' 130' ' ' LEU . . . -48.31 127.57 13.06 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.472 -0.331 . . . . 1.21 111.437 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 94.39 2.57 63.63 Favored Glycine 0 CA--C 1.521 0.422 0 C-N-CA 120.701 -0.762 . . . . 0.34000000000000002 113.446 179.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.481 ' HG ' ' H ' ' A' ' 40' ' ' GLY . 69.6 m -89.92 -174.59 4.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.885 0.374 . . . . 1.8899999999999999 111.609 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.7 m -152.3 112.78 4.11 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.066 -0.515 . . . . 0.88 110.773 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.579 ' HE1' ' HB2' ' A' ' 39' ' ' SER . 14.8 m0 -132.25 149.77 52.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.052 0.453 . . . . 0.67000000000000004 111.759 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -123.73 108.54 12.64 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.367 -0.975 . . . . 1.53 108.367 177.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.579 HG23 ' HB3' ' A' ' 34' ' ' TYR . 24.7 pt -107.68 139.68 28.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 112.974 0.731 . . . . 0.72999999999999998 112.974 -177.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -120.34 103.99 9.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.951 -1.022 . . . . 0.91000000000000003 108.262 178.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.3 t -109.12 102.43 48.9 Favored Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 113.764 1.024 . . . . 1.1399999999999999 113.764 -176.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.573 ' HG2' HD21 ' A' ' 107' ' ' LEU . 12.3 Cg_endo -59.62 150.94 73.3 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 121.872 1.715 . . . . 0.68000000000000005 110.037 176.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -47.56 -31.74 4.72 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.512 0.56 . . . . 2.3700000000000001 112.512 -178.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -57.09 -13.47 9.14 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.877 -0.677 . . . . 0.40000000000000002 114.084 -178.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.573 HD21 ' HG2' ' A' ' 104' ' ' PRO . 3.0 mm? -114.57 -5.55 12.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 117.193 0.496 . . . . 2.9300000000000002 111.763 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -109.1 -104.36 0.37 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.513 -0.312 . . . . 1.3799999999999999 110.385 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -91.23 -17.18 26.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.986 0.422 . . . . 1.6000000000000001 110.454 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 103.74 145.99 15.69 Favored Glycine 0 CA--C 1.521 0.428 0 CA-C-N 115.732 -0.667 . . . . 2.3399999999999999 113.857 178.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.8 -6.96 3.82 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.604 2.869 . . . . 1.9299999999999999 113.133 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.548 ' C ' ' H ' ' A' ' 114' ' ' VAL . 89.4 mtm180 -75.65 170.71 15.65 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.802 0.334 . . . . 3.8799999999999999 110.791 -178.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 79.7 p -60.05 6.96 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.034 -0.53 . . . . 2.0800000000000001 112.235 -179.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.548 ' H ' ' C ' ' A' ' 112' ' ' ARG . 3.2 t -99.92 20.6 2.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.133 0.492 . . . . 3.4199999999999999 110.502 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -63.85 110.42 3.4 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.931 -0.652 . . . . 1.0900000000000001 112.309 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -74.25 -116.6 0.08 OUTLIER Glycine 0 CA--C 1.522 0.497 0 C-N-CA 120.967 -0.635 . . . . 0.89000000000000001 112.603 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -55.93 -35.8 94.75 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.159 1.906 . . . . 1.0900000000000001 111.679 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.5 HG21 HD11 ' A' ' 124' ' ' LEU . 5.1 mp -91.55 120.06 39.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.77 -0.65 . . . . 1.8799999999999999 110.082 179.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -46.13 157.6 0.4 Allowed Glycine 0 C--N 1.333 0.416 0 CA-C-N 116.083 -0.508 . . . . 0.56000000000000005 113.308 -179.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.428 ' O ' ' HG3' ' A' ' 122' ' ' GLU . 26.5 Cg_endo -62.07 131.33 34.22 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.486 2.124 . . . . 0.84999999999999998 111.826 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 47.22 34.57 3.13 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.03 -0.532 . . . . 1.1200000000000001 110.371 -178.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.428 ' HG3' ' O ' ' A' ' 120' ' ' PRO . 37.0 mt-10 -115.64 122.92 47.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.34 -0.391 . . . . 1.8200000000000001 111.528 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.509 ' O ' ' HB ' ' A' ' 60' ' ' ILE . 91.2 m -89.17 127.9 35.76 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.782 -0.822 . . . . 1.0900000000000001 108.782 178.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.5 HD11 HG21 ' A' ' 118' ' ' ILE . 6.3 mp -114.42 155.82 25.63 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.217 0.532 . . . . 2.1000000000000001 112.268 -177.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.473 HD11 ' NE ' ' A' ' 58' ' ' ARG . 4.6 mp -113.9 132.88 61.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.306 -0.861 . . . . 1.0600000000000001 109.716 178.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -125.39 131.82 52.88 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.975 0.417 . . . . 0.28999999999999998 111.423 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -110.0 102.94 11.64 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.482 -0.933 . . . . 2.77 108.482 178.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.429 HD11 ' N ' ' A' ' 128' ' ' ILE . 5.0 mp -105.71 118.65 53.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 112.429 0.529 . . . . 1.5600000000000001 112.429 -177.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -109.18 99.32 8.62 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.282 -1.007 . . . . 0.29999999999999999 108.282 177.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.515 ' HA ' HG11 ' A' ' 53' ' ' VAL . 26.2 tp -79.3 114.9 18.61 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.86 -0.609 . . . . 2.0299999999999998 111.511 -178.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 67.8 mt -84.18 -56.73 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 CA-C-N 115.884 -0.598 . . . . 1.8899999999999999 110.288 179.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.458 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 11.3 p -164.27 165.15 22.14 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.246 -0.433 . . . . 1.75 111.409 179.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.52 HG22 ' HB2' ' A' ' 49' ' ' ASP . 7.2 p -117.04 122.24 69.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.902 -0.59 . . . . 2.1299999999999999 111.064 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.414 ' C ' ' O ' ' A' ' 133' ' ' VAL . 11.3 mttm 32.99 79.19 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.233 -0.44 . . . . 3.5600000000000001 111.344 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 15.6 pttm 51.86 30.7 7.38 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.783 -0.644 . . . . 3.6699999999999999 111.629 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 33.8 t 50.61 44.52 27.38 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.587 -0.733 . . . . 1.6000000000000001 111.096 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 42.3 t . . . . . 0 C--O 1.248 0.979 0 CA-C-O 118.24 -0.886 . . . . 2.7799999999999998 111.04 -179.734 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 . . . . . 0 N--CA 1.485 1.316 0 CA-C-O 120.799 0.333 . . . . 3.73 111.012 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.538 ' HA ' ' HB3' ' A' ' 5' ' ' ALA . 31.7 m-80 -68.94 -18.53 64.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 2.0800000000000001 111.11 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.478 ' HB3' ' NZ ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -57.89 -40.66 80.82 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.572 -0.529 . . . . 3.7599999999999998 109.572 179.172 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 59.9 mmtt -80.35 -35.69 35.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.782 -0.645 . . . . 3.1499999999999999 110.598 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.538 ' HB3' ' HA ' ' A' ' 2' ' ' ASN . . . -58.39 -48.67 79.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.975 -0.557 . . . . 1.27 110.7 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -75.14 -31.9 61.19 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.275 -0.42 . . . . 2.5699999999999998 110.916 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -56.78 -41.74 78.21 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.683 -0.488 . . . . 2.1400000000000001 109.683 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.494 ' HA ' ' HG2' ' A' ' 11' ' ' LYS . 23.7 p30 -78.97 -29.2 43.77 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.734 -0.666 . . . . 1.3999999999999999 111.415 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 121' ' ' ASN . 66.7 tttm -56.16 -44.12 78.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.005 0.431 . . . . 3.2400000000000002 110.741 179.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.4 HG21 ' N ' ' A' ' 11' ' ' LYS . 5.4 m -78.1 -44.97 27.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.915 -0.584 . . . . 1.9199999999999999 112.446 -179.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.494 ' HG2' ' HA ' ' A' ' 8' ' ' ASN . 17.9 ptmt -59.16 -33.57 71.07 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.703 0.287 . . . . 2.1499999999999999 111.429 -179.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.407 ' O ' ' HG ' ' A' ' 16' ' ' LEU . . . -76.34 -53.01 5.78 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.833 -0.699 . . . . 0.33000000000000002 112.202 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.525 ' HA ' HD13 ' A' ' 16' ' ' LEU . 47.8 mt-10 -59.21 -25.38 63.93 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.931 0.396 . . . . 2.3900000000000001 110.591 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.15 -37.61 45.55 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.061 -0.518 . . . . 0.92000000000000004 110.584 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -61.78 -51.91 66.37 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.165 -0.471 . . . . 0.27000000000000002 110.828 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.675 ' HA ' ' HB3' ' A' ' 19' ' ' ASN . 0.6 OUTLIER -67.84 -32.66 73.35 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.717 -0.393 . . . . 1.3100000000000001 111.143 -179.72 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.455 ' N ' HD11 ' A' ' 16' ' ' LEU . 6.2 m -57.65 -46.09 84.66 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.494 -0.558 . . . . 1.1599999999999999 109.494 178.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -74.27 -31.96 62.73 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.753 -0.658 . . . . 2.4700000000000002 109.856 178.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.675 ' HB3' ' HA ' ' A' ' 16' ' ' LEU . 0.6 OUTLIER -60.15 -26.36 66.23 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.436 -0.802 . . . . 0.22 112.532 -179.384 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -48.91 -19.46 0.39 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.764 0.316 . . . . 2.8799999999999999 111.689 -179.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.714 ' N ' HD21 ' A' ' 21' ' ' ASN . 0.7 OUTLIER -69.12 -34.71 75.48 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.135 0.42 . . . . 0.40000000000000002 112.135 -179.229 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.489 ' HG2' ' O ' ' A' ' 19' ' ' ASN . 18.7 mmtp -46.02 127.87 7.19 Favored Pre-proline 0 N--CA 1.465 0.298 0 CA-C-O 120.661 0.267 . . . . 1.9299999999999999 111.266 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -57.89 137.12 79.38 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.336 2.024 . . . . 1.0600000000000001 112.192 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.94 0.83 83.03 Favored Glycine 0 CA--C 1.52 0.374 0 C-N-CA 120.771 -0.728 . . . . 0.40999999999999998 113.955 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.432 HG21 ' O ' ' A' ' 22' ' ' LYS . 24.1 t -56.21 103.98 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.125 0 CA-C-N 117.541 0.67 . . . . 1.6000000000000001 110.17 179.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.6 p -126.49 135.68 63.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.611 -0.722 . . . . 1.6599999999999999 111.138 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 7.6 p -87.05 141.77 13.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.261 -0.427 . . . . 1.5600000000000001 111.157 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.443 HD11 ' HB2' ' A' ' 32' ' ' LEU . 55.5 mt -101.29 166.06 13.02 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.099 -0.5 . . . . 1.0800000000000001 110.804 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -53.79 -30.58 57.74 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 121.914 1.743 . . . . 0.65000000000000002 111.455 178.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.43 ' O ' HD11 ' A' ' 107' ' ' LEU . 38.8 t -83.85 -12.85 54.95 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.862 -0.608 . . . . 1.75 110.871 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.43 14.18 26.44 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 120.485 -0.864 . . . . 0.34999999999999998 114.291 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.463 HD23 ' HB1' ' A' ' 89' ' ' ALA . 6.6 mp -85.89 137.51 32.7 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 113.64 0.978 . . . . 2.0 113.64 -178.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.5 mp0 -118.4 142.7 47.28 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.985 -1.117 . . . . 2.3199999999999998 107.985 177.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.564 ' HB3' HG23 ' A' ' 101' ' ' ILE . 34.8 p90 -158.79 175.69 13.28 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.278 0.844 . . . . 0.92000000000000004 113.278 -178.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -121.58 117.46 26.8 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 114.901 -1.045 . . . . 2.6800000000000002 109.606 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.6 t -81.92 126.77 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 113.216 0.821 . . . . 0.77000000000000002 113.216 -178.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.437 HD11 HG21 ' A' ' 98' ' ' THR . 81.4 mt -101.73 -64.14 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 115.658 -0.701 . . . . 1.46 110.761 178.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -141.35 86.08 2.0 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.826 0.346 . . . . 1.05 110.931 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.656 ' HB2' ' HE1' ' A' ' 99' ' ' TRP . 39.5 t -106.82 146.06 31.38 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.315 -0.402 . . . . 2.02 112.047 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 93.41 85.19 1.59 Allowed Glycine 0 C--N 1.334 0.422 0 C-N-CA 121.05 -0.595 . . . . 1.0900000000000001 113.224 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -153.28 -71.75 0.14 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.693 0.282 . . . . 1.7 111.612 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.26 166.67 32.24 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 121.052 -0.594 . . . . 0.40000000000000002 114.376 -178.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.465 ' O ' ' HB3' ' A' ' 44' ' ' LYS . 2.6 t -90.45 176.18 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 123.516 0.726 . . . . 2.0299999999999998 109.905 179.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.465 ' HB3' ' O ' ' A' ' 43' ' ' VAL . 2.2 pptp? 165.72 156.06 0.09 OUTLIER Pre-proline 0 N--CA 1.47 0.552 0 CA-C-O 121.464 0.65 . . . . 2.7400000000000002 111.952 -179.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.488 ' HD2' ' HB2' ' A' ' 49' ' ' ASP . 3.1 Cg_exo -76.56 172.47 16.16 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 124.602 3.535 . . . . 0.34000000000000002 113.624 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.493 ' O ' ' N ' ' A' ' 48' ' ' SER . . . -67.76 -173.12 6.76 Favored Glycine 0 C--O 1.223 -0.568 0 CA-C-N 115.17 -0.923 . . . . 0.38 110.944 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.461 ' HG2' ' HB2' ' A' ' 91' ' ' GLN . 53.7 mtmt -42.14 -14.05 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.56 0.948 . . . . 2.9399999999999999 113.56 -177.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.493 ' N ' ' O ' ' A' ' 46' ' ' GLY . 45.1 t -86.52 7.69 25.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.137 0.494 . . . . 1.8999999999999999 110.256 178.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.488 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 3.0 p30 -76.18 162.96 27.54 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.515 -0.766 . . . . 1.73 111.368 -179.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 60.0 m -123.85 122.93 39.3 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.598 -0.89 . . . . 0.92000000000000004 108.598 178.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.426 HG11 HG21 ' A' ' 133' ' ' VAL . 2.3 m -122.85 141.08 44.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.285 0.564 . . . . 1.22 112.491 -177.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 66.3 m -113.07 120.08 40.1 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.228 -1.027 . . . . 1.05 108.228 177.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.521 HG11 ' HA ' ' A' ' 130' ' ' LEU . 4.8 m -144.97 177.56 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.231 0.538 . . . . 1.05 111.686 -178.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -125.22 131.86 53.08 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.642 -0.873 . . . . 2.3999999999999999 108.642 178.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -143.78 158.2 43.85 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.701 0.762 . . . . 0.93999999999999995 112.381 -179.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 59.4 m -122.71 112.44 17.94 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.312 -1.313 . . . . 1.0600000000000001 108.577 178.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -109.82 145.77 16.98 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 119.953 -1.118 . . . . 0.14000000000000001 112.7 -178.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.476 ' NE ' HD11 ' A' ' 125' ' ' ILE . 4.9 ppt_? -148.09 146.97 29.04 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.048 0.452 . . . . 2.6899999999999999 110.431 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.468 ' C ' ' H ' ' A' ' 61' ' ' ASP . 46.3 tp -76.1 160.36 29.84 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.759 -0.655 . . . . 1.77 109.809 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.518 ' HB ' ' O ' ' A' ' 123' ' ' THR . 9.5 tp -56.34 -10.68 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.251 0.548 . . . . 1.3700000000000001 109.879 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.468 ' H ' ' C ' ' A' ' 59' ' ' LEU . 20.4 t70 -66.02 -12.4 54.88 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.454 -0.794 . . . . 2.0099999999999998 110.861 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.82 -0.77 77.14 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.577 -0.821 . . . . 0.45000000000000001 113.315 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.4 t -118.65 142.33 47.75 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.053 0.454 . . . . 1.99 111.214 -179.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.0 p -65.96 133.71 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 115.827 -0.624 . . . . 1.0700000000000001 110.17 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.59 ' HD1' ' N ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -97.43 -22.79 16.39 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.988 -0.551 . . . . 0.25 110.497 179.719 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.59 ' N ' ' HD1' ' A' ' 65' ' ' PHE . 25.4 t70 -176.95 131.7 0.18 Allowed 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.922 -0.581 . . . . 0.29999999999999999 110.532 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 63.3 p -129.52 123.53 31.67 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.449 -0.342 . . . . 1.8100000000000001 110.966 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.51 HG23 ' HB3' ' A' ' 75' ' ' ALA . 59.7 p -78.65 -14.35 59.35 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.898 0.38 . . . . 0.93000000000000005 110.905 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -75.38 -51.83 12.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.048 -0.524 . . . . 2.1099999999999999 110.604 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.9 ttpm? -61.04 -36.8 80.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.044 -0.525 . . . . 3.79 110.911 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 41.2 m -57.91 -20.03 34.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.206 -0.452 . . . . 2.1200000000000001 110.744 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.29 4.88 90.03 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.831 -0.699 . . . . 0.80000000000000004 112.013 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -126.18 117.38 23.6 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.457 0.17 . . . . 3.52 110.931 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -52.99 156.66 9.34 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.395 2.063 . . . . 0.76000000000000001 112.046 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.51 ' HB3' HG23 ' A' ' 68' ' ' THR . . . -94.21 124.62 38.34 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.42 -0.355 . . . . 0.76000000000000001 110.601 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.1 t -127.79 118.09 23.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.162 0.506 . . . . 1.98 111.428 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -158.36 167.12 30.58 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.674 -0.694 . . . . 0.44 110.896 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.594 ' NE2' ' HB3' ' A' ' 80' ' ' SER . 5.7 tt0 -85.5 146.0 27.14 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.3 -0.63 . . . . 1.8 109.3 178.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 32.9 m -68.44 -26.51 33.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 113.032 0.753 . . . . 1.79 113.032 -178.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.594 ' HB3' ' NE2' ' A' ' 78' ' ' GLN . 33.4 t -95.53 -3.77 45.98 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 111.937 0.347 . . . . 1.6100000000000001 111.937 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 -84.87 5.65 27.96 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.733 0.272 . . . . 2.4199999999999999 111.733 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 1.7 m -112.06 -172.55 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.6 -0.273 . . . . 1.1799999999999999 111.553 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.504 HG13 ' HB2' ' A' ' 86' ' ' TRP . 29.2 pt -55.99 154.4 14.68 Favored Pre-proline 0 CA--C 1.528 0.13 0 CA-C-N 116.472 -0.331 . . . . 1.5900000000000001 111.629 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -48.01 -53.67 6.33 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.651 2.234 . . . . 1.01 112.91 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -52.93 -49.69 53.9 Favored Glycine 0 CA--C 1.521 0.458 0 C-N-CA 120.802 -0.713 . . . . 0.35999999999999999 113.112 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . 0.504 ' HB2' HG13 ' A' ' 83' ' ' ILE . 0.4 OUTLIER -59.49 -45.57 91.31 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.842 0.312 . . . . 0.98999999999999999 111.842 -179.069 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 98.4 m -55.66 -37.49 68.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.442 -0.345 . . . . 1.8899999999999999 111.689 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.64 -49.98 64.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.491 -0.322 . . . . 1.4299999999999999 111.745 -179.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.463 ' HB1' HD23 ' A' ' 32' ' ' LEU . . . -64.39 -49.24 72.36 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.009 0.374 . . . . 0.33000000000000002 112.009 -179.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -57.24 -26.72 61.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.423 -0.353 . . . . 1.1599999999999999 111.72 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.664 HE21 ' HA ' ' A' ' 91' ' ' GLN . 0.0 OUTLIER -66.43 -24.55 66.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.836 0.35 . . . . 2.23 110.976 -179.89 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.404 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 4.2 mm? -93.59 -7.51 43.85 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.168 -0.469 . . . . 2.0899999999999999 111.134 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 69.3 mtp -88.32 108.44 22.15 Favored Pre-proline 0 CA--C 1.531 0.222 0 CA-C-N 116.47 -0.332 . . . . 2.2799999999999998 111.891 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' A' ' 92' ' ' LEU . 99.0 Cg_endo -79.91 147.07 18.84 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.403 2.068 . . . . 0.72999999999999998 110.582 178.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.45 ' HB3' ' HA ' ' A' ' 132' ' ' SER . . . -45.58 126.59 6.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.779 0.323 . . . . 1.21 111.65 -179.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 97.66 -7.8 63.53 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 120.549 -0.834 . . . . 0.34000000000000002 113.281 178.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 33.5 t -69.82 174.83 4.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.876 0.37 . . . . 1.8899999999999999 111.264 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.437 HG21 HD11 ' A' ' 37' ' ' ILE . 24.5 m -147.31 90.82 1.91 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.987 -0.552 . . . . 0.88 110.471 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.656 ' HE1' ' HB2' ' A' ' 39' ' ' SER . 23.5 m0 -112.11 149.41 32.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.266 0.555 . . . . 0.67000000000000004 112.189 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -119.59 107.78 13.69 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.311 -0.996 . . . . 1.53 108.311 177.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.564 HG23 ' HB3' ' A' ' 34' ' ' TYR . 48.7 pt -111.07 146.27 16.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 113.221 0.822 . . . . 0.72999999999999998 113.221 -177.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -130.98 103.76 6.73 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.657 -1.156 . . . . 0.91000000000000003 108.145 178.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 4.7 t -105.39 99.75 22.33 Favored Pre-proline 0 C--N 1.33 -0.265 0 N-CA-C 113.709 1.003 . . . . 1.1399999999999999 113.709 -176.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.583 ' HG2' HD21 ' A' ' 107' ' ' LEU . 11.6 Cg_endo -58.73 151.15 65.78 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 121.701 1.601 . . . . 0.68000000000000005 109.814 176.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -47.49 -31.87 4.67 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.544 0.572 . . . . 2.3700000000000001 112.544 -178.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -56.97 -13.9 9.38 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.667 -0.778 . . . . 0.40000000000000002 113.949 -178.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.583 HD21 ' HG2' ' A' ' 104' ' ' PRO . 2.8 mm? -115.19 -5.87 12.42 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 117.09 0.445 . . . . 2.9300000000000002 111.788 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -109.41 -104.41 0.37 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.551 -0.295 . . . . 1.3799999999999999 110.621 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -90.22 -17.24 27.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.96 0.41 . . . . 1.6000000000000001 110.557 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 103.94 143.07 12.19 Favored Glycine 0 CA--C 1.522 0.471 0 CA-C-N 115.849 -0.614 . . . . 2.3399999999999999 113.863 178.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.76 -8.43 7.51 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.542 2.828 . . . . 1.9299999999999999 113.355 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.582 ' C ' ' H ' ' A' ' 114' ' ' VAL . 23.1 mtp180 -75.63 171.7 13.86 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.898 -0.321 . . . . 3.8799999999999999 110.643 -178.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 38.1 t -55.9 3.12 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.059 -0.519 . . . . 2.0800000000000001 112.244 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.582 ' H ' ' C ' ' A' ' 112' ' ' ARG . 31.0 m -96.52 19.67 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.75 0.309 . . . . 3.4199999999999999 110.823 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -63.48 116.36 9.17 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.736 -0.745 . . . . 1.0900000000000001 112.077 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -79.28 -115.38 0.24 Allowed Glycine 0 CA--C 1.521 0.448 0 C-N-CA 120.789 -0.72 . . . . 0.89000000000000001 112.885 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -58.86 -35.43 98.62 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.283 1.989 . . . . 1.0900000000000001 111.92 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.43 HG12 HD12 ' A' ' 124' ' ' LEU . 97.9 mt -91.07 124.65 43.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.993 -0.549 . . . . 1.8799999999999999 110.273 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -45.55 155.21 0.5 Allowed Glycine 0 CA--C 1.522 0.481 0 CA-C-N 115.981 -0.554 . . . . 0.56000000000000005 113.469 -179.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -62.11 131.02 32.73 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.282 1.988 . . . . 0.84999999999999998 111.466 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.458 ' O ' ' HA ' ' A' ' 9' ' ' LYS . 1.8 m-80 47.92 35.32 4.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.073 0.463 . . . . 1.1200000000000001 110.097 -178.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.432 ' HB3' HD13 ' A' ' 59' ' ' LEU . 11.3 mt-10 -115.6 135.39 54.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.044 -0.526 . . . . 1.8200000000000001 110.904 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.518 ' O ' ' HB ' ' A' ' 60' ' ' ILE . 92.6 m -95.7 129.36 42.94 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.568 -0.53 . . . . 1.0900000000000001 109.568 179.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.435 ' HG ' ' HA ' ' A' ' 59' ' ' LEU . 0.2 OUTLIER -117.45 150.48 38.84 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.168 0.509 . . . . 2.1000000000000001 111.53 -178.593 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.476 HD11 ' NE ' ' A' ' 58' ' ' ARG . 4.1 mp -113.48 140.56 33.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.567 -0.742 . . . . 1.0600000000000001 110.08 179.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -131.82 132.09 43.42 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.09 -0.505 . . . . 0.28999999999999998 111.179 -179.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -109.71 103.8 12.68 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.171 -0.677 . . . . 2.77 109.171 178.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 15.6 mt -102.81 122.58 55.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 112.634 0.605 . . . . 1.5600000000000001 112.634 -177.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -118.26 100.09 7.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.243 -0.889 . . . . 0.29999999999999999 108.74 178.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.521 ' HA ' HG11 ' A' ' 53' ' ' VAL . 0.8 OUTLIER -78.93 124.38 28.19 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.14 -0.482 . . . . 2.0299999999999998 111.92 -178.047 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 35.3 mm -94.25 -50.52 11.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.642 -0.708 . . . . 1.8899999999999999 110.09 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.45 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 51.9 p -164.5 165.12 21.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.922 -0.581 . . . . 1.75 110.244 179.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.493 HG22 HD23 ' A' ' 130' ' ' LEU . 96.8 t -130.72 117.86 40.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.803 0.335 . . . . 2.1299999999999999 111.302 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 5.5 tmtp? 51.03 62.39 2.74 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.933 -0.576 . . . . 3.5600000000000001 110.711 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 68.9 mttm 59.05 43.65 17.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.811 -0.631 . . . . 3.6699999999999999 110.35 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 86.8 p 50.55 31.88 6.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.431 -0.804 . . . . 1.6000000000000001 111.037 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 45.1 t . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.216 -0.897 . . . . 2.7799999999999998 110.847 -179.873 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 . . . . . 0 N--CA 1.485 1.305 0 CA-C-O 120.81 0.338 . . . . 3.73 110.962 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.446 ' HA ' ' HB2' ' A' ' 5' ' ' ALA . 6.8 p30 -62.86 -21.73 66.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 2.0800000000000001 111.153 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -61.52 -38.99 89.38 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.416 -0.587 . . . . 3.7599999999999998 109.416 178.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -79.6 -34.74 40.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.557 -0.747 . . . . 3.1499999999999999 109.622 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.472 ' HA ' ' ND2' ' A' ' 8' ' ' ASN . . . -57.65 -52.28 66.06 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.757 -0.656 . . . . 1.27 110.115 179.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -64.41 -36.15 83.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.784 -0.644 . . . . 2.5699999999999998 109.484 178.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.492 ' HG2' ' HZ3' ' A' ' 11' ' ' LYS . 31.4 tt0 -55.68 -33.46 64.15 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.8 -0.815 . . . . 2.1400000000000001 108.8 178.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.479 ' HA ' ' HG2' ' A' ' 11' ' ' LYS . 19.3 m-20 -69.1 -39.44 78.97 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 115.572 -0.74 . . . . 1.3999999999999999 109.961 179.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -56.7 -32.4 65.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.709 -0.678 . . . . 3.2400000000000002 111.037 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.8 t -78.03 -52.87 15.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.374 -0.375 . . . . 1.9199999999999999 111.895 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.492 ' HZ3' ' HG2' ' A' ' 7' ' ' GLU . 10.2 ptpp? -63.18 -26.06 68.63 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.895 0.379 . . . . 2.1499999999999999 110.59 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.405 ' O ' ' HG ' ' A' ' 16' ' ' LEU . . . -75.76 -50.33 8.06 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.841 -0.695 . . . . 0.33000000000000002 111.667 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.405 ' HA ' HD12 ' A' ' 16' ' ' LEU . 12.8 pt-20 -66.41 -27.56 67.94 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.873 0.368 . . . . 2.3900000000000001 110.188 179.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.02 -34.19 61.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.096 -0.502 . . . . 0.92000000000000004 110.491 179.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -63.75 -55.81 20.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.753 -0.658 . . . . 0.27000000000000002 110.573 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.676 ' HA ' ' HB3' ' A' ' 19' ' ' ASN . 0.4 OUTLIER -64.16 -31.79 73.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.228 -0.442 . . . . 1.3100000000000001 111.04 179.968 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.5 m -56.56 -47.65 79.01 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.607 -0.516 . . . . 1.1599999999999999 109.607 179.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -73.61 -32.19 63.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.825 -0.625 . . . . 2.4700000000000002 109.865 178.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.676 ' HB3' ' HA ' ' A' ' 16' ' ' LEU . 0.7 OUTLIER -59.09 -25.58 63.92 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.635 -0.711 . . . . 0.22 111.573 179.869 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -46.89 -20.21 0.13 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.536 -0.302 . . . . 2.8799999999999999 111.605 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.709 ' N ' HD21 ' A' ' 21' ' ' ASN . 0.7 OUTLIER -68.67 -37.12 79.37 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.436 -0.347 . . . . 0.40000000000000002 110.991 -179.482 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -50.53 118.83 10.2 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.067 -0.515 . . . . 1.9299999999999999 110.251 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -57.06 147.06 77.48 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.33 2.02 . . . . 1.0600000000000001 112.649 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.02 3.46 79.58 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.869 -0.681 . . . . 0.40999999999999998 113.967 179.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 38.1 t -55.09 106.43 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 117.563 0.681 . . . . 1.6000000000000001 110.681 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.6 p -130.76 126.73 60.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.868 -0.605 . . . . 1.6599999999999999 111.133 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.8 p -80.16 142.47 13.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.05 -0.523 . . . . 1.5600000000000001 110.77 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.559 HD13 ' HB2' ' A' ' 32' ' ' LEU . 63.0 mt -101.73 167.85 9.95 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.476 -0.329 . . . . 1.0800000000000001 110.673 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.436 ' HD2' ' HB3' ' A' ' 28' ' ' LEU . 71.4 Cg_exo -51.49 -31.95 41.3 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 121.923 1.748 . . . . 0.65000000000000002 111.742 178.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.463 ' O ' HD21 ' A' ' 107' ' ' LEU . 30.3 t -86.44 -11.21 52.49 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.231 -0.44 . . . . 1.75 110.87 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.04 14.91 23.43 Favored Glycine 0 C--N 1.335 0.474 0 C-N-CA 120.563 -0.827 . . . . 0.34999999999999998 114.298 178.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.559 ' HB2' HD13 ' A' ' 28' ' ' LEU . 6.8 mp -84.33 134.65 34.49 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.364 0.876 . . . . 2.0 113.364 -178.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.6 mp0 -114.28 142.54 46.17 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.082 -1.081 . . . . 2.3199999999999998 108.082 177.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.411 ' CB ' HG21 ' A' ' 101' ' ' ILE . 27.8 p90 -158.97 175.18 13.87 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 113.173 0.805 . . . . 0.92000000000000004 113.173 -178.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -122.48 117.3 25.61 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 114.768 -1.105 . . . . 2.6800000000000002 109.536 179.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 66.6 t -77.3 126.25 37.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 113.424 0.898 . . . . 0.77000000000000002 113.424 -178.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 78.0 mt -101.3 -65.99 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 115.408 -0.815 . . . . 1.46 109.872 178.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -129.84 95.54 3.99 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 116.394 -0.366 . . . . 1.05 110.094 178.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.65 ' HB3' ' HE1' ' A' ' 99' ' ' TRP . 68.2 p -105.15 145.88 29.97 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.262 0.467 . . . . 2.02 112.262 -178.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.92 103.18 0.07 OUTLIER Glycine 0 C--N 1.332 0.36 0 CA-C-N 115.686 -0.688 . . . . 1.0900000000000001 113.168 179.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 54.6 m-80 -152.52 -82.56 0.09 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.691 0.282 . . . . 1.7 111.15 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.13 174.2 38.49 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 121.191 -0.528 . . . . 0.40000000000000002 113.743 -179.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.611 ' O ' ' HB3' ' A' ' 44' ' ' LYS . 33.8 m -82.42 176.4 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 C-N-CA 123.401 0.68 . . . . 2.0299999999999998 110.409 179.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.611 ' HB3' ' O ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER 165.1 156.54 0.08 OUTLIER Pre-proline 0 N--CA 1.471 0.591 0 CA-C-O 121.47 0.653 . . . . 2.7400000000000002 112.33 -179.236 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.517 ' HD2' ' HB2' ' A' ' 49' ' ' ASP . 1.8 Cg_endo -85.36 173.47 7.63 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 125.082 3.854 . . . . 0.34000000000000002 113.367 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' A' ' 48' ' ' SER . . . -68.28 -172.34 6.94 Favored Glycine 0 C--O 1.223 -0.572 0 CA-C-N 115.216 -0.902 . . . . 0.38 111.451 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -41.64 -13.48 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.763 1.023 . . . . 2.9399999999999999 113.763 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 46' ' ' GLY . 50.5 m -86.16 7.51 24.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.46 0.647 . . . . 1.8999999999999999 109.851 178.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.517 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 1.8 t70 -74.84 162.15 28.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.887 -1.051 . . . . 1.73 112.326 -179.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 90.3 m -125.56 133.85 52.16 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 108.752 -0.833 . . . . 0.92000000000000004 108.752 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.519 HG13 HG23 ' A' ' 133' ' ' VAL . 30.1 m -131.74 140.37 48.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 112.807 0.669 . . . . 1.22 112.807 -178.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 89.4 m -112.98 119.86 39.39 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.083 -1.08 . . . . 1.05 108.083 177.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.516 HG11 ' HA ' ' A' ' 130' ' ' LEU . 5.0 m -146.4 -179.17 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.229 0.538 . . . . 1.05 111.943 -178.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -130.04 132.13 46.09 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.37 -0.832 . . . . 2.3999999999999999 108.977 178.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -147.18 167.11 25.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.757 0.789 . . . . 0.93999999999999995 112.412 -178.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 58.3 m -131.19 113.99 14.55 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.384 -1.28 . . . . 1.0600000000000001 108.728 178.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.4 ' O ' HG21 ' A' ' 64' ' ' VAL . . . -109.53 147.53 17.03 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 119.989 -1.1 . . . . 0.14000000000000001 112.452 -178.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.34 145.93 31.4 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.046 0.451 . . . . 2.6899999999999999 110.429 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.406 ' HA ' ' HG ' ' A' ' 124' ' ' LEU . 6.9 mt -79.9 153.39 29.04 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.688 -0.687 . . . . 1.77 110.255 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.485 ' HB ' ' O ' ' A' ' 123' ' ' THR . 0.4 OUTLIER -55.64 -14.35 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.401 0.619 . . . . 1.3700000000000001 109.411 178.936 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -65.11 -10.87 34.07 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.266 -0.879 . . . . 2.0099999999999998 110.93 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.02 0.03 75.14 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.547 -0.835 . . . . 0.45000000000000001 113.837 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.0 t -121.64 131.53 54.15 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 117.646 0.723 . . . . 1.99 111.865 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.4 HG21 ' O ' ' A' ' 57' ' ' GLY . 3.9 p -61.68 134.35 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-N 115.709 -0.678 . . . . 1.0700000000000001 110.049 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.688 ' HD1' ' H ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -97.66 -27.36 14.4 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.097 -0.501 . . . . 0.25 111.565 -179.882 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.688 ' H ' ' HD1' ' A' ' 65' ' ' PHE . 13.9 t70 -176.83 129.96 0.18 Allowed 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 120.619 0.247 . . . . 0.29999999999999999 110.54 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 57.6 p -129.18 117.46 20.8 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.455 -0.339 . . . . 1.8100000000000001 110.736 179.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.624 HG22 ' HB2' ' A' ' 75' ' ' ALA . 65.3 p -74.83 -12.35 60.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.065 0.459 . . . . 0.93000000000000005 110.449 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -75.73 -46.91 28.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.632 -0.713 . . . . 2.1099999999999999 111.25 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -71.18 -36.46 71.97 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.028 -0.533 . . . . 3.79 111.751 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 54.5 p -59.61 -12.62 7.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.788 0.327 . . . . 2.1200000000000001 111.296 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 75.01 8.47 83.06 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.795 -0.717 . . . . 0.80000000000000004 112.415 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -122.97 117.75 28.4 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.572 0.225 . . . . 3.52 110.875 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.09 153.18 16.54 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.667 2.245 . . . . 0.76000000000000001 112.6 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.624 ' HB2' HG22 ' A' ' 68' ' ' THR . . . -96.58 124.74 40.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.022 -0.535 . . . . 0.76000000000000001 110.448 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.8 t -130.44 118.19 20.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.089 0.471 . . . . 1.98 111.297 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -158.54 161.82 37.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.022 -0.535 . . . . 0.44 111.108 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.455 HE21 ' H ' ' A' ' 80' ' ' SER . 0.0 OUTLIER -81.66 146.5 30.01 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.12 -0.491 . . . . 1.8 109.965 179.143 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 87' ' ' THR . 20.0 m -66.54 -30.88 51.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 112.771 0.656 . . . . 1.79 112.771 -178.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.455 ' H ' HE21 ' A' ' 78' ' ' GLN . 46.8 t -95.76 -6.39 39.82 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 112.438 0.533 . . . . 1.6100000000000001 112.438 -178.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -84.92 5.66 28.13 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 111.89 0.33 . . . . 2.4199999999999999 111.89 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.7 m -110.41 -173.37 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 111.749 0.277 . . . . 1.1799999999999999 111.749 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 45.4 pt -56.03 156.43 10.25 Favored Pre-proline 0 CA--C 1.53 0.2 0 CA-C-N 116.428 -0.351 . . . . 1.5900000000000001 111.631 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -46.07 -59.56 1.16 Allowed 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.858 2.372 . . . . 1.01 113.262 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.436 ' O ' HD12 ' A' ' 32' ' ' LEU . . . -50.9 -49.46 41.87 Favored Glycine 0 CA--C 1.521 0.454 0 C-N-CA 120.858 -0.686 . . . . 0.35999999999999999 113.114 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -61.72 -38.51 88.17 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.915 0.339 . . . . 0.98999999999999999 111.915 -178.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 79' ' ' VAL . 50.6 m -61.02 -35.55 77.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.721 0.296 . . . . 1.8899999999999999 111.35 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -70.38 -42.64 71.46 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.279 -0.418 . . . . 1.4299999999999999 111.798 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.441 ' HB1' HD23 ' A' ' 32' ' ' LEU . . . -75.51 -51.99 11.68 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.429 0.529 . . . . 0.33000000000000002 112.429 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -54.93 -39.35 68.76 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.432 0.53 . . . . 1.1599999999999999 112.432 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -67.23 -9.59 41.95 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.667 0.27 . . . . 2.23 111.443 -179.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 83.2 mt -103.42 -7.88 20.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.433 -0.349 . . . . 2.0899999999999999 111.019 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.587 ' HE3' HD11 ' A' ' 128' ' ' ILE . 68.0 mtt -85.95 110.07 27.61 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.315 -0.402 . . . . 2.2799999999999998 111.641 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.522 ' HG2' ' HB3' ' A' ' 97' ' ' SER . 74.3 Cg_endo -74.67 147.28 35.22 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.35 2.033 . . . . 0.72999999999999998 111.477 179.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.474 ' HB3' ' HA ' ' A' ' 132' ' ' SER . . . -50.02 126.72 15.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.505 -0.316 . . . . 1.21 111.594 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 94.97 -8.84 70.43 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 120.717 -0.754 . . . . 0.34000000000000002 113.148 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.522 ' HB3' ' HG2' ' A' ' 94' ' ' PRO . 98.4 p -70.57 -176.52 1.29 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.926 0.393 . . . . 1.8899999999999999 111.417 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 24.3 m -159.03 97.44 1.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.762 -0.654 . . . . 0.88 110.605 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.65 ' HE1' ' HB3' ' A' ' 39' ' ' SER . 34.9 m0 -115.11 149.06 38.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.233 0.54 . . . . 0.67000000000000004 111.717 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.402 ' O ' ' HB2' ' A' ' 34' ' ' TYR . 27.0 tt0 -115.16 107.23 15.04 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.827 -1.175 . . . . 1.53 107.827 177.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.411 HG21 ' CB ' ' A' ' 34' ' ' TYR . 13.8 pt -114.58 140.57 34.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 113.602 0.964 . . . . 0.72999999999999998 113.602 -177.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -120.58 104.33 9.86 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.959 -1.126 . . . . 0.91000000000000003 107.959 177.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.549 HG12 HD11 ' A' ' 107' ' ' LEU . 52.9 t -93.35 98.23 2.37 Favored Pre-proline 0 C--N 1.329 -0.284 0 N-CA-C 113.563 0.949 . . . . 1.1399999999999999 113.563 -177.101 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.437 ' HG2' ' HG ' ' A' ' 107' ' ' LEU . 6.9 Cg_endo -53.08 150.94 22.69 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.267 1.978 . . . . 0.68000000000000005 111.407 177.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.527 ' HB2' ' HA2' ' A' ' 110' ' ' GLY . 3.5 p -48.02 -43.36 29.94 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.293 0.479 . . . . 2.3700000000000001 112.293 -179.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -57.32 -9.14 4.14 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 115.384 0.914 . . . . 0.40000000000000002 115.384 -177.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.549 HD11 HG12 ' A' ' 103' ' ' VAL . 46.3 mt -91.64 -19.27 22.86 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 118.244 1.022 . . . . 2.9300000000000002 112.937 -178.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -130.05 -125.53 0.21 Allowed 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.761 -0.376 . . . . 1.3799999999999999 111.769 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.4 ' O ' ' HB2' ' A' ' 112' ' ' ARG . 88.5 m-85 -89.23 4.72 47.74 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.198 0.523 . . . . 1.6000000000000001 110.147 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.527 ' HA2' ' HB2' ' A' ' 105' ' ' SER . . . -38.51 -79.0 0.04 OUTLIER Glycine 0 CA--C 1.524 0.628 0 CA-C-N 115.047 -0.978 . . . . 2.3399999999999999 114.986 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -56.62 -9.86 4.44 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 123.339 2.692 . . . . 1.9299999999999999 113.865 -177.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.449 ' C ' ' H ' ' A' ' 114' ' ' VAL . 40.6 mmt180 -79.48 139.71 37.53 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.897 -0.408 . . . . 3.8799999999999999 109.897 179.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 79.6 p -63.12 -2.12 1.21 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.991 0.424 . . . . 2.0800000000000001 111.193 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.449 ' H ' ' C ' ' A' ' 112' ' ' ARG . 7.9 p -110.65 60.55 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.85 -0.613 . . . . 3.4199999999999999 110.612 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -41.92 100.93 0.02 OUTLIER Glycine 0 C--N 1.334 0.457 0 CA-C-N 115.695 -0.684 . . . . 1.0900000000000001 112.848 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -69.21 -128.87 0.05 OUTLIER Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.878 -0.677 . . . . 0.89000000000000001 112.324 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_exo -60.46 -36.66 85.6 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 121.901 1.734 . . . . 1.0900000000000001 111.093 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.577 HG22 HD11 ' A' ' 124' ' ' LEU . 94.8 mt -92.37 134.03 31.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.5 -0.773 . . . . 1.8799999999999999 109.944 178.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -48.55 146.69 5.53 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.526 -0.845 . . . . 0.56000000000000005 112.244 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -54.78 130.54 40.98 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.265 1.976 . . . . 0.84999999999999998 111.861 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 42.75 35.16 0.66 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.033 -0.531 . . . . 1.1200000000000001 110.65 -179.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -116.54 142.86 46.33 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.826 -0.625 . . . . 1.8200000000000001 111.074 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.491 HG22 HD21 ' A' ' 16' ' ' LEU . 92.7 m -95.66 129.53 42.83 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.548 -0.538 . . . . 1.0900000000000001 109.548 178.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.577 HD11 HG22 ' A' ' 118' ' ' ILE . 0.1 OUTLIER -113.93 154.55 27.37 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.358 0.599 . . . . 2.1000000000000001 112.279 -177.992 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.5 mp -113.92 140.75 32.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.174 -0.921 . . . . 1.0600000000000001 109.585 178.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.4 ' CE1' HD23 ' A' ' 124' ' ' LEU . 82.2 m-85 -135.47 131.97 36.78 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.024 0.44 . . . . 0.28999999999999998 111.445 -179.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.547 ' HB3' ' HZ3' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -114.4 102.8 10.44 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.189 -1.041 . . . . 2.77 108.189 177.87 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.587 HD11 ' HE3' ' A' ' 93' ' ' MET . 12.2 mt -103.73 130.58 53.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 112.684 0.624 . . . . 1.5600000000000001 112.684 -177.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -117.88 101.01 7.95 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.129 -0.941 . . . . 0.29999999999999999 108.919 178.221 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.516 ' HA ' HG11 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -78.5 123.29 26.9 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.119 0.485 . . . . 2.0299999999999998 111.814 -178.274 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 58.6 mt -93.39 -53.13 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 115.518 -0.765 . . . . 1.8899999999999999 110.92 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.474 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 60.7 p -164.53 165.57 21.12 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.055 0.455 . . . . 1.75 111.259 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.519 HG23 HG13 ' A' ' 51' ' ' VAL . 2.1 t -111.84 126.09 69.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.642 -0.708 . . . . 2.1299999999999999 110.772 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 18.2 tttt 44.52 57.38 4.47 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.93 -0.577 . . . . 3.5600000000000001 110.917 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm 60.85 34.5 19.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.572 -0.74 . . . . 3.6699999999999999 111.336 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.421 ' HB2' ' HB2' ' A' ' 132' ' ' SER . 39.0 t 55.42 64.27 1.82 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.852 -0.613 . . . . 1.6000000000000001 111.205 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 53.6 m . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.3 -0.857 . . . . 2.7799999999999998 110.821 179.762 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 . . . . . 0 N--CA 1.485 1.306 0 CA-C-O 120.755 0.312 . . . . 3.73 110.841 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -67.45 -18.83 65.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 2.0800000000000001 110.895 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -58.51 -40.32 82.52 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.663 -0.495 . . . . 3.7599999999999998 109.663 179.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -78.78 -34.41 45.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.77 -0.65 . . . . 3.1499999999999999 109.89 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -58.97 -52.43 65.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.875 -0.602 . . . . 1.27 110.127 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -63.96 -35.23 80.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.725 -0.671 . . . . 2.5699999999999998 110.218 179.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -55.92 -32.58 63.9 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.334 -0.617 . . . . 2.1400000000000001 109.334 178.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 13.7 m-20 -74.07 -37.46 64.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.445 -0.798 . . . . 1.3999999999999999 110.826 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 52.6 tptt -63.9 -38.51 91.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 3.2400000000000002 111.64 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.1 m -71.58 -48.44 52.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 C-N-CA 121.189 -0.204 . . . . 1.9199999999999999 111.514 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.426 ' HG3' HG23 ' A' ' 60' ' ' ILE . 18.1 ptpt -68.81 -25.71 64.82 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.835 0.35 . . . . 2.1499999999999999 110.486 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.62 -53.26 8.63 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 121.066 -0.588 . . . . 0.33000000000000002 112.143 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.41 ' HA ' HD13 ' A' ' 16' ' ' LEU . 43.8 tt0 -62.13 -27.89 69.25 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.096 0.474 . . . . 2.3900000000000001 110.313 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.13 -30.63 49.43 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.951 -0.568 . . . . 0.92000000000000004 110.423 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -65.94 -52.73 47.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.752 -0.658 . . . . 0.27000000000000002 110.612 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.644 ' HA ' ' HB3' ' A' ' 19' ' ' ASN . 0.4 OUTLIER -67.62 -32.06 72.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.268 -0.424 . . . . 1.3100000000000001 111.078 179.91 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.2 m -56.67 -47.58 79.5 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 109.748 -0.464 . . . . 1.1599999999999999 109.748 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -73.05 -32.52 65.1 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.859 -0.61 . . . . 2.4700000000000002 109.812 178.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.644 ' HB3' ' HA ' ' A' ' 16' ' ' LEU . 0.6 OUTLIER -59.46 -25.01 64.03 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.439 -0.8 . . . . 0.22 111.582 179.829 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -49.97 -20.35 0.91 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.518 -0.31 . . . . 2.8799999999999999 111.722 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.733 ' N ' HD21 ' A' ' 21' ' ' ASN . 0.7 OUTLIER -68.96 -33.13 73.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.378 -0.374 . . . . 0.40000000000000002 111.53 -178.98 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.447 ' O ' HG21 ' A' ' 25' ' ' VAL . 12.6 mptt -48.35 118.69 6.97 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 116.188 -0.46 . . . . 1.9299999999999999 110.906 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.441 ' O ' ' HG2' ' A' ' 35' ' ' LYS . 32.1 Cg_exo -57.52 139.18 89.38 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.316 2.011 . . . . 1.0600000000000001 112.651 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.83 3.39 80.27 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 120.863 -0.684 . . . . 0.40999999999999998 114.025 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.578 HG23 ' HH ' ' A' ' 102' ' ' TYR . 4.0 t -53.52 117.67 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.175 0 CA-C-N 117.425 0.613 . . . . 1.6000000000000001 110.826 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 33' ' ' GLN . 4.3 p -129.87 128.16 64.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.064 -0.516 . . . . 1.6599999999999999 111.061 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.3 p -85.69 141.97 13.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.459 . . . . 1.5600000000000001 111.078 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.514 HD13 ' HB2' ' A' ' 32' ' ' LEU . 41.5 mt -104.1 165.34 13.57 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.011 -0.541 . . . . 1.0800000000000001 110.609 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.431 ' HD2' ' HB3' ' A' ' 28' ' ' LEU . 72.2 Cg_exo -50.48 -38.34 53.64 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.179 1.919 . . . . 0.65000000000000002 112.26 179.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.527 ' HB3' HD22 ' A' ' 107' ' ' LEU . 7.3 m -80.76 -9.59 59.79 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.2 -0.454 . . . . 1.75 111.368 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.3 14.52 27.99 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.331 -0.938 . . . . 0.34999999999999998 113.48 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.514 ' HB2' HD13 ' A' ' 28' ' ' LEU . 0.4 OUTLIER -83.11 134.86 34.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.45 0.643 . . . . 2.0 112.168 -179.28 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.411 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 47.4 mt-30 -123.34 143.0 50.38 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.984 -1.007 . . . . 2.3199999999999998 108.636 178.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.492 ' HB3' HG23 ' A' ' 101' ' ' ILE . 48.3 p90 -157.83 175.39 13.93 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.809 0.67 . . . . 0.92000000000000004 112.809 -178.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.441 ' HG2' ' O ' ' A' ' 23' ' ' PRO . 3.5 tmmm? -122.2 118.94 29.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.001 -0.999 . . . . 2.6800000000000002 109.321 178.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.619 HG12 ' HE1' ' A' ' 99' ' ' TRP . 48.5 t -71.93 125.61 30.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 113.279 0.844 . . . . 0.77000000000000002 113.279 -177.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.3 mp -98.81 -66.24 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.319 -0.855 . . . . 1.46 110.11 178.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.487 ' ND2' HD22 ' A' ' 41' ' ' ASN . 7.3 t30 -144.89 90.51 2.06 Favored 'General case' 0 CA--C 1.527 0.062 0 CA-C-N 116.471 -0.332 . . . . 1.05 110.166 179.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.601 ' HB3' ' HE1' ' A' ' 99' ' ' TRP . 94.9 p -105.32 145.98 30.0 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.932 0.396 . . . . 2.02 112.006 -178.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 91.59 94.4 1.33 Allowed Glycine 0 C--N 1.332 0.352 0 CA-C-N 115.854 -0.612 . . . . 1.0900000000000001 112.764 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.487 HD22 ' ND2' ' A' ' 38' ' ' ASN . 35.4 m-80 -150.93 -81.89 0.1 Allowed 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 111.776 0.287 . . . . 1.7 111.776 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.09 178.53 42.01 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 121.088 -0.577 . . . . 0.40000000000000002 114.161 -178.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.611 ' O ' ' HB3' ' A' ' 44' ' ' LYS . 27.3 m -90.32 176.89 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 123.729 0.812 . . . . 2.0299999999999998 110.33 179.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.611 ' HB3' ' O ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER 165.08 156.6 0.08 OUTLIER Pre-proline 0 N--CA 1.472 0.668 0 CA-C-O 121.486 0.66 . . . . 2.7400000000000002 112.172 -179.61 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 44' ' ' LYS . 2.8 Cg_exo -77.72 173.52 14.0 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 124.752 3.634 . . . . 0.34000000000000002 112.955 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.492 ' O ' ' N ' ' A' ' 48' ' ' SER . . . -67.54 -172.84 6.28 Favored Glycine 0 N--CA 1.448 -0.5 0 CA-C-N 115.368 -0.833 . . . . 0.38 111.037 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.421 ' HE3' ' NE2' ' A' ' 91' ' ' GLN . 9.2 ptpp? -41.88 -13.88 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.707 1.003 . . . . 2.9399999999999999 113.707 -177.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 46' ' ' GLY . 84.5 p -86.54 7.37 26.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.065 0.459 . . . . 1.8999999999999999 110.522 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -72.08 156.14 39.52 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.71 -0.677 . . . . 1.73 111.993 -179.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 26.0 m -126.67 119.72 27.69 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 108.481 -0.933 . . . . 0.92000000000000004 108.481 178.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.518 HG23 HD23 ' A' ' 130' ' ' LEU . 14.3 m -128.67 158.4 41.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.222 0.534 . . . . 1.22 112.326 -178.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 94.2 m -113.78 120.8 42.05 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.337 -0.847 . . . . 1.05 109.115 178.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.626 HG13 HD21 ' A' ' 130' ' ' LEU . 6.1 m -139.4 170.11 16.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.137 0.494 . . . . 1.05 111.6 -178.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -124.05 132.31 53.66 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.375 -0.83 . . . . 2.3999999999999999 109.128 178.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 14.7 p90 -144.05 164.6 30.17 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.683 0.754 . . . . 0.93999999999999995 112.491 -178.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.543 HG21 ' HG ' ' A' ' 67' ' ' SER . 37.9 m -123.56 113.39 18.64 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.426 -1.261 . . . . 1.0600000000000001 108.565 178.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -110.02 143.81 16.79 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 119.684 -1.246 . . . . 0.14000000000000001 112.677 -178.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.457 ' NH2' ' HA3' ' A' ' 62' ' ' GLY . 0.5 OUTLIER -147.62 147.0 29.57 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.004 0.431 . . . . 2.6899999999999999 110.589 179.552 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.434 ' HA ' ' HG ' ' A' ' 124' ' ' LEU . 3.8 mt -78.83 158.03 28.24 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.858 -0.61 . . . . 1.77 110.254 179.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.455 ' HB ' ' O ' ' A' ' 123' ' ' THR . 0.4 OUTLIER -58.16 -14.21 3.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 108.957 -0.757 . . . . 1.3700000000000001 108.957 178.64 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -63.64 -12.48 34.05 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.14 -0.936 . . . . 2.0099999999999998 110.837 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.457 ' HA3' ' NH2' ' A' ' 58' ' ' ARG . . . 91.15 -0.31 75.31 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 120.634 -0.793 . . . . 0.45000000000000001 113.673 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.3 t -119.85 132.46 55.58 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 117.374 0.587 . . . . 1.99 111.507 -178.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.2 p -61.18 134.7 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 115.807 -0.633 . . . . 1.0700000000000001 109.906 179.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.647 ' HD1' ' H ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -97.5 -26.54 14.79 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.241 -0.436 . . . . 0.25 111.266 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.647 ' H ' ' HD1' ' A' ' 65' ' ' PHE . 16.3 t70 -176.33 129.98 0.21 Allowed 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 120.809 0.338 . . . . 0.29999999999999999 111.085 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.543 ' HG ' HG21 ' A' ' 56' ' ' THR . 62.4 m -123.79 123.89 41.48 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.235 -0.439 . . . . 1.8100000000000001 110.452 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.611 HG22 ' HB3' ' A' ' 75' ' ' ALA . 33.7 p -70.56 -8.41 51.2 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.94 0.4 . . . . 0.93000000000000005 110.652 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -75.39 -46.85 30.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.861 -0.609 . . . . 2.1099999999999999 110.794 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -61.94 -38.7 89.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.981 -0.554 . . . . 3.79 111.304 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 14.2 m -60.73 -13.54 15.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.143 0.496 . . . . 2.1200000000000001 110.182 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 73.8 3.54 63.92 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.69 -0.687 . . . . 0.80000000000000004 112.351 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -127.21 124.68 23.85 Favored Pre-proline 0 C--N 1.33 -0.262 0 C-N-CA 121.325 -0.15 . . . . 3.52 111.071 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -53.75 162.68 3.45 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.284 1.989 . . . . 0.76000000000000001 111.517 179.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.611 ' HB3' HG22 ' A' ' 68' ' ' THR . . . -93.94 124.31 37.86 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.446 -0.343 . . . . 0.76000000000000001 110.812 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 27.5 m -123.87 116.22 22.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.751 0.31 . . . . 1.98 111.079 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -158.72 159.46 35.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 0.44 111.34 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.541 HE21 ' H ' ' A' ' 80' ' ' SER . 0.0 OUTLIER -81.48 143.74 31.85 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 108.983 -0.747 . . . . 1.8 108.983 178.317 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.8 m -70.83 -14.4 17.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 113.008 0.744 . . . . 1.79 113.008 -178.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.543 ' HA ' ' HG1' ' A' ' 87' ' ' THR . 66.0 m -95.49 -19.18 20.05 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.197 0.443 . . . . 1.6100000000000001 112.197 -179.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.408 ' HG2' ' HB3' ' A' ' 78' ' ' GLN . 78.2 mm-40 -79.62 6.26 11.06 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.412 0.523 . . . . 2.4199999999999999 112.412 -179.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.4 m -111.25 -175.7 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 112.685 0.624 . . . . 1.1799999999999999 112.685 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.432 ' HB ' ' HD2' ' A' ' 84' ' ' PRO . 42.4 pt -56.12 160.45 4.75 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 115.836 -0.62 . . . . 1.5900000000000001 112.595 -179.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.454 ' O ' HG23 ' A' ' 87' ' ' THR . 78.1 Cg_exo -47.86 -60.75 0.76 Allowed 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 123.102 2.535 . . . . 1.01 114.204 -178.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.554 ' H ' ' CD1' ' A' ' 107' ' ' LEU . . . -53.17 -48.3 59.28 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.759 -0.734 . . . . 0.35999999999999999 113.386 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -54.81 -47.95 73.38 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.798 0.666 . . . . 0.98999999999999999 112.798 -178.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.543 ' HG1' ' HA ' ' A' ' 80' ' ' SER . 11.6 t -62.68 -33.87 75.97 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.713 -0.395 . . . . 1.8899999999999999 111.779 -179.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.465 ' O ' ' HG2' ' A' ' 91' ' ' GLN . 18.3 mm-40 -70.79 -40.85 72.3 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.924 0.342 . . . . 1.4299999999999999 111.924 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.439 ' HB1' HD11 ' A' ' 32' ' ' LEU . . . -75.84 -49.45 17.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.871 0.367 . . . . 0.33000000000000002 111.585 -179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.45 HD11 ' SD ' ' A' ' 93' ' ' MET . 3.5 mm? -55.87 -41.33 74.24 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.888 -0.596 . . . . 1.1599999999999999 112.06 -179.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.465 ' HG2' ' O ' ' A' ' 88' ' ' GLU . 3.2 pt20 -65.41 -3.76 4.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.635 -0.257 . . . . 2.23 111.636 -179.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 94.7 mt -104.97 -29.61 10.35 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.713 0.264 . . . . 2.0899999999999999 111.713 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.45 ' SD ' HD11 ' A' ' 90' ' ' LEU . 24.0 ptp -81.91 111.05 23.5 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-O 120.615 0.245 . . . . 2.2799999999999998 111.537 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.87 147.18 61.59 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.227 1.952 . . . . 0.72999999999999998 111.45 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.496 ' HB3' ' HA ' ' A' ' 132' ' ' SER . . . -46.35 127.15 8.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.469 -0.332 . . . . 1.21 111.115 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 103.56 -7.61 50.6 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.896 -0.669 . . . . 0.34000000000000002 112.717 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 66.4 m -79.94 -175.47 4.96 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.845 0.355 . . . . 1.8899999999999999 111.39 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 14.1 m -156.75 104.09 2.12 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.032 -0.531 . . . . 0.88 111.083 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.619 ' HE1' HG12 ' A' ' 36' ' ' VAL . 30.5 m0 -125.15 149.23 48.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.252 -0.431 . . . . 0.67000000000000004 111.058 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 100' ' ' GLU . 12.6 pt-20 -119.05 108.52 14.82 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.556 -0.905 . . . . 1.53 108.556 177.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.492 HG23 ' HB3' ' A' ' 34' ' ' TYR . 37.3 pt -108.17 139.67 29.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 112.963 0.727 . . . . 0.72999999999999998 112.963 -177.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.578 ' HH ' HG23 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -113.95 103.91 11.63 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.783 -1.192 . . . . 0.91000000000000003 107.783 177.886 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.408 ' HA ' ' HD2' ' A' ' 104' ' ' PRO . 40.7 t -94.57 102.04 7.98 Favored Pre-proline 0 C--N 1.329 -0.296 0 N-CA-C 113.78 1.03 . . . . 1.1399999999999999 113.78 -176.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.433 ' HA ' HG21 ' A' ' 123' ' ' THR . 9.3 Cg_endo -56.07 149.89 50.75 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.192 1.928 . . . . 0.68000000000000005 111.085 177.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.465 ' HB2' ' HA2' ' A' ' 110' ' ' GLY . 4.4 p -49.11 -43.26 41.23 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.247 0.462 . . . . 2.3700000000000001 112.247 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -56.24 -8.42 2.45 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 115.19 0.836 . . . . 0.40000000000000002 115.19 -177.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.554 ' CD1' ' H ' ' A' ' 85' ' ' GLY . 1.1 tm? -82.25 -31.75 30.02 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 117.863 0.831 . . . . 2.9300000000000002 112.748 -178.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.42 ' HB1' ' HB ' ' A' ' 83' ' ' ILE . . . -129.45 -118.5 0.24 Allowed 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.375 -0.53 . . . . 1.3799999999999999 112.382 -178.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -89.09 4.74 47.41 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 121.15 0.5 . . . . 1.6000000000000001 110.567 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.465 ' HA2' ' HB2' ' A' ' 105' ' ' SER . . . -42.4 -76.78 0.1 OUTLIER Glycine 0 CA--C 1.524 0.607 0 CA-C-N 115.129 -0.941 . . . . 2.3399999999999999 115.001 -179.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -55.81 -9.93 3.45 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 123.315 2.677 . . . . 1.9299999999999999 113.904 -177.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.461 ' C ' ' H ' ' A' ' 114' ' ' VAL . 96.2 mtt180 -79.8 139.27 37.29 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.631 -0.507 . . . . 3.8799999999999999 109.631 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 66.4 m -61.68 -6.35 2.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.247 0.546 . . . . 2.0800000000000001 110.485 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.461 ' H ' ' C ' ' A' ' 112' ' ' ARG . 7.9 t -111.25 60.45 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.147 -0.933 . . . . 3.4199999999999999 110.631 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -54.58 117.7 8.35 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.975 -0.631 . . . . 1.0900000000000001 112.956 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -73.92 -115.38 0.08 OUTLIER Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.751 -0.738 . . . . 0.89000000000000001 112.214 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.71 -35.8 35.31 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.127 1.885 . . . . 1.0900000000000001 112.019 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.528 HG21 HD11 ' A' ' 124' ' ' LEU . 92.6 mt -91.45 135.66 26.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.069 -0.514 . . . . 1.8799999999999999 110.322 179.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -46.97 148.3 2.88 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.748 -0.739 . . . . 0.56000000000000005 112.087 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -56.05 130.03 38.09 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.119 1.88 . . . . 0.84999999999999998 111.986 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 41.49 35.45 0.45 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.792 -0.64 . . . . 1.1200000000000001 110.878 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -116.89 145.86 43.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.881 -0.6 . . . . 1.8200000000000001 111.258 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.455 ' O ' ' HB ' ' A' ' 60' ' ' ILE . 90.6 m -95.2 134.04 38.39 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.646 -0.501 . . . . 1.0900000000000001 109.646 179.004 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.528 HD11 HG21 ' A' ' 118' ' ' ILE . 0.1 OUTLIER -120.55 156.54 31.36 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.342 0.592 . . . . 2.1000000000000001 112.46 -178.249 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.405 HD11 ' N ' ' A' ' 125' ' ' ILE . 4.4 mp -113.85 148.17 16.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.128 -0.942 . . . . 1.0600000000000001 109.467 178.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -139.96 132.28 28.34 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.166 0.508 . . . . 0.28999999999999998 111.761 -179.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 2.2 tmtp? -110.91 104.04 12.6 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.575 -0.898 . . . . 2.77 108.575 178.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.479 HD13 ' N ' ' A' ' 128' ' ' ILE . 4.1 mp -102.12 127.19 55.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.377 0.608 . . . . 1.5600000000000001 112.582 -177.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -118.38 99.97 7.18 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.036 -0.984 . . . . 0.29999999999999999 108.492 177.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.626 HD21 HG13 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -77.94 120.95 23.52 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.122 -0.49 . . . . 2.0299999999999998 111.135 -178.39 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 49.7 mm -94.9 -56.22 5.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.852 -0.613 . . . . 1.8899999999999999 110.946 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.496 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 89.8 p -163.4 164.66 24.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.003 0.43 . . . . 1.75 111.351 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.473 ' HA ' HG11 ' A' ' 51' ' ' VAL . 7.1 p -107.93 127.24 64.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.904 -0.589 . . . . 2.1299999999999999 111.054 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 12.8 tttp 45.34 -149.22 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.255 -0.43 . . . . 3.5600000000000001 110.785 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -64.65 -5.4 5.6 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.226 -0.443 . . . . 3.6699999999999999 110.979 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 32.9 t 65.42 82.6 0.18 Allowed 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.935 -0.575 . . . . 1.6000000000000001 110.953 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 81.6 p . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.17 -0.919 . . . . 2.7799999999999998 111.387 179.885 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.713 0.292 . . . . 3.73 110.84 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 26.2 p30 -63.61 -18.82 64.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.297 -0.411 . . . . 2.0800000000000001 111.077 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -56.94 -40.88 77.22 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.614 -0.513 . . . . 3.7599999999999998 109.614 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -79.76 -36.91 36.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.583 -0.735 . . . . 3.1499999999999999 110.464 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -56.58 -51.94 66.7 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 116.145 -0.479 . . . . 1.27 110.386 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -67.59 -33.37 74.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.837 -0.62 . . . . 2.5699999999999998 110.226 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.423 ' O ' ' HG2' ' A' ' 11' ' ' LYS . 41.3 tt0 -55.58 -33.53 64.0 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 109.096 -0.705 . . . . 2.1400000000000001 109.096 178.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.466 ' HA ' ' HE2' ' A' ' 11' ' ' LYS . 10.1 m-20 -75.54 -38.42 59.31 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.371 -0.831 . . . . 1.3999999999999999 110.286 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -56.24 -38.82 71.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.75 -0.659 . . . . 3.2400000000000002 111.605 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.403 HG22 ' N ' ' A' ' 11' ' ' LYS . 18.6 m -78.33 -49.81 20.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 112.639 0.607 . . . . 1.9199999999999999 112.639 -178.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.466 ' HE2' ' HA ' ' A' ' 8' ' ' ASN . 61.1 pttt -66.94 -26.25 66.75 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 120.861 -0.336 . . . . 2.1499999999999999 111.445 -179.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.413 ' O ' ' HG ' ' A' ' 16' ' ' LEU . . . -76.41 -53.43 5.56 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.734 -0.746 . . . . 0.33000000000000002 112.313 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.418 ' HA ' HD13 ' A' ' 16' ' ' LEU . 20.4 tp10 -61.86 -28.21 69.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.096 0.474 . . . . 2.3900000000000001 110.604 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.3 -36.46 46.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.839 -0.619 . . . . 0.92000000000000004 110.747 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -59.82 -53.71 54.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.076 -0.511 . . . . 0.27000000000000002 110.617 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.666 ' HA ' ' HB3' ' A' ' 19' ' ' ASN . 0.4 OUTLIER -66.59 -33.77 76.4 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.737 -0.385 . . . . 1.3100000000000001 111.101 -179.784 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.1 m -57.43 -45.96 84.08 Favored 'General case' 0 N--CA 1.456 -0.125 0 N-CA-C 109.622 -0.51 . . . . 1.1599999999999999 109.622 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -74.35 -32.38 62.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.91 -0.586 . . . . 2.4700000000000002 109.9 178.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.666 ' HB3' ' HA ' ' A' ' 16' ' ' LEU . 0.4 OUTLIER -57.58 -26.46 61.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.514 -0.767 . . . . 0.22 111.497 -179.822 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -49.19 -19.2 0.43 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.169 -0.469 . . . . 2.8799999999999999 111.824 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.711 ' N ' HD21 ' A' ' 21' ' ' ASN . 0.8 OUTLIER -68.46 -31.87 71.47 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.192 0.441 . . . . 0.40000000000000002 112.192 -178.482 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' A' ' 19' ' ' ASN . 27.2 mmtm -52.97 119.21 15.66 Favored Pre-proline 0 CA--C 1.531 0.237 0 C-N-CA 121.322 -0.151 . . . . 1.9299999999999999 110.619 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -57.86 143.64 95.34 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.189 1.926 . . . . 1.0600000000000001 112.278 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.75 2.94 81.08 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.858 -0.687 . . . . 0.40999999999999998 113.705 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.421 HG21 ' O ' ' A' ' 22' ' ' LYS . 5.9 t -59.73 120.86 6.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 117.167 0.483 . . . . 1.6000000000000001 110.481 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.3 p -130.17 133.32 64.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 1.6599999999999999 111.204 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.5 p -92.37 137.04 23.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.145 -0.479 . . . . 1.5600000000000001 110.745 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.466 ' HB2' ' HB2' ' A' ' 32' ' ' LEU . 35.1 mt -100.94 162.94 19.05 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 1.0800000000000001 110.751 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -53.26 -30.72 52.82 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.176 1.917 . . . . 0.65000000000000002 112.309 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.445 ' HB2' ' HG3' ' A' ' 88' ' ' GLU . 30.9 t -84.32 -10.08 57.91 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.175 -0.466 . . . . 1.75 111.551 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.27 15.49 25.48 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.367 -0.92 . . . . 0.34999999999999998 112.595 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.508 HD22 ' HA3' ' A' ' 85' ' ' GLY . 2.6 mm? -80.86 133.54 35.6 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.222 0.535 . . . . 2.0 112.05 -178.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -126.07 138.27 53.69 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.329 -0.85 . . . . 2.3199999999999998 109.175 178.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.46 ' HB3' HG23 ' A' ' 101' ' ' ILE . 38.6 p90 -160.84 174.81 13.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.269 0.557 . . . . 0.92000000000000004 112.361 -178.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -121.71 117.51 26.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.198 -0.91 . . . . 2.6800000000000002 109.3 178.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 86.9 t -72.56 125.53 31.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 113.081 0.771 . . . . 0.77000000000000002 113.081 -178.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 64.6 mt -102.3 -64.2 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.387 -0.824 . . . . 1.46 110.125 178.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.493 ' ND2' HD22 ' A' ' 41' ' ' ASN . 9.7 t30 -139.46 89.49 2.34 Favored 'General case' 0 CA--C 1.528 0.099 0 CA-C-N 116.37 -0.377 . . . . 1.05 110.192 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.755 ' HB2' ' HE1' ' A' ' 99' ' ' TRP . 31.9 t -105.37 146.2 29.75 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 112.334 0.494 . . . . 2.02 112.334 -178.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 87.31 95.65 0.9 Allowed Glycine 0 C--N 1.332 0.341 0 CA-C-N 115.684 -0.689 . . . . 1.0900000000000001 112.936 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.493 HD22 ' ND2' ' A' ' 38' ' ' ASN . 43.3 m-80 -150.72 -83.65 0.09 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 111.675 0.25 . . . . 1.7 111.675 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.51 178.01 41.05 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 121.061 -0.59 . . . . 0.40000000000000002 114.285 -178.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.578 ' O ' ' HB3' ' A' ' 44' ' ' LYS . 9.3 p -90.68 178.38 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 123.666 0.786 . . . . 2.0299999999999998 109.688 178.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.578 ' HB3' ' O ' ' A' ' 43' ' ' VAL . 12.6 pttm 165.95 157.66 0.1 OUTLIER Pre-proline 0 N--CA 1.47 0.55 0 CA-C-O 121.482 0.658 . . . . 2.7400000000000002 112.628 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.611 ' HD2' ' HB2' ' A' ' 49' ' ' ASP . 1.3 Cg_endo -85.03 173.79 7.75 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 125.061 3.841 . . . . 0.34000000000000002 113.767 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.462 ' O ' ' N ' ' A' ' 48' ' ' SER . . . -68.05 -171.66 6.22 Favored Glycine 0 C--O 1.221 -0.714 0 CA-C-N 114.984 -1.007 . . . . 0.38 111.741 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.574 ' HG3' HE21 ' A' ' 91' ' ' GLN . 54.8 mtpt -41.22 -15.74 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.875 1.065 . . . . 2.9399999999999999 113.875 -177.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.462 ' N ' ' O ' ' A' ' 46' ' ' GLY . 51.0 m -85.89 7.83 22.58 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.522 0.677 . . . . 1.8999999999999999 109.677 178.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.611 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 0.0 OUTLIER -69.33 151.03 46.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.796 -1.093 . . . . 1.73 112.329 -179.073 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 48.4 m -126.86 119.74 27.52 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.71 -0.677 . . . . 0.92000000000000004 109.257 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.578 HG13 ' HA ' ' A' ' 133' ' ' VAL . 34.9 m -133.24 154.98 40.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.26 0.553 . . . . 1.22 112.24 -178.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 90.3 m -111.12 121.24 44.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.339 -0.846 . . . . 1.05 109.148 178.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.472 HG11 ' HA ' ' A' ' 130' ' ' LEU . 4.2 m -141.28 -179.62 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.06 0.457 . . . . 1.05 111.833 -178.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -135.11 133.06 38.84 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.635 -0.712 . . . . 2.3999999999999999 109.384 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -143.63 158.38 43.71 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.731 0.777 . . . . 0.93999999999999995 112.124 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 63.2 m -125.37 113.26 17.32 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.353 -1.294 . . . . 1.0600000000000001 108.582 178.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.402 ' O ' HG22 ' A' ' 64' ' ' VAL . . . -109.69 145.15 16.85 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 119.914 -1.136 . . . . 0.14000000000000001 112.756 -178.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.503 HH11 HD11 ' A' ' 125' ' ' ILE . 0.1 OUTLIER -148.07 146.48 28.86 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 120.891 0.377 . . . . 2.6899999999999999 110.193 179.325 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.447 ' HA ' ' HG ' ' A' ' 124' ' ' LEU . 5.7 mt -76.27 156.64 33.29 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.989 -0.55 . . . . 1.77 109.744 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.439 HG23 ' HG3' ' A' ' 11' ' ' LYS . 0.4 OUTLIER -58.09 -11.17 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.199 -0.667 . . . . 1.3700000000000001 109.199 179.021 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.432 ' H ' ' C ' ' A' ' 59' ' ' LEU . 19.5 t70 -65.0 -11.58 40.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.357 -0.838 . . . . 2.0099999999999998 110.722 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.456 ' HA3' ' NH2' ' A' ' 58' ' ' ARG . . . 90.81 -0.72 77.08 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.544 -0.836 . . . . 0.45000000000000001 113.511 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 40.7 p -118.94 128.36 54.35 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 117.277 0.538 . . . . 1.99 111.381 -178.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.402 HG22 ' O ' ' A' ' 57' ' ' GLY . 6.5 p -60.71 134.9 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 115.936 -0.574 . . . . 1.0700000000000001 109.807 179.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.632 ' HD1' ' H ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -97.31 -26.24 14.97 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.185 -0.462 . . . . 0.25 110.888 -179.554 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.632 ' H ' ' HD1' ' A' ' 65' ' ' PHE . 21.4 t70 -177.29 134.46 0.18 Allowed 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.438 -0.346 . . . . 0.29999999999999999 110.744 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 40.4 t -131.14 122.58 26.89 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.322 -0.399 . . . . 1.8100000000000001 110.451 179.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.676 HG23 ' HB2' ' A' ' 75' ' ' ALA . 47.9 p -71.62 -17.88 62.24 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.007 0.432 . . . . 0.93000000000000005 110.382 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -75.14 -45.58 39.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.916 -0.583 . . . . 2.1099999999999999 110.508 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -62.55 -41.74 99.09 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.861 -0.609 . . . . 3.79 111.114 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 21.6 m -58.38 -17.63 21.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.315 -0.402 . . . . 2.1200000000000001 110.662 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.42 3.61 88.43 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.821 -0.704 . . . . 0.80000000000000004 112.46 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.597 ' HB3' ' HZ2' ' A' ' 73' ' ' LYS . 8.6 mtpm? -126.38 117.68 23.22 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.347 0.118 . . . . 3.52 111.039 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.43 163.38 3.67 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.476 2.117 . . . . 0.76000000000000001 112.228 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.676 ' HB2' HG23 ' A' ' 68' ' ' THR . . . -96.33 124.72 40.43 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.207 -0.451 . . . . 0.76000000000000001 110.511 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 61.8 m -124.79 111.44 15.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.922 0.391 . . . . 1.98 111.262 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -158.5 163.29 37.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.894 -0.594 . . . . 0.44 110.564 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.635 ' HG3' ' HB2' ' A' ' 81' ' ' GLN . 1.5 pt20 -89.7 147.49 23.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.385 0.612 . . . . 1.8 109.989 178.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 27.5 m -57.61 -23.36 19.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 N-CA-C 114.039 1.125 . . . . 1.79 114.039 -177.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 91.8 p -95.35 -2.55 48.94 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.515 0.561 . . . . 1.6100000000000001 112.515 -178.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.635 ' HB2' ' HG3' ' A' ' 78' ' ' GLN . 6.6 tt0 -83.22 5.32 23.33 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.751 0.278 . . . . 2.4199999999999999 111.751 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -112.87 -178.86 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.912 0.386 . . . . 1.1799999999999999 111.977 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.559 HG13 ' H ' ' A' ' 86' ' ' TRP . 25.6 pt -56.1 154.46 15.02 Favored Pre-proline 0 C--O 1.231 0.102 0 CA-C-N 115.951 -0.568 . . . . 1.5900000000000001 111.741 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -47.81 -44.67 26.32 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.483 2.122 . . . . 1.01 112.414 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.508 ' HA3' HD22 ' A' ' 32' ' ' LEU . . . -61.19 -49.26 79.95 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 120.622 -0.799 . . . . 0.35999999999999999 113.024 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . 0.559 ' H ' HG13 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -63.03 -53.1 59.18 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.894 0.331 . . . . 0.98999999999999999 111.894 -178.985 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.0 t -53.93 -34.23 59.02 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.006 0.373 . . . . 1.8899999999999999 112.006 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.445 ' HG3' ' HB2' ' A' ' 30' ' ' SER . 0.6 OUTLIER -66.09 -51.09 61.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.6 -0.273 . . . . 1.4299999999999999 111.076 -179.829 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.404 ' HB1' ' HG ' ' A' ' 32' ' ' LEU . . . -65.07 -44.41 89.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.512 -0.313 . . . . 0.33000000000000002 111.549 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.5 HD12 ' HE1' ' A' ' 93' ' ' MET . 3.8 mm? -57.42 -29.85 64.49 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.252 -0.431 . . . . 1.1599999999999999 111.354 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.574 HE21 ' HG3' ' A' ' 47' ' ' LYS . 29.6 tt0 -62.24 -23.67 66.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.271 -0.422 . . . . 2.23 111.233 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 8.3 mp -93.2 -7.66 44.62 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.153 0.427 . . . . 2.0899999999999999 112.153 -178.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.5 ' HE1' HD12 ' A' ' 90' ' ' LEU . 2.9 ttm -92.21 107.81 26.01 Favored Pre-proline 0 C--N 1.33 -0.253 0 C-N-CA 120.99 -0.284 . . . . 2.2799999999999998 111.512 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -75.19 146.77 32.39 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.232 1.954 . . . . 0.72999999999999998 110.496 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.463 ' HB3' ' HA ' ' A' ' 132' ' ' SER . . . -45.81 124.96 5.67 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.917 -0.313 . . . . 1.21 111.363 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 102.38 -9.49 55.97 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 120.518 -0.848 . . . . 0.34000000000000002 113.328 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 31.2 t -72.74 175.0 6.85 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 117.005 0.403 . . . . 1.8899999999999999 111.193 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.3 m -146.46 96.35 2.75 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.94 -0.573 . . . . 0.88 110.473 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.755 ' HE1' ' HB2' ' A' ' 39' ' ' SER . 30.8 m0 -119.57 149.79 41.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.192 0.52 . . . . 0.67000000000000004 111.961 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.406 ' HB3' ' HD3' ' A' ' 127' ' ' LYS . 8.9 pt-20 -119.46 107.99 14.0 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.966 -1.124 . . . . 1.53 107.966 177.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.46 HG23 ' HB3' ' A' ' 34' ' ' TYR . 41.8 pt -108.14 142.75 20.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 113.53 0.937 . . . . 0.72999999999999998 113.53 -177.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -123.45 103.63 8.58 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.498 -1.228 . . . . 0.91000000000000003 108.228 177.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.2 t -107.55 96.89 17.63 Favored Pre-proline 0 C--N 1.329 -0.307 0 N-CA-C 113.219 0.822 . . . . 1.1399999999999999 113.219 -176.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.529 ' HG2' HD21 ' A' ' 107' ' ' LEU . 9.5 Cg_endo -54.5 149.68 37.84 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 121.861 1.708 . . . . 0.68000000000000005 110.484 177.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.5 p -48.63 -27.8 3.07 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.873 0.694 . . . . 2.3700000000000001 112.873 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.404 ' N ' ' HD3' ' A' ' 111' ' ' PRO . . . -60.22 -10.46 15.76 Favored Glycine 0 CA--C 1.521 0.441 0 C-N-CA 120.799 -0.715 . . . . 0.40000000000000002 113.754 -179.031 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.529 HD21 ' HG2' ' A' ' 104' ' ' PRO . 3.0 mm? -114.66 -0.94 13.45 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.242 0.46 . . . . 2.9300000000000002 112.242 -178.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.496 ' HB1' HD13 ' A' ' 83' ' ' ILE . . . -109.3 -104.71 0.37 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 110.34 -0.244 . . . . 1.3799999999999999 110.34 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -99.37 -2.25 36.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.341 0.591 . . . . 1.6000000000000001 109.683 178.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 90.58 138.33 7.43 Favored Glycine 0 CA--C 1.522 0.518 0 CA-C-N 115.157 -0.928 . . . . 2.3399999999999999 113.862 178.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.462 ' HB3' ' HA ' ' A' ' 121' ' ' ASN . 21.3 Cg_endo -59.97 -5.48 3.8 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.946 3.097 . . . . 1.9299999999999999 113.265 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -75.04 161.33 29.54 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.735 0.302 . . . . 3.8799999999999999 110.401 -177.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 81.2 p 53.97 -119.64 1.52 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.829 -0.623 . . . . 2.0800000000000001 110.131 -178.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.482 ' HA ' ' HB3' ' A' ' 120' ' ' PRO . 2.5 t -114.14 17.28 7.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.764 0.316 . . . . 3.4199999999999999 111.338 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 55.84 171.58 0.11 Allowed Glycine 0 CA--C 1.522 0.509 0 C-N-CA 120.833 -0.699 . . . . 1.0900000000000001 112.861 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -80.77 -136.2 1.74 Allowed Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.768 -0.729 . . . . 0.89000000000000001 111.918 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.82 -23.93 69.49 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.072 1.848 . . . . 1.0900000000000001 110.83 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.607 HG21 HD11 ' A' ' 124' ' ' LEU . 93.2 mt -90.09 135.57 26.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.311 -0.859 . . . . 1.8799999999999999 110.031 179.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -42.88 152.0 0.3 Allowed Glycine 0 CA--C 1.52 0.386 0 C-N-CA 121.247 -0.501 . . . . 0.56000000000000005 113.101 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.482 ' HB3' ' HA ' ' A' ' 114' ' ' VAL . 21.6 Cg_endo -60.33 130.88 35.78 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.436 2.091 . . . . 0.84999999999999998 111.71 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.462 ' HA ' ' HB3' ' A' ' 111' ' ' PRO . 2.0 m-80 43.73 34.89 0.92 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.161 -0.472 . . . . 1.1200000000000001 110.081 -178.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -115.72 136.37 53.13 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.914 -0.584 . . . . 1.8200000000000001 111.495 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.436 HG22 HD21 ' A' ' 16' ' ' LEU . 96.7 m -95.53 134.08 38.81 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.02 -0.733 . . . . 1.0900000000000001 109.02 178.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.607 HD11 HG21 ' A' ' 118' ' ' ILE . 0.1 OUTLIER -121.5 154.79 36.16 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.31 0.576 . . . . 2.1000000000000001 112.413 -178.085 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.503 HD11 HH11 ' A' ' 58' ' ' ARG . 4.4 mp -113.81 141.22 30.62 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 CA-C-N 115.237 -0.892 . . . . 1.0600000000000001 109.387 178.307 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -133.83 132.06 39.97 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.173 0.511 . . . . 0.28999999999999998 111.809 -179.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.406 ' HD3' ' HB3' ' A' ' 100' ' ' GLU . 42.6 mmtm -107.21 103.55 12.95 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.811 -0.811 . . . . 2.77 108.811 178.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 36.2 mt -102.68 119.03 50.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.047 0.451 . . . . 1.5600000000000001 112.075 -178.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -114.99 99.97 7.85 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.655 -0.702 . . . . 0.29999999999999999 109.327 178.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.472 ' HA ' HG11 ' A' ' 53' ' ' VAL . 0.6 OUTLIER -79.31 123.28 27.31 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.002 -0.545 . . . . 2.0299999999999998 111.06 -178.838 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 48.3 mm -93.43 -56.77 4.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.067 -0.515 . . . . 1.8899999999999999 111.012 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.463 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 13.6 m -163.45 165.23 24.03 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.976 0.417 . . . . 1.75 111.622 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.578 ' HA ' HG13 ' A' ' 51' ' ' VAL . 2.7 p -107.93 129.92 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 115.734 -0.666 . . . . 2.1299999999999999 110.441 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.436 ' HG2' HG23 ' A' ' 133' ' ' VAL . 17.3 ptmt 34.55 55.25 0.67 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.036 0.446 . . . . 3.5600000000000001 111.316 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm 61.62 42.94 10.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.764 -0.653 . . . . 3.6699999999999999 110.929 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 43.5 t 52.5 61.14 3.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.78 -0.646 . . . . 1.6000000000000001 110.993 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 71.2 m . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.2 -0.905 . . . . 2.7799999999999998 111.139 -179.689 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.798 0.333 . . . . 3.73 110.893 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -66.09 -19.06 65.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.293 -0.412 . . . . 2.0800000000000001 111.135 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -59.22 -40.98 87.55 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.675 -0.491 . . . . 3.7599999999999998 109.675 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -79.82 -36.5 36.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.79 -0.641 . . . . 3.1499999999999999 110.116 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.72 -52.52 62.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.739 -0.664 . . . . 1.27 110.179 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.402 ' O ' HG21 ' A' ' 10' ' ' VAL . 20.9 m-20 -67.4 -36.3 81.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.62 -0.718 . . . . 2.5699999999999998 110.293 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -55.76 -32.99 63.91 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 109.335 -0.617 . . . . 2.1400000000000001 109.335 178.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.526 ' HA ' ' HE2' ' A' ' 11' ' ' LYS . 21.4 m-20 -72.78 -38.84 67.14 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.494 -0.775 . . . . 1.3999999999999999 110.471 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 8.3 tmtm? -59.8 -31.45 69.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.097 -0.501 . . . . 3.2400000000000002 111.353 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.402 HG21 ' O ' ' A' ' 6' ' ' ASP . 11.8 t -77.81 -53.48 14.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 111.895 0.331 . . . . 1.9199999999999999 111.895 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.526 ' HE2' ' HA ' ' A' ' 8' ' ' ASN . 58.9 pttt -66.1 -27.21 67.89 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.943 0.401 . . . . 2.1499999999999999 110.523 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.95 -45.07 12.51 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.789 -0.72 . . . . 0.33000000000000002 111.8 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -68.07 -34.4 76.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.697 0.284 . . . . 2.3900000000000001 110.767 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.47 -42.46 64.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.92000000000000004 111.342 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -58.38 -56.28 24.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.541 -0.299 . . . . 0.27000000000000002 110.496 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.523 ' HA ' ' HB3' ' A' ' 19' ' ' ASN . 4.1 pp -60.01 -33.06 71.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.262 -0.426 . . . . 1.3100000000000001 110.482 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.8 m -58.09 -48.56 79.81 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.989 -0.551 . . . . 1.1599999999999999 110.204 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -73.69 -32.01 63.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.934 -0.575 . . . . 2.4700000000000002 110.034 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.523 ' HB3' ' HA ' ' A' ' 16' ' ' LEU . 0.4 OUTLIER -53.69 -32.45 51.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.408 -0.815 . . . . 0.22 111.478 179.934 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.575 ' HE2' HE22 ' A' ' 33' ' ' GLN . 35.6 mmtp -44.02 -20.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.996 -0.547 . . . . 2.8799999999999999 112.332 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.647 ' N ' HD21 ' A' ' 21' ' ' ASN . 0.8 OUTLIER -68.49 -33.05 73.46 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.983 0.364 . . . . 0.40000000000000002 111.983 -178.751 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.434 ' HD2' ' OD1' ' A' ' 19' ' ' ASN . 67.3 mttm -54.14 119.11 18.12 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.686 -0.234 . . . . 1.9299999999999999 110.988 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.46 142.73 95.33 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.449 2.099 . . . . 1.0600000000000001 112.258 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.14 -1.63 86.56 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.769 -0.729 . . . . 0.40999999999999998 113.249 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' A' ' 34' ' ' TYR . 3.7 p -61.26 110.53 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 121.21 0.529 . . . . 1.6000000000000001 110.58 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.0 p -130.04 130.94 66.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.838 -0.619 . . . . 1.6599999999999999 111.508 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 9.7 p -82.89 138.38 19.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 1.5600000000000001 110.861 179.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.517 HD13 ' HB2' ' A' ' 32' ' ' LEU . 55.3 mt -96.22 167.45 12.37 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.255 -0.429 . . . . 1.0800000000000001 110.704 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.455 ' HD2' ' HB3' ' A' ' 28' ' ' LEU . 75.0 Cg_exo -51.06 -30.97 33.36 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.129 1.886 . . . . 0.65000000000000002 112.265 179.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 31.9 m -89.25 -9.41 50.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.265 -0.425 . . . . 1.75 111.782 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.58 15.68 22.15 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.388 -0.91 . . . . 0.34999999999999998 113.627 178.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.517 ' HB2' HD13 ' A' ' 28' ' ' LEU . 2.7 mm? -83.02 134.27 35.05 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.008 0.432 . . . . 2.0 111.92 -179.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.575 HE22 ' HE2' ' A' ' 20' ' ' LYS . 46.1 mt-30 -125.23 139.02 54.09 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.282 -0.636 . . . . 2.3199999999999998 109.282 178.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.58 ' HB3' HG23 ' A' ' 101' ' ' ILE . 28.8 p90 -151.17 175.72 11.88 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.788 0.662 . . . . 0.92000000000000004 112.788 -178.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -121.09 117.06 26.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.226 -0.897 . . . . 2.6800000000000002 109.175 178.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.5 t -72.66 126.66 33.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 113.299 0.852 . . . . 0.77000000000000002 113.299 -177.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.486 HD11 HG23 ' A' ' 98' ' ' THR . 76.8 mt -107.42 -66.75 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 115.401 -0.818 . . . . 1.46 110.131 178.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -142.59 82.86 1.79 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.19 -0.459 . . . . 1.05 110.157 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.433 ' OG ' ' NE1' ' A' ' 99' ' ' TRP . 17.8 m -106.03 146.38 30.18 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 112.515 0.561 . . . . 2.02 112.515 -178.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 92.43 83.65 1.5 Allowed Glycine 0 C--N 1.334 0.455 0 CA-C-N 115.755 -0.657 . . . . 1.0900000000000001 113.038 178.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -150.61 -72.77 0.17 Allowed 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 111.681 0.252 . . . . 1.7 111.681 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.12 172.29 36.45 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 121.072 -0.585 . . . . 0.40000000000000002 114.298 -178.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.473 HG13 ' H ' ' A' ' 44' ' ' LYS . 2.0 t -90.47 175.99 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 123.474 0.71 . . . . 2.0299999999999998 110.022 179.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.473 ' H ' HG13 ' A' ' 43' ' ' VAL . 2.1 pptp? 164.96 156.53 0.07 OUTLIER Pre-proline 0 N--CA 1.472 0.657 0 CA-C-O 121.503 0.668 . . . . 2.7400000000000002 112.028 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 44' ' ' LYS . 1.2 Cg_endo -83.84 172.54 9.88 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 124.823 3.682 . . . . 0.34000000000000002 113.692 -179.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 48' ' ' SER . . . -67.98 -172.93 6.92 Favored Glycine 0 C--O 1.223 -0.565 0 CA-C-N 115.096 -0.956 . . . . 0.38 111.237 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -41.63 -13.98 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.825 1.046 . . . . 2.9399999999999999 113.825 -177.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.487 ' N ' ' O ' ' A' ' 46' ' ' GLY . 55.6 m -86.32 7.24 26.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.268 0.556 . . . . 1.8999999999999999 110.092 178.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.441 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 3.0 p30 -74.79 166.23 23.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.267 -0.879 . . . . 1.73 111.676 -179.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 91.7 m -126.07 121.26 32.43 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 108.691 -0.855 . . . . 0.92000000000000004 108.691 178.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.562 HG11 HG21 ' A' ' 133' ' ' VAL . 6.4 m -122.92 142.63 38.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 112.97 0.73 . . . . 1.22 112.97 -177.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 39.3 m -115.35 119.79 37.45 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.067 -1.086 . . . . 1.05 108.067 177.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.535 HG11 ' HA ' ' A' ' 130' ' ' LEU . 2.7 m -146.34 178.78 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.26 0.552 . . . . 1.05 111.961 -177.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -128.78 132.45 47.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.291 -0.868 . . . . 2.3999999999999999 109.107 178.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -146.13 159.28 43.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.584 0.707 . . . . 0.93999999999999995 112.345 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 57.0 m -121.84 112.89 18.9 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.483 -1.235 . . . . 1.0600000000000001 108.223 178.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.403 ' O ' HG22 ' A' ' 64' ' ' VAL . . . -110.66 143.54 17.02 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 119.664 -1.255 . . . . 0.14000000000000001 113.236 -178.113 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.517 ' O ' HD11 ' A' ' 124' ' ' LEU . 0.1 OUTLIER -148.43 145.61 28.07 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.566 -0.317 . . . . 2.6899999999999999 110.176 179.266 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.531 HD21 HD12 ' A' ' 124' ' ' LEU . 2.3 mt -74.9 154.02 38.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.978 -0.555 . . . . 1.77 110.586 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.469 ' HB ' ' O ' ' A' ' 123' ' ' THR . 0.4 OUTLIER -56.55 -11.94 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.362 0.601 . . . . 1.3700000000000001 109.621 179.001 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.439 ' H ' ' C ' ' A' ' 59' ' ' LEU . 21.4 t70 -71.11 -10.01 59.03 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.434 -0.803 . . . . 2.0099999999999998 110.816 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.7 0.18 75.92 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.597 -0.811 . . . . 0.45000000000000001 113.629 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 61.4 p -113.3 121.43 44.38 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 117.339 0.57 . . . . 1.99 111.724 -178.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.403 HG22 ' O ' ' A' ' 57' ' ' GLY . 5.9 p -60.61 132.4 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-N 115.889 -0.596 . . . . 1.0700000000000001 109.819 179.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.694 ' HD1' ' H ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -97.79 -28.07 14.03 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.333 -0.394 . . . . 0.25 111.908 -179.4 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.694 ' H ' ' HD1' ' A' ' 65' ' ' PHE . 15.1 t70 -177.64 131.49 0.16 Allowed 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.606 0.241 . . . . 0.29999999999999999 110.821 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.6 m -131.41 116.84 18.05 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.879 0.371 . . . . 1.8100000000000001 110.487 178.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 80.4 p -74.84 -29.59 61.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.478 . . . . 0.93000000000000005 111.323 -179.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -70.18 -39.45 75.26 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.199 -0.455 . . . . 2.1099999999999999 110.654 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -71.02 -37.95 72.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.226 -0.443 . . . . 3.79 111.042 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 33.8 m -57.11 -22.75 42.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.233 -0.44 . . . . 2.1200000000000001 110.794 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 95.21 2.15 62.33 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.869 -0.681 . . . . 0.80000000000000004 112.618 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.559 ' HZ3' ' HB2' ' A' ' 73' ' ' LYS . 3.6 ttmp? -126.35 118.03 23.28 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.638 0.219 . . . . 3.52 111.111 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -52.65 150.25 22.39 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.62 2.213 . . . . 0.76000000000000001 112.125 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -94.73 125.02 39.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.39 -0.368 . . . . 0.76000000000000001 110.811 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.7 t -123.85 113.97 19.24 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.952 0.406 . . . . 1.98 111.428 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -159.03 154.65 26.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.021 -0.536 . . . . 0.44 111.121 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.553 ' NE2' ' HB3' ' A' ' 80' ' ' SER . 0.0 OUTLIER -84.5 148.84 26.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.35 0.595 . . . . 1.8 109.871 178.487 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.5 m -68.79 -25.78 31.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 113.925 1.084 . . . . 1.79 113.925 -177.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.553 ' HB3' ' NE2' ' A' ' 78' ' ' GLN . 37.7 t -86.17 -2.35 58.27 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.616 0.599 . . . . 1.6100000000000001 112.616 -178.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -95.33 5.56 51.35 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.274 0.472 . . . . 2.4199999999999999 112.274 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 1.7 m -113.63 -173.17 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 112.334 0.494 . . . . 1.1799999999999999 112.334 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.537 HG13 ' H ' ' A' ' 86' ' ' TRP . 42.2 pt -56.14 158.95 6.52 Favored Pre-proline 0 CA--C 1.53 0.201 0 CA-C-N 115.906 -0.588 . . . . 1.5900000000000001 112.268 -179.127 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -51.38 -47.37 26.36 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.894 2.396 . . . . 1.01 113.043 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.466 ' HA3' HD22 ' A' ' 32' ' ' LEU . . . -59.85 -48.66 84.97 Favored Glycine 0 CA--C 1.521 0.407 0 C-N-CA 120.524 -0.846 . . . . 0.35999999999999999 112.953 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . 0.537 ' H ' HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -64.06 -44.72 91.56 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.651 0.611 . . . . 0.98999999999999999 112.651 -178.695 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.0 t -60.25 -37.14 79.46 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.072 0.397 . . . . 1.8899999999999999 112.072 -178.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.421 ' O ' ' HG2' ' A' ' 91' ' ' GLN . 10.3 tp10 -70.75 -40.2 72.85 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.008 0.373 . . . . 1.4299999999999999 112.008 -179.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.09 -52.46 10.11 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.013 0.375 . . . . 0.33000000000000002 112.013 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.563 HD13 HD12 ' A' ' 128' ' ' ILE . 4.6 mm? -57.38 -34.69 69.11 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.778 0.658 . . . . 1.1599999999999999 112.778 -178.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.421 ' HG2' ' O ' ' A' ' 88' ' ' GLU . 18.1 pt20 -65.55 -4.79 6.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.635 0.255 . . . . 2.23 111.653 -179.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 82.6 mt -108.22 -7.85 15.89 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.564 -0.289 . . . . 2.0899999999999999 111.207 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.461 ' HE2' ' N ' ' A' ' 99' ' ' TRP . 13.8 ttt -78.08 112.93 28.97 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.417 -0.356 . . . . 2.2799999999999998 111.102 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.464 ' HA ' ' HG2' ' A' ' 44' ' ' LYS . 4.5 Cg_exo -77.04 142.37 21.85 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.761 2.307 . . . . 0.72999999999999998 111.84 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.464 ' HB3' ' HA ' ' A' ' 132' ' ' SER . . . -50.41 128.28 19.46 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.372 -0.377 . . . . 1.21 111.499 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 92.25 2.27 68.56 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.689 -0.767 . . . . 0.34000000000000002 113.292 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.4 ' HB3' ' HA ' ' A' ' 39' ' ' SER . 19.8 m -92.85 -179.72 5.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.094 0.473 . . . . 1.8899999999999999 111.776 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.486 HG23 HD11 ' A' ' 37' ' ' ILE . 3.9 m -144.63 120.4 10.55 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.658 -0.701 . . . . 0.88 110.084 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.461 ' N ' ' HE2' ' A' ' 93' ' ' MET . 4.9 m0 -132.36 150.65 52.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.23 0.538 . . . . 0.67000000000000004 112.264 -178.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -122.46 106.85 11.4 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.715 -1.217 . . . . 1.53 107.715 177.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.58 HG23 ' HB3' ' A' ' 34' ' ' TYR . 41.0 pt -109.44 139.28 33.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 112.923 0.712 . . . . 0.72999999999999998 112.923 -177.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -122.72 103.33 8.59 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.826 -1.079 . . . . 0.91000000000000003 108.214 178.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.7 t -107.3 97.08 17.49 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 112.501 0.556 . . . . 1.1399999999999999 112.501 -177.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.598 ' HA ' ' HA ' ' A' ' 123' ' ' THR . 9.9 Cg_endo -54.12 149.06 37.28 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 121.621 1.547 . . . . 0.68000000000000005 110.528 177.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.573 ' HB3' ' HA2' ' A' ' 110' ' ' GLY . 3.3 m -48.15 -29.49 3.72 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.489 0.551 . . . . 2.3700000000000001 112.489 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -56.64 -9.79 3.87 Favored Glycine 0 CA--C 1.521 0.444 0 C-N-CA 121.016 -0.611 . . . . 0.40000000000000002 113.992 -178.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.479 HD21 ' HG2' ' A' ' 104' ' ' PRO . 3.4 mm? -110.6 1.98 18.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 117.251 0.526 . . . . 2.9300000000000002 111.897 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.466 ' HB1' HD11 ' A' ' 83' ' ' ILE . . . -123.09 -111.01 0.32 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.715 -0.22 . . . . 1.3799999999999999 111.586 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -130.92 4.17 4.48 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.793 0.33 . . . . 1.6000000000000001 111.594 -179.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.677 ' N ' ' HD2' ' A' ' 111' ' ' PRO . . . -67.09 -36.44 90.5 Favored Glycine 0 CA--C 1.532 1.104 0 N-CA-C 115.836 1.095 . . . . 2.3399999999999999 115.836 -178.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.677 ' HD2' ' N ' ' A' ' 110' ' ' GLY . 12.9 Cg_endo -56.52 -16.65 19.28 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.519 2.146 . . . . 1.9299999999999999 112.969 -178.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.432 ' C ' ' H ' ' A' ' 114' ' ' VAL . 99.7 mtt180 -95.81 160.73 14.34 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.382 -0.372 . . . . 3.8799999999999999 110.379 179.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 87.6 p -64.71 -2.33 2.41 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.063 0.458 . . . . 2.0800000000000001 110.912 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.432 ' H ' ' C ' ' A' ' 112' ' ' ARG . 10.9 t -111.44 60.75 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.577 -0.738 . . . . 3.4199999999999999 110.618 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -40.69 112.84 0.37 Allowed Glycine 0 C--N 1.333 0.401 0 CA-C-N 116.11 -0.496 . . . . 1.0900000000000001 112.85 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.96 -145.13 0.07 OUTLIER Glycine 0 CA--C 1.52 0.373 0 C-N-CA 121.0 -0.619 . . . . 0.89000000000000001 112.296 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.502 ' HB2' HD13 ' A' ' 118' ' ' ILE . 49.6 Cg_exo -54.76 -36.44 90.59 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 121.864 1.709 . . . . 1.0900000000000001 111.453 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.502 HD13 ' HB2' ' A' ' 117' ' ' PRO . 4.0 mp -92.53 135.65 26.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.753 -0.658 . . . . 1.8799999999999999 110.212 178.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -42.64 149.53 0.46 Allowed Glycine 0 C--N 1.335 0.493 0 C-N-CA 120.917 -0.658 . . . . 0.56000000000000005 112.489 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -55.73 131.31 45.31 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.263 1.976 . . . . 0.84999999999999998 112.282 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 42.99 37.68 1.2 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.311 -0.404 . . . . 1.1200000000000001 110.862 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.443 ' OE1' HD23 ' A' ' 59' ' ' LEU . 30.8 tt0 -114.09 144.28 43.4 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.012 -0.54 . . . . 1.8200000000000001 111.957 -179.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.598 ' HA ' ' HA ' ' A' ' 104' ' ' PRO . 70.0 m -97.0 129.3 44.49 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.369 -0.604 . . . . 1.0900000000000001 109.369 178.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.531 HD12 HD21 ' A' ' 59' ' ' LEU . 1.4 mm? -115.53 152.43 33.02 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.121 0.486 . . . . 2.1000000000000001 111.838 -178.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.8 mp -114.3 136.36 51.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.557 -0.747 . . . . 1.0600000000000001 110.02 178.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -133.53 131.7 40.07 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.275 -0.42 . . . . 0.28999999999999998 111.397 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -108.43 102.38 11.49 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.862 -1.162 . . . . 2.77 107.862 177.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.563 HD12 HD13 ' A' ' 90' ' ' LEU . 18.2 mt -102.83 126.56 57.03 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 CA-C-O 121.238 0.542 . . . . 1.5600000000000001 112.148 -177.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.458 ' O ' ' HB ' ' A' ' 53' ' ' VAL . 1.3 t-160 -118.56 98.37 6.21 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.227 -0.897 . . . . 0.29999999999999999 109.297 178.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.535 ' HA ' HG11 ' A' ' 53' ' ' VAL . 17.3 tp -80.25 113.61 18.54 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.187 -0.46 . . . . 2.0299999999999998 111.113 -178.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 34.3 mm -81.98 -50.29 16.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.786 -0.643 . . . . 1.8899999999999999 110.782 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.464 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 5.3 m -163.4 165.22 24.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 1.75 110.358 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.562 HG21 HG11 ' A' ' 51' ' ' VAL . 91.7 t -129.16 135.77 61.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.01 -0.541 . . . . 2.1299999999999999 110.589 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.521 ' HE2' ' HB2' ' A' ' 137' ' ' SER . 21.4 ptmt 40.74 49.8 2.87 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.878 -0.601 . . . . 3.5600000000000001 111.277 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt 63.77 41.21 7.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.345 -0.843 . . . . 3.6699999999999999 111.507 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 33.9 t 48.03 32.61 2.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.71 -0.677 . . . . 1.6000000000000001 111.477 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.521 ' HB2' ' HE2' ' A' ' 134' ' ' LYS . 69.8 m . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.213 -0.898 . . . . 2.7799999999999998 110.894 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp . . . . . 0 N--CA 1.456 -0.168 0 CA-C-O 120.755 0.312 . . . . 2.63 110.222 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -57.79 -52.04 67.09 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.101 -0.499 . . . . 0.82 110.145 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -66.64 -34.39 77.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.864 -0.607 . . . . 2.57 109.936 178.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -55.79 -32.61 63.64 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.089 -0.708 . . . . 2.1 109.089 178.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.517 ' HA ' ' HG2' ' A' ' 11' ' ' LYS . 41.5 m-20 -75.7 -38.37 58.71 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.201 -0.909 . . . . 1.4 110.509 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -56.39 -39.6 73.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.878 -0.601 . . . . 2.67 111.571 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.402 HG23 ' N ' ' A' ' 11' ' ' LYS . 16.2 m -78.33 -47.83 23.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 112.604 0.594 . . . . 1.27 112.604 -178.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.53 ' HE2' HG13 ' A' ' 60' ' ' ILE . 22.1 ptmt -63.55 -33.99 76.81 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.602 0.223 . . . . 1.69 111.602 -179.196 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.86 -52.98 5.54 Favored Glycine 0 C--N 1.33 0.231 0 C-N-CA 120.75 -0.738 . . . . 0.31 112.461 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -57.66 -26.27 61.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.969 0.414 . . . . 2.39 110.346 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.17 -40.67 37.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.814 -0.63 . . . . 0.23 110.529 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -58.69 -48.92 79.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.076 -0.511 . . . . 0.23 110.278 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.562 ' HA ' ' HB3' ' A' ' 19' ' ' ASN . 4.2 pp -67.0 -34.52 77.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.32 -0.4 . . . . 0.55 110.714 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.43 ' N ' HD12 ' A' ' 16' ' ' LEU . 18.5 m -57.72 -49.65 75.85 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.246 -0.434 . . . . 0.27 110.209 179.481 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -73.72 -32.01 63.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.86 -0.609 . . . . 2.47 110.074 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.562 ' HB3' ' HA ' ' A' ' 16' ' ' LEU . 1.3 t-20 -54.29 -33.14 58.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.467 -0.788 . . . . 0.22 111.521 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -46.66 -19.75 0.1 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.041 -0.527 . . . . 2.45 112.163 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -68.03 -33.52 74.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.638 -0.256 . . . . 0.4 111.594 -178.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.758 ' O ' HG23 ' A' ' 25' ' ' VAL . 67.7 mttm -52.05 119.03 13.32 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.551 -0.295 . . . . 1.4 110.511 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -57.73 146.41 85.51 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.231 1.954 . . . . 0.65 112.222 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.05 3.16 79.87 Favored Glycine 0 CA--C 1.522 0.471 0 C-N-CA 120.869 -0.682 . . . . 0.37 114.16 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.758 HG23 ' O ' ' A' ' 22' ' ' LYS . 35.6 t -56.8 110.71 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 117.65 0.725 . . . . 0.91 110.435 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.9 p -126.12 127.58 71.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.898 -0.592 . . . . 1.03 111.126 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.1 p -83.09 143.08 12.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.073 -0.512 . . . . 0.91 111.021 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.505 ' HB3' ' HD2' ' A' ' 29' ' ' PRO . 69.3 mt -103.86 168.56 8.46 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.102 -0.499 . . . . 0.4 110.806 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.505 ' HD2' ' HB3' ' A' ' 28' ' ' LEU . 78.4 Cg_exo -51.48 -33.45 47.39 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 121.943 1.762 . . . . 0.59 111.754 178.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.5 m -84.49 -11.95 55.16 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.046 -0.524 . . . . 1.14 111.195 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.04 14.16 27.25 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.507 -0.854 . . . . 0.34 114.258 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.633 HD22 ' HB2' ' A' ' 89' ' ' ALA . 6.5 mp -83.08 134.77 35.0 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.068 0.766 . . . . 1.35 113.068 -178.349 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -116.6 143.65 45.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.191 -0.913 . . . . 1.75 108.542 177.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.495 ' HB3' HG22 ' A' ' 101' ' ' ILE . 30.7 p90 -160.27 175.56 12.72 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.37 0.507 . . . . 0.32 112.37 -178.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -120.54 116.86 26.21 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.38 -0.827 . . . . 2.15 109.331 178.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.6 t -78.1 125.34 37.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 113.475 0.917 . . . . 0.3 113.475 -177.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 63.3 mt -101.21 -60.83 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.289 -0.869 . . . . 0.65 109.109 177.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -134.77 100.06 4.5 Favored 'General case' 0 CA--C 1.527 0.072 0 CA-C-N 115.799 -0.637 . . . . 1.03 109.673 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.617 ' HB3' ' HE1' ' A' ' 99' ' ' TRP . 59.9 p -103.18 145.62 29.66 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.113 0.482 . . . . 1.5 112.161 -178.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 94.82 -126.54 8.76 Favored Glycine 0 C--N 1.333 0.384 0 CA-C-N 115.599 -0.728 . . . . 1.09 113.146 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 12.2 m120 70.08 -83.07 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.559 0.577 . . . . 1.7 112.559 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.11 167.36 30.37 Favored Glycine 0 CA--C 1.521 0.429 0 N-CA-C 115.289 0.875 . . . . 0.35 115.289 -177.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.644 HG12 ' H ' ' A' ' 44' ' ' LYS . 2.5 t -91.81 176.88 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 114.365 -0.917 . . . . 1.42 109.592 178.512 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.737 ' HG2' ' HA ' ' A' ' 94' ' ' PRO . 0.0 OUTLIER 165.46 157.64 0.09 OUTLIER Pre-proline 0 N--CA 1.475 0.781 0 CA-C-O 121.357 0.599 . . . . 2.18 112.35 -179.878 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.563 ' HD2' ' HB2' ' A' ' 49' ' ' ASP . 1.2 Cg_endo -84.65 173.35 8.47 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 125.076 3.851 . . . . 0.3 113.882 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 48' ' ' SER . . . -67.99 -171.97 6.34 Favored Glycine 0 C--O 1.222 -0.625 0 CA-C-N 114.947 -1.024 . . . . 0.35 111.664 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.509 ' O ' HG13 ' A' ' 79' ' ' VAL . 23.0 pttm -41.33 -13.46 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 113.921 1.082 . . . . 2.35 113.921 -177.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.487 ' N ' ' O ' ' A' ' 46' ' ' GLY . 80.9 p -86.25 7.52 24.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.549 0.69 . . . . 1.45 109.364 177.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.563 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 0.0 OUTLIER -71.79 149.17 45.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.666 -1.152 . . . . 1.73 112.183 -179.255 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 58.8 m -126.67 119.39 26.88 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 109.055 -0.72 . . . . 0.44 109.055 178.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.515 HG12 ' HA ' ' A' ' 133' ' ' VAL . 33.1 m -132.45 156.28 42.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 112.671 0.619 . . . . 0.65 112.671 -178.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 96.6 m -111.93 121.14 44.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.06 -0.973 . . . . 0.32 108.973 178.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.512 HG12 ' HA ' ' A' ' 130' ' ' LEU . 2.6 m -142.57 -179.66 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.328 0.585 . . . . 0.24 112.012 -178.582 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.496 ' HB3' ' HG2' ' A' ' 69' ' ' GLU . 28.6 mt-10 -131.38 132.75 44.64 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.267 -0.879 . . . . 2.4 109.426 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -143.82 158.11 43.91 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.793 0.806 . . . . 0.26 112.229 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 82.5 m -126.0 113.63 17.39 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.133 -1.394 . . . . 0.26 108.532 178.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.459 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -108.93 147.26 16.72 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 119.78 -1.2 . . . . 0.12 112.72 -178.471 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.01 147.45 32.64 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.852 0.358 . . . . 1.93 110.199 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.477 HD23 HD21 ' A' ' 124' ' ' LEU . 13.2 mt -84.95 157.78 20.72 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.003 -0.544 . . . . 1.21 110.233 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.53 HG13 ' HE2' ' A' ' 11' ' ' LYS . 10.2 tp -57.16 -10.93 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.347 0.594 . . . . 0.64 109.709 178.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.412 ' N ' ' C ' ' A' ' 59' ' ' LEU . 24.7 t70 -67.4 -11.53 57.98 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.373 -0.83 . . . . 2.01 111.007 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.13 -0.34 75.41 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.483 -0.865 . . . . 0.45 113.578 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.3 t -122.89 138.93 54.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 117.37 0.585 . . . . 1.4 111.712 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 57' ' ' GLY . 7.5 p -62.99 133.99 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 115.825 -0.625 . . . . 0.28 110.064 179.284 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.636 ' HD1' ' H ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -97.99 -25.61 14.91 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.067 -0.515 . . . . 0.24 111.147 -179.848 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.636 ' H ' ' HD1' ' A' ' 65' ' ' PHE . 19.1 t70 -176.51 131.17 0.21 Allowed 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 120.733 0.302 . . . . 0.3 110.889 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 70.8 p -128.35 126.52 40.87 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.293 -0.412 . . . . 1.3 110.531 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.443 HG21 ' HB2' ' A' ' 75' ' ' ALA . 81.1 p -81.83 -21.59 37.53 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.767 0.318 . . . . 0.34 111.235 -179.528 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.496 ' HG2' ' HB3' ' A' ' 54' ' ' GLU . 41.2 mt-10 -75.08 -47.76 27.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.284 -0.416 . . . . 2.11 111.226 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm -63.01 -36.87 84.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.43 . . . . 3.41 111.166 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 41.6 m -59.07 -22.89 61.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.312 -0.404 . . . . 1.47 110.719 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 92.05 4.75 66.61 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.808 -0.711 . . . . 0.7 112.355 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -126.5 116.95 22.98 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.454 0.127 . . . . 3.05 110.771 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.46 159.01 11.5 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.139 1.893 . . . . 0.51 111.923 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.443 ' HB2' HG21 ' A' ' 68' ' ' THR . . . -94.78 124.62 38.92 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.355 -0.384 . . . . 0.23 110.475 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 48.4 m -127.44 111.95 14.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.838 0.352 . . . . 1.26 111.446 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -158.67 163.78 36.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.091 -0.504 . . . . 0.36 110.904 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.572 ' HG3' ' HB2' ' A' ' 81' ' ' GLN . 6.1 pt20 -95.28 148.33 22.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.379 0.609 . . . . 1.58 110.503 178.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.533 ' HB ' ' HB3' ' A' ' 90' ' ' LEU . 0.6 OUTLIER -59.29 -28.38 39.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 114.93 -1.032 . . . . 1.07 113.262 -178.431 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 46.7 t -85.44 -2.42 58.09 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.78 0.659 . . . . 1.14 112.78 -178.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.572 ' HB2' ' HG3' ' A' ' 78' ' ' GLN . 5.3 tp-100 -96.93 5.85 49.74 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.534 0.568 . . . . 2.08 112.534 -179.162 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.6 m -112.77 -178.15 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 N-CA-C 112.361 0.504 . . . . 0.45 112.361 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.518 ' O ' HG23 ' A' ' 87' ' ' THR . 28.1 pt -56.88 155.37 15.48 Favored Pre-proline 0 N--CA 1.464 0.273 0 CA-C-N 116.0 -0.546 . . . . 0.75 112.017 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -44.33 -60.43 0.81 Allowed 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.074 2.516 . . . . 0.65 113.597 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.632 ' CA ' HD11 ' A' ' 32' ' ' LEU . . . -49.12 -49.08 31.14 Favored Glycine 0 CA--C 1.522 0.529 0 C-N-CA 120.493 -0.86 . . . . 0.31 112.721 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' TRP . . . . . 0.462 ' HB2' HG13 ' A' ' 83' ' ' ILE . 0.7 OUTLIER -61.81 -43.87 97.99 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.248 0.462 . . . . 0.78 112.248 -179.003 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.518 HG23 ' O ' ' A' ' 83' ' ' ILE . 53.7 p -56.12 -34.49 66.11 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.7 0.286 . . . . 1.4 111.395 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -70.27 -51.46 30.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.404 -0.362 . . . . 1.43 111.835 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.633 ' HB2' HD22 ' A' ' 32' ' ' LEU . . . -65.78 -52.24 52.48 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 112.418 0.525 . . . . 0.33 112.418 -178.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.533 ' HB3' ' HB ' ' A' ' 79' ' ' VAL . 4.1 mm? -56.97 -26.91 60.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.424 -0.353 . . . . 0.39 111.615 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.449 ' HG3' ' N ' ' A' ' 47' ' ' LYS . 53.2 tt0 -67.7 -23.47 65.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.789 0.328 . . . . 1.87 111.182 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.436 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 88.8 mt -100.75 -8.04 23.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.298 -0.41 . . . . 1.31 111.526 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.525 ' SD ' HD13 ' A' ' 90' ' ' LEU . 62.1 mtt -76.41 110.78 12.37 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 116.748 -0.205 . . . . 1.66 111.281 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.737 ' HA ' ' HG2' ' A' ' 44' ' ' LYS . 67.4 Cg_endo -84.93 147.45 10.54 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.837 2.358 . . . . 0.44 112.771 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.555 ' HB1' ' HA ' ' A' ' 132' ' ' SER . . . -45.8 131.02 9.46 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.288 -0.415 . . . . 0.36 112.06 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 88.99 -11.94 67.65 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.845 -0.693 . . . . 0.34 113.613 179.048 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.496 ' HB3' ' HG2' ' A' ' 94' ' ' PRO . 96.6 p -67.75 -175.92 0.59 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.963 0.411 . . . . 1.41 111.284 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 17.6 m -161.54 97.75 1.1 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.899 -0.592 . . . . 0.23 110.81 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.617 ' HE1' ' HB3' ' A' ' 39' ' ' SER . 43.9 m0 -119.93 152.11 37.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.082 0.468 . . . . 0.53 111.563 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -122.25 108.27 13.09 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.459 -0.941 . . . . 1.37 108.459 177.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.495 HG22 ' HB3' ' A' ' 34' ' ' TYR . 31.5 pt -106.4 141.7 21.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 113.217 0.821 . . . . 0.25 113.217 -177.46 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.42 ' OH ' HG22 ' A' ' 25' ' ' VAL . 0.6 OUTLIER -125.53 103.97 8.16 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.578 -1.192 . . . . 0.31 108.368 178.309 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.405 ' HA ' ' HD2' ' A' ' 104' ' ' PRO . 4.1 t -106.2 110.79 64.24 Favored Pre-proline 0 C--N 1.33 -0.262 0 N-CA-C 113.114 0.783 . . . . 0.52 113.114 -177.182 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.575 ' HG2' HD13 ' A' ' 107' ' ' LEU . 17.7 Cg_endo -61.96 152.19 76.66 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.308 2.006 . . . . 0.48 111.131 177.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -47.12 -42.14 18.7 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.834 0.679 . . . . 1.81 112.834 -178.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.454 ' C ' HD12 ' A' ' 107' ' ' LEU . . . -57.4 -9.36 4.51 Favored Glycine 0 CA--C 1.521 0.452 0 C-N-CA 121.043 -0.598 . . . . 0.4 113.882 -178.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.575 HD13 ' HG2' ' A' ' 104' ' ' PRO . 9.2 mp -113.4 -7.71 13.46 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.138 0.422 . . . . 2.35 112.138 -178.576 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.439 0 CA-C-N 116.692 -0.231 . . . . 1.03 110.63 179.777 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo . . . . . 0 C--O 1.231 0.142 0 CA-C-O 120.959 0.316 . . . . 0.7 111.51 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.693 HG23 HD13 ' A' ' 124' ' ' LEU . 57.4 mt -90.84 115.21 29.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.791 -0.64 . . . . 1.25 110.015 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -44.18 157.41 0.17 Allowed Glycine 0 C--N 1.334 0.463 0 CA-C-N 116.153 -0.476 . . . . 0.48 113.13 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -63.64 131.65 32.29 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.274 1.983 . . . . 0.67 111.643 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 49.3 34.18 6.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.262 -0.426 . . . . 1.12 110.356 -178.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -116.29 129.17 56.13 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.203 -0.453 . . . . 1.73 111.358 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.51 ' O ' ' HB ' ' A' ' 60' ' ' ILE . 77.5 m -93.07 127.27 38.54 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.722 -0.844 . . . . 0.29 108.722 178.238 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.693 HD13 HG23 ' A' ' 118' ' ' ILE . 7.4 mp -115.22 157.84 23.14 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.27 0.557 . . . . 1.47 112.399 -178.011 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.432 ' N ' HD12 ' A' ' 125' ' ' ILE . 4.8 mp -114.86 139.35 41.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.255 -0.884 . . . . 0.2 109.502 178.162 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -131.13 131.79 44.36 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.099 0.476 . . . . 0.24 111.544 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.456 ' NZ ' ' HB3' ' A' ' 127' ' ' LYS . 3.3 mmmp? -110.45 103.78 12.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.514 -0.766 . . . . 2.28 109.18 178.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.4 mp -103.94 118.7 51.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.163 0.506 . . . . 0.82 112.242 -178.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -113.35 98.34 7.04 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.41 -0.959 . . . . 0.26 108.41 177.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.512 ' HA ' HG12 ' A' ' 53' ' ' VAL . 21.9 tp -82.74 123.18 29.07 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.552 -0.749 . . . . 1.41 111.683 -178.32 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 55.8 mt -89.81 -55.99 5.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.799 -0.637 . . . . 1.17 110.785 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.555 ' HA ' ' HB1' ' A' ' 95' ' ' ALA . 60.5 p -163.64 165.04 23.78 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.072 0.463 . . . . 1.17 111.628 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.515 ' HA ' HG12 ' A' ' 51' ' ' VAL . 2.5 p -108.95 131.53 59.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.715 -0.675 . . . . 1.43 111.418 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 5.8 tttp 34.37 64.96 0.35 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.012 -0.54 . . . . 3.08 111.574 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm 62.03 42.86 9.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.897 -0.592 . . . . 3.16 111.229 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 90.0 p 47.82 64.42 1.63 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.752 -0.658 . . . . 1.31 111.413 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 43.4 t . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.21 -0.9 . . . . 2.53 110.865 179.994 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp . . . . . 0 N--CA 1.456 -0.139 0 CA-C-O 120.772 0.32 . . . . 2.63 110.358 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -57.53 -51.42 69.53 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.085 -0.507 . . . . 0.82 110.265 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -67.22 -35.14 78.95 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.927 -0.579 . . . . 2.57 110.215 179.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -55.78 -32.47 63.49 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 109.386 -0.598 . . . . 2.1 109.386 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.568 ' HB3' ' HG2' ' A' ' 122' ' ' GLU . 19.0 m-20 -75.66 -39.13 58.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.491 -0.777 . . . . 1.4 110.38 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.423 ' O ' ' HD2' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -56.79 -40.84 76.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.9 -0.591 . . . . 2.67 111.331 179.816 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.431 HG23 ' N ' ' A' ' 11' ' ' LYS . 19.6 m -74.15 -48.23 38.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 112.169 0.433 . . . . 1.27 112.169 -179.134 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.53 ' HG2' ' HA ' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -64.07 -29.91 71.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.776 0.322 . . . . 1.69 111.029 -179.683 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.69 -48.33 8.99 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 121.051 -0.595 . . . . 0.31 112.176 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -59.01 -30.15 67.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.035 0.445 . . . . 2.39 110.377 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.88 -41.33 37.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.794 -0.639 . . . . 0.23 111.118 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -56.02 -52.71 63.26 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 120.768 0.318 . . . . 0.23 110.288 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.48 ' HA ' ' HB3' ' A' ' 19' ' ' ASN . 4.0 pp -63.71 -35.51 80.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.083 -0.508 . . . . 0.55 110.446 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.4 m -57.33 -48.53 78.72 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.066 -0.516 . . . . 0.27 110.343 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -73.22 -31.82 64.38 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.948 -0.569 . . . . 2.47 109.876 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.486 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 3.7 t-20 -56.03 -30.43 61.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.368 -0.833 . . . . 0.22 111.817 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -43.22 -19.99 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.244 0.461 . . . . 2.45 112.244 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -68.6 -34.03 75.08 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.462 0.542 . . . . 0.4 112.462 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.732 ' O ' HG23 ' A' ' 25' ' ' VAL . 38.3 mmtt -46.7 119.46 5.58 Favored Pre-proline 0 N--CA 1.463 0.198 0 CA-C-O 120.527 0.203 . . . . 1.4 110.899 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.445 ' HD2' ' HE2' ' A' ' 35' ' ' LYS . 40.5 Cg_exo -57.0 135.6 71.79 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.006 1.804 . . . . 0.65 112.049 179.44 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.31 3.24 78.92 Favored Glycine 0 CA--C 1.52 0.362 0 C-N-CA 120.755 -0.736 . . . . 0.37 113.949 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.732 HG23 ' O ' ' A' ' 22' ' ' LYS . 8.9 t -52.05 111.57 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 117.606 0.703 . . . . 0.91 110.218 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.438 HG13 ' CE1' ' A' ' 34' ' ' TYR . 2.1 p -127.46 133.69 67.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.891 -0.595 . . . . 1.03 111.078 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.424 HG23 ' NE2' ' A' ' 33' ' ' GLN . 7.6 p -85.77 141.91 13.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.953 -0.567 . . . . 0.91 110.968 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.597 HD12 ' HB2' ' A' ' 32' ' ' LEU . 64.5 mt -99.66 166.61 12.53 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.4 110.782 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.44 ' HD2' ' HB3' ' A' ' 28' ' ' LEU . 52.4 Cg_exo -53.14 -30.57 50.95 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 121.908 1.739 . . . . 0.59 111.513 178.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 39.8 t -86.02 -12.74 49.48 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.014 -0.539 . . . . 1.14 111.031 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.05 14.42 24.64 Favored Glycine 0 C--N 1.334 0.436 0 C-N-CA 120.464 -0.874 . . . . 0.34 114.313 178.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.68 HD11 ' HA2' ' A' ' 85' ' ' GLY . 6.6 mp -85.11 139.26 31.85 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.098 0.777 . . . . 1.35 113.098 -179.24 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.424 ' NE2' HG23 ' A' ' 27' ' ' VAL . 26.5 mp0 -116.01 144.18 44.45 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.918 -1.037 . . . . 1.75 108.438 177.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.586 ' HB3' HG22 ' A' ' 101' ' ' ILE . 15.5 p90 -160.29 175.37 12.93 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.898 0.703 . . . . 0.32 112.898 -178.499 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.445 ' HE2' ' HD2' ' A' ' 23' ' ' PRO . 24.5 tttm -121.93 116.77 24.96 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.006 -0.997 . . . . 2.15 109.413 178.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.497 HG13 ' HE1' ' A' ' 99' ' ' TRP . 60.7 t -77.87 126.17 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 113.188 0.81 . . . . 0.3 113.188 -178.229 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.422 HD12 HG22 ' A' ' 98' ' ' THR . 83.5 mt -101.9 -65.69 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.562 -0.745 . . . . 0.65 110.733 178.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -148.39 80.63 1.46 Allowed 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 120.845 0.355 . . . . 1.03 111.002 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.543 ' HB2' ' NE1' ' A' ' 99' ' ' TRP . 38.9 t -106.96 146.14 31.43 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.254 -0.43 . . . . 1.5 111.968 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 99.27 100.38 2.25 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.834 -0.698 . . . . 1.09 113.135 178.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -177.93 -57.39 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 120.671 0.272 . . . . 1.7 111.617 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.27 165.47 31.45 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.833 -0.699 . . . . 0.35 114.073 -178.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.644 HG12 ' H ' ' A' ' 44' ' ' LYS . 2.7 t -90.5 175.34 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 123.324 0.65 . . . . 1.42 109.733 179.05 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.644 ' H ' HG12 ' A' ' 43' ' ' VAL . 18.5 ptmt 164.65 156.87 0.07 OUTLIER Pre-proline 0 N--CA 1.47 0.557 0 CA-C-O 121.475 0.655 . . . . 2.18 112.324 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.46 ' HD2' ' HB2' ' A' ' 49' ' ' ASP . 2.1 Cg_endo -84.43 174.25 8.04 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 124.908 3.739 . . . . 0.3 113.21 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.51 ' O ' ' N ' ' A' ' 48' ' ' SER . . . -67.47 -172.03 5.72 Favored Glycine 0 C--O 1.225 -0.42 0 CA-C-N 115.326 -0.852 . . . . 0.35 111.356 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.561 ' HG2' ' HB2' ' A' ' 91' ' ' GLN . 33.9 mtmm -41.26 -13.18 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 113.499 0.926 . . . . 2.35 113.499 -177.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.51 ' N ' ' O ' ' A' ' 46' ' ' GLY . 47.2 t -85.75 7.08 25.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.085 0.469 . . . . 1.45 110.313 178.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.46 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 3.5 p30 -77.34 150.32 35.19 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.568 -0.742 . . . . 1.73 112.048 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 86.1 m -126.47 119.25 26.74 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.657 -0.868 . . . . 0.44 108.657 178.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.517 HG12 ' HA ' ' A' ' 133' ' ' VAL . 12.2 m -124.34 158.47 31.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.443 0.534 . . . . 0.65 112.443 -178.489 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 83.7 m -112.65 120.89 43.09 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.748 -0.834 . . . . 0.32 108.748 178.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.747 HG11 HD22 ' A' ' 130' ' ' LEU . 12.3 m -141.9 179.85 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.393 0.616 . . . . 0.24 112.043 -178.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -127.09 132.34 50.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.149 -0.932 . . . . 2.4 109.236 178.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -146.49 161.1 41.17 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.614 0.721 . . . . 0.26 112.184 -179.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 57.9 m -126.99 112.34 15.13 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.621 -1.172 . . . . 0.26 108.677 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.48 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -111.41 146.25 17.78 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.045 -1.074 . . . . 0.12 112.986 -178.683 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.49 ' NE ' HD13 ' A' ' 125' ' ' ILE . 3.2 ppt_? -148.03 148.4 30.65 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.817 0.342 . . . . 1.93 110.17 179.117 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.401 ' C ' ' N ' ' A' ' 61' ' ' ASP . 19.3 mt -77.51 160.87 28.34 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.102 -0.499 . . . . 1.21 109.991 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.499 ' HB ' ' O ' ' A' ' 123' ' ' THR . 8.0 tp -59.1 -11.43 2.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.211 -0.662 . . . . 0.64 109.211 178.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.401 ' N ' ' C ' ' A' ' 59' ' ' LEU . 8.1 m-20 -65.69 -11.31 44.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.081 -0.963 . . . . 2.01 110.774 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.46 -0.85 78.34 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.665 -0.779 . . . . 0.45 113.531 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.8 t -118.53 138.45 52.52 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 117.227 0.514 . . . . 1.4 111.579 -178.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 57' ' ' GLY . 6.0 p -64.2 133.15 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 115.822 -0.626 . . . . 0.28 110.147 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.598 ' HD1' ' N ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -97.49 -22.53 16.5 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.09 -0.505 . . . . 0.24 110.739 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.598 ' N ' ' HD1' ' A' ' 65' ' ' PHE . 19.8 t70 -175.68 130.15 0.26 Allowed 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.262 -0.426 . . . . 0.3 110.649 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 70.2 p -126.61 123.99 38.9 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.28 -0.418 . . . . 1.3 110.721 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.493 HG21 ' HB2' ' A' ' 75' ' ' ALA . 70.8 p -90.55 -41.05 11.6 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.381 -0.372 . . . . 0.34 111.002 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -70.87 -35.6 72.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 2.11 111.147 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.9 tmtm? -63.03 -51.49 66.57 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.365 -0.379 . . . . 3.41 110.857 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 77.1 p -58.63 -19.56 40.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.29 -0.414 . . . . 1.47 111.099 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.09 10.36 58.61 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.799 -0.715 . . . . 0.7 112.437 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -115.53 116.68 41.18 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.535 0.167 . . . . 3.05 110.678 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -58.88 144.97 98.44 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.274 1.983 . . . . 0.51 112.085 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.493 ' HB2' HG21 ' A' ' 68' ' ' THR . . . -94.6 124.25 38.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.206 -0.452 . . . . 0.23 111.038 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.2 t -126.18 120.18 29.42 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.33 -0.395 . . . . 1.26 110.767 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -158.04 169.13 25.25 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.263 0.554 . . . . 0.36 111.863 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.42 ' HG2' ' NE2' ' A' ' 81' ' ' GLN . 0.3 OUTLIER -87.96 145.29 26.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.32 -0.854 . . . . 1.58 109.168 178.762 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 26.1 m -79.71 -27.42 12.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 113.111 0.782 . . . . 1.07 113.111 -177.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 80.3 p -85.84 -2.08 57.89 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 111.743 0.275 . . . . 1.14 111.743 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.42 ' NE2' ' HG2' ' A' ' 78' ' ' GLN . 1.2 mp0 -93.88 5.88 50.22 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.546 0.573 . . . . 2.08 112.546 -178.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.43 HG21 ' HE3' ' A' ' 86' ' ' TRP . 0.0 OUTLIER -110.6 -175.04 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 N-CA-C 112.244 0.461 . . . . 0.45 112.244 -179.69 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.563 HG13 ' H ' ' A' ' 86' ' ' TRP . 34.3 pt -56.32 158.17 8.09 Favored Pre-proline 0 N--CA 1.462 0.17 0 CA-C-N 115.962 -0.563 . . . . 0.75 112.212 -179.225 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.434 ' HD2' ' HB ' ' A' ' 83' ' ' ILE . 6.2 Cg_endo -48.71 -50.28 12.87 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.868 2.379 . . . . 0.65 112.553 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.68 ' HA2' HD11 ' A' ' 32' ' ' LEU . . . -57.86 -49.11 77.43 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.671 -0.776 . . . . 0.31 113.411 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' TRP . . . . . 0.563 ' H ' HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -62.51 -53.39 55.41 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.518 0.562 . . . . 0.78 112.518 -178.457 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.0 t -52.9 -33.38 50.1 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.739 0.274 . . . . 1.4 111.739 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -68.99 -50.71 46.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.528 -0.305 . . . . 1.43 111.726 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.662 ' HB2' HD22 ' A' ' 32' ' ' LEU . . . -64.16 -45.46 88.34 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.932 0.345 . . . . 0.33 111.932 -179.23 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.486 HD13 ' SD ' ' A' ' 93' ' ' MET . 4.3 mm? -56.59 -30.43 63.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.387 -0.369 . . . . 0.39 111.483 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.561 ' HB2' ' HG2' ' A' ' 47' ' ' LYS . 57.7 tt0 -64.82 -23.93 67.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.404 -0.362 . . . . 1.87 111.15 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.419 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 9.1 mp -95.79 -7.84 36.0 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.145 -0.48 . . . . 1.31 111.582 -179.327 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.486 ' SD ' HD13 ' A' ' 90' ' ' LEU . 60.4 mtt -88.79 107.79 19.48 Favored Pre-proline 0 N--CA 1.452 -0.344 0 CA-C-N 116.719 -0.219 . . . . 1.66 111.517 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.45 ' HA ' ' CD ' ' A' ' 44' ' ' LYS . 95.7 Cg_endo -79.86 145.27 17.73 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.651 2.234 . . . . 0.44 111.817 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.627 ' HB1' ' HA ' ' A' ' 132' ' ' SER . . . -46.94 127.27 9.89 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 120.649 0.262 . . . . 0.36 110.973 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 96.71 -5.39 64.24 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 120.689 -0.767 . . . . 0.34 112.997 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.418 ' OG ' ' N ' ' A' ' 98' ' ' THR . 11.2 t -74.78 177.8 5.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.837 0.351 . . . . 1.41 111.117 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.422 HG22 HD12 ' A' ' 37' ' ' ILE . 18.8 m -151.38 92.86 1.83 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.045 -0.525 . . . . 0.23 110.444 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.543 ' NE1' ' HB2' ' A' ' 39' ' ' SER . 24.2 m0 -116.6 149.18 40.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.171 0.51 . . . . 0.53 111.867 -179.501 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -120.99 108.03 13.37 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.758 -1.201 . . . . 1.37 107.758 176.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.586 HG22 ' HB3' ' A' ' 34' ' ' TYR . 46.2 pt -107.6 139.44 29.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 113.112 0.782 . . . . 0.25 113.112 -177.246 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.463 ' OH ' HG22 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -117.89 103.9 10.41 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.734 -1.21 . . . . 0.31 107.734 177.294 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 39.6 t -97.84 105.53 27.85 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 113.39 0.885 . . . . 0.52 113.39 -176.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.484 ' HA ' HG23 ' A' ' 123' ' ' THR . 33.4 Cg_exo -59.84 151.17 73.03 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.344 2.029 . . . . 0.48 111.392 177.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.5 p -48.31 -43.13 32.78 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 111.969 0.359 . . . . 1.81 111.969 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -57.21 -8.85 3.7 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 114.328 0.491 . . . . 0.4 114.328 -178.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.42 HD12 ' HA3' ' A' ' 85' ' ' GLY . 0.1 OUTLIER -84.57 -25.66 28.52 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.542 0.571 . . . . 2.35 112.542 -178.294 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.443 ' HB2' HD12 ' A' ' 83' ' ' ILE . . . . . . . . 0 C--N 1.328 -0.357 0 C-N-CA 121.033 -0.267 . . . . 1.03 111.288 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo . . . . . 0 C--O 1.231 0.174 0 CA-C-O 120.802 0.251 . . . . 0.7 111.882 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.604 HG13 HD22 ' A' ' 124' ' ' LEU . 3.4 mp -91.88 131.19 39.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 1.25 109.993 178.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -47.95 153.9 1.62 Allowed Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.934 -0.651 . . . . 0.48 112.515 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.441 ' O ' ' HG3' ' A' ' 122' ' ' GLU . 29.1 Cg_endo -62.44 130.28 29.55 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.102 1.868 . . . . 0.67 111.655 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.2 m120 47.63 35.13 4.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.959 -0.564 . . . . 1.12 110.24 -179.028 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.568 ' HG2' ' HB3' ' A' ' 8' ' ' ASN . 43.1 mt-10 -115.23 132.55 56.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.831 -0.622 . . . . 1.73 111.279 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.499 ' O ' ' HB ' ' A' ' 60' ' ' ILE . 87.6 m -95.11 127.53 41.23 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.929 -0.767 . . . . 0.29 108.929 178.219 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.604 HD22 HG13 ' A' ' 118' ' ' ILE . 6.5 mp -116.72 157.81 24.86 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.197 0.522 . . . . 1.47 112.092 -178.381 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.49 ' N ' HD12 ' A' ' 125' ' ' ILE . 4.5 mp -114.21 142.87 25.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.438 -0.801 . . . . 0.2 109.617 178.481 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -135.35 132.26 37.41 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.089 0.471 . . . . 0.24 111.717 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 24.4 tptm -108.67 103.55 12.67 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.565 -0.902 . . . . 2.28 108.565 178.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 9.1 mt -102.76 122.38 55.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 113.007 0.743 . . . . 0.82 113.007 -177.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -116.89 100.31 7.68 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.378 -0.971 . . . . 0.26 108.378 177.319 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.747 HD22 HG11 ' A' ' 53' ' ' VAL . 0.2 OUTLIER -77.95 121.32 24.02 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.926 -0.579 . . . . 1.41 111.545 -178.042 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 48.3 mm -93.47 -57.45 4.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.018 -0.537 . . . . 1.17 110.092 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.627 ' HA ' ' HB1' ' A' ' 95' ' ' ALA . 59.8 p -164.67 163.11 21.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.108 -0.496 . . . . 1.17 111.449 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.517 ' HA ' HG12 ' A' ' 51' ' ' VAL . 11.0 p -107.74 135.14 47.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.691 -0.686 . . . . 1.43 110.094 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.504 ' HE3' ' H ' ' A' ' 137' ' ' SER . 58.9 pttt 38.5 -149.07 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 O-C-N 123.243 0.339 . . . . 3.08 111.234 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.414 ' HD2' ' N ' ' A' ' 135' ' ' LYS . 1.0 OUTLIER -78.21 13.48 1.47 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.058 0.456 . . . . 3.16 110.261 179.133 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.404 ' H ' ' C ' ' A' ' 134' ' ' LYS . 47.2 t 65.43 67.03 0.51 Allowed 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.487 -0.778 . . . . 1.31 110.925 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.504 ' H ' ' HE3' ' A' ' 134' ' ' LYS . 35.8 m . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.213 -0.899 . . . . 2.53 110.863 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? . . . . . 0 N--CA 1.455 -0.178 0 CA-C-O 120.815 0.341 . . . . 2.63 110.367 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -55.5 -51.68 66.19 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.014 -0.539 . . . . 0.82 110.169 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -67.38 -36.52 81.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.842 -0.617 . . . . 2.57 109.93 179.093 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -56.34 -32.8 65.04 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.119 -0.697 . . . . 2.1 109.119 178.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.491 ' HA ' ' HG2' ' A' ' 11' ' ' LYS . 50.3 m-20 -72.72 -38.51 67.44 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.276 -0.875 . . . . 1.4 110.63 179.334 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -56.31 -37.83 70.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.008 -0.542 . . . . 2.67 111.595 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.9 t -77.69 -52.54 16.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 112.047 0.388 . . . . 1.27 112.047 -179.083 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.526 ' HE2' HG13 ' A' ' 60' ' ' ILE . 21.3 ptmt -61.13 -29.72 69.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.544 -0.298 . . . . 1.69 111.683 -179.005 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.26 -52.88 5.9 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.569 -0.824 . . . . 0.31 112.005 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -63.98 -26.59 68.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.968 0.413 . . . . 2.39 110.406 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.0 -39.31 50.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.958 -0.565 . . . . 0.23 110.53 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -59.13 -51.03 71.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.992 -0.549 . . . . 0.23 110.324 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.518 ' HA ' ' HB3' ' A' ' 19' ' ' ASN . 4.2 pp -64.9 -34.44 78.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.309 -0.405 . . . . 0.55 110.577 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.2 m -57.5 -48.8 78.28 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.211 -0.449 . . . . 0.27 110.201 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -73.2 -32.05 64.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.81 -0.632 . . . . 2.47 109.986 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.518 ' HB3' ' HA ' ' A' ' 16' ' ' LEU . 3.0 t-20 -57.58 -27.39 62.66 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.53 -0.759 . . . . 0.22 111.317 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.1 mttm -46.71 -19.85 0.11 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.302 -0.408 . . . . 2.45 111.884 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -68.58 -30.26 68.98 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.469 0.544 . . . . 0.4 112.469 -178.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.679 ' O ' HG23 ' A' ' 25' ' ' VAL . 18.6 mmtp -53.75 118.76 16.01 Favored Pre-proline 0 N--CA 1.464 0.246 0 C-N-CA 121.245 -0.182 . . . . 1.4 110.766 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.28 140.73 95.48 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.343 2.029 . . . . 0.65 112.523 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.91 3.84 79.47 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.743 -0.742 . . . . 0.37 114.318 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 22' ' ' LYS . 7.0 t -52.4 112.21 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 117.602 0.701 . . . . 0.91 110.667 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -118.93 131.03 72.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.904 -0.589 . . . . 1.03 111.669 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.2 t -89.27 132.85 32.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.777 -0.647 . . . . 0.91 110.49 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.594 HD12 ' HB2' ' A' ' 32' ' ' LEU . 66.1 mt -94.71 163.48 22.36 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.406 -0.361 . . . . 0.4 110.925 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -51.81 -30.66 39.05 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.25 1.967 . . . . 0.59 112.019 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.486 ' O ' HD11 ' A' ' 107' ' ' LEU . 1.8 m -85.49 -13.28 49.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.114 -0.494 . . . . 1.14 111.36 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.646 ' HA3' HD21 ' A' ' 107' ' ' LEU . . . 104.84 15.79 19.21 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.134 -1.031 . . . . 0.34 113.874 179.285 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.594 ' HB2' HD12 ' A' ' 28' ' ' LEU . 2.4 mp -83.34 138.74 33.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.373 0.606 . . . . 1.35 112.243 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -119.22 138.93 52.64 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.158 -0.928 . . . . 1.75 108.623 177.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.581 ' HB3' HG22 ' A' ' 101' ' ' ILE . 16.8 p90 -160.61 175.52 12.59 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.206 0.527 . . . . 0.32 112.301 -178.459 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -121.45 117.08 25.98 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.37 -0.832 . . . . 2.15 109.591 178.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.45 HG13 ' HE1' ' A' ' 99' ' ' TRP . 67.8 t -73.49 125.97 33.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 113.473 0.916 . . . . 0.3 113.473 -178.005 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 63.2 mt -103.63 -66.7 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.434 -0.803 . . . . 0.65 110.049 178.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 37.7 t30 -130.96 91.92 3.13 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 116.337 -0.392 . . . . 1.03 110.164 178.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.745 ' HB3' ' HE1' ' A' ' 99' ' ' TRP . 96.3 p -105.41 144.83 31.64 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.204 0.446 . . . . 1.5 112.204 -178.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.516 ' HA2' ' HG3' ' A' ' 94' ' ' PRO . . . 80.44 98.55 0.33 Allowed Glycine 0 C--N 1.332 0.351 0 CA-C-N 115.823 -0.626 . . . . 1.09 113.141 178.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -151.48 -82.29 0.1 Allowed 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 111.75 0.278 . . . . 1.7 111.75 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.47 -178.83 42.56 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 121.142 -0.551 . . . . 0.35 114.098 -178.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.463 ' O ' ' HB3' ' A' ' 44' ' ' LYS . 0.2 OUTLIER -90.32 177.73 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 123.667 0.787 . . . . 1.42 110.439 178.937 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.517 ' HB3' HG11 ' A' ' 133' ' ' VAL . 0.0 OUTLIER 165.92 155.24 0.09 OUTLIER Pre-proline 0 N--CA 1.47 0.545 0 CA-C-O 121.668 0.747 . . . . 2.18 112.419 -179.681 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.449 ' HD2' HG21 ' A' ' 133' ' ' VAL . 2.3 Cg_endo -85.72 173.39 7.28 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 125.102 3.868 . . . . 0.3 113.39 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.493 ' O ' ' N ' ' A' ' 48' ' ' SER . . . -68.1 -172.57 6.85 Favored Glycine 0 C--O 1.225 -0.461 0 CA-C-N 115.109 -0.95 . . . . 0.35 111.453 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.497 ' O ' HG13 ' A' ' 79' ' ' VAL . 55.8 mttp -41.71 -13.22 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 113.603 0.964 . . . . 2.35 113.603 -178.058 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.493 ' N ' ' O ' ' A' ' 46' ' ' GLY . 39.2 t -86.45 6.92 28.04 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.065 0.46 . . . . 1.45 110.625 178.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.435 ' CB ' ' HD2' ' A' ' 45' ' ' PRO . 3.1 p30 -76.63 155.88 33.13 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.776 -0.647 . . . . 1.73 111.487 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.564 ' HB ' ' HG2' ' A' ' 134' ' ' LYS . 33.1 m -125.07 122.27 36.74 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.347 -0.983 . . . . 0.44 108.347 178.481 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.0 m -126.78 151.34 33.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 112.826 0.676 . . . . 0.65 112.826 -177.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 95.5 m -114.1 120.96 42.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.05 -0.977 . . . . 0.32 109.152 178.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.484 HG12 ' HA ' ' A' ' 130' ' ' LEU . 3.1 m -142.13 176.88 3.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.149 0.5 . . . . 0.24 111.742 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -126.15 132.03 51.92 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.462 -0.79 . . . . 2.4 108.969 178.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -145.56 165.37 28.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.606 0.717 . . . . 0.26 112.125 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 88.5 m -130.02 113.47 14.6 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.606 -1.179 . . . . 0.26 108.491 178.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.442 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -110.62 144.32 17.15 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 119.838 -1.173 . . . . 0.12 113.065 -178.181 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.531 ' NH2' ' HA2' ' A' ' 62' ' ' GLY . 0.1 OUTLIER -147.47 146.83 29.67 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.794 0.331 . . . . 1.93 110.192 179.037 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.454 ' HA ' ' HG ' ' A' ' 124' ' ' LEU . 9.8 mt -80.14 157.67 26.55 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.196 -0.456 . . . . 1.21 110.327 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.526 HG13 ' HE2' ' A' ' 11' ' ' LYS . 9.7 tp -59.1 -10.93 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.41 -0.589 . . . . 0.64 109.41 178.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -66.39 -9.76 36.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.281 -0.872 . . . . 2.01 110.673 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.531 ' HA2' ' NH2' ' A' ' 58' ' ' ARG . . . 90.98 -0.23 75.73 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.516 -0.85 . . . . 0.45 113.317 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.5 t -121.51 138.71 54.18 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 117.357 0.578 . . . . 1.4 111.702 -178.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 57' ' ' GLY . 5.3 p -66.86 133.34 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-N 115.654 -0.703 . . . . 0.28 109.979 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.673 ' HD1' ' H ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -97.93 -27.25 14.35 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.271 -0.422 . . . . 0.24 111.523 -179.74 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.673 ' H ' ' HD1' ' A' ' 65' ' ' PHE . 25.0 t70 -177.25 130.74 0.17 Allowed 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 116.709 -0.223 . . . . 0.3 110.564 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 68.0 m -134.61 124.51 25.52 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.791 0.329 . . . . 1.3 111.12 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.575 HG21 ' HB2' ' A' ' 75' ' ' ALA . 80.9 p -86.14 -12.99 48.47 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.072 0.463 . . . . 0.34 110.391 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.89 -48.28 25.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.705 -0.68 . . . . 2.11 111.303 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -64.57 -37.86 89.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.111 -0.495 . . . . 3.41 111.418 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 62.9 p -60.23 -14.58 18.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.47 -0.332 . . . . 1.47 111.405 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.92 8.02 88.05 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.779 -0.724 . . . . 0.7 112.624 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -123.44 118.35 27.6 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 120.268 0.08 . . . . 3.05 110.874 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.62 150.05 45.82 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.42 2.08 . . . . 0.51 112.447 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.575 ' HB2' HG21 ' A' ' 68' ' ' THR . . . -94.76 126.65 40.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 0.23 111.344 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 78.7 m -118.51 115.72 25.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.388 -0.369 . . . . 1.26 110.901 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -150.58 148.66 28.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.309 -0.405 . . . . 0.36 111.396 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.78 141.77 33.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.819 -0.628 . . . . 1.58 110.107 179.364 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.596 HG23 ' HB2' ' A' ' 90' ' ' LEU . 2.6 p -64.26 -24.95 36.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.273 -0.421 . . . . 1.07 112.126 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.3 t -90.93 -9.72 45.1 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.718 0.266 . . . . 1.14 111.718 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -91.99 5.8 48.77 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.991 0.367 . . . . 2.08 111.991 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 10.5 m -116.24 -178.46 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 112.279 0.474 . . . . 0.45 112.279 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.516 ' O ' HG23 ' A' ' 87' ' ' THR . 24.8 pt -56.6 155.87 13.29 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 115.915 -0.584 . . . . 0.75 112.035 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -48.16 -60.24 0.95 Allowed 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.211 2.607 . . . . 0.65 113.168 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.504 ' C ' HD21 ' A' ' 32' ' ' LEU . . . -44.39 -48.82 8.5 Favored Glycine 0 CA--C 1.522 0.497 0 C-N-CA 120.596 -0.812 . . . . 0.31 112.17 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 1.1 m0 -62.44 -36.63 83.02 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.014 0.375 . . . . 0.78 112.014 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.516 HG23 ' O ' ' A' ' 83' ' ' ILE . 30.5 p -58.7 -40.21 83.0 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 121.03 -0.268 . . . . 1.4 111.609 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -70.46 -51.67 27.54 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.494 0.553 . . . . 1.43 112.494 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.79 -52.41 51.05 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.381 0.511 . . . . 0.33 112.381 -178.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.596 ' HB2' HG23 ' A' ' 79' ' ' VAL . 4.2 mm? -57.6 -25.72 60.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.334 -0.394 . . . . 0.39 111.779 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 21.5 tm0? -81.58 -19.36 42.14 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.754 0.279 . . . . 1.87 111.754 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 98.2 mt -90.25 -22.16 21.76 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.77 0.285 . . . . 1.31 111.77 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.537 ' SD ' HD13 ' A' ' 90' ' ' LEU . 15.4 ptp -81.75 121.01 79.11 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-O 120.555 0.217 . . . . 1.66 111.511 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.516 ' HG3' ' HA2' ' A' ' 40' ' ' GLY . 92.8 Cg_endo -80.4 147.51 18.04 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.767 2.312 . . . . 0.44 111.791 179.311 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.635 ' HB1' ' HA ' ' A' ' 132' ' ' SER . . . -45.79 126.46 7.12 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.707 0.289 . . . . 0.36 111.151 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 97.84 -2.38 60.14 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 120.82 -0.705 . . . . 0.34 113.024 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.433 ' OG ' ' HB2' ' A' ' 93' ' ' MET . 83.0 p -79.42 -174.47 4.24 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.934 0.397 . . . . 1.41 111.563 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.5 m -159.89 105.79 1.59 Allowed 'General case' 0 C--O 1.231 0.085 0 CA-C-N 116.029 -0.532 . . . . 0.23 111.001 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.745 ' HE1' ' HB3' ' A' ' 39' ' ' SER . 40.0 m0 -126.9 149.37 49.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.04 0.448 . . . . 0.53 111.781 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -117.8 107.91 14.71 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 107.847 -1.168 . . . . 1.37 107.847 177.061 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.581 HG22 ' HB3' ' A' ' 34' ' ' TYR . 43.3 pt -109.35 140.05 29.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 113.515 0.932 . . . . 0.25 113.515 -177.04 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -116.41 103.57 10.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.76 -1.109 . . . . 0.31 108.031 177.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.546 HG22 HD23 ' A' ' 32' ' ' LEU . 9.6 t -102.53 102.74 27.67 Favored Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 113.191 0.812 . . . . 0.52 113.191 -177.175 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -62.0 151.73 79.67 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.101 1.868 . . . . 0.48 110.774 177.608 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -48.34 -42.5 31.54 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 111.883 0.327 . . . . 1.81 111.883 -179.149 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -57.27 -10.07 5.06 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.982 -0.628 . . . . 0.4 113.315 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.646 HD21 ' HA3' ' A' ' 31' ' ' GLY . 0.2 OUTLIER -103.6 -15.89 15.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.766 0.317 . . . . 2.35 111.504 -179.575 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.503 -0.317 . . . . 1.03 111.173 -179.787 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo . . . . . 0 C--O 1.231 0.153 0 CA-C-O 121.038 0.349 . . . . 0.7 111.573 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.611 HG23 HD12 ' A' ' 124' ' ' LEU . 92.8 mt -90.75 124.18 43.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.753 -0.658 . . . . 1.25 110.261 179.27 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.404 ' H ' HD21 ' A' ' 59' ' ' LEU . . . -48.56 156.59 1.21 Allowed Glycine 0 C--N 1.331 0.304 0 CA-C-N 116.097 -0.501 . . . . 0.48 113.048 -179.345 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -62.05 131.43 34.72 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.373 2.048 . . . . 0.67 111.653 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 50.14 34.41 8.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.272 -0.422 . . . . 1.12 110.259 -178.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -115.91 127.11 54.74 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.341 -0.39 . . . . 1.73 111.738 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.492 ' O ' ' HB ' ' A' ' 60' ' ' ILE . 97.3 m -90.72 128.63 36.73 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.376 -0.972 . . . . 0.29 108.376 177.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.611 HD12 HG23 ' A' ' 118' ' ' ILE . 0.1 OUTLIER -113.35 156.45 23.39 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.829 0.677 . . . . 1.47 112.829 -177.577 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 5.1 mp -114.78 138.41 45.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 114.973 -1.012 . . . . 0.2 109.228 177.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.485 ' CE1' HD22 ' A' ' 124' ' ' LEU . 68.7 m-85 -131.51 132.47 44.22 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.95 0.405 . . . . 0.24 111.893 -178.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -109.12 103.62 12.66 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.521 -0.918 . . . . 2.28 108.521 178.077 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 19.6 mt -104.11 122.92 57.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 112.974 0.731 . . . . 0.82 112.974 -177.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -118.43 99.29 6.73 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.508 -0.923 . . . . 0.26 108.508 177.314 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.484 ' HA ' HG12 ' A' ' 53' ' ' VAL . 20.2 tp -79.56 120.24 23.64 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.889 -0.596 . . . . 1.41 111.365 -178.099 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 50.1 mm -89.75 -56.45 5.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.895 -0.593 . . . . 1.17 110.561 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.635 ' HA ' ' HB1' ' A' ' 95' ' ' ALA . 2.1 m -161.11 165.4 29.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.203 -0.453 . . . . 1.17 110.802 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.571 HG22 ' HG3' ' A' ' 134' ' ' LYS . 7.2 p -111.66 121.38 64.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.048 -0.524 . . . . 1.43 111.663 -179.392 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.571 ' HG3' HG22 ' A' ' 133' ' ' VAL . 34.0 mtpt 43.42 65.72 0.93 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.908 -0.587 . . . . 3.08 111.097 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 95.5 mttt 59.53 30.84 20.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.904 -0.589 . . . . 3.16 111.09 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 42.0 t 55.86 65.2 1.51 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.884 -0.598 . . . . 1.31 111.096 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 58.7 m . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.211 -0.9 . . . . 2.53 110.871 179.97 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--O 1.233 0.208 0 CA-C-O 121.063 0.459 . . . . 2.63 109.936 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.37 -41.74 98.86 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.718 -0.674 . . . . 0.82 110.428 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -74.83 -31.5 61.69 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.261 -0.427 . . . . 2.57 110.419 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.464 ' HG3' ' HE3' ' A' ' 11' ' ' LYS . 9.6 tp10 -55.93 -40.75 73.59 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.767 -0.457 . . . . 2.1 109.767 179.037 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.534 ' HA ' ' HG2' ' A' ' 11' ' ' LYS . 25.7 p30 -78.64 -29.28 45.71 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.193 -0.458 . . . . 1.4 110.44 179.09 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 121' ' ' ASN . 64.5 tttp -61.16 -39.57 90.6 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.104 -0.498 . . . . 2.67 111.125 178.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.489 HG23 ' N ' ' A' ' 11' ' ' LYS . 27.4 m -77.46 -50.63 19.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 112.462 0.541 . . . . 1.27 112.462 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.534 ' HG2' ' HA ' ' A' ' 8' ' ' ASN . 19.5 ptpt -64.95 -26.63 68.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.626 0.25 . . . . 1.69 111.359 -179.435 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -75.05 -53.74 6.06 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.648 -0.787 . . . . 0.31 112.206 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -63.52 -24.98 68.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.052 0.453 . . . . 2.39 110.384 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.96 -42.38 33.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.795 -0.638 . . . . 0.23 110.915 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -57.46 -48.47 79.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.202 -0.454 . . . . 0.23 110.578 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.545 ' HA ' ' HB3' ' A' ' 19' ' ' ASN . 4.3 pp -67.64 -35.88 79.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.295 -0.411 . . . . 0.55 110.74 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.412 ' O ' ' HD3' ' A' ' 20' ' ' LYS . 12.1 m -57.57 -48.34 79.63 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.114 0.483 . . . . 0.27 109.854 178.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -72.28 -31.79 66.05 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.821 -0.627 . . . . 2.47 109.809 178.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.545 ' HB3' ' HA ' ' A' ' 16' ' ' LEU . 3.1 t-20 -58.41 -27.09 63.98 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.744 -0.662 . . . . 0.22 111.378 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.412 ' HD3' ' O ' ' A' ' 17' ' ' THR . 55.3 mtpt -46.02 -20.0 0.08 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.423 -0.353 . . . . 2.45 111.659 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -70.6 -33.16 70.74 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.346 0.499 . . . . 0.4 112.346 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.525 ' HG2' ' O ' ' A' ' 19' ' ' ASN . 44.3 mmtt -43.09 118.25 2.42 Favored Pre-proline 0 N--CA 1.467 0.377 0 CA-C-N 116.77 -0.196 . . . . 1.4 111.373 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.448 ' HD2' ' HE2' ' A' ' 35' ' ' LYS . 18.8 Cg_endo -58.0 133.2 54.15 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.607 2.205 . . . . 0.65 112.44 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.69 1.58 85.26 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.754 -0.736 . . . . 0.37 113.177 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' A' ' 34' ' ' TYR . 7.4 p -60.3 114.48 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 121.205 0.526 . . . . 0.91 110.519 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.1 p -128.06 141.14 47.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.763 -0.653 . . . . 1.03 111.291 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.5 p -89.51 140.59 15.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.13 -0.486 . . . . 0.91 111.032 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.589 HD12 ' HB2' ' A' ' 32' ' ' LEU . 73.7 mt -96.92 167.61 11.75 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.036 -0.529 . . . . 0.4 110.845 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.473 ' HD2' ' HB3' ' A' ' 28' ' ' LEU . 71.8 Cg_exo -52.25 -31.28 45.67 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 121.878 1.719 . . . . 0.59 111.388 178.591 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.1 m -86.38 -11.83 50.92 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.842 -0.617 . . . . 1.14 111.142 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.453 ' O ' HD21 ' A' ' 107' ' ' LEU . . . 103.28 13.32 28.95 Favored Glycine 0 CA--C 1.521 0.446 0 C-N-CA 120.483 -0.865 . . . . 0.34 114.885 178.205 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.589 ' HB2' HD12 ' A' ' 28' ' ' LEU . 4.0 mp -83.44 134.86 34.85 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 117.882 0.841 . . . . 1.35 112.762 -178.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -114.4 140.69 48.47 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.065 -1.087 . . . . 1.75 108.065 177.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.727 ' HB3' HG22 ' A' ' 101' ' ' ILE . 36.9 p90 -155.16 176.03 13.07 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 113.206 0.817 . . . . 0.32 113.206 -177.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.448 ' HE2' ' HD2' ' A' ' 23' ' ' PRO . 33.8 tttm -120.75 116.89 26.12 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.012 -0.995 . . . . 2.15 109.2 178.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.514 HG13 ' HE1' ' A' ' 99' ' ' TRP . 36.2 t -73.27 126.59 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 113.346 0.869 . . . . 0.3 113.346 -177.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.571 HD12 HG22 ' A' ' 98' ' ' THR . 72.6 mt -104.6 -64.1 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 115.436 -0.802 . . . . 0.65 110.672 178.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.418 ' O ' ' HA ' ' A' ' 97' ' ' SER . 9.7 t30 -151.26 78.6 1.28 Allowed 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.653 0.263 . . . . 1.03 110.819 179.259 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.462 ' HB3' ' NE1' ' A' ' 99' ' ' TRP . 79.3 p -106.45 146.13 30.92 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.964 0.411 . . . . 1.5 112.076 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 97.55 99.71 2.03 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 121.025 -0.607 . . . . 1.09 113.026 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -176.48 -62.1 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 111.776 0.287 . . . . 1.7 111.776 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.07 160.97 28.84 Favored Glycine 0 CA--C 1.518 0.281 0 C-N-CA 120.843 -0.694 . . . . 0.35 113.858 -179.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.494 ' O ' ' HB3' ' A' ' 44' ' ' LYS . 0.2 OUTLIER -90.71 175.85 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 123.215 0.606 . . . . 1.42 110.516 179.152 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.617 ' HD3' ' HA ' ' A' ' 94' ' ' PRO . 10.0 ptmm? 163.71 156.29 0.06 OUTLIER Pre-proline 0 N--CA 1.471 0.61 0 CA-C-O 121.427 0.632 . . . . 2.18 111.933 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.443 ' HD2' ' HB2' ' A' ' 49' ' ' ASP . 7.2 Cg_exo -74.57 173.11 14.87 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 124.485 3.457 . . . . 0.3 113.202 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 48' ' ' SER . . . -67.5 -172.56 6.06 Favored Glycine 0 C--O 1.224 -0.497 0 N-CA-C 110.895 -0.882 . . . . 0.35 110.895 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.432 ' O ' ' HB2' ' A' ' 80' ' ' SER . 24.2 pttm -41.61 -13.2 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.388 0.884 . . . . 2.35 113.388 -178.017 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.522 ' N ' ' O ' ' A' ' 46' ' ' GLY . 60.4 m -86.12 7.74 23.62 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 121.036 0.446 . . . . 1.45 110.376 178.636 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.443 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 3.3 p30 -77.84 160.2 28.47 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.656 -0.702 . . . . 1.73 111.611 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.552 ' HB ' ' HG3' ' A' ' 134' ' ' LYS . 48.3 m -126.34 119.5 27.49 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.814 -0.81 . . . . 0.44 108.814 178.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.434 HG12 ' HA ' ' A' ' 133' ' ' VAL . 26.5 m -130.07 150.73 34.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.156 0.503 . . . . 0.65 112.319 -178.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 53.3 m -111.74 121.15 44.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.477 -0.783 . . . . 0.32 109.299 178.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.586 HG12 ' HA ' ' A' ' 130' ' ' LEU . 3.4 m -137.83 177.8 5.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.154 0.502 . . . . 0.24 111.772 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -126.55 132.9 51.24 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.441 -0.8 . . . . 2.4 109.77 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -144.69 159.63 42.52 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.682 0.753 . . . . 0.26 112.161 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 62.9 m -124.71 112.09 16.33 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.42 -1.263 . . . . 0.26 108.412 178.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.416 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -110.63 141.38 16.35 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 119.813 -1.184 . . . . 0.12 113.173 -178.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.457 ' NE ' HD13 ' A' ' 125' ' ' ILE . 2.5 ppt_? -147.36 146.35 29.62 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.786 0.327 . . . . 1.93 110.197 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.466 ' HA ' ' HG ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER -73.31 163.48 28.02 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.038 -0.528 . . . . 1.21 110.38 -179.863 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.494 ' HB ' ' O ' ' A' ' 123' ' ' THR . 9.0 tp -59.4 -11.01 2.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.357 0.598 . . . . 0.64 109.499 178.62 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -71.73 -12.48 61.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.321 -0.854 . . . . 2.01 110.979 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.429 ' HA2' HH11 ' A' ' 58' ' ' ARG . . . 90.02 -0.88 79.64 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.604 -0.808 . . . . 0.45 112.921 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.3 m -110.18 128.46 55.49 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 120.92 0.391 . . . . 1.4 111.21 -178.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 57' ' ' GLY . 5.1 p -61.0 130.7 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 115.968 -0.56 . . . . 0.28 110.099 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.605 ' HD1' ' N ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -97.45 -21.92 16.87 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.976 -0.556 . . . . 0.24 110.912 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.605 ' N ' ' HD1' ' A' ' 65' ' ' PHE . 16.2 t70 -175.82 129.5 0.25 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.164 -0.471 . . . . 0.3 110.559 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 30.2 p -132.21 122.28 24.99 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.279 -0.419 . . . . 1.3 110.516 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.586 HG21 ' HB2' ' A' ' 75' ' ' ALA . 69.4 p -79.12 -29.17 43.06 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.426 -0.352 . . . . 0.34 111.184 -179.492 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -69.74 -30.98 68.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.463 -0.335 . . . . 2.11 110.922 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -71.26 -42.13 69.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 3.41 110.995 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 53.6 p -59.72 -18.93 46.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.908 0.385 . . . . 1.47 110.947 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 92.55 2.74 67.33 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.918 -0.658 . . . . 0.7 112.604 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -125.98 140.58 37.18 Favored Pre-proline 0 N--CA 1.453 -0.303 0 CA-C-O 120.929 0.395 . . . . 3.05 110.786 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -71.25 160.1 49.91 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.422 2.082 . . . . 0.51 112.193 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.586 ' HB2' HG21 ' A' ' 68' ' ' THR . . . -93.63 124.82 37.88 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 116.13 -0.486 . . . . 0.23 110.86 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.2 t -126.34 118.29 24.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.007 0.432 . . . . 1.26 110.946 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -157.63 154.28 28.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.118 -0.492 . . . . 0.36 111.578 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.31 130.21 34.94 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.926 -0.768 . . . . 1.58 108.926 178.69 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.415 ' O ' HG22 ' A' ' 87' ' ' THR . 12.0 m -64.14 -6.5 2.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 112.851 0.686 . . . . 1.07 112.851 -178.233 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.432 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 40.8 t -96.54 -14.0 22.58 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.503 0.557 . . . . 1.14 112.503 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -97.43 5.76 49.24 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.839 0.681 . . . . 2.08 112.839 -178.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 6.1 m -99.36 178.32 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.992 -0.283 . . . . 0.45 111.744 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.496 HG13 ' HB2' ' A' ' 86' ' ' TRP . 26.8 pt -56.16 155.92 11.67 Favored Pre-proline 0 CA--C 1.531 0.225 0 CA-C-N 116.379 -0.373 . . . . 0.75 111.646 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -45.75 -59.92 1.03 Allowed 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.191 2.594 . . . . 0.65 113.049 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.445 ' O ' HD11 ' A' ' 32' ' ' LEU . . . -49.51 -49.08 33.81 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 120.701 -0.761 . . . . 0.31 112.719 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' TRP . . . . . 0.496 ' HB2' HG13 ' A' ' 83' ' ' ILE . 0.6 OUTLIER -61.19 -46.5 90.21 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.325 0.491 . . . . 0.78 112.325 -179.015 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.45 HG23 ' O ' ' A' ' 83' ' ' ILE . 71.6 p -54.92 -36.44 65.24 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 111.791 0.293 . . . . 1.4 111.791 -179.158 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -70.46 -50.27 39.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.547 -0.297 . . . . 1.43 111.654 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.48 ' HB2' HD22 ' A' ' 32' ' ' LEU . . . -63.5 -52.14 62.54 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.486 -0.324 . . . . 0.33 111.852 -179.2 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -57.4 -30.02 64.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.16 -0.473 . . . . 0.39 111.827 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -69.84 -17.81 63.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.444 -0.344 . . . . 1.87 111.391 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 89.5 mt -101.6 -7.52 22.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.293 -0.412 . . . . 1.31 111.7 -179.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.452 ' O ' ' HD3' ' A' ' 44' ' ' LYS . 90.6 mtp -91.59 107.37 21.61 Favored Pre-proline 0 C--N 1.33 -0.26 0 N-CA-C 111.76 0.282 . . . . 1.66 111.76 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.617 ' HA ' ' HD3' ' A' ' 44' ' ' LYS . 38.8 Cg_endo -69.44 142.71 50.1 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.032 1.822 . . . . 0.44 110.799 178.385 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.515 ' HA ' HD13 ' A' ' 130' ' ' LEU . . . -45.82 126.66 7.35 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.78 0.324 . . . . 0.36 111.511 -179.173 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.551 ' H ' HD22 ' A' ' 130' ' ' LEU . . . 101.32 -2.75 54.27 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.636 -0.792 . . . . 0.34 113.229 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.418 ' HA ' ' O ' ' A' ' 38' ' ' ASN . 74.9 m -76.35 -177.54 4.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.048 0.451 . . . . 1.41 111.847 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.571 HG22 HD12 ' A' ' 37' ' ' ILE . 9.7 m -155.26 98.68 2.01 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.67 -0.696 . . . . 0.23 110.55 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.514 ' HE1' HG13 ' A' ' 36' ' ' VAL . 20.6 m0 -121.79 149.31 43.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.138 0.494 . . . . 0.53 111.581 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -115.28 107.63 15.51 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.156 -1.053 . . . . 1.37 108.156 177.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.727 HG22 ' HB3' ' A' ' 34' ' ' TYR . 48.7 pt -110.14 145.94 16.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 113.339 0.866 . . . . 0.25 113.339 -177.459 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -127.31 103.69 7.53 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.694 -1.139 . . . . 0.31 108.099 178.138 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.523 HG22 HD23 ' A' ' 32' ' ' LEU . 2.4 t -104.7 98.88 16.11 Favored Pre-proline 0 CA--C 1.53 0.205 0 N-CA-C 113.448 0.907 . . . . 0.52 113.448 -176.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.628 ' HG2' HD13 ' A' ' 107' ' ' LEU . 12.4 Cg_endo -58.6 151.92 59.29 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.0 1.8 . . . . 0.48 110.507 177.085 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -47.73 -38.9 16.35 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.273 0.471 . . . . 1.81 112.273 -178.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.407 ' C ' HD12 ' A' ' 107' ' ' LEU . . . -57.29 -9.35 4.32 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.985 -0.626 . . . . 0.4 113.288 -179.335 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.628 HD13 ' HG2' ' A' ' 104' ' ' PRO . 6.5 mp -110.41 -13.85 14.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.668 0.27 . . . . 2.35 111.52 -178.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.55 -0.296 . . . . 1.03 111.061 -179.67 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo . . . . . 0 C--O 1.232 0.186 0 CA-C-O 120.748 0.228 . . . . 0.7 111.976 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.64 HD12 HD13 ' A' ' 124' ' ' LEU . 26.0 mm -90.65 125.16 43.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.482 . . . . 1.25 110.567 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -44.81 155.33 0.35 Allowed Glycine 0 C--N 1.334 0.435 0 CA-C-N 115.724 -0.671 . . . . 0.48 113.554 -179.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -60.82 132.75 44.05 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.444 2.096 . . . . 0.67 111.437 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.437 ' HB2' ' OD1' ' A' ' 8' ' ' ASN . 1.4 m-80 47.71 35.73 4.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.231 -0.44 . . . . 1.12 109.925 -178.611 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.485 ' HG3' HG22 ' A' ' 60' ' ' ILE . 41.1 tt0 -114.7 128.84 56.53 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.051 -0.522 . . . . 1.73 111.394 -179.114 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.494 ' O ' ' HB ' ' A' ' 60' ' ' ILE . 87.4 m -95.44 129.58 42.55 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.184 -0.673 . . . . 0.29 109.184 178.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.64 HD13 HD12 ' A' ' 118' ' ' ILE . 0.1 OUTLIER -120.33 159.9 24.1 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.104 0.478 . . . . 1.47 111.956 -178.266 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.469 ' N ' HD12 ' A' ' 125' ' ' ILE . 4.5 mp -114.6 143.44 24.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.657 -0.701 . . . . 0.2 109.977 178.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -133.17 132.3 41.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.953 0.406 . . . . 0.24 111.541 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 10.3 tmtt? -111.36 103.56 11.94 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.558 -0.904 . . . . 2.28 108.558 178.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 20.8 mt -102.68 122.92 55.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.91 0.707 . . . . 0.82 112.91 -177.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -118.7 99.75 6.98 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.891 -0.781 . . . . 0.26 108.891 177.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.586 ' HA ' HG12 ' A' ' 53' ' ' VAL . 0.7 OUTLIER -78.48 124.84 28.58 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.157 -0.474 . . . . 1.41 111.558 -178.615 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 43.6 mm -94.06 -57.07 4.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.753 -0.658 . . . . 1.17 110.735 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.497 ' HA ' ' HB1' ' A' ' 95' ' ' ALA . 4.3 m -163.68 166.07 22.62 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.951 0.405 . . . . 1.17 111.491 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.448 HG11 ' HB3' ' A' ' 44' ' ' LYS . 7.3 p -107.63 124.33 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 115.945 -0.57 . . . . 1.43 111.012 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.552 ' HG3' ' HB ' ' A' ' 50' ' ' THR . 0.7 OUTLIER 33.36 73.16 0.07 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.057 -0.52 . . . . 3.08 111.792 -179.5 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 95.4 mttt 60.48 29.91 19.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.863 -0.608 . . . . 3.16 111.57 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.411 ' HB2' ' HB3' ' A' ' 132' ' ' SER . 46.9 t 55.41 67.78 0.96 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.055 -0.521 . . . . 1.31 111.083 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 66.2 m . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.345 -0.836 . . . . 2.53 110.889 179.964 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 23.3 tptm . . . . . 0 N--CA 1.455 -0.216 0 CA-C-O 120.79 0.329 . . . . 2.63 110.242 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -58.11 -52.0 67.36 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.092 -0.504 . . . . 0.82 109.977 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -64.85 -36.42 84.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.979 -0.555 . . . . 2.57 110.008 178.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -55.88 -33.13 64.32 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.89 -0.781 . . . . 2.1 108.89 178.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.502 ' HA ' ' HG2' ' A' ' 11' ' ' LYS . 53.2 m-20 -72.34 -38.24 68.65 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.165 -0.925 . . . . 1.4 110.428 179.281 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.434 ' NZ ' ' HB3' ' A' ' 9' ' ' LYS . 4.2 ttpm? -57.27 -35.64 70.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.977 -0.556 . . . . 2.67 111.212 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.9 t -76.35 -52.61 17.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 111.959 0.355 . . . . 1.27 111.959 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.502 ' HG2' ' HA ' ' A' ' 8' ' ' ASN . 19.0 ptpt -58.59 -33.35 69.89 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.668 0.27 . . . . 1.69 111.314 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.452 ' O ' ' HG ' ' A' ' 16' ' ' LEU . . . -76.39 -53.2 5.67 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.719 -0.753 . . . . 0.31 112.329 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -61.08 -30.75 70.52 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.837 0.351 . . . . 2.39 110.839 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.23 -32.09 55.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.319 -0.401 . . . . 0.23 110.458 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -63.99 -54.53 32.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.938 -0.573 . . . . 0.23 110.66 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.738 ' HA ' ' HB3' ' A' ' 19' ' ' ASN . 0.6 OUTLIER -65.59 -32.5 74.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.28 -0.418 . . . . 0.55 111.152 -179.724 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.434 ' N ' HD12 ' A' ' 16' ' ' LEU . 8.3 m -57.2 -48.54 78.52 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.606 -0.516 . . . . 0.27 109.606 179.063 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -74.16 -31.85 62.87 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.93 -0.577 . . . . 2.47 110.065 178.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.738 ' HB3' ' HA ' ' A' ' 16' ' ' LEU . 0.4 OUTLIER -57.12 -28.38 62.65 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.305 -0.861 . . . . 0.22 112.133 -179.523 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -48.04 -18.58 0.2 Allowed 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 112.32 0.489 . . . . 2.45 112.32 -179.301 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -67.67 -33.11 74.27 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.88 0.326 . . . . 0.4 111.88 -178.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.725 ' O ' HG23 ' A' ' 25' ' ' VAL . 68.1 mttm -54.04 119.48 19.74 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.716 -0.22 . . . . 1.4 111.022 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -56.8 145.56 82.77 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.246 1.964 . . . . 0.65 112.374 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.71 3.11 81.0 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.735 -0.745 . . . . 0.37 113.921 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 22' ' ' LYS . 18.0 t -58.65 109.48 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 117.517 0.659 . . . . 0.91 110.637 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.5 p -130.35 128.56 64.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.908 -0.587 . . . . 1.03 111.089 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.2 p -82.69 137.24 21.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.184 -0.462 . . . . 0.91 110.866 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.521 HD12 ' HB2' ' A' ' 32' ' ' LEU . 61.2 mt -95.52 166.88 13.76 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.102 -0.499 . . . . 0.4 110.713 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.443 ' HD2' ' HB3' ' A' ' 28' ' ' LEU . 53.2 Cg_exo -53.53 -30.93 56.61 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 121.889 1.726 . . . . 0.59 111.53 178.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.525 ' O ' HD12 ' A' ' 107' ' ' LEU . 28.0 t -85.43 -10.96 55.49 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.057 -0.519 . . . . 1.14 110.953 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.83 13.98 28.19 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 120.425 -0.893 . . . . 0.34 114.645 178.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.626 HD22 ' HB2' ' A' ' 89' ' ' ALA . 5.8 mp -85.61 136.98 33.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 117.747 0.774 . . . . 1.35 112.951 -179.07 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -119.01 139.9 50.92 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.118 -0.946 . . . . 1.75 108.49 177.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.654 ' HB3' HG22 ' A' ' 101' ' ' ILE . 41.0 p90 -155.04 176.39 12.6 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.794 0.664 . . . . 0.32 112.794 -178.389 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.433 ' HE2' ' HB3' ' A' ' 22' ' ' LYS . 23.4 ttmt -120.78 117.36 27.24 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.974 -1.012 . . . . 2.15 109.583 179.075 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.439 HG13 ' HE1' ' A' ' 99' ' ' TRP . 51.6 t -74.52 125.61 34.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 113.297 0.851 . . . . 0.3 113.297 -177.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 54.9 mt -107.22 -66.82 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.288 -0.869 . . . . 0.65 109.92 178.107 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -134.77 85.14 2.16 Favored 'General case' 0 C--O 1.226 -0.143 0 CA-C-N 116.022 -0.536 . . . . 1.03 109.754 178.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.611 ' HB2' ' HE1' ' A' ' 99' ' ' TRP . 47.0 t -106.47 145.16 32.14 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.376 0.51 . . . . 1.5 112.376 -179.153 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.1 109.19 0.27 Allowed Glycine 0 C--N 1.333 0.366 0 CA-C-N 115.665 -0.698 . . . . 1.09 113.936 178.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -177.75 -62.28 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 111.644 0.239 . . . . 1.7 111.644 178.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.2 168.98 34.28 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 120.63 -0.795 . . . . 0.35 113.763 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.744 HG22 ' H ' ' A' ' 44' ' ' LYS . 7.9 p -90.72 176.88 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 123.208 0.603 . . . . 1.42 109.959 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.744 ' H ' HG22 ' A' ' 43' ' ' VAL . 19.4 ptmt 164.94 156.2 0.07 OUTLIER Pre-proline 0 N--CA 1.469 0.519 0 CA-C-O 121.602 0.715 . . . . 2.18 112.86 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.528 ' HD2' HG21 ' A' ' 133' ' ' VAL . 1.2 Cg_endo -85.18 173.48 7.81 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 125.169 3.913 . . . . 0.3 113.097 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.508 ' O ' ' N ' ' A' ' 48' ' ' SER . . . -67.99 -172.18 6.46 Favored Glycine 0 C--O 1.225 -0.43 0 CA-C-N 115.393 -0.821 . . . . 0.35 111.383 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.405 ' HG2' ' HB2' ' A' ' 91' ' ' GLN . 98.8 mttt -41.41 -13.5 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 113.448 0.907 . . . . 2.35 113.448 -178.077 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.508 ' N ' ' O ' ' A' ' 46' ' ' GLY . 84.5 p -85.84 7.28 24.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.094 0.473 . . . . 1.45 110.282 178.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.469 ' O ' ' NE2' ' A' ' 78' ' ' GLN . 3.2 p30 -76.64 140.88 41.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.459 -0.791 . . . . 1.73 111.857 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 62.8 m -113.45 119.4 37.47 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.615 -0.883 . . . . 0.44 108.615 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.445 HG12 ' HB ' ' A' ' 133' ' ' VAL . 16.9 m -124.28 154.54 31.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 113.051 0.76 . . . . 0.65 113.051 -177.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 87.4 m -114.52 120.8 41.47 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.026 -0.988 . . . . 0.32 108.638 178.125 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.559 HG12 ' HA ' ' A' ' 130' ' ' LEU . 4.4 m -142.97 -179.71 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.296 0.57 . . . . 0.24 111.991 -178.448 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.527 ' HB3' ' HG2' ' A' ' 69' ' ' GLU . 28.3 mt-10 -129.55 132.79 46.92 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.114 -0.948 . . . . 2.4 109.455 178.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -146.48 160.86 41.55 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.703 0.763 . . . . 0.26 112.203 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 62.1 m -128.31 112.85 14.9 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.358 -1.292 . . . . 0.26 108.428 178.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.454 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -110.0 147.14 17.22 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.008 -1.091 . . . . 0.12 113.021 -178.361 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.485 ' NE ' HD13 ' A' ' 125' ' ' ILE . 1.8 ppt_? -147.91 148.05 30.39 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.888 0.375 . . . . 1.93 110.122 179.187 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.419 HD23 HD21 ' A' ' 124' ' ' LEU . 23.4 mt -77.55 162.18 27.31 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.981 -0.554 . . . . 1.21 110.102 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.513 ' HB ' ' O ' ' A' ' 123' ' ' THR . 6.9 tp -59.18 -10.75 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.365 0.603 . . . . 0.64 109.458 178.728 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -67.65 -12.61 60.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.312 -0.858 . . . . 2.01 110.721 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.434 ' HA2' HH11 ' A' ' 58' ' ' ARG . . . 90.55 -0.94 78.19 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.594 -0.812 . . . . 0.45 113.238 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 71.6 p -115.84 134.35 55.09 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 117.088 0.444 . . . . 1.4 111.458 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 57' ' ' GLY . 6.7 p -62.71 132.43 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-N 115.951 -0.568 . . . . 0.28 110.044 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.583 ' HD1' ' N ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -97.65 -22.35 16.52 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.083 -0.508 . . . . 0.24 110.99 -179.95 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.583 ' N ' ' HD1' ' A' ' 65' ' ' PHE . 24.9 t70 -175.91 130.05 0.24 Allowed 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 116.323 -0.399 . . . . 0.3 110.995 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.7 p -125.55 124.36 41.11 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.103 -0.499 . . . . 1.3 110.544 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.7 HG21 ' HB2' ' A' ' 75' ' ' ALA . 69.8 p -83.26 -25.33 31.72 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 120.848 0.356 . . . . 0.34 111.032 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.527 ' HG2' ' HB3' ' A' ' 54' ' ' GLU . 38.1 mt-10 -75.09 -39.32 60.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 2.11 110.98 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -63.54 -44.86 92.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 3.41 110.639 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 54.7 m -58.25 -21.4 48.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.258 -0.428 . . . . 1.47 110.556 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 90.46 7.5 67.08 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.808 -0.71 . . . . 0.7 112.311 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -125.99 117.01 23.98 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.355 0.122 . . . . 3.05 110.937 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -55.47 157.19 15.51 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.314 2.01 . . . . 0.51 112.107 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.7 ' HB2' HG21 ' A' ' 68' ' ' THR . . . -94.72 123.99 38.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.346 -0.388 . . . . 0.23 110.622 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.6 t -125.89 118.48 25.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.786 0.327 . . . . 1.26 111.189 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -158.47 163.49 37.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.11 0.481 . . . . 0.36 111.865 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.484 ' OE1' ' HB3' ' A' ' 80' ' ' SER . 0.0 OUTLIER -83.04 137.8 33.98 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.524 -0.762 . . . . 1.58 109.03 178.608 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.424 ' O ' HG22 ' A' ' 87' ' ' THR . 21.6 m -69.26 -20.07 24.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 113.587 0.958 . . . . 1.07 113.587 -177.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.484 ' HB3' ' OE1' ' A' ' 78' ' ' GLN . 33.2 t -95.3 -2.56 49.1 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.955 0.354 . . . . 1.14 111.955 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.43 ' H ' ' HG3' ' A' ' 78' ' ' GLN . 29.2 mt-30 -96.17 5.58 50.74 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.895 0.331 . . . . 2.08 111.895 -179.474 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.467 ' HB ' HD13 ' A' ' 83' ' ' ILE . 3.1 m -107.38 -175.66 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 111.662 0.245 . . . . 0.45 111.662 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.74 HD13 ' H ' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -56.45 147.73 47.72 Favored Pre-proline 0 N--CA 1.463 0.191 0 CA-C-N 116.507 -0.315 . . . . 0.75 111.711 -179.468 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo -42.25 -54.12 3.23 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.19 2.594 . . . . 0.65 113.365 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.533 ' HA2' HD11 ' A' ' 32' ' ' LEU . . . -51.87 -49.21 49.05 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.517 -0.849 . . . . 0.31 112.7 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -60.9 -47.7 85.18 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.693 0.257 . . . . 0.78 111.693 -179.348 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.424 HG22 ' O ' ' A' ' 79' ' ' VAL . 30.9 p -53.52 -33.73 55.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.766 0.317 . . . . 1.4 111.598 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -70.61 -51.41 28.35 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.161 0.43 . . . . 1.43 112.161 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.626 ' HB2' HD22 ' A' ' 32' ' ' LEU . . . -68.01 -48.49 65.57 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.483 0.549 . . . . 0.33 112.483 -178.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -55.19 -30.99 61.04 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.021 0.378 . . . . 0.39 112.021 -179.219 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.405 ' HB2' ' HG2' ' A' ' 47' ' ' LYS . 46.7 tt0 -65.68 -21.15 66.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.595 -0.275 . . . . 1.87 111.574 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.411 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 10.6 mp -96.41 -22.13 17.34 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.382 0.512 . . . . 1.31 112.382 -178.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 22.2 ttm -71.41 108.73 4.22 Favored Pre-proline 0 CA--C 1.532 0.278 0 N-CA-C 111.472 0.175 . . . . 1.66 111.472 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.421 ' HD2' ' OG ' ' A' ' 97' ' ' SER . 6.1 Cg_exo -75.67 144.89 28.64 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.751 2.301 . . . . 0.44 111.889 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.609 ' HB1' ' HA ' ' A' ' 132' ' ' SER . . . -48.31 127.57 13.06 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.472 -0.331 . . . . 0.36 111.437 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 94.39 2.57 63.63 Favored Glycine 0 CA--C 1.521 0.422 0 C-N-CA 120.701 -0.762 . . . . 0.34 113.446 179.211 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.421 ' OG ' ' HD2' ' A' ' 94' ' ' PRO . 69.6 m -89.92 -174.59 4.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.885 0.374 . . . . 1.41 111.609 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.7 m -152.3 112.78 4.11 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.066 -0.515 . . . . 0.23 110.773 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.611 ' HE1' ' HB2' ' A' ' 39' ' ' SER . 14.8 m0 -132.25 149.77 52.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.052 0.453 . . . . 0.53 111.759 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -123.73 108.54 12.64 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.367 -0.975 . . . . 1.37 108.367 177.302 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.654 HG22 ' HB3' ' A' ' 34' ' ' TYR . 24.7 pt -107.68 139.68 28.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 112.974 0.731 . . . . 0.25 112.974 -177.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.497 ' OH ' HG22 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -120.34 103.99 9.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.951 -1.022 . . . . 0.31 108.262 178.232 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.417 ' HA ' ' HD2' ' A' ' 104' ' ' PRO . 3.3 t -109.12 102.43 48.9 Favored Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 113.764 1.024 . . . . 0.52 113.764 -176.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.593 ' HG2' HD23 ' A' ' 107' ' ' LEU . 12.3 Cg_endo -59.62 150.94 73.3 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 121.872 1.715 . . . . 0.48 110.037 176.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -47.56 -31.74 4.72 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.512 0.56 . . . . 1.81 112.512 -178.428 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -57.09 -13.47 9.14 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.877 -0.677 . . . . 0.4 114.084 -178.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.593 HD23 ' HG2' ' A' ' 104' ' ' PRO . 3.0 mm? -114.57 -5.55 12.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 117.193 0.496 . . . . 2.35 111.763 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.412 0 CA-C-N 116.513 -0.312 . . . . 1.03 110.385 179.658 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.911 0.296 . . . . 0.7 111.679 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.598 HG23 HD13 ' A' ' 124' ' ' LEU . 5.1 mp -91.55 120.06 39.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.77 -0.65 . . . . 1.25 110.082 179.15 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -46.13 157.6 0.4 Allowed Glycine 0 C--N 1.333 0.416 0 CA-C-N 116.083 -0.508 . . . . 0.48 113.308 -179.193 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.431 ' O ' ' HG3' ' A' ' 122' ' ' GLU . 26.5 Cg_endo -62.07 131.33 34.22 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.486 2.124 . . . . 0.67 111.826 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.9 m120 47.22 34.57 3.13 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.03 -0.532 . . . . 1.12 110.371 -178.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.431 ' HG3' ' O ' ' A' ' 120' ' ' PRO . 37.0 mt-10 -115.64 122.92 47.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.34 -0.391 . . . . 1.73 111.528 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.513 ' O ' ' HB ' ' A' ' 60' ' ' ILE . 91.2 m -89.17 127.9 35.76 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.782 -0.822 . . . . 0.29 108.782 178.11 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.598 HD13 HG23 ' A' ' 118' ' ' ILE . 6.3 mp -114.42 155.82 25.63 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.217 0.532 . . . . 1.47 112.268 -177.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.485 HD13 ' NE ' ' A' ' 58' ' ' ARG . 4.6 mp -113.9 132.88 61.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.306 -0.861 . . . . 0.2 109.716 178.027 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -125.39 131.82 52.88 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.975 0.417 . . . . 0.24 111.423 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -110.0 102.94 11.64 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.482 -0.933 . . . . 2.28 108.482 178.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.43 ' N ' HD12 ' A' ' 128' ' ' ILE . 5.0 mp -105.71 118.65 53.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 112.429 0.529 . . . . 0.82 112.429 -177.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -109.18 99.32 8.62 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.282 -1.007 . . . . 0.26 108.282 177.563 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.559 ' HA ' HG12 ' A' ' 53' ' ' VAL . 26.2 tp -79.3 114.9 18.61 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.86 -0.609 . . . . 1.41 111.511 -178.126 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 67.8 mt -84.18 -56.73 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 CA-C-N 115.884 -0.598 . . . . 1.17 110.288 179.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.609 ' HA ' ' HB1' ' A' ' 95' ' ' ALA . 11.3 p -164.27 165.15 22.14 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.246 -0.433 . . . . 1.17 111.409 179.209 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.691 HG11 ' CB ' ' A' ' 44' ' ' LYS . 7.2 p -117.04 122.24 69.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.902 -0.59 . . . . 1.43 111.064 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.414 ' C ' ' O ' ' A' ' 133' ' ' VAL . 11.3 mttm 32.99 79.19 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.233 -0.44 . . . . 3.08 111.344 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 15.6 pttm 51.86 30.7 7.38 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.783 -0.644 . . . . 3.16 111.629 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 33.8 t 50.61 44.52 27.38 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.587 -0.733 . . . . 1.31 111.096 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 42.3 t . . . . . 0 C--O 1.248 0.979 0 CA-C-O 118.24 -0.886 . . . . 2.53 111.04 -179.734 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 59.9 mmtt . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.843 0.354 . . . . 2.63 110.598 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -58.39 -48.67 79.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.975 -0.557 . . . . 0.82 110.7 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -75.14 -31.9 61.19 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.275 -0.42 . . . . 2.57 110.916 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -56.78 -41.74 78.21 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.683 -0.488 . . . . 2.1 109.683 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.514 ' HA ' ' HG2' ' A' ' 11' ' ' LYS . 23.7 p30 -78.97 -29.2 43.77 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.734 -0.666 . . . . 1.4 111.415 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 121' ' ' ASN . 66.7 tttm -56.16 -44.12 78.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.005 0.431 . . . . 2.67 110.741 179.2 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.425 HG22 ' H ' ' A' ' 10' ' ' VAL . 5.4 m -78.1 -44.97 27.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.915 -0.584 . . . . 1.27 112.446 -179.224 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.517 ' HE2' HG13 ' A' ' 60' ' ' ILE . 17.9 ptmt -59.16 -33.57 71.07 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.703 0.287 . . . . 1.69 111.429 -179.18 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.411 ' O ' ' HG ' ' A' ' 16' ' ' LEU . . . -76.34 -53.01 5.78 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.833 -0.699 . . . . 0.31 112.202 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.505 ' HA ' HD11 ' A' ' 16' ' ' LEU . 47.8 mt-10 -59.21 -25.38 63.93 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.931 0.396 . . . . 2.39 110.591 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.15 -37.61 45.55 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.061 -0.518 . . . . 0.23 110.584 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -61.78 -51.91 66.37 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.165 -0.471 . . . . 0.23 110.828 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.686 ' HA ' ' HB3' ' A' ' 19' ' ' ASN . 0.6 OUTLIER -67.84 -32.66 73.35 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.717 -0.393 . . . . 0.55 111.143 -179.72 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.451 ' N ' HD12 ' A' ' 16' ' ' LEU . 6.2 m -57.65 -46.09 84.66 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.494 -0.558 . . . . 0.27 109.494 178.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -74.27 -31.96 62.73 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.753 -0.658 . . . . 2.47 109.856 178.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.686 ' HB3' ' HA ' ' A' ' 16' ' ' LEU . 0.9 OUTLIER -60.15 -26.36 66.23 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.436 -0.802 . . . . 0.22 112.532 -179.384 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -48.91 -19.46 0.39 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.764 0.316 . . . . 2.45 111.689 -179.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -69.12 -34.71 75.48 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.135 0.42 . . . . 0.4 112.135 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.715 ' O ' HG23 ' A' ' 25' ' ' VAL . 18.7 mmtp -46.02 127.87 7.19 Favored Pre-proline 0 N--CA 1.465 0.298 0 CA-C-O 120.661 0.267 . . . . 1.4 111.266 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -57.89 137.12 79.38 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.336 2.024 . . . . 0.65 112.192 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.94 0.83 83.03 Favored Glycine 0 CA--C 1.52 0.374 0 C-N-CA 120.771 -0.728 . . . . 0.37 113.955 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 22' ' ' LYS . 24.1 t -56.21 103.98 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.125 0 CA-C-N 117.541 0.67 . . . . 0.91 110.17 179.438 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.6 p -126.49 135.68 63.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.611 -0.722 . . . . 1.03 111.138 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.427 HG23 ' NE2' ' A' ' 33' ' ' GLN . 7.6 p -87.05 141.77 13.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.261 -0.427 . . . . 0.91 111.157 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.48 HD12 ' HB2' ' A' ' 32' ' ' LEU . 55.5 mt -101.29 166.06 13.02 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.099 -0.5 . . . . 0.4 110.804 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.416 ' HD2' ' HB3' ' A' ' 28' ' ' LEU . 54.2 Cg_exo -53.79 -30.58 57.74 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 121.914 1.743 . . . . 0.59 111.455 178.514 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.569 ' O ' HD12 ' A' ' 107' ' ' LEU . 38.8 t -83.85 -12.85 54.95 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.862 -0.608 . . . . 1.14 110.871 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.43 14.18 26.44 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 120.485 -0.864 . . . . 0.34 114.291 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.676 HD11 ' CA ' ' A' ' 85' ' ' GLY . 6.6 mp -85.89 137.51 32.7 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 113.64 0.978 . . . . 1.35 113.64 -178.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.427 ' NE2' HG23 ' A' ' 27' ' ' VAL . 25.5 mp0 -118.4 142.7 47.28 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.985 -1.117 . . . . 1.75 107.985 177.117 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.604 ' HB3' HG22 ' A' ' 101' ' ' ILE . 34.8 p90 -158.79 175.69 13.28 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.278 0.844 . . . . 0.32 113.278 -178.255 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -121.58 117.46 26.8 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 114.901 -1.045 . . . . 2.15 109.606 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.484 HG13 ' HE1' ' A' ' 99' ' ' TRP . 46.6 t -81.92 126.77 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 113.216 0.821 . . . . 0.3 113.216 -178.227 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.452 HD12 HG22 ' A' ' 98' ' ' THR . 81.4 mt -101.73 -64.14 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 115.658 -0.701 . . . . 0.65 110.761 178.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.4 ' O ' ' HA ' ' A' ' 97' ' ' SER . 27.5 t-20 -141.35 86.08 2.0 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.826 0.346 . . . . 1.03 110.931 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.702 ' HB2' ' HE1' ' A' ' 99' ' ' TRP . 39.5 t -106.82 146.06 31.38 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.315 -0.402 . . . . 1.5 112.047 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 93.41 85.19 1.59 Allowed Glycine 0 C--N 1.334 0.422 0 C-N-CA 121.05 -0.595 . . . . 1.09 113.224 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -153.28 -71.75 0.14 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.693 0.282 . . . . 1.7 111.612 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.26 166.67 32.24 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 121.052 -0.594 . . . . 0.35 114.376 -178.444 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.662 HG12 ' H ' ' A' ' 44' ' ' LYS . 2.6 t -90.45 176.18 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 123.516 0.726 . . . . 1.42 109.905 179.197 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.662 ' H ' HG12 ' A' ' 43' ' ' VAL . 2.2 pptp? 165.72 156.06 0.09 OUTLIER Pre-proline 0 N--CA 1.47 0.552 0 CA-C-O 121.464 0.65 . . . . 2.18 111.952 -179.51 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.515 ' HD2' ' HB2' ' A' ' 49' ' ' ASP . 3.1 Cg_exo -76.56 172.47 16.16 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 124.602 3.535 . . . . 0.3 113.624 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.493 ' O ' ' N ' ' A' ' 48' ' ' SER . . . -67.76 -173.12 6.76 Favored Glycine 0 C--O 1.223 -0.568 0 CA-C-N 115.17 -0.923 . . . . 0.35 110.944 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.492 ' HG2' ' HB2' ' A' ' 91' ' ' GLN . 53.7 mtmt -42.14 -14.05 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.56 0.948 . . . . 2.35 113.56 -177.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.493 ' N ' ' O ' ' A' ' 46' ' ' GLY . 45.1 t -86.52 7.69 25.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.137 0.494 . . . . 1.45 110.256 178.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.515 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 3.0 p30 -76.18 162.96 27.54 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.515 -0.766 . . . . 1.73 111.368 -179.135 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 60.0 m -123.85 122.93 39.3 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.598 -0.89 . . . . 0.44 108.598 178.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.65 HG12 HG22 ' A' ' 133' ' ' VAL . 2.3 m -122.85 141.08 44.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.285 0.564 . . . . 0.65 112.491 -177.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 66.3 m -113.07 120.08 40.1 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.228 -1.027 . . . . 0.32 108.228 177.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.6 HG12 ' HA ' ' A' ' 130' ' ' LEU . 4.8 m -144.97 177.56 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.231 0.538 . . . . 0.24 111.686 -178.258 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -125.22 131.86 53.08 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.642 -0.873 . . . . 2.4 108.642 178.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -143.78 158.2 43.85 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.701 0.762 . . . . 0.26 112.381 -179.014 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 59.4 m -122.71 112.44 17.94 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.312 -1.313 . . . . 0.26 108.577 178.328 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.473 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -109.82 145.77 16.98 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 119.953 -1.118 . . . . 0.12 112.7 -178.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.516 ' NE ' HD13 ' A' ' 125' ' ' ILE . 4.9 ppt_? -148.09 146.97 29.04 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.048 0.452 . . . . 1.93 110.431 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.452 HD11 ' HB3' ' A' ' 122' ' ' GLU . 46.3 tp -76.1 160.36 29.84 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.759 -0.655 . . . . 1.21 109.809 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.525 ' HB ' ' O ' ' A' ' 123' ' ' THR . 9.5 tp -56.34 -10.68 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.251 0.548 . . . . 0.64 109.879 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.422 ' H ' ' C ' ' A' ' 59' ' ' LEU . 20.4 t70 -66.02 -12.4 54.88 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.454 -0.794 . . . . 2.01 110.861 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.82 -0.77 77.14 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.577 -0.821 . . . . 0.45 113.315 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.4 t -118.65 142.33 47.75 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.053 0.454 . . . . 1.4 111.214 -179.012 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 57' ' ' GLY . 7.0 p -65.96 133.71 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 115.827 -0.624 . . . . 0.28 110.17 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.598 ' HD1' ' N ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -97.43 -22.79 16.39 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.988 -0.551 . . . . 0.24 110.497 179.719 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.598 ' N ' ' HD1' ' A' ' 65' ' ' PHE . 25.4 t70 -176.95 131.7 0.18 Allowed 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.922 -0.581 . . . . 0.3 110.532 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 63.3 p -129.52 123.53 31.67 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.449 -0.342 . . . . 1.3 110.966 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.684 HG21 ' HB2' ' A' ' 75' ' ' ALA . 59.7 p -78.65 -14.35 59.35 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.898 0.38 . . . . 0.34 110.905 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -75.38 -51.83 12.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.048 -0.524 . . . . 2.11 110.604 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.9 ttpm? -61.04 -36.8 80.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.044 -0.525 . . . . 3.41 110.911 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 41.2 m -57.91 -20.03 34.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.206 -0.452 . . . . 1.47 110.744 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.29 4.88 90.03 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.831 -0.699 . . . . 0.7 112.013 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -126.18 117.38 23.6 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.457 0.17 . . . . 3.05 110.931 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -52.99 156.66 9.34 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.395 2.063 . . . . 0.51 112.046 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.684 ' HB2' HG21 ' A' ' 68' ' ' THR . . . -94.21 124.62 38.34 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.42 -0.355 . . . . 0.23 110.601 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.1 t -127.79 118.09 23.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.162 0.506 . . . . 1.26 111.428 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -158.36 167.12 30.58 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.674 -0.694 . . . . 0.36 110.896 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.455 ' OE1' ' HB3' ' A' ' 80' ' ' SER . 18.4 tt0 -85.5 146.0 27.14 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.3 -0.63 . . . . 1.58 109.3 178.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 32.9 m -68.44 -26.51 33.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 113.032 0.753 . . . . 1.07 113.032 -178.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.455 ' HB3' ' OE1' ' A' ' 78' ' ' GLN . 33.4 t -95.53 -3.77 45.98 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 111.937 0.347 . . . . 1.14 111.937 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 -84.87 5.65 27.96 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.733 0.272 . . . . 2.08 111.733 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 1.7 m -112.06 -172.55 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.6 -0.273 . . . . 0.45 111.553 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.529 HG13 ' HB2' ' A' ' 86' ' ' TRP . 29.2 pt -55.99 154.4 14.68 Favored Pre-proline 0 CA--C 1.528 0.13 0 CA-C-N 116.472 -0.331 . . . . 0.75 111.629 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -48.01 -53.67 6.33 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.651 2.234 . . . . 0.65 112.91 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.676 ' CA ' HD11 ' A' ' 32' ' ' LEU . . . -52.93 -49.69 53.9 Favored Glycine 0 CA--C 1.521 0.458 0 C-N-CA 120.802 -0.713 . . . . 0.31 113.112 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' TRP . . . . . 0.529 ' HB2' HG13 ' A' ' 83' ' ' ILE . 0.4 OUTLIER -59.49 -45.57 91.31 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.842 0.312 . . . . 0.78 111.842 -179.069 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 98.4 m -55.66 -37.49 68.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.442 -0.345 . . . . 1.4 111.689 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.64 -49.98 64.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.491 -0.322 . . . . 1.43 111.745 -179.317 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.642 ' HB2' HD22 ' A' ' 32' ' ' LEU . . . -64.39 -49.24 72.36 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.009 0.374 . . . . 0.33 112.009 -179.086 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -57.24 -26.72 61.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.423 -0.353 . . . . 0.39 111.72 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.492 ' HB2' ' HG2' ' A' ' 47' ' ' LYS . 5.1 tp60 -66.43 -24.55 66.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.836 0.35 . . . . 1.87 110.976 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.412 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 4.2 mm? -93.59 -7.51 43.85 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.168 -0.469 . . . . 1.31 111.134 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 69.3 mtp -88.32 108.44 22.15 Favored Pre-proline 0 CA--C 1.531 0.222 0 CA-C-N 116.47 -0.332 . . . . 1.66 111.891 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' A' ' 92' ' ' LEU . 99.0 Cg_endo -79.91 147.07 18.84 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.403 2.068 . . . . 0.44 110.582 178.213 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.495 ' HA ' HD13 ' A' ' 130' ' ' LEU . . . -45.58 126.59 6.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.779 0.323 . . . . 0.36 111.65 -179.145 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.563 ' H ' HD22 ' A' ' 130' ' ' LEU . . . 97.66 -7.8 63.53 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 120.549 -0.834 . . . . 0.34 113.281 178.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 38' ' ' ASN . 33.5 t -69.82 174.83 4.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.876 0.37 . . . . 1.41 111.264 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.452 HG22 HD12 ' A' ' 37' ' ' ILE . 24.5 m -147.31 90.82 1.91 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.987 -0.552 . . . . 0.23 110.471 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.702 ' HE1' ' HB2' ' A' ' 39' ' ' SER . 23.5 m0 -112.11 149.41 32.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.266 0.555 . . . . 0.53 112.189 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -119.59 107.78 13.69 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.311 -0.996 . . . . 1.37 108.311 177.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.604 HG22 ' HB3' ' A' ' 34' ' ' TYR . 48.7 pt -111.07 146.27 16.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 113.221 0.822 . . . . 0.25 113.221 -177.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.471 ' OH ' HG22 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -130.98 103.76 6.73 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.657 -1.156 . . . . 0.31 108.145 178.276 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 4.7 t -105.39 99.75 22.33 Favored Pre-proline 0 C--N 1.33 -0.265 0 N-CA-C 113.709 1.003 . . . . 0.52 113.709 -176.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.59 ' HG2' HD23 ' A' ' 107' ' ' LEU . 11.6 Cg_endo -58.73 151.15 65.78 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 121.701 1.601 . . . . 0.48 109.814 176.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -47.49 -31.87 4.67 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.544 0.572 . . . . 1.81 112.544 -178.239 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -56.97 -13.9 9.38 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.667 -0.778 . . . . 0.4 113.949 -178.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.59 HD23 ' HG2' ' A' ' 104' ' ' PRO . 2.8 mm? -115.19 -5.87 12.42 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 117.09 0.445 . . . . 2.35 111.788 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.421 0 CA-C-N 116.551 -0.295 . . . . 1.03 110.621 179.954 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo . . . . . 0 C--O 1.231 0.155 0 CA-C-O 120.913 0.297 . . . . 0.7 111.92 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.47 HG12 HD13 ' A' ' 124' ' ' LEU . 97.9 mt -91.07 124.65 43.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.993 -0.549 . . . . 1.25 110.273 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -45.55 155.21 0.5 Allowed Glycine 0 CA--C 1.522 0.481 0 CA-C-N 115.981 -0.554 . . . . 0.48 113.469 -179.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -62.11 131.02 32.73 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.282 1.988 . . . . 0.67 111.466 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.467 ' O ' ' HA ' ' A' ' 9' ' ' LYS . 2.3 m120 47.92 35.32 4.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.073 0.463 . . . . 1.12 110.097 -178.432 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.452 ' HB3' HD11 ' A' ' 59' ' ' LEU . 11.3 mt-10 -115.6 135.39 54.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.044 -0.526 . . . . 1.73 110.904 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.525 ' O ' ' HB ' ' A' ' 60' ' ' ILE . 92.6 m -95.7 129.36 42.94 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.568 -0.53 . . . . 0.29 109.568 179.005 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.47 HD13 HG12 ' A' ' 118' ' ' ILE . 0.2 OUTLIER -117.45 150.48 38.84 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.168 0.509 . . . . 1.47 111.53 -178.593 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.536 ' N ' HD12 ' A' ' 125' ' ' ILE . 4.1 mp -113.48 140.56 33.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.567 -0.742 . . . . 0.2 110.08 179.076 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.413 ' CE1' HD22 ' A' ' 124' ' ' LEU . 74.9 m-85 -131.82 132.09 43.42 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.09 -0.505 . . . . 0.24 111.179 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -109.71 103.8 12.68 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.171 -0.677 . . . . 2.28 109.171 178.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 15.6 mt -102.81 122.58 55.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 112.634 0.605 . . . . 0.82 112.634 -177.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -118.26 100.09 7.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.243 -0.889 . . . . 0.26 108.74 178.076 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.6 ' HA ' HG12 ' A' ' 53' ' ' VAL . 0.8 OUTLIER -78.93 124.38 28.19 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.14 -0.482 . . . . 1.41 111.92 -178.047 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 35.3 mm -94.25 -50.52 11.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.642 -0.708 . . . . 1.17 110.09 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.463 ' HA ' ' HB1' ' A' ' 95' ' ' ALA . 51.9 p -164.5 165.12 21.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.922 -0.581 . . . . 1.17 110.244 179.302 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.65 HG22 HG12 ' A' ' 51' ' ' VAL . 96.8 t -130.72 117.86 40.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.803 0.335 . . . . 1.43 111.302 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 5.5 tmtp? 51.03 62.39 2.74 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.933 -0.576 . . . . 3.08 110.711 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 68.9 mttm 59.05 43.65 17.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.811 -0.631 . . . . 3.16 110.35 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 86.8 p 50.55 31.88 6.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.431 -0.804 . . . . 1.31 111.037 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 45.1 t . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.216 -0.897 . . . . 2.53 110.847 -179.873 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 62.7 tttp . . . . . 0 N--CA 1.455 -0.185 0 N-CA-C 109.622 -0.51 . . . . 2.63 109.622 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.485 ' HA ' ' ND2' ' A' ' 8' ' ' ASN . . . -57.65 -52.28 66.06 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.757 -0.656 . . . . 0.82 110.115 179.273 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -64.41 -36.15 83.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.784 -0.644 . . . . 2.57 109.484 178.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -55.68 -33.46 64.15 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.8 -0.815 . . . . 2.1 108.8 178.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.485 ' ND2' ' HA ' ' A' ' 5' ' ' ALA . 19.3 m-20 -69.1 -39.44 78.97 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 115.572 -0.74 . . . . 1.4 109.961 179.171 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -56.7 -32.4 65.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.709 -0.678 . . . . 2.67 111.037 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.8 t -78.03 -52.87 15.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.374 -0.375 . . . . 1.27 111.895 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.483 ' HG2' ' HA ' ' A' ' 8' ' ' ASN . 10.2 ptpp? -63.18 -26.06 68.63 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.895 0.379 . . . . 1.69 110.59 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.409 ' O ' ' HG ' ' A' ' 16' ' ' LEU . . . -75.76 -50.33 8.06 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.841 -0.695 . . . . 0.31 111.667 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.471 ' HA ' HD11 ' A' ' 16' ' ' LEU . 12.8 pt-20 -66.41 -27.56 67.94 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.873 0.368 . . . . 2.39 110.188 179.281 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.02 -34.19 61.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.096 -0.502 . . . . 0.23 110.491 179.299 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -63.75 -55.81 20.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.753 -0.658 . . . . 0.23 110.573 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.699 ' HA ' ' HB3' ' A' ' 19' ' ' ASN . 0.4 OUTLIER -64.16 -31.79 73.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.228 -0.442 . . . . 0.55 111.04 179.968 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.5 m -56.56 -47.65 79.01 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.607 -0.516 . . . . 0.27 109.607 179.316 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -73.61 -32.19 63.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.825 -0.625 . . . . 2.47 109.865 178.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.699 ' HB3' ' HA ' ' A' ' 16' ' ' LEU . 1.2 t-20 -59.09 -25.58 63.92 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.635 -0.711 . . . . 0.22 111.573 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -46.89 -20.21 0.13 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.536 -0.302 . . . . 2.45 111.605 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -68.67 -37.12 79.37 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.436 -0.347 . . . . 0.4 110.991 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.805 ' O ' HG23 ' A' ' 25' ' ' VAL . 4.3 mptp? -50.53 118.83 10.2 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.067 -0.515 . . . . 1.4 110.251 179.058 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 22' ' ' LYS . 18.1 Cg_endo -57.06 147.06 77.48 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.33 2.02 . . . . 0.65 112.649 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.02 3.46 79.58 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.869 -0.681 . . . . 0.37 113.967 179.079 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.805 HG23 ' O ' ' A' ' 22' ' ' LYS . 38.1 t -55.09 106.43 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 117.563 0.681 . . . . 0.91 110.681 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.4 HG13 ' CE1' ' A' ' 34' ' ' TYR . 2.6 p -130.76 126.73 60.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.868 -0.605 . . . . 1.03 111.133 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.8 p -80.16 142.47 13.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.05 -0.523 . . . . 0.91 110.77 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.578 HD12 ' HB2' ' A' ' 32' ' ' LEU . 63.0 mt -101.73 167.85 9.95 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.476 -0.329 . . . . 0.4 110.673 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.46 ' HD2' ' HB3' ' A' ' 28' ' ' LEU . 71.4 Cg_exo -51.49 -31.95 41.3 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 121.923 1.748 . . . . 0.59 111.742 178.695 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.476 ' O ' HD22 ' A' ' 107' ' ' LEU . 30.3 t -86.44 -11.21 52.49 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.231 -0.44 . . . . 1.14 110.87 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.04 14.91 23.43 Favored Glycine 0 C--N 1.335 0.474 0 C-N-CA 120.563 -0.827 . . . . 0.34 114.298 178.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.748 HD11 ' CA ' ' A' ' 85' ' ' GLY . 6.8 mp -84.33 134.65 34.49 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.364 0.876 . . . . 1.35 113.364 -178.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.6 mp0 -114.28 142.54 46.17 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.082 -1.081 . . . . 1.75 108.082 177.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.484 ' CB ' HG22 ' A' ' 101' ' ' ILE . 27.8 p90 -158.97 175.18 13.87 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 113.173 0.805 . . . . 0.32 113.173 -178.343 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -122.48 117.3 25.61 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 114.768 -1.105 . . . . 2.15 109.536 179.269 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 66.6 t -77.3 126.25 37.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 113.424 0.898 . . . . 0.3 113.424 -178.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.405 ' HB ' ' O ' ' A' ' 98' ' ' THR . 78.0 mt -101.3 -65.99 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 115.408 -0.815 . . . . 0.65 109.872 178.096 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -129.84 95.54 3.99 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 116.394 -0.366 . . . . 1.03 110.094 178.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.713 ' HB3' ' HE1' ' A' ' 99' ' ' TRP . 68.2 p -105.15 145.88 29.97 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.262 0.467 . . . . 1.5 112.262 -178.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.92 103.18 0.07 OUTLIER Glycine 0 C--N 1.332 0.36 0 CA-C-N 115.686 -0.688 . . . . 1.09 113.168 179.056 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -152.52 -82.56 0.09 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.691 0.282 . . . . 1.7 111.15 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.13 174.2 38.49 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 121.191 -0.528 . . . . 0.35 113.743 -179.088 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.619 ' O ' ' HB3' ' A' ' 44' ' ' LYS . 33.8 m -82.42 176.4 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 C-N-CA 123.401 0.68 . . . . 1.42 110.409 179.029 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.619 ' HB3' ' O ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER 165.1 156.54 0.08 OUTLIER Pre-proline 0 N--CA 1.471 0.591 0 CA-C-O 121.47 0.653 . . . . 2.18 112.33 -179.236 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.555 ' HD3' HG11 ' A' ' 133' ' ' VAL . 1.8 Cg_endo -85.36 173.47 7.63 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 125.082 3.854 . . . . 0.3 113.367 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' A' ' 48' ' ' SER . . . -68.28 -172.34 6.94 Favored Glycine 0 C--O 1.223 -0.572 0 CA-C-N 115.216 -0.902 . . . . 0.35 111.451 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -41.64 -13.48 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.763 1.023 . . . . 2.35 113.763 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 46' ' ' GLY . 50.5 m -86.16 7.51 24.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.46 0.647 . . . . 1.45 109.851 178.312 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.487 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 1.8 t70 -74.84 162.15 28.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.887 -1.051 . . . . 1.73 112.326 -179.04 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 90.3 m -125.56 133.85 52.16 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 108.752 -0.833 . . . . 0.44 108.752 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.636 HG12 HG22 ' A' ' 133' ' ' VAL . 30.1 m -131.74 140.37 48.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 112.807 0.669 . . . . 0.65 112.807 -178.331 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 89.4 m -112.98 119.86 39.39 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.083 -1.08 . . . . 0.32 108.083 177.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.568 HG12 ' HA ' ' A' ' 130' ' ' LEU . 5.0 m -146.4 -179.17 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.229 0.538 . . . . 0.24 111.943 -178.032 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -130.04 132.13 46.09 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.37 -0.832 . . . . 2.4 108.977 178.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -147.18 167.11 25.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.757 0.789 . . . . 0.26 112.412 -178.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 58.3 m -131.19 113.99 14.55 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.384 -1.28 . . . . 0.26 108.728 178.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.405 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -109.53 147.53 17.03 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 119.989 -1.1 . . . . 0.12 112.452 -178.681 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.34 145.93 31.4 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.046 0.451 . . . . 1.93 110.429 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.494 HD23 HD11 ' A' ' 124' ' ' LEU . 6.9 mt -79.9 153.39 29.04 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.688 -0.687 . . . . 1.21 110.255 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.497 ' HB ' ' O ' ' A' ' 123' ' ' THR . 0.4 OUTLIER -55.64 -14.35 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.401 0.619 . . . . 0.64 109.411 178.936 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -65.11 -10.87 34.07 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.266 -0.879 . . . . 2.01 110.93 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.02 0.03 75.14 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.547 -0.835 . . . . 0.45 113.837 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.0 t -121.64 131.53 54.15 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 117.646 0.723 . . . . 1.4 111.865 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 57' ' ' GLY . 3.9 p -61.68 134.35 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-N 115.709 -0.678 . . . . 0.28 110.049 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.69 ' HD1' ' H ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -97.66 -27.36 14.4 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.097 -0.501 . . . . 0.24 111.565 -179.882 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.69 ' H ' ' HD1' ' A' ' 65' ' ' PHE . 13.9 t70 -176.83 129.96 0.18 Allowed 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 120.619 0.247 . . . . 0.3 110.54 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 57.6 p -129.18 117.46 20.8 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.455 -0.339 . . . . 1.3 110.736 179.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 65.3 p -74.83 -12.35 60.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.065 0.459 . . . . 0.34 110.449 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -75.73 -46.91 28.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.632 -0.713 . . . . 2.11 111.25 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -71.18 -36.46 71.97 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.028 -0.533 . . . . 3.41 111.751 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 54.5 p -59.61 -12.62 7.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.788 0.327 . . . . 1.47 111.296 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 75.01 8.47 83.06 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.795 -0.717 . . . . 0.7 112.415 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -122.97 117.75 28.4 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.572 0.225 . . . . 3.05 110.875 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.09 153.18 16.54 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.667 2.245 . . . . 0.51 112.6 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -96.58 124.74 40.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.022 -0.535 . . . . 0.23 110.448 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.8 t -130.44 118.19 20.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.089 0.471 . . . . 1.26 111.297 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -158.54 161.82 37.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.022 -0.535 . . . . 0.36 111.108 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.66 146.5 30.01 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.12 -0.491 . . . . 1.58 109.965 179.143 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 87' ' ' THR . 20.0 m -66.54 -30.88 51.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 112.771 0.656 . . . . 1.07 112.771 -178.721 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.474 ' HA ' HG23 ' A' ' 87' ' ' THR . 46.8 t -95.76 -6.39 39.82 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 112.438 0.533 . . . . 1.14 112.438 -178.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -84.92 5.66 28.13 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 111.89 0.33 . . . . 2.08 111.89 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.408 HG21 ' HB3' ' A' ' 86' ' ' TRP . 3.7 m -110.41 -173.37 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 111.749 0.277 . . . . 0.45 111.749 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.464 HG13 ' H ' ' A' ' 86' ' ' TRP . 45.4 pt -56.03 156.43 10.25 Favored Pre-proline 0 CA--C 1.53 0.2 0 CA-C-N 116.428 -0.351 . . . . 0.75 111.631 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -46.07 -59.56 1.16 Allowed 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.858 2.372 . . . . 0.65 113.262 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.748 ' CA ' HD11 ' A' ' 32' ' ' LEU . . . -50.9 -49.46 41.87 Favored Glycine 0 CA--C 1.521 0.454 0 C-N-CA 120.858 -0.686 . . . . 0.31 113.114 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' TRP . . . . . 0.464 ' H ' HG13 ' A' ' 83' ' ' ILE . 0.3 OUTLIER -61.72 -38.51 88.17 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.915 0.339 . . . . 0.78 111.915 -178.955 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' ' 79' ' ' VAL . 50.6 m -61.02 -35.55 77.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.721 0.296 . . . . 1.4 111.35 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -70.38 -42.64 71.46 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.279 -0.418 . . . . 1.43 111.798 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.544 ' HB2' HD22 ' A' ' 32' ' ' LEU . . . -75.51 -51.99 11.68 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.429 0.529 . . . . 0.33 112.429 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -54.93 -39.35 68.76 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.432 0.53 . . . . 0.39 112.432 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -67.23 -9.59 41.95 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.667 0.27 . . . . 1.87 111.443 -179.255 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 83.2 mt -103.42 -7.88 20.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.433 -0.349 . . . . 1.31 111.019 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.402 ' HE2' ' HE3' ' A' ' 99' ' ' TRP . 68.0 mtt -85.95 110.07 27.61 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.315 -0.402 . . . . 1.66 111.641 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.534 ' HG2' ' HB3' ' A' ' 97' ' ' SER . 74.3 Cg_endo -74.67 147.28 35.22 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.35 2.033 . . . . 0.44 111.477 179.163 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.594 ' HA ' HD23 ' A' ' 130' ' ' LEU . . . -50.02 126.72 15.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.505 -0.316 . . . . 0.36 111.594 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 94.97 -8.84 70.43 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 120.717 -0.754 . . . . 0.34 113.148 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.534 ' HB3' ' HG2' ' A' ' 94' ' ' PRO . 98.4 p -70.57 -176.52 1.29 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.926 0.393 . . . . 1.41 111.417 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.405 ' O ' ' HB ' ' A' ' 37' ' ' ILE . 24.3 m -159.03 97.44 1.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.762 -0.654 . . . . 0.23 110.605 -179.415 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.713 ' HE1' ' HB3' ' A' ' 39' ' ' SER . 34.9 m0 -115.11 149.06 38.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.233 0.54 . . . . 0.53 111.717 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.424 ' O ' ' HB2' ' A' ' 34' ' ' TYR . 27.0 tt0 -115.16 107.23 15.04 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.827 -1.175 . . . . 1.37 107.827 177.357 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.484 HG22 ' CB ' ' A' ' 34' ' ' TYR . 13.8 pt -114.58 140.57 34.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 113.602 0.964 . . . . 0.25 113.602 -177.019 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -120.58 104.33 9.86 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.959 -1.126 . . . . 0.31 107.959 177.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.59 HG13 HD12 ' A' ' 107' ' ' LEU . 52.9 t -93.35 98.23 2.37 Favored Pre-proline 0 C--N 1.329 -0.284 0 N-CA-C 113.563 0.949 . . . . 0.52 113.563 -177.101 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.458 ' HD2' ' HA ' ' A' ' 103' ' ' VAL . 6.9 Cg_endo -53.08 150.94 22.69 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.267 1.978 . . . . 0.48 111.407 177.352 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.5 p -48.02 -43.36 29.94 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.293 0.479 . . . . 1.81 112.293 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -57.32 -9.14 4.14 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 115.384 0.914 . . . . 0.4 115.384 -177.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.59 HD12 HG13 ' A' ' 103' ' ' VAL . 46.3 mt -91.64 -19.27 22.86 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 118.244 1.022 . . . . 2.35 112.937 -178.267 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.429 ' HB2' HD12 ' A' ' 83' ' ' ILE . . . . . . . . 0 C--N 1.329 -0.31 0 C-N-CA 120.761 -0.376 . . . . 1.03 111.769 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_exo . . . . . 0 N--CA 1.465 -0.173 0 N-CA-C 111.093 -0.387 . . . . 0.7 111.093 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.59 HG23 HD12 ' A' ' 124' ' ' LEU . 94.8 mt -92.37 134.03 31.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.5 -0.773 . . . . 1.25 109.944 178.456 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -48.55 146.69 5.53 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.526 -0.845 . . . . 0.48 112.244 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -54.78 130.54 40.98 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.265 1.976 . . . . 0.67 111.861 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.3 m120 42.75 35.16 0.66 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.033 -0.531 . . . . 1.12 110.65 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.453 ' OE1' HD22 ' A' ' 59' ' ' LEU . 24.5 tt0 -116.54 142.86 46.33 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.826 -0.625 . . . . 1.73 111.074 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.54 HG21 HD23 ' A' ' 16' ' ' LEU . 92.7 m -95.66 129.53 42.83 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.548 -0.538 . . . . 0.29 109.548 178.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.59 HD12 HG23 ' A' ' 118' ' ' ILE . 0.1 OUTLIER -113.93 154.55 27.37 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.358 0.599 . . . . 1.47 112.279 -177.992 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.5 mp -113.92 140.75 32.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.174 -0.921 . . . . 0.2 109.585 178.076 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.457 ' CE1' HD22 ' A' ' 124' ' ' LEU . 82.2 m-85 -135.47 131.97 36.78 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.024 0.44 . . . . 0.24 111.445 -179.324 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.432 ' NZ ' ' HB3' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -114.4 102.8 10.44 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.189 -1.041 . . . . 2.28 108.189 177.87 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.441 HG23 HG21 ' A' ' 53' ' ' VAL . 12.2 mt -103.73 130.58 53.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 112.684 0.624 . . . . 0.82 112.684 -177.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -117.88 101.01 7.95 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.129 -0.941 . . . . 0.26 108.919 178.221 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.594 HD23 ' HA ' ' A' ' 95' ' ' ALA . 0.3 OUTLIER -78.5 123.29 26.9 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.119 0.485 . . . . 1.41 111.814 -178.274 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 58.6 mt -93.39 -53.13 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 115.518 -0.765 . . . . 1.17 110.92 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.469 ' HA ' ' HB1' ' A' ' 95' ' ' ALA . 60.7 p -164.53 165.57 21.12 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.055 0.455 . . . . 1.17 111.259 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.636 HG22 HG12 ' A' ' 51' ' ' VAL . 2.1 t -111.84 126.09 69.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.642 -0.708 . . . . 1.43 110.772 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 18.2 tttt 44.52 57.38 4.47 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.93 -0.577 . . . . 3.08 110.917 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm 60.85 34.5 19.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.572 -0.74 . . . . 3.16 111.336 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.439 ' HB2' ' HB2' ' A' ' 132' ' ' SER . 39.0 t 55.42 64.27 1.82 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.852 -0.613 . . . . 1.31 111.205 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 53.6 m . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.3 -0.857 . . . . 2.53 110.821 179.762 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 28.9 tptp . . . . . 0 CA--C 1.521 -0.146 0 N-CA-C 109.89 -0.411 . . . . 2.63 109.89 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.494 ' HB1' ' ND2' ' A' ' 121' ' ' ASN . . . -58.97 -52.43 65.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.875 -0.602 . . . . 0.82 110.127 179.347 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -63.96 -35.23 80.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.725 -0.671 . . . . 2.57 110.218 179.14 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -55.92 -32.58 63.9 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.334 -0.617 . . . . 2.1 109.334 178.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 13.7 m-20 -74.07 -37.46 64.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.445 -0.798 . . . . 1.4 110.826 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 52.6 tptt -63.9 -38.51 91.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 2.67 111.64 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.404 HG23 ' N ' ' A' ' 11' ' ' LYS . 16.1 m -71.58 -48.44 52.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 C-N-CA 121.189 -0.204 . . . . 1.27 111.514 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.497 ' HG3' HG21 ' A' ' 60' ' ' ILE . 18.1 ptpt -68.81 -25.71 64.82 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.835 0.35 . . . . 1.69 110.486 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.62 -53.26 8.63 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 121.066 -0.588 . . . . 0.31 112.143 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.412 ' HA ' HD11 ' A' ' 16' ' ' LEU . 43.8 tt0 -62.13 -27.89 69.25 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.096 0.474 . . . . 2.39 110.313 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.13 -30.63 49.43 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.951 -0.568 . . . . 0.23 110.423 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -65.94 -52.73 47.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.752 -0.658 . . . . 0.23 110.612 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.663 ' HA ' ' HB3' ' A' ' 19' ' ' ASN . 0.4 OUTLIER -67.62 -32.06 72.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.268 -0.424 . . . . 0.55 111.078 179.91 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.2 m -56.67 -47.58 79.5 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 109.748 -0.464 . . . . 0.27 109.748 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -73.05 -32.52 65.1 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.859 -0.61 . . . . 2.47 109.812 178.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.663 ' HB3' ' HA ' ' A' ' 16' ' ' LEU . 1.1 t-20 -59.46 -25.01 64.03 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.439 -0.8 . . . . 0.22 111.582 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -49.97 -20.35 0.91 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.518 -0.31 . . . . 2.45 111.722 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -68.96 -33.13 73.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.378 -0.374 . . . . 0.4 111.53 -178.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.663 ' O ' HG23 ' A' ' 25' ' ' VAL . 12.6 mptt -48.35 118.69 6.97 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 116.188 -0.46 . . . . 1.4 110.906 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.46 ' O ' ' HG2' ' A' ' 35' ' ' LYS . 32.1 Cg_exo -57.52 139.18 89.38 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.316 2.011 . . . . 0.65 112.651 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.83 3.39 80.27 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 120.863 -0.684 . . . . 0.37 114.025 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.663 HG23 ' O ' ' A' ' 22' ' ' LYS . 4.0 t -53.52 117.67 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.175 0 CA-C-N 117.425 0.613 . . . . 0.91 110.826 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 33' ' ' GLN . 4.3 p -129.87 128.16 64.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.064 -0.516 . . . . 1.03 111.061 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.3 p -85.69 141.97 13.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.459 . . . . 0.91 111.078 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.537 HD12 ' HB2' ' A' ' 32' ' ' LEU . 41.5 mt -104.1 165.34 13.57 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.011 -0.541 . . . . 0.4 110.609 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.45 ' HD2' ' HB3' ' A' ' 28' ' ' LEU . 72.2 Cg_exo -50.48 -38.34 53.64 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.179 1.919 . . . . 0.59 112.26 179.326 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.421 ' OG ' ' HG3' ' A' ' 88' ' ' GLU . 7.3 m -80.76 -9.59 59.79 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.2 -0.454 . . . . 1.14 111.368 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.3 14.52 27.99 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.331 -0.938 . . . . 0.34 113.48 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.537 ' HB2' HD12 ' A' ' 28' ' ' LEU . 0.4 OUTLIER -83.11 134.86 34.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.45 0.643 . . . . 1.35 112.168 -179.28 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.422 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 47.4 mt-30 -123.34 143.0 50.38 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.984 -1.007 . . . . 1.75 108.636 178.332 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.799 ' HB3' HG22 ' A' ' 101' ' ' ILE . 48.3 p90 -157.83 175.39 13.93 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.809 0.67 . . . . 0.32 112.809 -178.303 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.46 ' HG2' ' O ' ' A' ' 23' ' ' PRO . 3.5 tmmm? -122.2 118.94 29.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.001 -0.999 . . . . 2.15 109.321 178.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.646 HG13 ' HE1' ' A' ' 99' ' ' TRP . 48.5 t -71.93 125.61 30.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 113.279 0.844 . . . . 0.3 113.279 -177.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.3 mp -98.81 -66.24 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.319 -0.855 . . . . 0.65 110.11 178.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -144.89 90.51 2.06 Favored 'General case' 0 CA--C 1.527 0.062 0 CA-C-N 116.471 -0.332 . . . . 1.03 110.166 179.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.637 ' HB3' ' HE1' ' A' ' 99' ' ' TRP . 94.9 p -105.32 145.98 30.0 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.932 0.396 . . . . 1.5 112.006 -178.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 91.59 94.4 1.33 Allowed Glycine 0 C--N 1.332 0.352 0 CA-C-N 115.854 -0.612 . . . . 1.09 112.764 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -150.93 -81.89 0.1 Allowed 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 111.776 0.287 . . . . 1.7 111.776 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.09 178.53 42.01 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 121.088 -0.577 . . . . 0.35 114.161 -178.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.621 ' O ' ' HB3' ' A' ' 44' ' ' LYS . 27.3 m -90.32 176.89 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 123.729 0.812 . . . . 1.42 110.33 179.169 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.621 ' HB3' ' O ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER 165.08 156.6 0.08 OUTLIER Pre-proline 0 N--CA 1.472 0.668 0 CA-C-O 121.486 0.66 . . . . 2.18 112.172 -179.61 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.431 ' HD2' HG21 ' A' ' 133' ' ' VAL . 2.8 Cg_exo -77.72 173.52 14.0 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 124.752 3.634 . . . . 0.3 112.955 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.492 ' O ' ' N ' ' A' ' 48' ' ' SER . . . -67.54 -172.84 6.28 Favored Glycine 0 N--CA 1.448 -0.5 0 CA-C-N 115.368 -0.833 . . . . 0.35 111.037 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? -41.88 -13.88 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.707 1.003 . . . . 2.35 113.707 -177.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 46' ' ' GLY . 84.5 p -86.54 7.37 26.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.065 0.459 . . . . 1.45 110.522 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.411 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 4.0 p30 -72.08 156.14 39.52 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.71 -0.677 . . . . 1.73 111.993 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 26.0 m -126.67 119.72 27.69 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 108.481 -0.933 . . . . 0.44 108.481 178.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.471 HG12 ' HA ' ' A' ' 133' ' ' VAL . 14.3 m -128.67 158.4 41.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.222 0.534 . . . . 0.65 112.326 -178.233 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 94.2 m -113.78 120.8 42.05 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.337 -0.847 . . . . 0.32 109.115 178.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.693 HG11 HD22 ' A' ' 130' ' ' LEU . 6.1 m -139.4 170.11 16.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.137 0.494 . . . . 0.24 111.6 -178.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -124.05 132.31 53.66 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.375 -0.83 . . . . 2.4 109.128 178.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.408 ' HB2' ' O ' ' A' ' 127' ' ' LYS . 14.7 p90 -144.05 164.6 30.17 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.683 0.754 . . . . 0.26 112.491 -178.486 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 37.9 m -123.56 113.39 18.64 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.426 -1.261 . . . . 0.26 108.565 178.219 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.467 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -110.02 143.81 16.79 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 119.684 -1.246 . . . . 0.12 112.677 -178.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.466 ' NH2' ' HA2' ' A' ' 62' ' ' GLY . 0.5 OUTLIER -147.62 147.0 29.57 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.004 0.431 . . . . 1.93 110.589 179.552 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.48 HD22 ' OE1' ' A' ' 122' ' ' GLU . 3.8 mt -78.83 158.03 28.24 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.858 -0.61 . . . . 1.21 110.254 179.32 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.497 HG21 ' HG3' ' A' ' 11' ' ' LYS . 0.4 OUTLIER -58.16 -14.21 3.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 108.957 -0.757 . . . . 0.64 108.957 178.64 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -63.64 -12.48 34.05 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.14 -0.936 . . . . 2.01 110.837 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.466 ' HA2' ' NH2' ' A' ' 58' ' ' ARG . . . 91.15 -0.31 75.31 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 120.634 -0.793 . . . . 0.45 113.673 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.3 t -119.85 132.46 55.58 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 117.374 0.587 . . . . 1.4 111.507 -178.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 57' ' ' GLY . 6.2 p -61.18 134.7 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 115.807 -0.633 . . . . 0.28 109.906 179.187 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.646 ' HD1' ' H ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -97.5 -26.54 14.79 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.241 -0.436 . . . . 0.24 111.266 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.646 ' H ' ' HD1' ' A' ' 65' ' ' PHE . 16.3 t70 -176.33 129.98 0.21 Allowed 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 120.809 0.338 . . . . 0.3 111.085 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 62.4 m -123.79 123.89 41.48 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.235 -0.439 . . . . 1.3 110.452 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.871 HG21 ' HB2' ' A' ' 75' ' ' ALA . 33.7 p -70.56 -8.41 51.2 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.94 0.4 . . . . 0.34 110.652 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -75.39 -46.85 30.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.861 -0.609 . . . . 2.11 110.794 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -61.94 -38.7 89.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.981 -0.554 . . . . 3.41 111.304 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 14.2 m -60.73 -13.54 15.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.143 0.496 . . . . 1.47 110.182 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 73.8 3.54 63.92 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.69 -0.687 . . . . 0.7 112.351 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -127.21 124.68 23.85 Favored Pre-proline 0 C--N 1.33 -0.262 0 C-N-CA 121.325 -0.15 . . . . 3.05 111.071 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -53.75 162.68 3.45 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.284 1.989 . . . . 0.51 111.517 179.194 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.871 ' HB2' HG21 ' A' ' 68' ' ' THR . . . -93.94 124.31 37.86 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.446 -0.343 . . . . 0.23 110.812 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 27.5 m -123.87 116.22 22.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.751 0.31 . . . . 1.26 111.079 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -158.72 159.46 35.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 0.36 111.34 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.445 ' HB3' ' HG2' ' A' ' 81' ' ' GLN . 0.0 OUTLIER -81.48 143.74 31.85 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 108.983 -0.747 . . . . 1.58 108.983 178.317 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.8 m -70.83 -14.4 17.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 113.008 0.744 . . . . 1.07 113.008 -178.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 66.0 m -95.49 -19.18 20.05 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.197 0.443 . . . . 1.14 112.197 -179.191 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.445 ' HG2' ' HB3' ' A' ' 78' ' ' GLN . 78.2 mm-40 -79.62 6.26 11.06 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.412 0.523 . . . . 2.08 112.412 -179.028 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.4 m -111.25 -175.7 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 112.685 0.624 . . . . 0.45 112.685 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.488 HD12 HD12 ' A' ' 107' ' ' LEU . 42.4 pt -56.12 160.45 4.75 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 115.836 -0.62 . . . . 0.75 112.595 -179.112 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.637 ' O ' HG22 ' A' ' 87' ' ' THR . 78.1 Cg_exo -47.86 -60.75 0.76 Allowed 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 123.102 2.535 . . . . 0.65 114.204 -178.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 1.004 ' H ' HD11 ' A' ' 107' ' ' LEU . . . -53.17 -48.3 59.28 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.759 -0.734 . . . . 0.31 113.386 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' TRP . . . . . 0.4 ' HB2' HG13 ' A' ' 83' ' ' ILE . 0.9 OUTLIER -54.81 -47.95 73.38 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.798 0.666 . . . . 0.78 112.798 -178.567 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.637 HG22 ' O ' ' A' ' 84' ' ' PRO . 11.6 t -62.68 -33.87 75.97 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.713 -0.395 . . . . 1.4 111.779 -179.012 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.486 ' O ' ' HG2' ' A' ' 91' ' ' GLN . 18.3 mm-40 -70.79 -40.85 72.3 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.924 0.342 . . . . 1.43 111.924 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.84 -49.45 17.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.871 0.367 . . . . 0.33 111.585 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.559 HD13 ' SD ' ' A' ' 93' ' ' MET . 3.5 mm? -55.87 -41.33 74.24 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.888 -0.596 . . . . 0.39 112.06 -179.303 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.486 ' HG2' ' O ' ' A' ' 88' ' ' GLU . 13.6 pt20 -65.41 -3.76 4.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.635 -0.257 . . . . 1.87 111.636 -179.301 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 94.7 mt -104.97 -29.61 10.35 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.713 0.264 . . . . 1.31 111.713 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.559 ' SD ' HD13 ' A' ' 90' ' ' LEU . 24.0 ptp -81.91 111.05 23.5 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-O 120.615 0.245 . . . . 1.66 111.537 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.87 147.18 61.59 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.227 1.952 . . . . 0.44 111.45 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.58 ' HB1' ' HA ' ' A' ' 132' ' ' SER . . . -46.35 127.15 8.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.469 -0.332 . . . . 0.36 111.115 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 103.56 -7.61 50.6 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.896 -0.669 . . . . 0.34 112.717 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 66.4 m -79.94 -175.47 4.96 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.845 0.355 . . . . 1.41 111.39 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 14.1 m -156.75 104.09 2.12 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.032 -0.531 . . . . 0.23 111.083 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.646 ' HE1' HG13 ' A' ' 36' ' ' VAL . 30.5 m0 -125.15 149.23 48.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.252 -0.431 . . . . 0.53 111.058 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.417 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 12.6 pt-20 -119.05 108.52 14.82 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.556 -0.905 . . . . 1.37 108.556 177.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.799 HG22 ' HB3' ' A' ' 34' ' ' TYR . 37.3 pt -108.17 139.67 29.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 112.963 0.727 . . . . 0.25 112.963 -177.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.416 ' OH ' HG22 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -113.95 103.91 11.63 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.783 -1.192 . . . . 0.31 107.783 177.886 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.492 HG11 HD12 ' A' ' 107' ' ' LEU . 40.7 t -94.57 102.04 7.98 Favored Pre-proline 0 C--N 1.329 -0.296 0 N-CA-C 113.78 1.03 . . . . 0.52 113.78 -176.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.46 ' HA ' HG23 ' A' ' 123' ' ' THR . 9.3 Cg_endo -56.07 149.89 50.75 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.192 1.928 . . . . 0.48 111.085 177.181 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.4 p -49.11 -43.26 41.23 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.247 0.462 . . . . 1.81 112.247 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -56.24 -8.42 2.45 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 115.19 0.836 . . . . 0.4 115.19 -177.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 1.004 HD11 ' H ' ' A' ' 85' ' ' GLY . 1.1 tm? -82.25 -31.75 30.02 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 117.863 0.831 . . . . 2.35 112.748 -178.432 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.439 ' HB2' ' HB ' ' A' ' 83' ' ' ILE . . . . . . . . 0 C--N 1.326 -0.451 0 C-N-CA 120.375 -0.53 . . . . 1.03 112.382 -178.242 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo . . . . . 0 C--O 1.231 0.17 0 CA-C-O 120.876 0.282 . . . . 0.7 112.019 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.497 HG23 HD12 ' A' ' 124' ' ' LEU . 92.6 mt -91.45 135.66 26.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.069 -0.514 . . . . 1.25 110.322 179.025 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -46.97 148.3 2.88 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.748 -0.739 . . . . 0.48 112.087 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -56.05 130.03 38.09 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.119 1.88 . . . . 0.67 111.986 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.494 ' ND2' ' HB1' ' A' ' 5' ' ' ALA . 2.3 m-20 41.49 35.45 0.45 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.792 -0.64 . . . . 1.12 110.878 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.48 ' OE1' HD22 ' A' ' 59' ' ' LEU . 20.9 tt0 -116.89 145.86 43.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.881 -0.6 . . . . 1.73 111.258 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.468 ' O ' ' HB ' ' A' ' 60' ' ' ILE . 90.6 m -95.2 134.04 38.39 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.646 -0.501 . . . . 0.29 109.646 179.004 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.497 HD12 HG23 ' A' ' 118' ' ' ILE . 0.1 OUTLIER -120.55 156.54 31.36 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.342 0.592 . . . . 1.47 112.46 -178.249 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.406 HD12 ' N ' ' A' ' 125' ' ' ILE . 4.4 mp -113.85 148.17 16.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.128 -0.942 . . . . 0.2 109.467 178.128 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.459 ' CE1' HD22 ' A' ' 124' ' ' LEU . 81.2 m-85 -139.96 132.28 28.34 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.166 0.508 . . . . 0.24 111.761 -179.087 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.408 ' O ' ' HB2' ' A' ' 55' ' ' TYR . 2.2 tmtp? -110.91 104.04 12.6 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.575 -0.898 . . . . 2.28 108.575 178.447 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.534 ' N ' HD12 ' A' ' 128' ' ' ILE . 4.1 mp -102.12 127.19 55.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.377 0.608 . . . . 0.82 112.582 -177.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -118.38 99.97 7.18 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.036 -0.984 . . . . 0.26 108.492 177.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.693 HD22 HG11 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -77.94 120.95 23.52 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.122 -0.49 . . . . 1.41 111.135 -178.39 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 49.7 mm -94.9 -56.22 5.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.852 -0.613 . . . . 1.17 110.946 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.58 ' HA ' ' HB1' ' A' ' 95' ' ' ALA . 89.8 p -163.4 164.66 24.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.003 0.43 . . . . 1.17 111.351 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.471 ' HA ' HG12 ' A' ' 51' ' ' VAL . 7.1 p -107.93 127.24 64.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.904 -0.589 . . . . 1.43 111.054 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 12.8 tttp 45.34 -149.22 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.255 -0.43 . . . . 3.08 110.785 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -64.65 -5.4 5.6 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.226 -0.443 . . . . 3.16 110.979 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 32.9 t 65.42 82.6 0.18 Allowed 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.935 -0.575 . . . . 1.31 110.953 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 81.6 p . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.17 -0.919 . . . . 2.53 111.387 179.885 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp . . . . . 0 N--CA 1.455 -0.213 0 CA-C-O 120.791 0.329 . . . . 2.63 110.464 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -56.58 -51.94 66.7 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 116.145 -0.479 . . . . 0.82 110.386 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -67.59 -33.37 74.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.837 -0.62 . . . . 2.57 110.226 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.421 ' O ' ' HG2' ' A' ' 11' ' ' LYS . 41.3 tt0 -55.58 -33.53 64.0 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 109.096 -0.705 . . . . 2.1 109.096 178.479 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.496 ' HA ' ' HE2' ' A' ' 11' ' ' LYS . 10.1 m-20 -75.54 -38.42 59.31 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.371 -0.831 . . . . 1.4 110.286 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -56.24 -38.82 71.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.75 -0.659 . . . . 2.67 111.605 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.43 HG23 ' N ' ' A' ' 11' ' ' LYS . 18.6 m -78.33 -49.81 20.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 112.639 0.607 . . . . 1.27 112.639 -178.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.496 ' HE2' ' HA ' ' A' ' 8' ' ' ASN . 61.1 pttt -66.94 -26.25 66.75 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 120.861 -0.336 . . . . 1.69 111.445 -179.279 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.42 ' O ' ' HG ' ' A' ' 16' ' ' LEU . . . -76.41 -53.43 5.56 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.734 -0.746 . . . . 0.31 112.313 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.421 ' HA ' HD11 ' A' ' 16' ' ' LEU . 20.4 tp10 -61.86 -28.21 69.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.096 0.474 . . . . 2.39 110.604 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.3 -36.46 46.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.839 -0.619 . . . . 0.23 110.747 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -59.82 -53.71 54.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.076 -0.511 . . . . 0.23 110.617 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.684 ' HA ' ' HB3' ' A' ' 19' ' ' ASN . 0.4 OUTLIER -66.59 -33.77 76.4 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.737 -0.385 . . . . 0.55 111.101 -179.784 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.1 m -57.43 -45.96 84.08 Favored 'General case' 0 N--CA 1.456 -0.125 0 N-CA-C 109.622 -0.51 . . . . 0.27 109.622 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -74.35 -32.38 62.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.91 -0.586 . . . . 2.47 109.9 178.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.684 ' HB3' ' HA ' ' A' ' 16' ' ' LEU . 0.6 OUTLIER -57.58 -26.46 61.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.514 -0.767 . . . . 0.22 111.497 -179.822 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -49.19 -19.2 0.43 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.169 -0.469 . . . . 2.45 111.824 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -68.46 -31.87 71.47 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.192 0.441 . . . . 0.4 112.192 -178.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.643 ' O ' HG23 ' A' ' 25' ' ' VAL . 27.2 mmtm -52.97 119.21 15.66 Favored Pre-proline 0 CA--C 1.531 0.237 0 C-N-CA 121.322 -0.151 . . . . 1.4 110.619 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -57.86 143.64 95.34 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.189 1.926 . . . . 0.65 112.278 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.75 2.94 81.08 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.858 -0.687 . . . . 0.37 113.705 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 22' ' ' LYS . 5.9 t -59.73 120.86 6.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 117.167 0.483 . . . . 0.91 110.481 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.3 p -130.17 133.32 64.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 1.03 111.204 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.5 p -92.37 137.04 23.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.145 -0.479 . . . . 0.91 110.745 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.474 ' HB2' ' HB2' ' A' ' 32' ' ' LEU . 35.1 mt -100.94 162.94 19.05 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 0.4 110.751 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -53.26 -30.72 52.82 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.176 1.917 . . . . 0.59 112.309 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.531 ' O ' HD12 ' A' ' 107' ' ' LEU . 30.9 t -84.32 -10.08 57.91 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.175 -0.466 . . . . 1.14 111.551 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.27 15.49 25.48 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.367 -0.92 . . . . 0.34 112.595 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.506 HD21 ' HA2' ' A' ' 85' ' ' GLY . 2.6 mm? -80.86 133.54 35.6 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.222 0.535 . . . . 1.35 112.05 -178.4 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -126.07 138.27 53.69 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.329 -0.85 . . . . 1.75 109.175 178.13 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.751 ' HB3' HG22 ' A' ' 101' ' ' ILE . 38.6 p90 -160.84 174.81 13.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.269 0.557 . . . . 0.32 112.361 -178.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -121.71 117.51 26.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.198 -0.91 . . . . 2.15 109.3 178.38 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.472 HG13 ' HE1' ' A' ' 99' ' ' TRP . 86.9 t -72.56 125.53 31.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 113.081 0.771 . . . . 0.3 113.081 -178.202 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.411 HD12 HG22 ' A' ' 98' ' ' THR . 64.6 mt -102.3 -64.2 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.387 -0.824 . . . . 0.65 110.125 178.187 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.405 ' O ' ' HA ' ' A' ' 97' ' ' SER . 28.5 t-20 -139.46 89.49 2.34 Favored 'General case' 0 CA--C 1.528 0.099 0 CA-C-N 116.37 -0.377 . . . . 1.03 110.192 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.796 ' HB2' ' HE1' ' A' ' 99' ' ' TRP . 31.9 t -105.37 146.2 29.75 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 112.334 0.494 . . . . 1.5 112.334 -178.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 87.31 95.65 0.9 Allowed Glycine 0 C--N 1.332 0.341 0 CA-C-N 115.684 -0.689 . . . . 1.09 112.936 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -150.72 -83.65 0.09 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 111.675 0.25 . . . . 1.7 111.675 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.51 178.01 41.05 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 121.061 -0.59 . . . . 0.35 114.285 -178.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.742 HG22 ' H ' ' A' ' 44' ' ' LYS . 9.3 p -90.68 178.38 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 123.666 0.786 . . . . 1.42 109.688 178.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.742 ' H ' HG22 ' A' ' 43' ' ' VAL . 12.6 pttm 165.95 157.66 0.1 OUTLIER Pre-proline 0 N--CA 1.47 0.55 0 CA-C-O 121.482 0.658 . . . . 2.18 112.628 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.672 ' HD3' HG21 ' A' ' 133' ' ' VAL . 1.3 Cg_endo -85.03 173.79 7.75 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 125.061 3.841 . . . . 0.3 113.767 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.462 ' O ' ' N ' ' A' ' 48' ' ' SER . . . -68.05 -171.66 6.22 Favored Glycine 0 C--O 1.221 -0.714 0 CA-C-N 114.984 -1.007 . . . . 0.35 111.741 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -41.22 -15.74 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.875 1.065 . . . . 2.35 113.875 -177.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.462 ' N ' ' O ' ' A' ' 46' ' ' GLY . 51.0 m -85.89 7.83 22.58 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.522 0.677 . . . . 1.45 109.677 178.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.579 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 0.0 OUTLIER -69.33 151.03 46.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.796 -1.093 . . . . 1.73 112.329 -179.073 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 48.4 m -126.86 119.74 27.52 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.71 -0.677 . . . . 0.44 109.257 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.609 HG12 ' HA ' ' A' ' 133' ' ' VAL . 34.9 m -133.24 154.98 40.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.26 0.553 . . . . 0.65 112.24 -178.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 90.3 m -111.12 121.24 44.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.339 -0.846 . . . . 0.32 109.148 178.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.514 HG12 ' HA ' ' A' ' 130' ' ' LEU . 4.2 m -141.28 -179.62 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.06 0.457 . . . . 0.24 111.833 -178.586 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -135.11 133.06 38.84 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.635 -0.712 . . . . 2.4 109.384 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -143.63 158.38 43.71 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.731 0.777 . . . . 0.26 112.124 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 63.2 m -125.37 113.26 17.32 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.353 -1.294 . . . . 0.26 108.582 178.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.468 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -109.69 145.15 16.85 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 119.914 -1.136 . . . . 0.12 112.756 -178.447 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.543 HH11 HD13 ' A' ' 125' ' ' ILE . 0.1 OUTLIER -148.07 146.48 28.86 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 120.891 0.377 . . . . 1.93 110.193 179.325 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.453 ' HA ' ' HG ' ' A' ' 124' ' ' LEU . 5.7 mt -76.27 156.64 33.29 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.989 -0.55 . . . . 1.21 109.744 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.475 HG21 ' HG3' ' A' ' 11' ' ' LYS . 0.4 OUTLIER -58.09 -11.17 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.199 -0.667 . . . . 0.64 109.199 179.021 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.41 ' N ' ' C ' ' A' ' 59' ' ' LEU . 19.5 t70 -65.0 -11.58 40.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.357 -0.838 . . . . 2.01 110.722 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.47 ' HA2' ' NH2' ' A' ' 58' ' ' ARG . . . 90.81 -0.72 77.08 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.544 -0.836 . . . . 0.45 113.511 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 40.7 p -118.94 128.36 54.35 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 117.277 0.538 . . . . 1.4 111.381 -178.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 57' ' ' GLY . 6.5 p -60.71 134.9 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 115.936 -0.574 . . . . 0.28 109.807 179.334 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.642 ' HD1' ' N ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -97.31 -26.24 14.97 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.185 -0.462 . . . . 0.24 110.888 -179.554 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.642 ' N ' ' HD1' ' A' ' 65' ' ' PHE . 21.4 t70 -177.29 134.46 0.18 Allowed 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.438 -0.346 . . . . 0.3 110.744 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 40.4 t -131.14 122.58 26.89 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.322 -0.399 . . . . 1.3 110.451 179.001 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.641 HG21 ' HB2' ' A' ' 75' ' ' ALA . 47.9 p -71.62 -17.88 62.24 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.007 0.432 . . . . 0.34 110.382 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -75.14 -45.58 39.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.916 -0.583 . . . . 2.11 110.508 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -62.55 -41.74 99.09 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.861 -0.609 . . . . 3.41 111.114 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 21.6 m -58.38 -17.63 21.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.315 -0.402 . . . . 1.47 110.662 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.42 3.61 88.43 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.821 -0.704 . . . . 0.7 112.46 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.455 ' NZ ' ' HB3' ' A' ' 73' ' ' LYS . 8.6 mtpm? -126.38 117.68 23.22 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.347 0.118 . . . . 3.05 111.039 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.43 163.38 3.67 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.476 2.117 . . . . 0.51 112.228 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.641 ' HB2' HG21 ' A' ' 68' ' ' THR . . . -96.33 124.72 40.43 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.207 -0.451 . . . . 0.23 110.511 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 61.8 m -124.79 111.44 15.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.922 0.391 . . . . 1.26 111.262 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -158.5 163.29 37.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.894 -0.594 . . . . 0.36 110.564 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.685 ' HG3' ' HB2' ' A' ' 81' ' ' GLN . 10.6 pt20 -89.7 147.49 23.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.385 0.612 . . . . 1.58 109.989 178.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 27.5 m -57.61 -23.36 19.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 N-CA-C 114.039 1.125 . . . . 1.07 114.039 -177.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 91.8 p -95.35 -2.55 48.94 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.515 0.561 . . . . 1.14 112.515 -178.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.685 ' HB2' ' HG3' ' A' ' 78' ' ' GLN . 40.0 tt0 -83.22 5.32 23.33 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.751 0.278 . . . . 2.08 111.751 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -112.87 -178.86 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.912 0.386 . . . . 0.45 111.977 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.629 HG13 ' H ' ' A' ' 86' ' ' TRP . 25.6 pt -56.1 154.46 15.02 Favored Pre-proline 0 C--O 1.231 0.102 0 CA-C-N 115.951 -0.568 . . . . 0.75 111.741 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -47.81 -44.67 26.32 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.483 2.122 . . . . 0.65 112.414 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.506 ' HA2' HD21 ' A' ' 32' ' ' LEU . . . -61.19 -49.26 79.95 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 120.622 -0.799 . . . . 0.31 113.024 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' TRP . . . . . 0.629 ' H ' HG13 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -63.03 -53.1 59.18 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.894 0.331 . . . . 0.78 111.894 -178.985 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.0 t -53.93 -34.23 59.02 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.006 0.373 . . . . 1.4 112.006 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.486 ' HG3' ' HB2' ' A' ' 30' ' ' SER . 0.6 OUTLIER -66.09 -51.09 61.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.6 -0.273 . . . . 1.43 111.076 -179.829 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.409 ' HB2' ' HG ' ' A' ' 32' ' ' LEU . . . -65.07 -44.41 89.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.512 -0.313 . . . . 0.33 111.549 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -57.42 -29.85 64.49 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.252 -0.431 . . . . 0.39 111.354 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -62.24 -23.67 66.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.271 -0.422 . . . . 1.87 111.233 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.425 HD12 ' N ' ' A' ' 92' ' ' LEU . 8.3 mp -93.2 -7.66 44.62 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.153 0.427 . . . . 1.31 112.153 -178.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 2.9 ttm -92.21 107.81 26.01 Favored Pre-proline 0 C--N 1.33 -0.253 0 C-N-CA 120.99 -0.284 . . . . 1.66 111.512 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.419 ' HA ' ' HD3' ' A' ' 44' ' ' LYS . 69.6 Cg_endo -75.19 146.77 32.39 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.232 1.954 . . . . 0.44 110.496 178.561 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.56 ' HA ' HD13 ' A' ' 130' ' ' LEU . . . -45.81 124.96 5.67 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.917 -0.313 . . . . 0.36 111.363 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 102.38 -9.49 55.97 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 120.518 -0.848 . . . . 0.34 113.328 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.405 ' HA ' ' O ' ' A' ' 38' ' ' ASN . 31.2 t -72.74 175.0 6.85 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 117.005 0.403 . . . . 1.41 111.193 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.411 HG22 HD12 ' A' ' 37' ' ' ILE . 18.3 m -146.46 96.35 2.75 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.94 -0.573 . . . . 0.23 110.473 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.796 ' HE1' ' HB2' ' A' ' 39' ' ' SER . 30.8 m0 -119.57 149.79 41.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.192 0.52 . . . . 0.53 111.961 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.437 ' HB3' ' HD3' ' A' ' 127' ' ' LYS . 8.9 pt-20 -119.46 107.99 14.0 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.966 -1.124 . . . . 1.37 107.966 177.373 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.751 HG22 ' HB3' ' A' ' 34' ' ' TYR . 41.8 pt -108.14 142.75 20.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 113.53 0.937 . . . . 0.25 113.53 -177.435 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -123.45 103.63 8.58 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.498 -1.228 . . . . 0.31 108.228 177.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.415 ' HA ' ' HD2' ' A' ' 104' ' ' PRO . 2.2 t -107.55 96.89 17.63 Favored Pre-proline 0 C--N 1.329 -0.307 0 N-CA-C 113.219 0.822 . . . . 0.52 113.219 -176.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.552 ' HG2' HD23 ' A' ' 107' ' ' LEU . 9.5 Cg_endo -54.5 149.68 37.84 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 121.861 1.708 . . . . 0.48 110.484 177.244 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.5 p -48.63 -27.8 3.07 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.873 0.694 . . . . 1.81 112.873 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -60.22 -10.46 15.76 Favored Glycine 0 CA--C 1.521 0.441 0 C-N-CA 120.799 -0.715 . . . . 0.4 113.754 -179.031 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.552 HD23 ' HG2' ' A' ' 104' ' ' PRO . 3.0 mm? -114.66 -0.94 13.45 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.242 0.46 . . . . 2.35 112.242 -178.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.487 ' HB2' HD12 ' A' ' 83' ' ' ILE . . . . . . . . 0 C--N 1.327 -0.399 0 N-CA-C 110.34 -0.244 . . . . 1.03 110.34 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo . . . . . 0 N--CA 1.464 -0.22 0 N-CA-C 110.83 -0.489 . . . . 0.7 110.83 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.568 HG23 HD12 ' A' ' 124' ' ' LEU . 93.2 mt -90.09 135.57 26.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.311 -0.859 . . . . 1.25 110.031 179.054 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -42.88 152.0 0.3 Allowed Glycine 0 CA--C 1.52 0.386 0 C-N-CA 121.247 -0.501 . . . . 0.48 113.101 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -60.33 130.88 35.78 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.436 2.091 . . . . 0.67 111.71 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.5 m120 43.73 34.89 0.92 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.161 -0.472 . . . . 1.12 110.081 -178.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -115.72 136.37 53.13 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.914 -0.584 . . . . 1.73 111.495 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.474 HG21 HD23 ' A' ' 16' ' ' LEU . 96.7 m -95.53 134.08 38.81 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.02 -0.733 . . . . 0.29 109.02 178.34 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.568 HD12 HG23 ' A' ' 118' ' ' ILE . 0.1 OUTLIER -121.5 154.79 36.16 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.31 0.576 . . . . 1.47 112.413 -178.085 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.543 HD13 HH11 ' A' ' 58' ' ' ARG . 4.4 mp -113.81 141.22 30.62 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 CA-C-N 115.237 -0.892 . . . . 0.2 109.387 178.307 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.437 ' CE1' HD22 ' A' ' 124' ' ' LEU . 80.9 m-85 -133.83 132.06 39.97 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.173 0.511 . . . . 0.24 111.809 -179.078 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.437 ' HD3' ' HB3' ' A' ' 100' ' ' GLU . 42.6 mmtm -107.21 103.55 12.95 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.811 -0.811 . . . . 2.28 108.811 178.278 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 36.2 mt -102.68 119.03 50.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.047 0.451 . . . . 0.82 112.075 -178.177 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -114.99 99.97 7.85 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.655 -0.702 . . . . 0.26 109.327 178.543 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.56 HD13 ' HA ' ' A' ' 95' ' ' ALA . 0.6 OUTLIER -79.31 123.28 27.31 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.002 -0.545 . . . . 1.41 111.06 -178.838 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 48.3 mm -93.43 -56.77 4.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.067 -0.515 . . . . 1.17 111.012 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.484 ' HA ' ' HB1' ' A' ' 95' ' ' ALA . 13.6 m -163.45 165.23 24.03 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.976 0.417 . . . . 1.17 111.622 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.844 HG22 ' HG2' ' A' ' 134' ' ' LYS . 2.7 p -107.93 129.92 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 115.734 -0.666 . . . . 1.43 110.441 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.844 ' HG2' HG22 ' A' ' 133' ' ' VAL . 17.3 ptmt 34.55 55.25 0.67 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.036 0.446 . . . . 3.08 111.316 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm 61.62 42.94 10.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.764 -0.653 . . . . 3.16 110.929 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 43.5 t 52.5 61.14 3.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.78 -0.646 . . . . 1.31 110.993 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 71.2 m . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.2 -0.905 . . . . 2.53 111.139 -179.689 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 61.0 tttm . . . . . 0 N--CA 1.455 -0.179 0 CA-C-O 120.877 0.37 . . . . 2.63 110.116 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.72 -52.52 62.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.739 -0.664 . . . . 0.82 110.179 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.408 ' O ' HG23 ' A' ' 10' ' ' VAL . 20.9 m-20 -67.4 -36.3 81.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.62 -0.718 . . . . 2.57 110.293 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -55.76 -32.99 63.91 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 109.335 -0.617 . . . . 2.1 109.335 178.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.565 ' HA ' ' HE2' ' A' ' 11' ' ' LYS . 21.4 m-20 -72.78 -38.84 67.14 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.494 -0.775 . . . . 1.4 110.471 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 8.3 tmtm? -59.8 -31.45 69.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.097 -0.501 . . . . 2.67 111.353 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 6' ' ' ASP . 11.8 t -77.81 -53.48 14.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 111.895 0.331 . . . . 1.27 111.895 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.565 ' HE2' ' HA ' ' A' ' 8' ' ' ASN . 58.9 pttt -66.1 -27.21 67.89 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.943 0.401 . . . . 1.69 110.523 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.95 -45.07 12.51 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.789 -0.72 . . . . 0.31 111.8 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.435 ' OE2' HD11 ' A' ' 16' ' ' LEU . 16.2 tp10 -68.07 -34.4 76.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.697 0.284 . . . . 2.39 110.767 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.47 -42.46 64.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.23 111.342 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -58.38 -56.28 24.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.541 -0.299 . . . . 0.23 110.496 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.549 ' HA ' ' HB3' ' A' ' 19' ' ' ASN . 4.1 pp -60.01 -33.06 71.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.262 -0.426 . . . . 0.55 110.482 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.8 m -58.09 -48.56 79.81 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.989 -0.551 . . . . 0.27 110.204 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -73.69 -32.01 63.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.934 -0.575 . . . . 2.47 110.034 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.582 ' ND2' ' HD2' ' A' ' 22' ' ' LYS . 0.9 OUTLIER -53.69 -32.45 51.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.408 -0.815 . . . . 0.22 111.478 179.934 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -44.02 -20.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.996 -0.547 . . . . 2.45 112.332 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -68.49 -33.05 73.46 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.983 0.364 . . . . 0.4 111.983 -178.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.582 ' HD2' ' ND2' ' A' ' 19' ' ' ASN . 67.3 mttm -54.14 119.11 18.12 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.686 -0.234 . . . . 1.4 110.988 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.46 142.73 95.33 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.449 2.099 . . . . 0.65 112.258 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.14 -1.63 86.56 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.769 -0.729 . . . . 0.37 113.249 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' A' ' 34' ' ' TYR . 3.7 p -61.26 110.53 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 121.21 0.529 . . . . 0.91 110.58 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.0 p -130.04 130.94 66.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.838 -0.619 . . . . 1.03 111.508 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 9.7 p -82.89 138.38 19.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.91 110.861 179.155 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.53 HD12 ' HB2' ' A' ' 32' ' ' LEU . 55.3 mt -96.22 167.45 12.37 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.255 -0.429 . . . . 0.4 110.704 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.48 ' HD2' ' HB3' ' A' ' 28' ' ' LEU . 75.0 Cg_exo -51.06 -30.97 33.36 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.129 1.886 . . . . 0.59 112.265 179.414 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.479 ' HB2' HD23 ' A' ' 32' ' ' LEU . 31.9 m -89.25 -9.41 50.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.265 -0.425 . . . . 1.14 111.782 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.58 15.68 22.15 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.388 -0.91 . . . . 0.34 113.627 178.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.691 HD21 ' HA2' ' A' ' 85' ' ' GLY . 2.7 mm? -83.02 134.27 35.05 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.008 0.432 . . . . 1.35 111.92 -179.089 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -125.23 139.02 54.09 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.282 -0.636 . . . . 1.75 109.282 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.803 ' HB3' HG22 ' A' ' 101' ' ' ILE . 28.8 p90 -151.17 175.72 11.88 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.788 0.662 . . . . 0.32 112.788 -178.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -121.09 117.06 26.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.226 -0.897 . . . . 2.15 109.175 178.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.5 t -72.66 126.66 33.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 113.299 0.852 . . . . 0.3 113.299 -177.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.462 HD12 HG22 ' A' ' 98' ' ' THR . 76.8 mt -107.42 -66.75 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 115.401 -0.818 . . . . 0.65 110.131 178.58 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -142.59 82.86 1.79 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.19 -0.459 . . . . 1.03 110.157 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.417 ' OG ' ' NE1' ' A' ' 99' ' ' TRP . 17.8 m -106.03 146.38 30.18 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 112.515 0.561 . . . . 1.5 112.515 -178.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 92.43 83.65 1.5 Allowed Glycine 0 C--N 1.334 0.455 0 CA-C-N 115.755 -0.657 . . . . 1.09 113.038 178.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -150.61 -72.77 0.17 Allowed 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 111.681 0.252 . . . . 1.7 111.681 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.12 172.29 36.45 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 121.072 -0.585 . . . . 0.35 114.298 -178.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.598 HG12 ' H ' ' A' ' 44' ' ' LYS . 2.0 t -90.47 175.99 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 123.474 0.71 . . . . 1.42 110.022 179.069 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.598 ' H ' HG12 ' A' ' 43' ' ' VAL . 2.1 pptp? 164.96 156.53 0.07 OUTLIER Pre-proline 0 N--CA 1.472 0.657 0 CA-C-O 121.503 0.668 . . . . 2.18 112.028 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.471 ' HD2' ' HB2' ' A' ' 49' ' ' ASP . 1.2 Cg_endo -83.84 172.54 9.88 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 124.823 3.682 . . . . 0.3 113.692 -179.396 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 48' ' ' SER . . . -67.98 -172.93 6.92 Favored Glycine 0 C--O 1.223 -0.565 0 CA-C-N 115.096 -0.956 . . . . 0.35 111.237 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -41.63 -13.98 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.825 1.046 . . . . 2.35 113.825 -177.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.487 ' N ' ' O ' ' A' ' 46' ' ' GLY . 55.6 m -86.32 7.24 26.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.268 0.556 . . . . 1.45 110.092 178.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.471 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 3.0 p30 -74.79 166.23 23.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.267 -0.879 . . . . 1.73 111.676 -179.206 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 91.7 m -126.07 121.26 32.43 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 108.691 -0.855 . . . . 0.44 108.691 178.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.819 HG12 HG22 ' A' ' 133' ' ' VAL . 6.4 m -122.92 142.63 38.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 112.97 0.73 . . . . 0.65 112.97 -177.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 39.3 m -115.35 119.79 37.45 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.067 -1.086 . . . . 0.32 108.067 177.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.62 HG12 ' HA ' ' A' ' 130' ' ' LEU . 2.7 m -146.34 178.78 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.26 0.552 . . . . 0.24 111.961 -177.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -128.78 132.45 47.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.291 -0.868 . . . . 2.4 109.107 178.478 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -146.13 159.28 43.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.584 0.707 . . . . 0.26 112.345 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 57.0 m -121.84 112.89 18.9 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.483 -1.235 . . . . 0.26 108.223 178.192 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.473 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -110.66 143.54 17.02 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 119.664 -1.255 . . . . 0.12 113.236 -178.113 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.543 ' O ' HD13 ' A' ' 124' ' ' LEU . 0.1 OUTLIER -148.43 145.61 28.07 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.566 -0.317 . . . . 1.93 110.176 179.266 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.538 HD23 HD11 ' A' ' 124' ' ' LEU . 2.3 mt -74.9 154.02 38.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.978 -0.555 . . . . 1.21 110.586 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.482 ' HB ' ' O ' ' A' ' 123' ' ' THR . 0.4 OUTLIER -56.55 -11.94 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.362 0.601 . . . . 0.64 109.621 179.001 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.402 ' N ' ' C ' ' A' ' 59' ' ' LEU . 21.4 t70 -71.11 -10.01 59.03 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.434 -0.803 . . . . 2.01 110.816 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.7 0.18 75.92 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.597 -0.811 . . . . 0.45 113.629 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 61.4 p -113.3 121.43 44.38 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 117.339 0.57 . . . . 1.4 111.724 -178.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 57' ' ' GLY . 5.9 p -60.61 132.4 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-N 115.889 -0.596 . . . . 0.28 109.819 179.02 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.701 ' HD1' ' H ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -97.79 -28.07 14.03 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.333 -0.394 . . . . 0.24 111.908 -179.4 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.701 ' H ' ' HD1' ' A' ' 65' ' ' PHE . 15.1 t70 -177.64 131.49 0.16 Allowed 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.606 0.241 . . . . 0.3 110.821 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.6 m -131.41 116.84 18.05 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.879 0.371 . . . . 1.3 110.487 178.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.544 HG21 ' HB2' ' A' ' 75' ' ' ALA . 80.4 p -74.84 -29.59 61.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.478 . . . . 0.34 111.323 -179.351 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -70.18 -39.45 75.26 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.199 -0.455 . . . . 2.11 110.654 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -71.02 -37.95 72.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.226 -0.443 . . . . 3.41 111.042 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 33.8 m -57.11 -22.75 42.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.233 -0.44 . . . . 1.47 110.794 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 95.21 2.15 62.33 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.869 -0.681 . . . . 0.7 112.618 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.449 ' HB2' ' NZ ' ' A' ' 73' ' ' LYS . 3.6 ttmp? -126.35 118.03 23.28 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.638 0.219 . . . . 3.05 111.111 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -52.65 150.25 22.39 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.62 2.213 . . . . 0.51 112.125 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.544 ' HB2' HG21 ' A' ' 68' ' ' THR . . . -94.73 125.02 39.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.39 -0.368 . . . . 0.23 110.811 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.7 t -123.85 113.97 19.24 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.952 0.406 . . . . 1.26 111.428 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -159.03 154.65 26.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.021 -0.536 . . . . 0.36 111.121 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.427 ' OE1' ' HB3' ' A' ' 80' ' ' SER . 3.2 pt20 -84.5 148.84 26.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.35 0.595 . . . . 1.58 109.871 178.487 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.4 ' CG1' ' HB3' ' A' ' 90' ' ' LEU . 2.5 m -68.79 -25.78 31.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 113.925 1.084 . . . . 1.07 113.925 -177.227 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.427 ' HB3' ' OE1' ' A' ' 78' ' ' GLN . 37.7 t -86.17 -2.35 58.27 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.616 0.599 . . . . 1.14 112.616 -178.504 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.422 ' HB2' ' HG3' ' A' ' 78' ' ' GLN . 43.5 tt0 -95.33 5.56 51.35 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.274 0.472 . . . . 2.08 112.274 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 1.7 m -113.63 -173.17 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 112.334 0.494 . . . . 0.45 112.334 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.593 HG13 ' H ' ' A' ' 86' ' ' TRP . 42.2 pt -56.14 158.95 6.52 Favored Pre-proline 0 CA--C 1.53 0.201 0 CA-C-N 115.906 -0.588 . . . . 0.75 112.268 -179.127 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.435 ' O ' HG22 ' A' ' 87' ' ' THR . 75.3 Cg_exo -51.38 -47.37 26.36 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.894 2.396 . . . . 0.65 113.043 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.691 ' HA2' HD21 ' A' ' 32' ' ' LEU . . . -59.85 -48.66 84.97 Favored Glycine 0 CA--C 1.521 0.407 0 C-N-CA 120.524 -0.846 . . . . 0.31 112.953 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' TRP . . . . . 0.593 ' H ' HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -64.06 -44.72 91.56 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.651 0.611 . . . . 0.78 112.651 -178.695 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.435 HG22 ' O ' ' A' ' 84' ' ' PRO . 10.0 t -60.25 -37.14 79.46 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.072 0.397 . . . . 1.4 112.072 -178.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.446 ' O ' ' HG2' ' A' ' 91' ' ' GLN . 10.3 tp10 -70.75 -40.2 72.85 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.008 0.373 . . . . 1.43 112.008 -179.434 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.495 ' HB2' ' HG ' ' A' ' 32' ' ' LEU . . . -76.09 -52.46 10.11 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.013 0.375 . . . . 0.33 112.013 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.691 HD11 HD13 ' A' ' 128' ' ' ILE . 4.6 mm? -57.38 -34.69 69.11 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.778 0.658 . . . . 0.39 112.778 -178.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.446 ' HG2' ' O ' ' A' ' 88' ' ' GLU . 18.1 pt20 -65.55 -4.79 6.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.635 0.255 . . . . 1.87 111.653 -179.169 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 82.6 mt -108.22 -7.85 15.89 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.564 -0.289 . . . . 1.31 111.207 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.553 ' HE3' ' N ' ' A' ' 99' ' ' TRP . 13.8 ttt -78.08 112.93 28.97 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.417 -0.356 . . . . 1.66 111.102 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.532 ' HA ' ' HG2' ' A' ' 44' ' ' LYS . 4.5 Cg_exo -77.04 142.37 21.85 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.761 2.307 . . . . 0.44 111.84 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.484 ' HB1' ' HA ' ' A' ' 132' ' ' SER . . . -50.41 128.28 19.46 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.372 -0.377 . . . . 0.36 111.499 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 92.25 2.27 68.56 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.689 -0.767 . . . . 0.34 113.292 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 19.8 m -92.85 -179.72 5.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.094 0.473 . . . . 1.41 111.776 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.462 HG22 HD12 ' A' ' 37' ' ' ILE . 3.9 m -144.63 120.4 10.55 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.658 -0.701 . . . . 0.23 110.084 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.553 ' N ' ' HE3' ' A' ' 93' ' ' MET . 4.9 m0 -132.36 150.65 52.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.23 0.538 . . . . 0.53 112.264 -178.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -122.46 106.85 11.4 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.715 -1.217 . . . . 1.37 107.715 177.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.803 HG22 ' HB3' ' A' ' 34' ' ' TYR . 41.0 pt -109.44 139.28 33.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 112.923 0.712 . . . . 0.25 112.923 -177.384 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -122.72 103.33 8.59 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.826 -1.079 . . . . 0.31 108.214 178.012 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.402 HG12 ' HB2' ' A' ' 107' ' ' LEU . 2.7 t -107.3 97.08 17.49 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 112.501 0.556 . . . . 0.52 112.501 -177.51 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.634 ' HA ' ' HA ' ' A' ' 123' ' ' THR . 9.9 Cg_endo -54.12 149.06 37.28 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 121.621 1.547 . . . . 0.48 110.528 177.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.3 m -48.15 -29.49 3.72 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.489 0.551 . . . . 1.81 112.489 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -56.64 -9.79 3.87 Favored Glycine 0 CA--C 1.521 0.444 0 C-N-CA 121.016 -0.611 . . . . 0.4 113.992 -178.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.488 HD23 ' HG2' ' A' ' 104' ' ' PRO . 3.4 mm? -110.6 1.98 18.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 117.251 0.526 . . . . 2.35 111.897 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.472 ' HB2' HD12 ' A' ' 83' ' ' ILE . . . . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.715 -0.22 . . . . 1.03 111.586 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.504 ' HB2' HD12 ' A' ' 118' ' ' ILE . 49.6 Cg_exo . . . . . 0 C--O 1.231 0.144 0 CA-C-O 120.995 0.331 . . . . 0.7 111.453 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.539 HG23 HD23 ' A' ' 124' ' ' LEU . 4.0 mp -92.53 135.65 26.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.753 -0.658 . . . . 1.25 110.212 178.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -42.64 149.53 0.46 Allowed Glycine 0 C--N 1.335 0.493 0 C-N-CA 120.917 -0.658 . . . . 0.48 112.489 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -55.73 131.31 45.31 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.263 1.976 . . . . 0.67 112.282 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.3 m120 42.99 37.68 1.2 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.311 -0.404 . . . . 1.12 110.862 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.462 ' OE1' HD22 ' A' ' 59' ' ' LEU . 30.8 tt0 -114.09 144.28 43.4 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.012 -0.54 . . . . 1.73 111.957 -179.03 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.634 ' HA ' ' HA ' ' A' ' 104' ' ' PRO . 70.0 m -97.0 129.3 44.49 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.369 -0.604 . . . . 0.29 109.369 178.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.543 HD13 ' O ' ' A' ' 58' ' ' ARG . 1.4 mm? -115.53 152.43 33.02 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.121 0.486 . . . . 1.47 111.838 -178.543 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.423 ' N ' HD12 ' A' ' 125' ' ' ILE . 4.8 mp -114.3 136.36 51.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.557 -0.747 . . . . 0.2 110.02 178.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -133.53 131.7 40.07 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.275 -0.42 . . . . 0.24 111.397 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -108.43 102.38 11.49 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.862 -1.162 . . . . 2.28 107.862 177.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.691 HD13 HD11 ' A' ' 90' ' ' LEU . 18.2 mt -102.83 126.56 57.03 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 CA-C-O 121.238 0.542 . . . . 0.82 112.148 -177.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' HIS . . . . . 0.469 ' O ' ' HB ' ' A' ' 53' ' ' VAL . 1.3 t-160 -118.56 98.37 6.21 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.227 -0.897 . . . . 0.26 109.297 178.278 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.62 ' HA ' HG12 ' A' ' 53' ' ' VAL . 17.3 tp -80.25 113.61 18.54 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.187 -0.46 . . . . 1.41 111.113 -178.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 34.3 mm -81.98 -50.29 16.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.786 -0.643 . . . . 1.17 110.782 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.484 ' HA ' ' HB1' ' A' ' 95' ' ' ALA . 5.3 m -163.4 165.22 24.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 1.17 110.358 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.819 HG22 HG12 ' A' ' 51' ' ' VAL . 91.7 t -129.16 135.77 61.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.01 -0.541 . . . . 1.43 110.589 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.56 ' HE2' ' HB2' ' A' ' 137' ' ' SER . 21.4 ptmt 40.74 49.8 2.87 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.878 -0.601 . . . . 3.08 111.277 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt 63.77 41.21 7.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.345 -0.843 . . . . 3.16 111.507 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 33.9 t 48.03 32.61 2.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.71 -0.677 . . . . 1.31 111.477 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.56 ' HB2' ' HE2' ' A' ' 134' ' ' LYS . 69.8 m . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.213 -0.898 . . . . 2.53 110.894 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 76.2 t80 . . . . . 0 N--CA 1.485 1.276 0 CA-C-O 120.791 0.329 . . . . 3.09 110.806 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -70.11 -20.54 63.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.228 -0.442 . . . . 2.08 110.976 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -57.51 -39.73 77.14 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.622 -0.51 . . . . 3.23 109.622 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -79.43 -36.12 39.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.685 -0.689 . . . . 2.63 110.222 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -57.79 -52.04 67.09 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.101 -0.499 . . . . 0.82 110.145 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -66.64 -34.39 77.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.864 -0.607 . . . . 2.57 109.936 178.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -55.79 -32.61 63.64 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.089 -0.708 . . . . 2.1 109.089 178.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.517 ' HA ' ' HG2' ' A' ' 11' ' ' LYS . 41.5 m-20 -75.7 -38.37 58.71 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.201 -0.909 . . . . 1.4 110.509 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -56.39 -39.6 73.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.878 -0.601 . . . . 2.67 111.571 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.402 HG23 ' N ' ' A' ' 11' ' ' LYS . 16.2 m -78.33 -47.83 23.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 112.604 0.594 . . . . 1.27 112.604 -178.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.53 ' HE2' HG13 ' A' ' 60' ' ' ILE . 22.1 ptmt -63.55 -33.99 76.81 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.602 0.223 . . . . 1.69 111.602 -179.196 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.86 -52.98 5.54 Favored Glycine 0 C--N 1.33 0.231 0 C-N-CA 120.75 -0.738 . . . . 0.31 112.461 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -57.66 -26.27 61.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.969 0.414 . . . . 2.39 110.346 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.17 -40.67 37.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.814 -0.63 . . . . 0.23 110.529 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -58.69 -48.92 79.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.076 -0.511 . . . . 0.23 110.278 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.562 ' HA ' ' HB3' ' A' ' 19' ' ' ASN . 4.2 pp -67.0 -34.52 77.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.32 -0.4 . . . . 0.55 110.714 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.43 ' N ' HD12 ' A' ' 16' ' ' LEU . 18.5 m -57.72 -49.65 75.85 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.246 -0.434 . . . . 0.27 110.209 179.481 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -73.72 -32.01 63.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.86 -0.609 . . . . 2.47 110.074 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.562 ' HB3' ' HA ' ' A' ' 16' ' ' LEU . 1.3 t-20 -54.29 -33.14 58.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.467 -0.788 . . . . 0.22 111.521 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -46.66 -19.75 0.1 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.041 -0.527 . . . . 2.45 112.163 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -68.03 -33.52 74.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.638 -0.256 . . . . 0.4 111.594 -178.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.758 ' O ' HG23 ' A' ' 25' ' ' VAL . 67.7 mttm -52.05 119.03 13.32 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.551 -0.295 . . . . 1.4 110.511 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -57.73 146.41 85.51 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.231 1.954 . . . . 0.65 112.222 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.05 3.16 79.87 Favored Glycine 0 CA--C 1.522 0.471 0 C-N-CA 120.869 -0.682 . . . . 0.37 114.16 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.758 HG23 ' O ' ' A' ' 22' ' ' LYS . 35.6 t -56.8 110.71 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 117.65 0.725 . . . . 0.91 110.435 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.9 p -126.12 127.58 71.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.898 -0.592 . . . . 1.03 111.126 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.1 p -83.09 143.08 12.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.073 -0.512 . . . . 0.91 111.021 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.505 ' HB3' ' HD2' ' A' ' 29' ' ' PRO . 69.3 mt -103.86 168.56 8.46 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.102 -0.499 . . . . 0.4 110.806 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.505 ' HD2' ' HB3' ' A' ' 28' ' ' LEU . 78.4 Cg_exo -51.48 -33.45 47.39 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 121.943 1.762 . . . . 0.59 111.754 178.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.5 m -84.49 -11.95 55.16 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.046 -0.524 . . . . 1.14 111.195 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.04 14.16 27.25 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.507 -0.854 . . . . 0.34 114.258 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.633 HD22 ' HB2' ' A' ' 89' ' ' ALA . 6.5 mp -83.08 134.77 35.0 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.068 0.766 . . . . 1.35 113.068 -178.349 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -116.6 143.65 45.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.191 -0.913 . . . . 1.75 108.542 177.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.495 ' HB3' HG22 ' A' ' 101' ' ' ILE . 30.7 p90 -160.27 175.56 12.72 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.37 0.507 . . . . 0.32 112.37 -178.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -120.54 116.86 26.21 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.38 -0.827 . . . . 2.15 109.331 178.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.6 t -78.1 125.34 37.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 113.475 0.917 . . . . 0.3 113.475 -177.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 63.3 mt -101.21 -60.83 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.289 -0.869 . . . . 0.65 109.109 177.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -134.77 100.06 4.5 Favored 'General case' 0 CA--C 1.527 0.072 0 CA-C-N 115.799 -0.637 . . . . 1.03 109.673 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.617 ' HB3' ' HE1' ' A' ' 99' ' ' TRP . 59.9 p -103.18 145.62 29.66 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.113 0.482 . . . . 1.5 112.161 -178.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 94.82 -126.54 8.76 Favored Glycine 0 C--N 1.333 0.384 0 CA-C-N 115.599 -0.728 . . . . 1.09 113.146 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 12.2 m120 70.08 -83.07 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.559 0.577 . . . . 1.7 112.559 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.11 167.36 30.37 Favored Glycine 0 CA--C 1.521 0.429 0 N-CA-C 115.289 0.875 . . . . 0.35 115.289 -177.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.644 HG12 ' H ' ' A' ' 44' ' ' LYS . 2.5 t -91.81 176.88 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 114.365 -0.917 . . . . 1.42 109.592 178.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.737 ' HG2' ' HA ' ' A' ' 94' ' ' PRO . 0.0 OUTLIER 165.46 157.64 0.09 OUTLIER Pre-proline 0 N--CA 1.475 0.781 0 CA-C-O 121.357 0.599 . . . . 2.18 112.35 -179.878 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.563 ' HD2' ' HB2' ' A' ' 49' ' ' ASP . 1.2 Cg_endo -84.65 173.35 8.47 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 125.076 3.851 . . . . 0.3 113.882 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 48' ' ' SER . . . -67.99 -171.97 6.34 Favored Glycine 0 C--O 1.222 -0.625 0 CA-C-N 114.947 -1.024 . . . . 0.35 111.664 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.509 ' O ' HG13 ' A' ' 79' ' ' VAL . 23.0 pttm -41.33 -13.46 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 113.921 1.082 . . . . 2.35 113.921 -177.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.487 ' N ' ' O ' ' A' ' 46' ' ' GLY . 80.9 p -86.25 7.52 24.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.549 0.69 . . . . 1.45 109.364 177.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.563 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 0.0 OUTLIER -71.79 149.17 45.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.666 -1.152 . . . . 1.73 112.183 -179.255 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 58.8 m -126.67 119.39 26.88 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 109.055 -0.72 . . . . 0.44 109.055 178.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.515 HG12 ' HA ' ' A' ' 133' ' ' VAL . 33.1 m -132.45 156.28 42.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 112.671 0.619 . . . . 0.65 112.671 -178.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 96.6 m -111.93 121.14 44.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.06 -0.973 . . . . 0.32 108.973 178.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.512 HG12 ' HA ' ' A' ' 130' ' ' LEU . 2.6 m -142.57 -179.66 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.328 0.585 . . . . 0.24 112.012 -178.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.496 ' HB3' ' HG2' ' A' ' 69' ' ' GLU . 28.6 mt-10 -131.38 132.75 44.64 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.267 -0.879 . . . . 2.4 109.426 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -143.82 158.11 43.91 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.793 0.806 . . . . 0.26 112.229 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 82.5 m -126.0 113.63 17.39 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.133 -1.394 . . . . 0.26 108.532 178.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.459 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -108.93 147.26 16.72 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 119.78 -1.2 . . . . 0.12 112.72 -178.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.01 147.45 32.64 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.852 0.358 . . . . 1.93 110.199 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.477 HD23 HD21 ' A' ' 124' ' ' LEU . 13.2 mt -84.95 157.78 20.72 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.003 -0.544 . . . . 1.21 110.233 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.53 HG13 ' HE2' ' A' ' 11' ' ' LYS . 10.2 tp -57.16 -10.93 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.347 0.594 . . . . 0.64 109.709 178.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.412 ' N ' ' C ' ' A' ' 59' ' ' LEU . 24.7 t70 -67.4 -11.53 57.98 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.373 -0.83 . . . . 2.01 111.007 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.13 -0.34 75.41 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.483 -0.865 . . . . 0.45 113.578 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.3 t -122.89 138.93 54.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 117.37 0.585 . . . . 1.4 111.712 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 57' ' ' GLY . 7.5 p -62.99 133.99 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 115.825 -0.625 . . . . 0.28 110.064 179.284 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.636 ' HD1' ' H ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -97.99 -25.61 14.91 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.067 -0.515 . . . . 0.24 111.147 -179.848 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.636 ' H ' ' HD1' ' A' ' 65' ' ' PHE . 19.1 t70 -176.51 131.17 0.21 Allowed 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 120.733 0.302 . . . . 0.3 110.889 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 70.8 p -128.35 126.52 40.87 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.293 -0.412 . . . . 1.3 110.531 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.443 HG21 ' HB2' ' A' ' 75' ' ' ALA . 81.1 p -81.83 -21.59 37.53 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.767 0.318 . . . . 0.34 111.235 -179.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.496 ' HG2' ' HB3' ' A' ' 54' ' ' GLU . 41.2 mt-10 -75.08 -47.76 27.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.284 -0.416 . . . . 2.11 111.226 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm -63.01 -36.87 84.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.43 . . . . 3.41 111.166 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 41.6 m -59.07 -22.89 61.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.312 -0.404 . . . . 1.47 110.719 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 92.05 4.75 66.61 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.808 -0.711 . . . . 0.7 112.355 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -126.5 116.95 22.98 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.454 0.127 . . . . 3.05 110.771 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.46 159.01 11.5 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.139 1.893 . . . . 0.51 111.923 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.443 ' HB2' HG21 ' A' ' 68' ' ' THR . . . -94.78 124.62 38.92 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.355 -0.384 . . . . 0.23 110.475 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 48.4 m -127.44 111.95 14.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.838 0.352 . . . . 1.26 111.446 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -158.67 163.78 36.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.091 -0.504 . . . . 0.36 110.904 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.572 ' HG3' ' HB2' ' A' ' 81' ' ' GLN . 6.1 pt20 -95.28 148.33 22.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.379 0.609 . . . . 1.58 110.503 178.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.533 ' HB ' ' HB3' ' A' ' 90' ' ' LEU . 0.6 OUTLIER -59.29 -28.38 39.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 114.93 -1.032 . . . . 1.07 113.262 -178.431 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 46.7 t -85.44 -2.42 58.09 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.78 0.659 . . . . 1.14 112.78 -178.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.572 ' HB2' ' HG3' ' A' ' 78' ' ' GLN . 5.3 tp-100 -96.93 5.85 49.74 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.534 0.568 . . . . 2.08 112.534 -179.162 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.6 m -112.77 -178.15 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 N-CA-C 112.361 0.504 . . . . 0.45 112.361 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.518 ' O ' HG23 ' A' ' 87' ' ' THR . 28.1 pt -56.88 155.37 15.48 Favored Pre-proline 0 N--CA 1.464 0.273 0 CA-C-N 116.0 -0.546 . . . . 0.75 112.017 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -44.33 -60.43 0.81 Allowed 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.074 2.516 . . . . 0.65 113.597 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.632 ' CA ' HD11 ' A' ' 32' ' ' LEU . . . -49.12 -49.08 31.14 Favored Glycine 0 CA--C 1.522 0.529 0 C-N-CA 120.493 -0.86 . . . . 0.31 112.721 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' TRP . . . . . 0.462 ' HB2' HG13 ' A' ' 83' ' ' ILE . 0.7 OUTLIER -61.81 -43.87 97.99 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.248 0.462 . . . . 0.78 112.248 -179.003 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.518 HG23 ' O ' ' A' ' 83' ' ' ILE . 53.7 p -56.12 -34.49 66.11 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.7 0.286 . . . . 1.4 111.395 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -70.27 -51.46 30.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.404 -0.362 . . . . 1.43 111.835 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.633 ' HB2' HD22 ' A' ' 32' ' ' LEU . . . -65.78 -52.24 52.48 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 112.418 0.525 . . . . 0.33 112.418 -178.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.533 ' HB3' ' HB ' ' A' ' 79' ' ' VAL . 4.1 mm? -56.97 -26.91 60.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.424 -0.353 . . . . 0.39 111.615 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.449 ' HG3' ' N ' ' A' ' 47' ' ' LYS . 53.2 tt0 -67.7 -23.47 65.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.789 0.328 . . . . 1.87 111.182 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.436 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 88.8 mt -100.75 -8.04 23.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.298 -0.41 . . . . 1.31 111.526 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.525 ' SD ' HD13 ' A' ' 90' ' ' LEU . 62.1 mtt -76.41 110.78 12.37 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 116.748 -0.205 . . . . 1.66 111.281 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.737 ' HA ' ' HG2' ' A' ' 44' ' ' LYS . 67.4 Cg_endo -84.93 147.45 10.54 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.837 2.358 . . . . 0.44 112.771 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.555 ' HB1' ' HA ' ' A' ' 132' ' ' SER . . . -45.8 131.02 9.46 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.288 -0.415 . . . . 0.36 112.06 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 88.99 -11.94 67.65 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.845 -0.693 . . . . 0.34 113.613 179.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.496 ' HB3' ' HG2' ' A' ' 94' ' ' PRO . 96.6 p -67.75 -175.92 0.59 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.963 0.411 . . . . 1.41 111.284 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 17.6 m -161.54 97.75 1.1 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.899 -0.592 . . . . 0.23 110.81 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.617 ' HE1' ' HB3' ' A' ' 39' ' ' SER . 43.9 m0 -119.93 152.11 37.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.082 0.468 . . . . 0.53 111.563 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -122.25 108.27 13.09 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.459 -0.941 . . . . 1.37 108.459 177.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.495 HG22 ' HB3' ' A' ' 34' ' ' TYR . 31.5 pt -106.4 141.7 21.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 113.217 0.821 . . . . 0.25 113.217 -177.46 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.42 ' OH ' HG22 ' A' ' 25' ' ' VAL . 0.6 OUTLIER -125.53 103.97 8.16 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.578 -1.192 . . . . 0.31 108.368 178.309 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.405 ' HA ' ' HD2' ' A' ' 104' ' ' PRO . 4.1 t -106.2 110.79 64.24 Favored Pre-proline 0 C--N 1.33 -0.262 0 N-CA-C 113.114 0.783 . . . . 0.52 113.114 -177.182 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.575 ' HG2' HD13 ' A' ' 107' ' ' LEU . 17.7 Cg_endo -61.96 152.19 76.66 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.308 2.006 . . . . 0.48 111.131 177.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.43 ' HB2' ' N ' ' A' ' 111' ' ' PRO . 0.3 OUTLIER -47.12 -42.14 18.7 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.834 0.679 . . . . 1.81 112.834 -178.69 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.454 ' C ' HD12 ' A' ' 107' ' ' LEU . . . -57.4 -9.36 4.51 Favored Glycine 0 CA--C 1.521 0.452 0 C-N-CA 121.043 -0.598 . . . . 0.4 113.882 -178.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.575 HD13 ' HG2' ' A' ' 104' ' ' PRO . 9.2 mp -113.4 -7.71 13.46 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.138 0.422 . . . . 2.35 112.138 -178.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -109.93 -104.31 0.37 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.692 -0.231 . . . . 1.03 110.63 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -91.73 -13.93 30.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.991 0.424 . . . . 1.44 110.409 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 102.87 144.54 14.3 Favored Glycine 0 CA--C 1.523 0.533 0 CA-C-N 115.829 -0.623 . . . . 1.58 113.577 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.445 ' HA ' ' H ' ' A' ' 121' ' ' ASN . 17.3 Cg_endo -57.99 -7.05 3.11 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 123.702 2.935 . . . . 1.49 112.835 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.529 ' C ' ' H ' ' A' ' 114' ' ' VAL . 88.5 mtt180 -75.64 171.4 14.38 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.807 0.337 . . . . 3.51 110.365 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 54.5 m -63.25 14.24 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.138 -0.483 . . . . 1.63 112.22 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.529 ' H ' ' C ' ' A' ' 112' ' ' ARG . 2.9 t -103.28 19.28 3.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.117 0.484 . . . . 2.9 110.353 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -66.11 104.16 0.99 Allowed Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.801 -0.636 . . . . 1.05 112.426 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.98 -113.25 0.01 OUTLIER Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.977 -0.63 . . . . 0.8 112.479 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.7 -34.87 96.07 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.16 1.907 . . . . 0.7 111.51 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.693 HG23 HD13 ' A' ' 124' ' ' LEU . 57.4 mt -90.84 115.21 29.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.791 -0.64 . . . . 1.25 110.015 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -44.18 157.41 0.17 Allowed Glycine 0 C--N 1.334 0.463 0 CA-C-N 116.153 -0.476 . . . . 0.48 113.13 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -63.64 131.65 32.29 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.274 1.983 . . . . 0.67 111.643 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.445 ' H ' ' HA ' ' A' ' 111' ' ' PRO . 3.8 m-80 49.3 34.18 6.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.262 -0.426 . . . . 1.12 110.356 -178.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -116.29 129.17 56.13 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.203 -0.453 . . . . 1.73 111.358 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.51 ' O ' ' HB ' ' A' ' 60' ' ' ILE . 77.5 m -93.07 127.27 38.54 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.722 -0.844 . . . . 0.29 108.722 178.238 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.693 HD13 HG23 ' A' ' 118' ' ' ILE . 7.4 mp -115.22 157.84 23.14 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.27 0.557 . . . . 1.47 112.399 -178.011 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.432 ' N ' HD12 ' A' ' 125' ' ' ILE . 4.8 mp -114.86 139.35 41.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.255 -0.884 . . . . 0.2 109.502 178.162 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -131.13 131.79 44.36 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.099 0.476 . . . . 0.24 111.544 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.456 ' NZ ' ' HB3' ' A' ' 127' ' ' LYS . 3.3 mmmp? -110.45 103.78 12.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.514 -0.766 . . . . 2.28 109.18 178.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.4 mp -103.94 118.7 51.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.163 0.506 . . . . 0.82 112.242 -178.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -113.35 98.34 7.04 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.41 -0.959 . . . . 0.26 108.41 177.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.512 ' HA ' HG12 ' A' ' 53' ' ' VAL . 21.9 tp -82.74 123.18 29.07 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.552 -0.749 . . . . 1.41 111.683 -178.32 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 55.8 mt -89.81 -55.99 5.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.799 -0.637 . . . . 1.17 110.785 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.555 ' HA ' ' HB1' ' A' ' 95' ' ' ALA . 60.5 p -163.64 165.04 23.78 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.072 0.463 . . . . 1.17 111.628 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.515 ' HA ' HG12 ' A' ' 51' ' ' VAL . 2.5 p -108.95 131.53 59.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.715 -0.675 . . . . 1.43 111.418 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 5.8 tttp 34.37 64.96 0.35 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.012 -0.54 . . . . 3.08 111.574 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm 62.03 42.86 9.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.897 -0.592 . . . . 3.16 111.229 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 90.0 p 47.82 64.42 1.63 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.752 -0.658 . . . . 1.31 111.413 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 43.4 t . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.21 -0.9 . . . . 2.53 110.865 179.994 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.733 0.302 . . . . 3.09 110.96 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -66.37 -18.84 65.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 2.08 111.2 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -58.06 -41.13 82.67 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.592 -0.521 . . . . 3.23 109.592 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -79.83 -35.06 38.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.72 -0.673 . . . . 2.63 110.358 179.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -57.53 -51.42 69.53 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.085 -0.507 . . . . 0.82 110.265 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -67.22 -35.14 78.95 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.927 -0.579 . . . . 2.57 110.215 179.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -55.78 -32.47 63.49 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 109.386 -0.598 . . . . 2.1 109.386 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.568 ' HB3' ' HG2' ' A' ' 122' ' ' GLU . 19.0 m-20 -75.66 -39.13 58.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.491 -0.777 . . . . 1.4 110.38 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.423 ' O ' ' HD2' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -56.79 -40.84 76.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.9 -0.591 . . . . 2.67 111.331 179.816 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.431 HG23 ' N ' ' A' ' 11' ' ' LYS . 19.6 m -74.15 -48.23 38.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 112.169 0.433 . . . . 1.27 112.169 -179.134 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.53 ' HG2' ' HA ' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -64.07 -29.91 71.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.776 0.322 . . . . 1.69 111.029 -179.683 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.69 -48.33 8.99 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 121.051 -0.595 . . . . 0.31 112.176 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -59.01 -30.15 67.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.035 0.445 . . . . 2.39 110.377 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.88 -41.33 37.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.794 -0.639 . . . . 0.23 111.118 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -56.02 -52.71 63.26 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 120.768 0.318 . . . . 0.23 110.288 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.48 ' HA ' ' HB3' ' A' ' 19' ' ' ASN . 4.0 pp -63.71 -35.51 80.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.083 -0.508 . . . . 0.55 110.446 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.4 m -57.33 -48.53 78.72 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.066 -0.516 . . . . 0.27 110.343 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -73.22 -31.82 64.38 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.948 -0.569 . . . . 2.47 109.876 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.486 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 3.7 t-20 -56.03 -30.43 61.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.368 -0.833 . . . . 0.22 111.817 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -43.22 -19.99 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.244 0.461 . . . . 2.45 112.244 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -68.6 -34.03 75.08 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.462 0.542 . . . . 0.4 112.462 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.732 ' O ' HG23 ' A' ' 25' ' ' VAL . 38.3 mmtt -46.7 119.46 5.58 Favored Pre-proline 0 N--CA 1.463 0.198 0 CA-C-O 120.527 0.203 . . . . 1.4 110.899 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.445 ' HD2' ' HE2' ' A' ' 35' ' ' LYS . 40.5 Cg_exo -57.0 135.6 71.79 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.006 1.804 . . . . 0.65 112.049 179.44 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.31 3.24 78.92 Favored Glycine 0 CA--C 1.52 0.362 0 C-N-CA 120.755 -0.736 . . . . 0.37 113.949 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.732 HG23 ' O ' ' A' ' 22' ' ' LYS . 8.9 t -52.05 111.57 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 117.606 0.703 . . . . 0.91 110.218 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.438 HG13 ' CE1' ' A' ' 34' ' ' TYR . 2.1 p -127.46 133.69 67.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.891 -0.595 . . . . 1.03 111.078 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.424 HG23 ' NE2' ' A' ' 33' ' ' GLN . 7.6 p -85.77 141.91 13.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.953 -0.567 . . . . 0.91 110.968 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.597 HD12 ' HB2' ' A' ' 32' ' ' LEU . 64.5 mt -99.66 166.61 12.53 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.4 110.782 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.44 ' HD2' ' HB3' ' A' ' 28' ' ' LEU . 52.4 Cg_exo -53.14 -30.57 50.95 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 121.908 1.739 . . . . 0.59 111.513 178.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 39.8 t -86.02 -12.74 49.48 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.014 -0.539 . . . . 1.14 111.031 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.05 14.42 24.64 Favored Glycine 0 C--N 1.334 0.436 0 C-N-CA 120.464 -0.874 . . . . 0.34 114.313 178.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.68 HD11 ' HA2' ' A' ' 85' ' ' GLY . 6.6 mp -85.11 139.26 31.85 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.098 0.777 . . . . 1.35 113.098 -179.24 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.424 ' NE2' HG23 ' A' ' 27' ' ' VAL . 26.5 mp0 -116.01 144.18 44.45 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.918 -1.037 . . . . 1.75 108.438 177.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.586 ' HB3' HG22 ' A' ' 101' ' ' ILE . 15.5 p90 -160.29 175.37 12.93 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.898 0.703 . . . . 0.32 112.898 -178.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.445 ' HE2' ' HD2' ' A' ' 23' ' ' PRO . 24.5 tttm -121.93 116.77 24.96 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.006 -0.997 . . . . 2.15 109.413 178.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.497 HG13 ' HE1' ' A' ' 99' ' ' TRP . 60.7 t -77.87 126.17 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 113.188 0.81 . . . . 0.3 113.188 -178.229 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.422 HD12 HG22 ' A' ' 98' ' ' THR . 83.5 mt -101.9 -65.69 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.562 -0.745 . . . . 0.65 110.733 178.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -148.39 80.63 1.46 Allowed 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 120.845 0.355 . . . . 1.03 111.002 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.543 ' HB2' ' NE1' ' A' ' 99' ' ' TRP . 38.9 t -106.96 146.14 31.43 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.254 -0.43 . . . . 1.5 111.968 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 99.27 100.38 2.25 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.834 -0.698 . . . . 1.09 113.135 178.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -177.93 -57.39 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 120.671 0.272 . . . . 1.7 111.617 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.27 165.47 31.45 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.833 -0.699 . . . . 0.35 114.073 -178.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.644 HG12 ' H ' ' A' ' 44' ' ' LYS . 2.7 t -90.5 175.34 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 123.324 0.65 . . . . 1.42 109.733 179.05 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.644 ' H ' HG12 ' A' ' 43' ' ' VAL . 18.5 ptmt 164.65 156.87 0.07 OUTLIER Pre-proline 0 N--CA 1.47 0.557 0 CA-C-O 121.475 0.655 . . . . 2.18 112.324 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.46 ' HD2' ' HB2' ' A' ' 49' ' ' ASP . 2.1 Cg_endo -84.43 174.25 8.04 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 124.908 3.739 . . . . 0.3 113.21 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.51 ' O ' ' N ' ' A' ' 48' ' ' SER . . . -67.47 -172.03 5.72 Favored Glycine 0 C--O 1.225 -0.42 0 CA-C-N 115.326 -0.852 . . . . 0.35 111.356 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.561 ' HG2' ' HB2' ' A' ' 91' ' ' GLN . 33.9 mtmm -41.26 -13.18 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 113.499 0.926 . . . . 2.35 113.499 -177.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.51 ' N ' ' O ' ' A' ' 46' ' ' GLY . 47.2 t -85.75 7.08 25.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.085 0.469 . . . . 1.45 110.313 178.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.46 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 3.5 p30 -77.34 150.32 35.19 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.568 -0.742 . . . . 1.73 112.048 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 86.1 m -126.47 119.25 26.74 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.657 -0.868 . . . . 0.44 108.657 178.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.517 HG12 ' HA ' ' A' ' 133' ' ' VAL . 12.2 m -124.34 158.47 31.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.443 0.534 . . . . 0.65 112.443 -178.489 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 83.7 m -112.65 120.89 43.09 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.748 -0.834 . . . . 0.32 108.748 178.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.747 HG11 HD22 ' A' ' 130' ' ' LEU . 12.3 m -141.9 179.85 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.393 0.616 . . . . 0.24 112.043 -178.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -127.09 132.34 50.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.149 -0.932 . . . . 2.4 109.236 178.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -146.49 161.1 41.17 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.614 0.721 . . . . 0.26 112.184 -179.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 57.9 m -126.99 112.34 15.13 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.621 -1.172 . . . . 0.26 108.677 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.48 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -111.41 146.25 17.78 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.045 -1.074 . . . . 0.12 112.986 -178.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.49 ' NE ' HD13 ' A' ' 125' ' ' ILE . 3.2 ppt_? -148.03 148.4 30.65 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.817 0.342 . . . . 1.93 110.17 179.117 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.401 ' C ' ' N ' ' A' ' 61' ' ' ASP . 19.3 mt -77.51 160.87 28.34 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.102 -0.499 . . . . 1.21 109.991 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.499 ' HB ' ' O ' ' A' ' 123' ' ' THR . 8.0 tp -59.1 -11.43 2.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.211 -0.662 . . . . 0.64 109.211 178.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.401 ' N ' ' C ' ' A' ' 59' ' ' LEU . 8.1 m-20 -65.69 -11.31 44.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.081 -0.963 . . . . 2.01 110.774 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.46 -0.85 78.34 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.665 -0.779 . . . . 0.45 113.531 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.8 t -118.53 138.45 52.52 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 117.227 0.514 . . . . 1.4 111.579 -178.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 57' ' ' GLY . 6.0 p -64.2 133.15 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 115.822 -0.626 . . . . 0.28 110.147 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.598 ' HD1' ' N ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -97.49 -22.53 16.5 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.09 -0.505 . . . . 0.24 110.739 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.598 ' N ' ' HD1' ' A' ' 65' ' ' PHE . 19.8 t70 -175.68 130.15 0.26 Allowed 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.262 -0.426 . . . . 0.3 110.649 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 70.2 p -126.61 123.99 38.9 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.28 -0.418 . . . . 1.3 110.721 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.493 HG21 ' HB2' ' A' ' 75' ' ' ALA . 70.8 p -90.55 -41.05 11.6 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.381 -0.372 . . . . 0.34 111.002 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -70.87 -35.6 72.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 2.11 111.147 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.9 tmtm? -63.03 -51.49 66.57 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.365 -0.379 . . . . 3.41 110.857 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 77.1 p -58.63 -19.56 40.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.29 -0.414 . . . . 1.47 111.099 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.09 10.36 58.61 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.799 -0.715 . . . . 0.7 112.437 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -115.53 116.68 41.18 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.535 0.167 . . . . 3.05 110.678 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -58.88 144.97 98.44 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.274 1.983 . . . . 0.51 112.085 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.493 ' HB2' HG21 ' A' ' 68' ' ' THR . . . -94.6 124.25 38.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.206 -0.452 . . . . 0.23 111.038 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.2 t -126.18 120.18 29.42 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.33 -0.395 . . . . 1.26 110.767 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -158.04 169.13 25.25 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.263 0.554 . . . . 0.36 111.863 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.42 ' HG2' ' NE2' ' A' ' 81' ' ' GLN . 0.3 OUTLIER -87.96 145.29 26.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.32 -0.854 . . . . 1.58 109.168 178.762 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 26.1 m -79.71 -27.42 12.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 113.111 0.782 . . . . 1.07 113.111 -177.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 80.3 p -85.84 -2.08 57.89 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 111.743 0.275 . . . . 1.14 111.743 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.42 ' NE2' ' HG2' ' A' ' 78' ' ' GLN . 1.2 mp0 -93.88 5.88 50.22 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.546 0.573 . . . . 2.08 112.546 -178.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.43 HG21 ' HE3' ' A' ' 86' ' ' TRP . 0.0 OUTLIER -110.6 -175.04 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 N-CA-C 112.244 0.461 . . . . 0.45 112.244 -179.69 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.563 HG13 ' H ' ' A' ' 86' ' ' TRP . 34.3 pt -56.32 158.17 8.09 Favored Pre-proline 0 N--CA 1.462 0.17 0 CA-C-N 115.962 -0.563 . . . . 0.75 112.212 -179.225 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.434 ' HD2' ' HB ' ' A' ' 83' ' ' ILE . 6.2 Cg_endo -48.71 -50.28 12.87 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.868 2.379 . . . . 0.65 112.553 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.68 ' HA2' HD11 ' A' ' 32' ' ' LEU . . . -57.86 -49.11 77.43 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.671 -0.776 . . . . 0.31 113.411 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' TRP . . . . . 0.563 ' H ' HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -62.51 -53.39 55.41 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.518 0.562 . . . . 0.78 112.518 -178.457 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.0 t -52.9 -33.38 50.1 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.739 0.274 . . . . 1.4 111.739 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -68.99 -50.71 46.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.528 -0.305 . . . . 1.43 111.726 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.662 ' HB2' HD22 ' A' ' 32' ' ' LEU . . . -64.16 -45.46 88.34 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.932 0.345 . . . . 0.33 111.932 -179.23 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.486 HD13 ' SD ' ' A' ' 93' ' ' MET . 4.3 mm? -56.59 -30.43 63.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.387 -0.369 . . . . 0.39 111.483 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.561 ' HB2' ' HG2' ' A' ' 47' ' ' LYS . 57.7 tt0 -64.82 -23.93 67.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.404 -0.362 . . . . 1.87 111.15 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.419 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 9.1 mp -95.79 -7.84 36.0 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.145 -0.48 . . . . 1.31 111.582 -179.327 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.486 ' SD ' HD13 ' A' ' 90' ' ' LEU . 60.4 mtt -88.79 107.79 19.48 Favored Pre-proline 0 N--CA 1.452 -0.344 0 CA-C-N 116.719 -0.219 . . . . 1.66 111.517 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.45 ' HA ' ' CD ' ' A' ' 44' ' ' LYS . 95.7 Cg_endo -79.86 145.27 17.73 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.651 2.234 . . . . 0.44 111.817 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.627 ' HB1' ' HA ' ' A' ' 132' ' ' SER . . . -46.94 127.27 9.89 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 120.649 0.262 . . . . 0.36 110.973 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 96.71 -5.39 64.24 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 120.689 -0.767 . . . . 0.34 112.997 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.418 ' OG ' ' N ' ' A' ' 98' ' ' THR . 11.2 t -74.78 177.8 5.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.837 0.351 . . . . 1.41 111.117 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.422 HG22 HD12 ' A' ' 37' ' ' ILE . 18.8 m -151.38 92.86 1.83 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.045 -0.525 . . . . 0.23 110.444 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.543 ' NE1' ' HB2' ' A' ' 39' ' ' SER . 24.2 m0 -116.6 149.18 40.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.171 0.51 . . . . 0.53 111.867 -179.501 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -120.99 108.03 13.37 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.758 -1.201 . . . . 1.37 107.758 176.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.586 HG22 ' HB3' ' A' ' 34' ' ' TYR . 46.2 pt -107.6 139.44 29.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 113.112 0.782 . . . . 0.25 113.112 -177.246 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.463 ' OH ' HG22 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -117.89 103.9 10.41 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.734 -1.21 . . . . 0.31 107.734 177.294 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 39.6 t -97.84 105.53 27.85 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 113.39 0.885 . . . . 0.52 113.39 -176.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.484 ' HA ' HG23 ' A' ' 123' ' ' THR . 33.4 Cg_exo -59.84 151.17 73.03 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.344 2.029 . . . . 0.48 111.392 177.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.576 ' HB2' ' HA3' ' A' ' 110' ' ' GLY . 2.5 p -48.31 -43.13 32.78 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 111.969 0.359 . . . . 1.81 111.969 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -57.21 -8.85 3.7 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 114.328 0.491 . . . . 0.4 114.328 -178.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.42 HD12 ' HA3' ' A' ' 85' ' ' GLY . 0.1 OUTLIER -84.57 -25.66 28.52 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.542 0.571 . . . . 2.35 112.542 -178.294 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.443 ' HB2' HD12 ' A' ' 83' ' ' ILE . . . -127.73 -125.11 0.23 Allowed 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 121.033 -0.267 . . . . 1.03 111.288 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.499 ' HB2' ' H ' ' A' ' 116' ' ' GLY . 47.2 m-85 -89.51 4.63 48.62 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 121.133 0.492 . . . . 1.44 110.408 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.576 ' HA3' ' HB2' ' A' ' 105' ' ' SER . . . -37.5 -78.48 0.05 OUTLIER Glycine 0 CA--C 1.525 0.712 0 CA-C-N 115.134 -0.939 . . . . 1.58 114.983 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.451 ' HA ' ' OD1' ' A' ' 121' ' ' ASN . 12.0 Cg_endo -56.19 -12.75 8.22 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.252 2.634 . . . . 1.49 113.405 -178.025 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.423 ' C ' ' H ' ' A' ' 114' ' ' VAL . 3.3 mmp_? -82.39 139.75 33.87 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.888 -0.412 . . . . 3.51 109.888 178.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 36.1 t -62.18 -4.51 1.77 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.105 0.479 . . . . 1.63 110.607 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.423 ' H ' ' C ' ' A' ' 112' ' ' ARG . 6.4 t -111.09 55.21 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.453 -0.794 . . . . 2.9 110.577 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -53.48 115.9 5.27 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.803 -0.713 . . . . 1.05 112.651 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.499 ' H ' ' HB2' ' A' ' 109' ' ' TYR . . . -71.44 -125.51 0.06 OUTLIER Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.769 -0.729 . . . . 0.8 112.142 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.54 -35.94 98.01 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.008 1.806 . . . . 0.7 111.882 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.604 HG13 HD22 ' A' ' 124' ' ' LEU . 3.4 mp -91.88 131.19 39.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 1.25 109.993 178.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -47.95 153.9 1.62 Allowed Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.934 -0.651 . . . . 0.48 112.515 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.441 ' O ' ' HG3' ' A' ' 122' ' ' GLU . 29.1 Cg_endo -62.44 130.28 29.55 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.102 1.868 . . . . 0.67 111.655 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.451 ' OD1' ' HA ' ' A' ' 111' ' ' PRO . 3.1 m-80 47.63 35.13 4.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.959 -0.564 . . . . 1.12 110.24 -179.028 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.568 ' HG2' ' HB3' ' A' ' 8' ' ' ASN . 43.1 mt-10 -115.23 132.55 56.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.831 -0.622 . . . . 1.73 111.279 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.499 ' O ' ' HB ' ' A' ' 60' ' ' ILE . 87.6 m -95.11 127.53 41.23 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.929 -0.767 . . . . 0.29 108.929 178.219 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.604 HD22 HG13 ' A' ' 118' ' ' ILE . 6.5 mp -116.72 157.81 24.86 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.197 0.522 . . . . 1.47 112.092 -178.381 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.49 ' N ' HD12 ' A' ' 125' ' ' ILE . 4.5 mp -114.21 142.87 25.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.438 -0.801 . . . . 0.2 109.617 178.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -135.35 132.26 37.41 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.089 0.471 . . . . 0.24 111.717 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 24.4 tptm -108.67 103.55 12.67 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.565 -0.902 . . . . 2.28 108.565 178.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 9.1 mt -102.76 122.38 55.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 113.007 0.743 . . . . 0.82 113.007 -177.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -116.89 100.31 7.68 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.378 -0.971 . . . . 0.26 108.378 177.319 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.747 HD22 HG11 ' A' ' 53' ' ' VAL . 0.2 OUTLIER -77.95 121.32 24.02 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.926 -0.579 . . . . 1.41 111.545 -178.042 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 48.3 mm -93.47 -57.45 4.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.018 -0.537 . . . . 1.17 110.092 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.627 ' HA ' ' HB1' ' A' ' 95' ' ' ALA . 59.8 p -164.67 163.11 21.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.108 -0.496 . . . . 1.17 111.449 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.517 ' HA ' HG12 ' A' ' 51' ' ' VAL . 11.0 p -107.74 135.14 47.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.691 -0.686 . . . . 1.43 110.094 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.504 ' HE3' ' H ' ' A' ' 137' ' ' SER . 58.9 pttt 38.5 -149.07 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 O-C-N 123.243 0.339 . . . . 3.08 111.234 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.414 ' HD2' ' N ' ' A' ' 135' ' ' LYS . 1.0 OUTLIER -78.21 13.48 1.47 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.058 0.456 . . . . 3.16 110.261 179.133 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.404 ' H ' ' C ' ' A' ' 134' ' ' LYS . 47.2 t 65.43 67.03 0.51 Allowed 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.487 -0.778 . . . . 1.31 110.925 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.504 ' H ' ' HE3' ' A' ' 134' ' ' LYS . 35.8 m . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.213 -0.899 . . . . 2.53 110.863 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 120.847 0.356 . . . . 3.09 110.889 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -68.47 -18.61 64.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.105 -0.498 . . . . 2.08 111.103 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.438 ' HB3' ' NZ ' ' A' ' 3' ' ' LYS . 8.2 mtpm? -57.45 -40.86 79.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.21 0.528 . . . . 3.23 109.823 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -79.98 -37.17 34.89 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.633 -0.712 . . . . 2.63 110.367 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -55.5 -51.68 66.19 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.014 -0.539 . . . . 0.82 110.169 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -67.38 -36.52 81.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.842 -0.617 . . . . 2.57 109.93 179.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -56.34 -32.8 65.04 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.119 -0.697 . . . . 2.1 109.119 178.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.491 ' HA ' ' HG2' ' A' ' 11' ' ' LYS . 50.3 m-20 -72.72 -38.51 67.44 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.276 -0.875 . . . . 1.4 110.63 179.334 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -56.31 -37.83 70.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.008 -0.542 . . . . 2.67 111.595 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.9 t -77.69 -52.54 16.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 112.047 0.388 . . . . 1.27 112.047 -179.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.526 ' HE2' HG13 ' A' ' 60' ' ' ILE . 21.3 ptmt -61.13 -29.72 69.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.544 -0.298 . . . . 1.69 111.683 -179.005 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.26 -52.88 5.9 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.569 -0.824 . . . . 0.31 112.005 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -63.98 -26.59 68.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.968 0.413 . . . . 2.39 110.406 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.0 -39.31 50.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.958 -0.565 . . . . 0.23 110.53 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -59.13 -51.03 71.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.992 -0.549 . . . . 0.23 110.324 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.518 ' HA ' ' HB3' ' A' ' 19' ' ' ASN . 4.2 pp -64.9 -34.44 78.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.309 -0.405 . . . . 0.55 110.577 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.2 m -57.5 -48.8 78.28 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.211 -0.449 . . . . 0.27 110.201 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -73.2 -32.05 64.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.81 -0.632 . . . . 2.47 109.986 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.518 ' HB3' ' HA ' ' A' ' 16' ' ' LEU . 3.0 t-20 -57.58 -27.39 62.66 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.53 -0.759 . . . . 0.22 111.317 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.1 mttm -46.71 -19.85 0.11 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.302 -0.408 . . . . 2.45 111.884 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -68.58 -30.26 68.98 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.469 0.544 . . . . 0.4 112.469 -178.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.679 ' O ' HG23 ' A' ' 25' ' ' VAL . 18.6 mmtp -53.75 118.76 16.01 Favored Pre-proline 0 N--CA 1.464 0.246 0 C-N-CA 121.245 -0.182 . . . . 1.4 110.766 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.28 140.73 95.48 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.343 2.029 . . . . 0.65 112.523 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.91 3.84 79.47 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.743 -0.742 . . . . 0.37 114.318 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 22' ' ' LYS . 7.0 t -52.4 112.21 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 117.602 0.701 . . . . 0.91 110.667 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -118.93 131.03 72.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.904 -0.589 . . . . 1.03 111.669 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.2 t -89.27 132.85 32.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.777 -0.647 . . . . 0.91 110.49 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.594 HD12 ' HB2' ' A' ' 32' ' ' LEU . 66.1 mt -94.71 163.48 22.36 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.406 -0.361 . . . . 0.4 110.925 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -51.81 -30.66 39.05 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.25 1.967 . . . . 0.59 112.019 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.486 ' O ' HD11 ' A' ' 107' ' ' LEU . 1.8 m -85.49 -13.28 49.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.114 -0.494 . . . . 1.14 111.36 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.646 ' HA3' HD21 ' A' ' 107' ' ' LEU . . . 104.84 15.79 19.21 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.134 -1.031 . . . . 0.34 113.874 179.285 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.594 ' HB2' HD12 ' A' ' 28' ' ' LEU . 2.4 mp -83.34 138.74 33.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.373 0.606 . . . . 1.35 112.243 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -119.22 138.93 52.64 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.158 -0.928 . . . . 1.75 108.623 177.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.581 ' HB3' HG22 ' A' ' 101' ' ' ILE . 16.8 p90 -160.61 175.52 12.59 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.206 0.527 . . . . 0.32 112.301 -178.459 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -121.45 117.08 25.98 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.37 -0.832 . . . . 2.15 109.591 178.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.45 HG13 ' HE1' ' A' ' 99' ' ' TRP . 67.8 t -73.49 125.97 33.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 113.473 0.916 . . . . 0.3 113.473 -178.005 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 63.2 mt -103.63 -66.7 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.434 -0.803 . . . . 0.65 110.049 178.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 37.7 t30 -130.96 91.92 3.13 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 116.337 -0.392 . . . . 1.03 110.164 178.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.745 ' HB3' ' HE1' ' A' ' 99' ' ' TRP . 96.3 p -105.41 144.83 31.64 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.204 0.446 . . . . 1.5 112.204 -178.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.516 ' HA2' ' HG3' ' A' ' 94' ' ' PRO . . . 80.44 98.55 0.33 Allowed Glycine 0 C--N 1.332 0.351 0 CA-C-N 115.823 -0.626 . . . . 1.09 113.141 178.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -151.48 -82.29 0.1 Allowed 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 111.75 0.278 . . . . 1.7 111.75 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.47 -178.83 42.56 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 121.142 -0.551 . . . . 0.35 114.098 -178.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.463 ' O ' ' HB3' ' A' ' 44' ' ' LYS . 0.2 OUTLIER -90.32 177.73 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 123.667 0.787 . . . . 1.42 110.439 178.937 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.517 ' HB3' HG11 ' A' ' 133' ' ' VAL . 0.0 OUTLIER 165.92 155.24 0.09 OUTLIER Pre-proline 0 N--CA 1.47 0.545 0 CA-C-O 121.668 0.747 . . . . 2.18 112.419 -179.681 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.449 ' HD2' HG21 ' A' ' 133' ' ' VAL . 2.3 Cg_endo -85.72 173.39 7.28 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 125.102 3.868 . . . . 0.3 113.39 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.493 ' O ' ' N ' ' A' ' 48' ' ' SER . . . -68.1 -172.57 6.85 Favored Glycine 0 C--O 1.225 -0.461 0 CA-C-N 115.109 -0.95 . . . . 0.35 111.453 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.497 ' O ' HG13 ' A' ' 79' ' ' VAL . 55.8 mttp -41.71 -13.22 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 113.603 0.964 . . . . 2.35 113.603 -178.058 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.493 ' N ' ' O ' ' A' ' 46' ' ' GLY . 39.2 t -86.45 6.92 28.04 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.065 0.46 . . . . 1.45 110.625 178.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.435 ' CB ' ' HD2' ' A' ' 45' ' ' PRO . 3.1 p30 -76.63 155.88 33.13 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.776 -0.647 . . . . 1.73 111.487 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.564 ' HB ' ' HG2' ' A' ' 134' ' ' LYS . 33.1 m -125.07 122.27 36.74 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.347 -0.983 . . . . 0.44 108.347 178.481 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.0 m -126.78 151.34 33.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 112.826 0.676 . . . . 0.65 112.826 -177.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 95.5 m -114.1 120.96 42.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.05 -0.977 . . . . 0.32 109.152 178.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.484 HG12 ' HA ' ' A' ' 130' ' ' LEU . 3.1 m -142.13 176.88 3.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.149 0.5 . . . . 0.24 111.742 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -126.15 132.03 51.92 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.462 -0.79 . . . . 2.4 108.969 178.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -145.56 165.37 28.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.606 0.717 . . . . 0.26 112.125 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 88.5 m -130.02 113.47 14.6 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.606 -1.179 . . . . 0.26 108.491 178.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.442 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -110.62 144.32 17.15 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 119.838 -1.173 . . . . 0.12 113.065 -178.181 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.531 ' NH2' ' HA2' ' A' ' 62' ' ' GLY . 0.1 OUTLIER -147.47 146.83 29.67 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.794 0.331 . . . . 1.93 110.192 179.037 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.454 ' HA ' ' HG ' ' A' ' 124' ' ' LEU . 9.8 mt -80.14 157.67 26.55 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.196 -0.456 . . . . 1.21 110.327 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.526 HG13 ' HE2' ' A' ' 11' ' ' LYS . 9.7 tp -59.1 -10.93 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.41 -0.589 . . . . 0.64 109.41 178.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -66.39 -9.76 36.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.281 -0.872 . . . . 2.01 110.673 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.531 ' HA2' ' NH2' ' A' ' 58' ' ' ARG . . . 90.98 -0.23 75.73 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.516 -0.85 . . . . 0.45 113.317 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.5 t -121.51 138.71 54.18 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 117.357 0.578 . . . . 1.4 111.702 -178.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 57' ' ' GLY . 5.3 p -66.86 133.34 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-N 115.654 -0.703 . . . . 0.28 109.979 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.673 ' HD1' ' H ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -97.93 -27.25 14.35 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.271 -0.422 . . . . 0.24 111.523 -179.74 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.673 ' H ' ' HD1' ' A' ' 65' ' ' PHE . 25.0 t70 -177.25 130.74 0.17 Allowed 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 116.709 -0.223 . . . . 0.3 110.564 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 68.0 m -134.61 124.51 25.52 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.791 0.329 . . . . 1.3 111.12 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.575 HG21 ' HB2' ' A' ' 75' ' ' ALA . 80.9 p -86.14 -12.99 48.47 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.072 0.463 . . . . 0.34 110.391 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.89 -48.28 25.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.705 -0.68 . . . . 2.11 111.303 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -64.57 -37.86 89.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.111 -0.495 . . . . 3.41 111.418 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 62.9 p -60.23 -14.58 18.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.47 -0.332 . . . . 1.47 111.405 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.92 8.02 88.05 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.779 -0.724 . . . . 0.7 112.624 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -123.44 118.35 27.6 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 120.268 0.08 . . . . 3.05 110.874 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.62 150.05 45.82 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.42 2.08 . . . . 0.51 112.447 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.575 ' HB2' HG21 ' A' ' 68' ' ' THR . . . -94.76 126.65 40.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 0.23 111.344 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 78.7 m -118.51 115.72 25.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.388 -0.369 . . . . 1.26 110.901 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -150.58 148.66 28.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.309 -0.405 . . . . 0.36 111.396 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.78 141.77 33.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.819 -0.628 . . . . 1.58 110.107 179.364 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.596 HG23 ' HB2' ' A' ' 90' ' ' LEU . 2.6 p -64.26 -24.95 36.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.273 -0.421 . . . . 1.07 112.126 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 47.3 t -90.93 -9.72 45.1 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.718 0.266 . . . . 1.14 111.718 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -91.99 5.8 48.77 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.991 0.367 . . . . 2.08 111.991 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 10.5 m -116.24 -178.46 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 112.279 0.474 . . . . 0.45 112.279 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.516 ' O ' HG23 ' A' ' 87' ' ' THR . 24.8 pt -56.6 155.87 13.29 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 115.915 -0.584 . . . . 0.75 112.035 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -48.16 -60.24 0.95 Allowed 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.211 2.607 . . . . 0.65 113.168 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.504 ' C ' HD21 ' A' ' 32' ' ' LEU . . . -44.39 -48.82 8.5 Favored Glycine 0 CA--C 1.522 0.497 0 C-N-CA 120.596 -0.812 . . . . 0.31 112.17 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 1.1 m0 -62.44 -36.63 83.02 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.014 0.375 . . . . 0.78 112.014 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.516 HG23 ' O ' ' A' ' 83' ' ' ILE . 30.5 p -58.7 -40.21 83.0 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 121.03 -0.268 . . . . 1.4 111.609 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -70.46 -51.67 27.54 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.494 0.553 . . . . 1.43 112.494 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.79 -52.41 51.05 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.381 0.511 . . . . 0.33 112.381 -178.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.596 ' HB2' HG23 ' A' ' 79' ' ' VAL . 4.2 mm? -57.6 -25.72 60.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.334 -0.394 . . . . 0.39 111.779 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 21.5 tm0? -81.58 -19.36 42.14 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.754 0.279 . . . . 1.87 111.754 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 98.2 mt -90.25 -22.16 21.76 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.77 0.285 . . . . 1.31 111.77 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.537 ' SD ' HD13 ' A' ' 90' ' ' LEU . 15.4 ptp -81.75 121.01 79.11 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-O 120.555 0.217 . . . . 1.66 111.511 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.516 ' HG3' ' HA2' ' A' ' 40' ' ' GLY . 92.8 Cg_endo -80.4 147.51 18.04 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.767 2.312 . . . . 0.44 111.791 179.311 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.635 ' HB1' ' HA ' ' A' ' 132' ' ' SER . . . -45.79 126.46 7.12 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.707 0.289 . . . . 0.36 111.151 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 97.84 -2.38 60.14 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 120.82 -0.705 . . . . 0.34 113.024 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.433 ' OG ' ' HB2' ' A' ' 93' ' ' MET . 83.0 p -79.42 -174.47 4.24 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.934 0.397 . . . . 1.41 111.563 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.5 m -159.89 105.79 1.59 Allowed 'General case' 0 C--O 1.231 0.085 0 CA-C-N 116.029 -0.532 . . . . 0.23 111.001 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.745 ' HE1' ' HB3' ' A' ' 39' ' ' SER . 40.0 m0 -126.9 149.37 49.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.04 0.448 . . . . 0.53 111.781 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -117.8 107.91 14.71 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 107.847 -1.168 . . . . 1.37 107.847 177.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.581 HG22 ' HB3' ' A' ' 34' ' ' TYR . 43.3 pt -109.35 140.05 29.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 113.515 0.932 . . . . 0.25 113.515 -177.04 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -116.41 103.57 10.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.76 -1.109 . . . . 0.31 108.031 177.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.546 HG22 HD23 ' A' ' 32' ' ' LEU . 9.6 t -102.53 102.74 27.67 Favored Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 113.191 0.812 . . . . 0.52 113.191 -177.175 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -62.0 151.73 79.67 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.101 1.868 . . . . 0.48 110.774 177.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -48.34 -42.5 31.54 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 111.883 0.327 . . . . 1.81 111.883 -179.149 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -57.27 -10.07 5.06 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.982 -0.628 . . . . 0.4 113.315 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.646 HD21 ' HA3' ' A' ' 31' ' ' GLY . 0.2 OUTLIER -103.6 -15.89 15.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.766 0.317 . . . . 2.35 111.504 -179.575 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -109.19 -104.17 0.37 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.503 -0.317 . . . . 1.03 111.173 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -89.42 -17.43 28.78 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.836 0.35 . . . . 1.44 110.73 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 102.76 151.52 23.38 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.949 -0.644 . . . . 1.58 114.332 178.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.486 ' HA ' ' H ' ' A' ' 121' ' ' ASN . 19.4 Cg_endo -58.62 -6.52 3.31 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.846 3.031 . . . . 1.49 113.262 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.546 ' C ' ' H ' ' A' ' 114' ' ' VAL . 99.3 mtt180 -74.87 170.61 15.59 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.799 0.333 . . . . 3.51 110.88 -178.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 78.4 p -63.0 11.85 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.947 -0.57 . . . . 1.63 112.0 -179.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.546 ' H ' ' C ' ' A' ' 112' ' ' ARG . 30.0 m -102.53 19.51 3.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.902 0.382 . . . . 2.9 110.692 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -62.42 103.91 0.68 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.906 -0.664 . . . . 1.05 112.13 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.22 -110.0 0.01 OUTLIER Glycine 0 CA--C 1.52 0.39 0 C-N-CA 120.862 -0.685 . . . . 0.8 112.4 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -62.95 -34.93 69.42 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.138 1.892 . . . . 0.7 111.573 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.611 HG23 HD12 ' A' ' 124' ' ' LEU . 92.8 mt -90.75 124.18 43.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.753 -0.658 . . . . 1.25 110.261 179.27 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.404 ' H ' HD21 ' A' ' 59' ' ' LEU . . . -48.56 156.59 1.21 Allowed Glycine 0 C--N 1.331 0.304 0 CA-C-N 116.097 -0.501 . . . . 0.48 113.048 -179.345 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -62.05 131.43 34.72 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.373 2.048 . . . . 0.67 111.653 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.486 ' H ' ' HA ' ' A' ' 111' ' ' PRO . 5.1 m-80 50.14 34.41 8.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.272 -0.422 . . . . 1.12 110.259 -178.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -115.91 127.11 54.74 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.341 -0.39 . . . . 1.73 111.738 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.492 ' O ' ' HB ' ' A' ' 60' ' ' ILE . 97.3 m -90.72 128.63 36.73 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.376 -0.972 . . . . 0.29 108.376 177.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.611 HD12 HG23 ' A' ' 118' ' ' ILE . 0.1 OUTLIER -113.35 156.45 23.39 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.829 0.677 . . . . 1.47 112.829 -177.577 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 5.1 mp -114.78 138.41 45.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 114.973 -1.012 . . . . 0.2 109.228 177.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.485 ' CE1' HD22 ' A' ' 124' ' ' LEU . 68.7 m-85 -131.51 132.47 44.22 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.95 0.405 . . . . 0.24 111.893 -178.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -109.12 103.62 12.66 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.521 -0.918 . . . . 2.28 108.521 178.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 19.6 mt -104.11 122.92 57.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 112.974 0.731 . . . . 0.82 112.974 -177.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -118.43 99.29 6.73 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.508 -0.923 . . . . 0.26 108.508 177.314 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.484 ' HA ' HG12 ' A' ' 53' ' ' VAL . 20.2 tp -79.56 120.24 23.64 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.889 -0.596 . . . . 1.41 111.365 -178.099 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 50.1 mm -89.75 -56.45 5.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.895 -0.593 . . . . 1.17 110.561 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.635 ' HA ' ' HB1' ' A' ' 95' ' ' ALA . 2.1 m -161.11 165.4 29.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.203 -0.453 . . . . 1.17 110.802 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.571 HG22 ' HG3' ' A' ' 134' ' ' LYS . 7.2 p -111.66 121.38 64.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.048 -0.524 . . . . 1.43 111.663 -179.392 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.571 ' HG3' HG22 ' A' ' 133' ' ' VAL . 34.0 mtpt 43.42 65.72 0.93 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.908 -0.587 . . . . 3.08 111.097 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 95.5 mttt 59.53 30.84 20.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.904 -0.589 . . . . 3.16 111.09 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 42.0 t 55.86 65.2 1.51 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.884 -0.598 . . . . 1.31 111.096 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 58.7 m . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.211 -0.9 . . . . 2.53 110.871 179.97 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.81 0.338 . . . . 3.09 110.921 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -69.26 -22.6 63.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.433 . . . . 2.08 111.136 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.599 ' H ' ' HD3' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -61.85 -38.96 90.16 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.232 -0.655 . . . . 3.23 109.232 178.773 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.449 ' N ' ' HG2' ' A' ' 3' ' ' LYS . 88.4 tttt -80.0 -34.97 38.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.463 -0.79 . . . . 2.63 109.936 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.37 -41.74 98.86 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.718 -0.674 . . . . 0.82 110.428 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -74.83 -31.5 61.69 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.261 -0.427 . . . . 2.57 110.419 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.464 ' HG3' ' HE3' ' A' ' 11' ' ' LYS . 9.6 tp10 -55.93 -40.75 73.59 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.767 -0.457 . . . . 2.1 109.767 179.037 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.534 ' HA ' ' HG2' ' A' ' 11' ' ' LYS . 25.7 p30 -78.64 -29.28 45.71 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.193 -0.458 . . . . 1.4 110.44 179.09 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 121' ' ' ASN . 64.5 tttp -61.16 -39.57 90.6 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.104 -0.498 . . . . 2.67 111.125 178.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.489 HG23 ' N ' ' A' ' 11' ' ' LYS . 27.4 m -77.46 -50.63 19.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 112.462 0.541 . . . . 1.27 112.462 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.534 ' HG2' ' HA ' ' A' ' 8' ' ' ASN . 19.5 ptpt -64.95 -26.63 68.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.626 0.25 . . . . 1.69 111.359 -179.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -75.05 -53.74 6.06 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.648 -0.787 . . . . 0.31 112.206 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -63.52 -24.98 68.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.052 0.453 . . . . 2.39 110.384 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.96 -42.38 33.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.795 -0.638 . . . . 0.23 110.915 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -57.46 -48.47 79.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.202 -0.454 . . . . 0.23 110.578 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.545 ' HA ' ' HB3' ' A' ' 19' ' ' ASN . 4.3 pp -67.64 -35.88 79.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.295 -0.411 . . . . 0.55 110.74 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.412 ' O ' ' HD3' ' A' ' 20' ' ' LYS . 12.1 m -57.57 -48.34 79.63 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.114 0.483 . . . . 0.27 109.854 178.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -72.28 -31.79 66.05 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.821 -0.627 . . . . 2.47 109.809 178.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.545 ' HB3' ' HA ' ' A' ' 16' ' ' LEU . 3.1 t-20 -58.41 -27.09 63.98 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.744 -0.662 . . . . 0.22 111.378 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.412 ' HD3' ' O ' ' A' ' 17' ' ' THR . 55.3 mtpt -46.02 -20.0 0.08 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.423 -0.353 . . . . 2.45 111.659 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -70.6 -33.16 70.74 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.346 0.499 . . . . 0.4 112.346 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.525 ' HG2' ' O ' ' A' ' 19' ' ' ASN . 44.3 mmtt -43.09 118.25 2.42 Favored Pre-proline 0 N--CA 1.467 0.377 0 CA-C-N 116.77 -0.196 . . . . 1.4 111.373 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.448 ' HD2' ' HE2' ' A' ' 35' ' ' LYS . 18.8 Cg_endo -58.0 133.2 54.15 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.607 2.205 . . . . 0.65 112.44 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.69 1.58 85.26 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.754 -0.736 . . . . 0.37 113.177 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' A' ' 34' ' ' TYR . 7.4 p -60.3 114.48 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 121.205 0.526 . . . . 0.91 110.519 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.1 p -128.06 141.14 47.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.763 -0.653 . . . . 1.03 111.291 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.5 p -89.51 140.59 15.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.13 -0.486 . . . . 0.91 111.032 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.589 HD12 ' HB2' ' A' ' 32' ' ' LEU . 73.7 mt -96.92 167.61 11.75 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.036 -0.529 . . . . 0.4 110.845 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.473 ' HD2' ' HB3' ' A' ' 28' ' ' LEU . 71.8 Cg_exo -52.25 -31.28 45.67 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 121.878 1.719 . . . . 0.59 111.388 178.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.1 m -86.38 -11.83 50.92 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.842 -0.617 . . . . 1.14 111.142 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.453 ' O ' HD21 ' A' ' 107' ' ' LEU . . . 103.28 13.32 28.95 Favored Glycine 0 CA--C 1.521 0.446 0 C-N-CA 120.483 -0.865 . . . . 0.34 114.885 178.205 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.589 ' HB2' HD12 ' A' ' 28' ' ' LEU . 4.0 mp -83.44 134.86 34.85 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 117.882 0.841 . . . . 1.35 112.762 -178.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -114.4 140.69 48.47 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.065 -1.087 . . . . 1.75 108.065 177.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.727 ' HB3' HG22 ' A' ' 101' ' ' ILE . 36.9 p90 -155.16 176.03 13.07 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 113.206 0.817 . . . . 0.32 113.206 -177.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.448 ' HE2' ' HD2' ' A' ' 23' ' ' PRO . 33.8 tttm -120.75 116.89 26.12 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.012 -0.995 . . . . 2.15 109.2 178.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.514 HG13 ' HE1' ' A' ' 99' ' ' TRP . 36.2 t -73.27 126.59 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 113.346 0.869 . . . . 0.3 113.346 -177.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.571 HD12 HG22 ' A' ' 98' ' ' THR . 72.6 mt -104.6 -64.1 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 115.436 -0.802 . . . . 0.65 110.672 178.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.418 ' O ' ' HA ' ' A' ' 97' ' ' SER . 9.7 t30 -151.26 78.6 1.28 Allowed 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.653 0.263 . . . . 1.03 110.819 179.259 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.462 ' HB3' ' NE1' ' A' ' 99' ' ' TRP . 79.3 p -106.45 146.13 30.92 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.964 0.411 . . . . 1.5 112.076 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 97.55 99.71 2.03 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 121.025 -0.607 . . . . 1.09 113.026 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -176.48 -62.1 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 111.776 0.287 . . . . 1.7 111.776 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.07 160.97 28.84 Favored Glycine 0 CA--C 1.518 0.281 0 C-N-CA 120.843 -0.694 . . . . 0.35 113.858 -179.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.494 ' O ' ' HB3' ' A' ' 44' ' ' LYS . 0.2 OUTLIER -90.71 175.85 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 123.215 0.606 . . . . 1.42 110.516 179.152 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.617 ' HD3' ' HA ' ' A' ' 94' ' ' PRO . 10.0 ptmm? 163.71 156.29 0.06 OUTLIER Pre-proline 0 N--CA 1.471 0.61 0 CA-C-O 121.427 0.632 . . . . 2.18 111.933 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.443 ' HD2' ' HB2' ' A' ' 49' ' ' ASP . 7.2 Cg_exo -74.57 173.11 14.87 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 124.485 3.457 . . . . 0.3 113.202 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 48' ' ' SER . . . -67.5 -172.56 6.06 Favored Glycine 0 C--O 1.224 -0.497 0 N-CA-C 110.895 -0.882 . . . . 0.35 110.895 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.432 ' O ' ' HB2' ' A' ' 80' ' ' SER . 24.2 pttm -41.61 -13.2 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.388 0.884 . . . . 2.35 113.388 -178.017 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.522 ' N ' ' O ' ' A' ' 46' ' ' GLY . 60.4 m -86.12 7.74 23.62 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 121.036 0.446 . . . . 1.45 110.376 178.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.443 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 3.3 p30 -77.84 160.2 28.47 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.656 -0.702 . . . . 1.73 111.611 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.552 ' HB ' ' HG3' ' A' ' 134' ' ' LYS . 48.3 m -126.34 119.5 27.49 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.814 -0.81 . . . . 0.44 108.814 178.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.434 HG12 ' HA ' ' A' ' 133' ' ' VAL . 26.5 m -130.07 150.73 34.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.156 0.503 . . . . 0.65 112.319 -178.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 53.3 m -111.74 121.15 44.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.477 -0.783 . . . . 0.32 109.299 178.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.586 HG12 ' HA ' ' A' ' 130' ' ' LEU . 3.4 m -137.83 177.8 5.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.154 0.502 . . . . 0.24 111.772 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -126.55 132.9 51.24 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.441 -0.8 . . . . 2.4 109.77 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -144.69 159.63 42.52 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.682 0.753 . . . . 0.26 112.161 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 62.9 m -124.71 112.09 16.33 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.42 -1.263 . . . . 0.26 108.412 178.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.416 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -110.63 141.38 16.35 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 119.813 -1.184 . . . . 0.12 113.173 -178.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.457 ' NE ' HD13 ' A' ' 125' ' ' ILE . 2.5 ppt_? -147.36 146.35 29.62 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.786 0.327 . . . . 1.93 110.197 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.466 ' HA ' ' HG ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER -73.31 163.48 28.02 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.038 -0.528 . . . . 1.21 110.38 -179.863 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.494 ' HB ' ' O ' ' A' ' 123' ' ' THR . 9.0 tp -59.4 -11.01 2.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.357 0.598 . . . . 0.64 109.499 178.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -71.73 -12.48 61.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.321 -0.854 . . . . 2.01 110.979 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.429 ' HA2' HH11 ' A' ' 58' ' ' ARG . . . 90.02 -0.88 79.64 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.604 -0.808 . . . . 0.45 112.921 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.3 m -110.18 128.46 55.49 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 120.92 0.391 . . . . 1.4 111.21 -178.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 57' ' ' GLY . 5.1 p -61.0 130.7 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 115.968 -0.56 . . . . 0.28 110.099 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.605 ' HD1' ' N ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -97.45 -21.92 16.87 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.976 -0.556 . . . . 0.24 110.912 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.605 ' N ' ' HD1' ' A' ' 65' ' ' PHE . 16.2 t70 -175.82 129.5 0.25 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.164 -0.471 . . . . 0.3 110.559 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 30.2 p -132.21 122.28 24.99 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.279 -0.419 . . . . 1.3 110.516 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.586 HG21 ' HB2' ' A' ' 75' ' ' ALA . 69.4 p -79.12 -29.17 43.06 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.426 -0.352 . . . . 0.34 111.184 -179.492 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -69.74 -30.98 68.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.463 -0.335 . . . . 2.11 110.922 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -71.26 -42.13 69.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 3.41 110.995 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 53.6 p -59.72 -18.93 46.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.908 0.385 . . . . 1.47 110.947 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 92.55 2.74 67.33 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.918 -0.658 . . . . 0.7 112.604 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -125.98 140.58 37.18 Favored Pre-proline 0 N--CA 1.453 -0.303 0 CA-C-O 120.929 0.395 . . . . 3.05 110.786 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -71.25 160.1 49.91 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.422 2.082 . . . . 0.51 112.193 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.586 ' HB2' HG21 ' A' ' 68' ' ' THR . . . -93.63 124.82 37.88 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 116.13 -0.486 . . . . 0.23 110.86 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.2 t -126.34 118.29 24.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.007 0.432 . . . . 1.26 110.946 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -157.63 154.28 28.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.118 -0.492 . . . . 0.36 111.578 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.31 130.21 34.94 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.926 -0.768 . . . . 1.58 108.926 178.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.415 ' O ' HG22 ' A' ' 87' ' ' THR . 12.0 m -64.14 -6.5 2.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 112.851 0.686 . . . . 1.07 112.851 -178.233 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.432 ' HB2' ' O ' ' A' ' 47' ' ' LYS . 40.8 t -96.54 -14.0 22.58 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.503 0.557 . . . . 1.14 112.503 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -97.43 5.76 49.24 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.839 0.681 . . . . 2.08 112.839 -178.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 6.1 m -99.36 178.32 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.992 -0.283 . . . . 0.45 111.744 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.496 HG13 ' HB2' ' A' ' 86' ' ' TRP . 26.8 pt -56.16 155.92 11.67 Favored Pre-proline 0 CA--C 1.531 0.225 0 CA-C-N 116.379 -0.373 . . . . 0.75 111.646 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -45.75 -59.92 1.03 Allowed 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.191 2.594 . . . . 0.65 113.049 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.445 ' O ' HD11 ' A' ' 32' ' ' LEU . . . -49.51 -49.08 33.81 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 120.701 -0.761 . . . . 0.31 112.719 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' TRP . . . . . 0.496 ' HB2' HG13 ' A' ' 83' ' ' ILE . 0.6 OUTLIER -61.19 -46.5 90.21 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.325 0.491 . . . . 0.78 112.325 -179.015 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.45 HG23 ' O ' ' A' ' 83' ' ' ILE . 71.6 p -54.92 -36.44 65.24 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 111.791 0.293 . . . . 1.4 111.791 -179.158 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -70.46 -50.27 39.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.547 -0.297 . . . . 1.43 111.654 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.48 ' HB2' HD22 ' A' ' 32' ' ' LEU . . . -63.5 -52.14 62.54 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.486 -0.324 . . . . 0.33 111.852 -179.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -57.4 -30.02 64.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.16 -0.473 . . . . 0.39 111.827 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -69.84 -17.81 63.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.444 -0.344 . . . . 1.87 111.391 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 89.5 mt -101.6 -7.52 22.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.293 -0.412 . . . . 1.31 111.7 -179.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.452 ' O ' ' HD3' ' A' ' 44' ' ' LYS . 90.6 mtp -91.59 107.37 21.61 Favored Pre-proline 0 C--N 1.33 -0.26 0 N-CA-C 111.76 0.282 . . . . 1.66 111.76 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.617 ' HA ' ' HD3' ' A' ' 44' ' ' LYS . 38.8 Cg_endo -69.44 142.71 50.1 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.032 1.822 . . . . 0.44 110.799 178.385 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.515 ' HA ' HD13 ' A' ' 130' ' ' LEU . . . -45.82 126.66 7.35 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.78 0.324 . . . . 0.36 111.511 -179.173 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.551 ' H ' HD22 ' A' ' 130' ' ' LEU . . . 101.32 -2.75 54.27 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.636 -0.792 . . . . 0.34 113.229 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.418 ' HA ' ' O ' ' A' ' 38' ' ' ASN . 74.9 m -76.35 -177.54 4.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.048 0.451 . . . . 1.41 111.847 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.571 HG22 HD12 ' A' ' 37' ' ' ILE . 9.7 m -155.26 98.68 2.01 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.67 -0.696 . . . . 0.23 110.55 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.514 ' HE1' HG13 ' A' ' 36' ' ' VAL . 20.6 m0 -121.79 149.31 43.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.138 0.494 . . . . 0.53 111.581 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -115.28 107.63 15.51 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.156 -1.053 . . . . 1.37 108.156 177.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.727 HG22 ' HB3' ' A' ' 34' ' ' TYR . 48.7 pt -110.14 145.94 16.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 113.339 0.866 . . . . 0.25 113.339 -177.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -127.31 103.69 7.53 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.694 -1.139 . . . . 0.31 108.099 178.138 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.523 HG22 HD23 ' A' ' 32' ' ' LEU . 2.4 t -104.7 98.88 16.11 Favored Pre-proline 0 CA--C 1.53 0.205 0 N-CA-C 113.448 0.907 . . . . 0.52 113.448 -176.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.628 ' HG2' HD13 ' A' ' 107' ' ' LEU . 12.4 Cg_endo -58.6 151.92 59.29 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.0 1.8 . . . . 0.48 110.507 177.085 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -47.73 -38.9 16.35 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.273 0.471 . . . . 1.81 112.273 -178.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.407 ' C ' HD12 ' A' ' 107' ' ' LEU . . . -57.29 -9.35 4.32 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.985 -0.626 . . . . 0.4 113.288 -179.335 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.628 HD13 ' HG2' ' A' ' 104' ' ' PRO . 6.5 mp -110.41 -13.85 14.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.668 0.27 . . . . 2.35 111.52 -178.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -109.18 -104.1 0.37 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.55 -0.296 . . . . 1.03 111.061 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -89.64 -17.08 29.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.768 0.318 . . . . 1.44 111.026 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 107.64 145.02 11.68 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.889 -0.672 . . . . 1.58 113.869 178.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.533 ' HA ' ' H ' ' A' ' 121' ' ' ASN . 28.1 Cg_endo -61.45 -8.55 10.98 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 123.579 2.852 . . . . 1.49 113.299 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.54 ' C ' ' H ' ' A' ' 114' ' ' VAL . 84.3 mtm180 -75.95 171.21 14.82 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.879 0.371 . . . . 3.51 110.969 -178.462 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 42.9 t -55.71 -0.6 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.861 -0.609 . . . . 1.63 111.774 -179.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.54 ' H ' ' C ' ' A' ' 112' ' ' ARG . 2.8 t -91.91 19.47 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.181 0.515 . . . . 2.9 110.226 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -62.59 112.06 4.58 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.794 -0.639 . . . . 1.05 112.151 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -68.71 -113.93 0.02 OUTLIER Glycine 0 CA--C 1.521 0.438 0 C-N-CA 120.99 -0.624 . . . . 0.8 112.743 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.6 -34.69 51.05 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.241 1.961 . . . . 0.7 111.976 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.64 HD12 HD13 ' A' ' 124' ' ' LEU . 26.0 mm -90.65 125.16 43.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.482 . . . . 1.25 110.567 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -44.81 155.33 0.35 Allowed Glycine 0 C--N 1.334 0.435 0 CA-C-N 115.724 -0.671 . . . . 0.48 113.554 -179.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -60.82 132.75 44.05 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.444 2.096 . . . . 0.67 111.437 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.533 ' H ' ' HA ' ' A' ' 111' ' ' PRO . 1.4 m-80 47.71 35.73 4.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.231 -0.44 . . . . 1.12 109.925 -178.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.485 ' HG3' HG22 ' A' ' 60' ' ' ILE . 41.1 tt0 -114.7 128.84 56.53 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.051 -0.522 . . . . 1.73 111.394 -179.114 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.494 ' O ' ' HB ' ' A' ' 60' ' ' ILE . 87.4 m -95.44 129.58 42.55 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.184 -0.673 . . . . 0.29 109.184 178.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.64 HD13 HD12 ' A' ' 118' ' ' ILE . 0.1 OUTLIER -120.33 159.9 24.1 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.104 0.478 . . . . 1.47 111.956 -178.266 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.469 ' N ' HD12 ' A' ' 125' ' ' ILE . 4.5 mp -114.6 143.44 24.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.657 -0.701 . . . . 0.2 109.977 178.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -133.17 132.3 41.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.953 0.406 . . . . 0.24 111.541 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 10.3 tmtt? -111.36 103.56 11.94 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.558 -0.904 . . . . 2.28 108.558 178.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 20.8 mt -102.68 122.92 55.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.91 0.707 . . . . 0.82 112.91 -177.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -118.7 99.75 6.98 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.891 -0.781 . . . . 0.26 108.891 177.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.586 ' HA ' HG12 ' A' ' 53' ' ' VAL . 0.7 OUTLIER -78.48 124.84 28.58 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.157 -0.474 . . . . 1.41 111.558 -178.615 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 43.6 mm -94.06 -57.07 4.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.753 -0.658 . . . . 1.17 110.735 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.497 ' HA ' ' HB1' ' A' ' 95' ' ' ALA . 4.3 m -163.68 166.07 22.62 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.951 0.405 . . . . 1.17 111.491 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.448 HG11 ' HB3' ' A' ' 44' ' ' LYS . 7.3 p -107.63 124.33 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 115.945 -0.57 . . . . 1.43 111.012 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.552 ' HG3' ' HB ' ' A' ' 50' ' ' THR . 0.7 OUTLIER 33.36 73.16 0.07 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.057 -0.52 . . . . 3.08 111.792 -179.5 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 95.4 mttt 60.48 29.91 19.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.863 -0.608 . . . . 3.16 111.57 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.411 ' HB2' ' HB3' ' A' ' 132' ' ' SER . 46.9 t 55.41 67.78 0.96 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.055 -0.521 . . . . 1.31 111.083 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 66.2 m . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.345 -0.836 . . . . 2.53 110.889 179.964 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.593 0.235 . . . . 3.09 110.883 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -60.59 -35.36 75.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.554 -0.294 . . . . 2.08 111.077 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -54.76 -37.93 66.59 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.274 -0.639 . . . . 3.23 109.274 178.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -79.68 -34.97 39.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.433 -0.803 . . . . 2.63 110.242 179.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -58.11 -52.0 67.36 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.092 -0.504 . . . . 0.82 109.977 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -64.85 -36.42 84.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.979 -0.555 . . . . 2.57 110.008 178.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -55.88 -33.13 64.32 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.89 -0.781 . . . . 2.1 108.89 178.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.502 ' HA ' ' HG2' ' A' ' 11' ' ' LYS . 53.2 m-20 -72.34 -38.24 68.65 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.165 -0.925 . . . . 1.4 110.428 179.281 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.434 ' NZ ' ' HB3' ' A' ' 9' ' ' LYS . 4.2 ttpm? -57.27 -35.64 70.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.977 -0.556 . . . . 2.67 111.212 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.9 t -76.35 -52.61 17.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 111.959 0.355 . . . . 1.27 111.959 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.502 ' HG2' ' HA ' ' A' ' 8' ' ' ASN . 19.0 ptpt -58.59 -33.35 69.89 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.668 0.27 . . . . 1.69 111.314 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.452 ' O ' ' HG ' ' A' ' 16' ' ' LEU . . . -76.39 -53.2 5.67 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.719 -0.753 . . . . 0.31 112.329 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -61.08 -30.75 70.52 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.837 0.351 . . . . 2.39 110.839 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.23 -32.09 55.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.319 -0.401 . . . . 0.23 110.458 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -63.99 -54.53 32.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.938 -0.573 . . . . 0.23 110.66 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.738 ' HA ' ' HB3' ' A' ' 19' ' ' ASN . 0.6 OUTLIER -65.59 -32.5 74.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.28 -0.418 . . . . 0.55 111.152 -179.724 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.434 ' N ' HD12 ' A' ' 16' ' ' LEU . 8.3 m -57.2 -48.54 78.52 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.606 -0.516 . . . . 0.27 109.606 179.063 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -74.16 -31.85 62.87 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.93 -0.577 . . . . 2.47 110.065 178.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.738 ' HB3' ' HA ' ' A' ' 16' ' ' LEU . 0.4 OUTLIER -57.12 -28.38 62.65 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.305 -0.861 . . . . 0.22 112.133 -179.523 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -48.04 -18.58 0.2 Allowed 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 112.32 0.489 . . . . 2.45 112.32 -179.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -67.67 -33.11 74.27 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.88 0.326 . . . . 0.4 111.88 -178.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.725 ' O ' HG23 ' A' ' 25' ' ' VAL . 68.1 mttm -54.04 119.48 19.74 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.716 -0.22 . . . . 1.4 111.022 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -56.8 145.56 82.77 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.246 1.964 . . . . 0.65 112.374 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.71 3.11 81.0 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.735 -0.745 . . . . 0.37 113.921 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 22' ' ' LYS . 18.0 t -58.65 109.48 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 117.517 0.659 . . . . 0.91 110.637 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.5 p -130.35 128.56 64.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.908 -0.587 . . . . 1.03 111.089 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.2 p -82.69 137.24 21.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.184 -0.462 . . . . 0.91 110.866 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.521 HD12 ' HB2' ' A' ' 32' ' ' LEU . 61.2 mt -95.52 166.88 13.76 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.102 -0.499 . . . . 0.4 110.713 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.443 ' HD2' ' HB3' ' A' ' 28' ' ' LEU . 53.2 Cg_exo -53.53 -30.93 56.61 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 121.889 1.726 . . . . 0.59 111.53 178.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.525 ' O ' HD12 ' A' ' 107' ' ' LEU . 28.0 t -85.43 -10.96 55.49 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.057 -0.519 . . . . 1.14 110.953 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.83 13.98 28.19 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 120.425 -0.893 . . . . 0.34 114.645 178.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.626 HD22 ' HB2' ' A' ' 89' ' ' ALA . 5.8 mp -85.61 136.98 33.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 117.747 0.774 . . . . 1.35 112.951 -179.07 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -119.01 139.9 50.92 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.118 -0.946 . . . . 1.75 108.49 177.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.654 ' HB3' HG22 ' A' ' 101' ' ' ILE . 41.0 p90 -155.04 176.39 12.6 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.794 0.664 . . . . 0.32 112.794 -178.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.433 ' HE2' ' HB3' ' A' ' 22' ' ' LYS . 23.4 ttmt -120.78 117.36 27.24 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.974 -1.012 . . . . 2.15 109.583 179.075 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.439 HG13 ' HE1' ' A' ' 99' ' ' TRP . 51.6 t -74.52 125.61 34.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 113.297 0.851 . . . . 0.3 113.297 -177.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 54.9 mt -107.22 -66.82 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.288 -0.869 . . . . 0.65 109.92 178.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -134.77 85.14 2.16 Favored 'General case' 0 C--O 1.226 -0.143 0 CA-C-N 116.022 -0.536 . . . . 1.03 109.754 178.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.611 ' HB2' ' HE1' ' A' ' 99' ' ' TRP . 47.0 t -106.47 145.16 32.14 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.376 0.51 . . . . 1.5 112.376 -179.153 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.1 109.19 0.27 Allowed Glycine 0 C--N 1.333 0.366 0 CA-C-N 115.665 -0.698 . . . . 1.09 113.936 178.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -177.75 -62.28 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 111.644 0.239 . . . . 1.7 111.644 178.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.2 168.98 34.28 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 120.63 -0.795 . . . . 0.35 113.763 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.744 HG22 ' H ' ' A' ' 44' ' ' LYS . 7.9 p -90.72 176.88 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 123.208 0.603 . . . . 1.42 109.959 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.744 ' H ' HG22 ' A' ' 43' ' ' VAL . 19.4 ptmt 164.94 156.2 0.07 OUTLIER Pre-proline 0 N--CA 1.469 0.519 0 CA-C-O 121.602 0.715 . . . . 2.18 112.86 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.528 ' HD2' HG21 ' A' ' 133' ' ' VAL . 1.2 Cg_endo -85.18 173.48 7.81 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 125.169 3.913 . . . . 0.3 113.097 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.508 ' O ' ' N ' ' A' ' 48' ' ' SER . . . -67.99 -172.18 6.46 Favored Glycine 0 C--O 1.225 -0.43 0 CA-C-N 115.393 -0.821 . . . . 0.35 111.383 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.405 ' HG2' ' HB2' ' A' ' 91' ' ' GLN . 98.8 mttt -41.41 -13.5 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 113.448 0.907 . . . . 2.35 113.448 -178.077 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.508 ' N ' ' O ' ' A' ' 46' ' ' GLY . 84.5 p -85.84 7.28 24.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.094 0.473 . . . . 1.45 110.282 178.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.469 ' O ' ' NE2' ' A' ' 78' ' ' GLN . 3.2 p30 -76.64 140.88 41.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.459 -0.791 . . . . 1.73 111.857 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 62.8 m -113.45 119.4 37.47 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.615 -0.883 . . . . 0.44 108.615 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.445 HG12 ' HB ' ' A' ' 133' ' ' VAL . 16.9 m -124.28 154.54 31.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 113.051 0.76 . . . . 0.65 113.051 -177.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 87.4 m -114.52 120.8 41.47 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.026 -0.988 . . . . 0.32 108.638 178.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.559 HG12 ' HA ' ' A' ' 130' ' ' LEU . 4.4 m -142.97 -179.71 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.296 0.57 . . . . 0.24 111.991 -178.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.527 ' HB3' ' HG2' ' A' ' 69' ' ' GLU . 28.3 mt-10 -129.55 132.79 46.92 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.114 -0.948 . . . . 2.4 109.455 178.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -146.48 160.86 41.55 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.703 0.763 . . . . 0.26 112.203 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 62.1 m -128.31 112.85 14.9 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.358 -1.292 . . . . 0.26 108.428 178.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.454 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -110.0 147.14 17.22 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.008 -1.091 . . . . 0.12 113.021 -178.361 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.485 ' NE ' HD13 ' A' ' 125' ' ' ILE . 1.8 ppt_? -147.91 148.05 30.39 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.888 0.375 . . . . 1.93 110.122 179.187 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.419 HD23 HD21 ' A' ' 124' ' ' LEU . 23.4 mt -77.55 162.18 27.31 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.981 -0.554 . . . . 1.21 110.102 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.513 ' HB ' ' O ' ' A' ' 123' ' ' THR . 6.9 tp -59.18 -10.75 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.365 0.603 . . . . 0.64 109.458 178.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -67.65 -12.61 60.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.312 -0.858 . . . . 2.01 110.721 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.434 ' HA2' HH11 ' A' ' 58' ' ' ARG . . . 90.55 -0.94 78.19 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.594 -0.812 . . . . 0.45 113.238 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 71.6 p -115.84 134.35 55.09 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 117.088 0.444 . . . . 1.4 111.458 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 57' ' ' GLY . 6.7 p -62.71 132.43 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-N 115.951 -0.568 . . . . 0.28 110.044 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.583 ' HD1' ' N ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -97.65 -22.35 16.52 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.083 -0.508 . . . . 0.24 110.99 -179.95 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.583 ' N ' ' HD1' ' A' ' 65' ' ' PHE . 24.9 t70 -175.91 130.05 0.24 Allowed 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 116.323 -0.399 . . . . 0.3 110.995 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.7 p -125.55 124.36 41.11 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.103 -0.499 . . . . 1.3 110.544 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.7 HG21 ' HB2' ' A' ' 75' ' ' ALA . 69.8 p -83.26 -25.33 31.72 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 120.848 0.356 . . . . 0.34 111.032 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.527 ' HG2' ' HB3' ' A' ' 54' ' ' GLU . 38.1 mt-10 -75.09 -39.32 60.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 2.11 110.98 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -63.54 -44.86 92.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 3.41 110.639 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 54.7 m -58.25 -21.4 48.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.258 -0.428 . . . . 1.47 110.556 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 90.46 7.5 67.08 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.808 -0.71 . . . . 0.7 112.311 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -125.99 117.01 23.98 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.355 0.122 . . . . 3.05 110.937 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -55.47 157.19 15.51 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.314 2.01 . . . . 0.51 112.107 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.7 ' HB2' HG21 ' A' ' 68' ' ' THR . . . -94.72 123.99 38.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.346 -0.388 . . . . 0.23 110.622 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.6 t -125.89 118.48 25.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.786 0.327 . . . . 1.26 111.189 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -158.47 163.49 37.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.11 0.481 . . . . 0.36 111.865 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.484 ' OE1' ' HB3' ' A' ' 80' ' ' SER . 0.0 OUTLIER -83.04 137.8 33.98 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.524 -0.762 . . . . 1.58 109.03 178.608 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.424 ' O ' HG22 ' A' ' 87' ' ' THR . 21.6 m -69.26 -20.07 24.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 113.587 0.958 . . . . 1.07 113.587 -177.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.484 ' HB3' ' OE1' ' A' ' 78' ' ' GLN . 33.2 t -95.3 -2.56 49.1 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.955 0.354 . . . . 1.14 111.955 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.43 ' H ' ' HG3' ' A' ' 78' ' ' GLN . 29.2 mt-30 -96.17 5.58 50.74 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.895 0.331 . . . . 2.08 111.895 -179.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.467 ' HB ' HD13 ' A' ' 83' ' ' ILE . 3.1 m -107.38 -175.66 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 111.662 0.245 . . . . 0.45 111.662 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.74 HD13 ' H ' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -56.45 147.73 47.72 Favored Pre-proline 0 N--CA 1.463 0.191 0 CA-C-N 116.507 -0.315 . . . . 0.75 111.711 -179.468 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo -42.25 -54.12 3.23 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.19 2.594 . . . . 0.65 113.365 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.533 ' HA2' HD11 ' A' ' 32' ' ' LEU . . . -51.87 -49.21 49.05 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.517 -0.849 . . . . 0.31 112.7 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -60.9 -47.7 85.18 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.693 0.257 . . . . 0.78 111.693 -179.348 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.424 HG22 ' O ' ' A' ' 79' ' ' VAL . 30.9 p -53.52 -33.73 55.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.766 0.317 . . . . 1.4 111.598 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -70.61 -51.41 28.35 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.161 0.43 . . . . 1.43 112.161 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.626 ' HB2' HD22 ' A' ' 32' ' ' LEU . . . -68.01 -48.49 65.57 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.483 0.549 . . . . 0.33 112.483 -178.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -55.19 -30.99 61.04 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.021 0.378 . . . . 0.39 112.021 -179.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.405 ' HB2' ' HG2' ' A' ' 47' ' ' LYS . 46.7 tt0 -65.68 -21.15 66.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.595 -0.275 . . . . 1.87 111.574 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.411 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 10.6 mp -96.41 -22.13 17.34 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.382 0.512 . . . . 1.31 112.382 -178.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 22.2 ttm -71.41 108.73 4.22 Favored Pre-proline 0 CA--C 1.532 0.278 0 N-CA-C 111.472 0.175 . . . . 1.66 111.472 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.421 ' HD2' ' OG ' ' A' ' 97' ' ' SER . 6.1 Cg_exo -75.67 144.89 28.64 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.751 2.301 . . . . 0.44 111.889 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.609 ' HB1' ' HA ' ' A' ' 132' ' ' SER . . . -48.31 127.57 13.06 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.472 -0.331 . . . . 0.36 111.437 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 94.39 2.57 63.63 Favored Glycine 0 CA--C 1.521 0.422 0 C-N-CA 120.701 -0.762 . . . . 0.34 113.446 179.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.421 ' OG ' ' HD2' ' A' ' 94' ' ' PRO . 69.6 m -89.92 -174.59 4.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.885 0.374 . . . . 1.41 111.609 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.7 m -152.3 112.78 4.11 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.066 -0.515 . . . . 0.23 110.773 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.611 ' HE1' ' HB2' ' A' ' 39' ' ' SER . 14.8 m0 -132.25 149.77 52.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.052 0.453 . . . . 0.53 111.759 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -123.73 108.54 12.64 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.367 -0.975 . . . . 1.37 108.367 177.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.654 HG22 ' HB3' ' A' ' 34' ' ' TYR . 24.7 pt -107.68 139.68 28.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 112.974 0.731 . . . . 0.25 112.974 -177.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.497 ' OH ' HG22 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -120.34 103.99 9.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.951 -1.022 . . . . 0.31 108.262 178.232 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.417 ' HA ' ' HD2' ' A' ' 104' ' ' PRO . 3.3 t -109.12 102.43 48.9 Favored Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 113.764 1.024 . . . . 0.52 113.764 -176.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.593 ' HG2' HD23 ' A' ' 107' ' ' LEU . 12.3 Cg_endo -59.62 150.94 73.3 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 121.872 1.715 . . . . 0.48 110.037 176.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -47.56 -31.74 4.72 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.512 0.56 . . . . 1.81 112.512 -178.428 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -57.09 -13.47 9.14 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.877 -0.677 . . . . 0.4 114.084 -178.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.593 HD23 ' HG2' ' A' ' 104' ' ' PRO . 3.0 mm? -114.57 -5.55 12.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 117.193 0.496 . . . . 2.35 111.763 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -109.1 -104.36 0.37 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.513 -0.312 . . . . 1.03 110.385 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -91.23 -17.18 26.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.986 0.422 . . . . 1.44 110.454 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 103.74 145.99 15.69 Favored Glycine 0 CA--C 1.521 0.428 0 CA-C-N 115.732 -0.667 . . . . 1.58 113.857 178.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.49 ' HA ' ' H ' ' A' ' 121' ' ' ASN . 19.2 Cg_endo -58.8 -6.96 3.82 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.604 2.869 . . . . 1.49 113.133 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.531 ' C ' ' H ' ' A' ' 114' ' ' VAL . 89.4 mtm180 -75.65 170.71 15.65 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.802 0.334 . . . . 3.51 110.791 -178.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 79.7 p -60.05 6.96 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.034 -0.53 . . . . 1.63 112.235 -179.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.531 ' H ' ' C ' ' A' ' 112' ' ' ARG . 3.2 t -99.92 20.6 2.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.133 0.492 . . . . 2.9 110.502 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -63.85 110.42 3.4 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.931 -0.652 . . . . 1.05 112.309 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -74.25 -116.6 0.08 OUTLIER Glycine 0 CA--C 1.522 0.497 0 C-N-CA 120.967 -0.635 . . . . 0.8 112.603 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -55.93 -35.8 94.75 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.159 1.906 . . . . 0.7 111.679 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.598 HG23 HD13 ' A' ' 124' ' ' LEU . 5.1 mp -91.55 120.06 39.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.77 -0.65 . . . . 1.25 110.082 179.15 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -46.13 157.6 0.4 Allowed Glycine 0 C--N 1.333 0.416 0 CA-C-N 116.083 -0.508 . . . . 0.48 113.308 -179.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.431 ' O ' ' HG3' ' A' ' 122' ' ' GLU . 26.5 Cg_endo -62.07 131.33 34.22 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.486 2.124 . . . . 0.67 111.826 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.49 ' H ' ' HA ' ' A' ' 111' ' ' PRO . 3.2 m-80 47.22 34.57 3.13 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.03 -0.532 . . . . 1.12 110.371 -178.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.431 ' HG3' ' O ' ' A' ' 120' ' ' PRO . 37.0 mt-10 -115.64 122.92 47.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.34 -0.391 . . . . 1.73 111.528 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.513 ' O ' ' HB ' ' A' ' 60' ' ' ILE . 91.2 m -89.17 127.9 35.76 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.782 -0.822 . . . . 0.29 108.782 178.11 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.598 HD13 HG23 ' A' ' 118' ' ' ILE . 6.3 mp -114.42 155.82 25.63 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.217 0.532 . . . . 1.47 112.268 -177.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.485 HD13 ' NE ' ' A' ' 58' ' ' ARG . 4.6 mp -113.9 132.88 61.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.306 -0.861 . . . . 0.2 109.716 178.027 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -125.39 131.82 52.88 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.975 0.417 . . . . 0.24 111.423 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -110.0 102.94 11.64 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.482 -0.933 . . . . 2.28 108.482 178.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.43 ' N ' HD12 ' A' ' 128' ' ' ILE . 5.0 mp -105.71 118.65 53.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 112.429 0.529 . . . . 0.82 112.429 -177.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -109.18 99.32 8.62 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.282 -1.007 . . . . 0.26 108.282 177.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.559 ' HA ' HG12 ' A' ' 53' ' ' VAL . 26.2 tp -79.3 114.9 18.61 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.86 -0.609 . . . . 1.41 111.511 -178.126 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 67.8 mt -84.18 -56.73 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 CA-C-N 115.884 -0.598 . . . . 1.17 110.288 179.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.609 ' HA ' ' HB1' ' A' ' 95' ' ' ALA . 11.3 p -164.27 165.15 22.14 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.246 -0.433 . . . . 1.17 111.409 179.209 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.691 HG11 ' CB ' ' A' ' 44' ' ' LYS . 7.2 p -117.04 122.24 69.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.902 -0.59 . . . . 1.43 111.064 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.414 ' C ' ' O ' ' A' ' 133' ' ' VAL . 11.3 mttm 32.99 79.19 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.233 -0.44 . . . . 3.08 111.344 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 15.6 pttm 51.86 30.7 7.38 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.783 -0.644 . . . . 3.16 111.629 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 33.8 t 50.61 44.52 27.38 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.587 -0.733 . . . . 1.31 111.096 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 42.3 t . . . . . 0 C--O 1.248 0.979 0 CA-C-O 118.24 -0.886 . . . . 2.53 111.04 -179.734 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 . . . . . 0 N--CA 1.485 1.316 0 CA-C-O 120.799 0.333 . . . . 3.09 111.012 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -68.94 -18.53 64.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 2.08 111.11 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.478 ' HB3' ' NZ ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -57.89 -40.66 80.82 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.572 -0.529 . . . . 3.23 109.572 179.172 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 59.9 mmtt -80.35 -35.69 35.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.782 -0.645 . . . . 2.63 110.598 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -58.39 -48.67 79.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.975 -0.557 . . . . 0.82 110.7 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -75.14 -31.9 61.19 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.275 -0.42 . . . . 2.57 110.916 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -56.78 -41.74 78.21 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.683 -0.488 . . . . 2.1 109.683 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.514 ' HA ' ' HG2' ' A' ' 11' ' ' LYS . 23.7 p30 -78.97 -29.2 43.77 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.734 -0.666 . . . . 1.4 111.415 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 121' ' ' ASN . 66.7 tttm -56.16 -44.12 78.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.005 0.431 . . . . 2.67 110.741 179.2 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.425 HG22 ' H ' ' A' ' 10' ' ' VAL . 5.4 m -78.1 -44.97 27.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.915 -0.584 . . . . 1.27 112.446 -179.224 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.517 ' HE2' HG13 ' A' ' 60' ' ' ILE . 17.9 ptmt -59.16 -33.57 71.07 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.703 0.287 . . . . 1.69 111.429 -179.18 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.411 ' O ' ' HG ' ' A' ' 16' ' ' LEU . . . -76.34 -53.01 5.78 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.833 -0.699 . . . . 0.31 112.202 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.505 ' HA ' HD11 ' A' ' 16' ' ' LEU . 47.8 mt-10 -59.21 -25.38 63.93 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.931 0.396 . . . . 2.39 110.591 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.15 -37.61 45.55 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.061 -0.518 . . . . 0.23 110.584 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -61.78 -51.91 66.37 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.165 -0.471 . . . . 0.23 110.828 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.686 ' HA ' ' HB3' ' A' ' 19' ' ' ASN . 0.6 OUTLIER -67.84 -32.66 73.35 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.717 -0.393 . . . . 0.55 111.143 -179.72 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.451 ' N ' HD12 ' A' ' 16' ' ' LEU . 6.2 m -57.65 -46.09 84.66 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.494 -0.558 . . . . 0.27 109.494 178.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -74.27 -31.96 62.73 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.753 -0.658 . . . . 2.47 109.856 178.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.686 ' HB3' ' HA ' ' A' ' 16' ' ' LEU . 0.9 OUTLIER -60.15 -26.36 66.23 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.436 -0.802 . . . . 0.22 112.532 -179.384 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -48.91 -19.46 0.39 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.764 0.316 . . . . 2.45 111.689 -179.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -69.12 -34.71 75.48 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.135 0.42 . . . . 0.4 112.135 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.715 ' O ' HG23 ' A' ' 25' ' ' VAL . 18.7 mmtp -46.02 127.87 7.19 Favored Pre-proline 0 N--CA 1.465 0.298 0 CA-C-O 120.661 0.267 . . . . 1.4 111.266 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -57.89 137.12 79.38 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.336 2.024 . . . . 0.65 112.192 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.94 0.83 83.03 Favored Glycine 0 CA--C 1.52 0.374 0 C-N-CA 120.771 -0.728 . . . . 0.37 113.955 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 22' ' ' LYS . 24.1 t -56.21 103.98 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.125 0 CA-C-N 117.541 0.67 . . . . 0.91 110.17 179.438 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.6 p -126.49 135.68 63.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.611 -0.722 . . . . 1.03 111.138 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.427 HG23 ' NE2' ' A' ' 33' ' ' GLN . 7.6 p -87.05 141.77 13.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.261 -0.427 . . . . 0.91 111.157 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.48 HD12 ' HB2' ' A' ' 32' ' ' LEU . 55.5 mt -101.29 166.06 13.02 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.099 -0.5 . . . . 0.4 110.804 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.416 ' HD2' ' HB3' ' A' ' 28' ' ' LEU . 54.2 Cg_exo -53.79 -30.58 57.74 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 121.914 1.743 . . . . 0.59 111.455 178.514 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.569 ' O ' HD12 ' A' ' 107' ' ' LEU . 38.8 t -83.85 -12.85 54.95 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.862 -0.608 . . . . 1.14 110.871 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.43 14.18 26.44 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 120.485 -0.864 . . . . 0.34 114.291 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.676 HD11 ' CA ' ' A' ' 85' ' ' GLY . 6.6 mp -85.89 137.51 32.7 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 113.64 0.978 . . . . 1.35 113.64 -178.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.427 ' NE2' HG23 ' A' ' 27' ' ' VAL . 25.5 mp0 -118.4 142.7 47.28 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.985 -1.117 . . . . 1.75 107.985 177.117 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.604 ' HB3' HG22 ' A' ' 101' ' ' ILE . 34.8 p90 -158.79 175.69 13.28 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.278 0.844 . . . . 0.32 113.278 -178.255 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -121.58 117.46 26.8 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 114.901 -1.045 . . . . 2.15 109.606 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.484 HG13 ' HE1' ' A' ' 99' ' ' TRP . 46.6 t -81.92 126.77 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 113.216 0.821 . . . . 0.3 113.216 -178.227 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.452 HD12 HG22 ' A' ' 98' ' ' THR . 81.4 mt -101.73 -64.14 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 115.658 -0.701 . . . . 0.65 110.761 178.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.4 ' O ' ' HA ' ' A' ' 97' ' ' SER . 27.5 t-20 -141.35 86.08 2.0 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.826 0.346 . . . . 1.03 110.931 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.702 ' HB2' ' HE1' ' A' ' 99' ' ' TRP . 39.5 t -106.82 146.06 31.38 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.315 -0.402 . . . . 1.5 112.047 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 93.41 85.19 1.59 Allowed Glycine 0 C--N 1.334 0.422 0 C-N-CA 121.05 -0.595 . . . . 1.09 113.224 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -153.28 -71.75 0.14 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.693 0.282 . . . . 1.7 111.612 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.26 166.67 32.24 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 121.052 -0.594 . . . . 0.35 114.376 -178.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.662 HG12 ' H ' ' A' ' 44' ' ' LYS . 2.6 t -90.45 176.18 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 123.516 0.726 . . . . 1.42 109.905 179.197 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.662 ' H ' HG12 ' A' ' 43' ' ' VAL . 2.2 pptp? 165.72 156.06 0.09 OUTLIER Pre-proline 0 N--CA 1.47 0.552 0 CA-C-O 121.464 0.65 . . . . 2.18 111.952 -179.51 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.515 ' HD2' ' HB2' ' A' ' 49' ' ' ASP . 3.1 Cg_exo -76.56 172.47 16.16 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 124.602 3.535 . . . . 0.3 113.624 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.493 ' O ' ' N ' ' A' ' 48' ' ' SER . . . -67.76 -173.12 6.76 Favored Glycine 0 C--O 1.223 -0.568 0 CA-C-N 115.17 -0.923 . . . . 0.35 110.944 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.492 ' HG2' ' HB2' ' A' ' 91' ' ' GLN . 53.7 mtmt -42.14 -14.05 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.56 0.948 . . . . 2.35 113.56 -177.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.493 ' N ' ' O ' ' A' ' 46' ' ' GLY . 45.1 t -86.52 7.69 25.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.137 0.494 . . . . 1.45 110.256 178.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.515 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 3.0 p30 -76.18 162.96 27.54 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.515 -0.766 . . . . 1.73 111.368 -179.135 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 60.0 m -123.85 122.93 39.3 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.598 -0.89 . . . . 0.44 108.598 178.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.65 HG12 HG22 ' A' ' 133' ' ' VAL . 2.3 m -122.85 141.08 44.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.285 0.564 . . . . 0.65 112.491 -177.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 66.3 m -113.07 120.08 40.1 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.228 -1.027 . . . . 0.32 108.228 177.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.6 HG12 ' HA ' ' A' ' 130' ' ' LEU . 4.8 m -144.97 177.56 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.231 0.538 . . . . 0.24 111.686 -178.258 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -125.22 131.86 53.08 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.642 -0.873 . . . . 2.4 108.642 178.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -143.78 158.2 43.85 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.701 0.762 . . . . 0.26 112.381 -179.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 59.4 m -122.71 112.44 17.94 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.312 -1.313 . . . . 0.26 108.577 178.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.473 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -109.82 145.77 16.98 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 119.953 -1.118 . . . . 0.12 112.7 -178.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.516 ' NE ' HD13 ' A' ' 125' ' ' ILE . 4.9 ppt_? -148.09 146.97 29.04 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.048 0.452 . . . . 1.93 110.431 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.452 HD11 ' HB3' ' A' ' 122' ' ' GLU . 46.3 tp -76.1 160.36 29.84 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.759 -0.655 . . . . 1.21 109.809 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.525 ' HB ' ' O ' ' A' ' 123' ' ' THR . 9.5 tp -56.34 -10.68 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.251 0.548 . . . . 0.64 109.879 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.422 ' H ' ' C ' ' A' ' 59' ' ' LEU . 20.4 t70 -66.02 -12.4 54.88 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.454 -0.794 . . . . 2.01 110.861 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.82 -0.77 77.14 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.577 -0.821 . . . . 0.45 113.315 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.4 t -118.65 142.33 47.75 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.053 0.454 . . . . 1.4 111.214 -179.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 57' ' ' GLY . 7.0 p -65.96 133.71 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 115.827 -0.624 . . . . 0.28 110.17 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.598 ' HD1' ' N ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -97.43 -22.79 16.39 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.988 -0.551 . . . . 0.24 110.497 179.719 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.598 ' N ' ' HD1' ' A' ' 65' ' ' PHE . 25.4 t70 -176.95 131.7 0.18 Allowed 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.922 -0.581 . . . . 0.3 110.532 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 63.3 p -129.52 123.53 31.67 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.449 -0.342 . . . . 1.3 110.966 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.684 HG21 ' HB2' ' A' ' 75' ' ' ALA . 59.7 p -78.65 -14.35 59.35 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.898 0.38 . . . . 0.34 110.905 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -75.38 -51.83 12.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.048 -0.524 . . . . 2.11 110.604 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.9 ttpm? -61.04 -36.8 80.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.044 -0.525 . . . . 3.41 110.911 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 41.2 m -57.91 -20.03 34.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.206 -0.452 . . . . 1.47 110.744 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.29 4.88 90.03 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.831 -0.699 . . . . 0.7 112.013 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -126.18 117.38 23.6 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.457 0.17 . . . . 3.05 110.931 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -52.99 156.66 9.34 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.395 2.063 . . . . 0.51 112.046 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.684 ' HB2' HG21 ' A' ' 68' ' ' THR . . . -94.21 124.62 38.34 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.42 -0.355 . . . . 0.23 110.601 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.1 t -127.79 118.09 23.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.162 0.506 . . . . 1.26 111.428 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -158.36 167.12 30.58 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.674 -0.694 . . . . 0.36 110.896 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.455 ' OE1' ' HB3' ' A' ' 80' ' ' SER . 18.4 tt0 -85.5 146.0 27.14 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.3 -0.63 . . . . 1.58 109.3 178.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 32.9 m -68.44 -26.51 33.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 113.032 0.753 . . . . 1.07 113.032 -178.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.455 ' HB3' ' OE1' ' A' ' 78' ' ' GLN . 33.4 t -95.53 -3.77 45.98 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 111.937 0.347 . . . . 1.14 111.937 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 -84.87 5.65 27.96 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.733 0.272 . . . . 2.08 111.733 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 1.7 m -112.06 -172.55 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.6 -0.273 . . . . 0.45 111.553 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.529 HG13 ' HB2' ' A' ' 86' ' ' TRP . 29.2 pt -55.99 154.4 14.68 Favored Pre-proline 0 CA--C 1.528 0.13 0 CA-C-N 116.472 -0.331 . . . . 0.75 111.629 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -48.01 -53.67 6.33 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.651 2.234 . . . . 0.65 112.91 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.676 ' CA ' HD11 ' A' ' 32' ' ' LEU . . . -52.93 -49.69 53.9 Favored Glycine 0 CA--C 1.521 0.458 0 C-N-CA 120.802 -0.713 . . . . 0.31 113.112 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' TRP . . . . . 0.529 ' HB2' HG13 ' A' ' 83' ' ' ILE . 0.4 OUTLIER -59.49 -45.57 91.31 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.842 0.312 . . . . 0.78 111.842 -179.069 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 98.4 m -55.66 -37.49 68.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.442 -0.345 . . . . 1.4 111.689 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.64 -49.98 64.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.491 -0.322 . . . . 1.43 111.745 -179.317 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.642 ' HB2' HD22 ' A' ' 32' ' ' LEU . . . -64.39 -49.24 72.36 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.009 0.374 . . . . 0.33 112.009 -179.086 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -57.24 -26.72 61.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.423 -0.353 . . . . 0.39 111.72 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.492 ' HB2' ' HG2' ' A' ' 47' ' ' LYS . 5.1 tp60 -66.43 -24.55 66.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.836 0.35 . . . . 1.87 110.976 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.412 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 4.2 mm? -93.59 -7.51 43.85 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.168 -0.469 . . . . 1.31 111.134 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 69.3 mtp -88.32 108.44 22.15 Favored Pre-proline 0 CA--C 1.531 0.222 0 CA-C-N 116.47 -0.332 . . . . 1.66 111.891 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' A' ' 92' ' ' LEU . 99.0 Cg_endo -79.91 147.07 18.84 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.403 2.068 . . . . 0.44 110.582 178.213 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.495 ' HA ' HD13 ' A' ' 130' ' ' LEU . . . -45.58 126.59 6.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.779 0.323 . . . . 0.36 111.65 -179.145 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.563 ' H ' HD22 ' A' ' 130' ' ' LEU . . . 97.66 -7.8 63.53 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 120.549 -0.834 . . . . 0.34 113.281 178.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 38' ' ' ASN . 33.5 t -69.82 174.83 4.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.876 0.37 . . . . 1.41 111.264 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.452 HG22 HD12 ' A' ' 37' ' ' ILE . 24.5 m -147.31 90.82 1.91 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.987 -0.552 . . . . 0.23 110.471 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.702 ' HE1' ' HB2' ' A' ' 39' ' ' SER . 23.5 m0 -112.11 149.41 32.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.266 0.555 . . . . 0.53 112.189 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -119.59 107.78 13.69 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.311 -0.996 . . . . 1.37 108.311 177.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.604 HG22 ' HB3' ' A' ' 34' ' ' TYR . 48.7 pt -111.07 146.27 16.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 113.221 0.822 . . . . 0.25 113.221 -177.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.471 ' OH ' HG22 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -130.98 103.76 6.73 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.657 -1.156 . . . . 0.31 108.145 178.276 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 4.7 t -105.39 99.75 22.33 Favored Pre-proline 0 C--N 1.33 -0.265 0 N-CA-C 113.709 1.003 . . . . 0.52 113.709 -176.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.59 ' HG2' HD23 ' A' ' 107' ' ' LEU . 11.6 Cg_endo -58.73 151.15 65.78 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 121.701 1.601 . . . . 0.48 109.814 176.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -47.49 -31.87 4.67 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.544 0.572 . . . . 1.81 112.544 -178.239 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -56.97 -13.9 9.38 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.667 -0.778 . . . . 0.4 113.949 -178.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.59 HD23 ' HG2' ' A' ' 104' ' ' PRO . 2.8 mm? -115.19 -5.87 12.42 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 117.09 0.445 . . . . 2.35 111.788 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -109.41 -104.41 0.37 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.551 -0.295 . . . . 1.03 110.621 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -90.22 -17.24 27.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.96 0.41 . . . . 1.44 110.557 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 103.94 143.07 12.19 Favored Glycine 0 CA--C 1.522 0.471 0 CA-C-N 115.849 -0.614 . . . . 1.58 113.863 178.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.482 ' HA ' ' H ' ' A' ' 121' ' ' ASN . 18.8 Cg_endo -59.76 -8.43 7.51 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.542 2.828 . . . . 1.49 113.355 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.558 ' C ' ' H ' ' A' ' 114' ' ' VAL . 23.1 mtp180 -75.63 171.7 13.86 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.898 -0.321 . . . . 3.51 110.643 -178.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 38.1 t -55.9 3.12 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.059 -0.519 . . . . 1.63 112.244 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.558 ' H ' ' C ' ' A' ' 112' ' ' ARG . 31.0 m -96.52 19.67 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.75 0.309 . . . . 2.9 110.823 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -63.48 116.36 9.17 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.736 -0.745 . . . . 1.05 112.077 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -79.28 -115.38 0.24 Allowed Glycine 0 CA--C 1.521 0.448 0 C-N-CA 120.789 -0.72 . . . . 0.8 112.885 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -58.86 -35.43 98.62 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.283 1.989 . . . . 0.7 111.92 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.47 HG12 HD13 ' A' ' 124' ' ' LEU . 97.9 mt -91.07 124.65 43.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.993 -0.549 . . . . 1.25 110.273 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -45.55 155.21 0.5 Allowed Glycine 0 CA--C 1.522 0.481 0 CA-C-N 115.981 -0.554 . . . . 0.48 113.469 -179.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -62.11 131.02 32.73 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.282 1.988 . . . . 0.67 111.466 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.482 ' H ' ' HA ' ' A' ' 111' ' ' PRO . 1.8 m-80 47.92 35.32 4.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.073 0.463 . . . . 1.12 110.097 -178.432 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.452 ' HB3' HD11 ' A' ' 59' ' ' LEU . 11.3 mt-10 -115.6 135.39 54.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.044 -0.526 . . . . 1.73 110.904 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.525 ' O ' ' HB ' ' A' ' 60' ' ' ILE . 92.6 m -95.7 129.36 42.94 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.568 -0.53 . . . . 0.29 109.568 179.005 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.47 HD13 HG12 ' A' ' 118' ' ' ILE . 0.2 OUTLIER -117.45 150.48 38.84 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.168 0.509 . . . . 1.47 111.53 -178.593 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.536 ' N ' HD12 ' A' ' 125' ' ' ILE . 4.1 mp -113.48 140.56 33.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.567 -0.742 . . . . 0.2 110.08 179.076 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.413 ' CE1' HD22 ' A' ' 124' ' ' LEU . 74.9 m-85 -131.82 132.09 43.42 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.09 -0.505 . . . . 0.24 111.179 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -109.71 103.8 12.68 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.171 -0.677 . . . . 2.28 109.171 178.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 15.6 mt -102.81 122.58 55.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 112.634 0.605 . . . . 0.82 112.634 -177.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -118.26 100.09 7.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.243 -0.889 . . . . 0.26 108.74 178.076 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.6 ' HA ' HG12 ' A' ' 53' ' ' VAL . 0.8 OUTLIER -78.93 124.38 28.19 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.14 -0.482 . . . . 1.41 111.92 -178.047 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 35.3 mm -94.25 -50.52 11.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.642 -0.708 . . . . 1.17 110.09 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.463 ' HA ' ' HB1' ' A' ' 95' ' ' ALA . 51.9 p -164.5 165.12 21.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.922 -0.581 . . . . 1.17 110.244 179.302 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.65 HG22 HG12 ' A' ' 51' ' ' VAL . 96.8 t -130.72 117.86 40.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.803 0.335 . . . . 1.43 111.302 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 5.5 tmtp? 51.03 62.39 2.74 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.933 -0.576 . . . . 3.08 110.711 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 68.9 mttm 59.05 43.65 17.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.811 -0.631 . . . . 3.16 110.35 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 86.8 p 50.55 31.88 6.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.431 -0.804 . . . . 1.31 111.037 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 45.1 t . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.216 -0.897 . . . . 2.53 110.847 -179.873 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 . . . . . 0 N--CA 1.485 1.305 0 CA-C-O 120.81 0.338 . . . . 3.09 110.962 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -62.86 -21.73 66.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 2.08 111.153 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -61.52 -38.99 89.38 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.416 -0.587 . . . . 3.23 109.416 178.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -79.6 -34.74 40.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.557 -0.747 . . . . 2.63 109.622 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.485 ' HA ' ' ND2' ' A' ' 8' ' ' ASN . . . -57.65 -52.28 66.06 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.757 -0.656 . . . . 0.82 110.115 179.273 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -64.41 -36.15 83.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.784 -0.644 . . . . 2.57 109.484 178.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -55.68 -33.46 64.15 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.8 -0.815 . . . . 2.1 108.8 178.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.485 ' ND2' ' HA ' ' A' ' 5' ' ' ALA . 19.3 m-20 -69.1 -39.44 78.97 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 115.572 -0.74 . . . . 1.4 109.961 179.171 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -56.7 -32.4 65.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.709 -0.678 . . . . 2.67 111.037 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.8 t -78.03 -52.87 15.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.374 -0.375 . . . . 1.27 111.895 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.483 ' HG2' ' HA ' ' A' ' 8' ' ' ASN . 10.2 ptpp? -63.18 -26.06 68.63 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.895 0.379 . . . . 1.69 110.59 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.409 ' O ' ' HG ' ' A' ' 16' ' ' LEU . . . -75.76 -50.33 8.06 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.841 -0.695 . . . . 0.31 111.667 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.471 ' HA ' HD11 ' A' ' 16' ' ' LEU . 12.8 pt-20 -66.41 -27.56 67.94 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.873 0.368 . . . . 2.39 110.188 179.281 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.02 -34.19 61.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.096 -0.502 . . . . 0.23 110.491 179.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -63.75 -55.81 20.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.753 -0.658 . . . . 0.23 110.573 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.699 ' HA ' ' HB3' ' A' ' 19' ' ' ASN . 0.4 OUTLIER -64.16 -31.79 73.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.228 -0.442 . . . . 0.55 111.04 179.968 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.5 m -56.56 -47.65 79.01 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.607 -0.516 . . . . 0.27 109.607 179.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -73.61 -32.19 63.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.825 -0.625 . . . . 2.47 109.865 178.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.699 ' HB3' ' HA ' ' A' ' 16' ' ' LEU . 1.2 t-20 -59.09 -25.58 63.92 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.635 -0.711 . . . . 0.22 111.573 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -46.89 -20.21 0.13 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.536 -0.302 . . . . 2.45 111.605 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -68.67 -37.12 79.37 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.436 -0.347 . . . . 0.4 110.991 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.805 ' O ' HG23 ' A' ' 25' ' ' VAL . 4.3 mptp? -50.53 118.83 10.2 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.067 -0.515 . . . . 1.4 110.251 179.058 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 22' ' ' LYS . 18.1 Cg_endo -57.06 147.06 77.48 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.33 2.02 . . . . 0.65 112.649 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.02 3.46 79.58 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.869 -0.681 . . . . 0.37 113.967 179.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.805 HG23 ' O ' ' A' ' 22' ' ' LYS . 38.1 t -55.09 106.43 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 117.563 0.681 . . . . 0.91 110.681 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.4 HG13 ' CE1' ' A' ' 34' ' ' TYR . 2.6 p -130.76 126.73 60.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.868 -0.605 . . . . 1.03 111.133 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.8 p -80.16 142.47 13.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.05 -0.523 . . . . 0.91 110.77 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.578 HD12 ' HB2' ' A' ' 32' ' ' LEU . 63.0 mt -101.73 167.85 9.95 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.476 -0.329 . . . . 0.4 110.673 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.46 ' HD2' ' HB3' ' A' ' 28' ' ' LEU . 71.4 Cg_exo -51.49 -31.95 41.3 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 121.923 1.748 . . . . 0.59 111.742 178.695 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.476 ' O ' HD22 ' A' ' 107' ' ' LEU . 30.3 t -86.44 -11.21 52.49 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.231 -0.44 . . . . 1.14 110.87 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.04 14.91 23.43 Favored Glycine 0 C--N 1.335 0.474 0 C-N-CA 120.563 -0.827 . . . . 0.34 114.298 178.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.748 HD11 ' CA ' ' A' ' 85' ' ' GLY . 6.8 mp -84.33 134.65 34.49 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.364 0.876 . . . . 1.35 113.364 -178.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.6 mp0 -114.28 142.54 46.17 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.082 -1.081 . . . . 1.75 108.082 177.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.484 ' CB ' HG22 ' A' ' 101' ' ' ILE . 27.8 p90 -158.97 175.18 13.87 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 113.173 0.805 . . . . 0.32 113.173 -178.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -122.48 117.3 25.61 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 114.768 -1.105 . . . . 2.15 109.536 179.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 66.6 t -77.3 126.25 37.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 113.424 0.898 . . . . 0.3 113.424 -178.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.405 ' HB ' ' O ' ' A' ' 98' ' ' THR . 78.0 mt -101.3 -65.99 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 115.408 -0.815 . . . . 0.65 109.872 178.096 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -129.84 95.54 3.99 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 116.394 -0.366 . . . . 1.03 110.094 178.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.713 ' HB3' ' HE1' ' A' ' 99' ' ' TRP . 68.2 p -105.15 145.88 29.97 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.262 0.467 . . . . 1.5 112.262 -178.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.92 103.18 0.07 OUTLIER Glycine 0 C--N 1.332 0.36 0 CA-C-N 115.686 -0.688 . . . . 1.09 113.168 179.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -152.52 -82.56 0.09 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.691 0.282 . . . . 1.7 111.15 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.13 174.2 38.49 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 121.191 -0.528 . . . . 0.35 113.743 -179.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.619 ' O ' ' HB3' ' A' ' 44' ' ' LYS . 33.8 m -82.42 176.4 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 C-N-CA 123.401 0.68 . . . . 1.42 110.409 179.029 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.619 ' HB3' ' O ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER 165.1 156.54 0.08 OUTLIER Pre-proline 0 N--CA 1.471 0.591 0 CA-C-O 121.47 0.653 . . . . 2.18 112.33 -179.236 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.555 ' HD3' HG11 ' A' ' 133' ' ' VAL . 1.8 Cg_endo -85.36 173.47 7.63 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 125.082 3.854 . . . . 0.3 113.367 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' A' ' 48' ' ' SER . . . -68.28 -172.34 6.94 Favored Glycine 0 C--O 1.223 -0.572 0 CA-C-N 115.216 -0.902 . . . . 0.35 111.451 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -41.64 -13.48 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.763 1.023 . . . . 2.35 113.763 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 46' ' ' GLY . 50.5 m -86.16 7.51 24.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.46 0.647 . . . . 1.45 109.851 178.312 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.487 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 1.8 t70 -74.84 162.15 28.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.887 -1.051 . . . . 1.73 112.326 -179.04 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 90.3 m -125.56 133.85 52.16 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 108.752 -0.833 . . . . 0.44 108.752 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.636 HG12 HG22 ' A' ' 133' ' ' VAL . 30.1 m -131.74 140.37 48.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 112.807 0.669 . . . . 0.65 112.807 -178.331 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 89.4 m -112.98 119.86 39.39 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.083 -1.08 . . . . 0.32 108.083 177.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.568 HG12 ' HA ' ' A' ' 130' ' ' LEU . 5.0 m -146.4 -179.17 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.229 0.538 . . . . 0.24 111.943 -178.032 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -130.04 132.13 46.09 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.37 -0.832 . . . . 2.4 108.977 178.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -147.18 167.11 25.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.757 0.789 . . . . 0.26 112.412 -178.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 58.3 m -131.19 113.99 14.55 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.384 -1.28 . . . . 0.26 108.728 178.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.405 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -109.53 147.53 17.03 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 119.989 -1.1 . . . . 0.12 112.452 -178.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.34 145.93 31.4 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.046 0.451 . . . . 1.93 110.429 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.494 HD23 HD11 ' A' ' 124' ' ' LEU . 6.9 mt -79.9 153.39 29.04 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.688 -0.687 . . . . 1.21 110.255 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.497 ' HB ' ' O ' ' A' ' 123' ' ' THR . 0.4 OUTLIER -55.64 -14.35 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.401 0.619 . . . . 0.64 109.411 178.936 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -65.11 -10.87 34.07 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.266 -0.879 . . . . 2.01 110.93 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.02 0.03 75.14 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.547 -0.835 . . . . 0.45 113.837 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.0 t -121.64 131.53 54.15 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 117.646 0.723 . . . . 1.4 111.865 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 57' ' ' GLY . 3.9 p -61.68 134.35 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-N 115.709 -0.678 . . . . 0.28 110.049 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.69 ' HD1' ' H ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -97.66 -27.36 14.4 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.097 -0.501 . . . . 0.24 111.565 -179.882 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.69 ' H ' ' HD1' ' A' ' 65' ' ' PHE . 13.9 t70 -176.83 129.96 0.18 Allowed 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 120.619 0.247 . . . . 0.3 110.54 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 57.6 p -129.18 117.46 20.8 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.455 -0.339 . . . . 1.3 110.736 179.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 65.3 p -74.83 -12.35 60.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.065 0.459 . . . . 0.34 110.449 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -75.73 -46.91 28.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.632 -0.713 . . . . 2.11 111.25 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -71.18 -36.46 71.97 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.028 -0.533 . . . . 3.41 111.751 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 54.5 p -59.61 -12.62 7.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.788 0.327 . . . . 1.47 111.296 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 75.01 8.47 83.06 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.795 -0.717 . . . . 0.7 112.415 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -122.97 117.75 28.4 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.572 0.225 . . . . 3.05 110.875 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.09 153.18 16.54 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.667 2.245 . . . . 0.51 112.6 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -96.58 124.74 40.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.022 -0.535 . . . . 0.23 110.448 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.8 t -130.44 118.19 20.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.089 0.471 . . . . 1.26 111.297 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -158.54 161.82 37.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.022 -0.535 . . . . 0.36 111.108 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.66 146.5 30.01 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.12 -0.491 . . . . 1.58 109.965 179.143 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 87' ' ' THR . 20.0 m -66.54 -30.88 51.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 112.771 0.656 . . . . 1.07 112.771 -178.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.474 ' HA ' HG23 ' A' ' 87' ' ' THR . 46.8 t -95.76 -6.39 39.82 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 112.438 0.533 . . . . 1.14 112.438 -178.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -84.92 5.66 28.13 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 111.89 0.33 . . . . 2.08 111.89 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.408 HG21 ' HB3' ' A' ' 86' ' ' TRP . 3.7 m -110.41 -173.37 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 111.749 0.277 . . . . 0.45 111.749 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.464 HG13 ' H ' ' A' ' 86' ' ' TRP . 45.4 pt -56.03 156.43 10.25 Favored Pre-proline 0 CA--C 1.53 0.2 0 CA-C-N 116.428 -0.351 . . . . 0.75 111.631 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -46.07 -59.56 1.16 Allowed 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.858 2.372 . . . . 0.65 113.262 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.748 ' CA ' HD11 ' A' ' 32' ' ' LEU . . . -50.9 -49.46 41.87 Favored Glycine 0 CA--C 1.521 0.454 0 C-N-CA 120.858 -0.686 . . . . 0.31 113.114 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' TRP . . . . . 0.464 ' H ' HG13 ' A' ' 83' ' ' ILE . 0.3 OUTLIER -61.72 -38.51 88.17 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.915 0.339 . . . . 0.78 111.915 -178.955 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' ' 79' ' ' VAL . 50.6 m -61.02 -35.55 77.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.721 0.296 . . . . 1.4 111.35 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -70.38 -42.64 71.46 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.279 -0.418 . . . . 1.43 111.798 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.544 ' HB2' HD22 ' A' ' 32' ' ' LEU . . . -75.51 -51.99 11.68 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.429 0.529 . . . . 0.33 112.429 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -54.93 -39.35 68.76 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.432 0.53 . . . . 0.39 112.432 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -67.23 -9.59 41.95 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.667 0.27 . . . . 1.87 111.443 -179.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 83.2 mt -103.42 -7.88 20.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.433 -0.349 . . . . 1.31 111.019 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.402 ' HE2' ' HE3' ' A' ' 99' ' ' TRP . 68.0 mtt -85.95 110.07 27.61 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.315 -0.402 . . . . 1.66 111.641 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.534 ' HG2' ' HB3' ' A' ' 97' ' ' SER . 74.3 Cg_endo -74.67 147.28 35.22 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.35 2.033 . . . . 0.44 111.477 179.163 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.594 ' HA ' HD23 ' A' ' 130' ' ' LEU . . . -50.02 126.72 15.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.505 -0.316 . . . . 0.36 111.594 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 94.97 -8.84 70.43 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 120.717 -0.754 . . . . 0.34 113.148 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.534 ' HB3' ' HG2' ' A' ' 94' ' ' PRO . 98.4 p -70.57 -176.52 1.29 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.926 0.393 . . . . 1.41 111.417 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.405 ' O ' ' HB ' ' A' ' 37' ' ' ILE . 24.3 m -159.03 97.44 1.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.762 -0.654 . . . . 0.23 110.605 -179.415 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.713 ' HE1' ' HB3' ' A' ' 39' ' ' SER . 34.9 m0 -115.11 149.06 38.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.233 0.54 . . . . 0.53 111.717 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.424 ' O ' ' HB2' ' A' ' 34' ' ' TYR . 27.0 tt0 -115.16 107.23 15.04 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.827 -1.175 . . . . 1.37 107.827 177.357 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.484 HG22 ' CB ' ' A' ' 34' ' ' TYR . 13.8 pt -114.58 140.57 34.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 113.602 0.964 . . . . 0.25 113.602 -177.019 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -120.58 104.33 9.86 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.959 -1.126 . . . . 0.31 107.959 177.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.59 HG13 HD12 ' A' ' 107' ' ' LEU . 52.9 t -93.35 98.23 2.37 Favored Pre-proline 0 C--N 1.329 -0.284 0 N-CA-C 113.563 0.949 . . . . 0.52 113.563 -177.101 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.458 ' HD2' ' HA ' ' A' ' 103' ' ' VAL . 6.9 Cg_endo -53.08 150.94 22.69 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.267 1.978 . . . . 0.48 111.407 177.352 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.555 ' HB2' ' HA3' ' A' ' 110' ' ' GLY . 3.5 p -48.02 -43.36 29.94 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.293 0.479 . . . . 1.81 112.293 -179.52 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -57.32 -9.14 4.14 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 115.384 0.914 . . . . 0.4 115.384 -177.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.59 HD12 HG13 ' A' ' 103' ' ' VAL . 46.3 mt -91.64 -19.27 22.86 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 118.244 1.022 . . . . 2.35 112.937 -178.267 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.429 ' HB2' HD12 ' A' ' 83' ' ' ILE . . . -130.05 -125.53 0.21 Allowed 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.761 -0.376 . . . . 1.03 111.769 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.406 ' HE2' HG22 ' A' ' 83' ' ' ILE . 88.5 m-85 -89.23 4.72 47.74 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.198 0.523 . . . . 1.44 110.147 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.555 ' HA3' ' HB2' ' A' ' 105' ' ' SER . . . -38.51 -79.0 0.04 OUTLIER Glycine 0 CA--C 1.524 0.628 0 CA-C-N 115.047 -0.978 . . . . 1.58 114.986 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -56.62 -9.86 4.44 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 123.339 2.692 . . . . 1.49 113.865 -177.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.409 ' C ' ' H ' ' A' ' 114' ' ' VAL . 40.6 mmt180 -79.48 139.71 37.53 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.897 -0.408 . . . . 3.51 109.897 179.053 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 79.6 p -63.12 -2.12 1.21 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.991 0.424 . . . . 1.63 111.193 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.429 HG13 ' O ' ' A' ' 114' ' ' VAL . 7.9 p -110.65 60.55 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.85 -0.613 . . . . 2.9 110.612 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -41.92 100.93 0.02 OUTLIER Glycine 0 C--N 1.334 0.457 0 CA-C-N 115.695 -0.684 . . . . 1.05 112.848 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -69.21 -128.87 0.05 OUTLIER Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.878 -0.677 . . . . 0.8 112.324 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_exo -60.46 -36.66 85.6 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 121.901 1.734 . . . . 0.7 111.093 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.59 HG23 HD12 ' A' ' 124' ' ' LEU . 94.8 mt -92.37 134.03 31.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.5 -0.773 . . . . 1.25 109.944 178.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -48.55 146.69 5.53 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.526 -0.845 . . . . 0.48 112.244 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -54.78 130.54 40.98 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.265 1.976 . . . . 0.67 111.861 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 42.75 35.16 0.66 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.033 -0.531 . . . . 1.12 110.65 -179.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.453 ' OE1' HD22 ' A' ' 59' ' ' LEU . 24.5 tt0 -116.54 142.86 46.33 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.826 -0.625 . . . . 1.73 111.074 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.54 HG21 HD23 ' A' ' 16' ' ' LEU . 92.7 m -95.66 129.53 42.83 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.548 -0.538 . . . . 0.29 109.548 178.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.59 HD12 HG23 ' A' ' 118' ' ' ILE . 0.1 OUTLIER -113.93 154.55 27.37 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.358 0.599 . . . . 1.47 112.279 -177.992 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.5 mp -113.92 140.75 32.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.174 -0.921 . . . . 0.2 109.585 178.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.457 ' CE1' HD22 ' A' ' 124' ' ' LEU . 82.2 m-85 -135.47 131.97 36.78 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.024 0.44 . . . . 0.24 111.445 -179.324 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.432 ' NZ ' ' HB3' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -114.4 102.8 10.44 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.189 -1.041 . . . . 2.28 108.189 177.87 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.441 HG23 HG21 ' A' ' 53' ' ' VAL . 12.2 mt -103.73 130.58 53.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 112.684 0.624 . . . . 0.82 112.684 -177.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -117.88 101.01 7.95 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.129 -0.941 . . . . 0.26 108.919 178.221 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.594 HD23 ' HA ' ' A' ' 95' ' ' ALA . 0.3 OUTLIER -78.5 123.29 26.9 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.119 0.485 . . . . 1.41 111.814 -178.274 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 58.6 mt -93.39 -53.13 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 115.518 -0.765 . . . . 1.17 110.92 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.469 ' HA ' ' HB1' ' A' ' 95' ' ' ALA . 60.7 p -164.53 165.57 21.12 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.055 0.455 . . . . 1.17 111.259 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.636 HG22 HG12 ' A' ' 51' ' ' VAL . 2.1 t -111.84 126.09 69.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.642 -0.708 . . . . 1.43 110.772 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 18.2 tttt 44.52 57.38 4.47 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.93 -0.577 . . . . 3.08 110.917 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm 60.85 34.5 19.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.572 -0.74 . . . . 3.16 111.336 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.439 ' HB2' ' HB2' ' A' ' 132' ' ' SER . 39.0 t 55.42 64.27 1.82 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.852 -0.613 . . . . 1.31 111.205 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 53.6 m . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.3 -0.857 . . . . 2.53 110.821 179.762 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 . . . . . 0 N--CA 1.485 1.306 0 CA-C-O 120.755 0.312 . . . . 3.09 110.841 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -67.45 -18.83 65.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 2.08 110.895 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -58.51 -40.32 82.52 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.663 -0.495 . . . . 3.23 109.663 179.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -78.78 -34.41 45.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.77 -0.65 . . . . 2.63 109.89 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.494 ' HB1' ' ND2' ' A' ' 121' ' ' ASN . . . -58.97 -52.43 65.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.875 -0.602 . . . . 0.82 110.127 179.347 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -63.96 -35.23 80.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.725 -0.671 . . . . 2.57 110.218 179.14 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -55.92 -32.58 63.9 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.334 -0.617 . . . . 2.1 109.334 178.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 13.7 m-20 -74.07 -37.46 64.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.445 -0.798 . . . . 1.4 110.826 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 52.6 tptt -63.9 -38.51 91.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 2.67 111.64 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.404 HG23 ' N ' ' A' ' 11' ' ' LYS . 16.1 m -71.58 -48.44 52.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 C-N-CA 121.189 -0.204 . . . . 1.27 111.514 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.497 ' HG3' HG21 ' A' ' 60' ' ' ILE . 18.1 ptpt -68.81 -25.71 64.82 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.835 0.35 . . . . 1.69 110.486 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.62 -53.26 8.63 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 121.066 -0.588 . . . . 0.31 112.143 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.412 ' HA ' HD11 ' A' ' 16' ' ' LEU . 43.8 tt0 -62.13 -27.89 69.25 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.096 0.474 . . . . 2.39 110.313 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.13 -30.63 49.43 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.951 -0.568 . . . . 0.23 110.423 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -65.94 -52.73 47.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.752 -0.658 . . . . 0.23 110.612 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.663 ' HA ' ' HB3' ' A' ' 19' ' ' ASN . 0.4 OUTLIER -67.62 -32.06 72.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.268 -0.424 . . . . 0.55 111.078 179.91 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.2 m -56.67 -47.58 79.5 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 109.748 -0.464 . . . . 0.27 109.748 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -73.05 -32.52 65.1 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.859 -0.61 . . . . 2.47 109.812 178.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.663 ' HB3' ' HA ' ' A' ' 16' ' ' LEU . 1.1 t-20 -59.46 -25.01 64.03 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.439 -0.8 . . . . 0.22 111.582 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -49.97 -20.35 0.91 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.518 -0.31 . . . . 2.45 111.722 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -68.96 -33.13 73.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.378 -0.374 . . . . 0.4 111.53 -178.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.663 ' O ' HG23 ' A' ' 25' ' ' VAL . 12.6 mptt -48.35 118.69 6.97 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 116.188 -0.46 . . . . 1.4 110.906 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.46 ' O ' ' HG2' ' A' ' 35' ' ' LYS . 32.1 Cg_exo -57.52 139.18 89.38 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.316 2.011 . . . . 0.65 112.651 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.83 3.39 80.27 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 120.863 -0.684 . . . . 0.37 114.025 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.663 HG23 ' O ' ' A' ' 22' ' ' LYS . 4.0 t -53.52 117.67 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.175 0 CA-C-N 117.425 0.613 . . . . 0.91 110.826 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 33' ' ' GLN . 4.3 p -129.87 128.16 64.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.064 -0.516 . . . . 1.03 111.061 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.3 p -85.69 141.97 13.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.459 . . . . 0.91 111.078 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.537 HD12 ' HB2' ' A' ' 32' ' ' LEU . 41.5 mt -104.1 165.34 13.57 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.011 -0.541 . . . . 0.4 110.609 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.45 ' HD2' ' HB3' ' A' ' 28' ' ' LEU . 72.2 Cg_exo -50.48 -38.34 53.64 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.179 1.919 . . . . 0.59 112.26 179.326 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.421 ' OG ' ' HG3' ' A' ' 88' ' ' GLU . 7.3 m -80.76 -9.59 59.79 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.2 -0.454 . . . . 1.14 111.368 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.3 14.52 27.99 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.331 -0.938 . . . . 0.34 113.48 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.537 ' HB2' HD12 ' A' ' 28' ' ' LEU . 0.4 OUTLIER -83.11 134.86 34.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.45 0.643 . . . . 1.35 112.168 -179.28 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.422 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 47.4 mt-30 -123.34 143.0 50.38 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.984 -1.007 . . . . 1.75 108.636 178.332 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.799 ' HB3' HG22 ' A' ' 101' ' ' ILE . 48.3 p90 -157.83 175.39 13.93 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.809 0.67 . . . . 0.32 112.809 -178.303 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.46 ' HG2' ' O ' ' A' ' 23' ' ' PRO . 3.5 tmmm? -122.2 118.94 29.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.001 -0.999 . . . . 2.15 109.321 178.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.646 HG13 ' HE1' ' A' ' 99' ' ' TRP . 48.5 t -71.93 125.61 30.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 113.279 0.844 . . . . 0.3 113.279 -177.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.3 mp -98.81 -66.24 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.319 -0.855 . . . . 0.65 110.11 178.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -144.89 90.51 2.06 Favored 'General case' 0 CA--C 1.527 0.062 0 CA-C-N 116.471 -0.332 . . . . 1.03 110.166 179.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.637 ' HB3' ' HE1' ' A' ' 99' ' ' TRP . 94.9 p -105.32 145.98 30.0 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.932 0.396 . . . . 1.5 112.006 -178.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 91.59 94.4 1.33 Allowed Glycine 0 C--N 1.332 0.352 0 CA-C-N 115.854 -0.612 . . . . 1.09 112.764 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -150.93 -81.89 0.1 Allowed 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 111.776 0.287 . . . . 1.7 111.776 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.09 178.53 42.01 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 121.088 -0.577 . . . . 0.35 114.161 -178.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.621 ' O ' ' HB3' ' A' ' 44' ' ' LYS . 27.3 m -90.32 176.89 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 123.729 0.812 . . . . 1.42 110.33 179.169 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.621 ' HB3' ' O ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER 165.08 156.6 0.08 OUTLIER Pre-proline 0 N--CA 1.472 0.668 0 CA-C-O 121.486 0.66 . . . . 2.18 112.172 -179.61 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.431 ' HD2' HG21 ' A' ' 133' ' ' VAL . 2.8 Cg_exo -77.72 173.52 14.0 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 124.752 3.634 . . . . 0.3 112.955 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.492 ' O ' ' N ' ' A' ' 48' ' ' SER . . . -67.54 -172.84 6.28 Favored Glycine 0 N--CA 1.448 -0.5 0 CA-C-N 115.368 -0.833 . . . . 0.35 111.037 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? -41.88 -13.88 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.707 1.003 . . . . 2.35 113.707 -177.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 46' ' ' GLY . 84.5 p -86.54 7.37 26.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.065 0.459 . . . . 1.45 110.522 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.411 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 4.0 p30 -72.08 156.14 39.52 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.71 -0.677 . . . . 1.73 111.993 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 26.0 m -126.67 119.72 27.69 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 108.481 -0.933 . . . . 0.44 108.481 178.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.471 HG12 ' HA ' ' A' ' 133' ' ' VAL . 14.3 m -128.67 158.4 41.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.222 0.534 . . . . 0.65 112.326 -178.233 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 94.2 m -113.78 120.8 42.05 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.337 -0.847 . . . . 0.32 109.115 178.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.693 HG11 HD22 ' A' ' 130' ' ' LEU . 6.1 m -139.4 170.11 16.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.137 0.494 . . . . 0.24 111.6 -178.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -124.05 132.31 53.66 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.375 -0.83 . . . . 2.4 109.128 178.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.408 ' HB2' ' O ' ' A' ' 127' ' ' LYS . 14.7 p90 -144.05 164.6 30.17 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.683 0.754 . . . . 0.26 112.491 -178.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 37.9 m -123.56 113.39 18.64 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.426 -1.261 . . . . 0.26 108.565 178.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.467 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -110.02 143.81 16.79 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 119.684 -1.246 . . . . 0.12 112.677 -178.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.466 ' NH2' ' HA2' ' A' ' 62' ' ' GLY . 0.5 OUTLIER -147.62 147.0 29.57 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.004 0.431 . . . . 1.93 110.589 179.552 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.48 HD22 ' OE1' ' A' ' 122' ' ' GLU . 3.8 mt -78.83 158.03 28.24 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.858 -0.61 . . . . 1.21 110.254 179.32 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.497 HG21 ' HG3' ' A' ' 11' ' ' LYS . 0.4 OUTLIER -58.16 -14.21 3.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 108.957 -0.757 . . . . 0.64 108.957 178.64 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -63.64 -12.48 34.05 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.14 -0.936 . . . . 2.01 110.837 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.466 ' HA2' ' NH2' ' A' ' 58' ' ' ARG . . . 91.15 -0.31 75.31 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 120.634 -0.793 . . . . 0.45 113.673 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.3 t -119.85 132.46 55.58 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 117.374 0.587 . . . . 1.4 111.507 -178.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 57' ' ' GLY . 6.2 p -61.18 134.7 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 115.807 -0.633 . . . . 0.28 109.906 179.187 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.646 ' HD1' ' H ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -97.5 -26.54 14.79 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.241 -0.436 . . . . 0.24 111.266 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.646 ' H ' ' HD1' ' A' ' 65' ' ' PHE . 16.3 t70 -176.33 129.98 0.21 Allowed 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 120.809 0.338 . . . . 0.3 111.085 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 62.4 m -123.79 123.89 41.48 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.235 -0.439 . . . . 1.3 110.452 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.871 HG21 ' HB2' ' A' ' 75' ' ' ALA . 33.7 p -70.56 -8.41 51.2 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.94 0.4 . . . . 0.34 110.652 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -75.39 -46.85 30.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.861 -0.609 . . . . 2.11 110.794 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -61.94 -38.7 89.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.981 -0.554 . . . . 3.41 111.304 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 14.2 m -60.73 -13.54 15.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.143 0.496 . . . . 1.47 110.182 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 73.8 3.54 63.92 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.69 -0.687 . . . . 0.7 112.351 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -127.21 124.68 23.85 Favored Pre-proline 0 C--N 1.33 -0.262 0 C-N-CA 121.325 -0.15 . . . . 3.05 111.071 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -53.75 162.68 3.45 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.284 1.989 . . . . 0.51 111.517 179.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.871 ' HB2' HG21 ' A' ' 68' ' ' THR . . . -93.94 124.31 37.86 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.446 -0.343 . . . . 0.23 110.812 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 27.5 m -123.87 116.22 22.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.751 0.31 . . . . 1.26 111.079 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -158.72 159.46 35.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 0.36 111.34 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.445 ' HB3' ' HG2' ' A' ' 81' ' ' GLN . 0.0 OUTLIER -81.48 143.74 31.85 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 108.983 -0.747 . . . . 1.58 108.983 178.317 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.8 m -70.83 -14.4 17.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 113.008 0.744 . . . . 1.07 113.008 -178.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 66.0 m -95.49 -19.18 20.05 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.197 0.443 . . . . 1.14 112.197 -179.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.445 ' HG2' ' HB3' ' A' ' 78' ' ' GLN . 78.2 mm-40 -79.62 6.26 11.06 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.412 0.523 . . . . 2.08 112.412 -179.028 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.4 m -111.25 -175.7 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 112.685 0.624 . . . . 0.45 112.685 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.488 HD12 HD12 ' A' ' 107' ' ' LEU . 42.4 pt -56.12 160.45 4.75 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 115.836 -0.62 . . . . 0.75 112.595 -179.112 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.637 ' O ' HG22 ' A' ' 87' ' ' THR . 78.1 Cg_exo -47.86 -60.75 0.76 Allowed 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 123.102 2.535 . . . . 0.65 114.204 -178.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 1.004 ' H ' HD11 ' A' ' 107' ' ' LEU . . . -53.17 -48.3 59.28 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.759 -0.734 . . . . 0.31 113.386 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' TRP . . . . . 0.4 ' HB2' HG13 ' A' ' 83' ' ' ILE . 0.9 OUTLIER -54.81 -47.95 73.38 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.798 0.666 . . . . 0.78 112.798 -178.567 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.637 HG22 ' O ' ' A' ' 84' ' ' PRO . 11.6 t -62.68 -33.87 75.97 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.713 -0.395 . . . . 1.4 111.779 -179.012 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.486 ' O ' ' HG2' ' A' ' 91' ' ' GLN . 18.3 mm-40 -70.79 -40.85 72.3 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.924 0.342 . . . . 1.43 111.924 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.84 -49.45 17.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.871 0.367 . . . . 0.33 111.585 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.559 HD13 ' SD ' ' A' ' 93' ' ' MET . 3.5 mm? -55.87 -41.33 74.24 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.888 -0.596 . . . . 0.39 112.06 -179.303 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.486 ' HG2' ' O ' ' A' ' 88' ' ' GLU . 13.6 pt20 -65.41 -3.76 4.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.635 -0.257 . . . . 1.87 111.636 -179.301 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 94.7 mt -104.97 -29.61 10.35 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.713 0.264 . . . . 1.31 111.713 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.559 ' SD ' HD13 ' A' ' 90' ' ' LEU . 24.0 ptp -81.91 111.05 23.5 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-O 120.615 0.245 . . . . 1.66 111.537 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.87 147.18 61.59 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.227 1.952 . . . . 0.44 111.45 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.58 ' HB1' ' HA ' ' A' ' 132' ' ' SER . . . -46.35 127.15 8.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.469 -0.332 . . . . 0.36 111.115 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 103.56 -7.61 50.6 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.896 -0.669 . . . . 0.34 112.717 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 66.4 m -79.94 -175.47 4.96 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.845 0.355 . . . . 1.41 111.39 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 14.1 m -156.75 104.09 2.12 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.032 -0.531 . . . . 0.23 111.083 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.646 ' HE1' HG13 ' A' ' 36' ' ' VAL . 30.5 m0 -125.15 149.23 48.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.252 -0.431 . . . . 0.53 111.058 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.417 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 12.6 pt-20 -119.05 108.52 14.82 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.556 -0.905 . . . . 1.37 108.556 177.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.799 HG22 ' HB3' ' A' ' 34' ' ' TYR . 37.3 pt -108.17 139.67 29.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 112.963 0.727 . . . . 0.25 112.963 -177.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.416 ' OH ' HG22 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -113.95 103.91 11.63 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.783 -1.192 . . . . 0.31 107.783 177.886 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.492 HG11 HD12 ' A' ' 107' ' ' LEU . 40.7 t -94.57 102.04 7.98 Favored Pre-proline 0 C--N 1.329 -0.296 0 N-CA-C 113.78 1.03 . . . . 0.52 113.78 -176.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.46 ' HA ' HG23 ' A' ' 123' ' ' THR . 9.3 Cg_endo -56.07 149.89 50.75 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.192 1.928 . . . . 0.48 111.085 177.181 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.489 ' HB2' ' HA3' ' A' ' 110' ' ' GLY . 4.4 p -49.11 -43.26 41.23 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.247 0.462 . . . . 1.81 112.247 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -56.24 -8.42 2.45 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 115.19 0.836 . . . . 0.4 115.19 -177.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 1.004 HD11 ' H ' ' A' ' 85' ' ' GLY . 1.1 tm? -82.25 -31.75 30.02 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 117.863 0.831 . . . . 2.35 112.748 -178.432 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.439 ' HB2' ' HB ' ' A' ' 83' ' ' ILE . . . -129.45 -118.5 0.24 Allowed 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.375 -0.53 . . . . 1.03 112.382 -178.242 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -89.09 4.74 47.41 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 121.15 0.5 . . . . 1.44 110.567 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.489 ' HA3' ' HB2' ' A' ' 105' ' ' SER . . . -42.4 -76.78 0.1 OUTLIER Glycine 0 CA--C 1.524 0.607 0 CA-C-N 115.129 -0.941 . . . . 1.58 115.001 -179.051 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -55.81 -9.93 3.45 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 123.315 2.677 . . . . 1.49 113.904 -177.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.408 ' C ' ' H ' ' A' ' 114' ' ' VAL . 96.2 mtt180 -79.8 139.27 37.29 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.631 -0.507 . . . . 3.51 109.631 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 66.4 m -61.68 -6.35 2.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.247 0.546 . . . . 1.63 110.485 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.408 ' H ' ' C ' ' A' ' 112' ' ' ARG . 7.9 t -111.25 60.45 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.147 -0.933 . . . . 2.9 110.631 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -54.58 117.7 8.35 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.975 -0.631 . . . . 1.05 112.956 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -73.92 -115.38 0.08 OUTLIER Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.751 -0.738 . . . . 0.8 112.214 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.71 -35.8 35.31 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.127 1.885 . . . . 0.7 112.019 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.497 HG23 HD12 ' A' ' 124' ' ' LEU . 92.6 mt -91.45 135.66 26.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.069 -0.514 . . . . 1.25 110.322 179.025 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -46.97 148.3 2.88 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.748 -0.739 . . . . 0.48 112.087 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -56.05 130.03 38.09 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.119 1.88 . . . . 0.67 111.986 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.494 ' ND2' ' HB1' ' A' ' 5' ' ' ALA . 2.3 m-20 41.49 35.45 0.45 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.792 -0.64 . . . . 1.12 110.878 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.48 ' OE1' HD22 ' A' ' 59' ' ' LEU . 20.9 tt0 -116.89 145.86 43.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.881 -0.6 . . . . 1.73 111.258 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.468 ' O ' ' HB ' ' A' ' 60' ' ' ILE . 90.6 m -95.2 134.04 38.39 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.646 -0.501 . . . . 0.29 109.646 179.004 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.497 HD12 HG23 ' A' ' 118' ' ' ILE . 0.1 OUTLIER -120.55 156.54 31.36 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.342 0.592 . . . . 1.47 112.46 -178.249 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.406 HD12 ' N ' ' A' ' 125' ' ' ILE . 4.4 mp -113.85 148.17 16.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.128 -0.942 . . . . 0.2 109.467 178.128 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.459 ' CE1' HD22 ' A' ' 124' ' ' LEU . 81.2 m-85 -139.96 132.28 28.34 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.166 0.508 . . . . 0.24 111.761 -179.087 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.408 ' O ' ' HB2' ' A' ' 55' ' ' TYR . 2.2 tmtp? -110.91 104.04 12.6 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.575 -0.898 . . . . 2.28 108.575 178.447 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.534 ' N ' HD12 ' A' ' 128' ' ' ILE . 4.1 mp -102.12 127.19 55.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.377 0.608 . . . . 0.82 112.582 -177.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -118.38 99.97 7.18 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.036 -0.984 . . . . 0.26 108.492 177.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.693 HD22 HG11 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -77.94 120.95 23.52 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.122 -0.49 . . . . 1.41 111.135 -178.39 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 49.7 mm -94.9 -56.22 5.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.852 -0.613 . . . . 1.17 110.946 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.58 ' HA ' ' HB1' ' A' ' 95' ' ' ALA . 89.8 p -163.4 164.66 24.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.003 0.43 . . . . 1.17 111.351 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.471 ' HA ' HG12 ' A' ' 51' ' ' VAL . 7.1 p -107.93 127.24 64.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.904 -0.589 . . . . 1.43 111.054 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 12.8 tttp 45.34 -149.22 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.255 -0.43 . . . . 3.08 110.785 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -64.65 -5.4 5.6 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.226 -0.443 . . . . 3.16 110.979 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 32.9 t 65.42 82.6 0.18 Allowed 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.935 -0.575 . . . . 1.31 110.953 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 81.6 p . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.17 -0.919 . . . . 2.53 111.387 179.885 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.713 0.292 . . . . 3.09 110.84 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 26.2 p30 -63.61 -18.82 64.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.297 -0.411 . . . . 2.08 111.077 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -56.94 -40.88 77.22 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.614 -0.513 . . . . 3.23 109.614 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -79.76 -36.91 36.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.583 -0.735 . . . . 2.63 110.464 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -56.58 -51.94 66.7 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 116.145 -0.479 . . . . 0.82 110.386 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -67.59 -33.37 74.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.837 -0.62 . . . . 2.57 110.226 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.421 ' O ' ' HG2' ' A' ' 11' ' ' LYS . 41.3 tt0 -55.58 -33.53 64.0 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 109.096 -0.705 . . . . 2.1 109.096 178.479 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.496 ' HA ' ' HE2' ' A' ' 11' ' ' LYS . 10.1 m-20 -75.54 -38.42 59.31 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.371 -0.831 . . . . 1.4 110.286 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -56.24 -38.82 71.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.75 -0.659 . . . . 2.67 111.605 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.43 HG23 ' N ' ' A' ' 11' ' ' LYS . 18.6 m -78.33 -49.81 20.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 112.639 0.607 . . . . 1.27 112.639 -178.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.496 ' HE2' ' HA ' ' A' ' 8' ' ' ASN . 61.1 pttt -66.94 -26.25 66.75 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 120.861 -0.336 . . . . 1.69 111.445 -179.279 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.42 ' O ' ' HG ' ' A' ' 16' ' ' LEU . . . -76.41 -53.43 5.56 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.734 -0.746 . . . . 0.31 112.313 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.421 ' HA ' HD11 ' A' ' 16' ' ' LEU . 20.4 tp10 -61.86 -28.21 69.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.096 0.474 . . . . 2.39 110.604 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.3 -36.46 46.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.839 -0.619 . . . . 0.23 110.747 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -59.82 -53.71 54.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.076 -0.511 . . . . 0.23 110.617 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.684 ' HA ' ' HB3' ' A' ' 19' ' ' ASN . 0.4 OUTLIER -66.59 -33.77 76.4 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.737 -0.385 . . . . 0.55 111.101 -179.784 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.1 m -57.43 -45.96 84.08 Favored 'General case' 0 N--CA 1.456 -0.125 0 N-CA-C 109.622 -0.51 . . . . 0.27 109.622 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -74.35 -32.38 62.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.91 -0.586 . . . . 2.47 109.9 178.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.684 ' HB3' ' HA ' ' A' ' 16' ' ' LEU . 0.6 OUTLIER -57.58 -26.46 61.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.514 -0.767 . . . . 0.22 111.497 -179.822 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -49.19 -19.2 0.43 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.169 -0.469 . . . . 2.45 111.824 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -68.46 -31.87 71.47 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.192 0.441 . . . . 0.4 112.192 -178.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.643 ' O ' HG23 ' A' ' 25' ' ' VAL . 27.2 mmtm -52.97 119.21 15.66 Favored Pre-proline 0 CA--C 1.531 0.237 0 C-N-CA 121.322 -0.151 . . . . 1.4 110.619 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -57.86 143.64 95.34 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.189 1.926 . . . . 0.65 112.278 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.75 2.94 81.08 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.858 -0.687 . . . . 0.37 113.705 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 22' ' ' LYS . 5.9 t -59.73 120.86 6.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 117.167 0.483 . . . . 0.91 110.481 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.3 p -130.17 133.32 64.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 1.03 111.204 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.5 p -92.37 137.04 23.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.145 -0.479 . . . . 0.91 110.745 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.474 ' HB2' ' HB2' ' A' ' 32' ' ' LEU . 35.1 mt -100.94 162.94 19.05 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 0.4 110.751 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -53.26 -30.72 52.82 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.176 1.917 . . . . 0.59 112.309 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.531 ' O ' HD12 ' A' ' 107' ' ' LEU . 30.9 t -84.32 -10.08 57.91 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.175 -0.466 . . . . 1.14 111.551 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.27 15.49 25.48 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.367 -0.92 . . . . 0.34 112.595 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.506 HD21 ' HA2' ' A' ' 85' ' ' GLY . 2.6 mm? -80.86 133.54 35.6 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.222 0.535 . . . . 1.35 112.05 -178.4 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -126.07 138.27 53.69 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.329 -0.85 . . . . 1.75 109.175 178.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.751 ' HB3' HG22 ' A' ' 101' ' ' ILE . 38.6 p90 -160.84 174.81 13.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.269 0.557 . . . . 0.32 112.361 -178.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -121.71 117.51 26.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.198 -0.91 . . . . 2.15 109.3 178.38 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.472 HG13 ' HE1' ' A' ' 99' ' ' TRP . 86.9 t -72.56 125.53 31.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 113.081 0.771 . . . . 0.3 113.081 -178.202 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.411 HD12 HG22 ' A' ' 98' ' ' THR . 64.6 mt -102.3 -64.2 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.387 -0.824 . . . . 0.65 110.125 178.187 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.405 ' O ' ' HA ' ' A' ' 97' ' ' SER . 28.5 t-20 -139.46 89.49 2.34 Favored 'General case' 0 CA--C 1.528 0.099 0 CA-C-N 116.37 -0.377 . . . . 1.03 110.192 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.796 ' HB2' ' HE1' ' A' ' 99' ' ' TRP . 31.9 t -105.37 146.2 29.75 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 112.334 0.494 . . . . 1.5 112.334 -178.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 87.31 95.65 0.9 Allowed Glycine 0 C--N 1.332 0.341 0 CA-C-N 115.684 -0.689 . . . . 1.09 112.936 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -150.72 -83.65 0.09 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 111.675 0.25 . . . . 1.7 111.675 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.51 178.01 41.05 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 121.061 -0.59 . . . . 0.35 114.285 -178.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.742 HG22 ' H ' ' A' ' 44' ' ' LYS . 9.3 p -90.68 178.38 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 123.666 0.786 . . . . 1.42 109.688 178.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.742 ' H ' HG22 ' A' ' 43' ' ' VAL . 12.6 pttm 165.95 157.66 0.1 OUTLIER Pre-proline 0 N--CA 1.47 0.55 0 CA-C-O 121.482 0.658 . . . . 2.18 112.628 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.672 ' HD3' HG21 ' A' ' 133' ' ' VAL . 1.3 Cg_endo -85.03 173.79 7.75 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 125.061 3.841 . . . . 0.3 113.767 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.462 ' O ' ' N ' ' A' ' 48' ' ' SER . . . -68.05 -171.66 6.22 Favored Glycine 0 C--O 1.221 -0.714 0 CA-C-N 114.984 -1.007 . . . . 0.35 111.741 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -41.22 -15.74 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.875 1.065 . . . . 2.35 113.875 -177.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.462 ' N ' ' O ' ' A' ' 46' ' ' GLY . 51.0 m -85.89 7.83 22.58 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.522 0.677 . . . . 1.45 109.677 178.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.579 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 0.0 OUTLIER -69.33 151.03 46.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.796 -1.093 . . . . 1.73 112.329 -179.073 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 48.4 m -126.86 119.74 27.52 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.71 -0.677 . . . . 0.44 109.257 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.609 HG12 ' HA ' ' A' ' 133' ' ' VAL . 34.9 m -133.24 154.98 40.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.26 0.553 . . . . 0.65 112.24 -178.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 90.3 m -111.12 121.24 44.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.339 -0.846 . . . . 0.32 109.148 178.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.514 HG12 ' HA ' ' A' ' 130' ' ' LEU . 4.2 m -141.28 -179.62 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.06 0.457 . . . . 0.24 111.833 -178.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -135.11 133.06 38.84 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.635 -0.712 . . . . 2.4 109.384 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -143.63 158.38 43.71 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.731 0.777 . . . . 0.26 112.124 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 63.2 m -125.37 113.26 17.32 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.353 -1.294 . . . . 0.26 108.582 178.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.468 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -109.69 145.15 16.85 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 119.914 -1.136 . . . . 0.12 112.756 -178.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.543 HH11 HD13 ' A' ' 125' ' ' ILE . 0.1 OUTLIER -148.07 146.48 28.86 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 120.891 0.377 . . . . 1.93 110.193 179.325 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.453 ' HA ' ' HG ' ' A' ' 124' ' ' LEU . 5.7 mt -76.27 156.64 33.29 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.989 -0.55 . . . . 1.21 109.744 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.475 HG21 ' HG3' ' A' ' 11' ' ' LYS . 0.4 OUTLIER -58.09 -11.17 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.199 -0.667 . . . . 0.64 109.199 179.021 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.41 ' N ' ' C ' ' A' ' 59' ' ' LEU . 19.5 t70 -65.0 -11.58 40.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.357 -0.838 . . . . 2.01 110.722 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.47 ' HA2' ' NH2' ' A' ' 58' ' ' ARG . . . 90.81 -0.72 77.08 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.544 -0.836 . . . . 0.45 113.511 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 40.7 p -118.94 128.36 54.35 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 117.277 0.538 . . . . 1.4 111.381 -178.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 57' ' ' GLY . 6.5 p -60.71 134.9 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 115.936 -0.574 . . . . 0.28 109.807 179.334 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.642 ' HD1' ' N ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -97.31 -26.24 14.97 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.185 -0.462 . . . . 0.24 110.888 -179.554 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.642 ' N ' ' HD1' ' A' ' 65' ' ' PHE . 21.4 t70 -177.29 134.46 0.18 Allowed 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.438 -0.346 . . . . 0.3 110.744 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 40.4 t -131.14 122.58 26.89 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.322 -0.399 . . . . 1.3 110.451 179.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.641 HG21 ' HB2' ' A' ' 75' ' ' ALA . 47.9 p -71.62 -17.88 62.24 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.007 0.432 . . . . 0.34 110.382 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -75.14 -45.58 39.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.916 -0.583 . . . . 2.11 110.508 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -62.55 -41.74 99.09 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.861 -0.609 . . . . 3.41 111.114 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 21.6 m -58.38 -17.63 21.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.315 -0.402 . . . . 1.47 110.662 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.42 3.61 88.43 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.821 -0.704 . . . . 0.7 112.46 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.455 ' NZ ' ' HB3' ' A' ' 73' ' ' LYS . 8.6 mtpm? -126.38 117.68 23.22 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.347 0.118 . . . . 3.05 111.039 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.43 163.38 3.67 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.476 2.117 . . . . 0.51 112.228 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.641 ' HB2' HG21 ' A' ' 68' ' ' THR . . . -96.33 124.72 40.43 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.207 -0.451 . . . . 0.23 110.511 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 61.8 m -124.79 111.44 15.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.922 0.391 . . . . 1.26 111.262 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -158.5 163.29 37.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.894 -0.594 . . . . 0.36 110.564 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.685 ' HG3' ' HB2' ' A' ' 81' ' ' GLN . 10.6 pt20 -89.7 147.49 23.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.385 0.612 . . . . 1.58 109.989 178.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 27.5 m -57.61 -23.36 19.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 N-CA-C 114.039 1.125 . . . . 1.07 114.039 -177.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 91.8 p -95.35 -2.55 48.94 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.515 0.561 . . . . 1.14 112.515 -178.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.685 ' HB2' ' HG3' ' A' ' 78' ' ' GLN . 40.0 tt0 -83.22 5.32 23.33 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.751 0.278 . . . . 2.08 111.751 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -112.87 -178.86 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.912 0.386 . . . . 0.45 111.977 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.629 HG13 ' H ' ' A' ' 86' ' ' TRP . 25.6 pt -56.1 154.46 15.02 Favored Pre-proline 0 C--O 1.231 0.102 0 CA-C-N 115.951 -0.568 . . . . 0.75 111.741 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -47.81 -44.67 26.32 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.483 2.122 . . . . 0.65 112.414 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.506 ' HA2' HD21 ' A' ' 32' ' ' LEU . . . -61.19 -49.26 79.95 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 120.622 -0.799 . . . . 0.31 113.024 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' TRP . . . . . 0.629 ' H ' HG13 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -63.03 -53.1 59.18 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.894 0.331 . . . . 0.78 111.894 -178.985 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.0 t -53.93 -34.23 59.02 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.006 0.373 . . . . 1.4 112.006 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.486 ' HG3' ' HB2' ' A' ' 30' ' ' SER . 0.6 OUTLIER -66.09 -51.09 61.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.6 -0.273 . . . . 1.43 111.076 -179.829 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.409 ' HB2' ' HG ' ' A' ' 32' ' ' LEU . . . -65.07 -44.41 89.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.512 -0.313 . . . . 0.33 111.549 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -57.42 -29.85 64.49 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.252 -0.431 . . . . 0.39 111.354 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -62.24 -23.67 66.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.271 -0.422 . . . . 1.87 111.233 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.425 HD12 ' N ' ' A' ' 92' ' ' LEU . 8.3 mp -93.2 -7.66 44.62 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.153 0.427 . . . . 1.31 112.153 -178.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 2.9 ttm -92.21 107.81 26.01 Favored Pre-proline 0 C--N 1.33 -0.253 0 C-N-CA 120.99 -0.284 . . . . 1.66 111.512 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.419 ' HA ' ' HD3' ' A' ' 44' ' ' LYS . 69.6 Cg_endo -75.19 146.77 32.39 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.232 1.954 . . . . 0.44 110.496 178.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.56 ' HA ' HD13 ' A' ' 130' ' ' LEU . . . -45.81 124.96 5.67 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.917 -0.313 . . . . 0.36 111.363 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 102.38 -9.49 55.97 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 120.518 -0.848 . . . . 0.34 113.328 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.405 ' HA ' ' O ' ' A' ' 38' ' ' ASN . 31.2 t -72.74 175.0 6.85 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 117.005 0.403 . . . . 1.41 111.193 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.411 HG22 HD12 ' A' ' 37' ' ' ILE . 18.3 m -146.46 96.35 2.75 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.94 -0.573 . . . . 0.23 110.473 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.796 ' HE1' ' HB2' ' A' ' 39' ' ' SER . 30.8 m0 -119.57 149.79 41.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.192 0.52 . . . . 0.53 111.961 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.437 ' HB3' ' HD3' ' A' ' 127' ' ' LYS . 8.9 pt-20 -119.46 107.99 14.0 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.966 -1.124 . . . . 1.37 107.966 177.373 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.751 HG22 ' HB3' ' A' ' 34' ' ' TYR . 41.8 pt -108.14 142.75 20.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 113.53 0.937 . . . . 0.25 113.53 -177.435 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -123.45 103.63 8.58 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.498 -1.228 . . . . 0.31 108.228 177.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.415 ' HA ' ' HD2' ' A' ' 104' ' ' PRO . 2.2 t -107.55 96.89 17.63 Favored Pre-proline 0 C--N 1.329 -0.307 0 N-CA-C 113.219 0.822 . . . . 0.52 113.219 -176.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.552 ' HG2' HD23 ' A' ' 107' ' ' LEU . 9.5 Cg_endo -54.5 149.68 37.84 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 121.861 1.708 . . . . 0.48 110.484 177.244 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.5 p -48.63 -27.8 3.07 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.873 0.694 . . . . 1.81 112.873 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.429 ' N ' ' HD3' ' A' ' 111' ' ' PRO . . . -60.22 -10.46 15.76 Favored Glycine 0 CA--C 1.521 0.441 0 C-N-CA 120.799 -0.715 . . . . 0.4 113.754 -179.031 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.552 HD23 ' HG2' ' A' ' 104' ' ' PRO . 3.0 mm? -114.66 -0.94 13.45 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.242 0.46 . . . . 2.35 112.242 -178.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.487 ' HB2' HD12 ' A' ' 83' ' ' ILE . . . -109.3 -104.71 0.37 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 110.34 -0.244 . . . . 1.03 110.34 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -99.37 -2.25 36.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.341 0.591 . . . . 1.44 109.683 178.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 90.58 138.33 7.43 Favored Glycine 0 CA--C 1.522 0.518 0 CA-C-N 115.157 -0.928 . . . . 1.58 113.862 178.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.484 ' HB3' ' HA ' ' A' ' 121' ' ' ASN . 21.3 Cg_endo -59.97 -5.48 3.8 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.946 3.097 . . . . 1.49 113.265 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -75.04 161.33 29.54 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.735 0.302 . . . . 3.51 110.401 -177.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 81.2 p 53.97 -119.64 1.52 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.829 -0.623 . . . . 1.63 110.131 -178.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.505 ' HA ' ' HB3' ' A' ' 120' ' ' PRO . 2.5 t -114.14 17.28 7.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.764 0.316 . . . . 2.9 111.338 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 55.84 171.58 0.11 Allowed Glycine 0 CA--C 1.522 0.509 0 C-N-CA 120.833 -0.699 . . . . 1.05 112.861 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.402 ' HA3' ' HD2' ' A' ' 117' ' ' PRO . . . -80.77 -136.2 1.74 Allowed Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.768 -0.729 . . . . 0.8 111.918 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.402 ' HD2' ' HA3' ' A' ' 116' ' ' GLY . 19.4 Cg_endo -58.82 -23.93 69.49 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.072 1.848 . . . . 0.7 110.83 178.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.568 HG23 HD12 ' A' ' 124' ' ' LEU . 93.2 mt -90.09 135.57 26.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.311 -0.859 . . . . 1.25 110.031 179.054 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -42.88 152.0 0.3 Allowed Glycine 0 CA--C 1.52 0.386 0 C-N-CA 121.247 -0.501 . . . . 0.48 113.101 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.505 ' HB3' ' HA ' ' A' ' 114' ' ' VAL . 21.6 Cg_endo -60.33 130.88 35.78 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.436 2.091 . . . . 0.67 111.71 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.484 ' HA ' ' HB3' ' A' ' 111' ' ' PRO . 2.0 m-80 43.73 34.89 0.92 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.161 -0.472 . . . . 1.12 110.081 -178.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -115.72 136.37 53.13 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.914 -0.584 . . . . 1.73 111.495 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.474 HG21 HD23 ' A' ' 16' ' ' LEU . 96.7 m -95.53 134.08 38.81 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.02 -0.733 . . . . 0.29 109.02 178.34 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.568 HD12 HG23 ' A' ' 118' ' ' ILE . 0.1 OUTLIER -121.5 154.79 36.16 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.31 0.576 . . . . 1.47 112.413 -178.085 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.543 HD13 HH11 ' A' ' 58' ' ' ARG . 4.4 mp -113.81 141.22 30.62 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 CA-C-N 115.237 -0.892 . . . . 0.2 109.387 178.307 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.437 ' CE1' HD22 ' A' ' 124' ' ' LEU . 80.9 m-85 -133.83 132.06 39.97 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.173 0.511 . . . . 0.24 111.809 -179.078 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.437 ' HD3' ' HB3' ' A' ' 100' ' ' GLU . 42.6 mmtm -107.21 103.55 12.95 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.811 -0.811 . . . . 2.28 108.811 178.278 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 36.2 mt -102.68 119.03 50.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.047 0.451 . . . . 0.82 112.075 -178.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -114.99 99.97 7.85 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.655 -0.702 . . . . 0.26 109.327 178.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.56 HD13 ' HA ' ' A' ' 95' ' ' ALA . 0.6 OUTLIER -79.31 123.28 27.31 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.002 -0.545 . . . . 1.41 111.06 -178.838 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 48.3 mm -93.43 -56.77 4.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.067 -0.515 . . . . 1.17 111.012 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.484 ' HA ' ' HB1' ' A' ' 95' ' ' ALA . 13.6 m -163.45 165.23 24.03 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.976 0.417 . . . . 1.17 111.622 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.844 HG22 ' HG2' ' A' ' 134' ' ' LYS . 2.7 p -107.93 129.92 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 115.734 -0.666 . . . . 1.43 110.441 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.844 ' HG2' HG22 ' A' ' 133' ' ' VAL . 17.3 ptmt 34.55 55.25 0.67 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.036 0.446 . . . . 3.08 111.316 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm 61.62 42.94 10.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.764 -0.653 . . . . 3.16 110.929 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 43.5 t 52.5 61.14 3.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.78 -0.646 . . . . 1.31 110.993 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 71.2 m . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.2 -0.905 . . . . 2.53 111.139 -179.689 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.798 0.333 . . . . 3.09 110.893 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -66.09 -19.06 65.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.293 -0.412 . . . . 2.08 111.135 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -59.22 -40.98 87.55 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.675 -0.491 . . . . 3.23 109.675 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -79.82 -36.5 36.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.79 -0.641 . . . . 2.63 110.116 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.72 -52.52 62.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.739 -0.664 . . . . 0.82 110.179 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.408 ' O ' HG23 ' A' ' 10' ' ' VAL . 20.9 m-20 -67.4 -36.3 81.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.62 -0.718 . . . . 2.57 110.293 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -55.76 -32.99 63.91 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 109.335 -0.617 . . . . 2.1 109.335 178.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.565 ' HA ' ' HE2' ' A' ' 11' ' ' LYS . 21.4 m-20 -72.78 -38.84 67.14 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.494 -0.775 . . . . 1.4 110.471 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 8.3 tmtm? -59.8 -31.45 69.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.097 -0.501 . . . . 2.67 111.353 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 6' ' ' ASP . 11.8 t -77.81 -53.48 14.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 111.895 0.331 . . . . 1.27 111.895 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.565 ' HE2' ' HA ' ' A' ' 8' ' ' ASN . 58.9 pttt -66.1 -27.21 67.89 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.943 0.401 . . . . 1.69 110.523 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.95 -45.07 12.51 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.789 -0.72 . . . . 0.31 111.8 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.435 ' OE2' HD11 ' A' ' 16' ' ' LEU . 16.2 tp10 -68.07 -34.4 76.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.697 0.284 . . . . 2.39 110.767 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.47 -42.46 64.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.23 111.342 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -58.38 -56.28 24.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.541 -0.299 . . . . 0.23 110.496 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.549 ' HA ' ' HB3' ' A' ' 19' ' ' ASN . 4.1 pp -60.01 -33.06 71.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.262 -0.426 . . . . 0.55 110.482 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.8 m -58.09 -48.56 79.81 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.989 -0.551 . . . . 0.27 110.204 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -73.69 -32.01 63.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.934 -0.575 . . . . 2.47 110.034 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.582 ' ND2' ' HD2' ' A' ' 22' ' ' LYS . 0.9 OUTLIER -53.69 -32.45 51.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.408 -0.815 . . . . 0.22 111.478 179.934 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -44.02 -20.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.996 -0.547 . . . . 2.45 112.332 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -68.49 -33.05 73.46 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.983 0.364 . . . . 0.4 111.983 -178.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.582 ' HD2' ' ND2' ' A' ' 19' ' ' ASN . 67.3 mttm -54.14 119.11 18.12 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.686 -0.234 . . . . 1.4 110.988 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.46 142.73 95.33 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.449 2.099 . . . . 0.65 112.258 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.14 -1.63 86.56 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.769 -0.729 . . . . 0.37 113.249 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' A' ' 34' ' ' TYR . 3.7 p -61.26 110.53 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 121.21 0.529 . . . . 0.91 110.58 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.0 p -130.04 130.94 66.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.838 -0.619 . . . . 1.03 111.508 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 9.7 p -82.89 138.38 19.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.91 110.861 179.155 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.53 HD12 ' HB2' ' A' ' 32' ' ' LEU . 55.3 mt -96.22 167.45 12.37 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.255 -0.429 . . . . 0.4 110.704 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.48 ' HD2' ' HB3' ' A' ' 28' ' ' LEU . 75.0 Cg_exo -51.06 -30.97 33.36 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.129 1.886 . . . . 0.59 112.265 179.414 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.479 ' HB2' HD23 ' A' ' 32' ' ' LEU . 31.9 m -89.25 -9.41 50.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.265 -0.425 . . . . 1.14 111.782 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.58 15.68 22.15 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.388 -0.91 . . . . 0.34 113.627 178.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.691 HD21 ' HA2' ' A' ' 85' ' ' GLY . 2.7 mm? -83.02 134.27 35.05 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.008 0.432 . . . . 1.35 111.92 -179.089 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -125.23 139.02 54.09 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.282 -0.636 . . . . 1.75 109.282 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.803 ' HB3' HG22 ' A' ' 101' ' ' ILE . 28.8 p90 -151.17 175.72 11.88 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.788 0.662 . . . . 0.32 112.788 -178.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -121.09 117.06 26.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.226 -0.897 . . . . 2.15 109.175 178.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.5 t -72.66 126.66 33.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 113.299 0.852 . . . . 0.3 113.299 -177.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.462 HD12 HG22 ' A' ' 98' ' ' THR . 76.8 mt -107.42 -66.75 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 115.401 -0.818 . . . . 0.65 110.131 178.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -142.59 82.86 1.79 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.19 -0.459 . . . . 1.03 110.157 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.417 ' OG ' ' NE1' ' A' ' 99' ' ' TRP . 17.8 m -106.03 146.38 30.18 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 112.515 0.561 . . . . 1.5 112.515 -178.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 92.43 83.65 1.5 Allowed Glycine 0 C--N 1.334 0.455 0 CA-C-N 115.755 -0.657 . . . . 1.09 113.038 178.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -150.61 -72.77 0.17 Allowed 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 111.681 0.252 . . . . 1.7 111.681 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.12 172.29 36.45 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 121.072 -0.585 . . . . 0.35 114.298 -178.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.598 HG12 ' H ' ' A' ' 44' ' ' LYS . 2.0 t -90.47 175.99 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 123.474 0.71 . . . . 1.42 110.022 179.069 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.598 ' H ' HG12 ' A' ' 43' ' ' VAL . 2.1 pptp? 164.96 156.53 0.07 OUTLIER Pre-proline 0 N--CA 1.472 0.657 0 CA-C-O 121.503 0.668 . . . . 2.18 112.028 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.471 ' HD2' ' HB2' ' A' ' 49' ' ' ASP . 1.2 Cg_endo -83.84 172.54 9.88 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 124.823 3.682 . . . . 0.3 113.692 -179.396 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 48' ' ' SER . . . -67.98 -172.93 6.92 Favored Glycine 0 C--O 1.223 -0.565 0 CA-C-N 115.096 -0.956 . . . . 0.35 111.237 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -41.63 -13.98 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.825 1.046 . . . . 2.35 113.825 -177.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.487 ' N ' ' O ' ' A' ' 46' ' ' GLY . 55.6 m -86.32 7.24 26.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.268 0.556 . . . . 1.45 110.092 178.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.471 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 3.0 p30 -74.79 166.23 23.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.267 -0.879 . . . . 1.73 111.676 -179.206 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 91.7 m -126.07 121.26 32.43 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 108.691 -0.855 . . . . 0.44 108.691 178.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.819 HG12 HG22 ' A' ' 133' ' ' VAL . 6.4 m -122.92 142.63 38.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 112.97 0.73 . . . . 0.65 112.97 -177.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 39.3 m -115.35 119.79 37.45 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.067 -1.086 . . . . 0.32 108.067 177.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.62 HG12 ' HA ' ' A' ' 130' ' ' LEU . 2.7 m -146.34 178.78 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.26 0.552 . . . . 0.24 111.961 -177.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -128.78 132.45 47.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.291 -0.868 . . . . 2.4 109.107 178.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -146.13 159.28 43.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.584 0.707 . . . . 0.26 112.345 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 57.0 m -121.84 112.89 18.9 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.483 -1.235 . . . . 0.26 108.223 178.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.473 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -110.66 143.54 17.02 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 119.664 -1.255 . . . . 0.12 113.236 -178.113 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.543 ' O ' HD13 ' A' ' 124' ' ' LEU . 0.1 OUTLIER -148.43 145.61 28.07 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.566 -0.317 . . . . 1.93 110.176 179.266 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.538 HD23 HD11 ' A' ' 124' ' ' LEU . 2.3 mt -74.9 154.02 38.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.978 -0.555 . . . . 1.21 110.586 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.482 ' HB ' ' O ' ' A' ' 123' ' ' THR . 0.4 OUTLIER -56.55 -11.94 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.362 0.601 . . . . 0.64 109.621 179.001 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.402 ' N ' ' C ' ' A' ' 59' ' ' LEU . 21.4 t70 -71.11 -10.01 59.03 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.434 -0.803 . . . . 2.01 110.816 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.7 0.18 75.92 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.597 -0.811 . . . . 0.45 113.629 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 61.4 p -113.3 121.43 44.38 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 117.339 0.57 . . . . 1.4 111.724 -178.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 57' ' ' GLY . 5.9 p -60.61 132.4 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-N 115.889 -0.596 . . . . 0.28 109.819 179.02 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.701 ' HD1' ' H ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -97.79 -28.07 14.03 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.333 -0.394 . . . . 0.24 111.908 -179.4 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.701 ' H ' ' HD1' ' A' ' 65' ' ' PHE . 15.1 t70 -177.64 131.49 0.16 Allowed 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.606 0.241 . . . . 0.3 110.821 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.6 m -131.41 116.84 18.05 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.879 0.371 . . . . 1.3 110.487 178.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.544 HG21 ' HB2' ' A' ' 75' ' ' ALA . 80.4 p -74.84 -29.59 61.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.478 . . . . 0.34 111.323 -179.351 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -70.18 -39.45 75.26 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.199 -0.455 . . . . 2.11 110.654 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -71.02 -37.95 72.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.226 -0.443 . . . . 3.41 111.042 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 33.8 m -57.11 -22.75 42.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.233 -0.44 . . . . 1.47 110.794 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 95.21 2.15 62.33 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.869 -0.681 . . . . 0.7 112.618 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.449 ' HB2' ' NZ ' ' A' ' 73' ' ' LYS . 3.6 ttmp? -126.35 118.03 23.28 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.638 0.219 . . . . 3.05 111.111 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -52.65 150.25 22.39 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.62 2.213 . . . . 0.51 112.125 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.544 ' HB2' HG21 ' A' ' 68' ' ' THR . . . -94.73 125.02 39.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.39 -0.368 . . . . 0.23 110.811 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.7 t -123.85 113.97 19.24 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.952 0.406 . . . . 1.26 111.428 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -159.03 154.65 26.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.021 -0.536 . . . . 0.36 111.121 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.427 ' OE1' ' HB3' ' A' ' 80' ' ' SER . 3.2 pt20 -84.5 148.84 26.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.35 0.595 . . . . 1.58 109.871 178.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.4 ' CG1' ' HB3' ' A' ' 90' ' ' LEU . 2.5 m -68.79 -25.78 31.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 113.925 1.084 . . . . 1.07 113.925 -177.227 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.427 ' HB3' ' OE1' ' A' ' 78' ' ' GLN . 37.7 t -86.17 -2.35 58.27 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.616 0.599 . . . . 1.14 112.616 -178.504 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.422 ' HB2' ' HG3' ' A' ' 78' ' ' GLN . 43.5 tt0 -95.33 5.56 51.35 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.274 0.472 . . . . 2.08 112.274 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 1.7 m -113.63 -173.17 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 112.334 0.494 . . . . 0.45 112.334 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.593 HG13 ' H ' ' A' ' 86' ' ' TRP . 42.2 pt -56.14 158.95 6.52 Favored Pre-proline 0 CA--C 1.53 0.201 0 CA-C-N 115.906 -0.588 . . . . 0.75 112.268 -179.127 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.435 ' O ' HG22 ' A' ' 87' ' ' THR . 75.3 Cg_exo -51.38 -47.37 26.36 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.894 2.396 . . . . 0.65 113.043 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.691 ' HA2' HD21 ' A' ' 32' ' ' LEU . . . -59.85 -48.66 84.97 Favored Glycine 0 CA--C 1.521 0.407 0 C-N-CA 120.524 -0.846 . . . . 0.31 112.953 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' TRP . . . . . 0.593 ' H ' HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -64.06 -44.72 91.56 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.651 0.611 . . . . 0.78 112.651 -178.695 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.435 HG22 ' O ' ' A' ' 84' ' ' PRO . 10.0 t -60.25 -37.14 79.46 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.072 0.397 . . . . 1.4 112.072 -178.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.446 ' O ' ' HG2' ' A' ' 91' ' ' GLN . 10.3 tp10 -70.75 -40.2 72.85 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.008 0.373 . . . . 1.43 112.008 -179.434 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.495 ' HB2' ' HG ' ' A' ' 32' ' ' LEU . . . -76.09 -52.46 10.11 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.013 0.375 . . . . 0.33 112.013 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.691 HD11 HD13 ' A' ' 128' ' ' ILE . 4.6 mm? -57.38 -34.69 69.11 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.778 0.658 . . . . 0.39 112.778 -178.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.446 ' HG2' ' O ' ' A' ' 88' ' ' GLU . 18.1 pt20 -65.55 -4.79 6.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.635 0.255 . . . . 1.87 111.653 -179.169 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 82.6 mt -108.22 -7.85 15.89 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.564 -0.289 . . . . 1.31 111.207 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.553 ' HE3' ' N ' ' A' ' 99' ' ' TRP . 13.8 ttt -78.08 112.93 28.97 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.417 -0.356 . . . . 1.66 111.102 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.532 ' HA ' ' HG2' ' A' ' 44' ' ' LYS . 4.5 Cg_exo -77.04 142.37 21.85 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.761 2.307 . . . . 0.44 111.84 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.484 ' HB1' ' HA ' ' A' ' 132' ' ' SER . . . -50.41 128.28 19.46 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.372 -0.377 . . . . 0.36 111.499 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 92.25 2.27 68.56 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.689 -0.767 . . . . 0.34 113.292 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 19.8 m -92.85 -179.72 5.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.094 0.473 . . . . 1.41 111.776 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.462 HG22 HD12 ' A' ' 37' ' ' ILE . 3.9 m -144.63 120.4 10.55 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.658 -0.701 . . . . 0.23 110.084 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.553 ' N ' ' HE3' ' A' ' 93' ' ' MET . 4.9 m0 -132.36 150.65 52.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.23 0.538 . . . . 0.53 112.264 -178.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -122.46 106.85 11.4 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.715 -1.217 . . . . 1.37 107.715 177.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.803 HG22 ' HB3' ' A' ' 34' ' ' TYR . 41.0 pt -109.44 139.28 33.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 112.923 0.712 . . . . 0.25 112.923 -177.384 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -122.72 103.33 8.59 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.826 -1.079 . . . . 0.31 108.214 178.012 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.402 HG12 ' HB2' ' A' ' 107' ' ' LEU . 2.7 t -107.3 97.08 17.49 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 112.501 0.556 . . . . 0.52 112.501 -177.51 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.634 ' HA ' ' HA ' ' A' ' 123' ' ' THR . 9.9 Cg_endo -54.12 149.06 37.28 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 121.621 1.547 . . . . 0.48 110.528 177.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.567 ' HB3' ' HA3' ' A' ' 110' ' ' GLY . 3.3 m -48.15 -29.49 3.72 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.489 0.551 . . . . 1.81 112.489 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -56.64 -9.79 3.87 Favored Glycine 0 CA--C 1.521 0.444 0 C-N-CA 121.016 -0.611 . . . . 0.4 113.992 -178.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.488 HD23 ' HG2' ' A' ' 104' ' ' PRO . 3.4 mm? -110.6 1.98 18.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 117.251 0.526 . . . . 2.35 111.897 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.472 ' HB2' HD12 ' A' ' 83' ' ' ILE . . . -123.09 -111.01 0.32 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.715 -0.22 . . . . 1.03 111.586 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -130.92 4.17 4.48 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.793 0.33 . . . . 1.44 111.594 -179.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.687 ' N ' ' HD2' ' A' ' 111' ' ' PRO . . . -67.09 -36.44 90.5 Favored Glycine 0 CA--C 1.532 1.104 0 N-CA-C 115.836 1.095 . . . . 1.58 115.836 -178.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.687 ' HD2' ' N ' ' A' ' 110' ' ' GLY . 12.9 Cg_endo -56.52 -16.65 19.28 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.519 2.146 . . . . 1.49 112.969 -178.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -95.81 160.73 14.34 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.382 -0.372 . . . . 3.51 110.379 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 87.6 p -64.71 -2.33 2.41 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.063 0.458 . . . . 1.63 110.912 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 10.9 t -111.44 60.75 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.577 -0.738 . . . . 2.9 110.618 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -40.69 112.84 0.37 Allowed Glycine 0 C--N 1.333 0.401 0 CA-C-N 116.11 -0.496 . . . . 1.05 112.85 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.96 -145.13 0.07 OUTLIER Glycine 0 CA--C 1.52 0.373 0 C-N-CA 121.0 -0.619 . . . . 0.8 112.296 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.504 ' HB2' HD12 ' A' ' 118' ' ' ILE . 49.6 Cg_exo -54.76 -36.44 90.59 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 121.864 1.709 . . . . 0.7 111.453 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.539 HG23 HD23 ' A' ' 124' ' ' LEU . 4.0 mp -92.53 135.65 26.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.753 -0.658 . . . . 1.25 110.212 178.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -42.64 149.53 0.46 Allowed Glycine 0 C--N 1.335 0.493 0 C-N-CA 120.917 -0.658 . . . . 0.48 112.489 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -55.73 131.31 45.31 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.263 1.976 . . . . 0.67 112.282 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 42.99 37.68 1.2 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.311 -0.404 . . . . 1.12 110.862 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.462 ' OE1' HD22 ' A' ' 59' ' ' LEU . 30.8 tt0 -114.09 144.28 43.4 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.012 -0.54 . . . . 1.73 111.957 -179.03 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.634 ' HA ' ' HA ' ' A' ' 104' ' ' PRO . 70.0 m -97.0 129.3 44.49 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.369 -0.604 . . . . 0.29 109.369 178.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.543 HD13 ' O ' ' A' ' 58' ' ' ARG . 1.4 mm? -115.53 152.43 33.02 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.121 0.486 . . . . 1.47 111.838 -178.543 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.423 ' N ' HD12 ' A' ' 125' ' ' ILE . 4.8 mp -114.3 136.36 51.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.557 -0.747 . . . . 0.2 110.02 178.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -133.53 131.7 40.07 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.275 -0.42 . . . . 0.24 111.397 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -108.43 102.38 11.49 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.862 -1.162 . . . . 2.28 107.862 177.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.691 HD13 HD11 ' A' ' 90' ' ' LEU . 18.2 mt -102.83 126.56 57.03 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 CA-C-O 121.238 0.542 . . . . 0.82 112.148 -177.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.469 ' O ' ' HB ' ' A' ' 53' ' ' VAL . 1.3 t-160 -118.56 98.37 6.21 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.227 -0.897 . . . . 0.26 109.297 178.278 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.62 ' HA ' HG12 ' A' ' 53' ' ' VAL . 17.3 tp -80.25 113.61 18.54 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.187 -0.46 . . . . 1.41 111.113 -178.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 34.3 mm -81.98 -50.29 16.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.786 -0.643 . . . . 1.17 110.782 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.484 ' HA ' ' HB1' ' A' ' 95' ' ' ALA . 5.3 m -163.4 165.22 24.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 1.17 110.358 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.819 HG22 HG12 ' A' ' 51' ' ' VAL . 91.7 t -129.16 135.77 61.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.01 -0.541 . . . . 1.43 110.589 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.56 ' HE2' ' HB2' ' A' ' 137' ' ' SER . 21.4 ptmt 40.74 49.8 2.87 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.878 -0.601 . . . . 3.08 111.277 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt 63.77 41.21 7.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.345 -0.843 . . . . 3.16 111.507 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 33.9 t 48.03 32.61 2.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.71 -0.677 . . . . 1.31 111.477 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.56 ' HB2' ' HE2' ' A' ' 134' ' ' LYS . 69.8 m . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.213 -0.898 . . . . 2.53 110.894 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp . . . . . 0 N--CA 1.456 -0.168 0 CA-C-O 120.755 0.312 . . . . 2.63 110.222 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -57.79 -52.04 67.09 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.101 -0.499 . . . . 0.82 110.145 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -66.64 -34.39 77.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.864 -0.607 . . . . 2.57 109.936 178.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -55.79 -32.61 63.64 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.089 -0.708 . . . . 2.1 109.089 178.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.517 ' HA ' ' HG2' ' A' ' 11' ' ' LYS . 41.5 m-20 -75.7 -38.37 58.71 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.201 -0.909 . . . . 1.4 110.509 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -56.39 -39.6 73.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.878 -0.601 . . . . 2.67 111.571 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.402 HG23 ' N ' ' A' ' 11' ' ' LYS . 16.2 m -78.33 -47.83 23.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 112.604 0.594 . . . . 1.27 112.604 -178.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.53 ' HE2' HG13 ' A' ' 60' ' ' ILE . 22.1 ptmt -63.55 -33.99 76.81 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.602 0.223 . . . . 1.69 111.602 -179.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.86 -52.98 5.54 Favored Glycine 0 C--N 1.33 0.231 0 C-N-CA 120.75 -0.738 . . . . 0.31 112.461 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -57.66 -26.27 61.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.969 0.414 . . . . 2.39 110.346 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.17 -40.67 37.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.814 -0.63 . . . . 0.23 110.529 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -58.69 -48.92 79.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.076 -0.511 . . . . 0.23 110.278 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.562 ' HA ' ' HB3' ' A' ' 19' ' ' ASN . 4.2 pp -67.0 -34.52 77.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.32 -0.4 . . . . 0.55 110.714 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.43 ' N ' HD12 ' A' ' 16' ' ' LEU . 18.5 m -57.72 -49.65 75.85 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.246 -0.434 . . . . 0.27 110.209 179.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -73.72 -32.01 63.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.86 -0.609 . . . . 2.47 110.074 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.562 ' HB3' ' HA ' ' A' ' 16' ' ' LEU . 0.5 OUTLIER -54.29 -33.14 58.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.467 -0.788 . . . . 0.22 111.521 -179.915 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -46.66 -19.75 0.1 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.041 -0.527 . . . . 2.45 112.163 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.691 HD22 ' N ' ' A' ' 21' ' ' ASN . 0.8 OUTLIER -68.03 -33.52 74.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.638 -0.256 . . . . 0.4 111.594 -178.789 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.758 ' O ' HG23 ' A' ' 25' ' ' VAL . 67.7 mttm -52.05 119.03 13.32 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.551 -0.295 . . . . 1.4 110.511 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -57.73 146.41 85.51 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.231 1.954 . . . . 0.65 112.222 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.05 3.16 79.87 Favored Glycine 0 CA--C 1.522 0.471 0 C-N-CA 120.869 -0.682 . . . . 0.37 114.16 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.758 HG23 ' O ' ' A' ' 22' ' ' LYS . 35.6 t -56.8 110.71 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 117.65 0.725 . . . . 0.91 110.435 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.9 p -126.12 127.58 71.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.898 -0.592 . . . . 1.03 111.126 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.1 p -83.09 143.08 12.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.073 -0.512 . . . . 0.91 111.021 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.505 ' HB3' ' HD2' ' A' ' 29' ' ' PRO . 69.3 mt -103.86 168.56 8.46 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.102 -0.499 . . . . 0.4 110.806 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.505 ' HD2' ' HB3' ' A' ' 28' ' ' LEU . 78.4 Cg_exo -51.48 -33.45 47.39 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 121.943 1.762 . . . . 0.59 111.754 178.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.5 m -84.49 -11.95 55.16 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.046 -0.524 . . . . 1.14 111.195 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.04 14.16 27.25 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.507 -0.854 . . . . 0.34 114.258 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.633 HD22 ' HB2' ' A' ' 89' ' ' ALA . 6.5 mp -83.08 134.77 35.0 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.068 0.766 . . . . 1.35 113.068 -178.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -116.6 143.65 45.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.191 -0.913 . . . . 1.75 108.542 177.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.495 ' HB3' HG22 ' A' ' 101' ' ' ILE . 30.7 p90 -160.27 175.56 12.72 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.37 0.507 . . . . 0.32 112.37 -178.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -120.54 116.86 26.21 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.38 -0.827 . . . . 2.15 109.331 178.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.6 t -78.1 125.34 37.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 113.475 0.917 . . . . 0.3 113.475 -177.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 63.3 mt -101.21 -60.83 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.289 -0.869 . . . . 0.65 109.109 177.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -134.77 100.06 4.5 Favored 'General case' 0 CA--C 1.527 0.072 0 CA-C-N 115.799 -0.637 . . . . 1.03 109.673 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.617 ' HB3' ' HE1' ' A' ' 99' ' ' TRP . 59.9 p -103.18 145.62 29.66 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.113 0.482 . . . . 1.5 112.161 -178.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 94.82 -126.54 8.76 Favored Glycine 0 C--N 1.333 0.384 0 CA-C-N 115.599 -0.728 . . . . 1.09 113.146 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 16.9 m-80 70.08 -83.07 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.559 0.577 . . . . 1.7 112.559 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.11 167.36 30.37 Favored Glycine 0 CA--C 1.521 0.429 0 N-CA-C 115.289 0.875 . . . . 0.35 115.289 -177.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.644 HG12 ' H ' ' A' ' 44' ' ' LYS . 2.5 t -91.81 176.88 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 114.365 -0.917 . . . . 1.42 109.592 178.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.737 ' HG2' ' HA ' ' A' ' 94' ' ' PRO . 0.0 OUTLIER 165.46 157.64 0.09 OUTLIER Pre-proline 0 N--CA 1.475 0.781 0 CA-C-O 121.357 0.599 . . . . 2.18 112.35 -179.878 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.563 ' HD2' ' HB2' ' A' ' 49' ' ' ASP . 1.2 Cg_endo -84.65 173.35 8.47 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 125.076 3.851 . . . . 0.3 113.882 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 48' ' ' SER . . . -67.99 -171.97 6.34 Favored Glycine 0 C--O 1.222 -0.625 0 CA-C-N 114.947 -1.024 . . . . 0.35 111.664 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.509 ' O ' HG13 ' A' ' 79' ' ' VAL . 23.0 pttm -41.33 -13.46 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 113.921 1.082 . . . . 2.35 113.921 -177.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.487 ' N ' ' O ' ' A' ' 46' ' ' GLY . 80.9 p -86.25 7.52 24.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.549 0.69 . . . . 1.45 109.364 177.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.563 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 0.0 OUTLIER -71.79 149.17 45.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.666 -1.152 . . . . 1.73 112.183 -179.255 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 58.8 m -126.67 119.39 26.88 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 109.055 -0.72 . . . . 0.44 109.055 178.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.515 HG12 ' HA ' ' A' ' 133' ' ' VAL . 33.1 m -132.45 156.28 42.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 112.671 0.619 . . . . 0.65 112.671 -178.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 96.6 m -111.93 121.14 44.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.06 -0.973 . . . . 0.32 108.973 178.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.512 HG12 ' HA ' ' A' ' 130' ' ' LEU . 2.6 m -142.57 -179.66 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.328 0.585 . . . . 0.24 112.012 -178.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.496 ' HB3' ' HG2' ' A' ' 69' ' ' GLU . 28.6 mt-10 -131.38 132.75 44.64 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.267 -0.879 . . . . 2.4 109.426 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -143.82 158.11 43.91 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.793 0.806 . . . . 0.26 112.229 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 82.5 m -126.0 113.63 17.39 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.133 -1.394 . . . . 0.26 108.532 178.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.459 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -108.93 147.26 16.72 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 119.78 -1.2 . . . . 0.12 112.72 -178.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.01 147.45 32.64 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.852 0.358 . . . . 1.93 110.199 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.477 HD23 HD21 ' A' ' 124' ' ' LEU . 13.2 mt -84.95 157.78 20.72 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.003 -0.544 . . . . 1.21 110.233 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.53 HG13 ' HE2' ' A' ' 11' ' ' LYS . 10.2 tp -57.16 -10.93 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.347 0.594 . . . . 0.64 109.709 178.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.412 ' N ' ' C ' ' A' ' 59' ' ' LEU . 24.7 t70 -67.4 -11.53 57.98 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.373 -0.83 . . . . 2.01 111.007 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.13 -0.34 75.41 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.483 -0.865 . . . . 0.45 113.578 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.3 t -122.89 138.93 54.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 117.37 0.585 . . . . 1.4 111.712 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 57' ' ' GLY . 7.5 p -62.99 133.99 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 115.825 -0.625 . . . . 0.28 110.064 179.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.636 ' HD1' ' H ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -97.99 -25.61 14.91 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.067 -0.515 . . . . 0.24 111.147 -179.848 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.636 ' H ' ' HD1' ' A' ' 65' ' ' PHE . 19.1 t70 -176.51 131.17 0.21 Allowed 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 120.733 0.302 . . . . 0.3 110.889 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 70.8 p -128.35 126.52 40.87 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.293 -0.412 . . . . 1.3 110.531 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.443 HG21 ' HB2' ' A' ' 75' ' ' ALA . 81.1 p -81.83 -21.59 37.53 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.767 0.318 . . . . 0.34 111.235 -179.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.496 ' HG2' ' HB3' ' A' ' 54' ' ' GLU . 41.2 mt-10 -75.08 -47.76 27.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.284 -0.416 . . . . 2.11 111.226 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm -63.01 -36.87 84.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.43 . . . . 3.41 111.166 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 41.6 m -59.07 -22.89 61.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.312 -0.404 . . . . 1.47 110.719 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 92.05 4.75 66.61 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.808 -0.711 . . . . 0.7 112.355 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -126.5 116.95 22.98 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.454 0.127 . . . . 3.05 110.771 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.46 159.01 11.5 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.139 1.893 . . . . 0.51 111.923 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.443 ' HB2' HG21 ' A' ' 68' ' ' THR . . . -94.78 124.62 38.92 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.355 -0.384 . . . . 0.23 110.475 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 48.4 m -127.44 111.95 14.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.838 0.352 . . . . 1.26 111.446 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -158.67 163.78 36.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.091 -0.504 . . . . 0.36 110.904 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.572 ' HG3' ' HB2' ' A' ' 81' ' ' GLN . 0.4 OUTLIER -95.28 148.33 22.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.379 0.609 . . . . 1.58 110.503 178.931 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.533 ' HB ' ' HB3' ' A' ' 90' ' ' LEU . 0.6 OUTLIER -59.29 -28.38 39.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 114.93 -1.032 . . . . 1.07 113.262 -178.431 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.52 ' HB3' ' NE2' ' A' ' 78' ' ' GLN . 46.7 t -85.44 -2.42 58.09 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.78 0.659 . . . . 1.14 112.78 -178.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.572 ' HB2' ' HG3' ' A' ' 78' ' ' GLN . 5.3 tp-100 -96.93 5.85 49.74 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.534 0.568 . . . . 2.08 112.534 -179.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.6 m -112.77 -178.15 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 N-CA-C 112.361 0.504 . . . . 0.45 112.361 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.518 ' O ' HG23 ' A' ' 87' ' ' THR . 28.1 pt -56.88 155.37 15.48 Favored Pre-proline 0 N--CA 1.464 0.273 0 CA-C-N 116.0 -0.546 . . . . 0.75 112.017 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -44.33 -60.43 0.81 Allowed 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.074 2.516 . . . . 0.65 113.597 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.632 ' CA ' HD11 ' A' ' 32' ' ' LEU . . . -49.12 -49.08 31.14 Favored Glycine 0 CA--C 1.522 0.529 0 C-N-CA 120.493 -0.86 . . . . 0.31 112.721 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . 0.462 ' HB2' HG13 ' A' ' 83' ' ' ILE . 0.7 OUTLIER -61.81 -43.87 97.99 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.248 0.462 . . . . 0.78 112.248 -179.003 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.518 HG23 ' O ' ' A' ' 83' ' ' ILE . 53.7 p -56.12 -34.49 66.11 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.7 0.286 . . . . 1.4 111.395 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -70.27 -51.46 30.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.404 -0.362 . . . . 1.43 111.835 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.633 ' HB2' HD22 ' A' ' 32' ' ' LEU . . . -65.78 -52.24 52.48 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 112.418 0.525 . . . . 0.33 112.418 -178.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.533 ' HB3' ' HB ' ' A' ' 79' ' ' VAL . 4.1 mm? -56.97 -26.91 60.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.424 -0.353 . . . . 0.39 111.615 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.449 ' HG3' ' N ' ' A' ' 47' ' ' LYS . 53.2 tt0 -67.7 -23.47 65.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.789 0.328 . . . . 1.87 111.182 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.436 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 88.8 mt -100.75 -8.04 23.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.298 -0.41 . . . . 1.31 111.526 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.525 ' SD ' HD13 ' A' ' 90' ' ' LEU . 62.1 mtt -76.41 110.78 12.37 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 116.748 -0.205 . . . . 1.66 111.281 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.737 ' HA ' ' HG2' ' A' ' 44' ' ' LYS . 67.4 Cg_endo -84.93 147.45 10.54 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.837 2.358 . . . . 0.44 112.771 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.555 ' HB1' ' HA ' ' A' ' 132' ' ' SER . . . -45.8 131.02 9.46 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.288 -0.415 . . . . 0.36 112.06 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 88.99 -11.94 67.65 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.845 -0.693 . . . . 0.34 113.613 179.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.496 ' HB3' ' HG2' ' A' ' 94' ' ' PRO . 96.6 p -67.75 -175.92 0.59 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.963 0.411 . . . . 1.41 111.284 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 17.6 m -161.54 97.75 1.1 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.899 -0.592 . . . . 0.23 110.81 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.617 ' HE1' ' HB3' ' A' ' 39' ' ' SER . 43.9 m0 -119.93 152.11 37.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.082 0.468 . . . . 0.53 111.563 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -122.25 108.27 13.09 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.459 -0.941 . . . . 1.37 108.459 177.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.495 HG22 ' HB3' ' A' ' 34' ' ' TYR . 31.5 pt -106.4 141.7 21.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 113.217 0.821 . . . . 0.25 113.217 -177.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.42 ' OH ' HG22 ' A' ' 25' ' ' VAL . 0.6 OUTLIER -125.53 103.97 8.16 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.578 -1.192 . . . . 0.31 108.368 178.309 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.405 ' HA ' ' HD2' ' A' ' 104' ' ' PRO . 4.1 t -106.2 110.79 64.24 Favored Pre-proline 0 C--N 1.33 -0.262 0 N-CA-C 113.114 0.783 . . . . 0.52 113.114 -177.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.575 ' HG2' HD13 ' A' ' 107' ' ' LEU . 17.7 Cg_endo -61.96 152.19 76.66 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.308 2.006 . . . . 0.48 111.131 177.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -47.12 -42.14 18.7 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.834 0.679 . . . . 1.81 112.834 -178.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.454 ' C ' HD12 ' A' ' 107' ' ' LEU . . . -57.4 -9.36 4.51 Favored Glycine 0 CA--C 1.521 0.452 0 C-N-CA 121.043 -0.598 . . . . 0.4 113.882 -178.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.575 HD13 ' HG2' ' A' ' 104' ' ' PRO . 9.2 mp -113.4 -7.71 13.46 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.138 0.422 . . . . 2.35 112.138 -178.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.439 0 CA-C-N 116.692 -0.231 . . . . 1.03 110.63 179.777 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo . . . . . 0 C--O 1.231 0.142 0 CA-C-O 120.959 0.316 . . . . 0.7 111.51 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.693 HG23 HD13 ' A' ' 124' ' ' LEU . 57.4 mt -90.84 115.21 29.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.791 -0.64 . . . . 1.25 110.015 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -44.18 157.41 0.17 Allowed Glycine 0 C--N 1.334 0.463 0 CA-C-N 116.153 -0.476 . . . . 0.48 113.13 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -63.64 131.65 32.29 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.274 1.983 . . . . 0.67 111.643 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 49.3 34.18 6.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.262 -0.426 . . . . 1.12 110.356 -178.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -116.29 129.17 56.13 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.203 -0.453 . . . . 1.73 111.358 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.51 ' O ' ' HB ' ' A' ' 60' ' ' ILE . 77.5 m -93.07 127.27 38.54 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.722 -0.844 . . . . 0.29 108.722 178.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.693 HD13 HG23 ' A' ' 118' ' ' ILE . 7.4 mp -115.22 157.84 23.14 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.27 0.557 . . . . 1.47 112.399 -178.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.432 ' N ' HD12 ' A' ' 125' ' ' ILE . 4.8 mp -114.86 139.35 41.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.255 -0.884 . . . . 0.2 109.502 178.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -131.13 131.79 44.36 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.099 0.476 . . . . 0.24 111.544 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.456 ' NZ ' ' HB3' ' A' ' 127' ' ' LYS . 3.3 mmmp? -110.45 103.78 12.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.514 -0.766 . . . . 2.28 109.18 178.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.4 mp -103.94 118.7 51.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.163 0.506 . . . . 0.82 112.242 -178.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -113.35 98.34 7.04 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.41 -0.959 . . . . 0.26 108.41 177.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.512 ' HA ' HG12 ' A' ' 53' ' ' VAL . 21.9 tp -82.74 123.18 29.07 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.552 -0.749 . . . . 1.41 111.683 -178.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 55.8 mt -89.81 -55.99 5.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.799 -0.637 . . . . 1.17 110.785 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.555 ' HA ' ' HB1' ' A' ' 95' ' ' ALA . 60.5 p -163.64 165.04 23.78 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.072 0.463 . . . . 1.17 111.628 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.515 ' HA ' HG12 ' A' ' 51' ' ' VAL . 2.5 p -108.95 131.53 59.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.715 -0.675 . . . . 1.43 111.418 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 5.8 tttp 34.37 64.96 0.35 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.012 -0.54 . . . . 3.08 111.574 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm 62.03 42.86 9.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.897 -0.592 . . . . 3.16 111.229 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 90.0 p 47.82 64.42 1.63 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.752 -0.658 . . . . 1.31 111.413 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 43.4 t . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.21 -0.9 . . . . 2.53 110.865 179.994 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp . . . . . 0 N--CA 1.456 -0.139 0 CA-C-O 120.772 0.32 . . . . 2.63 110.358 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -57.53 -51.42 69.53 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.085 -0.507 . . . . 0.82 110.265 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -67.22 -35.14 78.95 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.927 -0.579 . . . . 2.57 110.215 179.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -55.78 -32.47 63.49 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 109.386 -0.598 . . . . 2.1 109.386 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.568 ' HB3' ' HG2' ' A' ' 122' ' ' GLU . 19.0 m-20 -75.66 -39.13 58.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.491 -0.777 . . . . 1.4 110.38 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.423 ' O ' ' HD2' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -56.79 -40.84 76.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.9 -0.591 . . . . 2.67 111.331 179.816 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.431 HG23 ' N ' ' A' ' 11' ' ' LYS . 19.6 m -74.15 -48.23 38.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 112.169 0.433 . . . . 1.27 112.169 -179.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.53 ' HG2' ' HA ' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -64.07 -29.91 71.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.776 0.322 . . . . 1.69 111.029 -179.683 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.69 -48.33 8.99 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 121.051 -0.595 . . . . 0.31 112.176 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -59.01 -30.15 67.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.035 0.445 . . . . 2.39 110.377 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.88 -41.33 37.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.794 -0.639 . . . . 0.23 111.118 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -56.02 -52.71 63.26 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 120.768 0.318 . . . . 0.23 110.288 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.48 ' HA ' ' HB3' ' A' ' 19' ' ' ASN . 4.0 pp -63.71 -35.51 80.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.083 -0.508 . . . . 0.55 110.446 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.4 m -57.33 -48.53 78.72 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.066 -0.516 . . . . 0.27 110.343 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -73.22 -31.82 64.38 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.948 -0.569 . . . . 2.47 109.876 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.486 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 0.9 OUTLIER -56.03 -30.43 61.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.368 -0.833 . . . . 0.22 111.817 -179.883 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -43.22 -19.99 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.244 0.461 . . . . 2.45 112.244 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.675 HD22 ' N ' ' A' ' 21' ' ' ASN . 0.8 OUTLIER -68.6 -34.03 75.08 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.462 0.542 . . . . 0.4 112.462 -178.627 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.732 ' O ' HG23 ' A' ' 25' ' ' VAL . 38.3 mmtt -46.7 119.46 5.58 Favored Pre-proline 0 N--CA 1.463 0.198 0 CA-C-O 120.527 0.203 . . . . 1.4 110.899 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.445 ' HD2' ' HE2' ' A' ' 35' ' ' LYS . 40.5 Cg_exo -57.0 135.6 71.79 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.006 1.804 . . . . 0.65 112.049 179.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.31 3.24 78.92 Favored Glycine 0 CA--C 1.52 0.362 0 C-N-CA 120.755 -0.736 . . . . 0.37 113.949 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.732 HG23 ' O ' ' A' ' 22' ' ' LYS . 8.9 t -52.05 111.57 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 117.606 0.703 . . . . 0.91 110.218 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.438 HG13 ' CE1' ' A' ' 34' ' ' TYR . 2.1 p -127.46 133.69 67.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.891 -0.595 . . . . 1.03 111.078 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.424 HG23 ' NE2' ' A' ' 33' ' ' GLN . 7.6 p -85.77 141.91 13.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.953 -0.567 . . . . 0.91 110.968 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.597 HD12 ' HB2' ' A' ' 32' ' ' LEU . 64.5 mt -99.66 166.61 12.53 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.4 110.782 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.44 ' HD2' ' HB3' ' A' ' 28' ' ' LEU . 52.4 Cg_exo -53.14 -30.57 50.95 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 121.908 1.739 . . . . 0.59 111.513 178.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 39.8 t -86.02 -12.74 49.48 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.014 -0.539 . . . . 1.14 111.031 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.05 14.42 24.64 Favored Glycine 0 C--N 1.334 0.436 0 C-N-CA 120.464 -0.874 . . . . 0.34 114.313 178.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.68 HD11 ' HA2' ' A' ' 85' ' ' GLY . 6.6 mp -85.11 139.26 31.85 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.098 0.777 . . . . 1.35 113.098 -179.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.424 ' NE2' HG23 ' A' ' 27' ' ' VAL . 26.5 mp0 -116.01 144.18 44.45 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.918 -1.037 . . . . 1.75 108.438 177.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.586 ' HB3' HG22 ' A' ' 101' ' ' ILE . 15.5 p90 -160.29 175.37 12.93 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.898 0.703 . . . . 0.32 112.898 -178.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.445 ' HE2' ' HD2' ' A' ' 23' ' ' PRO . 24.5 tttm -121.93 116.77 24.96 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.006 -0.997 . . . . 2.15 109.413 178.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.497 HG13 ' HE1' ' A' ' 99' ' ' TRP . 60.7 t -77.87 126.17 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 113.188 0.81 . . . . 0.3 113.188 -178.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.422 HD12 HG22 ' A' ' 98' ' ' THR . 83.5 mt -101.9 -65.69 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.562 -0.745 . . . . 0.65 110.733 178.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -148.39 80.63 1.46 Allowed 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 120.845 0.355 . . . . 1.03 111.002 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.543 ' HB2' ' NE1' ' A' ' 99' ' ' TRP . 38.9 t -106.96 146.14 31.43 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.254 -0.43 . . . . 1.5 111.968 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 99.27 100.38 2.25 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.834 -0.698 . . . . 1.09 113.135 178.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -177.93 -57.39 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 120.671 0.272 . . . . 1.7 111.617 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.27 165.47 31.45 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.833 -0.699 . . . . 0.35 114.073 -178.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.644 HG12 ' H ' ' A' ' 44' ' ' LYS . 2.7 t -90.5 175.34 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 123.324 0.65 . . . . 1.42 109.733 179.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.644 ' H ' HG12 ' A' ' 43' ' ' VAL . 18.5 ptmt 164.65 156.87 0.07 OUTLIER Pre-proline 0 N--CA 1.47 0.557 0 CA-C-O 121.475 0.655 . . . . 2.18 112.324 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.46 ' HD2' ' HB2' ' A' ' 49' ' ' ASP . 2.1 Cg_endo -84.43 174.25 8.04 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 124.908 3.739 . . . . 0.3 113.21 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.51 ' O ' ' N ' ' A' ' 48' ' ' SER . . . -67.47 -172.03 5.72 Favored Glycine 0 C--O 1.225 -0.42 0 CA-C-N 115.326 -0.852 . . . . 0.35 111.356 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.561 ' HG2' ' HB2' ' A' ' 91' ' ' GLN . 33.9 mtmm -41.26 -13.18 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 113.499 0.926 . . . . 2.35 113.499 -177.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.51 ' N ' ' O ' ' A' ' 46' ' ' GLY . 47.2 t -85.75 7.08 25.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.085 0.469 . . . . 1.45 110.313 178.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.46 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 3.5 p30 -77.34 150.32 35.19 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.568 -0.742 . . . . 1.73 112.048 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 86.1 m -126.47 119.25 26.74 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.657 -0.868 . . . . 0.44 108.657 178.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.517 HG12 ' HA ' ' A' ' 133' ' ' VAL . 12.2 m -124.34 158.47 31.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.443 0.534 . . . . 0.65 112.443 -178.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 83.7 m -112.65 120.89 43.09 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.748 -0.834 . . . . 0.32 108.748 178.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.747 HG11 HD22 ' A' ' 130' ' ' LEU . 12.3 m -141.9 179.85 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.393 0.616 . . . . 0.24 112.043 -178.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -127.09 132.34 50.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.149 -0.932 . . . . 2.4 109.236 178.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -146.49 161.1 41.17 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.614 0.721 . . . . 0.26 112.184 -179.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 57.9 m -126.99 112.34 15.13 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.621 -1.172 . . . . 0.26 108.677 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.48 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -111.41 146.25 17.78 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.045 -1.074 . . . . 0.12 112.986 -178.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.49 ' NE ' HD13 ' A' ' 125' ' ' ILE . 3.2 ppt_? -148.03 148.4 30.65 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.817 0.342 . . . . 1.93 110.17 179.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.401 ' C ' ' N ' ' A' ' 61' ' ' ASP . 19.3 mt -77.51 160.87 28.34 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.102 -0.499 . . . . 1.21 109.991 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.499 ' HB ' ' O ' ' A' ' 123' ' ' THR . 8.0 tp -59.1 -11.43 2.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.211 -0.662 . . . . 0.64 109.211 178.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.401 ' N ' ' C ' ' A' ' 59' ' ' LEU . 8.1 m-20 -65.69 -11.31 44.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.081 -0.963 . . . . 2.01 110.774 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.46 -0.85 78.34 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.665 -0.779 . . . . 0.45 113.531 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.8 t -118.53 138.45 52.52 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 117.227 0.514 . . . . 1.4 111.579 -178.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 57' ' ' GLY . 6.0 p -64.2 133.15 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 115.822 -0.626 . . . . 0.28 110.147 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.598 ' HD1' ' N ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -97.49 -22.53 16.5 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.09 -0.505 . . . . 0.24 110.739 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.598 ' N ' ' HD1' ' A' ' 65' ' ' PHE . 19.8 t70 -175.68 130.15 0.26 Allowed 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.262 -0.426 . . . . 0.3 110.649 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 70.2 p -126.61 123.99 38.9 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.28 -0.418 . . . . 1.3 110.721 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.493 HG21 ' HB2' ' A' ' 75' ' ' ALA . 70.8 p -90.55 -41.05 11.6 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.381 -0.372 . . . . 0.34 111.002 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -70.87 -35.6 72.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 2.11 111.147 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.9 tmtm? -63.03 -51.49 66.57 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.365 -0.379 . . . . 3.41 110.857 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 77.1 p -58.63 -19.56 40.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.29 -0.414 . . . . 1.47 111.099 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.09 10.36 58.61 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.799 -0.715 . . . . 0.7 112.437 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -115.53 116.68 41.18 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.535 0.167 . . . . 3.05 110.678 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -58.88 144.97 98.44 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.274 1.983 . . . . 0.51 112.085 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.493 ' HB2' HG21 ' A' ' 68' ' ' THR . . . -94.6 124.25 38.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.206 -0.452 . . . . 0.23 111.038 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.2 t -126.18 120.18 29.42 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.33 -0.395 . . . . 1.26 110.767 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -158.04 169.13 25.25 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.263 0.554 . . . . 0.36 111.863 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.641 HE21 ' N ' ' A' ' 79' ' ' VAL . 3.9 tp60 -87.96 145.29 26.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.32 -0.854 . . . . 1.58 109.168 178.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.641 ' N ' HE21 ' A' ' 78' ' ' GLN . 26.1 m -79.71 -27.42 12.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 113.111 0.782 . . . . 1.07 113.111 -177.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.56 ' H ' HE21 ' A' ' 78' ' ' GLN . 80.3 p -85.84 -2.08 57.89 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 111.743 0.275 . . . . 1.14 111.743 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.42 ' NE2' ' HG2' ' A' ' 78' ' ' GLN . 1.2 mp0 -93.88 5.88 50.22 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.546 0.573 . . . . 2.08 112.546 -178.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.43 HG21 ' HE3' ' A' ' 86' ' ' TRP . 0.0 OUTLIER -110.6 -175.04 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 N-CA-C 112.244 0.461 . . . . 0.45 112.244 -179.69 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.563 HG13 ' H ' ' A' ' 86' ' ' TRP . 34.3 pt -56.32 158.17 8.09 Favored Pre-proline 0 N--CA 1.462 0.17 0 CA-C-N 115.962 -0.563 . . . . 0.75 112.212 -179.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.434 ' HD2' ' HB ' ' A' ' 83' ' ' ILE . 6.2 Cg_endo -48.71 -50.28 12.87 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.868 2.379 . . . . 0.65 112.553 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.68 ' HA2' HD11 ' A' ' 32' ' ' LEU . . . -57.86 -49.11 77.43 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.671 -0.776 . . . . 0.31 113.411 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . 0.563 ' H ' HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -62.51 -53.39 55.41 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.518 0.562 . . . . 0.78 112.518 -178.457 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.0 t -52.9 -33.38 50.1 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.739 0.274 . . . . 1.4 111.739 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -68.99 -50.71 46.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.528 -0.305 . . . . 1.43 111.726 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.662 ' HB2' HD22 ' A' ' 32' ' ' LEU . . . -64.16 -45.46 88.34 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.932 0.345 . . . . 0.33 111.932 -179.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.486 HD13 ' SD ' ' A' ' 93' ' ' MET . 4.3 mm? -56.59 -30.43 63.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.387 -0.369 . . . . 0.39 111.483 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.561 ' HB2' ' HG2' ' A' ' 47' ' ' LYS . 7.8 tt0 -64.82 -23.93 67.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.404 -0.362 . . . . 1.87 111.15 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.419 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 9.1 mp -95.79 -7.84 36.0 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.145 -0.48 . . . . 1.31 111.582 -179.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.486 ' SD ' HD13 ' A' ' 90' ' ' LEU . 60.4 mtt -88.79 107.79 19.48 Favored Pre-proline 0 N--CA 1.452 -0.344 0 CA-C-N 116.719 -0.219 . . . . 1.66 111.517 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.45 ' HA ' ' CD ' ' A' ' 44' ' ' LYS . 95.7 Cg_endo -79.86 145.27 17.73 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.651 2.234 . . . . 0.44 111.817 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.627 ' HB1' ' HA ' ' A' ' 132' ' ' SER . . . -46.94 127.27 9.89 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 120.649 0.262 . . . . 0.36 110.973 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 96.71 -5.39 64.24 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 120.689 -0.767 . . . . 0.34 112.997 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.418 ' OG ' ' N ' ' A' ' 98' ' ' THR . 11.2 t -74.78 177.8 5.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.837 0.351 . . . . 1.41 111.117 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.422 HG22 HD12 ' A' ' 37' ' ' ILE . 18.8 m -151.38 92.86 1.83 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.045 -0.525 . . . . 0.23 110.444 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.543 ' NE1' ' HB2' ' A' ' 39' ' ' SER . 24.2 m0 -116.6 149.18 40.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.171 0.51 . . . . 0.53 111.867 -179.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -120.99 108.03 13.37 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.758 -1.201 . . . . 1.37 107.758 176.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.586 HG22 ' HB3' ' A' ' 34' ' ' TYR . 46.2 pt -107.6 139.44 29.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 113.112 0.782 . . . . 0.25 113.112 -177.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.463 ' OH ' HG22 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -117.89 103.9 10.41 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.734 -1.21 . . . . 0.31 107.734 177.294 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 39.6 t -97.84 105.53 27.85 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 113.39 0.885 . . . . 0.52 113.39 -176.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.484 ' HA ' HG23 ' A' ' 123' ' ' THR . 33.4 Cg_exo -59.84 151.17 73.03 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.344 2.029 . . . . 0.48 111.392 177.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.5 p -48.31 -43.13 32.78 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 111.969 0.359 . . . . 1.81 111.969 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -57.21 -8.85 3.7 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 114.328 0.491 . . . . 0.4 114.328 -178.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.42 HD12 ' HA3' ' A' ' 85' ' ' GLY . 0.1 OUTLIER -84.57 -25.66 28.52 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.542 0.571 . . . . 2.35 112.542 -178.294 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.443 ' HB2' HD12 ' A' ' 83' ' ' ILE . . . . . . . . 0 C--N 1.328 -0.357 0 C-N-CA 121.033 -0.267 . . . . 1.03 111.288 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo . . . . . 0 C--O 1.231 0.174 0 CA-C-O 120.802 0.251 . . . . 0.7 111.882 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.604 HG13 HD22 ' A' ' 124' ' ' LEU . 3.4 mp -91.88 131.19 39.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 1.25 109.993 178.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -47.95 153.9 1.62 Allowed Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.934 -0.651 . . . . 0.48 112.515 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.441 ' O ' ' HG3' ' A' ' 122' ' ' GLU . 29.1 Cg_endo -62.44 130.28 29.55 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.102 1.868 . . . . 0.67 111.655 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 47.63 35.13 4.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.959 -0.564 . . . . 1.12 110.24 -179.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.568 ' HG2' ' HB3' ' A' ' 8' ' ' ASN . 43.1 mt-10 -115.23 132.55 56.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.831 -0.622 . . . . 1.73 111.279 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.499 ' O ' ' HB ' ' A' ' 60' ' ' ILE . 87.6 m -95.11 127.53 41.23 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.929 -0.767 . . . . 0.29 108.929 178.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.604 HD22 HG13 ' A' ' 118' ' ' ILE . 6.5 mp -116.72 157.81 24.86 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.197 0.522 . . . . 1.47 112.092 -178.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.49 ' N ' HD12 ' A' ' 125' ' ' ILE . 4.5 mp -114.21 142.87 25.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.438 -0.801 . . . . 0.2 109.617 178.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -135.35 132.26 37.41 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.089 0.471 . . . . 0.24 111.717 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 24.4 tptm -108.67 103.55 12.67 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.565 -0.902 . . . . 2.28 108.565 178.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 9.1 mt -102.76 122.38 55.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 113.007 0.743 . . . . 0.82 113.007 -177.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -116.89 100.31 7.68 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.378 -0.971 . . . . 0.26 108.378 177.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.747 HD22 HG11 ' A' ' 53' ' ' VAL . 0.2 OUTLIER -77.95 121.32 24.02 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.926 -0.579 . . . . 1.41 111.545 -178.042 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 48.3 mm -93.47 -57.45 4.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.018 -0.537 . . . . 1.17 110.092 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.627 ' HA ' ' HB1' ' A' ' 95' ' ' ALA . 59.8 p -164.67 163.11 21.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.108 -0.496 . . . . 1.17 111.449 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.517 ' HA ' HG12 ' A' ' 51' ' ' VAL . 11.0 p -107.74 135.14 47.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.691 -0.686 . . . . 1.43 110.094 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.504 ' HE3' ' H ' ' A' ' 137' ' ' SER . 58.9 pttt 38.5 -149.07 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 O-C-N 123.243 0.339 . . . . 3.08 111.234 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.414 ' HD2' ' N ' ' A' ' 135' ' ' LYS . 1.0 OUTLIER -78.21 13.48 1.47 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.058 0.456 . . . . 3.16 110.261 179.133 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.404 ' H ' ' C ' ' A' ' 134' ' ' LYS . 47.2 t 65.43 67.03 0.51 Allowed 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.487 -0.778 . . . . 1.31 110.925 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.504 ' H ' ' HE3' ' A' ' 134' ' ' LYS . 35.8 m . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.213 -0.899 . . . . 2.53 110.863 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? . . . . . 0 N--CA 1.455 -0.178 0 CA-C-O 120.815 0.341 . . . . 2.63 110.367 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -55.5 -51.68 66.19 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.014 -0.539 . . . . 0.82 110.169 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -67.38 -36.52 81.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.842 -0.617 . . . . 2.57 109.93 179.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -56.34 -32.8 65.04 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.119 -0.697 . . . . 2.1 109.119 178.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.491 ' HA ' ' HG2' ' A' ' 11' ' ' LYS . 50.3 m-20 -72.72 -38.51 67.44 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.276 -0.875 . . . . 1.4 110.63 179.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -56.31 -37.83 70.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.008 -0.542 . . . . 2.67 111.595 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.9 t -77.69 -52.54 16.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 112.047 0.388 . . . . 1.27 112.047 -179.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.526 ' HE2' HG13 ' A' ' 60' ' ' ILE . 21.3 ptmt -61.13 -29.72 69.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.544 -0.298 . . . . 1.69 111.683 -179.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.26 -52.88 5.9 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.569 -0.824 . . . . 0.31 112.005 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -63.98 -26.59 68.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.968 0.413 . . . . 2.39 110.406 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.0 -39.31 50.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.958 -0.565 . . . . 0.23 110.53 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -59.13 -51.03 71.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.992 -0.549 . . . . 0.23 110.324 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.518 ' HA ' ' HB3' ' A' ' 19' ' ' ASN . 4.2 pp -64.9 -34.44 78.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.309 -0.405 . . . . 0.55 110.577 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.2 m -57.5 -48.8 78.28 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.211 -0.449 . . . . 0.27 110.201 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -73.2 -32.05 64.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.81 -0.632 . . . . 2.47 109.986 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.518 ' HB3' ' HA ' ' A' ' 16' ' ' LEU . 0.8 OUTLIER -57.58 -27.39 62.66 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.53 -0.759 . . . . 0.22 111.317 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.1 mttm -46.71 -19.85 0.11 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.302 -0.408 . . . . 2.45 111.884 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.72 HD22 ' N ' ' A' ' 21' ' ' ASN . 0.7 OUTLIER -68.58 -30.26 68.98 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.469 0.544 . . . . 0.4 112.469 -178.491 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.679 ' O ' HG23 ' A' ' 25' ' ' VAL . 18.6 mmtp -53.75 118.76 16.01 Favored Pre-proline 0 N--CA 1.464 0.246 0 C-N-CA 121.245 -0.182 . . . . 1.4 110.766 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.28 140.73 95.48 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.343 2.029 . . . . 0.65 112.523 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.91 3.84 79.47 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.743 -0.742 . . . . 0.37 114.318 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 22' ' ' LYS . 7.0 t -52.4 112.21 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 117.602 0.701 . . . . 0.91 110.667 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -118.93 131.03 72.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.904 -0.589 . . . . 1.03 111.669 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.2 t -89.27 132.85 32.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.777 -0.647 . . . . 0.91 110.49 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.594 HD12 ' HB2' ' A' ' 32' ' ' LEU . 66.1 mt -94.71 163.48 22.36 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.406 -0.361 . . . . 0.4 110.925 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -51.81 -30.66 39.05 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.25 1.967 . . . . 0.59 112.019 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.486 ' O ' HD11 ' A' ' 107' ' ' LEU . 1.8 m -85.49 -13.28 49.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.114 -0.494 . . . . 1.14 111.36 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.646 ' HA3' HD21 ' A' ' 107' ' ' LEU . . . 104.84 15.79 19.21 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.134 -1.031 . . . . 0.34 113.874 179.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.594 ' HB2' HD12 ' A' ' 28' ' ' LEU . 2.4 mp -83.34 138.74 33.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.373 0.606 . . . . 1.35 112.243 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -119.22 138.93 52.64 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.158 -0.928 . . . . 1.75 108.623 177.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.581 ' HB3' HG22 ' A' ' 101' ' ' ILE . 16.8 p90 -160.61 175.52 12.59 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.206 0.527 . . . . 0.32 112.301 -178.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -121.45 117.08 25.98 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.37 -0.832 . . . . 2.15 109.591 178.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.45 HG13 ' HE1' ' A' ' 99' ' ' TRP . 67.8 t -73.49 125.97 33.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 113.473 0.916 . . . . 0.3 113.473 -178.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 63.2 mt -103.63 -66.7 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.434 -0.803 . . . . 0.65 110.049 178.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 37.7 t30 -130.96 91.92 3.13 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 116.337 -0.392 . . . . 1.03 110.164 178.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.745 ' HB3' ' HE1' ' A' ' 99' ' ' TRP . 96.3 p -105.41 144.83 31.64 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.204 0.446 . . . . 1.5 112.204 -178.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.516 ' HA2' ' HG3' ' A' ' 94' ' ' PRO . . . 80.44 98.55 0.33 Allowed Glycine 0 C--N 1.332 0.351 0 CA-C-N 115.823 -0.626 . . . . 1.09 113.141 178.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -151.48 -82.29 0.1 Allowed 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 111.75 0.278 . . . . 1.7 111.75 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.47 -178.83 42.56 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 121.142 -0.551 . . . . 0.35 114.098 -178.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.463 ' O ' ' HB3' ' A' ' 44' ' ' LYS . 0.2 OUTLIER -90.32 177.73 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 123.667 0.787 . . . . 1.42 110.439 178.937 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.517 ' HB3' HG11 ' A' ' 133' ' ' VAL . 0.0 OUTLIER 165.92 155.24 0.09 OUTLIER Pre-proline 0 N--CA 1.47 0.545 0 CA-C-O 121.668 0.747 . . . . 2.18 112.419 -179.681 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.449 ' HD2' HG21 ' A' ' 133' ' ' VAL . 2.3 Cg_endo -85.72 173.39 7.28 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 125.102 3.868 . . . . 0.3 113.39 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.493 ' O ' ' N ' ' A' ' 48' ' ' SER . . . -68.1 -172.57 6.85 Favored Glycine 0 C--O 1.225 -0.461 0 CA-C-N 115.109 -0.95 . . . . 0.35 111.453 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.497 ' O ' HG13 ' A' ' 79' ' ' VAL . 55.8 mttp -41.71 -13.22 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 113.603 0.964 . . . . 2.35 113.603 -178.058 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.493 ' N ' ' O ' ' A' ' 46' ' ' GLY . 39.2 t -86.45 6.92 28.04 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.065 0.46 . . . . 1.45 110.625 178.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.435 ' CB ' ' HD2' ' A' ' 45' ' ' PRO . 3.1 p30 -76.63 155.88 33.13 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.776 -0.647 . . . . 1.73 111.487 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.564 ' HB ' ' HG2' ' A' ' 134' ' ' LYS . 33.1 m -125.07 122.27 36.74 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.347 -0.983 . . . . 0.44 108.347 178.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.0 m -126.78 151.34 33.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 112.826 0.676 . . . . 0.65 112.826 -177.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 95.5 m -114.1 120.96 42.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.05 -0.977 . . . . 0.32 109.152 178.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.484 HG12 ' HA ' ' A' ' 130' ' ' LEU . 3.1 m -142.13 176.88 3.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.149 0.5 . . . . 0.24 111.742 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -126.15 132.03 51.92 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.462 -0.79 . . . . 2.4 108.969 178.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -145.56 165.37 28.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.606 0.717 . . . . 0.26 112.125 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 88.5 m -130.02 113.47 14.6 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.606 -1.179 . . . . 0.26 108.491 178.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.442 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -110.62 144.32 17.15 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 119.838 -1.173 . . . . 0.12 113.065 -178.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.531 ' NH2' ' HA2' ' A' ' 62' ' ' GLY . 0.1 OUTLIER -147.47 146.83 29.67 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.794 0.331 . . . . 1.93 110.192 179.037 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.454 ' HA ' ' HG ' ' A' ' 124' ' ' LEU . 9.8 mt -80.14 157.67 26.55 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.196 -0.456 . . . . 1.21 110.327 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.526 HG13 ' HE2' ' A' ' 11' ' ' LYS . 9.7 tp -59.1 -10.93 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.41 -0.589 . . . . 0.64 109.41 178.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -66.39 -9.76 36.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.281 -0.872 . . . . 2.01 110.673 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.531 ' HA2' ' NH2' ' A' ' 58' ' ' ARG . . . 90.98 -0.23 75.73 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.516 -0.85 . . . . 0.45 113.317 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.5 t -121.51 138.71 54.18 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 117.357 0.578 . . . . 1.4 111.702 -178.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 57' ' ' GLY . 5.3 p -66.86 133.34 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-N 115.654 -0.703 . . . . 0.28 109.979 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.673 ' HD1' ' H ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -97.93 -27.25 14.35 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.271 -0.422 . . . . 0.24 111.523 -179.74 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.673 ' H ' ' HD1' ' A' ' 65' ' ' PHE . 25.0 t70 -177.25 130.74 0.17 Allowed 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 116.709 -0.223 . . . . 0.3 110.564 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 68.0 m -134.61 124.51 25.52 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.791 0.329 . . . . 1.3 111.12 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.575 HG21 ' HB2' ' A' ' 75' ' ' ALA . 80.9 p -86.14 -12.99 48.47 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.072 0.463 . . . . 0.34 110.391 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.89 -48.28 25.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.705 -0.68 . . . . 2.11 111.303 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -64.57 -37.86 89.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.111 -0.495 . . . . 3.41 111.418 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 62.9 p -60.23 -14.58 18.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.47 -0.332 . . . . 1.47 111.405 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.92 8.02 88.05 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.779 -0.724 . . . . 0.7 112.624 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -123.44 118.35 27.6 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 120.268 0.08 . . . . 3.05 110.874 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.62 150.05 45.82 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.42 2.08 . . . . 0.51 112.447 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.575 ' HB2' HG21 ' A' ' 68' ' ' THR . . . -94.76 126.65 40.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 0.23 111.344 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 78.7 m -118.51 115.72 25.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.388 -0.369 . . . . 1.26 110.901 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -150.58 148.66 28.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.309 -0.405 . . . . 0.36 111.396 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.55 HE21 ' H ' ' A' ' 80' ' ' SER . 0.0 OUTLIER -81.78 141.77 33.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.819 -0.628 . . . . 1.58 110.107 179.364 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.596 HG23 ' HB2' ' A' ' 90' ' ' LEU . 2.6 p -64.26 -24.95 36.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.273 -0.421 . . . . 1.07 112.126 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.55 ' H ' HE21 ' A' ' 78' ' ' GLN . 47.3 t -90.93 -9.72 45.1 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.718 0.266 . . . . 1.14 111.718 -179.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -91.99 5.8 48.77 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.991 0.367 . . . . 2.08 111.991 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 10.5 m -116.24 -178.46 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 112.279 0.474 . . . . 0.45 112.279 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.516 ' O ' HG23 ' A' ' 87' ' ' THR . 24.8 pt -56.6 155.87 13.29 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 115.915 -0.584 . . . . 0.75 112.035 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -48.16 -60.24 0.95 Allowed 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.211 2.607 . . . . 0.65 113.168 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.504 ' C ' HD21 ' A' ' 32' ' ' LEU . . . -44.39 -48.82 8.5 Favored Glycine 0 CA--C 1.522 0.497 0 C-N-CA 120.596 -0.812 . . . . 0.31 112.17 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 1.1 m0 -62.44 -36.63 83.02 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.014 0.375 . . . . 0.78 112.014 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.516 HG23 ' O ' ' A' ' 83' ' ' ILE . 30.5 p -58.7 -40.21 83.0 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 121.03 -0.268 . . . . 1.4 111.609 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -70.46 -51.67 27.54 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.494 0.553 . . . . 1.43 112.494 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.79 -52.41 51.05 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.381 0.511 . . . . 0.33 112.381 -178.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.596 ' HB2' HG23 ' A' ' 79' ' ' VAL . 4.2 mm? -57.6 -25.72 60.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.334 -0.394 . . . . 0.39 111.779 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 21.5 tm0? -81.58 -19.36 42.14 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.754 0.279 . . . . 1.87 111.754 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 98.2 mt -90.25 -22.16 21.76 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.77 0.285 . . . . 1.31 111.77 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.537 ' SD ' HD13 ' A' ' 90' ' ' LEU . 15.4 ptp -81.75 121.01 79.11 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-O 120.555 0.217 . . . . 1.66 111.511 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.516 ' HG3' ' HA2' ' A' ' 40' ' ' GLY . 92.8 Cg_endo -80.4 147.51 18.04 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.767 2.312 . . . . 0.44 111.791 179.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.635 ' HB1' ' HA ' ' A' ' 132' ' ' SER . . . -45.79 126.46 7.12 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.707 0.289 . . . . 0.36 111.151 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 97.84 -2.38 60.14 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 120.82 -0.705 . . . . 0.34 113.024 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.433 ' OG ' ' HB2' ' A' ' 93' ' ' MET . 83.0 p -79.42 -174.47 4.24 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.934 0.397 . . . . 1.41 111.563 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.5 m -159.89 105.79 1.59 Allowed 'General case' 0 C--O 1.231 0.085 0 CA-C-N 116.029 -0.532 . . . . 0.23 111.001 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.745 ' HE1' ' HB3' ' A' ' 39' ' ' SER . 40.0 m0 -126.9 149.37 49.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.04 0.448 . . . . 0.53 111.781 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -117.8 107.91 14.71 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 107.847 -1.168 . . . . 1.37 107.847 177.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.581 HG22 ' HB3' ' A' ' 34' ' ' TYR . 43.3 pt -109.35 140.05 29.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 113.515 0.932 . . . . 0.25 113.515 -177.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -116.41 103.57 10.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.76 -1.109 . . . . 0.31 108.031 177.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.546 HG22 HD23 ' A' ' 32' ' ' LEU . 9.6 t -102.53 102.74 27.67 Favored Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 113.191 0.812 . . . . 0.52 113.191 -177.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -62.0 151.73 79.67 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.101 1.868 . . . . 0.48 110.774 177.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -48.34 -42.5 31.54 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 111.883 0.327 . . . . 1.81 111.883 -179.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -57.27 -10.07 5.06 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.982 -0.628 . . . . 0.4 113.315 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.646 HD21 ' HA3' ' A' ' 31' ' ' GLY . 0.2 OUTLIER -103.6 -15.89 15.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.766 0.317 . . . . 2.35 111.504 -179.575 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.503 -0.317 . . . . 1.03 111.173 -179.787 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo . . . . . 0 C--O 1.231 0.153 0 CA-C-O 121.038 0.349 . . . . 0.7 111.573 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.611 HG23 HD12 ' A' ' 124' ' ' LEU . 92.8 mt -90.75 124.18 43.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.753 -0.658 . . . . 1.25 110.261 179.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.404 ' H ' HD21 ' A' ' 59' ' ' LEU . . . -48.56 156.59 1.21 Allowed Glycine 0 C--N 1.331 0.304 0 CA-C-N 116.097 -0.501 . . . . 0.48 113.048 -179.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -62.05 131.43 34.72 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.373 2.048 . . . . 0.67 111.653 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 50.14 34.41 8.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.272 -0.422 . . . . 1.12 110.259 -178.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -115.91 127.11 54.74 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.341 -0.39 . . . . 1.73 111.738 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.492 ' O ' ' HB ' ' A' ' 60' ' ' ILE . 97.3 m -90.72 128.63 36.73 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.376 -0.972 . . . . 0.29 108.376 177.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.611 HD12 HG23 ' A' ' 118' ' ' ILE . 0.1 OUTLIER -113.35 156.45 23.39 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.829 0.677 . . . . 1.47 112.829 -177.577 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 5.1 mp -114.78 138.41 45.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 114.973 -1.012 . . . . 0.2 109.228 177.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.485 ' CE1' HD22 ' A' ' 124' ' ' LEU . 68.7 m-85 -131.51 132.47 44.22 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.95 0.405 . . . . 0.24 111.893 -178.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -109.12 103.62 12.66 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.521 -0.918 . . . . 2.28 108.521 178.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 19.6 mt -104.11 122.92 57.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 112.974 0.731 . . . . 0.82 112.974 -177.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -118.43 99.29 6.73 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.508 -0.923 . . . . 0.26 108.508 177.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.484 ' HA ' HG12 ' A' ' 53' ' ' VAL . 20.2 tp -79.56 120.24 23.64 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.889 -0.596 . . . . 1.41 111.365 -178.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 50.1 mm -89.75 -56.45 5.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.895 -0.593 . . . . 1.17 110.561 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.635 ' HA ' ' HB1' ' A' ' 95' ' ' ALA . 2.1 m -161.11 165.4 29.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.203 -0.453 . . . . 1.17 110.802 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.571 HG22 ' HG3' ' A' ' 134' ' ' LYS . 7.2 p -111.66 121.38 64.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.048 -0.524 . . . . 1.43 111.663 -179.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.571 ' HG3' HG22 ' A' ' 133' ' ' VAL . 34.0 mtpt 43.42 65.72 0.93 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.908 -0.587 . . . . 3.08 111.097 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 95.5 mttt 59.53 30.84 20.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.904 -0.589 . . . . 3.16 111.09 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 42.0 t 55.86 65.2 1.51 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.884 -0.598 . . . . 1.31 111.096 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 58.7 m . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.211 -0.9 . . . . 2.53 110.871 179.97 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--O 1.233 0.208 0 CA-C-O 121.063 0.459 . . . . 2.63 109.936 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.37 -41.74 98.86 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.718 -0.674 . . . . 0.82 110.428 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -74.83 -31.5 61.69 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.261 -0.427 . . . . 2.57 110.419 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.464 ' HG3' ' HE3' ' A' ' 11' ' ' LYS . 9.6 tp10 -55.93 -40.75 73.59 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.767 -0.457 . . . . 2.1 109.767 179.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.534 ' HA ' ' HG2' ' A' ' 11' ' ' LYS . 25.7 p30 -78.64 -29.28 45.71 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.193 -0.458 . . . . 1.4 110.44 179.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 121' ' ' ASN . 64.5 tttp -61.16 -39.57 90.6 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.104 -0.498 . . . . 2.67 111.125 178.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.489 HG23 ' N ' ' A' ' 11' ' ' LYS . 27.4 m -77.46 -50.63 19.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 112.462 0.541 . . . . 1.27 112.462 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.534 ' HG2' ' HA ' ' A' ' 8' ' ' ASN . 19.5 ptpt -64.95 -26.63 68.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.626 0.25 . . . . 1.69 111.359 -179.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -75.05 -53.74 6.06 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.648 -0.787 . . . . 0.31 112.206 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -63.52 -24.98 68.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.052 0.453 . . . . 2.39 110.384 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.96 -42.38 33.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.795 -0.638 . . . . 0.23 110.915 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -57.46 -48.47 79.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.202 -0.454 . . . . 0.23 110.578 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.545 ' HA ' ' HB3' ' A' ' 19' ' ' ASN . 4.3 pp -67.64 -35.88 79.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.295 -0.411 . . . . 0.55 110.74 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.412 ' O ' ' HD3' ' A' ' 20' ' ' LYS . 12.1 m -57.57 -48.34 79.63 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.114 0.483 . . . . 0.27 109.854 178.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -72.28 -31.79 66.05 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.821 -0.627 . . . . 2.47 109.809 178.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.545 ' HB3' ' HA ' ' A' ' 16' ' ' LEU . 0.8 OUTLIER -58.41 -27.09 63.98 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.744 -0.662 . . . . 0.22 111.378 179.902 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.412 ' HD3' ' O ' ' A' ' 17' ' ' THR . 55.3 mtpt -46.02 -20.0 0.08 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.423 -0.353 . . . . 2.45 111.659 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.713 HD22 ' N ' ' A' ' 21' ' ' ASN . 0.7 OUTLIER -70.6 -33.16 70.74 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.346 0.499 . . . . 0.4 112.346 -179.218 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.525 ' HG2' ' O ' ' A' ' 19' ' ' ASN . 44.3 mmtt -43.09 118.25 2.42 Favored Pre-proline 0 N--CA 1.467 0.377 0 CA-C-N 116.77 -0.196 . . . . 1.4 111.373 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.448 ' HD2' ' HE2' ' A' ' 35' ' ' LYS . 18.8 Cg_endo -58.0 133.2 54.15 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.607 2.205 . . . . 0.65 112.44 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.69 1.58 85.26 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.754 -0.736 . . . . 0.37 113.177 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' A' ' 34' ' ' TYR . 7.4 p -60.3 114.48 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 121.205 0.526 . . . . 0.91 110.519 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.1 p -128.06 141.14 47.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.763 -0.653 . . . . 1.03 111.291 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.5 p -89.51 140.59 15.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.13 -0.486 . . . . 0.91 111.032 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.589 HD12 ' HB2' ' A' ' 32' ' ' LEU . 73.7 mt -96.92 167.61 11.75 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.036 -0.529 . . . . 0.4 110.845 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.473 ' HD2' ' HB3' ' A' ' 28' ' ' LEU . 71.8 Cg_exo -52.25 -31.28 45.67 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 121.878 1.719 . . . . 0.59 111.388 178.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.1 m -86.38 -11.83 50.92 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.842 -0.617 . . . . 1.14 111.142 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.453 ' O ' HD21 ' A' ' 107' ' ' LEU . . . 103.28 13.32 28.95 Favored Glycine 0 CA--C 1.521 0.446 0 C-N-CA 120.483 -0.865 . . . . 0.34 114.885 178.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.589 ' HB2' HD12 ' A' ' 28' ' ' LEU . 4.0 mp -83.44 134.86 34.85 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 117.882 0.841 . . . . 1.35 112.762 -178.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -114.4 140.69 48.47 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.065 -1.087 . . . . 1.75 108.065 177.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.727 ' HB3' HG22 ' A' ' 101' ' ' ILE . 36.9 p90 -155.16 176.03 13.07 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 113.206 0.817 . . . . 0.32 113.206 -177.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.448 ' HE2' ' HD2' ' A' ' 23' ' ' PRO . 33.8 tttm -120.75 116.89 26.12 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.012 -0.995 . . . . 2.15 109.2 178.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.514 HG13 ' HE1' ' A' ' 99' ' ' TRP . 36.2 t -73.27 126.59 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 113.346 0.869 . . . . 0.3 113.346 -177.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.571 HD12 HG22 ' A' ' 98' ' ' THR . 72.6 mt -104.6 -64.1 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 115.436 -0.802 . . . . 0.65 110.672 178.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.418 ' O ' ' HA ' ' A' ' 97' ' ' SER . 9.7 t30 -151.26 78.6 1.28 Allowed 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.653 0.263 . . . . 1.03 110.819 179.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.462 ' HB3' ' NE1' ' A' ' 99' ' ' TRP . 79.3 p -106.45 146.13 30.92 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.964 0.411 . . . . 1.5 112.076 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 97.55 99.71 2.03 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 121.025 -0.607 . . . . 1.09 113.026 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -176.48 -62.1 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 111.776 0.287 . . . . 1.7 111.776 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.07 160.97 28.84 Favored Glycine 0 CA--C 1.518 0.281 0 C-N-CA 120.843 -0.694 . . . . 0.35 113.858 -179.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.494 ' O ' ' HB3' ' A' ' 44' ' ' LYS . 0.2 OUTLIER -90.71 175.85 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 123.215 0.606 . . . . 1.42 110.516 179.152 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.617 ' HD3' ' HA ' ' A' ' 94' ' ' PRO . 10.0 ptmm? 163.71 156.29 0.06 OUTLIER Pre-proline 0 N--CA 1.471 0.61 0 CA-C-O 121.427 0.632 . . . . 2.18 111.933 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.443 ' HD2' ' HB2' ' A' ' 49' ' ' ASP . 7.2 Cg_exo -74.57 173.11 14.87 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 124.485 3.457 . . . . 0.3 113.202 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 48' ' ' SER . . . -67.5 -172.56 6.06 Favored Glycine 0 C--O 1.224 -0.497 0 N-CA-C 110.895 -0.882 . . . . 0.35 110.895 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.432 ' O ' ' HB2' ' A' ' 80' ' ' SER . 24.2 pttm -41.61 -13.2 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.388 0.884 . . . . 2.35 113.388 -178.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.522 ' N ' ' O ' ' A' ' 46' ' ' GLY . 60.4 m -86.12 7.74 23.62 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 121.036 0.446 . . . . 1.45 110.376 178.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.443 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 3.3 p30 -77.84 160.2 28.47 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.656 -0.702 . . . . 1.73 111.611 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.552 ' HB ' ' HG3' ' A' ' 134' ' ' LYS . 48.3 m -126.34 119.5 27.49 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.814 -0.81 . . . . 0.44 108.814 178.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.434 HG12 ' HA ' ' A' ' 133' ' ' VAL . 26.5 m -130.07 150.73 34.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.156 0.503 . . . . 0.65 112.319 -178.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 53.3 m -111.74 121.15 44.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.477 -0.783 . . . . 0.32 109.299 178.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.586 HG12 ' HA ' ' A' ' 130' ' ' LEU . 3.4 m -137.83 177.8 5.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.154 0.502 . . . . 0.24 111.772 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -126.55 132.9 51.24 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.441 -0.8 . . . . 2.4 109.77 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -144.69 159.63 42.52 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.682 0.753 . . . . 0.26 112.161 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 62.9 m -124.71 112.09 16.33 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.42 -1.263 . . . . 0.26 108.412 178.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.416 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -110.63 141.38 16.35 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 119.813 -1.184 . . . . 0.12 113.173 -178.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.457 ' NE ' HD13 ' A' ' 125' ' ' ILE . 2.5 ppt_? -147.36 146.35 29.62 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.786 0.327 . . . . 1.93 110.197 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.466 ' HA ' ' HG ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER -73.31 163.48 28.02 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.038 -0.528 . . . . 1.21 110.38 -179.863 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.494 ' HB ' ' O ' ' A' ' 123' ' ' THR . 9.0 tp -59.4 -11.01 2.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.357 0.598 . . . . 0.64 109.499 178.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -71.73 -12.48 61.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.321 -0.854 . . . . 2.01 110.979 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.429 ' HA2' HH11 ' A' ' 58' ' ' ARG . . . 90.02 -0.88 79.64 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.604 -0.808 . . . . 0.45 112.921 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.3 m -110.18 128.46 55.49 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 120.92 0.391 . . . . 1.4 111.21 -178.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 57' ' ' GLY . 5.1 p -61.0 130.7 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 115.968 -0.56 . . . . 0.28 110.099 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.605 ' HD1' ' N ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -97.45 -21.92 16.87 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.976 -0.556 . . . . 0.24 110.912 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.605 ' N ' ' HD1' ' A' ' 65' ' ' PHE . 16.2 t70 -175.82 129.5 0.25 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.164 -0.471 . . . . 0.3 110.559 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 30.2 p -132.21 122.28 24.99 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.279 -0.419 . . . . 1.3 110.516 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.586 HG21 ' HB2' ' A' ' 75' ' ' ALA . 69.4 p -79.12 -29.17 43.06 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.426 -0.352 . . . . 0.34 111.184 -179.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -69.74 -30.98 68.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.463 -0.335 . . . . 2.11 110.922 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -71.26 -42.13 69.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 3.41 110.995 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 53.6 p -59.72 -18.93 46.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.908 0.385 . . . . 1.47 110.947 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 92.55 2.74 67.33 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.918 -0.658 . . . . 0.7 112.604 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -125.98 140.58 37.18 Favored Pre-proline 0 N--CA 1.453 -0.303 0 CA-C-O 120.929 0.395 . . . . 3.05 110.786 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -71.25 160.1 49.91 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.422 2.082 . . . . 0.51 112.193 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.586 ' HB2' HG21 ' A' ' 68' ' ' THR . . . -93.63 124.82 37.88 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 116.13 -0.486 . . . . 0.23 110.86 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.2 t -126.34 118.29 24.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.007 0.432 . . . . 1.26 110.946 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -157.63 154.28 28.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.118 -0.492 . . . . 0.36 111.578 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.576 HE21 ' H ' ' A' ' 80' ' ' SER . 0.0 OUTLIER -81.31 130.21 34.94 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.926 -0.768 . . . . 1.58 108.926 178.69 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.431 ' N ' HE21 ' A' ' 78' ' ' GLN . 12.0 m -64.14 -6.5 2.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 112.851 0.686 . . . . 1.07 112.851 -178.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.576 ' H ' HE21 ' A' ' 78' ' ' GLN . 40.8 t -96.54 -14.0 22.58 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.503 0.557 . . . . 1.14 112.503 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.567 HE21 ' HB2' ' A' ' 78' ' ' GLN . 50.6 mt-30 -97.43 5.76 49.24 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.839 0.681 . . . . 2.08 112.839 -178.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 6.1 m -99.36 178.32 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.992 -0.283 . . . . 0.45 111.744 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.496 HG13 ' HB2' ' A' ' 86' ' ' TRP . 26.8 pt -56.16 155.92 11.67 Favored Pre-proline 0 CA--C 1.531 0.225 0 CA-C-N 116.379 -0.373 . . . . 0.75 111.646 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -45.75 -59.92 1.03 Allowed 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.191 2.594 . . . . 0.65 113.049 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.445 ' O ' HD11 ' A' ' 32' ' ' LEU . . . -49.51 -49.08 33.81 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 120.701 -0.761 . . . . 0.31 112.719 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . 0.496 ' HB2' HG13 ' A' ' 83' ' ' ILE . 0.6 OUTLIER -61.19 -46.5 90.21 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.325 0.491 . . . . 0.78 112.325 -179.015 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.45 HG23 ' O ' ' A' ' 83' ' ' ILE . 71.6 p -54.92 -36.44 65.24 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 111.791 0.293 . . . . 1.4 111.791 -179.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -70.46 -50.27 39.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.547 -0.297 . . . . 1.43 111.654 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.48 ' HB2' HD22 ' A' ' 32' ' ' LEU . . . -63.5 -52.14 62.54 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.486 -0.324 . . . . 0.33 111.852 -179.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -57.4 -30.02 64.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.16 -0.473 . . . . 0.39 111.827 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -69.84 -17.81 63.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.444 -0.344 . . . . 1.87 111.391 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 89.5 mt -101.6 -7.52 22.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.293 -0.412 . . . . 1.31 111.7 -179.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.452 ' O ' ' HD3' ' A' ' 44' ' ' LYS . 90.6 mtp -91.59 107.37 21.61 Favored Pre-proline 0 C--N 1.33 -0.26 0 N-CA-C 111.76 0.282 . . . . 1.66 111.76 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.617 ' HA ' ' HD3' ' A' ' 44' ' ' LYS . 38.8 Cg_endo -69.44 142.71 50.1 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.032 1.822 . . . . 0.44 110.799 178.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.515 ' HA ' HD13 ' A' ' 130' ' ' LEU . . . -45.82 126.66 7.35 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.78 0.324 . . . . 0.36 111.511 -179.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.551 ' H ' HD22 ' A' ' 130' ' ' LEU . . . 101.32 -2.75 54.27 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.636 -0.792 . . . . 0.34 113.229 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.418 ' HA ' ' O ' ' A' ' 38' ' ' ASN . 74.9 m -76.35 -177.54 4.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.048 0.451 . . . . 1.41 111.847 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.571 HG22 HD12 ' A' ' 37' ' ' ILE . 9.7 m -155.26 98.68 2.01 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.67 -0.696 . . . . 0.23 110.55 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.514 ' HE1' HG13 ' A' ' 36' ' ' VAL . 20.6 m0 -121.79 149.31 43.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.138 0.494 . . . . 0.53 111.581 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -115.28 107.63 15.51 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.156 -1.053 . . . . 1.37 108.156 177.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.727 HG22 ' HB3' ' A' ' 34' ' ' TYR . 48.7 pt -110.14 145.94 16.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 113.339 0.866 . . . . 0.25 113.339 -177.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -127.31 103.69 7.53 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.694 -1.139 . . . . 0.31 108.099 178.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.523 HG22 HD23 ' A' ' 32' ' ' LEU . 2.4 t -104.7 98.88 16.11 Favored Pre-proline 0 CA--C 1.53 0.205 0 N-CA-C 113.448 0.907 . . . . 0.52 113.448 -176.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.628 ' HG2' HD13 ' A' ' 107' ' ' LEU . 12.4 Cg_endo -58.6 151.92 59.29 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.0 1.8 . . . . 0.48 110.507 177.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -47.73 -38.9 16.35 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.273 0.471 . . . . 1.81 112.273 -178.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.407 ' C ' HD12 ' A' ' 107' ' ' LEU . . . -57.29 -9.35 4.32 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.985 -0.626 . . . . 0.4 113.288 -179.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.628 HD13 ' HG2' ' A' ' 104' ' ' PRO . 6.5 mp -110.41 -13.85 14.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.668 0.27 . . . . 2.35 111.52 -178.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.55 -0.296 . . . . 1.03 111.061 -179.67 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo . . . . . 0 C--O 1.232 0.186 0 CA-C-O 120.748 0.228 . . . . 0.7 111.976 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.64 HD12 HD13 ' A' ' 124' ' ' LEU . 26.0 mm -90.65 125.16 43.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.482 . . . . 1.25 110.567 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -44.81 155.33 0.35 Allowed Glycine 0 C--N 1.334 0.435 0 CA-C-N 115.724 -0.671 . . . . 0.48 113.554 -179.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -60.82 132.75 44.05 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.444 2.096 . . . . 0.67 111.437 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.437 ' HB2' ' OD1' ' A' ' 8' ' ' ASN . 1.4 m-80 47.71 35.73 4.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.231 -0.44 . . . . 1.12 109.925 -178.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.485 ' HG3' HG22 ' A' ' 60' ' ' ILE . 41.1 tt0 -114.7 128.84 56.53 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.051 -0.522 . . . . 1.73 111.394 -179.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.494 ' O ' ' HB ' ' A' ' 60' ' ' ILE . 87.4 m -95.44 129.58 42.55 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.184 -0.673 . . . . 0.29 109.184 178.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.64 HD13 HD12 ' A' ' 118' ' ' ILE . 0.1 OUTLIER -120.33 159.9 24.1 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.104 0.478 . . . . 1.47 111.956 -178.266 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.469 ' N ' HD12 ' A' ' 125' ' ' ILE . 4.5 mp -114.6 143.44 24.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.657 -0.701 . . . . 0.2 109.977 178.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -133.17 132.3 41.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.953 0.406 . . . . 0.24 111.541 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 10.3 tmtt? -111.36 103.56 11.94 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.558 -0.904 . . . . 2.28 108.558 178.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 20.8 mt -102.68 122.92 55.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.91 0.707 . . . . 0.82 112.91 -177.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -118.7 99.75 6.98 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.891 -0.781 . . . . 0.26 108.891 177.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.586 ' HA ' HG12 ' A' ' 53' ' ' VAL . 0.7 OUTLIER -78.48 124.84 28.58 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.157 -0.474 . . . . 1.41 111.558 -178.615 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 43.6 mm -94.06 -57.07 4.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.753 -0.658 . . . . 1.17 110.735 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.497 ' HA ' ' HB1' ' A' ' 95' ' ' ALA . 4.3 m -163.68 166.07 22.62 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.951 0.405 . . . . 1.17 111.491 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.448 HG11 ' HB3' ' A' ' 44' ' ' LYS . 7.3 p -107.63 124.33 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 115.945 -0.57 . . . . 1.43 111.012 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.552 ' HG3' ' HB ' ' A' ' 50' ' ' THR . 0.7 OUTLIER 33.36 73.16 0.07 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.057 -0.52 . . . . 3.08 111.792 -179.5 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 95.4 mttt 60.48 29.91 19.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.863 -0.608 . . . . 3.16 111.57 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.411 ' HB2' ' HB3' ' A' ' 132' ' ' SER . 46.9 t 55.41 67.78 0.96 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.055 -0.521 . . . . 1.31 111.083 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 66.2 m . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.345 -0.836 . . . . 2.53 110.889 179.964 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 23.3 tptm . . . . . 0 N--CA 1.455 -0.216 0 CA-C-O 120.79 0.329 . . . . 2.63 110.242 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -58.11 -52.0 67.36 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.092 -0.504 . . . . 0.82 109.977 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -64.85 -36.42 84.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.979 -0.555 . . . . 2.57 110.008 178.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -55.88 -33.13 64.32 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.89 -0.781 . . . . 2.1 108.89 178.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.502 ' HA ' ' HG2' ' A' ' 11' ' ' LYS . 53.2 m-20 -72.34 -38.24 68.65 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.165 -0.925 . . . . 1.4 110.428 179.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.434 ' NZ ' ' HB3' ' A' ' 9' ' ' LYS . 4.2 ttpm? -57.27 -35.64 70.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.977 -0.556 . . . . 2.67 111.212 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.9 t -76.35 -52.61 17.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 111.959 0.355 . . . . 1.27 111.959 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.502 ' HG2' ' HA ' ' A' ' 8' ' ' ASN . 19.0 ptpt -58.59 -33.35 69.89 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.668 0.27 . . . . 1.69 111.314 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.452 ' O ' ' HG ' ' A' ' 16' ' ' LEU . . . -76.39 -53.2 5.67 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.719 -0.753 . . . . 0.31 112.329 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -61.08 -30.75 70.52 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.837 0.351 . . . . 2.39 110.839 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.23 -32.09 55.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.319 -0.401 . . . . 0.23 110.458 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -63.99 -54.53 32.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.938 -0.573 . . . . 0.23 110.66 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.738 ' HA ' ' HB3' ' A' ' 19' ' ' ASN . 0.6 OUTLIER -65.59 -32.5 74.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.28 -0.418 . . . . 0.55 111.152 -179.724 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.434 ' N ' HD12 ' A' ' 16' ' ' LEU . 8.3 m -57.2 -48.54 78.52 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.606 -0.516 . . . . 0.27 109.606 179.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -74.16 -31.85 62.87 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.93 -0.577 . . . . 2.47 110.065 178.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.738 ' HB3' ' HA ' ' A' ' 16' ' ' LEU . 0.3 OUTLIER -57.12 -28.38 62.65 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.305 -0.861 . . . . 0.22 112.133 -179.523 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -48.04 -18.58 0.2 Allowed 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 112.32 0.489 . . . . 2.45 112.32 -179.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.68 HD22 ' N ' ' A' ' 21' ' ' ASN . 0.8 OUTLIER -67.67 -33.11 74.27 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.88 0.326 . . . . 0.4 111.88 -178.713 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.725 ' O ' HG23 ' A' ' 25' ' ' VAL . 68.1 mttm -54.04 119.48 19.74 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.716 -0.22 . . . . 1.4 111.022 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -56.8 145.56 82.77 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.246 1.964 . . . . 0.65 112.374 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.71 3.11 81.0 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.735 -0.745 . . . . 0.37 113.921 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 22' ' ' LYS . 18.0 t -58.65 109.48 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 117.517 0.659 . . . . 0.91 110.637 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.5 p -130.35 128.56 64.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.908 -0.587 . . . . 1.03 111.089 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.2 p -82.69 137.24 21.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.184 -0.462 . . . . 0.91 110.866 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.521 HD12 ' HB2' ' A' ' 32' ' ' LEU . 61.2 mt -95.52 166.88 13.76 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.102 -0.499 . . . . 0.4 110.713 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.443 ' HD2' ' HB3' ' A' ' 28' ' ' LEU . 53.2 Cg_exo -53.53 -30.93 56.61 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 121.889 1.726 . . . . 0.59 111.53 178.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.525 ' O ' HD12 ' A' ' 107' ' ' LEU . 28.0 t -85.43 -10.96 55.49 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.057 -0.519 . . . . 1.14 110.953 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.83 13.98 28.19 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 120.425 -0.893 . . . . 0.34 114.645 178.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.626 HD22 ' HB2' ' A' ' 89' ' ' ALA . 5.8 mp -85.61 136.98 33.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 117.747 0.774 . . . . 1.35 112.951 -179.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -119.01 139.9 50.92 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.118 -0.946 . . . . 1.75 108.49 177.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.654 ' HB3' HG22 ' A' ' 101' ' ' ILE . 41.0 p90 -155.04 176.39 12.6 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.794 0.664 . . . . 0.32 112.794 -178.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.433 ' HE2' ' HB3' ' A' ' 22' ' ' LYS . 23.4 ttmt -120.78 117.36 27.24 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.974 -1.012 . . . . 2.15 109.583 179.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.439 HG13 ' HE1' ' A' ' 99' ' ' TRP . 51.6 t -74.52 125.61 34.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 113.297 0.851 . . . . 0.3 113.297 -177.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 54.9 mt -107.22 -66.82 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.288 -0.869 . . . . 0.65 109.92 178.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.411 ' C ' ' ND2' ' A' ' 38' ' ' ASN . 0.7 OUTLIER -134.77 85.14 2.16 Favored 'General case' 0 C--O 1.226 -0.143 0 CA-C-N 116.022 -0.536 . . . . 1.03 109.754 178.927 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.611 ' HB2' ' HE1' ' A' ' 99' ' ' TRP . 47.0 t -106.47 145.16 32.14 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.376 0.51 . . . . 1.5 112.376 -179.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.1 109.19 0.27 Allowed Glycine 0 C--N 1.333 0.366 0 CA-C-N 115.665 -0.698 . . . . 1.09 113.936 178.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -177.75 -62.28 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 111.644 0.239 . . . . 1.7 111.644 178.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.2 168.98 34.28 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 120.63 -0.795 . . . . 0.35 113.763 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.744 HG22 ' H ' ' A' ' 44' ' ' LYS . 7.9 p -90.72 176.88 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 123.208 0.603 . . . . 1.42 109.959 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.744 ' H ' HG22 ' A' ' 43' ' ' VAL . 19.4 ptmt 164.94 156.2 0.07 OUTLIER Pre-proline 0 N--CA 1.469 0.519 0 CA-C-O 121.602 0.715 . . . . 2.18 112.86 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.528 ' HD2' HG21 ' A' ' 133' ' ' VAL . 1.2 Cg_endo -85.18 173.48 7.81 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 125.169 3.913 . . . . 0.3 113.097 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.508 ' O ' ' N ' ' A' ' 48' ' ' SER . . . -67.99 -172.18 6.46 Favored Glycine 0 C--O 1.225 -0.43 0 CA-C-N 115.393 -0.821 . . . . 0.35 111.383 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.405 ' HG2' ' HB2' ' A' ' 91' ' ' GLN . 98.8 mttt -41.41 -13.5 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 113.448 0.907 . . . . 2.35 113.448 -178.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.508 ' N ' ' O ' ' A' ' 46' ' ' GLY . 84.5 p -85.84 7.28 24.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.094 0.473 . . . . 1.45 110.282 178.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.469 ' O ' ' NE2' ' A' ' 78' ' ' GLN . 3.2 p30 -76.64 140.88 41.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.459 -0.791 . . . . 1.73 111.857 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 62.8 m -113.45 119.4 37.47 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.615 -0.883 . . . . 0.44 108.615 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.445 HG12 ' HB ' ' A' ' 133' ' ' VAL . 16.9 m -124.28 154.54 31.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 113.051 0.76 . . . . 0.65 113.051 -177.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 87.4 m -114.52 120.8 41.47 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.026 -0.988 . . . . 0.32 108.638 178.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.559 HG12 ' HA ' ' A' ' 130' ' ' LEU . 4.4 m -142.97 -179.71 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.296 0.57 . . . . 0.24 111.991 -178.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.527 ' HB3' ' HG2' ' A' ' 69' ' ' GLU . 28.3 mt-10 -129.55 132.79 46.92 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.114 -0.948 . . . . 2.4 109.455 178.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -146.48 160.86 41.55 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.703 0.763 . . . . 0.26 112.203 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 62.1 m -128.31 112.85 14.9 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.358 -1.292 . . . . 0.26 108.428 178.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.454 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -110.0 147.14 17.22 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.008 -1.091 . . . . 0.12 113.021 -178.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.485 ' NE ' HD13 ' A' ' 125' ' ' ILE . 1.8 ppt_? -147.91 148.05 30.39 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.888 0.375 . . . . 1.93 110.122 179.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.419 HD23 HD21 ' A' ' 124' ' ' LEU . 23.4 mt -77.55 162.18 27.31 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.981 -0.554 . . . . 1.21 110.102 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.513 ' HB ' ' O ' ' A' ' 123' ' ' THR . 6.9 tp -59.18 -10.75 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.365 0.603 . . . . 0.64 109.458 178.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -67.65 -12.61 60.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.312 -0.858 . . . . 2.01 110.721 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.434 ' HA2' HH11 ' A' ' 58' ' ' ARG . . . 90.55 -0.94 78.19 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.594 -0.812 . . . . 0.45 113.238 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 71.6 p -115.84 134.35 55.09 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 117.088 0.444 . . . . 1.4 111.458 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 57' ' ' GLY . 6.7 p -62.71 132.43 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-N 115.951 -0.568 . . . . 0.28 110.044 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.583 ' HD1' ' N ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -97.65 -22.35 16.52 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.083 -0.508 . . . . 0.24 110.99 -179.95 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.583 ' N ' ' HD1' ' A' ' 65' ' ' PHE . 24.9 t70 -175.91 130.05 0.24 Allowed 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 116.323 -0.399 . . . . 0.3 110.995 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.7 p -125.55 124.36 41.11 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.103 -0.499 . . . . 1.3 110.544 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.7 HG21 ' HB2' ' A' ' 75' ' ' ALA . 69.8 p -83.26 -25.33 31.72 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 120.848 0.356 . . . . 0.34 111.032 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.527 ' HG2' ' HB3' ' A' ' 54' ' ' GLU . 38.1 mt-10 -75.09 -39.32 60.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 2.11 110.98 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -63.54 -44.86 92.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 3.41 110.639 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 54.7 m -58.25 -21.4 48.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.258 -0.428 . . . . 1.47 110.556 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 90.46 7.5 67.08 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.808 -0.71 . . . . 0.7 112.311 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -125.99 117.01 23.98 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.355 0.122 . . . . 3.05 110.937 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -55.47 157.19 15.51 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.314 2.01 . . . . 0.51 112.107 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.7 ' HB2' HG21 ' A' ' 68' ' ' THR . . . -94.72 123.99 38.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.346 -0.388 . . . . 0.23 110.622 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.6 t -125.89 118.48 25.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.786 0.327 . . . . 1.26 111.189 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -158.47 163.49 37.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.11 0.481 . . . . 0.36 111.865 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.484 ' OE1' ' HB3' ' A' ' 80' ' ' SER . 0.0 OUTLIER -83.04 137.8 33.98 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.524 -0.762 . . . . 1.58 109.03 178.608 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.424 ' O ' HG22 ' A' ' 87' ' ' THR . 21.6 m -69.26 -20.07 24.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 113.587 0.958 . . . . 1.07 113.587 -177.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.484 ' HB3' ' OE1' ' A' ' 78' ' ' GLN . 33.2 t -95.3 -2.56 49.1 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.955 0.354 . . . . 1.14 111.955 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.453 HE21 ' HB3' ' A' ' 78' ' ' GLN . 23.4 mt-30 -96.17 5.58 50.74 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.895 0.331 . . . . 2.08 111.895 -179.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.467 ' HB ' HD13 ' A' ' 83' ' ' ILE . 3.1 m -107.38 -175.66 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 111.662 0.245 . . . . 0.45 111.662 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.74 HD13 ' H ' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -56.45 147.73 47.72 Favored Pre-proline 0 N--CA 1.463 0.191 0 CA-C-N 116.507 -0.315 . . . . 0.75 111.711 -179.468 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo -42.25 -54.12 3.23 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.19 2.594 . . . . 0.65 113.365 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.533 ' HA2' HD11 ' A' ' 32' ' ' LEU . . . -51.87 -49.21 49.05 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.517 -0.849 . . . . 0.31 112.7 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -60.9 -47.7 85.18 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.693 0.257 . . . . 0.78 111.693 -179.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.424 HG22 ' O ' ' A' ' 79' ' ' VAL . 30.9 p -53.52 -33.73 55.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.766 0.317 . . . . 1.4 111.598 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -70.61 -51.41 28.35 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.161 0.43 . . . . 1.43 112.161 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.626 ' HB2' HD22 ' A' ' 32' ' ' LEU . . . -68.01 -48.49 65.57 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.483 0.549 . . . . 0.33 112.483 -178.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -55.19 -30.99 61.04 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.021 0.378 . . . . 0.39 112.021 -179.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.405 ' HB2' ' HG2' ' A' ' 47' ' ' LYS . 46.7 tt0 -65.68 -21.15 66.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.595 -0.275 . . . . 1.87 111.574 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.411 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 10.6 mp -96.41 -22.13 17.34 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.382 0.512 . . . . 1.31 112.382 -178.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 22.2 ttm -71.41 108.73 4.22 Favored Pre-proline 0 CA--C 1.532 0.278 0 N-CA-C 111.472 0.175 . . . . 1.66 111.472 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.421 ' HD2' ' OG ' ' A' ' 97' ' ' SER . 6.1 Cg_exo -75.67 144.89 28.64 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.751 2.301 . . . . 0.44 111.889 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.609 ' HB1' ' HA ' ' A' ' 132' ' ' SER . . . -48.31 127.57 13.06 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.472 -0.331 . . . . 0.36 111.437 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 94.39 2.57 63.63 Favored Glycine 0 CA--C 1.521 0.422 0 C-N-CA 120.701 -0.762 . . . . 0.34 113.446 179.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.421 ' OG ' ' HD2' ' A' ' 94' ' ' PRO . 69.6 m -89.92 -174.59 4.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.885 0.374 . . . . 1.41 111.609 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.7 m -152.3 112.78 4.11 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.066 -0.515 . . . . 0.23 110.773 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.611 ' HE1' ' HB2' ' A' ' 39' ' ' SER . 14.8 m0 -132.25 149.77 52.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.052 0.453 . . . . 0.53 111.759 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -123.73 108.54 12.64 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.367 -0.975 . . . . 1.37 108.367 177.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.654 HG22 ' HB3' ' A' ' 34' ' ' TYR . 24.7 pt -107.68 139.68 28.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 112.974 0.731 . . . . 0.25 112.974 -177.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.497 ' OH ' HG22 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -120.34 103.99 9.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.951 -1.022 . . . . 0.31 108.262 178.232 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.417 ' HA ' ' HD2' ' A' ' 104' ' ' PRO . 3.3 t -109.12 102.43 48.9 Favored Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 113.764 1.024 . . . . 0.52 113.764 -176.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.593 ' HG2' HD23 ' A' ' 107' ' ' LEU . 12.3 Cg_endo -59.62 150.94 73.3 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 121.872 1.715 . . . . 0.48 110.037 176.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -47.56 -31.74 4.72 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.512 0.56 . . . . 1.81 112.512 -178.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -57.09 -13.47 9.14 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.877 -0.677 . . . . 0.4 114.084 -178.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.593 HD23 ' HG2' ' A' ' 104' ' ' PRO . 3.0 mm? -114.57 -5.55 12.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 117.193 0.496 . . . . 2.35 111.763 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.412 0 CA-C-N 116.513 -0.312 . . . . 1.03 110.385 179.658 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.911 0.296 . . . . 0.7 111.679 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.598 HG23 HD13 ' A' ' 124' ' ' LEU . 5.1 mp -91.55 120.06 39.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.77 -0.65 . . . . 1.25 110.082 179.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -46.13 157.6 0.4 Allowed Glycine 0 C--N 1.333 0.416 0 CA-C-N 116.083 -0.508 . . . . 0.48 113.308 -179.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.431 ' O ' ' HG3' ' A' ' 122' ' ' GLU . 26.5 Cg_endo -62.07 131.33 34.22 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.486 2.124 . . . . 0.67 111.826 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 47.22 34.57 3.13 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.03 -0.532 . . . . 1.12 110.371 -178.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.431 ' HG3' ' O ' ' A' ' 120' ' ' PRO . 37.0 mt-10 -115.64 122.92 47.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.34 -0.391 . . . . 1.73 111.528 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.513 ' O ' ' HB ' ' A' ' 60' ' ' ILE . 91.2 m -89.17 127.9 35.76 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.782 -0.822 . . . . 0.29 108.782 178.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.598 HD13 HG23 ' A' ' 118' ' ' ILE . 6.3 mp -114.42 155.82 25.63 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.217 0.532 . . . . 1.47 112.268 -177.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.485 HD13 ' NE ' ' A' ' 58' ' ' ARG . 4.6 mp -113.9 132.88 61.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.306 -0.861 . . . . 0.2 109.716 178.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -125.39 131.82 52.88 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.975 0.417 . . . . 0.24 111.423 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -110.0 102.94 11.64 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.482 -0.933 . . . . 2.28 108.482 178.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.43 ' N ' HD12 ' A' ' 128' ' ' ILE . 5.0 mp -105.71 118.65 53.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 112.429 0.529 . . . . 0.82 112.429 -177.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -109.18 99.32 8.62 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.282 -1.007 . . . . 0.26 108.282 177.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.559 ' HA ' HG12 ' A' ' 53' ' ' VAL . 26.2 tp -79.3 114.9 18.61 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.86 -0.609 . . . . 1.41 111.511 -178.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 67.8 mt -84.18 -56.73 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 CA-C-N 115.884 -0.598 . . . . 1.17 110.288 179.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.609 ' HA ' ' HB1' ' A' ' 95' ' ' ALA . 11.3 p -164.27 165.15 22.14 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.246 -0.433 . . . . 1.17 111.409 179.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.691 HG11 ' CB ' ' A' ' 44' ' ' LYS . 7.2 p -117.04 122.24 69.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.902 -0.59 . . . . 1.43 111.064 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.414 ' C ' ' O ' ' A' ' 133' ' ' VAL . 11.3 mttm 32.99 79.19 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.233 -0.44 . . . . 3.08 111.344 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 15.6 pttm 51.86 30.7 7.38 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.783 -0.644 . . . . 3.16 111.629 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 33.8 t 50.61 44.52 27.38 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.587 -0.733 . . . . 1.31 111.096 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 42.3 t . . . . . 0 C--O 1.248 0.979 0 CA-C-O 118.24 -0.886 . . . . 2.53 111.04 -179.734 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 59.9 mmtt . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.843 0.354 . . . . 2.63 110.598 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -58.39 -48.67 79.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.975 -0.557 . . . . 0.82 110.7 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -75.14 -31.9 61.19 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.275 -0.42 . . . . 2.57 110.916 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -56.78 -41.74 78.21 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.683 -0.488 . . . . 2.1 109.683 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.514 ' HA ' ' HG2' ' A' ' 11' ' ' LYS . 23.7 p30 -78.97 -29.2 43.77 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.734 -0.666 . . . . 1.4 111.415 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 121' ' ' ASN . 66.7 tttm -56.16 -44.12 78.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.005 0.431 . . . . 2.67 110.741 179.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.425 HG22 ' H ' ' A' ' 10' ' ' VAL . 5.4 m -78.1 -44.97 27.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.915 -0.584 . . . . 1.27 112.446 -179.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.517 ' HE2' HG13 ' A' ' 60' ' ' ILE . 17.9 ptmt -59.16 -33.57 71.07 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.703 0.287 . . . . 1.69 111.429 -179.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.411 ' O ' ' HG ' ' A' ' 16' ' ' LEU . . . -76.34 -53.01 5.78 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.833 -0.699 . . . . 0.31 112.202 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.505 ' HA ' HD11 ' A' ' 16' ' ' LEU . 47.8 mt-10 -59.21 -25.38 63.93 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.931 0.396 . . . . 2.39 110.591 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.15 -37.61 45.55 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.061 -0.518 . . . . 0.23 110.584 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -61.78 -51.91 66.37 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.165 -0.471 . . . . 0.23 110.828 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.686 ' HA ' ' HB3' ' A' ' 19' ' ' ASN . 0.6 OUTLIER -67.84 -32.66 73.35 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.717 -0.393 . . . . 0.55 111.143 -179.72 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.451 ' N ' HD12 ' A' ' 16' ' ' LEU . 6.2 m -57.65 -46.09 84.66 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.494 -0.558 . . . . 0.27 109.494 178.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -74.27 -31.96 62.73 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.753 -0.658 . . . . 2.47 109.856 178.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.686 ' HB3' ' HA ' ' A' ' 16' ' ' LEU . 0.6 OUTLIER -60.15 -26.36 66.23 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.436 -0.802 . . . . 0.22 112.532 -179.384 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -48.91 -19.46 0.39 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.764 0.316 . . . . 2.45 111.689 -179.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.72 HD22 ' N ' ' A' ' 21' ' ' ASN . 0.7 OUTLIER -69.12 -34.71 75.48 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.135 0.42 . . . . 0.4 112.135 -179.229 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.715 ' O ' HG23 ' A' ' 25' ' ' VAL . 18.7 mmtp -46.02 127.87 7.19 Favored Pre-proline 0 N--CA 1.465 0.298 0 CA-C-O 120.661 0.267 . . . . 1.4 111.266 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -57.89 137.12 79.38 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.336 2.024 . . . . 0.65 112.192 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.94 0.83 83.03 Favored Glycine 0 CA--C 1.52 0.374 0 C-N-CA 120.771 -0.728 . . . . 0.37 113.955 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 22' ' ' LYS . 24.1 t -56.21 103.98 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.125 0 CA-C-N 117.541 0.67 . . . . 0.91 110.17 179.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.6 p -126.49 135.68 63.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.611 -0.722 . . . . 1.03 111.138 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.427 HG23 ' NE2' ' A' ' 33' ' ' GLN . 7.6 p -87.05 141.77 13.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.261 -0.427 . . . . 0.91 111.157 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.48 HD12 ' HB2' ' A' ' 32' ' ' LEU . 55.5 mt -101.29 166.06 13.02 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.099 -0.5 . . . . 0.4 110.804 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.416 ' HD2' ' HB3' ' A' ' 28' ' ' LEU . 54.2 Cg_exo -53.79 -30.58 57.74 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 121.914 1.743 . . . . 0.59 111.455 178.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.569 ' O ' HD12 ' A' ' 107' ' ' LEU . 38.8 t -83.85 -12.85 54.95 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.862 -0.608 . . . . 1.14 110.871 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.43 14.18 26.44 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 120.485 -0.864 . . . . 0.34 114.291 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.676 HD11 ' CA ' ' A' ' 85' ' ' GLY . 6.6 mp -85.89 137.51 32.7 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 113.64 0.978 . . . . 1.35 113.64 -178.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.427 ' NE2' HG23 ' A' ' 27' ' ' VAL . 25.5 mp0 -118.4 142.7 47.28 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.985 -1.117 . . . . 1.75 107.985 177.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.604 ' HB3' HG22 ' A' ' 101' ' ' ILE . 34.8 p90 -158.79 175.69 13.28 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.278 0.844 . . . . 0.32 113.278 -178.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -121.58 117.46 26.8 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 114.901 -1.045 . . . . 2.15 109.606 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.484 HG13 ' HE1' ' A' ' 99' ' ' TRP . 46.6 t -81.92 126.77 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 113.216 0.821 . . . . 0.3 113.216 -178.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.452 HD12 HG22 ' A' ' 98' ' ' THR . 81.4 mt -101.73 -64.14 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 115.658 -0.701 . . . . 0.65 110.761 178.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.4 ' O ' ' HA ' ' A' ' 97' ' ' SER . 7.4 t30 -141.35 86.08 2.0 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.826 0.346 . . . . 1.03 110.931 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.702 ' HB2' ' HE1' ' A' ' 99' ' ' TRP . 39.5 t -106.82 146.06 31.38 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.315 -0.402 . . . . 1.5 112.047 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 93.41 85.19 1.59 Allowed Glycine 0 C--N 1.334 0.422 0 C-N-CA 121.05 -0.595 . . . . 1.09 113.224 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -153.28 -71.75 0.14 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.693 0.282 . . . . 1.7 111.612 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.26 166.67 32.24 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 121.052 -0.594 . . . . 0.35 114.376 -178.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.662 HG12 ' H ' ' A' ' 44' ' ' LYS . 2.6 t -90.45 176.18 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 123.516 0.726 . . . . 1.42 109.905 179.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.662 ' H ' HG12 ' A' ' 43' ' ' VAL . 2.2 pptp? 165.72 156.06 0.09 OUTLIER Pre-proline 0 N--CA 1.47 0.552 0 CA-C-O 121.464 0.65 . . . . 2.18 111.952 -179.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.515 ' HD2' ' HB2' ' A' ' 49' ' ' ASP . 3.1 Cg_exo -76.56 172.47 16.16 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 124.602 3.535 . . . . 0.3 113.624 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.495 ' HA2' HE22 ' A' ' 91' ' ' GLN . . . -67.76 -173.12 6.76 Favored Glycine 0 C--O 1.223 -0.568 0 CA-C-N 115.17 -0.923 . . . . 0.35 110.944 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.492 ' HG2' ' HB2' ' A' ' 91' ' ' GLN . 53.7 mtmt -42.14 -14.05 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.56 0.948 . . . . 2.35 113.56 -177.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.493 ' N ' ' O ' ' A' ' 46' ' ' GLY . 45.1 t -86.52 7.69 25.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.137 0.494 . . . . 1.45 110.256 178.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.515 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 3.0 p30 -76.18 162.96 27.54 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.515 -0.766 . . . . 1.73 111.368 -179.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 60.0 m -123.85 122.93 39.3 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.598 -0.89 . . . . 0.44 108.598 178.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.65 HG12 HG22 ' A' ' 133' ' ' VAL . 2.3 m -122.85 141.08 44.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.285 0.564 . . . . 0.65 112.491 -177.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 66.3 m -113.07 120.08 40.1 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.228 -1.027 . . . . 0.32 108.228 177.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.6 HG12 ' HA ' ' A' ' 130' ' ' LEU . 4.8 m -144.97 177.56 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.231 0.538 . . . . 0.24 111.686 -178.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -125.22 131.86 53.08 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.642 -0.873 . . . . 2.4 108.642 178.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -143.78 158.2 43.85 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.701 0.762 . . . . 0.26 112.381 -179.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 59.4 m -122.71 112.44 17.94 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.312 -1.313 . . . . 0.26 108.577 178.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.473 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -109.82 145.77 16.98 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 119.953 -1.118 . . . . 0.12 112.7 -178.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.516 ' NE ' HD13 ' A' ' 125' ' ' ILE . 4.9 ppt_? -148.09 146.97 29.04 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.048 0.452 . . . . 1.93 110.431 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.452 HD11 ' HB3' ' A' ' 122' ' ' GLU . 46.3 tp -76.1 160.36 29.84 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.759 -0.655 . . . . 1.21 109.809 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.525 ' HB ' ' O ' ' A' ' 123' ' ' THR . 9.5 tp -56.34 -10.68 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.251 0.548 . . . . 0.64 109.879 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.422 ' H ' ' C ' ' A' ' 59' ' ' LEU . 20.4 t70 -66.02 -12.4 54.88 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.454 -0.794 . . . . 2.01 110.861 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.82 -0.77 77.14 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.577 -0.821 . . . . 0.45 113.315 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.4 t -118.65 142.33 47.75 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.053 0.454 . . . . 1.4 111.214 -179.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 57' ' ' GLY . 7.0 p -65.96 133.71 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 115.827 -0.624 . . . . 0.28 110.17 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.598 ' HD1' ' N ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -97.43 -22.79 16.39 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.988 -0.551 . . . . 0.24 110.497 179.719 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.598 ' N ' ' HD1' ' A' ' 65' ' ' PHE . 25.4 t70 -176.95 131.7 0.18 Allowed 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.922 -0.581 . . . . 0.3 110.532 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 63.3 p -129.52 123.53 31.67 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.449 -0.342 . . . . 1.3 110.966 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.684 HG21 ' HB2' ' A' ' 75' ' ' ALA . 59.7 p -78.65 -14.35 59.35 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.898 0.38 . . . . 0.34 110.905 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -75.38 -51.83 12.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.048 -0.524 . . . . 2.11 110.604 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.9 ttpm? -61.04 -36.8 80.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.044 -0.525 . . . . 3.41 110.911 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 41.2 m -57.91 -20.03 34.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.206 -0.452 . . . . 1.47 110.744 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.29 4.88 90.03 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.831 -0.699 . . . . 0.7 112.013 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -126.18 117.38 23.6 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.457 0.17 . . . . 3.05 110.931 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -52.99 156.66 9.34 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.395 2.063 . . . . 0.51 112.046 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.684 ' HB2' HG21 ' A' ' 68' ' ' THR . . . -94.21 124.62 38.34 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.42 -0.355 . . . . 0.23 110.601 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.1 t -127.79 118.09 23.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.162 0.506 . . . . 1.26 111.428 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -158.36 167.12 30.58 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.674 -0.694 . . . . 0.36 110.896 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.603 ' NE2' ' HB3' ' A' ' 80' ' ' SER . 5.7 tt0 -85.5 146.0 27.14 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.3 -0.63 . . . . 1.58 109.3 178.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 32.9 m -68.44 -26.51 33.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 113.032 0.753 . . . . 1.07 113.032 -178.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.603 ' HB3' ' NE2' ' A' ' 78' ' ' GLN . 33.4 t -95.53 -3.77 45.98 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 111.937 0.347 . . . . 1.14 111.937 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 -84.87 5.65 27.96 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.733 0.272 . . . . 2.08 111.733 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 1.7 m -112.06 -172.55 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.6 -0.273 . . . . 0.45 111.553 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.529 HG13 ' HB2' ' A' ' 86' ' ' TRP . 29.2 pt -55.99 154.4 14.68 Favored Pre-proline 0 CA--C 1.528 0.13 0 CA-C-N 116.472 -0.331 . . . . 0.75 111.629 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -48.01 -53.67 6.33 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.651 2.234 . . . . 0.65 112.91 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.676 ' CA ' HD11 ' A' ' 32' ' ' LEU . . . -52.93 -49.69 53.9 Favored Glycine 0 CA--C 1.521 0.458 0 C-N-CA 120.802 -0.713 . . . . 0.31 113.112 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . 0.529 ' HB2' HG13 ' A' ' 83' ' ' ILE . 0.4 OUTLIER -59.49 -45.57 91.31 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.842 0.312 . . . . 0.78 111.842 -179.069 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 98.4 m -55.66 -37.49 68.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.442 -0.345 . . . . 1.4 111.689 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.64 -49.98 64.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.491 -0.322 . . . . 1.43 111.745 -179.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.642 ' HB2' HD22 ' A' ' 32' ' ' LEU . . . -64.39 -49.24 72.36 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.009 0.374 . . . . 0.33 112.009 -179.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -57.24 -26.72 61.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.423 -0.353 . . . . 0.39 111.72 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.712 ' HA ' HE21 ' A' ' 91' ' ' GLN . 0.0 OUTLIER -66.43 -24.55 66.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.836 0.35 . . . . 1.87 110.976 -179.89 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.412 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 4.2 mm? -93.59 -7.51 43.85 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.168 -0.469 . . . . 1.31 111.134 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 69.3 mtp -88.32 108.44 22.15 Favored Pre-proline 0 CA--C 1.531 0.222 0 CA-C-N 116.47 -0.332 . . . . 1.66 111.891 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' A' ' 92' ' ' LEU . 99.0 Cg_endo -79.91 147.07 18.84 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.403 2.068 . . . . 0.44 110.582 178.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.495 ' HA ' HD13 ' A' ' 130' ' ' LEU . . . -45.58 126.59 6.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.779 0.323 . . . . 0.36 111.65 -179.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.563 ' H ' HD22 ' A' ' 130' ' ' LEU . . . 97.66 -7.8 63.53 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 120.549 -0.834 . . . . 0.34 113.281 178.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 38' ' ' ASN . 33.5 t -69.82 174.83 4.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.876 0.37 . . . . 1.41 111.264 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.452 HG22 HD12 ' A' ' 37' ' ' ILE . 24.5 m -147.31 90.82 1.91 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.987 -0.552 . . . . 0.23 110.471 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.702 ' HE1' ' HB2' ' A' ' 39' ' ' SER . 23.5 m0 -112.11 149.41 32.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.266 0.555 . . . . 0.53 112.189 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -119.59 107.78 13.69 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.311 -0.996 . . . . 1.37 108.311 177.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.604 HG22 ' HB3' ' A' ' 34' ' ' TYR . 48.7 pt -111.07 146.27 16.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 113.221 0.822 . . . . 0.25 113.221 -177.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.471 ' OH ' HG22 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -130.98 103.76 6.73 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.657 -1.156 . . . . 0.31 108.145 178.276 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 4.7 t -105.39 99.75 22.33 Favored Pre-proline 0 C--N 1.33 -0.265 0 N-CA-C 113.709 1.003 . . . . 0.52 113.709 -176.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.59 ' HG2' HD23 ' A' ' 107' ' ' LEU . 11.6 Cg_endo -58.73 151.15 65.78 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 121.701 1.601 . . . . 0.48 109.814 176.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -47.49 -31.87 4.67 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.544 0.572 . . . . 1.81 112.544 -178.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -56.97 -13.9 9.38 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.667 -0.778 . . . . 0.4 113.949 -178.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.59 HD23 ' HG2' ' A' ' 104' ' ' PRO . 2.8 mm? -115.19 -5.87 12.42 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 117.09 0.445 . . . . 2.35 111.788 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.421 0 CA-C-N 116.551 -0.295 . . . . 1.03 110.621 179.954 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo . . . . . 0 C--O 1.231 0.155 0 CA-C-O 120.913 0.297 . . . . 0.7 111.92 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.47 HG12 HD13 ' A' ' 124' ' ' LEU . 97.9 mt -91.07 124.65 43.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.993 -0.549 . . . . 1.25 110.273 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -45.55 155.21 0.5 Allowed Glycine 0 CA--C 1.522 0.481 0 CA-C-N 115.981 -0.554 . . . . 0.48 113.469 -179.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -62.11 131.02 32.73 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.282 1.988 . . . . 0.67 111.466 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.467 ' O ' ' HA ' ' A' ' 9' ' ' LYS . 1.8 m-80 47.92 35.32 4.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.073 0.463 . . . . 1.12 110.097 -178.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.452 ' HB3' HD11 ' A' ' 59' ' ' LEU . 11.3 mt-10 -115.6 135.39 54.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.044 -0.526 . . . . 1.73 110.904 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.525 ' O ' ' HB ' ' A' ' 60' ' ' ILE . 92.6 m -95.7 129.36 42.94 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.568 -0.53 . . . . 0.29 109.568 179.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.47 HD13 HG12 ' A' ' 118' ' ' ILE . 0.2 OUTLIER -117.45 150.48 38.84 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.168 0.509 . . . . 1.47 111.53 -178.593 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.536 ' N ' HD12 ' A' ' 125' ' ' ILE . 4.1 mp -113.48 140.56 33.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.567 -0.742 . . . . 0.2 110.08 179.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.413 ' CE1' HD22 ' A' ' 124' ' ' LEU . 74.9 m-85 -131.82 132.09 43.42 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.09 -0.505 . . . . 0.24 111.179 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -109.71 103.8 12.68 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.171 -0.677 . . . . 2.28 109.171 178.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 15.6 mt -102.81 122.58 55.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 112.634 0.605 . . . . 0.82 112.634 -177.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -118.26 100.09 7.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.243 -0.889 . . . . 0.26 108.74 178.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.6 ' HA ' HG12 ' A' ' 53' ' ' VAL . 0.8 OUTLIER -78.93 124.38 28.19 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.14 -0.482 . . . . 1.41 111.92 -178.047 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 35.3 mm -94.25 -50.52 11.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.642 -0.708 . . . . 1.17 110.09 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.463 ' HA ' ' HB1' ' A' ' 95' ' ' ALA . 51.9 p -164.5 165.12 21.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.922 -0.581 . . . . 1.17 110.244 179.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.65 HG22 HG12 ' A' ' 51' ' ' VAL . 96.8 t -130.72 117.86 40.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.803 0.335 . . . . 1.43 111.302 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 5.5 tmtp? 51.03 62.39 2.74 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.933 -0.576 . . . . 3.08 110.711 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 68.9 mttm 59.05 43.65 17.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.811 -0.631 . . . . 3.16 110.35 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 86.8 p 50.55 31.88 6.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.431 -0.804 . . . . 1.31 111.037 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 45.1 t . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.216 -0.897 . . . . 2.53 110.847 -179.873 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 62.7 tttp . . . . . 0 N--CA 1.455 -0.185 0 N-CA-C 109.622 -0.51 . . . . 2.63 109.622 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.485 ' HA ' ' ND2' ' A' ' 8' ' ' ASN . . . -57.65 -52.28 66.06 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.757 -0.656 . . . . 0.82 110.115 179.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -64.41 -36.15 83.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.784 -0.644 . . . . 2.57 109.484 178.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -55.68 -33.46 64.15 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.8 -0.815 . . . . 2.1 108.8 178.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.485 ' ND2' ' HA ' ' A' ' 5' ' ' ALA . 19.3 m-20 -69.1 -39.44 78.97 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 115.572 -0.74 . . . . 1.4 109.961 179.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -56.7 -32.4 65.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.709 -0.678 . . . . 2.67 111.037 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.8 t -78.03 -52.87 15.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.374 -0.375 . . . . 1.27 111.895 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.483 ' HG2' ' HA ' ' A' ' 8' ' ' ASN . 10.2 ptpp? -63.18 -26.06 68.63 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.895 0.379 . . . . 1.69 110.59 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.409 ' O ' ' HG ' ' A' ' 16' ' ' LEU . . . -75.76 -50.33 8.06 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.841 -0.695 . . . . 0.31 111.667 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.471 ' HA ' HD11 ' A' ' 16' ' ' LEU . 12.8 pt-20 -66.41 -27.56 67.94 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.873 0.368 . . . . 2.39 110.188 179.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.02 -34.19 61.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.096 -0.502 . . . . 0.23 110.491 179.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -63.75 -55.81 20.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.753 -0.658 . . . . 0.23 110.573 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.699 ' HA ' ' HB3' ' A' ' 19' ' ' ASN . 0.4 OUTLIER -64.16 -31.79 73.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.228 -0.442 . . . . 0.55 111.04 179.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.5 m -56.56 -47.65 79.01 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.607 -0.516 . . . . 0.27 109.607 179.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -73.61 -32.19 63.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.825 -0.625 . . . . 2.47 109.865 178.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.699 ' HB3' ' HA ' ' A' ' 16' ' ' LEU . 0.7 OUTLIER -59.09 -25.58 63.92 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.635 -0.711 . . . . 0.22 111.573 179.869 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -46.89 -20.21 0.13 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.536 -0.302 . . . . 2.45 111.605 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.712 HD22 ' N ' ' A' ' 21' ' ' ASN . 0.7 OUTLIER -68.67 -37.12 79.37 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.436 -0.347 . . . . 0.4 110.991 -179.482 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.805 ' O ' HG23 ' A' ' 25' ' ' VAL . 4.3 mptp? -50.53 118.83 10.2 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.067 -0.515 . . . . 1.4 110.251 179.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 22' ' ' LYS . 18.1 Cg_endo -57.06 147.06 77.48 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.33 2.02 . . . . 0.65 112.649 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.02 3.46 79.58 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.869 -0.681 . . . . 0.37 113.967 179.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.805 HG23 ' O ' ' A' ' 22' ' ' LYS . 38.1 t -55.09 106.43 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 117.563 0.681 . . . . 0.91 110.681 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.4 HG13 ' CE1' ' A' ' 34' ' ' TYR . 2.6 p -130.76 126.73 60.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.868 -0.605 . . . . 1.03 111.133 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.8 p -80.16 142.47 13.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.05 -0.523 . . . . 0.91 110.77 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.578 HD12 ' HB2' ' A' ' 32' ' ' LEU . 63.0 mt -101.73 167.85 9.95 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.476 -0.329 . . . . 0.4 110.673 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.46 ' HD2' ' HB3' ' A' ' 28' ' ' LEU . 71.4 Cg_exo -51.49 -31.95 41.3 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 121.923 1.748 . . . . 0.59 111.742 178.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.476 ' O ' HD22 ' A' ' 107' ' ' LEU . 30.3 t -86.44 -11.21 52.49 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.231 -0.44 . . . . 1.14 110.87 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.04 14.91 23.43 Favored Glycine 0 C--N 1.335 0.474 0 C-N-CA 120.563 -0.827 . . . . 0.34 114.298 178.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.748 HD11 ' CA ' ' A' ' 85' ' ' GLY . 6.8 mp -84.33 134.65 34.49 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.364 0.876 . . . . 1.35 113.364 -178.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.6 mp0 -114.28 142.54 46.17 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.082 -1.081 . . . . 1.75 108.082 177.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.484 ' CB ' HG22 ' A' ' 101' ' ' ILE . 27.8 p90 -158.97 175.18 13.87 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 113.173 0.805 . . . . 0.32 113.173 -178.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -122.48 117.3 25.61 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 114.768 -1.105 . . . . 2.15 109.536 179.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 66.6 t -77.3 126.25 37.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 113.424 0.898 . . . . 0.3 113.424 -178.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.405 ' HB ' ' O ' ' A' ' 98' ' ' THR . 78.0 mt -101.3 -65.99 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 115.408 -0.815 . . . . 0.65 109.872 178.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -129.84 95.54 3.99 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 116.394 -0.366 . . . . 1.03 110.094 178.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.713 ' HB3' ' HE1' ' A' ' 99' ' ' TRP . 68.2 p -105.15 145.88 29.97 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.262 0.467 . . . . 1.5 112.262 -178.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.92 103.18 0.07 OUTLIER Glycine 0 C--N 1.332 0.36 0 CA-C-N 115.686 -0.688 . . . . 1.09 113.168 179.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 54.6 m-80 -152.52 -82.56 0.09 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.691 0.282 . . . . 1.7 111.15 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.13 174.2 38.49 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 121.191 -0.528 . . . . 0.35 113.743 -179.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.619 ' O ' ' HB3' ' A' ' 44' ' ' LYS . 33.8 m -82.42 176.4 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 C-N-CA 123.401 0.68 . . . . 1.42 110.409 179.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.619 ' HB3' ' O ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER 165.1 156.54 0.08 OUTLIER Pre-proline 0 N--CA 1.471 0.591 0 CA-C-O 121.47 0.653 . . . . 2.18 112.33 -179.236 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.555 ' HD3' HG11 ' A' ' 133' ' ' VAL . 1.8 Cg_endo -85.36 173.47 7.63 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 125.082 3.854 . . . . 0.3 113.367 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' A' ' 48' ' ' SER . . . -68.28 -172.34 6.94 Favored Glycine 0 C--O 1.223 -0.572 0 CA-C-N 115.216 -0.902 . . . . 0.35 111.451 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -41.64 -13.48 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.763 1.023 . . . . 2.35 113.763 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 46' ' ' GLY . 50.5 m -86.16 7.51 24.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.46 0.647 . . . . 1.45 109.851 178.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.487 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 1.8 t70 -74.84 162.15 28.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.887 -1.051 . . . . 1.73 112.326 -179.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 90.3 m -125.56 133.85 52.16 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 108.752 -0.833 . . . . 0.44 108.752 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.636 HG12 HG22 ' A' ' 133' ' ' VAL . 30.1 m -131.74 140.37 48.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 112.807 0.669 . . . . 0.65 112.807 -178.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 89.4 m -112.98 119.86 39.39 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.083 -1.08 . . . . 0.32 108.083 177.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.568 HG12 ' HA ' ' A' ' 130' ' ' LEU . 5.0 m -146.4 -179.17 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.229 0.538 . . . . 0.24 111.943 -178.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -130.04 132.13 46.09 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.37 -0.832 . . . . 2.4 108.977 178.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -147.18 167.11 25.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.757 0.789 . . . . 0.26 112.412 -178.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 58.3 m -131.19 113.99 14.55 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.384 -1.28 . . . . 0.26 108.728 178.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.405 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -109.53 147.53 17.03 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 119.989 -1.1 . . . . 0.12 112.452 -178.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.34 145.93 31.4 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.046 0.451 . . . . 1.93 110.429 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.494 HD23 HD11 ' A' ' 124' ' ' LEU . 6.9 mt -79.9 153.39 29.04 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.688 -0.687 . . . . 1.21 110.255 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.497 ' HB ' ' O ' ' A' ' 123' ' ' THR . 0.4 OUTLIER -55.64 -14.35 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.401 0.619 . . . . 0.64 109.411 178.936 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -65.11 -10.87 34.07 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.266 -0.879 . . . . 2.01 110.93 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.02 0.03 75.14 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.547 -0.835 . . . . 0.45 113.837 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.0 t -121.64 131.53 54.15 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 117.646 0.723 . . . . 1.4 111.865 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 57' ' ' GLY . 3.9 p -61.68 134.35 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-N 115.709 -0.678 . . . . 0.28 110.049 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.69 ' HD1' ' H ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -97.66 -27.36 14.4 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.097 -0.501 . . . . 0.24 111.565 -179.882 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.69 ' H ' ' HD1' ' A' ' 65' ' ' PHE . 13.9 t70 -176.83 129.96 0.18 Allowed 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 120.619 0.247 . . . . 0.3 110.54 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 57.6 p -129.18 117.46 20.8 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.455 -0.339 . . . . 1.3 110.736 179.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 65.3 p -74.83 -12.35 60.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.065 0.459 . . . . 0.34 110.449 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -75.73 -46.91 28.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.632 -0.713 . . . . 2.11 111.25 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -71.18 -36.46 71.97 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.028 -0.533 . . . . 3.41 111.751 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 54.5 p -59.61 -12.62 7.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.788 0.327 . . . . 1.47 111.296 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 75.01 8.47 83.06 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.795 -0.717 . . . . 0.7 112.415 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -122.97 117.75 28.4 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.572 0.225 . . . . 3.05 110.875 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.09 153.18 16.54 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.667 2.245 . . . . 0.51 112.6 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -96.58 124.74 40.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.022 -0.535 . . . . 0.23 110.448 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.8 t -130.44 118.19 20.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.089 0.471 . . . . 1.26 111.297 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -158.54 161.82 37.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.022 -0.535 . . . . 0.36 111.108 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.54 HE21 ' H ' ' A' ' 80' ' ' SER . 0.0 OUTLIER -81.66 146.5 30.01 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.12 -0.491 . . . . 1.58 109.965 179.143 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 87' ' ' THR . 20.0 m -66.54 -30.88 51.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 112.771 0.656 . . . . 1.07 112.771 -178.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.54 ' H ' HE21 ' A' ' 78' ' ' GLN . 46.8 t -95.76 -6.39 39.82 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 112.438 0.533 . . . . 1.14 112.438 -178.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -84.92 5.66 28.13 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 111.89 0.33 . . . . 2.08 111.89 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.408 HG21 ' HB3' ' A' ' 86' ' ' TRP . 3.7 m -110.41 -173.37 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 111.749 0.277 . . . . 0.45 111.749 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.464 HG13 ' H ' ' A' ' 86' ' ' TRP . 45.4 pt -56.03 156.43 10.25 Favored Pre-proline 0 CA--C 1.53 0.2 0 CA-C-N 116.428 -0.351 . . . . 0.75 111.631 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -46.07 -59.56 1.16 Allowed 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.858 2.372 . . . . 0.65 113.262 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.748 ' CA ' HD11 ' A' ' 32' ' ' LEU . . . -50.9 -49.46 41.87 Favored Glycine 0 CA--C 1.521 0.454 0 C-N-CA 120.858 -0.686 . . . . 0.31 113.114 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . 0.464 ' H ' HG13 ' A' ' 83' ' ' ILE . 0.3 OUTLIER -61.72 -38.51 88.17 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.915 0.339 . . . . 0.78 111.915 -178.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' ' 79' ' ' VAL . 50.6 m -61.02 -35.55 77.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.721 0.296 . . . . 1.4 111.35 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -70.38 -42.64 71.46 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.279 -0.418 . . . . 1.43 111.798 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.544 ' HB2' HD22 ' A' ' 32' ' ' LEU . . . -75.51 -51.99 11.68 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.429 0.529 . . . . 0.33 112.429 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -54.93 -39.35 68.76 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.432 0.53 . . . . 0.39 112.432 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -67.23 -9.59 41.95 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.667 0.27 . . . . 1.87 111.443 -179.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 83.2 mt -103.42 -7.88 20.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.433 -0.349 . . . . 1.31 111.019 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.402 ' HE2' ' HE3' ' A' ' 99' ' ' TRP . 68.0 mtt -85.95 110.07 27.61 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.315 -0.402 . . . . 1.66 111.641 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.534 ' HG2' ' HB3' ' A' ' 97' ' ' SER . 74.3 Cg_endo -74.67 147.28 35.22 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.35 2.033 . . . . 0.44 111.477 179.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.594 ' HA ' HD23 ' A' ' 130' ' ' LEU . . . -50.02 126.72 15.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.505 -0.316 . . . . 0.36 111.594 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 94.97 -8.84 70.43 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 120.717 -0.754 . . . . 0.34 113.148 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.534 ' HB3' ' HG2' ' A' ' 94' ' ' PRO . 98.4 p -70.57 -176.52 1.29 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.926 0.393 . . . . 1.41 111.417 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.405 ' O ' ' HB ' ' A' ' 37' ' ' ILE . 24.3 m -159.03 97.44 1.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.762 -0.654 . . . . 0.23 110.605 -179.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.713 ' HE1' ' HB3' ' A' ' 39' ' ' SER . 34.9 m0 -115.11 149.06 38.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.233 0.54 . . . . 0.53 111.717 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.424 ' O ' ' HB2' ' A' ' 34' ' ' TYR . 27.0 tt0 -115.16 107.23 15.04 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.827 -1.175 . . . . 1.37 107.827 177.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.484 HG22 ' CB ' ' A' ' 34' ' ' TYR . 13.8 pt -114.58 140.57 34.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 113.602 0.964 . . . . 0.25 113.602 -177.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -120.58 104.33 9.86 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.959 -1.126 . . . . 0.31 107.959 177.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.59 HG13 HD12 ' A' ' 107' ' ' LEU . 52.9 t -93.35 98.23 2.37 Favored Pre-proline 0 C--N 1.329 -0.284 0 N-CA-C 113.563 0.949 . . . . 0.52 113.563 -177.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.458 ' HD2' ' HA ' ' A' ' 103' ' ' VAL . 6.9 Cg_endo -53.08 150.94 22.69 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.267 1.978 . . . . 0.48 111.407 177.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.5 p -48.02 -43.36 29.94 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.293 0.479 . . . . 1.81 112.293 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -57.32 -9.14 4.14 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 115.384 0.914 . . . . 0.4 115.384 -177.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.59 HD12 HG13 ' A' ' 103' ' ' VAL . 46.3 mt -91.64 -19.27 22.86 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 118.244 1.022 . . . . 2.35 112.937 -178.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.429 ' HB2' HD12 ' A' ' 83' ' ' ILE . . . . . . . . 0 C--N 1.329 -0.31 0 C-N-CA 120.761 -0.376 . . . . 1.03 111.769 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_exo . . . . . 0 N--CA 1.465 -0.173 0 N-CA-C 111.093 -0.387 . . . . 0.7 111.093 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.59 HG23 HD12 ' A' ' 124' ' ' LEU . 94.8 mt -92.37 134.03 31.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.5 -0.773 . . . . 1.25 109.944 178.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -48.55 146.69 5.53 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.526 -0.845 . . . . 0.48 112.244 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -54.78 130.54 40.98 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.265 1.976 . . . . 0.67 111.861 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 42.75 35.16 0.66 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.033 -0.531 . . . . 1.12 110.65 -179.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.453 ' OE1' HD22 ' A' ' 59' ' ' LEU . 24.5 tt0 -116.54 142.86 46.33 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.826 -0.625 . . . . 1.73 111.074 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.54 HG21 HD23 ' A' ' 16' ' ' LEU . 92.7 m -95.66 129.53 42.83 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.548 -0.538 . . . . 0.29 109.548 178.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.59 HD12 HG23 ' A' ' 118' ' ' ILE . 0.1 OUTLIER -113.93 154.55 27.37 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.358 0.599 . . . . 1.47 112.279 -177.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.5 mp -113.92 140.75 32.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.174 -0.921 . . . . 0.2 109.585 178.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.457 ' CE1' HD22 ' A' ' 124' ' ' LEU . 82.2 m-85 -135.47 131.97 36.78 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.024 0.44 . . . . 0.24 111.445 -179.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.432 ' NZ ' ' HB3' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -114.4 102.8 10.44 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.189 -1.041 . . . . 2.28 108.189 177.87 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.441 HG23 HG21 ' A' ' 53' ' ' VAL . 12.2 mt -103.73 130.58 53.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 112.684 0.624 . . . . 0.82 112.684 -177.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -117.88 101.01 7.95 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.129 -0.941 . . . . 0.26 108.919 178.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.594 HD23 ' HA ' ' A' ' 95' ' ' ALA . 0.3 OUTLIER -78.5 123.29 26.9 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.119 0.485 . . . . 1.41 111.814 -178.274 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 58.6 mt -93.39 -53.13 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 115.518 -0.765 . . . . 1.17 110.92 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.469 ' HA ' ' HB1' ' A' ' 95' ' ' ALA . 60.7 p -164.53 165.57 21.12 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.055 0.455 . . . . 1.17 111.259 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.636 HG22 HG12 ' A' ' 51' ' ' VAL . 2.1 t -111.84 126.09 69.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.642 -0.708 . . . . 1.43 110.772 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 18.2 tttt 44.52 57.38 4.47 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.93 -0.577 . . . . 3.08 110.917 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm 60.85 34.5 19.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.572 -0.74 . . . . 3.16 111.336 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.439 ' HB2' ' HB2' ' A' ' 132' ' ' SER . 39.0 t 55.42 64.27 1.82 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.852 -0.613 . . . . 1.31 111.205 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 53.6 m . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.3 -0.857 . . . . 2.53 110.821 179.762 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 28.9 tptp . . . . . 0 CA--C 1.521 -0.146 0 N-CA-C 109.89 -0.411 . . . . 2.63 109.89 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.494 ' HB1' ' ND2' ' A' ' 121' ' ' ASN . . . -58.97 -52.43 65.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.875 -0.602 . . . . 0.82 110.127 179.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -63.96 -35.23 80.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.725 -0.671 . . . . 2.57 110.218 179.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -55.92 -32.58 63.9 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.334 -0.617 . . . . 2.1 109.334 178.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 13.7 m-20 -74.07 -37.46 64.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.445 -0.798 . . . . 1.4 110.826 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 52.6 tptt -63.9 -38.51 91.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 2.67 111.64 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.404 HG23 ' N ' ' A' ' 11' ' ' LYS . 16.1 m -71.58 -48.44 52.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 C-N-CA 121.189 -0.204 . . . . 1.27 111.514 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.497 ' HG3' HG21 ' A' ' 60' ' ' ILE . 18.1 ptpt -68.81 -25.71 64.82 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.835 0.35 . . . . 1.69 110.486 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.62 -53.26 8.63 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 121.066 -0.588 . . . . 0.31 112.143 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.412 ' HA ' HD11 ' A' ' 16' ' ' LEU . 43.8 tt0 -62.13 -27.89 69.25 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.096 0.474 . . . . 2.39 110.313 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.13 -30.63 49.43 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.951 -0.568 . . . . 0.23 110.423 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -65.94 -52.73 47.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.752 -0.658 . . . . 0.23 110.612 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.663 ' HA ' ' HB3' ' A' ' 19' ' ' ASN . 0.4 OUTLIER -67.62 -32.06 72.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.268 -0.424 . . . . 0.55 111.078 179.91 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.2 m -56.67 -47.58 79.5 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 109.748 -0.464 . . . . 0.27 109.748 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -73.05 -32.52 65.1 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.859 -0.61 . . . . 2.47 109.812 178.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.663 ' HB3' ' HA ' ' A' ' 16' ' ' LEU . 0.6 OUTLIER -59.46 -25.01 64.03 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.439 -0.8 . . . . 0.22 111.582 179.829 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -49.97 -20.35 0.91 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.518 -0.31 . . . . 2.45 111.722 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.745 HD22 ' N ' ' A' ' 21' ' ' ASN . 0.7 OUTLIER -68.96 -33.13 73.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.378 -0.374 . . . . 0.4 111.53 -178.98 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.663 ' O ' HG23 ' A' ' 25' ' ' VAL . 12.6 mptt -48.35 118.69 6.97 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 116.188 -0.46 . . . . 1.4 110.906 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.46 ' O ' ' HG2' ' A' ' 35' ' ' LYS . 32.1 Cg_exo -57.52 139.18 89.38 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.316 2.011 . . . . 0.65 112.651 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.83 3.39 80.27 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 120.863 -0.684 . . . . 0.37 114.025 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.663 HG23 ' O ' ' A' ' 22' ' ' LYS . 4.0 t -53.52 117.67 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.175 0 CA-C-N 117.425 0.613 . . . . 0.91 110.826 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 33' ' ' GLN . 4.3 p -129.87 128.16 64.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.064 -0.516 . . . . 1.03 111.061 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.3 p -85.69 141.97 13.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.459 . . . . 0.91 111.078 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.537 HD12 ' HB2' ' A' ' 32' ' ' LEU . 41.5 mt -104.1 165.34 13.57 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.011 -0.541 . . . . 0.4 110.609 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.45 ' HD2' ' HB3' ' A' ' 28' ' ' LEU . 72.2 Cg_exo -50.48 -38.34 53.64 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.179 1.919 . . . . 0.59 112.26 179.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.421 ' OG ' ' HG3' ' A' ' 88' ' ' GLU . 7.3 m -80.76 -9.59 59.79 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.2 -0.454 . . . . 1.14 111.368 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.3 14.52 27.99 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.331 -0.938 . . . . 0.34 113.48 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.537 ' HB2' HD12 ' A' ' 28' ' ' LEU . 0.4 OUTLIER -83.11 134.86 34.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.45 0.643 . . . . 1.35 112.168 -179.28 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.422 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 47.4 mt-30 -123.34 143.0 50.38 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.984 -1.007 . . . . 1.75 108.636 178.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.799 ' HB3' HG22 ' A' ' 101' ' ' ILE . 48.3 p90 -157.83 175.39 13.93 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.809 0.67 . . . . 0.32 112.809 -178.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.46 ' HG2' ' O ' ' A' ' 23' ' ' PRO . 3.5 tmmm? -122.2 118.94 29.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.001 -0.999 . . . . 2.15 109.321 178.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.646 HG13 ' HE1' ' A' ' 99' ' ' TRP . 48.5 t -71.93 125.61 30.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 113.279 0.844 . . . . 0.3 113.279 -177.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.3 mp -98.81 -66.24 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.319 -0.855 . . . . 0.65 110.11 178.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.508 ' ND2' HD21 ' A' ' 41' ' ' ASN . 7.3 t30 -144.89 90.51 2.06 Favored 'General case' 0 CA--C 1.527 0.062 0 CA-C-N 116.471 -0.332 . . . . 1.03 110.166 179.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.637 ' HB3' ' HE1' ' A' ' 99' ' ' TRP . 94.9 p -105.32 145.98 30.0 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.932 0.396 . . . . 1.5 112.006 -178.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 91.59 94.4 1.33 Allowed Glycine 0 C--N 1.332 0.352 0 CA-C-N 115.854 -0.612 . . . . 1.09 112.764 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.508 HD21 ' ND2' ' A' ' 38' ' ' ASN . 35.4 m-80 -150.93 -81.89 0.1 Allowed 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 111.776 0.287 . . . . 1.7 111.776 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.09 178.53 42.01 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 121.088 -0.577 . . . . 0.35 114.161 -178.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.621 ' O ' ' HB3' ' A' ' 44' ' ' LYS . 27.3 m -90.32 176.89 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 123.729 0.812 . . . . 1.42 110.33 179.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.621 ' HB3' ' O ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER 165.08 156.6 0.08 OUTLIER Pre-proline 0 N--CA 1.472 0.668 0 CA-C-O 121.486 0.66 . . . . 2.18 112.172 -179.61 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.431 ' HD2' HG21 ' A' ' 133' ' ' VAL . 2.8 Cg_exo -77.72 173.52 14.0 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 124.752 3.634 . . . . 0.3 112.955 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.492 ' O ' ' N ' ' A' ' 48' ' ' SER . . . -67.54 -172.84 6.28 Favored Glycine 0 N--CA 1.448 -0.5 0 CA-C-N 115.368 -0.833 . . . . 0.35 111.037 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.432 ' HE3' ' NE2' ' A' ' 91' ' ' GLN . 9.2 ptpp? -41.88 -13.88 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.707 1.003 . . . . 2.35 113.707 -177.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 46' ' ' GLY . 84.5 p -86.54 7.37 26.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.065 0.459 . . . . 1.45 110.522 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.411 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 4.0 p30 -72.08 156.14 39.52 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.71 -0.677 . . . . 1.73 111.993 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 26.0 m -126.67 119.72 27.69 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 108.481 -0.933 . . . . 0.44 108.481 178.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.471 HG12 ' HA ' ' A' ' 133' ' ' VAL . 14.3 m -128.67 158.4 41.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.222 0.534 . . . . 0.65 112.326 -178.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 94.2 m -113.78 120.8 42.05 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.337 -0.847 . . . . 0.32 109.115 178.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.693 HG11 HD22 ' A' ' 130' ' ' LEU . 6.1 m -139.4 170.11 16.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.137 0.494 . . . . 0.24 111.6 -178.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -124.05 132.31 53.66 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.375 -0.83 . . . . 2.4 109.128 178.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.408 ' HB2' ' O ' ' A' ' 127' ' ' LYS . 14.7 p90 -144.05 164.6 30.17 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.683 0.754 . . . . 0.26 112.491 -178.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 37.9 m -123.56 113.39 18.64 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.426 -1.261 . . . . 0.26 108.565 178.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.467 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -110.02 143.81 16.79 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 119.684 -1.246 . . . . 0.12 112.677 -178.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.466 ' NH2' ' HA2' ' A' ' 62' ' ' GLY . 0.5 OUTLIER -147.62 147.0 29.57 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.004 0.431 . . . . 1.93 110.589 179.552 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.48 HD22 ' OE1' ' A' ' 122' ' ' GLU . 3.8 mt -78.83 158.03 28.24 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.858 -0.61 . . . . 1.21 110.254 179.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.497 HG21 ' HG3' ' A' ' 11' ' ' LYS . 0.4 OUTLIER -58.16 -14.21 3.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 108.957 -0.757 . . . . 0.64 108.957 178.64 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -63.64 -12.48 34.05 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.14 -0.936 . . . . 2.01 110.837 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.466 ' HA2' ' NH2' ' A' ' 58' ' ' ARG . . . 91.15 -0.31 75.31 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 120.634 -0.793 . . . . 0.45 113.673 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.3 t -119.85 132.46 55.58 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 117.374 0.587 . . . . 1.4 111.507 -178.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 57' ' ' GLY . 6.2 p -61.18 134.7 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 115.807 -0.633 . . . . 0.28 109.906 179.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.646 ' HD1' ' H ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -97.5 -26.54 14.79 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.241 -0.436 . . . . 0.24 111.266 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.646 ' H ' ' HD1' ' A' ' 65' ' ' PHE . 16.3 t70 -176.33 129.98 0.21 Allowed 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 120.809 0.338 . . . . 0.3 111.085 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 62.4 m -123.79 123.89 41.48 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.235 -0.439 . . . . 1.3 110.452 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.871 HG21 ' HB2' ' A' ' 75' ' ' ALA . 33.7 p -70.56 -8.41 51.2 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.94 0.4 . . . . 0.34 110.652 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -75.39 -46.85 30.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.861 -0.609 . . . . 2.11 110.794 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -61.94 -38.7 89.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.981 -0.554 . . . . 3.41 111.304 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 14.2 m -60.73 -13.54 15.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.143 0.496 . . . . 1.47 110.182 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 73.8 3.54 63.92 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.69 -0.687 . . . . 0.7 112.351 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -127.21 124.68 23.85 Favored Pre-proline 0 C--N 1.33 -0.262 0 C-N-CA 121.325 -0.15 . . . . 3.05 111.071 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -53.75 162.68 3.45 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.284 1.989 . . . . 0.51 111.517 179.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.871 ' HB2' HG21 ' A' ' 68' ' ' THR . . . -93.94 124.31 37.86 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.446 -0.343 . . . . 0.23 110.812 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 27.5 m -123.87 116.22 22.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.751 0.31 . . . . 1.26 111.079 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -158.72 159.46 35.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 0.36 111.34 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.608 HE21 ' H ' ' A' ' 80' ' ' SER . 0.0 OUTLIER -81.48 143.74 31.85 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 108.983 -0.747 . . . . 1.58 108.983 178.317 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.411 ' N ' HE21 ' A' ' 78' ' ' GLN . 10.8 m -70.83 -14.4 17.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 113.008 0.744 . . . . 1.07 113.008 -178.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.608 ' H ' HE21 ' A' ' 78' ' ' GLN . 66.0 m -95.49 -19.18 20.05 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.197 0.443 . . . . 1.14 112.197 -179.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.445 ' HG2' ' HB3' ' A' ' 78' ' ' GLN . 78.2 mm-40 -79.62 6.26 11.06 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.412 0.523 . . . . 2.08 112.412 -179.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.4 m -111.25 -175.7 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 112.685 0.624 . . . . 0.45 112.685 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.488 HD12 HD12 ' A' ' 107' ' ' LEU . 42.4 pt -56.12 160.45 4.75 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 115.836 -0.62 . . . . 0.75 112.595 -179.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.637 ' O ' HG22 ' A' ' 87' ' ' THR . 78.1 Cg_exo -47.86 -60.75 0.76 Allowed 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 123.102 2.535 . . . . 0.65 114.204 -178.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 1.004 ' H ' HD11 ' A' ' 107' ' ' LEU . . . -53.17 -48.3 59.28 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.759 -0.734 . . . . 0.31 113.386 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . 0.4 ' HB2' HG13 ' A' ' 83' ' ' ILE . 0.9 OUTLIER -54.81 -47.95 73.38 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.798 0.666 . . . . 0.78 112.798 -178.567 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.637 HG22 ' O ' ' A' ' 84' ' ' PRO . 11.6 t -62.68 -33.87 75.97 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.713 -0.395 . . . . 1.4 111.779 -179.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.486 ' O ' ' HG2' ' A' ' 91' ' ' GLN . 18.3 mm-40 -70.79 -40.85 72.3 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.924 0.342 . . . . 1.43 111.924 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.84 -49.45 17.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.871 0.367 . . . . 0.33 111.585 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.559 HD13 ' SD ' ' A' ' 93' ' ' MET . 3.5 mm? -55.87 -41.33 74.24 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.888 -0.596 . . . . 0.39 112.06 -179.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.486 ' HG2' ' O ' ' A' ' 88' ' ' GLU . 3.2 pt20 -65.41 -3.76 4.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.635 -0.257 . . . . 1.87 111.636 -179.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 94.7 mt -104.97 -29.61 10.35 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.713 0.264 . . . . 1.31 111.713 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.559 ' SD ' HD13 ' A' ' 90' ' ' LEU . 24.0 ptp -81.91 111.05 23.5 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-O 120.615 0.245 . . . . 1.66 111.537 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.87 147.18 61.59 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.227 1.952 . . . . 0.44 111.45 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.58 ' HB1' ' HA ' ' A' ' 132' ' ' SER . . . -46.35 127.15 8.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.469 -0.332 . . . . 0.36 111.115 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 103.56 -7.61 50.6 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.896 -0.669 . . . . 0.34 112.717 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 66.4 m -79.94 -175.47 4.96 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.845 0.355 . . . . 1.41 111.39 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 14.1 m -156.75 104.09 2.12 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.032 -0.531 . . . . 0.23 111.083 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.646 ' HE1' HG13 ' A' ' 36' ' ' VAL . 30.5 m0 -125.15 149.23 48.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.252 -0.431 . . . . 0.53 111.058 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.417 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 12.6 pt-20 -119.05 108.52 14.82 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.556 -0.905 . . . . 1.37 108.556 177.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.799 HG22 ' HB3' ' A' ' 34' ' ' TYR . 37.3 pt -108.17 139.67 29.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 112.963 0.727 . . . . 0.25 112.963 -177.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.416 ' OH ' HG22 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -113.95 103.91 11.63 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.783 -1.192 . . . . 0.31 107.783 177.886 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.492 HG11 HD12 ' A' ' 107' ' ' LEU . 40.7 t -94.57 102.04 7.98 Favored Pre-proline 0 C--N 1.329 -0.296 0 N-CA-C 113.78 1.03 . . . . 0.52 113.78 -176.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.46 ' HA ' HG23 ' A' ' 123' ' ' THR . 9.3 Cg_endo -56.07 149.89 50.75 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.192 1.928 . . . . 0.48 111.085 177.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.4 p -49.11 -43.26 41.23 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.247 0.462 . . . . 1.81 112.247 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -56.24 -8.42 2.45 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 115.19 0.836 . . . . 0.4 115.19 -177.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 1.004 HD11 ' H ' ' A' ' 85' ' ' GLY . 1.1 tm? -82.25 -31.75 30.02 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 117.863 0.831 . . . . 2.35 112.748 -178.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.439 ' HB2' ' HB ' ' A' ' 83' ' ' ILE . . . . . . . . 0 C--N 1.326 -0.451 0 C-N-CA 120.375 -0.53 . . . . 1.03 112.382 -178.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo . . . . . 0 C--O 1.231 0.17 0 CA-C-O 120.876 0.282 . . . . 0.7 112.019 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.497 HG23 HD12 ' A' ' 124' ' ' LEU . 92.6 mt -91.45 135.66 26.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.069 -0.514 . . . . 1.25 110.322 179.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -46.97 148.3 2.88 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.748 -0.739 . . . . 0.48 112.087 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -56.05 130.03 38.09 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.119 1.88 . . . . 0.67 111.986 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.494 ' ND2' ' HB1' ' A' ' 5' ' ' ALA . 2.3 m-20 41.49 35.45 0.45 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.792 -0.64 . . . . 1.12 110.878 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.48 ' OE1' HD22 ' A' ' 59' ' ' LEU . 20.9 tt0 -116.89 145.86 43.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.881 -0.6 . . . . 1.73 111.258 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.468 ' O ' ' HB ' ' A' ' 60' ' ' ILE . 90.6 m -95.2 134.04 38.39 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.646 -0.501 . . . . 0.29 109.646 179.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.497 HD12 HG23 ' A' ' 118' ' ' ILE . 0.1 OUTLIER -120.55 156.54 31.36 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.342 0.592 . . . . 1.47 112.46 -178.249 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.406 HD12 ' N ' ' A' ' 125' ' ' ILE . 4.4 mp -113.85 148.17 16.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.128 -0.942 . . . . 0.2 109.467 178.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.459 ' CE1' HD22 ' A' ' 124' ' ' LEU . 81.2 m-85 -139.96 132.28 28.34 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.166 0.508 . . . . 0.24 111.761 -179.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.408 ' O ' ' HB2' ' A' ' 55' ' ' TYR . 2.2 tmtp? -110.91 104.04 12.6 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.575 -0.898 . . . . 2.28 108.575 178.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.534 ' N ' HD12 ' A' ' 128' ' ' ILE . 4.1 mp -102.12 127.19 55.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.377 0.608 . . . . 0.82 112.582 -177.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -118.38 99.97 7.18 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.036 -0.984 . . . . 0.26 108.492 177.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.693 HD22 HG11 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -77.94 120.95 23.52 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.122 -0.49 . . . . 1.41 111.135 -178.39 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 49.7 mm -94.9 -56.22 5.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.852 -0.613 . . . . 1.17 110.946 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.58 ' HA ' ' HB1' ' A' ' 95' ' ' ALA . 89.8 p -163.4 164.66 24.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.003 0.43 . . . . 1.17 111.351 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.471 ' HA ' HG12 ' A' ' 51' ' ' VAL . 7.1 p -107.93 127.24 64.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.904 -0.589 . . . . 1.43 111.054 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 12.8 tttp 45.34 -149.22 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.255 -0.43 . . . . 3.08 110.785 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -64.65 -5.4 5.6 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.226 -0.443 . . . . 3.16 110.979 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 32.9 t 65.42 82.6 0.18 Allowed 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.935 -0.575 . . . . 1.31 110.953 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 81.6 p . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.17 -0.919 . . . . 2.53 111.387 179.885 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp . . . . . 0 N--CA 1.455 -0.213 0 CA-C-O 120.791 0.329 . . . . 2.63 110.464 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -56.58 -51.94 66.7 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 116.145 -0.479 . . . . 0.82 110.386 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -67.59 -33.37 74.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.837 -0.62 . . . . 2.57 110.226 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.421 ' O ' ' HG2' ' A' ' 11' ' ' LYS . 41.3 tt0 -55.58 -33.53 64.0 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 109.096 -0.705 . . . . 2.1 109.096 178.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.496 ' HA ' ' HE2' ' A' ' 11' ' ' LYS . 10.1 m-20 -75.54 -38.42 59.31 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.371 -0.831 . . . . 1.4 110.286 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -56.24 -38.82 71.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.75 -0.659 . . . . 2.67 111.605 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.43 HG23 ' N ' ' A' ' 11' ' ' LYS . 18.6 m -78.33 -49.81 20.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 112.639 0.607 . . . . 1.27 112.639 -178.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.496 ' HE2' ' HA ' ' A' ' 8' ' ' ASN . 61.1 pttt -66.94 -26.25 66.75 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 120.861 -0.336 . . . . 1.69 111.445 -179.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.42 ' O ' ' HG ' ' A' ' 16' ' ' LEU . . . -76.41 -53.43 5.56 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.734 -0.746 . . . . 0.31 112.313 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.421 ' HA ' HD11 ' A' ' 16' ' ' LEU . 20.4 tp10 -61.86 -28.21 69.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.096 0.474 . . . . 2.39 110.604 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.3 -36.46 46.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.839 -0.619 . . . . 0.23 110.747 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -59.82 -53.71 54.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.076 -0.511 . . . . 0.23 110.617 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.684 ' HA ' ' HB3' ' A' ' 19' ' ' ASN . 0.4 OUTLIER -66.59 -33.77 76.4 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.737 -0.385 . . . . 0.55 111.101 -179.784 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.1 m -57.43 -45.96 84.08 Favored 'General case' 0 N--CA 1.456 -0.125 0 N-CA-C 109.622 -0.51 . . . . 0.27 109.622 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -74.35 -32.38 62.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.91 -0.586 . . . . 2.47 109.9 178.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.684 ' HB3' ' HA ' ' A' ' 16' ' ' LEU . 0.4 OUTLIER -57.58 -26.46 61.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.514 -0.767 . . . . 0.22 111.497 -179.822 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -49.19 -19.2 0.43 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.169 -0.469 . . . . 2.45 111.824 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.716 HD22 ' N ' ' A' ' 21' ' ' ASN . 0.8 OUTLIER -68.46 -31.87 71.47 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.192 0.441 . . . . 0.4 112.192 -178.482 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.643 ' O ' HG23 ' A' ' 25' ' ' VAL . 27.2 mmtm -52.97 119.21 15.66 Favored Pre-proline 0 CA--C 1.531 0.237 0 C-N-CA 121.322 -0.151 . . . . 1.4 110.619 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -57.86 143.64 95.34 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.189 1.926 . . . . 0.65 112.278 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.75 2.94 81.08 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.858 -0.687 . . . . 0.37 113.705 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 22' ' ' LYS . 5.9 t -59.73 120.86 6.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 117.167 0.483 . . . . 0.91 110.481 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.3 p -130.17 133.32 64.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 1.03 111.204 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.5 p -92.37 137.04 23.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.145 -0.479 . . . . 0.91 110.745 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.474 ' HB2' ' HB2' ' A' ' 32' ' ' LEU . 35.1 mt -100.94 162.94 19.05 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 0.4 110.751 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -53.26 -30.72 52.82 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.176 1.917 . . . . 0.59 112.309 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.531 ' O ' HD12 ' A' ' 107' ' ' LEU . 30.9 t -84.32 -10.08 57.91 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.175 -0.466 . . . . 1.14 111.551 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.27 15.49 25.48 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.367 -0.92 . . . . 0.34 112.595 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.506 HD21 ' HA2' ' A' ' 85' ' ' GLY . 2.6 mm? -80.86 133.54 35.6 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.222 0.535 . . . . 1.35 112.05 -178.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -126.07 138.27 53.69 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.329 -0.85 . . . . 1.75 109.175 178.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.751 ' HB3' HG22 ' A' ' 101' ' ' ILE . 38.6 p90 -160.84 174.81 13.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.269 0.557 . . . . 0.32 112.361 -178.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -121.71 117.51 26.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.198 -0.91 . . . . 2.15 109.3 178.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.472 HG13 ' HE1' ' A' ' 99' ' ' TRP . 86.9 t -72.56 125.53 31.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 113.081 0.771 . . . . 0.3 113.081 -178.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.411 HD12 HG22 ' A' ' 98' ' ' THR . 64.6 mt -102.3 -64.2 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.387 -0.824 . . . . 0.65 110.125 178.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.517 ' ND2' HD21 ' A' ' 41' ' ' ASN . 9.7 t30 -139.46 89.49 2.34 Favored 'General case' 0 CA--C 1.528 0.099 0 CA-C-N 116.37 -0.377 . . . . 1.03 110.192 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.796 ' HB2' ' HE1' ' A' ' 99' ' ' TRP . 31.9 t -105.37 146.2 29.75 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 112.334 0.494 . . . . 1.5 112.334 -178.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 87.31 95.65 0.9 Allowed Glycine 0 C--N 1.332 0.341 0 CA-C-N 115.684 -0.689 . . . . 1.09 112.936 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.517 HD21 ' ND2' ' A' ' 38' ' ' ASN . 43.3 m-80 -150.72 -83.65 0.09 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 111.675 0.25 . . . . 1.7 111.675 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.51 178.01 41.05 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 121.061 -0.59 . . . . 0.35 114.285 -178.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.742 HG22 ' H ' ' A' ' 44' ' ' LYS . 9.3 p -90.68 178.38 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 123.666 0.786 . . . . 1.42 109.688 178.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.742 ' H ' HG22 ' A' ' 43' ' ' VAL . 12.6 pttm 165.95 157.66 0.1 OUTLIER Pre-proline 0 N--CA 1.47 0.55 0 CA-C-O 121.482 0.658 . . . . 2.18 112.628 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.672 ' HD3' HG21 ' A' ' 133' ' ' VAL . 1.3 Cg_endo -85.03 173.79 7.75 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 125.061 3.841 . . . . 0.3 113.767 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.462 ' O ' ' N ' ' A' ' 48' ' ' SER . . . -68.05 -171.66 6.22 Favored Glycine 0 C--O 1.221 -0.714 0 CA-C-N 114.984 -1.007 . . . . 0.35 111.741 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.638 ' HG3' HE21 ' A' ' 91' ' ' GLN . 54.8 mtpt -41.22 -15.74 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.875 1.065 . . . . 2.35 113.875 -177.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.462 ' N ' ' O ' ' A' ' 46' ' ' GLY . 51.0 m -85.89 7.83 22.58 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.522 0.677 . . . . 1.45 109.677 178.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.579 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 0.0 OUTLIER -69.33 151.03 46.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.796 -1.093 . . . . 1.73 112.329 -179.073 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 48.4 m -126.86 119.74 27.52 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.71 -0.677 . . . . 0.44 109.257 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.609 HG12 ' HA ' ' A' ' 133' ' ' VAL . 34.9 m -133.24 154.98 40.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.26 0.553 . . . . 0.65 112.24 -178.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 90.3 m -111.12 121.24 44.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.339 -0.846 . . . . 0.32 109.148 178.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.514 HG12 ' HA ' ' A' ' 130' ' ' LEU . 4.2 m -141.28 -179.62 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.06 0.457 . . . . 0.24 111.833 -178.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -135.11 133.06 38.84 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.635 -0.712 . . . . 2.4 109.384 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -143.63 158.38 43.71 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.731 0.777 . . . . 0.26 112.124 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 63.2 m -125.37 113.26 17.32 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.353 -1.294 . . . . 0.26 108.582 178.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.468 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -109.69 145.15 16.85 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 119.914 -1.136 . . . . 0.12 112.756 -178.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.543 HH11 HD13 ' A' ' 125' ' ' ILE . 0.1 OUTLIER -148.07 146.48 28.86 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 120.891 0.377 . . . . 1.93 110.193 179.325 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.453 ' HA ' ' HG ' ' A' ' 124' ' ' LEU . 5.7 mt -76.27 156.64 33.29 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.989 -0.55 . . . . 1.21 109.744 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.475 HG21 ' HG3' ' A' ' 11' ' ' LYS . 0.4 OUTLIER -58.09 -11.17 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.199 -0.667 . . . . 0.64 109.199 179.021 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.41 ' N ' ' C ' ' A' ' 59' ' ' LEU . 19.5 t70 -65.0 -11.58 40.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.357 -0.838 . . . . 2.01 110.722 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.47 ' HA2' ' NH2' ' A' ' 58' ' ' ARG . . . 90.81 -0.72 77.08 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.544 -0.836 . . . . 0.45 113.511 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 40.7 p -118.94 128.36 54.35 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 117.277 0.538 . . . . 1.4 111.381 -178.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 57' ' ' GLY . 6.5 p -60.71 134.9 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 115.936 -0.574 . . . . 0.28 109.807 179.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.642 ' HD1' ' N ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -97.31 -26.24 14.97 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.185 -0.462 . . . . 0.24 110.888 -179.554 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.642 ' N ' ' HD1' ' A' ' 65' ' ' PHE . 21.4 t70 -177.29 134.46 0.18 Allowed 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.438 -0.346 . . . . 0.3 110.744 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 40.4 t -131.14 122.58 26.89 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.322 -0.399 . . . . 1.3 110.451 179.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.641 HG21 ' HB2' ' A' ' 75' ' ' ALA . 47.9 p -71.62 -17.88 62.24 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.007 0.432 . . . . 0.34 110.382 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -75.14 -45.58 39.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.916 -0.583 . . . . 2.11 110.508 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -62.55 -41.74 99.09 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.861 -0.609 . . . . 3.41 111.114 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 21.6 m -58.38 -17.63 21.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.315 -0.402 . . . . 1.47 110.662 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.42 3.61 88.43 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.821 -0.704 . . . . 0.7 112.46 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.455 ' NZ ' ' HB3' ' A' ' 73' ' ' LYS . 8.6 mtpm? -126.38 117.68 23.22 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.347 0.118 . . . . 3.05 111.039 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.43 163.38 3.67 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.476 2.117 . . . . 0.51 112.228 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.641 ' HB2' HG21 ' A' ' 68' ' ' THR . . . -96.33 124.72 40.43 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.207 -0.451 . . . . 0.23 110.511 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 61.8 m -124.79 111.44 15.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.922 0.391 . . . . 1.26 111.262 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -158.5 163.29 37.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.894 -0.594 . . . . 0.36 110.564 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.685 ' HG3' ' HB2' ' A' ' 81' ' ' GLN . 1.5 pt20 -89.7 147.49 23.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.385 0.612 . . . . 1.58 109.989 178.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 27.5 m -57.61 -23.36 19.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 N-CA-C 114.039 1.125 . . . . 1.07 114.039 -177.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 91.8 p -95.35 -2.55 48.94 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.515 0.561 . . . . 1.14 112.515 -178.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.685 ' HB2' ' HG3' ' A' ' 78' ' ' GLN . 6.6 tt0 -83.22 5.32 23.33 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.751 0.278 . . . . 2.08 111.751 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -112.87 -178.86 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.912 0.386 . . . . 0.45 111.977 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.629 HG13 ' H ' ' A' ' 86' ' ' TRP . 25.6 pt -56.1 154.46 15.02 Favored Pre-proline 0 C--O 1.231 0.102 0 CA-C-N 115.951 -0.568 . . . . 0.75 111.741 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -47.81 -44.67 26.32 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.483 2.122 . . . . 0.65 112.414 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.506 ' HA2' HD21 ' A' ' 32' ' ' LEU . . . -61.19 -49.26 79.95 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 120.622 -0.799 . . . . 0.31 113.024 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . 0.629 ' H ' HG13 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -63.03 -53.1 59.18 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.894 0.331 . . . . 0.78 111.894 -178.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.0 t -53.93 -34.23 59.02 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.006 0.373 . . . . 1.4 112.006 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.486 ' HG3' ' HB2' ' A' ' 30' ' ' SER . 0.6 OUTLIER -66.09 -51.09 61.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.6 -0.273 . . . . 1.43 111.076 -179.829 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.409 ' HB2' ' HG ' ' A' ' 32' ' ' LEU . . . -65.07 -44.41 89.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.512 -0.313 . . . . 0.33 111.549 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -57.42 -29.85 64.49 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.252 -0.431 . . . . 0.39 111.354 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.638 HE21 ' HG3' ' A' ' 47' ' ' LYS . 29.6 tt0 -62.24 -23.67 66.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.271 -0.422 . . . . 1.87 111.233 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.425 HD12 ' N ' ' A' ' 92' ' ' LEU . 8.3 mp -93.2 -7.66 44.62 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.153 0.427 . . . . 1.31 112.153 -178.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 2.9 ttm -92.21 107.81 26.01 Favored Pre-proline 0 C--N 1.33 -0.253 0 C-N-CA 120.99 -0.284 . . . . 1.66 111.512 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.419 ' HA ' ' HD3' ' A' ' 44' ' ' LYS . 69.6 Cg_endo -75.19 146.77 32.39 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.232 1.954 . . . . 0.44 110.496 178.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.56 ' HA ' HD13 ' A' ' 130' ' ' LEU . . . -45.81 124.96 5.67 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.917 -0.313 . . . . 0.36 111.363 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 102.38 -9.49 55.97 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 120.518 -0.848 . . . . 0.34 113.328 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.405 ' HA ' ' O ' ' A' ' 38' ' ' ASN . 31.2 t -72.74 175.0 6.85 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 117.005 0.403 . . . . 1.41 111.193 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.411 HG22 HD12 ' A' ' 37' ' ' ILE . 18.3 m -146.46 96.35 2.75 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.94 -0.573 . . . . 0.23 110.473 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.796 ' HE1' ' HB2' ' A' ' 39' ' ' SER . 30.8 m0 -119.57 149.79 41.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.192 0.52 . . . . 0.53 111.961 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.437 ' HB3' ' HD3' ' A' ' 127' ' ' LYS . 8.9 pt-20 -119.46 107.99 14.0 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.966 -1.124 . . . . 1.37 107.966 177.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.751 HG22 ' HB3' ' A' ' 34' ' ' TYR . 41.8 pt -108.14 142.75 20.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 113.53 0.937 . . . . 0.25 113.53 -177.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -123.45 103.63 8.58 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.498 -1.228 . . . . 0.31 108.228 177.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.415 ' HA ' ' HD2' ' A' ' 104' ' ' PRO . 2.2 t -107.55 96.89 17.63 Favored Pre-proline 0 C--N 1.329 -0.307 0 N-CA-C 113.219 0.822 . . . . 0.52 113.219 -176.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.552 ' HG2' HD23 ' A' ' 107' ' ' LEU . 9.5 Cg_endo -54.5 149.68 37.84 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 121.861 1.708 . . . . 0.48 110.484 177.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.5 p -48.63 -27.8 3.07 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.873 0.694 . . . . 1.81 112.873 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -60.22 -10.46 15.76 Favored Glycine 0 CA--C 1.521 0.441 0 C-N-CA 120.799 -0.715 . . . . 0.4 113.754 -179.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.552 HD23 ' HG2' ' A' ' 104' ' ' PRO . 3.0 mm? -114.66 -0.94 13.45 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.242 0.46 . . . . 2.35 112.242 -178.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.487 ' HB2' HD12 ' A' ' 83' ' ' ILE . . . . . . . . 0 C--N 1.327 -0.399 0 N-CA-C 110.34 -0.244 . . . . 1.03 110.34 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo . . . . . 0 N--CA 1.464 -0.22 0 N-CA-C 110.83 -0.489 . . . . 0.7 110.83 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.568 HG23 HD12 ' A' ' 124' ' ' LEU . 93.2 mt -90.09 135.57 26.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.311 -0.859 . . . . 1.25 110.031 179.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -42.88 152.0 0.3 Allowed Glycine 0 CA--C 1.52 0.386 0 C-N-CA 121.247 -0.501 . . . . 0.48 113.101 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -60.33 130.88 35.78 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.436 2.091 . . . . 0.67 111.71 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 43.73 34.89 0.92 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.161 -0.472 . . . . 1.12 110.081 -178.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -115.72 136.37 53.13 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.914 -0.584 . . . . 1.73 111.495 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.474 HG21 HD23 ' A' ' 16' ' ' LEU . 96.7 m -95.53 134.08 38.81 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.02 -0.733 . . . . 0.29 109.02 178.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.568 HD12 HG23 ' A' ' 118' ' ' ILE . 0.1 OUTLIER -121.5 154.79 36.16 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.31 0.576 . . . . 1.47 112.413 -178.085 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.543 HD13 HH11 ' A' ' 58' ' ' ARG . 4.4 mp -113.81 141.22 30.62 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 CA-C-N 115.237 -0.892 . . . . 0.2 109.387 178.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.437 ' CE1' HD22 ' A' ' 124' ' ' LEU . 80.9 m-85 -133.83 132.06 39.97 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.173 0.511 . . . . 0.24 111.809 -179.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.437 ' HD3' ' HB3' ' A' ' 100' ' ' GLU . 42.6 mmtm -107.21 103.55 12.95 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.811 -0.811 . . . . 2.28 108.811 178.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 36.2 mt -102.68 119.03 50.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.047 0.451 . . . . 0.82 112.075 -178.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -114.99 99.97 7.85 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.655 -0.702 . . . . 0.26 109.327 178.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.56 HD13 ' HA ' ' A' ' 95' ' ' ALA . 0.6 OUTLIER -79.31 123.28 27.31 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.002 -0.545 . . . . 1.41 111.06 -178.838 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 48.3 mm -93.43 -56.77 4.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.067 -0.515 . . . . 1.17 111.012 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.484 ' HA ' ' HB1' ' A' ' 95' ' ' ALA . 13.6 m -163.45 165.23 24.03 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.976 0.417 . . . . 1.17 111.622 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.844 HG22 ' HG2' ' A' ' 134' ' ' LYS . 2.7 p -107.93 129.92 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 115.734 -0.666 . . . . 1.43 110.441 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.844 ' HG2' HG22 ' A' ' 133' ' ' VAL . 17.3 ptmt 34.55 55.25 0.67 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.036 0.446 . . . . 3.08 111.316 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm 61.62 42.94 10.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.764 -0.653 . . . . 3.16 110.929 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 43.5 t 52.5 61.14 3.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.78 -0.646 . . . . 1.31 110.993 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 71.2 m . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.2 -0.905 . . . . 2.53 111.139 -179.689 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 61.0 tttm . . . . . 0 N--CA 1.455 -0.179 0 CA-C-O 120.877 0.37 . . . . 2.63 110.116 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.72 -52.52 62.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.739 -0.664 . . . . 0.82 110.179 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.408 ' O ' HG23 ' A' ' 10' ' ' VAL . 20.9 m-20 -67.4 -36.3 81.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.62 -0.718 . . . . 2.57 110.293 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -55.76 -32.99 63.91 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 109.335 -0.617 . . . . 2.1 109.335 178.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.565 ' HA ' ' HE2' ' A' ' 11' ' ' LYS . 21.4 m-20 -72.78 -38.84 67.14 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.494 -0.775 . . . . 1.4 110.471 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 8.3 tmtm? -59.8 -31.45 69.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.097 -0.501 . . . . 2.67 111.353 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 6' ' ' ASP . 11.8 t -77.81 -53.48 14.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 111.895 0.331 . . . . 1.27 111.895 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.565 ' HE2' ' HA ' ' A' ' 8' ' ' ASN . 58.9 pttt -66.1 -27.21 67.89 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.943 0.401 . . . . 1.69 110.523 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.95 -45.07 12.51 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.789 -0.72 . . . . 0.31 111.8 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.435 ' OE2' HD11 ' A' ' 16' ' ' LEU . 16.2 tp10 -68.07 -34.4 76.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.697 0.284 . . . . 2.39 110.767 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.47 -42.46 64.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.23 111.342 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -58.38 -56.28 24.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.541 -0.299 . . . . 0.23 110.496 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.549 ' HA ' ' HB3' ' A' ' 19' ' ' ASN . 4.1 pp -60.01 -33.06 71.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.262 -0.426 . . . . 0.55 110.482 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.8 m -58.09 -48.56 79.81 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.989 -0.551 . . . . 0.27 110.204 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -73.69 -32.01 63.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.934 -0.575 . . . . 2.47 110.034 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.549 ' HB3' ' HA ' ' A' ' 16' ' ' LEU . 0.4 OUTLIER -53.69 -32.45 51.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.408 -0.815 . . . . 0.22 111.478 179.934 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.58 ' HE2' HE22 ' A' ' 33' ' ' GLN . 35.6 mmtp -44.02 -20.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.996 -0.547 . . . . 2.45 112.332 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.664 HD22 ' N ' ' A' ' 21' ' ' ASN . 0.8 OUTLIER -68.49 -33.05 73.46 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.983 0.364 . . . . 0.4 111.983 -178.751 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.432 ' HD2' ' OD1' ' A' ' 19' ' ' ASN . 67.3 mttm -54.14 119.11 18.12 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.686 -0.234 . . . . 1.4 110.988 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.46 142.73 95.33 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.449 2.099 . . . . 0.65 112.258 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.14 -1.63 86.56 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.769 -0.729 . . . . 0.37 113.249 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' A' ' 34' ' ' TYR . 3.7 p -61.26 110.53 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 121.21 0.529 . . . . 0.91 110.58 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.0 p -130.04 130.94 66.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.838 -0.619 . . . . 1.03 111.508 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 9.7 p -82.89 138.38 19.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.91 110.861 179.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.53 HD12 ' HB2' ' A' ' 32' ' ' LEU . 55.3 mt -96.22 167.45 12.37 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.255 -0.429 . . . . 0.4 110.704 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.48 ' HD2' ' HB3' ' A' ' 28' ' ' LEU . 75.0 Cg_exo -51.06 -30.97 33.36 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.129 1.886 . . . . 0.59 112.265 179.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.479 ' HB2' HD23 ' A' ' 32' ' ' LEU . 31.9 m -89.25 -9.41 50.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.265 -0.425 . . . . 1.14 111.782 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.58 15.68 22.15 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.388 -0.91 . . . . 0.34 113.627 178.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.691 HD21 ' HA2' ' A' ' 85' ' ' GLY . 2.7 mm? -83.02 134.27 35.05 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.008 0.432 . . . . 1.35 111.92 -179.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.58 HE22 ' HE2' ' A' ' 20' ' ' LYS . 46.1 mt-30 -125.23 139.02 54.09 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.282 -0.636 . . . . 1.75 109.282 178.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.803 ' HB3' HG22 ' A' ' 101' ' ' ILE . 28.8 p90 -151.17 175.72 11.88 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.788 0.662 . . . . 0.32 112.788 -178.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -121.09 117.06 26.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.226 -0.897 . . . . 2.15 109.175 178.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.5 t -72.66 126.66 33.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 113.299 0.852 . . . . 0.3 113.299 -177.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.462 HD12 HG22 ' A' ' 98' ' ' THR . 76.8 mt -107.42 -66.75 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 115.401 -0.818 . . . . 0.65 110.131 178.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -142.59 82.86 1.79 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.19 -0.459 . . . . 1.03 110.157 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.417 ' OG ' ' NE1' ' A' ' 99' ' ' TRP . 17.8 m -106.03 146.38 30.18 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 112.515 0.561 . . . . 1.5 112.515 -178.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 92.43 83.65 1.5 Allowed Glycine 0 C--N 1.334 0.455 0 CA-C-N 115.755 -0.657 . . . . 1.09 113.038 178.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -150.61 -72.77 0.17 Allowed 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 111.681 0.252 . . . . 1.7 111.681 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.12 172.29 36.45 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 121.072 -0.585 . . . . 0.35 114.298 -178.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.598 HG12 ' H ' ' A' ' 44' ' ' LYS . 2.0 t -90.47 175.99 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 123.474 0.71 . . . . 1.42 110.022 179.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.598 ' H ' HG12 ' A' ' 43' ' ' VAL . 2.1 pptp? 164.96 156.53 0.07 OUTLIER Pre-proline 0 N--CA 1.472 0.657 0 CA-C-O 121.503 0.668 . . . . 2.18 112.028 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.471 ' HD2' ' HB2' ' A' ' 49' ' ' ASP . 1.2 Cg_endo -83.84 172.54 9.88 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 124.823 3.682 . . . . 0.3 113.692 -179.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 48' ' ' SER . . . -67.98 -172.93 6.92 Favored Glycine 0 C--O 1.223 -0.565 0 CA-C-N 115.096 -0.956 . . . . 0.35 111.237 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -41.63 -13.98 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.825 1.046 . . . . 2.35 113.825 -177.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.487 ' N ' ' O ' ' A' ' 46' ' ' GLY . 55.6 m -86.32 7.24 26.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.268 0.556 . . . . 1.45 110.092 178.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.471 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 3.0 p30 -74.79 166.23 23.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.267 -0.879 . . . . 1.73 111.676 -179.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 91.7 m -126.07 121.26 32.43 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 108.691 -0.855 . . . . 0.44 108.691 178.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.819 HG12 HG22 ' A' ' 133' ' ' VAL . 6.4 m -122.92 142.63 38.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 112.97 0.73 . . . . 0.65 112.97 -177.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 39.3 m -115.35 119.79 37.45 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.067 -1.086 . . . . 0.32 108.067 177.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.62 HG12 ' HA ' ' A' ' 130' ' ' LEU . 2.7 m -146.34 178.78 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.26 0.552 . . . . 0.24 111.961 -177.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -128.78 132.45 47.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.291 -0.868 . . . . 2.4 109.107 178.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -146.13 159.28 43.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.584 0.707 . . . . 0.26 112.345 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 57.0 m -121.84 112.89 18.9 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.483 -1.235 . . . . 0.26 108.223 178.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.473 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -110.66 143.54 17.02 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 119.664 -1.255 . . . . 0.12 113.236 -178.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.543 ' O ' HD13 ' A' ' 124' ' ' LEU . 0.1 OUTLIER -148.43 145.61 28.07 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.566 -0.317 . . . . 1.93 110.176 179.266 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.538 HD23 HD11 ' A' ' 124' ' ' LEU . 2.3 mt -74.9 154.02 38.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.978 -0.555 . . . . 1.21 110.586 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.482 ' HB ' ' O ' ' A' ' 123' ' ' THR . 0.4 OUTLIER -56.55 -11.94 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.362 0.601 . . . . 0.64 109.621 179.001 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.402 ' N ' ' C ' ' A' ' 59' ' ' LEU . 21.4 t70 -71.11 -10.01 59.03 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.434 -0.803 . . . . 2.01 110.816 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.7 0.18 75.92 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.597 -0.811 . . . . 0.45 113.629 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 61.4 p -113.3 121.43 44.38 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 117.339 0.57 . . . . 1.4 111.724 -178.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 57' ' ' GLY . 5.9 p -60.61 132.4 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-N 115.889 -0.596 . . . . 0.28 109.819 179.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.701 ' HD1' ' H ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -97.79 -28.07 14.03 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.333 -0.394 . . . . 0.24 111.908 -179.4 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.701 ' H ' ' HD1' ' A' ' 65' ' ' PHE . 15.1 t70 -177.64 131.49 0.16 Allowed 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.606 0.241 . . . . 0.3 110.821 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.6 m -131.41 116.84 18.05 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.879 0.371 . . . . 1.3 110.487 178.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.544 HG21 ' HB2' ' A' ' 75' ' ' ALA . 80.4 p -74.84 -29.59 61.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.478 . . . . 0.34 111.323 -179.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -70.18 -39.45 75.26 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.199 -0.455 . . . . 2.11 110.654 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -71.02 -37.95 72.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.226 -0.443 . . . . 3.41 111.042 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 33.8 m -57.11 -22.75 42.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.233 -0.44 . . . . 1.47 110.794 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 95.21 2.15 62.33 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.869 -0.681 . . . . 0.7 112.618 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.449 ' HB2' ' NZ ' ' A' ' 73' ' ' LYS . 3.6 ttmp? -126.35 118.03 23.28 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.638 0.219 . . . . 3.05 111.111 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -52.65 150.25 22.39 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.62 2.213 . . . . 0.51 112.125 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.544 ' HB2' HG21 ' A' ' 68' ' ' THR . . . -94.73 125.02 39.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.39 -0.368 . . . . 0.23 110.811 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.7 t -123.85 113.97 19.24 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.952 0.406 . . . . 1.26 111.428 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -159.03 154.65 26.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.021 -0.536 . . . . 0.36 111.121 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.591 HE22 ' HB3' ' A' ' 80' ' ' SER . 0.0 OUTLIER -84.5 148.84 26.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.35 0.595 . . . . 1.58 109.871 178.487 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.4 ' CG1' ' HB3' ' A' ' 90' ' ' LEU . 2.5 m -68.79 -25.78 31.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 113.925 1.084 . . . . 1.07 113.925 -177.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.591 ' HB3' HE22 ' A' ' 78' ' ' GLN . 37.7 t -86.17 -2.35 58.27 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.616 0.599 . . . . 1.14 112.616 -178.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.422 ' HB2' ' HG3' ' A' ' 78' ' ' GLN . 7.8 tt0 -95.33 5.56 51.35 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.274 0.472 . . . . 2.08 112.274 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 1.7 m -113.63 -173.17 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 112.334 0.494 . . . . 0.45 112.334 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.593 HG13 ' H ' ' A' ' 86' ' ' TRP . 42.2 pt -56.14 158.95 6.52 Favored Pre-proline 0 CA--C 1.53 0.201 0 CA-C-N 115.906 -0.588 . . . . 0.75 112.268 -179.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.435 ' O ' HG22 ' A' ' 87' ' ' THR . 75.3 Cg_exo -51.38 -47.37 26.36 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.894 2.396 . . . . 0.65 113.043 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.691 ' HA2' HD21 ' A' ' 32' ' ' LEU . . . -59.85 -48.66 84.97 Favored Glycine 0 CA--C 1.521 0.407 0 C-N-CA 120.524 -0.846 . . . . 0.31 112.953 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . 0.593 ' H ' HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -64.06 -44.72 91.56 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.651 0.611 . . . . 0.78 112.651 -178.695 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.435 HG22 ' O ' ' A' ' 84' ' ' PRO . 10.0 t -60.25 -37.14 79.46 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.072 0.397 . . . . 1.4 112.072 -178.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.446 ' O ' ' HG2' ' A' ' 91' ' ' GLN . 10.3 tp10 -70.75 -40.2 72.85 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.008 0.373 . . . . 1.43 112.008 -179.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.495 ' HB2' ' HG ' ' A' ' 32' ' ' LEU . . . -76.09 -52.46 10.11 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.013 0.375 . . . . 0.33 112.013 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.691 HD11 HD13 ' A' ' 128' ' ' ILE . 4.6 mm? -57.38 -34.69 69.11 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.778 0.658 . . . . 0.39 112.778 -178.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.446 ' HG2' ' O ' ' A' ' 88' ' ' GLU . 18.1 pt20 -65.55 -4.79 6.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.635 0.255 . . . . 1.87 111.653 -179.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 82.6 mt -108.22 -7.85 15.89 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.564 -0.289 . . . . 1.31 111.207 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.553 ' HE3' ' N ' ' A' ' 99' ' ' TRP . 13.8 ttt -78.08 112.93 28.97 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.417 -0.356 . . . . 1.66 111.102 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.532 ' HA ' ' HG2' ' A' ' 44' ' ' LYS . 4.5 Cg_exo -77.04 142.37 21.85 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.761 2.307 . . . . 0.44 111.84 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.484 ' HB1' ' HA ' ' A' ' 132' ' ' SER . . . -50.41 128.28 19.46 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.372 -0.377 . . . . 0.36 111.499 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 92.25 2.27 68.56 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.689 -0.767 . . . . 0.34 113.292 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 19.8 m -92.85 -179.72 5.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.094 0.473 . . . . 1.41 111.776 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.462 HG22 HD12 ' A' ' 37' ' ' ILE . 3.9 m -144.63 120.4 10.55 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.658 -0.701 . . . . 0.23 110.084 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.553 ' N ' ' HE3' ' A' ' 93' ' ' MET . 4.9 m0 -132.36 150.65 52.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.23 0.538 . . . . 0.53 112.264 -178.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -122.46 106.85 11.4 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.715 -1.217 . . . . 1.37 107.715 177.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.803 HG22 ' HB3' ' A' ' 34' ' ' TYR . 41.0 pt -109.44 139.28 33.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 112.923 0.712 . . . . 0.25 112.923 -177.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -122.72 103.33 8.59 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.826 -1.079 . . . . 0.31 108.214 178.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.402 HG12 ' HB2' ' A' ' 107' ' ' LEU . 2.7 t -107.3 97.08 17.49 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 112.501 0.556 . . . . 0.52 112.501 -177.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.634 ' HA ' ' HA ' ' A' ' 123' ' ' THR . 9.9 Cg_endo -54.12 149.06 37.28 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 121.621 1.547 . . . . 0.48 110.528 177.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.3 m -48.15 -29.49 3.72 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.489 0.551 . . . . 1.81 112.489 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -56.64 -9.79 3.87 Favored Glycine 0 CA--C 1.521 0.444 0 C-N-CA 121.016 -0.611 . . . . 0.4 113.992 -178.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.488 HD23 ' HG2' ' A' ' 104' ' ' PRO . 3.4 mm? -110.6 1.98 18.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 117.251 0.526 . . . . 2.35 111.897 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.472 ' HB2' HD12 ' A' ' 83' ' ' ILE . . . . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.715 -0.22 . . . . 1.03 111.586 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.504 ' HB2' HD12 ' A' ' 118' ' ' ILE . 49.6 Cg_exo . . . . . 0 C--O 1.231 0.144 0 CA-C-O 120.995 0.331 . . . . 0.7 111.453 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.539 HG23 HD23 ' A' ' 124' ' ' LEU . 4.0 mp -92.53 135.65 26.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.753 -0.658 . . . . 1.25 110.212 178.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -42.64 149.53 0.46 Allowed Glycine 0 C--N 1.335 0.493 0 C-N-CA 120.917 -0.658 . . . . 0.48 112.489 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -55.73 131.31 45.31 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.263 1.976 . . . . 0.67 112.282 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 42.99 37.68 1.2 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.311 -0.404 . . . . 1.12 110.862 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.462 ' OE1' HD22 ' A' ' 59' ' ' LEU . 30.8 tt0 -114.09 144.28 43.4 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.012 -0.54 . . . . 1.73 111.957 -179.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.634 ' HA ' ' HA ' ' A' ' 104' ' ' PRO . 70.0 m -97.0 129.3 44.49 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.369 -0.604 . . . . 0.29 109.369 178.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.543 HD13 ' O ' ' A' ' 58' ' ' ARG . 1.4 mm? -115.53 152.43 33.02 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.121 0.486 . . . . 1.47 111.838 -178.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.423 ' N ' HD12 ' A' ' 125' ' ' ILE . 4.8 mp -114.3 136.36 51.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.557 -0.747 . . . . 0.2 110.02 178.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -133.53 131.7 40.07 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.275 -0.42 . . . . 0.24 111.397 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -108.43 102.38 11.49 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.862 -1.162 . . . . 2.28 107.862 177.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.691 HD13 HD11 ' A' ' 90' ' ' LEU . 18.2 mt -102.83 126.56 57.03 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 CA-C-O 121.238 0.542 . . . . 0.82 112.148 -177.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . 0.469 ' O ' ' HB ' ' A' ' 53' ' ' VAL . 1.3 t-160 -118.56 98.37 6.21 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.227 -0.897 . . . . 0.26 109.297 178.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.62 ' HA ' HG12 ' A' ' 53' ' ' VAL . 17.3 tp -80.25 113.61 18.54 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.187 -0.46 . . . . 1.41 111.113 -178.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 34.3 mm -81.98 -50.29 16.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.786 -0.643 . . . . 1.17 110.782 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.484 ' HA ' ' HB1' ' A' ' 95' ' ' ALA . 5.3 m -163.4 165.22 24.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 1.17 110.358 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.819 HG22 HG12 ' A' ' 51' ' ' VAL . 91.7 t -129.16 135.77 61.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.01 -0.541 . . . . 1.43 110.589 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.56 ' HE2' ' HB2' ' A' ' 137' ' ' SER . 21.4 ptmt 40.74 49.8 2.87 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.878 -0.601 . . . . 3.08 111.277 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt 63.77 41.21 7.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.345 -0.843 . . . . 3.16 111.507 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 33.9 t 48.03 32.61 2.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.71 -0.677 . . . . 1.31 111.477 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.56 ' HB2' ' HE2' ' A' ' 134' ' ' LYS . 69.8 m . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.213 -0.898 . . . . 2.53 110.894 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 76.2 t80 . . . . . 0 N--CA 1.485 1.276 0 CA-C-O 120.791 0.329 . . . . 3.09 110.806 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -70.11 -20.54 63.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.228 -0.442 . . . . 2.08 110.976 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -57.51 -39.73 77.14 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.622 -0.51 . . . . 3.23 109.622 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -79.43 -36.12 39.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.685 -0.689 . . . . 2.63 110.222 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -57.79 -52.04 67.09 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.101 -0.499 . . . . 0.82 110.145 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -66.64 -34.39 77.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.864 -0.607 . . . . 2.57 109.936 178.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -55.79 -32.61 63.64 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.089 -0.708 . . . . 2.1 109.089 178.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.517 ' HA ' ' HG2' ' A' ' 11' ' ' LYS . 41.5 m-20 -75.7 -38.37 58.71 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.201 -0.909 . . . . 1.4 110.509 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -56.39 -39.6 73.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.878 -0.601 . . . . 2.67 111.571 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.402 HG23 ' N ' ' A' ' 11' ' ' LYS . 16.2 m -78.33 -47.83 23.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 112.604 0.594 . . . . 1.27 112.604 -178.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.53 ' HE2' HG13 ' A' ' 60' ' ' ILE . 22.1 ptmt -63.55 -33.99 76.81 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.602 0.223 . . . . 1.69 111.602 -179.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.86 -52.98 5.54 Favored Glycine 0 C--N 1.33 0.231 0 C-N-CA 120.75 -0.738 . . . . 0.31 112.461 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -57.66 -26.27 61.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.969 0.414 . . . . 2.39 110.346 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.17 -40.67 37.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.814 -0.63 . . . . 0.23 110.529 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -58.69 -48.92 79.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.076 -0.511 . . . . 0.23 110.278 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.562 ' HA ' ' HB3' ' A' ' 19' ' ' ASN . 4.2 pp -67.0 -34.52 77.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.32 -0.4 . . . . 0.55 110.714 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.43 ' N ' HD12 ' A' ' 16' ' ' LEU . 18.5 m -57.72 -49.65 75.85 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.246 -0.434 . . . . 0.27 110.209 179.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -73.72 -32.01 63.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.86 -0.609 . . . . 2.47 110.074 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.562 ' HB3' ' HA ' ' A' ' 16' ' ' LEU . 0.5 OUTLIER -54.29 -33.14 58.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.467 -0.788 . . . . 0.22 111.521 -179.915 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -46.66 -19.75 0.1 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.041 -0.527 . . . . 2.45 112.163 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.691 HD22 ' N ' ' A' ' 21' ' ' ASN . 0.8 OUTLIER -68.03 -33.52 74.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.638 -0.256 . . . . 0.4 111.594 -178.789 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.758 ' O ' HG23 ' A' ' 25' ' ' VAL . 67.7 mttm -52.05 119.03 13.32 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.551 -0.295 . . . . 1.4 110.511 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -57.73 146.41 85.51 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.231 1.954 . . . . 0.65 112.222 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.05 3.16 79.87 Favored Glycine 0 CA--C 1.522 0.471 0 C-N-CA 120.869 -0.682 . . . . 0.37 114.16 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.758 HG23 ' O ' ' A' ' 22' ' ' LYS . 35.6 t -56.8 110.71 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 117.65 0.725 . . . . 0.91 110.435 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.9 p -126.12 127.58 71.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.898 -0.592 . . . . 1.03 111.126 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.1 p -83.09 143.08 12.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.073 -0.512 . . . . 0.91 111.021 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.505 ' HB3' ' HD2' ' A' ' 29' ' ' PRO . 69.3 mt -103.86 168.56 8.46 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.102 -0.499 . . . . 0.4 110.806 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.505 ' HD2' ' HB3' ' A' ' 28' ' ' LEU . 78.4 Cg_exo -51.48 -33.45 47.39 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 121.943 1.762 . . . . 0.59 111.754 178.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.5 m -84.49 -11.95 55.16 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.046 -0.524 . . . . 1.14 111.195 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.04 14.16 27.25 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.507 -0.854 . . . . 0.34 114.258 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.633 HD22 ' HB2' ' A' ' 89' ' ' ALA . 6.5 mp -83.08 134.77 35.0 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.068 0.766 . . . . 1.35 113.068 -178.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -116.6 143.65 45.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.191 -0.913 . . . . 1.75 108.542 177.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.495 ' HB3' HG22 ' A' ' 101' ' ' ILE . 30.7 p90 -160.27 175.56 12.72 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.37 0.507 . . . . 0.32 112.37 -178.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -120.54 116.86 26.21 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.38 -0.827 . . . . 2.15 109.331 178.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.6 t -78.1 125.34 37.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 113.475 0.917 . . . . 0.3 113.475 -177.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 63.3 mt -101.21 -60.83 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.289 -0.869 . . . . 0.65 109.109 177.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -134.77 100.06 4.5 Favored 'General case' 0 CA--C 1.527 0.072 0 CA-C-N 115.799 -0.637 . . . . 1.03 109.673 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.617 ' HB3' ' HE1' ' A' ' 99' ' ' TRP . 59.9 p -103.18 145.62 29.66 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.113 0.482 . . . . 1.5 112.161 -178.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 94.82 -126.54 8.76 Favored Glycine 0 C--N 1.333 0.384 0 CA-C-N 115.599 -0.728 . . . . 1.09 113.146 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 16.9 m-80 70.08 -83.07 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.559 0.577 . . . . 1.7 112.559 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.11 167.36 30.37 Favored Glycine 0 CA--C 1.521 0.429 0 N-CA-C 115.289 0.875 . . . . 0.35 115.289 -177.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.644 HG12 ' H ' ' A' ' 44' ' ' LYS . 2.5 t -91.81 176.88 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 114.365 -0.917 . . . . 1.42 109.592 178.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.737 ' HG2' ' HA ' ' A' ' 94' ' ' PRO . 0.0 OUTLIER 165.46 157.64 0.09 OUTLIER Pre-proline 0 N--CA 1.475 0.781 0 CA-C-O 121.357 0.599 . . . . 2.18 112.35 -179.878 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.563 ' HD2' ' HB2' ' A' ' 49' ' ' ASP . 1.2 Cg_endo -84.65 173.35 8.47 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 125.076 3.851 . . . . 0.3 113.882 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 48' ' ' SER . . . -67.99 -171.97 6.34 Favored Glycine 0 C--O 1.222 -0.625 0 CA-C-N 114.947 -1.024 . . . . 0.35 111.664 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.509 ' O ' HG13 ' A' ' 79' ' ' VAL . 23.0 pttm -41.33 -13.46 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 113.921 1.082 . . . . 2.35 113.921 -177.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.487 ' N ' ' O ' ' A' ' 46' ' ' GLY . 80.9 p -86.25 7.52 24.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.549 0.69 . . . . 1.45 109.364 177.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.563 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 0.0 OUTLIER -71.79 149.17 45.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.666 -1.152 . . . . 1.73 112.183 -179.255 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 58.8 m -126.67 119.39 26.88 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 109.055 -0.72 . . . . 0.44 109.055 178.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.515 HG12 ' HA ' ' A' ' 133' ' ' VAL . 33.1 m -132.45 156.28 42.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 112.671 0.619 . . . . 0.65 112.671 -178.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 96.6 m -111.93 121.14 44.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.06 -0.973 . . . . 0.32 108.973 178.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.512 HG12 ' HA ' ' A' ' 130' ' ' LEU . 2.6 m -142.57 -179.66 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.328 0.585 . . . . 0.24 112.012 -178.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.496 ' HB3' ' HG2' ' A' ' 69' ' ' GLU . 28.6 mt-10 -131.38 132.75 44.64 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.267 -0.879 . . . . 2.4 109.426 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -143.82 158.11 43.91 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.793 0.806 . . . . 0.26 112.229 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 82.5 m -126.0 113.63 17.39 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.133 -1.394 . . . . 0.26 108.532 178.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.459 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -108.93 147.26 16.72 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 119.78 -1.2 . . . . 0.12 112.72 -178.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.01 147.45 32.64 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.852 0.358 . . . . 1.93 110.199 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.477 HD23 HD21 ' A' ' 124' ' ' LEU . 13.2 mt -84.95 157.78 20.72 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.003 -0.544 . . . . 1.21 110.233 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.53 HG13 ' HE2' ' A' ' 11' ' ' LYS . 10.2 tp -57.16 -10.93 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.347 0.594 . . . . 0.64 109.709 178.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.412 ' N ' ' C ' ' A' ' 59' ' ' LEU . 24.7 t70 -67.4 -11.53 57.98 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.373 -0.83 . . . . 2.01 111.007 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.13 -0.34 75.41 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.483 -0.865 . . . . 0.45 113.578 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.3 t -122.89 138.93 54.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 117.37 0.585 . . . . 1.4 111.712 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 57' ' ' GLY . 7.5 p -62.99 133.99 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 115.825 -0.625 . . . . 0.28 110.064 179.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.636 ' HD1' ' H ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -97.99 -25.61 14.91 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.067 -0.515 . . . . 0.24 111.147 -179.848 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.636 ' H ' ' HD1' ' A' ' 65' ' ' PHE . 19.1 t70 -176.51 131.17 0.21 Allowed 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 120.733 0.302 . . . . 0.3 110.889 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 70.8 p -128.35 126.52 40.87 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.293 -0.412 . . . . 1.3 110.531 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.443 HG21 ' HB2' ' A' ' 75' ' ' ALA . 81.1 p -81.83 -21.59 37.53 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.767 0.318 . . . . 0.34 111.235 -179.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.496 ' HG2' ' HB3' ' A' ' 54' ' ' GLU . 41.2 mt-10 -75.08 -47.76 27.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.284 -0.416 . . . . 2.11 111.226 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm -63.01 -36.87 84.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.43 . . . . 3.41 111.166 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 41.6 m -59.07 -22.89 61.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.312 -0.404 . . . . 1.47 110.719 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 92.05 4.75 66.61 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.808 -0.711 . . . . 0.7 112.355 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -126.5 116.95 22.98 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.454 0.127 . . . . 3.05 110.771 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.46 159.01 11.5 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.139 1.893 . . . . 0.51 111.923 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.443 ' HB2' HG21 ' A' ' 68' ' ' THR . . . -94.78 124.62 38.92 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.355 -0.384 . . . . 0.23 110.475 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 48.4 m -127.44 111.95 14.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.838 0.352 . . . . 1.26 111.446 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -158.67 163.78 36.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.091 -0.504 . . . . 0.36 110.904 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.572 ' HG3' ' HB2' ' A' ' 81' ' ' GLN . 0.4 OUTLIER -95.28 148.33 22.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.379 0.609 . . . . 1.58 110.503 178.931 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.533 ' HB ' ' HB3' ' A' ' 90' ' ' LEU . 0.6 OUTLIER -59.29 -28.38 39.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 114.93 -1.032 . . . . 1.07 113.262 -178.431 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.52 ' HB3' ' NE2' ' A' ' 78' ' ' GLN . 46.7 t -85.44 -2.42 58.09 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.78 0.659 . . . . 1.14 112.78 -178.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.572 ' HB2' ' HG3' ' A' ' 78' ' ' GLN . 5.3 tp-100 -96.93 5.85 49.74 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.534 0.568 . . . . 2.08 112.534 -179.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.6 m -112.77 -178.15 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 N-CA-C 112.361 0.504 . . . . 0.45 112.361 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.518 ' O ' HG23 ' A' ' 87' ' ' THR . 28.1 pt -56.88 155.37 15.48 Favored Pre-proline 0 N--CA 1.464 0.273 0 CA-C-N 116.0 -0.546 . . . . 0.75 112.017 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -44.33 -60.43 0.81 Allowed 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.074 2.516 . . . . 0.65 113.597 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.632 ' CA ' HD11 ' A' ' 32' ' ' LEU . . . -49.12 -49.08 31.14 Favored Glycine 0 CA--C 1.522 0.529 0 C-N-CA 120.493 -0.86 . . . . 0.31 112.721 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . 0.462 ' HB2' HG13 ' A' ' 83' ' ' ILE . 0.7 OUTLIER -61.81 -43.87 97.99 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.248 0.462 . . . . 0.78 112.248 -179.003 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.518 HG23 ' O ' ' A' ' 83' ' ' ILE . 53.7 p -56.12 -34.49 66.11 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.7 0.286 . . . . 1.4 111.395 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -70.27 -51.46 30.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.404 -0.362 . . . . 1.43 111.835 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.633 ' HB2' HD22 ' A' ' 32' ' ' LEU . . . -65.78 -52.24 52.48 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 112.418 0.525 . . . . 0.33 112.418 -178.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.533 ' HB3' ' HB ' ' A' ' 79' ' ' VAL . 4.1 mm? -56.97 -26.91 60.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.424 -0.353 . . . . 0.39 111.615 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.449 ' HG3' ' N ' ' A' ' 47' ' ' LYS . 53.2 tt0 -67.7 -23.47 65.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.789 0.328 . . . . 1.87 111.182 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.436 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 88.8 mt -100.75 -8.04 23.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.298 -0.41 . . . . 1.31 111.526 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.525 ' SD ' HD13 ' A' ' 90' ' ' LEU . 62.1 mtt -76.41 110.78 12.37 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 116.748 -0.205 . . . . 1.66 111.281 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.737 ' HA ' ' HG2' ' A' ' 44' ' ' LYS . 67.4 Cg_endo -84.93 147.45 10.54 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.837 2.358 . . . . 0.44 112.771 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.555 ' HB1' ' HA ' ' A' ' 132' ' ' SER . . . -45.8 131.02 9.46 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.288 -0.415 . . . . 0.36 112.06 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 88.99 -11.94 67.65 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.845 -0.693 . . . . 0.34 113.613 179.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.496 ' HB3' ' HG2' ' A' ' 94' ' ' PRO . 96.6 p -67.75 -175.92 0.59 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.963 0.411 . . . . 1.41 111.284 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 17.6 m -161.54 97.75 1.1 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.899 -0.592 . . . . 0.23 110.81 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.617 ' HE1' ' HB3' ' A' ' 39' ' ' SER . 43.9 m0 -119.93 152.11 37.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.082 0.468 . . . . 0.53 111.563 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -122.25 108.27 13.09 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.459 -0.941 . . . . 1.37 108.459 177.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.495 HG22 ' HB3' ' A' ' 34' ' ' TYR . 31.5 pt -106.4 141.7 21.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 113.217 0.821 . . . . 0.25 113.217 -177.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.42 ' OH ' HG22 ' A' ' 25' ' ' VAL . 0.6 OUTLIER -125.53 103.97 8.16 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.578 -1.192 . . . . 0.31 108.368 178.309 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.405 ' HA ' ' HD2' ' A' ' 104' ' ' PRO . 4.1 t -106.2 110.79 64.24 Favored Pre-proline 0 C--N 1.33 -0.262 0 N-CA-C 113.114 0.783 . . . . 0.52 113.114 -177.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.575 ' HG2' HD13 ' A' ' 107' ' ' LEU . 17.7 Cg_endo -61.96 152.19 76.66 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.308 2.006 . . . . 0.48 111.131 177.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.43 ' HB2' ' N ' ' A' ' 111' ' ' PRO . 0.3 OUTLIER -47.12 -42.14 18.7 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.834 0.679 . . . . 1.81 112.834 -178.69 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.454 ' C ' HD12 ' A' ' 107' ' ' LEU . . . -57.4 -9.36 4.51 Favored Glycine 0 CA--C 1.521 0.452 0 C-N-CA 121.043 -0.598 . . . . 0.4 113.882 -178.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.575 HD13 ' HG2' ' A' ' 104' ' ' PRO . 9.2 mp -113.4 -7.71 13.46 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.138 0.422 . . . . 2.35 112.138 -178.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -109.93 -104.31 0.37 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.692 -0.231 . . . . 1.03 110.63 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -91.73 -13.93 30.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.991 0.424 . . . . 1.44 110.409 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 102.87 144.54 14.3 Favored Glycine 0 CA--C 1.523 0.533 0 CA-C-N 115.829 -0.623 . . . . 1.58 113.577 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.445 ' HA ' ' H ' ' A' ' 121' ' ' ASN . 17.3 Cg_endo -57.99 -7.05 3.11 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 123.702 2.935 . . . . 1.49 112.835 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.529 ' C ' ' H ' ' A' ' 114' ' ' VAL . 88.5 mtt180 -75.64 171.4 14.38 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.807 0.337 . . . . 3.51 110.365 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 54.5 m -63.25 14.24 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.138 -0.483 . . . . 1.63 112.22 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.529 ' H ' ' C ' ' A' ' 112' ' ' ARG . 2.9 t -103.28 19.28 3.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.117 0.484 . . . . 2.9 110.353 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -66.11 104.16 0.99 Allowed Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.801 -0.636 . . . . 1.05 112.426 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.98 -113.25 0.01 OUTLIER Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.977 -0.63 . . . . 0.8 112.479 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.7 -34.87 96.07 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.16 1.907 . . . . 0.7 111.51 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.693 HG23 HD13 ' A' ' 124' ' ' LEU . 57.4 mt -90.84 115.21 29.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.791 -0.64 . . . . 1.25 110.015 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -44.18 157.41 0.17 Allowed Glycine 0 C--N 1.334 0.463 0 CA-C-N 116.153 -0.476 . . . . 0.48 113.13 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -63.64 131.65 32.29 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.274 1.983 . . . . 0.67 111.643 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.445 ' H ' ' HA ' ' A' ' 111' ' ' PRO . 3.8 m-80 49.3 34.18 6.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.262 -0.426 . . . . 1.12 110.356 -178.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -116.29 129.17 56.13 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.203 -0.453 . . . . 1.73 111.358 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.51 ' O ' ' HB ' ' A' ' 60' ' ' ILE . 77.5 m -93.07 127.27 38.54 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.722 -0.844 . . . . 0.29 108.722 178.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.693 HD13 HG23 ' A' ' 118' ' ' ILE . 7.4 mp -115.22 157.84 23.14 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.27 0.557 . . . . 1.47 112.399 -178.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.432 ' N ' HD12 ' A' ' 125' ' ' ILE . 4.8 mp -114.86 139.35 41.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.255 -0.884 . . . . 0.2 109.502 178.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -131.13 131.79 44.36 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.099 0.476 . . . . 0.24 111.544 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.456 ' NZ ' ' HB3' ' A' ' 127' ' ' LYS . 3.3 mmmp? -110.45 103.78 12.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.514 -0.766 . . . . 2.28 109.18 178.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.4 mp -103.94 118.7 51.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.163 0.506 . . . . 0.82 112.242 -178.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -113.35 98.34 7.04 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.41 -0.959 . . . . 0.26 108.41 177.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.512 ' HA ' HG12 ' A' ' 53' ' ' VAL . 21.9 tp -82.74 123.18 29.07 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.552 -0.749 . . . . 1.41 111.683 -178.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 55.8 mt -89.81 -55.99 5.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.799 -0.637 . . . . 1.17 110.785 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.555 ' HA ' ' HB1' ' A' ' 95' ' ' ALA . 60.5 p -163.64 165.04 23.78 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.072 0.463 . . . . 1.17 111.628 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.515 ' HA ' HG12 ' A' ' 51' ' ' VAL . 2.5 p -108.95 131.53 59.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.715 -0.675 . . . . 1.43 111.418 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 5.8 tttp 34.37 64.96 0.35 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.012 -0.54 . . . . 3.08 111.574 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm 62.03 42.86 9.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.897 -0.592 . . . . 3.16 111.229 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 90.0 p 47.82 64.42 1.63 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.752 -0.658 . . . . 1.31 111.413 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 43.4 t . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.21 -0.9 . . . . 2.53 110.865 179.994 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.733 0.302 . . . . 3.09 110.96 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -66.37 -18.84 65.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 2.08 111.2 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -58.06 -41.13 82.67 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.592 -0.521 . . . . 3.23 109.592 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -79.83 -35.06 38.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.72 -0.673 . . . . 2.63 110.358 179.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -57.53 -51.42 69.53 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.085 -0.507 . . . . 0.82 110.265 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -67.22 -35.14 78.95 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.927 -0.579 . . . . 2.57 110.215 179.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -55.78 -32.47 63.49 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 109.386 -0.598 . . . . 2.1 109.386 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.568 ' HB3' ' HG2' ' A' ' 122' ' ' GLU . 19.0 m-20 -75.66 -39.13 58.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.491 -0.777 . . . . 1.4 110.38 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.423 ' O ' ' HD2' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -56.79 -40.84 76.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.9 -0.591 . . . . 2.67 111.331 179.816 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.431 HG23 ' N ' ' A' ' 11' ' ' LYS . 19.6 m -74.15 -48.23 38.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 112.169 0.433 . . . . 1.27 112.169 -179.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.53 ' HG2' ' HA ' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -64.07 -29.91 71.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.776 0.322 . . . . 1.69 111.029 -179.683 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.69 -48.33 8.99 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 121.051 -0.595 . . . . 0.31 112.176 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -59.01 -30.15 67.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.035 0.445 . . . . 2.39 110.377 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.88 -41.33 37.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.794 -0.639 . . . . 0.23 111.118 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -56.02 -52.71 63.26 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 120.768 0.318 . . . . 0.23 110.288 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.48 ' HA ' ' HB3' ' A' ' 19' ' ' ASN . 4.0 pp -63.71 -35.51 80.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.083 -0.508 . . . . 0.55 110.446 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.4 m -57.33 -48.53 78.72 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.066 -0.516 . . . . 0.27 110.343 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -73.22 -31.82 64.38 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.948 -0.569 . . . . 2.47 109.876 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.486 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 0.9 OUTLIER -56.03 -30.43 61.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.368 -0.833 . . . . 0.22 111.817 -179.883 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -43.22 -19.99 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.244 0.461 . . . . 2.45 112.244 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.675 HD22 ' N ' ' A' ' 21' ' ' ASN . 0.8 OUTLIER -68.6 -34.03 75.08 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.462 0.542 . . . . 0.4 112.462 -178.627 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.732 ' O ' HG23 ' A' ' 25' ' ' VAL . 38.3 mmtt -46.7 119.46 5.58 Favored Pre-proline 0 N--CA 1.463 0.198 0 CA-C-O 120.527 0.203 . . . . 1.4 110.899 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.445 ' HD2' ' HE2' ' A' ' 35' ' ' LYS . 40.5 Cg_exo -57.0 135.6 71.79 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.006 1.804 . . . . 0.65 112.049 179.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.31 3.24 78.92 Favored Glycine 0 CA--C 1.52 0.362 0 C-N-CA 120.755 -0.736 . . . . 0.37 113.949 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.732 HG23 ' O ' ' A' ' 22' ' ' LYS . 8.9 t -52.05 111.57 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 117.606 0.703 . . . . 0.91 110.218 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.438 HG13 ' CE1' ' A' ' 34' ' ' TYR . 2.1 p -127.46 133.69 67.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.891 -0.595 . . . . 1.03 111.078 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.424 HG23 ' NE2' ' A' ' 33' ' ' GLN . 7.6 p -85.77 141.91 13.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.953 -0.567 . . . . 0.91 110.968 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.597 HD12 ' HB2' ' A' ' 32' ' ' LEU . 64.5 mt -99.66 166.61 12.53 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.4 110.782 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.44 ' HD2' ' HB3' ' A' ' 28' ' ' LEU . 52.4 Cg_exo -53.14 -30.57 50.95 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 121.908 1.739 . . . . 0.59 111.513 178.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 39.8 t -86.02 -12.74 49.48 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.014 -0.539 . . . . 1.14 111.031 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.05 14.42 24.64 Favored Glycine 0 C--N 1.334 0.436 0 C-N-CA 120.464 -0.874 . . . . 0.34 114.313 178.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.68 HD11 ' HA2' ' A' ' 85' ' ' GLY . 6.6 mp -85.11 139.26 31.85 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.098 0.777 . . . . 1.35 113.098 -179.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.424 ' NE2' HG23 ' A' ' 27' ' ' VAL . 26.5 mp0 -116.01 144.18 44.45 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.918 -1.037 . . . . 1.75 108.438 177.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.586 ' HB3' HG22 ' A' ' 101' ' ' ILE . 15.5 p90 -160.29 175.37 12.93 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.898 0.703 . . . . 0.32 112.898 -178.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.445 ' HE2' ' HD2' ' A' ' 23' ' ' PRO . 24.5 tttm -121.93 116.77 24.96 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.006 -0.997 . . . . 2.15 109.413 178.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.497 HG13 ' HE1' ' A' ' 99' ' ' TRP . 60.7 t -77.87 126.17 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 113.188 0.81 . . . . 0.3 113.188 -178.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.422 HD12 HG22 ' A' ' 98' ' ' THR . 83.5 mt -101.9 -65.69 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.562 -0.745 . . . . 0.65 110.733 178.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -148.39 80.63 1.46 Allowed 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 120.845 0.355 . . . . 1.03 111.002 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.543 ' HB2' ' NE1' ' A' ' 99' ' ' TRP . 38.9 t -106.96 146.14 31.43 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.254 -0.43 . . . . 1.5 111.968 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 99.27 100.38 2.25 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.834 -0.698 . . . . 1.09 113.135 178.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -177.93 -57.39 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 120.671 0.272 . . . . 1.7 111.617 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.27 165.47 31.45 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.833 -0.699 . . . . 0.35 114.073 -178.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.644 HG12 ' H ' ' A' ' 44' ' ' LYS . 2.7 t -90.5 175.34 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 123.324 0.65 . . . . 1.42 109.733 179.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.644 ' H ' HG12 ' A' ' 43' ' ' VAL . 18.5 ptmt 164.65 156.87 0.07 OUTLIER Pre-proline 0 N--CA 1.47 0.557 0 CA-C-O 121.475 0.655 . . . . 2.18 112.324 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.46 ' HD2' ' HB2' ' A' ' 49' ' ' ASP . 2.1 Cg_endo -84.43 174.25 8.04 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 124.908 3.739 . . . . 0.3 113.21 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.51 ' O ' ' N ' ' A' ' 48' ' ' SER . . . -67.47 -172.03 5.72 Favored Glycine 0 C--O 1.225 -0.42 0 CA-C-N 115.326 -0.852 . . . . 0.35 111.356 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.561 ' HG2' ' HB2' ' A' ' 91' ' ' GLN . 33.9 mtmm -41.26 -13.18 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 113.499 0.926 . . . . 2.35 113.499 -177.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.51 ' N ' ' O ' ' A' ' 46' ' ' GLY . 47.2 t -85.75 7.08 25.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.085 0.469 . . . . 1.45 110.313 178.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.46 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 3.5 p30 -77.34 150.32 35.19 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.568 -0.742 . . . . 1.73 112.048 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 86.1 m -126.47 119.25 26.74 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.657 -0.868 . . . . 0.44 108.657 178.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.517 HG12 ' HA ' ' A' ' 133' ' ' VAL . 12.2 m -124.34 158.47 31.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.443 0.534 . . . . 0.65 112.443 -178.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 83.7 m -112.65 120.89 43.09 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.748 -0.834 . . . . 0.32 108.748 178.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.747 HG11 HD22 ' A' ' 130' ' ' LEU . 12.3 m -141.9 179.85 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.393 0.616 . . . . 0.24 112.043 -178.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -127.09 132.34 50.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.149 -0.932 . . . . 2.4 109.236 178.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -146.49 161.1 41.17 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.614 0.721 . . . . 0.26 112.184 -179.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 57.9 m -126.99 112.34 15.13 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.621 -1.172 . . . . 0.26 108.677 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.48 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -111.41 146.25 17.78 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.045 -1.074 . . . . 0.12 112.986 -178.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.49 ' NE ' HD13 ' A' ' 125' ' ' ILE . 3.2 ppt_? -148.03 148.4 30.65 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.817 0.342 . . . . 1.93 110.17 179.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.401 ' C ' ' N ' ' A' ' 61' ' ' ASP . 19.3 mt -77.51 160.87 28.34 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.102 -0.499 . . . . 1.21 109.991 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.499 ' HB ' ' O ' ' A' ' 123' ' ' THR . 8.0 tp -59.1 -11.43 2.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.211 -0.662 . . . . 0.64 109.211 178.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.401 ' N ' ' C ' ' A' ' 59' ' ' LEU . 8.1 m-20 -65.69 -11.31 44.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.081 -0.963 . . . . 2.01 110.774 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.46 -0.85 78.34 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.665 -0.779 . . . . 0.45 113.531 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.8 t -118.53 138.45 52.52 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 117.227 0.514 . . . . 1.4 111.579 -178.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 57' ' ' GLY . 6.0 p -64.2 133.15 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 115.822 -0.626 . . . . 0.28 110.147 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.598 ' HD1' ' N ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -97.49 -22.53 16.5 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.09 -0.505 . . . . 0.24 110.739 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.598 ' N ' ' HD1' ' A' ' 65' ' ' PHE . 19.8 t70 -175.68 130.15 0.26 Allowed 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.262 -0.426 . . . . 0.3 110.649 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 70.2 p -126.61 123.99 38.9 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.28 -0.418 . . . . 1.3 110.721 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.493 HG21 ' HB2' ' A' ' 75' ' ' ALA . 70.8 p -90.55 -41.05 11.6 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.381 -0.372 . . . . 0.34 111.002 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -70.87 -35.6 72.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 2.11 111.147 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.9 tmtm? -63.03 -51.49 66.57 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.365 -0.379 . . . . 3.41 110.857 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 77.1 p -58.63 -19.56 40.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.29 -0.414 . . . . 1.47 111.099 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.09 10.36 58.61 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.799 -0.715 . . . . 0.7 112.437 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -115.53 116.68 41.18 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.535 0.167 . . . . 3.05 110.678 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -58.88 144.97 98.44 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.274 1.983 . . . . 0.51 112.085 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.493 ' HB2' HG21 ' A' ' 68' ' ' THR . . . -94.6 124.25 38.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.206 -0.452 . . . . 0.23 111.038 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.2 t -126.18 120.18 29.42 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.33 -0.395 . . . . 1.26 110.767 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -158.04 169.13 25.25 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.263 0.554 . . . . 0.36 111.863 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.641 HE21 ' N ' ' A' ' 79' ' ' VAL . 3.9 tp60 -87.96 145.29 26.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.32 -0.854 . . . . 1.58 109.168 178.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.641 ' N ' HE21 ' A' ' 78' ' ' GLN . 26.1 m -79.71 -27.42 12.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 113.111 0.782 . . . . 1.07 113.111 -177.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.56 ' H ' HE21 ' A' ' 78' ' ' GLN . 80.3 p -85.84 -2.08 57.89 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 111.743 0.275 . . . . 1.14 111.743 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.42 ' NE2' ' HG2' ' A' ' 78' ' ' GLN . 1.2 mp0 -93.88 5.88 50.22 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.546 0.573 . . . . 2.08 112.546 -178.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.43 HG21 ' HE3' ' A' ' 86' ' ' TRP . 0.0 OUTLIER -110.6 -175.04 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 N-CA-C 112.244 0.461 . . . . 0.45 112.244 -179.69 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.563 HG13 ' H ' ' A' ' 86' ' ' TRP . 34.3 pt -56.32 158.17 8.09 Favored Pre-proline 0 N--CA 1.462 0.17 0 CA-C-N 115.962 -0.563 . . . . 0.75 112.212 -179.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.434 ' HD2' ' HB ' ' A' ' 83' ' ' ILE . 6.2 Cg_endo -48.71 -50.28 12.87 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.868 2.379 . . . . 0.65 112.553 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.68 ' HA2' HD11 ' A' ' 32' ' ' LEU . . . -57.86 -49.11 77.43 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.671 -0.776 . . . . 0.31 113.411 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . 0.563 ' H ' HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -62.51 -53.39 55.41 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.518 0.562 . . . . 0.78 112.518 -178.457 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.0 t -52.9 -33.38 50.1 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.739 0.274 . . . . 1.4 111.739 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -68.99 -50.71 46.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.528 -0.305 . . . . 1.43 111.726 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.662 ' HB2' HD22 ' A' ' 32' ' ' LEU . . . -64.16 -45.46 88.34 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.932 0.345 . . . . 0.33 111.932 -179.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.486 HD13 ' SD ' ' A' ' 93' ' ' MET . 4.3 mm? -56.59 -30.43 63.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.387 -0.369 . . . . 0.39 111.483 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.561 ' HB2' ' HG2' ' A' ' 47' ' ' LYS . 7.8 tt0 -64.82 -23.93 67.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.404 -0.362 . . . . 1.87 111.15 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.419 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 9.1 mp -95.79 -7.84 36.0 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.145 -0.48 . . . . 1.31 111.582 -179.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.486 ' SD ' HD13 ' A' ' 90' ' ' LEU . 60.4 mtt -88.79 107.79 19.48 Favored Pre-proline 0 N--CA 1.452 -0.344 0 CA-C-N 116.719 -0.219 . . . . 1.66 111.517 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.45 ' HA ' ' CD ' ' A' ' 44' ' ' LYS . 95.7 Cg_endo -79.86 145.27 17.73 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.651 2.234 . . . . 0.44 111.817 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.627 ' HB1' ' HA ' ' A' ' 132' ' ' SER . . . -46.94 127.27 9.89 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 120.649 0.262 . . . . 0.36 110.973 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 96.71 -5.39 64.24 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 120.689 -0.767 . . . . 0.34 112.997 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.418 ' OG ' ' N ' ' A' ' 98' ' ' THR . 11.2 t -74.78 177.8 5.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.837 0.351 . . . . 1.41 111.117 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.422 HG22 HD12 ' A' ' 37' ' ' ILE . 18.8 m -151.38 92.86 1.83 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.045 -0.525 . . . . 0.23 110.444 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.543 ' NE1' ' HB2' ' A' ' 39' ' ' SER . 24.2 m0 -116.6 149.18 40.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.171 0.51 . . . . 0.53 111.867 -179.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -120.99 108.03 13.37 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.758 -1.201 . . . . 1.37 107.758 176.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.586 HG22 ' HB3' ' A' ' 34' ' ' TYR . 46.2 pt -107.6 139.44 29.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 113.112 0.782 . . . . 0.25 113.112 -177.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.463 ' OH ' HG22 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -117.89 103.9 10.41 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.734 -1.21 . . . . 0.31 107.734 177.294 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 39.6 t -97.84 105.53 27.85 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 113.39 0.885 . . . . 0.52 113.39 -176.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.484 ' HA ' HG23 ' A' ' 123' ' ' THR . 33.4 Cg_exo -59.84 151.17 73.03 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.344 2.029 . . . . 0.48 111.392 177.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.576 ' HB2' ' HA3' ' A' ' 110' ' ' GLY . 2.5 p -48.31 -43.13 32.78 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 111.969 0.359 . . . . 1.81 111.969 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -57.21 -8.85 3.7 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 114.328 0.491 . . . . 0.4 114.328 -178.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.42 HD12 ' HA3' ' A' ' 85' ' ' GLY . 0.1 OUTLIER -84.57 -25.66 28.52 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.542 0.571 . . . . 2.35 112.542 -178.294 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.443 ' HB2' HD12 ' A' ' 83' ' ' ILE . . . -127.73 -125.11 0.23 Allowed 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 121.033 -0.267 . . . . 1.03 111.288 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.499 ' HB2' ' H ' ' A' ' 116' ' ' GLY . 47.2 m-85 -89.51 4.63 48.62 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 121.133 0.492 . . . . 1.44 110.408 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.576 ' HA3' ' HB2' ' A' ' 105' ' ' SER . . . -37.5 -78.48 0.05 OUTLIER Glycine 0 CA--C 1.525 0.712 0 CA-C-N 115.134 -0.939 . . . . 1.58 114.983 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.451 ' HA ' ' OD1' ' A' ' 121' ' ' ASN . 12.0 Cg_endo -56.19 -12.75 8.22 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.252 2.634 . . . . 1.49 113.405 -178.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.423 ' C ' ' H ' ' A' ' 114' ' ' VAL . 3.3 mmp_? -82.39 139.75 33.87 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.888 -0.412 . . . . 3.51 109.888 178.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 36.1 t -62.18 -4.51 1.77 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.105 0.479 . . . . 1.63 110.607 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.423 ' H ' ' C ' ' A' ' 112' ' ' ARG . 6.4 t -111.09 55.21 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.453 -0.794 . . . . 2.9 110.577 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -53.48 115.9 5.27 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.803 -0.713 . . . . 1.05 112.651 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.499 ' H ' ' HB2' ' A' ' 109' ' ' TYR . . . -71.44 -125.51 0.06 OUTLIER Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.769 -0.729 . . . . 0.8 112.142 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.54 -35.94 98.01 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.008 1.806 . . . . 0.7 111.882 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.604 HG13 HD22 ' A' ' 124' ' ' LEU . 3.4 mp -91.88 131.19 39.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 1.25 109.993 178.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -47.95 153.9 1.62 Allowed Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.934 -0.651 . . . . 0.48 112.515 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.441 ' O ' ' HG3' ' A' ' 122' ' ' GLU . 29.1 Cg_endo -62.44 130.28 29.55 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.102 1.868 . . . . 0.67 111.655 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.451 ' OD1' ' HA ' ' A' ' 111' ' ' PRO . 3.1 m-80 47.63 35.13 4.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.959 -0.564 . . . . 1.12 110.24 -179.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.568 ' HG2' ' HB3' ' A' ' 8' ' ' ASN . 43.1 mt-10 -115.23 132.55 56.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.831 -0.622 . . . . 1.73 111.279 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.499 ' O ' ' HB ' ' A' ' 60' ' ' ILE . 87.6 m -95.11 127.53 41.23 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.929 -0.767 . . . . 0.29 108.929 178.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.604 HD22 HG13 ' A' ' 118' ' ' ILE . 6.5 mp -116.72 157.81 24.86 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.197 0.522 . . . . 1.47 112.092 -178.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.49 ' N ' HD12 ' A' ' 125' ' ' ILE . 4.5 mp -114.21 142.87 25.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.438 -0.801 . . . . 0.2 109.617 178.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -135.35 132.26 37.41 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.089 0.471 . . . . 0.24 111.717 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 24.4 tptm -108.67 103.55 12.67 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.565 -0.902 . . . . 2.28 108.565 178.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 9.1 mt -102.76 122.38 55.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 113.007 0.743 . . . . 0.82 113.007 -177.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -116.89 100.31 7.68 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.378 -0.971 . . . . 0.26 108.378 177.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.747 HD22 HG11 ' A' ' 53' ' ' VAL . 0.2 OUTLIER -77.95 121.32 24.02 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.926 -0.579 . . . . 1.41 111.545 -178.042 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 48.3 mm -93.47 -57.45 4.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.018 -0.537 . . . . 1.17 110.092 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.627 ' HA ' ' HB1' ' A' ' 95' ' ' ALA . 59.8 p -164.67 163.11 21.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.108 -0.496 . . . . 1.17 111.449 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.517 ' HA ' HG12 ' A' ' 51' ' ' VAL . 11.0 p -107.74 135.14 47.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.691 -0.686 . . . . 1.43 110.094 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.504 ' HE3' ' H ' ' A' ' 137' ' ' SER . 58.9 pttt 38.5 -149.07 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 O-C-N 123.243 0.339 . . . . 3.08 111.234 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.414 ' HD2' ' N ' ' A' ' 135' ' ' LYS . 1.0 OUTLIER -78.21 13.48 1.47 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.058 0.456 . . . . 3.16 110.261 179.133 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.404 ' H ' ' C ' ' A' ' 134' ' ' LYS . 47.2 t 65.43 67.03 0.51 Allowed 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.487 -0.778 . . . . 1.31 110.925 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.504 ' H ' ' HE3' ' A' ' 134' ' ' LYS . 35.8 m . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.213 -0.899 . . . . 2.53 110.863 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 120.847 0.356 . . . . 3.09 110.889 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -68.47 -18.61 64.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.105 -0.498 . . . . 2.08 111.103 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.438 ' HB3' ' NZ ' ' A' ' 3' ' ' LYS . 8.2 mtpm? -57.45 -40.86 79.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.21 0.528 . . . . 3.23 109.823 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -79.98 -37.17 34.89 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.633 -0.712 . . . . 2.63 110.367 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -55.5 -51.68 66.19 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.014 -0.539 . . . . 0.82 110.169 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -67.38 -36.52 81.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.842 -0.617 . . . . 2.57 109.93 179.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -56.34 -32.8 65.04 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.119 -0.697 . . . . 2.1 109.119 178.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.491 ' HA ' ' HG2' ' A' ' 11' ' ' LYS . 50.3 m-20 -72.72 -38.51 67.44 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.276 -0.875 . . . . 1.4 110.63 179.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -56.31 -37.83 70.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.008 -0.542 . . . . 2.67 111.595 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.9 t -77.69 -52.54 16.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 112.047 0.388 . . . . 1.27 112.047 -179.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.526 ' HE2' HG13 ' A' ' 60' ' ' ILE . 21.3 ptmt -61.13 -29.72 69.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.544 -0.298 . . . . 1.69 111.683 -179.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.26 -52.88 5.9 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.569 -0.824 . . . . 0.31 112.005 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -63.98 -26.59 68.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.968 0.413 . . . . 2.39 110.406 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.0 -39.31 50.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.958 -0.565 . . . . 0.23 110.53 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -59.13 -51.03 71.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.992 -0.549 . . . . 0.23 110.324 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.518 ' HA ' ' HB3' ' A' ' 19' ' ' ASN . 4.2 pp -64.9 -34.44 78.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.309 -0.405 . . . . 0.55 110.577 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.2 m -57.5 -48.8 78.28 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.211 -0.449 . . . . 0.27 110.201 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -73.2 -32.05 64.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.81 -0.632 . . . . 2.47 109.986 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.518 ' HB3' ' HA ' ' A' ' 16' ' ' LEU . 0.8 OUTLIER -57.58 -27.39 62.66 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.53 -0.759 . . . . 0.22 111.317 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.1 mttm -46.71 -19.85 0.11 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.302 -0.408 . . . . 2.45 111.884 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.72 HD22 ' N ' ' A' ' 21' ' ' ASN . 0.7 OUTLIER -68.58 -30.26 68.98 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.469 0.544 . . . . 0.4 112.469 -178.491 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.679 ' O ' HG23 ' A' ' 25' ' ' VAL . 18.6 mmtp -53.75 118.76 16.01 Favored Pre-proline 0 N--CA 1.464 0.246 0 C-N-CA 121.245 -0.182 . . . . 1.4 110.766 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.28 140.73 95.48 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.343 2.029 . . . . 0.65 112.523 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.91 3.84 79.47 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.743 -0.742 . . . . 0.37 114.318 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 22' ' ' LYS . 7.0 t -52.4 112.21 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 117.602 0.701 . . . . 0.91 110.667 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -118.93 131.03 72.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.904 -0.589 . . . . 1.03 111.669 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.2 t -89.27 132.85 32.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.777 -0.647 . . . . 0.91 110.49 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.594 HD12 ' HB2' ' A' ' 32' ' ' LEU . 66.1 mt -94.71 163.48 22.36 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.406 -0.361 . . . . 0.4 110.925 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -51.81 -30.66 39.05 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.25 1.967 . . . . 0.59 112.019 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.486 ' O ' HD11 ' A' ' 107' ' ' LEU . 1.8 m -85.49 -13.28 49.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.114 -0.494 . . . . 1.14 111.36 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.646 ' HA3' HD21 ' A' ' 107' ' ' LEU . . . 104.84 15.79 19.21 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.134 -1.031 . . . . 0.34 113.874 179.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.594 ' HB2' HD12 ' A' ' 28' ' ' LEU . 2.4 mp -83.34 138.74 33.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.373 0.606 . . . . 1.35 112.243 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -119.22 138.93 52.64 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.158 -0.928 . . . . 1.75 108.623 177.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.581 ' HB3' HG22 ' A' ' 101' ' ' ILE . 16.8 p90 -160.61 175.52 12.59 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.206 0.527 . . . . 0.32 112.301 -178.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -121.45 117.08 25.98 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.37 -0.832 . . . . 2.15 109.591 178.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.45 HG13 ' HE1' ' A' ' 99' ' ' TRP . 67.8 t -73.49 125.97 33.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 113.473 0.916 . . . . 0.3 113.473 -178.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 63.2 mt -103.63 -66.7 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.434 -0.803 . . . . 0.65 110.049 178.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 37.7 t30 -130.96 91.92 3.13 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 116.337 -0.392 . . . . 1.03 110.164 178.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.745 ' HB3' ' HE1' ' A' ' 99' ' ' TRP . 96.3 p -105.41 144.83 31.64 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.204 0.446 . . . . 1.5 112.204 -178.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.516 ' HA2' ' HG3' ' A' ' 94' ' ' PRO . . . 80.44 98.55 0.33 Allowed Glycine 0 C--N 1.332 0.351 0 CA-C-N 115.823 -0.626 . . . . 1.09 113.141 178.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -151.48 -82.29 0.1 Allowed 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 111.75 0.278 . . . . 1.7 111.75 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.47 -178.83 42.56 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 121.142 -0.551 . . . . 0.35 114.098 -178.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.463 ' O ' ' HB3' ' A' ' 44' ' ' LYS . 0.2 OUTLIER -90.32 177.73 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 123.667 0.787 . . . . 1.42 110.439 178.937 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.517 ' HB3' HG11 ' A' ' 133' ' ' VAL . 0.0 OUTLIER 165.92 155.24 0.09 OUTLIER Pre-proline 0 N--CA 1.47 0.545 0 CA-C-O 121.668 0.747 . . . . 2.18 112.419 -179.681 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.449 ' HD2' HG21 ' A' ' 133' ' ' VAL . 2.3 Cg_endo -85.72 173.39 7.28 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 125.102 3.868 . . . . 0.3 113.39 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.493 ' O ' ' N ' ' A' ' 48' ' ' SER . . . -68.1 -172.57 6.85 Favored Glycine 0 C--O 1.225 -0.461 0 CA-C-N 115.109 -0.95 . . . . 0.35 111.453 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.497 ' O ' HG13 ' A' ' 79' ' ' VAL . 55.8 mttp -41.71 -13.22 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 113.603 0.964 . . . . 2.35 113.603 -178.058 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.493 ' N ' ' O ' ' A' ' 46' ' ' GLY . 39.2 t -86.45 6.92 28.04 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.065 0.46 . . . . 1.45 110.625 178.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.435 ' CB ' ' HD2' ' A' ' 45' ' ' PRO . 3.1 p30 -76.63 155.88 33.13 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.776 -0.647 . . . . 1.73 111.487 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.564 ' HB ' ' HG2' ' A' ' 134' ' ' LYS . 33.1 m -125.07 122.27 36.74 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.347 -0.983 . . . . 0.44 108.347 178.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.0 m -126.78 151.34 33.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 112.826 0.676 . . . . 0.65 112.826 -177.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 95.5 m -114.1 120.96 42.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.05 -0.977 . . . . 0.32 109.152 178.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.484 HG12 ' HA ' ' A' ' 130' ' ' LEU . 3.1 m -142.13 176.88 3.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.149 0.5 . . . . 0.24 111.742 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -126.15 132.03 51.92 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.462 -0.79 . . . . 2.4 108.969 178.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -145.56 165.37 28.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.606 0.717 . . . . 0.26 112.125 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 88.5 m -130.02 113.47 14.6 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.606 -1.179 . . . . 0.26 108.491 178.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.442 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -110.62 144.32 17.15 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 119.838 -1.173 . . . . 0.12 113.065 -178.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.531 ' NH2' ' HA2' ' A' ' 62' ' ' GLY . 0.1 OUTLIER -147.47 146.83 29.67 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.794 0.331 . . . . 1.93 110.192 179.037 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.454 ' HA ' ' HG ' ' A' ' 124' ' ' LEU . 9.8 mt -80.14 157.67 26.55 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.196 -0.456 . . . . 1.21 110.327 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.526 HG13 ' HE2' ' A' ' 11' ' ' LYS . 9.7 tp -59.1 -10.93 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.41 -0.589 . . . . 0.64 109.41 178.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -66.39 -9.76 36.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.281 -0.872 . . . . 2.01 110.673 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.531 ' HA2' ' NH2' ' A' ' 58' ' ' ARG . . . 90.98 -0.23 75.73 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.516 -0.85 . . . . 0.45 113.317 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.5 t -121.51 138.71 54.18 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 117.357 0.578 . . . . 1.4 111.702 -178.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 57' ' ' GLY . 5.3 p -66.86 133.34 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-N 115.654 -0.703 . . . . 0.28 109.979 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.673 ' HD1' ' H ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -97.93 -27.25 14.35 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.271 -0.422 . . . . 0.24 111.523 -179.74 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.673 ' H ' ' HD1' ' A' ' 65' ' ' PHE . 25.0 t70 -177.25 130.74 0.17 Allowed 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 116.709 -0.223 . . . . 0.3 110.564 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 68.0 m -134.61 124.51 25.52 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.791 0.329 . . . . 1.3 111.12 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.575 HG21 ' HB2' ' A' ' 75' ' ' ALA . 80.9 p -86.14 -12.99 48.47 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.072 0.463 . . . . 0.34 110.391 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.89 -48.28 25.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.705 -0.68 . . . . 2.11 111.303 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -64.57 -37.86 89.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.111 -0.495 . . . . 3.41 111.418 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 62.9 p -60.23 -14.58 18.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.47 -0.332 . . . . 1.47 111.405 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.92 8.02 88.05 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.779 -0.724 . . . . 0.7 112.624 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -123.44 118.35 27.6 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 120.268 0.08 . . . . 3.05 110.874 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.62 150.05 45.82 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.42 2.08 . . . . 0.51 112.447 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.575 ' HB2' HG21 ' A' ' 68' ' ' THR . . . -94.76 126.65 40.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 0.23 111.344 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 78.7 m -118.51 115.72 25.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.388 -0.369 . . . . 1.26 110.901 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -150.58 148.66 28.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.309 -0.405 . . . . 0.36 111.396 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.55 HE21 ' H ' ' A' ' 80' ' ' SER . 0.0 OUTLIER -81.78 141.77 33.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.819 -0.628 . . . . 1.58 110.107 179.364 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.596 HG23 ' HB2' ' A' ' 90' ' ' LEU . 2.6 p -64.26 -24.95 36.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.273 -0.421 . . . . 1.07 112.126 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.55 ' H ' HE21 ' A' ' 78' ' ' GLN . 47.3 t -90.93 -9.72 45.1 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.718 0.266 . . . . 1.14 111.718 -179.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -91.99 5.8 48.77 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.991 0.367 . . . . 2.08 111.991 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 10.5 m -116.24 -178.46 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 112.279 0.474 . . . . 0.45 112.279 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.516 ' O ' HG23 ' A' ' 87' ' ' THR . 24.8 pt -56.6 155.87 13.29 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 115.915 -0.584 . . . . 0.75 112.035 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -48.16 -60.24 0.95 Allowed 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.211 2.607 . . . . 0.65 113.168 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.504 ' C ' HD21 ' A' ' 32' ' ' LEU . . . -44.39 -48.82 8.5 Favored Glycine 0 CA--C 1.522 0.497 0 C-N-CA 120.596 -0.812 . . . . 0.31 112.17 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 1.1 m0 -62.44 -36.63 83.02 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.014 0.375 . . . . 0.78 112.014 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.516 HG23 ' O ' ' A' ' 83' ' ' ILE . 30.5 p -58.7 -40.21 83.0 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 121.03 -0.268 . . . . 1.4 111.609 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -70.46 -51.67 27.54 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.494 0.553 . . . . 1.43 112.494 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.79 -52.41 51.05 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.381 0.511 . . . . 0.33 112.381 -178.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.596 ' HB2' HG23 ' A' ' 79' ' ' VAL . 4.2 mm? -57.6 -25.72 60.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.334 -0.394 . . . . 0.39 111.779 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 21.5 tm0? -81.58 -19.36 42.14 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.754 0.279 . . . . 1.87 111.754 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 98.2 mt -90.25 -22.16 21.76 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.77 0.285 . . . . 1.31 111.77 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.537 ' SD ' HD13 ' A' ' 90' ' ' LEU . 15.4 ptp -81.75 121.01 79.11 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-O 120.555 0.217 . . . . 1.66 111.511 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.516 ' HG3' ' HA2' ' A' ' 40' ' ' GLY . 92.8 Cg_endo -80.4 147.51 18.04 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.767 2.312 . . . . 0.44 111.791 179.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.635 ' HB1' ' HA ' ' A' ' 132' ' ' SER . . . -45.79 126.46 7.12 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.707 0.289 . . . . 0.36 111.151 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 97.84 -2.38 60.14 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 120.82 -0.705 . . . . 0.34 113.024 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.433 ' OG ' ' HB2' ' A' ' 93' ' ' MET . 83.0 p -79.42 -174.47 4.24 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.934 0.397 . . . . 1.41 111.563 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.5 m -159.89 105.79 1.59 Allowed 'General case' 0 C--O 1.231 0.085 0 CA-C-N 116.029 -0.532 . . . . 0.23 111.001 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.745 ' HE1' ' HB3' ' A' ' 39' ' ' SER . 40.0 m0 -126.9 149.37 49.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.04 0.448 . . . . 0.53 111.781 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -117.8 107.91 14.71 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 107.847 -1.168 . . . . 1.37 107.847 177.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.581 HG22 ' HB3' ' A' ' 34' ' ' TYR . 43.3 pt -109.35 140.05 29.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 113.515 0.932 . . . . 0.25 113.515 -177.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -116.41 103.57 10.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.76 -1.109 . . . . 0.31 108.031 177.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.546 HG22 HD23 ' A' ' 32' ' ' LEU . 9.6 t -102.53 102.74 27.67 Favored Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 113.191 0.812 . . . . 0.52 113.191 -177.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -62.0 151.73 79.67 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.101 1.868 . . . . 0.48 110.774 177.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -48.34 -42.5 31.54 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 111.883 0.327 . . . . 1.81 111.883 -179.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -57.27 -10.07 5.06 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.982 -0.628 . . . . 0.4 113.315 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.646 HD21 ' HA3' ' A' ' 31' ' ' GLY . 0.2 OUTLIER -103.6 -15.89 15.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.766 0.317 . . . . 2.35 111.504 -179.575 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -109.19 -104.17 0.37 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.503 -0.317 . . . . 1.03 111.173 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -89.42 -17.43 28.78 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.836 0.35 . . . . 1.44 110.73 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 102.76 151.52 23.38 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.949 -0.644 . . . . 1.58 114.332 178.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.486 ' HA ' ' H ' ' A' ' 121' ' ' ASN . 19.4 Cg_endo -58.62 -6.52 3.31 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.846 3.031 . . . . 1.49 113.262 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.546 ' C ' ' H ' ' A' ' 114' ' ' VAL . 99.3 mtt180 -74.87 170.61 15.59 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.799 0.333 . . . . 3.51 110.88 -178.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 78.4 p -63.0 11.85 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.947 -0.57 . . . . 1.63 112.0 -179.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.546 ' H ' ' C ' ' A' ' 112' ' ' ARG . 30.0 m -102.53 19.51 3.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.902 0.382 . . . . 2.9 110.692 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -62.42 103.91 0.68 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.906 -0.664 . . . . 1.05 112.13 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.22 -110.0 0.01 OUTLIER Glycine 0 CA--C 1.52 0.39 0 C-N-CA 120.862 -0.685 . . . . 0.8 112.4 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -62.95 -34.93 69.42 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.138 1.892 . . . . 0.7 111.573 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.611 HG23 HD12 ' A' ' 124' ' ' LEU . 92.8 mt -90.75 124.18 43.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.753 -0.658 . . . . 1.25 110.261 179.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.404 ' H ' HD21 ' A' ' 59' ' ' LEU . . . -48.56 156.59 1.21 Allowed Glycine 0 C--N 1.331 0.304 0 CA-C-N 116.097 -0.501 . . . . 0.48 113.048 -179.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -62.05 131.43 34.72 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.373 2.048 . . . . 0.67 111.653 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.486 ' H ' ' HA ' ' A' ' 111' ' ' PRO . 5.1 m-80 50.14 34.41 8.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.272 -0.422 . . . . 1.12 110.259 -178.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -115.91 127.11 54.74 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.341 -0.39 . . . . 1.73 111.738 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.492 ' O ' ' HB ' ' A' ' 60' ' ' ILE . 97.3 m -90.72 128.63 36.73 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.376 -0.972 . . . . 0.29 108.376 177.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.611 HD12 HG23 ' A' ' 118' ' ' ILE . 0.1 OUTLIER -113.35 156.45 23.39 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.829 0.677 . . . . 1.47 112.829 -177.577 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 5.1 mp -114.78 138.41 45.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 114.973 -1.012 . . . . 0.2 109.228 177.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.485 ' CE1' HD22 ' A' ' 124' ' ' LEU . 68.7 m-85 -131.51 132.47 44.22 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.95 0.405 . . . . 0.24 111.893 -178.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -109.12 103.62 12.66 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.521 -0.918 . . . . 2.28 108.521 178.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 19.6 mt -104.11 122.92 57.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 112.974 0.731 . . . . 0.82 112.974 -177.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -118.43 99.29 6.73 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.508 -0.923 . . . . 0.26 108.508 177.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.484 ' HA ' HG12 ' A' ' 53' ' ' VAL . 20.2 tp -79.56 120.24 23.64 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.889 -0.596 . . . . 1.41 111.365 -178.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 50.1 mm -89.75 -56.45 5.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.895 -0.593 . . . . 1.17 110.561 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.635 ' HA ' ' HB1' ' A' ' 95' ' ' ALA . 2.1 m -161.11 165.4 29.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.203 -0.453 . . . . 1.17 110.802 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.571 HG22 ' HG3' ' A' ' 134' ' ' LYS . 7.2 p -111.66 121.38 64.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.048 -0.524 . . . . 1.43 111.663 -179.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.571 ' HG3' HG22 ' A' ' 133' ' ' VAL . 34.0 mtpt 43.42 65.72 0.93 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.908 -0.587 . . . . 3.08 111.097 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 95.5 mttt 59.53 30.84 20.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.904 -0.589 . . . . 3.16 111.09 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 42.0 t 55.86 65.2 1.51 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.884 -0.598 . . . . 1.31 111.096 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 58.7 m . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.211 -0.9 . . . . 2.53 110.871 179.97 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.81 0.338 . . . . 3.09 110.921 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -69.26 -22.6 63.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.433 . . . . 2.08 111.136 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.599 ' H ' ' HD3' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -61.85 -38.96 90.16 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.232 -0.655 . . . . 3.23 109.232 178.773 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.449 ' N ' ' HG2' ' A' ' 3' ' ' LYS . 88.4 tttt -80.0 -34.97 38.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.463 -0.79 . . . . 2.63 109.936 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.37 -41.74 98.86 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.718 -0.674 . . . . 0.82 110.428 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -74.83 -31.5 61.69 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.261 -0.427 . . . . 2.57 110.419 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.464 ' HG3' ' HE3' ' A' ' 11' ' ' LYS . 9.6 tp10 -55.93 -40.75 73.59 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.767 -0.457 . . . . 2.1 109.767 179.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.534 ' HA ' ' HG2' ' A' ' 11' ' ' LYS . 25.7 p30 -78.64 -29.28 45.71 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.193 -0.458 . . . . 1.4 110.44 179.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 121' ' ' ASN . 64.5 tttp -61.16 -39.57 90.6 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.104 -0.498 . . . . 2.67 111.125 178.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.489 HG23 ' N ' ' A' ' 11' ' ' LYS . 27.4 m -77.46 -50.63 19.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 112.462 0.541 . . . . 1.27 112.462 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.534 ' HG2' ' HA ' ' A' ' 8' ' ' ASN . 19.5 ptpt -64.95 -26.63 68.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.626 0.25 . . . . 1.69 111.359 -179.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -75.05 -53.74 6.06 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.648 -0.787 . . . . 0.31 112.206 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -63.52 -24.98 68.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.052 0.453 . . . . 2.39 110.384 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.96 -42.38 33.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.795 -0.638 . . . . 0.23 110.915 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -57.46 -48.47 79.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.202 -0.454 . . . . 0.23 110.578 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.545 ' HA ' ' HB3' ' A' ' 19' ' ' ASN . 4.3 pp -67.64 -35.88 79.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.295 -0.411 . . . . 0.55 110.74 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.412 ' O ' ' HD3' ' A' ' 20' ' ' LYS . 12.1 m -57.57 -48.34 79.63 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.114 0.483 . . . . 0.27 109.854 178.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -72.28 -31.79 66.05 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.821 -0.627 . . . . 2.47 109.809 178.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.545 ' HB3' ' HA ' ' A' ' 16' ' ' LEU . 0.8 OUTLIER -58.41 -27.09 63.98 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.744 -0.662 . . . . 0.22 111.378 179.902 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.412 ' HD3' ' O ' ' A' ' 17' ' ' THR . 55.3 mtpt -46.02 -20.0 0.08 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.423 -0.353 . . . . 2.45 111.659 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.713 HD22 ' N ' ' A' ' 21' ' ' ASN . 0.7 OUTLIER -70.6 -33.16 70.74 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.346 0.499 . . . . 0.4 112.346 -179.218 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.525 ' HG2' ' O ' ' A' ' 19' ' ' ASN . 44.3 mmtt -43.09 118.25 2.42 Favored Pre-proline 0 N--CA 1.467 0.377 0 CA-C-N 116.77 -0.196 . . . . 1.4 111.373 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.448 ' HD2' ' HE2' ' A' ' 35' ' ' LYS . 18.8 Cg_endo -58.0 133.2 54.15 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.607 2.205 . . . . 0.65 112.44 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.69 1.58 85.26 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.754 -0.736 . . . . 0.37 113.177 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' A' ' 34' ' ' TYR . 7.4 p -60.3 114.48 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 121.205 0.526 . . . . 0.91 110.519 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.1 p -128.06 141.14 47.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.763 -0.653 . . . . 1.03 111.291 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.5 p -89.51 140.59 15.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.13 -0.486 . . . . 0.91 111.032 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.589 HD12 ' HB2' ' A' ' 32' ' ' LEU . 73.7 mt -96.92 167.61 11.75 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.036 -0.529 . . . . 0.4 110.845 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.473 ' HD2' ' HB3' ' A' ' 28' ' ' LEU . 71.8 Cg_exo -52.25 -31.28 45.67 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 121.878 1.719 . . . . 0.59 111.388 178.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.1 m -86.38 -11.83 50.92 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.842 -0.617 . . . . 1.14 111.142 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.453 ' O ' HD21 ' A' ' 107' ' ' LEU . . . 103.28 13.32 28.95 Favored Glycine 0 CA--C 1.521 0.446 0 C-N-CA 120.483 -0.865 . . . . 0.34 114.885 178.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.589 ' HB2' HD12 ' A' ' 28' ' ' LEU . 4.0 mp -83.44 134.86 34.85 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 117.882 0.841 . . . . 1.35 112.762 -178.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -114.4 140.69 48.47 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.065 -1.087 . . . . 1.75 108.065 177.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.727 ' HB3' HG22 ' A' ' 101' ' ' ILE . 36.9 p90 -155.16 176.03 13.07 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 113.206 0.817 . . . . 0.32 113.206 -177.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.448 ' HE2' ' HD2' ' A' ' 23' ' ' PRO . 33.8 tttm -120.75 116.89 26.12 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.012 -0.995 . . . . 2.15 109.2 178.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.514 HG13 ' HE1' ' A' ' 99' ' ' TRP . 36.2 t -73.27 126.59 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 113.346 0.869 . . . . 0.3 113.346 -177.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.571 HD12 HG22 ' A' ' 98' ' ' THR . 72.6 mt -104.6 -64.1 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 115.436 -0.802 . . . . 0.65 110.672 178.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.418 ' O ' ' HA ' ' A' ' 97' ' ' SER . 9.7 t30 -151.26 78.6 1.28 Allowed 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.653 0.263 . . . . 1.03 110.819 179.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.462 ' HB3' ' NE1' ' A' ' 99' ' ' TRP . 79.3 p -106.45 146.13 30.92 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.964 0.411 . . . . 1.5 112.076 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 97.55 99.71 2.03 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 121.025 -0.607 . . . . 1.09 113.026 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -176.48 -62.1 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 111.776 0.287 . . . . 1.7 111.776 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.07 160.97 28.84 Favored Glycine 0 CA--C 1.518 0.281 0 C-N-CA 120.843 -0.694 . . . . 0.35 113.858 -179.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.494 ' O ' ' HB3' ' A' ' 44' ' ' LYS . 0.2 OUTLIER -90.71 175.85 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 123.215 0.606 . . . . 1.42 110.516 179.152 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.617 ' HD3' ' HA ' ' A' ' 94' ' ' PRO . 10.0 ptmm? 163.71 156.29 0.06 OUTLIER Pre-proline 0 N--CA 1.471 0.61 0 CA-C-O 121.427 0.632 . . . . 2.18 111.933 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.443 ' HD2' ' HB2' ' A' ' 49' ' ' ASP . 7.2 Cg_exo -74.57 173.11 14.87 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 124.485 3.457 . . . . 0.3 113.202 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 48' ' ' SER . . . -67.5 -172.56 6.06 Favored Glycine 0 C--O 1.224 -0.497 0 N-CA-C 110.895 -0.882 . . . . 0.35 110.895 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.432 ' O ' ' HB2' ' A' ' 80' ' ' SER . 24.2 pttm -41.61 -13.2 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.388 0.884 . . . . 2.35 113.388 -178.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.522 ' N ' ' O ' ' A' ' 46' ' ' GLY . 60.4 m -86.12 7.74 23.62 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 121.036 0.446 . . . . 1.45 110.376 178.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.443 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 3.3 p30 -77.84 160.2 28.47 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.656 -0.702 . . . . 1.73 111.611 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.552 ' HB ' ' HG3' ' A' ' 134' ' ' LYS . 48.3 m -126.34 119.5 27.49 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.814 -0.81 . . . . 0.44 108.814 178.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.434 HG12 ' HA ' ' A' ' 133' ' ' VAL . 26.5 m -130.07 150.73 34.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.156 0.503 . . . . 0.65 112.319 -178.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 53.3 m -111.74 121.15 44.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.477 -0.783 . . . . 0.32 109.299 178.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.586 HG12 ' HA ' ' A' ' 130' ' ' LEU . 3.4 m -137.83 177.8 5.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.154 0.502 . . . . 0.24 111.772 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -126.55 132.9 51.24 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.441 -0.8 . . . . 2.4 109.77 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -144.69 159.63 42.52 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.682 0.753 . . . . 0.26 112.161 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 62.9 m -124.71 112.09 16.33 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.42 -1.263 . . . . 0.26 108.412 178.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.416 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -110.63 141.38 16.35 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 119.813 -1.184 . . . . 0.12 113.173 -178.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.457 ' NE ' HD13 ' A' ' 125' ' ' ILE . 2.5 ppt_? -147.36 146.35 29.62 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.786 0.327 . . . . 1.93 110.197 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.466 ' HA ' ' HG ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER -73.31 163.48 28.02 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.038 -0.528 . . . . 1.21 110.38 -179.863 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.494 ' HB ' ' O ' ' A' ' 123' ' ' THR . 9.0 tp -59.4 -11.01 2.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.357 0.598 . . . . 0.64 109.499 178.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -71.73 -12.48 61.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.321 -0.854 . . . . 2.01 110.979 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.429 ' HA2' HH11 ' A' ' 58' ' ' ARG . . . 90.02 -0.88 79.64 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.604 -0.808 . . . . 0.45 112.921 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.3 m -110.18 128.46 55.49 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 120.92 0.391 . . . . 1.4 111.21 -178.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 57' ' ' GLY . 5.1 p -61.0 130.7 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 115.968 -0.56 . . . . 0.28 110.099 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.605 ' HD1' ' N ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -97.45 -21.92 16.87 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.976 -0.556 . . . . 0.24 110.912 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.605 ' N ' ' HD1' ' A' ' 65' ' ' PHE . 16.2 t70 -175.82 129.5 0.25 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.164 -0.471 . . . . 0.3 110.559 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 30.2 p -132.21 122.28 24.99 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.279 -0.419 . . . . 1.3 110.516 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.586 HG21 ' HB2' ' A' ' 75' ' ' ALA . 69.4 p -79.12 -29.17 43.06 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.426 -0.352 . . . . 0.34 111.184 -179.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -69.74 -30.98 68.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.463 -0.335 . . . . 2.11 110.922 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -71.26 -42.13 69.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 3.41 110.995 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 53.6 p -59.72 -18.93 46.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.908 0.385 . . . . 1.47 110.947 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 92.55 2.74 67.33 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.918 -0.658 . . . . 0.7 112.604 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -125.98 140.58 37.18 Favored Pre-proline 0 N--CA 1.453 -0.303 0 CA-C-O 120.929 0.395 . . . . 3.05 110.786 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -71.25 160.1 49.91 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.422 2.082 . . . . 0.51 112.193 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.586 ' HB2' HG21 ' A' ' 68' ' ' THR . . . -93.63 124.82 37.88 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 116.13 -0.486 . . . . 0.23 110.86 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.2 t -126.34 118.29 24.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.007 0.432 . . . . 1.26 110.946 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -157.63 154.28 28.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.118 -0.492 . . . . 0.36 111.578 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.576 HE21 ' H ' ' A' ' 80' ' ' SER . 0.0 OUTLIER -81.31 130.21 34.94 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.926 -0.768 . . . . 1.58 108.926 178.69 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.431 ' N ' HE21 ' A' ' 78' ' ' GLN . 12.0 m -64.14 -6.5 2.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 112.851 0.686 . . . . 1.07 112.851 -178.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.576 ' H ' HE21 ' A' ' 78' ' ' GLN . 40.8 t -96.54 -14.0 22.58 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.503 0.557 . . . . 1.14 112.503 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.567 HE21 ' HB2' ' A' ' 78' ' ' GLN . 50.6 mt-30 -97.43 5.76 49.24 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.839 0.681 . . . . 2.08 112.839 -178.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 6.1 m -99.36 178.32 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.992 -0.283 . . . . 0.45 111.744 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.496 HG13 ' HB2' ' A' ' 86' ' ' TRP . 26.8 pt -56.16 155.92 11.67 Favored Pre-proline 0 CA--C 1.531 0.225 0 CA-C-N 116.379 -0.373 . . . . 0.75 111.646 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -45.75 -59.92 1.03 Allowed 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.191 2.594 . . . . 0.65 113.049 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.445 ' O ' HD11 ' A' ' 32' ' ' LEU . . . -49.51 -49.08 33.81 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 120.701 -0.761 . . . . 0.31 112.719 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . 0.496 ' HB2' HG13 ' A' ' 83' ' ' ILE . 0.6 OUTLIER -61.19 -46.5 90.21 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.325 0.491 . . . . 0.78 112.325 -179.015 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.45 HG23 ' O ' ' A' ' 83' ' ' ILE . 71.6 p -54.92 -36.44 65.24 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 111.791 0.293 . . . . 1.4 111.791 -179.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -70.46 -50.27 39.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.547 -0.297 . . . . 1.43 111.654 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.48 ' HB2' HD22 ' A' ' 32' ' ' LEU . . . -63.5 -52.14 62.54 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.486 -0.324 . . . . 0.33 111.852 -179.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -57.4 -30.02 64.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.16 -0.473 . . . . 0.39 111.827 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -69.84 -17.81 63.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.444 -0.344 . . . . 1.87 111.391 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 89.5 mt -101.6 -7.52 22.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.293 -0.412 . . . . 1.31 111.7 -179.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.452 ' O ' ' HD3' ' A' ' 44' ' ' LYS . 90.6 mtp -91.59 107.37 21.61 Favored Pre-proline 0 C--N 1.33 -0.26 0 N-CA-C 111.76 0.282 . . . . 1.66 111.76 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.617 ' HA ' ' HD3' ' A' ' 44' ' ' LYS . 38.8 Cg_endo -69.44 142.71 50.1 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.032 1.822 . . . . 0.44 110.799 178.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.515 ' HA ' HD13 ' A' ' 130' ' ' LEU . . . -45.82 126.66 7.35 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.78 0.324 . . . . 0.36 111.511 -179.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.551 ' H ' HD22 ' A' ' 130' ' ' LEU . . . 101.32 -2.75 54.27 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.636 -0.792 . . . . 0.34 113.229 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.418 ' HA ' ' O ' ' A' ' 38' ' ' ASN . 74.9 m -76.35 -177.54 4.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.048 0.451 . . . . 1.41 111.847 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.571 HG22 HD12 ' A' ' 37' ' ' ILE . 9.7 m -155.26 98.68 2.01 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.67 -0.696 . . . . 0.23 110.55 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.514 ' HE1' HG13 ' A' ' 36' ' ' VAL . 20.6 m0 -121.79 149.31 43.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.138 0.494 . . . . 0.53 111.581 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -115.28 107.63 15.51 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.156 -1.053 . . . . 1.37 108.156 177.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.727 HG22 ' HB3' ' A' ' 34' ' ' TYR . 48.7 pt -110.14 145.94 16.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 113.339 0.866 . . . . 0.25 113.339 -177.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -127.31 103.69 7.53 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.694 -1.139 . . . . 0.31 108.099 178.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.523 HG22 HD23 ' A' ' 32' ' ' LEU . 2.4 t -104.7 98.88 16.11 Favored Pre-proline 0 CA--C 1.53 0.205 0 N-CA-C 113.448 0.907 . . . . 0.52 113.448 -176.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.628 ' HG2' HD13 ' A' ' 107' ' ' LEU . 12.4 Cg_endo -58.6 151.92 59.29 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.0 1.8 . . . . 0.48 110.507 177.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -47.73 -38.9 16.35 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.273 0.471 . . . . 1.81 112.273 -178.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.407 ' C ' HD12 ' A' ' 107' ' ' LEU . . . -57.29 -9.35 4.32 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.985 -0.626 . . . . 0.4 113.288 -179.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.628 HD13 ' HG2' ' A' ' 104' ' ' PRO . 6.5 mp -110.41 -13.85 14.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.668 0.27 . . . . 2.35 111.52 -178.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -109.18 -104.1 0.37 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.55 -0.296 . . . . 1.03 111.061 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -89.64 -17.08 29.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.768 0.318 . . . . 1.44 111.026 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 107.64 145.02 11.68 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 120.889 -0.672 . . . . 1.58 113.869 178.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.533 ' HA ' ' H ' ' A' ' 121' ' ' ASN . 28.1 Cg_endo -61.45 -8.55 10.98 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 123.579 2.852 . . . . 1.49 113.299 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.54 ' C ' ' H ' ' A' ' 114' ' ' VAL . 84.3 mtm180 -75.95 171.21 14.82 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.879 0.371 . . . . 3.51 110.969 -178.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 42.9 t -55.71 -0.6 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.861 -0.609 . . . . 1.63 111.774 -179.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.54 ' H ' ' C ' ' A' ' 112' ' ' ARG . 2.8 t -91.91 19.47 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.181 0.515 . . . . 2.9 110.226 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -62.59 112.06 4.58 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.794 -0.639 . . . . 1.05 112.151 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -68.71 -113.93 0.02 OUTLIER Glycine 0 CA--C 1.521 0.438 0 C-N-CA 120.99 -0.624 . . . . 0.8 112.743 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.6 -34.69 51.05 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.241 1.961 . . . . 0.7 111.976 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.64 HD12 HD13 ' A' ' 124' ' ' LEU . 26.0 mm -90.65 125.16 43.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.482 . . . . 1.25 110.567 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -44.81 155.33 0.35 Allowed Glycine 0 C--N 1.334 0.435 0 CA-C-N 115.724 -0.671 . . . . 0.48 113.554 -179.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -60.82 132.75 44.05 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.444 2.096 . . . . 0.67 111.437 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.533 ' H ' ' HA ' ' A' ' 111' ' ' PRO . 1.4 m-80 47.71 35.73 4.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.231 -0.44 . . . . 1.12 109.925 -178.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.485 ' HG3' HG22 ' A' ' 60' ' ' ILE . 41.1 tt0 -114.7 128.84 56.53 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.051 -0.522 . . . . 1.73 111.394 -179.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.494 ' O ' ' HB ' ' A' ' 60' ' ' ILE . 87.4 m -95.44 129.58 42.55 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.184 -0.673 . . . . 0.29 109.184 178.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.64 HD13 HD12 ' A' ' 118' ' ' ILE . 0.1 OUTLIER -120.33 159.9 24.1 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.104 0.478 . . . . 1.47 111.956 -178.266 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.469 ' N ' HD12 ' A' ' 125' ' ' ILE . 4.5 mp -114.6 143.44 24.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.657 -0.701 . . . . 0.2 109.977 178.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -133.17 132.3 41.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.953 0.406 . . . . 0.24 111.541 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 10.3 tmtt? -111.36 103.56 11.94 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.558 -0.904 . . . . 2.28 108.558 178.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 20.8 mt -102.68 122.92 55.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.91 0.707 . . . . 0.82 112.91 -177.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -118.7 99.75 6.98 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.891 -0.781 . . . . 0.26 108.891 177.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.586 ' HA ' HG12 ' A' ' 53' ' ' VAL . 0.7 OUTLIER -78.48 124.84 28.58 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.157 -0.474 . . . . 1.41 111.558 -178.615 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 43.6 mm -94.06 -57.07 4.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.753 -0.658 . . . . 1.17 110.735 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.497 ' HA ' ' HB1' ' A' ' 95' ' ' ALA . 4.3 m -163.68 166.07 22.62 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.951 0.405 . . . . 1.17 111.491 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.448 HG11 ' HB3' ' A' ' 44' ' ' LYS . 7.3 p -107.63 124.33 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 115.945 -0.57 . . . . 1.43 111.012 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.552 ' HG3' ' HB ' ' A' ' 50' ' ' THR . 0.7 OUTLIER 33.36 73.16 0.07 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.057 -0.52 . . . . 3.08 111.792 -179.5 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 95.4 mttt 60.48 29.91 19.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.863 -0.608 . . . . 3.16 111.57 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.411 ' HB2' ' HB3' ' A' ' 132' ' ' SER . 46.9 t 55.41 67.78 0.96 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.055 -0.521 . . . . 1.31 111.083 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 66.2 m . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.345 -0.836 . . . . 2.53 110.889 179.964 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.593 0.235 . . . . 3.09 110.883 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -60.59 -35.36 75.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.554 -0.294 . . . . 2.08 111.077 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -54.76 -37.93 66.59 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.274 -0.639 . . . . 3.23 109.274 178.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -79.68 -34.97 39.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.433 -0.803 . . . . 2.63 110.242 179.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -58.11 -52.0 67.36 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.092 -0.504 . . . . 0.82 109.977 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -64.85 -36.42 84.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.979 -0.555 . . . . 2.57 110.008 178.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -55.88 -33.13 64.32 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.89 -0.781 . . . . 2.1 108.89 178.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.502 ' HA ' ' HG2' ' A' ' 11' ' ' LYS . 53.2 m-20 -72.34 -38.24 68.65 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.165 -0.925 . . . . 1.4 110.428 179.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.434 ' NZ ' ' HB3' ' A' ' 9' ' ' LYS . 4.2 ttpm? -57.27 -35.64 70.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.977 -0.556 . . . . 2.67 111.212 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.9 t -76.35 -52.61 17.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 111.959 0.355 . . . . 1.27 111.959 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.502 ' HG2' ' HA ' ' A' ' 8' ' ' ASN . 19.0 ptpt -58.59 -33.35 69.89 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.668 0.27 . . . . 1.69 111.314 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.452 ' O ' ' HG ' ' A' ' 16' ' ' LEU . . . -76.39 -53.2 5.67 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.719 -0.753 . . . . 0.31 112.329 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -61.08 -30.75 70.52 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.837 0.351 . . . . 2.39 110.839 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.23 -32.09 55.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.319 -0.401 . . . . 0.23 110.458 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -63.99 -54.53 32.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.938 -0.573 . . . . 0.23 110.66 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.738 ' HA ' ' HB3' ' A' ' 19' ' ' ASN . 0.6 OUTLIER -65.59 -32.5 74.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.28 -0.418 . . . . 0.55 111.152 -179.724 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.434 ' N ' HD12 ' A' ' 16' ' ' LEU . 8.3 m -57.2 -48.54 78.52 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.606 -0.516 . . . . 0.27 109.606 179.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -74.16 -31.85 62.87 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.93 -0.577 . . . . 2.47 110.065 178.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.738 ' HB3' ' HA ' ' A' ' 16' ' ' LEU . 0.3 OUTLIER -57.12 -28.38 62.65 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.305 -0.861 . . . . 0.22 112.133 -179.523 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -48.04 -18.58 0.2 Allowed 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 112.32 0.489 . . . . 2.45 112.32 -179.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.68 HD22 ' N ' ' A' ' 21' ' ' ASN . 0.8 OUTLIER -67.67 -33.11 74.27 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.88 0.326 . . . . 0.4 111.88 -178.713 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.725 ' O ' HG23 ' A' ' 25' ' ' VAL . 68.1 mttm -54.04 119.48 19.74 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.716 -0.22 . . . . 1.4 111.022 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -56.8 145.56 82.77 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.246 1.964 . . . . 0.65 112.374 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.71 3.11 81.0 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.735 -0.745 . . . . 0.37 113.921 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 22' ' ' LYS . 18.0 t -58.65 109.48 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 117.517 0.659 . . . . 0.91 110.637 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.5 p -130.35 128.56 64.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.908 -0.587 . . . . 1.03 111.089 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.2 p -82.69 137.24 21.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.184 -0.462 . . . . 0.91 110.866 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.521 HD12 ' HB2' ' A' ' 32' ' ' LEU . 61.2 mt -95.52 166.88 13.76 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.102 -0.499 . . . . 0.4 110.713 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.443 ' HD2' ' HB3' ' A' ' 28' ' ' LEU . 53.2 Cg_exo -53.53 -30.93 56.61 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 121.889 1.726 . . . . 0.59 111.53 178.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.525 ' O ' HD12 ' A' ' 107' ' ' LEU . 28.0 t -85.43 -10.96 55.49 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.057 -0.519 . . . . 1.14 110.953 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.83 13.98 28.19 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 120.425 -0.893 . . . . 0.34 114.645 178.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.626 HD22 ' HB2' ' A' ' 89' ' ' ALA . 5.8 mp -85.61 136.98 33.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 117.747 0.774 . . . . 1.35 112.951 -179.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -119.01 139.9 50.92 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.118 -0.946 . . . . 1.75 108.49 177.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.654 ' HB3' HG22 ' A' ' 101' ' ' ILE . 41.0 p90 -155.04 176.39 12.6 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.794 0.664 . . . . 0.32 112.794 -178.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.433 ' HE2' ' HB3' ' A' ' 22' ' ' LYS . 23.4 ttmt -120.78 117.36 27.24 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.974 -1.012 . . . . 2.15 109.583 179.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.439 HG13 ' HE1' ' A' ' 99' ' ' TRP . 51.6 t -74.52 125.61 34.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 113.297 0.851 . . . . 0.3 113.297 -177.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 54.9 mt -107.22 -66.82 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.288 -0.869 . . . . 0.65 109.92 178.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.411 ' C ' ' ND2' ' A' ' 38' ' ' ASN . 0.7 OUTLIER -134.77 85.14 2.16 Favored 'General case' 0 C--O 1.226 -0.143 0 CA-C-N 116.022 -0.536 . . . . 1.03 109.754 178.927 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.611 ' HB2' ' HE1' ' A' ' 99' ' ' TRP . 47.0 t -106.47 145.16 32.14 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.376 0.51 . . . . 1.5 112.376 -179.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.1 109.19 0.27 Allowed Glycine 0 C--N 1.333 0.366 0 CA-C-N 115.665 -0.698 . . . . 1.09 113.936 178.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -177.75 -62.28 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 111.644 0.239 . . . . 1.7 111.644 178.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.2 168.98 34.28 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 120.63 -0.795 . . . . 0.35 113.763 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.744 HG22 ' H ' ' A' ' 44' ' ' LYS . 7.9 p -90.72 176.88 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 123.208 0.603 . . . . 1.42 109.959 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.744 ' H ' HG22 ' A' ' 43' ' ' VAL . 19.4 ptmt 164.94 156.2 0.07 OUTLIER Pre-proline 0 N--CA 1.469 0.519 0 CA-C-O 121.602 0.715 . . . . 2.18 112.86 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.528 ' HD2' HG21 ' A' ' 133' ' ' VAL . 1.2 Cg_endo -85.18 173.48 7.81 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 125.169 3.913 . . . . 0.3 113.097 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.508 ' O ' ' N ' ' A' ' 48' ' ' SER . . . -67.99 -172.18 6.46 Favored Glycine 0 C--O 1.225 -0.43 0 CA-C-N 115.393 -0.821 . . . . 0.35 111.383 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.405 ' HG2' ' HB2' ' A' ' 91' ' ' GLN . 98.8 mttt -41.41 -13.5 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 113.448 0.907 . . . . 2.35 113.448 -178.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.508 ' N ' ' O ' ' A' ' 46' ' ' GLY . 84.5 p -85.84 7.28 24.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.094 0.473 . . . . 1.45 110.282 178.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.469 ' O ' ' NE2' ' A' ' 78' ' ' GLN . 3.2 p30 -76.64 140.88 41.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.459 -0.791 . . . . 1.73 111.857 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 62.8 m -113.45 119.4 37.47 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.615 -0.883 . . . . 0.44 108.615 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.445 HG12 ' HB ' ' A' ' 133' ' ' VAL . 16.9 m -124.28 154.54 31.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 113.051 0.76 . . . . 0.65 113.051 -177.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 87.4 m -114.52 120.8 41.47 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.026 -0.988 . . . . 0.32 108.638 178.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.559 HG12 ' HA ' ' A' ' 130' ' ' LEU . 4.4 m -142.97 -179.71 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.296 0.57 . . . . 0.24 111.991 -178.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.527 ' HB3' ' HG2' ' A' ' 69' ' ' GLU . 28.3 mt-10 -129.55 132.79 46.92 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.114 -0.948 . . . . 2.4 109.455 178.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -146.48 160.86 41.55 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.703 0.763 . . . . 0.26 112.203 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 62.1 m -128.31 112.85 14.9 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.358 -1.292 . . . . 0.26 108.428 178.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.454 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -110.0 147.14 17.22 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.008 -1.091 . . . . 0.12 113.021 -178.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.485 ' NE ' HD13 ' A' ' 125' ' ' ILE . 1.8 ppt_? -147.91 148.05 30.39 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.888 0.375 . . . . 1.93 110.122 179.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.419 HD23 HD21 ' A' ' 124' ' ' LEU . 23.4 mt -77.55 162.18 27.31 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.981 -0.554 . . . . 1.21 110.102 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.513 ' HB ' ' O ' ' A' ' 123' ' ' THR . 6.9 tp -59.18 -10.75 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.365 0.603 . . . . 0.64 109.458 178.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -67.65 -12.61 60.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.312 -0.858 . . . . 2.01 110.721 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.434 ' HA2' HH11 ' A' ' 58' ' ' ARG . . . 90.55 -0.94 78.19 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.594 -0.812 . . . . 0.45 113.238 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 71.6 p -115.84 134.35 55.09 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 117.088 0.444 . . . . 1.4 111.458 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 57' ' ' GLY . 6.7 p -62.71 132.43 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-N 115.951 -0.568 . . . . 0.28 110.044 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.583 ' HD1' ' N ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -97.65 -22.35 16.52 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.083 -0.508 . . . . 0.24 110.99 -179.95 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.583 ' N ' ' HD1' ' A' ' 65' ' ' PHE . 24.9 t70 -175.91 130.05 0.24 Allowed 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 116.323 -0.399 . . . . 0.3 110.995 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.7 p -125.55 124.36 41.11 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.103 -0.499 . . . . 1.3 110.544 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.7 HG21 ' HB2' ' A' ' 75' ' ' ALA . 69.8 p -83.26 -25.33 31.72 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 120.848 0.356 . . . . 0.34 111.032 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.527 ' HG2' ' HB3' ' A' ' 54' ' ' GLU . 38.1 mt-10 -75.09 -39.32 60.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 2.11 110.98 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -63.54 -44.86 92.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 3.41 110.639 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 54.7 m -58.25 -21.4 48.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.258 -0.428 . . . . 1.47 110.556 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 90.46 7.5 67.08 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.808 -0.71 . . . . 0.7 112.311 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -125.99 117.01 23.98 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.355 0.122 . . . . 3.05 110.937 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -55.47 157.19 15.51 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.314 2.01 . . . . 0.51 112.107 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.7 ' HB2' HG21 ' A' ' 68' ' ' THR . . . -94.72 123.99 38.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.346 -0.388 . . . . 0.23 110.622 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.6 t -125.89 118.48 25.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.786 0.327 . . . . 1.26 111.189 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -158.47 163.49 37.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.11 0.481 . . . . 0.36 111.865 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.484 ' OE1' ' HB3' ' A' ' 80' ' ' SER . 0.0 OUTLIER -83.04 137.8 33.98 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.524 -0.762 . . . . 1.58 109.03 178.608 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.424 ' O ' HG22 ' A' ' 87' ' ' THR . 21.6 m -69.26 -20.07 24.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 113.587 0.958 . . . . 1.07 113.587 -177.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.484 ' HB3' ' OE1' ' A' ' 78' ' ' GLN . 33.2 t -95.3 -2.56 49.1 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.955 0.354 . . . . 1.14 111.955 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.453 HE21 ' HB3' ' A' ' 78' ' ' GLN . 23.4 mt-30 -96.17 5.58 50.74 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.895 0.331 . . . . 2.08 111.895 -179.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.467 ' HB ' HD13 ' A' ' 83' ' ' ILE . 3.1 m -107.38 -175.66 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 111.662 0.245 . . . . 0.45 111.662 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.74 HD13 ' H ' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -56.45 147.73 47.72 Favored Pre-proline 0 N--CA 1.463 0.191 0 CA-C-N 116.507 -0.315 . . . . 0.75 111.711 -179.468 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo -42.25 -54.12 3.23 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.19 2.594 . . . . 0.65 113.365 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.533 ' HA2' HD11 ' A' ' 32' ' ' LEU . . . -51.87 -49.21 49.05 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.517 -0.849 . . . . 0.31 112.7 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -60.9 -47.7 85.18 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.693 0.257 . . . . 0.78 111.693 -179.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.424 HG22 ' O ' ' A' ' 79' ' ' VAL . 30.9 p -53.52 -33.73 55.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.766 0.317 . . . . 1.4 111.598 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -70.61 -51.41 28.35 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.161 0.43 . . . . 1.43 112.161 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.626 ' HB2' HD22 ' A' ' 32' ' ' LEU . . . -68.01 -48.49 65.57 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.483 0.549 . . . . 0.33 112.483 -178.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -55.19 -30.99 61.04 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.021 0.378 . . . . 0.39 112.021 -179.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.405 ' HB2' ' HG2' ' A' ' 47' ' ' LYS . 46.7 tt0 -65.68 -21.15 66.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.595 -0.275 . . . . 1.87 111.574 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.411 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 10.6 mp -96.41 -22.13 17.34 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.382 0.512 . . . . 1.31 112.382 -178.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 22.2 ttm -71.41 108.73 4.22 Favored Pre-proline 0 CA--C 1.532 0.278 0 N-CA-C 111.472 0.175 . . . . 1.66 111.472 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.421 ' HD2' ' OG ' ' A' ' 97' ' ' SER . 6.1 Cg_exo -75.67 144.89 28.64 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.751 2.301 . . . . 0.44 111.889 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.609 ' HB1' ' HA ' ' A' ' 132' ' ' SER . . . -48.31 127.57 13.06 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.472 -0.331 . . . . 0.36 111.437 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 94.39 2.57 63.63 Favored Glycine 0 CA--C 1.521 0.422 0 C-N-CA 120.701 -0.762 . . . . 0.34 113.446 179.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.421 ' OG ' ' HD2' ' A' ' 94' ' ' PRO . 69.6 m -89.92 -174.59 4.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.885 0.374 . . . . 1.41 111.609 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.7 m -152.3 112.78 4.11 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.066 -0.515 . . . . 0.23 110.773 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.611 ' HE1' ' HB2' ' A' ' 39' ' ' SER . 14.8 m0 -132.25 149.77 52.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.052 0.453 . . . . 0.53 111.759 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -123.73 108.54 12.64 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.367 -0.975 . . . . 1.37 108.367 177.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.654 HG22 ' HB3' ' A' ' 34' ' ' TYR . 24.7 pt -107.68 139.68 28.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 112.974 0.731 . . . . 0.25 112.974 -177.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.497 ' OH ' HG22 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -120.34 103.99 9.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.951 -1.022 . . . . 0.31 108.262 178.232 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.417 ' HA ' ' HD2' ' A' ' 104' ' ' PRO . 3.3 t -109.12 102.43 48.9 Favored Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 113.764 1.024 . . . . 0.52 113.764 -176.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.593 ' HG2' HD23 ' A' ' 107' ' ' LEU . 12.3 Cg_endo -59.62 150.94 73.3 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 121.872 1.715 . . . . 0.48 110.037 176.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -47.56 -31.74 4.72 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.512 0.56 . . . . 1.81 112.512 -178.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -57.09 -13.47 9.14 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.877 -0.677 . . . . 0.4 114.084 -178.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.593 HD23 ' HG2' ' A' ' 104' ' ' PRO . 3.0 mm? -114.57 -5.55 12.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 117.193 0.496 . . . . 2.35 111.763 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -109.1 -104.36 0.37 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.513 -0.312 . . . . 1.03 110.385 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -91.23 -17.18 26.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.986 0.422 . . . . 1.44 110.454 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 103.74 145.99 15.69 Favored Glycine 0 CA--C 1.521 0.428 0 CA-C-N 115.732 -0.667 . . . . 1.58 113.857 178.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.49 ' HA ' ' H ' ' A' ' 121' ' ' ASN . 19.2 Cg_endo -58.8 -6.96 3.82 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.604 2.869 . . . . 1.49 113.133 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.531 ' C ' ' H ' ' A' ' 114' ' ' VAL . 89.4 mtm180 -75.65 170.71 15.65 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.802 0.334 . . . . 3.51 110.791 -178.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 79.7 p -60.05 6.96 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.034 -0.53 . . . . 1.63 112.235 -179.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.531 ' H ' ' C ' ' A' ' 112' ' ' ARG . 3.2 t -99.92 20.6 2.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.133 0.492 . . . . 2.9 110.502 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -63.85 110.42 3.4 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.931 -0.652 . . . . 1.05 112.309 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -74.25 -116.6 0.08 OUTLIER Glycine 0 CA--C 1.522 0.497 0 C-N-CA 120.967 -0.635 . . . . 0.8 112.603 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -55.93 -35.8 94.75 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.159 1.906 . . . . 0.7 111.679 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.598 HG23 HD13 ' A' ' 124' ' ' LEU . 5.1 mp -91.55 120.06 39.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.77 -0.65 . . . . 1.25 110.082 179.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -46.13 157.6 0.4 Allowed Glycine 0 C--N 1.333 0.416 0 CA-C-N 116.083 -0.508 . . . . 0.48 113.308 -179.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.431 ' O ' ' HG3' ' A' ' 122' ' ' GLU . 26.5 Cg_endo -62.07 131.33 34.22 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.486 2.124 . . . . 0.67 111.826 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.49 ' H ' ' HA ' ' A' ' 111' ' ' PRO . 3.2 m-80 47.22 34.57 3.13 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.03 -0.532 . . . . 1.12 110.371 -178.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.431 ' HG3' ' O ' ' A' ' 120' ' ' PRO . 37.0 mt-10 -115.64 122.92 47.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.34 -0.391 . . . . 1.73 111.528 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.513 ' O ' ' HB ' ' A' ' 60' ' ' ILE . 91.2 m -89.17 127.9 35.76 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.782 -0.822 . . . . 0.29 108.782 178.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.598 HD13 HG23 ' A' ' 118' ' ' ILE . 6.3 mp -114.42 155.82 25.63 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.217 0.532 . . . . 1.47 112.268 -177.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.485 HD13 ' NE ' ' A' ' 58' ' ' ARG . 4.6 mp -113.9 132.88 61.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.306 -0.861 . . . . 0.2 109.716 178.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -125.39 131.82 52.88 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.975 0.417 . . . . 0.24 111.423 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -110.0 102.94 11.64 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.482 -0.933 . . . . 2.28 108.482 178.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.43 ' N ' HD12 ' A' ' 128' ' ' ILE . 5.0 mp -105.71 118.65 53.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 112.429 0.529 . . . . 0.82 112.429 -177.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -109.18 99.32 8.62 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.282 -1.007 . . . . 0.26 108.282 177.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.559 ' HA ' HG12 ' A' ' 53' ' ' VAL . 26.2 tp -79.3 114.9 18.61 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.86 -0.609 . . . . 1.41 111.511 -178.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 67.8 mt -84.18 -56.73 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 CA-C-N 115.884 -0.598 . . . . 1.17 110.288 179.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.609 ' HA ' ' HB1' ' A' ' 95' ' ' ALA . 11.3 p -164.27 165.15 22.14 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.246 -0.433 . . . . 1.17 111.409 179.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.691 HG11 ' CB ' ' A' ' 44' ' ' LYS . 7.2 p -117.04 122.24 69.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.902 -0.59 . . . . 1.43 111.064 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.414 ' C ' ' O ' ' A' ' 133' ' ' VAL . 11.3 mttm 32.99 79.19 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.233 -0.44 . . . . 3.08 111.344 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 15.6 pttm 51.86 30.7 7.38 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.783 -0.644 . . . . 3.16 111.629 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 33.8 t 50.61 44.52 27.38 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.587 -0.733 . . . . 1.31 111.096 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 42.3 t . . . . . 0 C--O 1.248 0.979 0 CA-C-O 118.24 -0.886 . . . . 2.53 111.04 -179.734 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 . . . . . 0 N--CA 1.485 1.316 0 CA-C-O 120.799 0.333 . . . . 3.09 111.012 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -68.94 -18.53 64.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 2.08 111.11 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.478 ' HB3' ' NZ ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -57.89 -40.66 80.82 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.572 -0.529 . . . . 3.23 109.572 179.172 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 59.9 mmtt -80.35 -35.69 35.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.782 -0.645 . . . . 2.63 110.598 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -58.39 -48.67 79.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.975 -0.557 . . . . 0.82 110.7 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -75.14 -31.9 61.19 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.275 -0.42 . . . . 2.57 110.916 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -56.78 -41.74 78.21 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.683 -0.488 . . . . 2.1 109.683 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.514 ' HA ' ' HG2' ' A' ' 11' ' ' LYS . 23.7 p30 -78.97 -29.2 43.77 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.734 -0.666 . . . . 1.4 111.415 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 121' ' ' ASN . 66.7 tttm -56.16 -44.12 78.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.005 0.431 . . . . 2.67 110.741 179.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.425 HG22 ' H ' ' A' ' 10' ' ' VAL . 5.4 m -78.1 -44.97 27.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.915 -0.584 . . . . 1.27 112.446 -179.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.517 ' HE2' HG13 ' A' ' 60' ' ' ILE . 17.9 ptmt -59.16 -33.57 71.07 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.703 0.287 . . . . 1.69 111.429 -179.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.411 ' O ' ' HG ' ' A' ' 16' ' ' LEU . . . -76.34 -53.01 5.78 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.833 -0.699 . . . . 0.31 112.202 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.505 ' HA ' HD11 ' A' ' 16' ' ' LEU . 47.8 mt-10 -59.21 -25.38 63.93 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.931 0.396 . . . . 2.39 110.591 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.15 -37.61 45.55 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.061 -0.518 . . . . 0.23 110.584 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -61.78 -51.91 66.37 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.165 -0.471 . . . . 0.23 110.828 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.686 ' HA ' ' HB3' ' A' ' 19' ' ' ASN . 0.6 OUTLIER -67.84 -32.66 73.35 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.717 -0.393 . . . . 0.55 111.143 -179.72 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.451 ' N ' HD12 ' A' ' 16' ' ' LEU . 6.2 m -57.65 -46.09 84.66 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.494 -0.558 . . . . 0.27 109.494 178.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -74.27 -31.96 62.73 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.753 -0.658 . . . . 2.47 109.856 178.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.686 ' HB3' ' HA ' ' A' ' 16' ' ' LEU . 0.6 OUTLIER -60.15 -26.36 66.23 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.436 -0.802 . . . . 0.22 112.532 -179.384 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -48.91 -19.46 0.39 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.764 0.316 . . . . 2.45 111.689 -179.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.72 HD22 ' N ' ' A' ' 21' ' ' ASN . 0.7 OUTLIER -69.12 -34.71 75.48 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.135 0.42 . . . . 0.4 112.135 -179.229 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.715 ' O ' HG23 ' A' ' 25' ' ' VAL . 18.7 mmtp -46.02 127.87 7.19 Favored Pre-proline 0 N--CA 1.465 0.298 0 CA-C-O 120.661 0.267 . . . . 1.4 111.266 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -57.89 137.12 79.38 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.336 2.024 . . . . 0.65 112.192 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.94 0.83 83.03 Favored Glycine 0 CA--C 1.52 0.374 0 C-N-CA 120.771 -0.728 . . . . 0.37 113.955 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 22' ' ' LYS . 24.1 t -56.21 103.98 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.125 0 CA-C-N 117.541 0.67 . . . . 0.91 110.17 179.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.6 p -126.49 135.68 63.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.611 -0.722 . . . . 1.03 111.138 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.427 HG23 ' NE2' ' A' ' 33' ' ' GLN . 7.6 p -87.05 141.77 13.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.261 -0.427 . . . . 0.91 111.157 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.48 HD12 ' HB2' ' A' ' 32' ' ' LEU . 55.5 mt -101.29 166.06 13.02 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.099 -0.5 . . . . 0.4 110.804 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.416 ' HD2' ' HB3' ' A' ' 28' ' ' LEU . 54.2 Cg_exo -53.79 -30.58 57.74 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 121.914 1.743 . . . . 0.59 111.455 178.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.569 ' O ' HD12 ' A' ' 107' ' ' LEU . 38.8 t -83.85 -12.85 54.95 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.862 -0.608 . . . . 1.14 110.871 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.43 14.18 26.44 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 120.485 -0.864 . . . . 0.34 114.291 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.676 HD11 ' CA ' ' A' ' 85' ' ' GLY . 6.6 mp -85.89 137.51 32.7 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 113.64 0.978 . . . . 1.35 113.64 -178.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.427 ' NE2' HG23 ' A' ' 27' ' ' VAL . 25.5 mp0 -118.4 142.7 47.28 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.985 -1.117 . . . . 1.75 107.985 177.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.604 ' HB3' HG22 ' A' ' 101' ' ' ILE . 34.8 p90 -158.79 175.69 13.28 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.278 0.844 . . . . 0.32 113.278 -178.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -121.58 117.46 26.8 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 114.901 -1.045 . . . . 2.15 109.606 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.484 HG13 ' HE1' ' A' ' 99' ' ' TRP . 46.6 t -81.92 126.77 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 113.216 0.821 . . . . 0.3 113.216 -178.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.452 HD12 HG22 ' A' ' 98' ' ' THR . 81.4 mt -101.73 -64.14 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 115.658 -0.701 . . . . 0.65 110.761 178.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.4 ' O ' ' HA ' ' A' ' 97' ' ' SER . 7.4 t30 -141.35 86.08 2.0 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.826 0.346 . . . . 1.03 110.931 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.702 ' HB2' ' HE1' ' A' ' 99' ' ' TRP . 39.5 t -106.82 146.06 31.38 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.315 -0.402 . . . . 1.5 112.047 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 93.41 85.19 1.59 Allowed Glycine 0 C--N 1.334 0.422 0 C-N-CA 121.05 -0.595 . . . . 1.09 113.224 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -153.28 -71.75 0.14 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.693 0.282 . . . . 1.7 111.612 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.26 166.67 32.24 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 121.052 -0.594 . . . . 0.35 114.376 -178.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.662 HG12 ' H ' ' A' ' 44' ' ' LYS . 2.6 t -90.45 176.18 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 123.516 0.726 . . . . 1.42 109.905 179.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.662 ' H ' HG12 ' A' ' 43' ' ' VAL . 2.2 pptp? 165.72 156.06 0.09 OUTLIER Pre-proline 0 N--CA 1.47 0.552 0 CA-C-O 121.464 0.65 . . . . 2.18 111.952 -179.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.515 ' HD2' ' HB2' ' A' ' 49' ' ' ASP . 3.1 Cg_exo -76.56 172.47 16.16 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 124.602 3.535 . . . . 0.3 113.624 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.495 ' HA2' HE22 ' A' ' 91' ' ' GLN . . . -67.76 -173.12 6.76 Favored Glycine 0 C--O 1.223 -0.568 0 CA-C-N 115.17 -0.923 . . . . 0.35 110.944 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.492 ' HG2' ' HB2' ' A' ' 91' ' ' GLN . 53.7 mtmt -42.14 -14.05 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.56 0.948 . . . . 2.35 113.56 -177.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.493 ' N ' ' O ' ' A' ' 46' ' ' GLY . 45.1 t -86.52 7.69 25.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.137 0.494 . . . . 1.45 110.256 178.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.515 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 3.0 p30 -76.18 162.96 27.54 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.515 -0.766 . . . . 1.73 111.368 -179.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 60.0 m -123.85 122.93 39.3 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.598 -0.89 . . . . 0.44 108.598 178.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.65 HG12 HG22 ' A' ' 133' ' ' VAL . 2.3 m -122.85 141.08 44.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.285 0.564 . . . . 0.65 112.491 -177.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 66.3 m -113.07 120.08 40.1 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.228 -1.027 . . . . 0.32 108.228 177.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.6 HG12 ' HA ' ' A' ' 130' ' ' LEU . 4.8 m -144.97 177.56 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.231 0.538 . . . . 0.24 111.686 -178.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -125.22 131.86 53.08 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.642 -0.873 . . . . 2.4 108.642 178.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -143.78 158.2 43.85 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.701 0.762 . . . . 0.26 112.381 -179.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 59.4 m -122.71 112.44 17.94 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.312 -1.313 . . . . 0.26 108.577 178.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.473 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -109.82 145.77 16.98 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 119.953 -1.118 . . . . 0.12 112.7 -178.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.516 ' NE ' HD13 ' A' ' 125' ' ' ILE . 4.9 ppt_? -148.09 146.97 29.04 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.048 0.452 . . . . 1.93 110.431 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.452 HD11 ' HB3' ' A' ' 122' ' ' GLU . 46.3 tp -76.1 160.36 29.84 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.759 -0.655 . . . . 1.21 109.809 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.525 ' HB ' ' O ' ' A' ' 123' ' ' THR . 9.5 tp -56.34 -10.68 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.251 0.548 . . . . 0.64 109.879 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.422 ' H ' ' C ' ' A' ' 59' ' ' LEU . 20.4 t70 -66.02 -12.4 54.88 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.454 -0.794 . . . . 2.01 110.861 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.82 -0.77 77.14 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.577 -0.821 . . . . 0.45 113.315 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.4 t -118.65 142.33 47.75 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.053 0.454 . . . . 1.4 111.214 -179.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 57' ' ' GLY . 7.0 p -65.96 133.71 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 115.827 -0.624 . . . . 0.28 110.17 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.598 ' HD1' ' N ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -97.43 -22.79 16.39 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.988 -0.551 . . . . 0.24 110.497 179.719 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.598 ' N ' ' HD1' ' A' ' 65' ' ' PHE . 25.4 t70 -176.95 131.7 0.18 Allowed 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.922 -0.581 . . . . 0.3 110.532 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 63.3 p -129.52 123.53 31.67 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.449 -0.342 . . . . 1.3 110.966 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.684 HG21 ' HB2' ' A' ' 75' ' ' ALA . 59.7 p -78.65 -14.35 59.35 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.898 0.38 . . . . 0.34 110.905 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -75.38 -51.83 12.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.048 -0.524 . . . . 2.11 110.604 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.9 ttpm? -61.04 -36.8 80.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.044 -0.525 . . . . 3.41 110.911 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 41.2 m -57.91 -20.03 34.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.206 -0.452 . . . . 1.47 110.744 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.29 4.88 90.03 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.831 -0.699 . . . . 0.7 112.013 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -126.18 117.38 23.6 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.457 0.17 . . . . 3.05 110.931 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -52.99 156.66 9.34 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.395 2.063 . . . . 0.51 112.046 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.684 ' HB2' HG21 ' A' ' 68' ' ' THR . . . -94.21 124.62 38.34 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.42 -0.355 . . . . 0.23 110.601 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.1 t -127.79 118.09 23.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.162 0.506 . . . . 1.26 111.428 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -158.36 167.12 30.58 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.674 -0.694 . . . . 0.36 110.896 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.603 ' NE2' ' HB3' ' A' ' 80' ' ' SER . 5.7 tt0 -85.5 146.0 27.14 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.3 -0.63 . . . . 1.58 109.3 178.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 32.9 m -68.44 -26.51 33.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 113.032 0.753 . . . . 1.07 113.032 -178.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.603 ' HB3' ' NE2' ' A' ' 78' ' ' GLN . 33.4 t -95.53 -3.77 45.98 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 111.937 0.347 . . . . 1.14 111.937 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 -84.87 5.65 27.96 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.733 0.272 . . . . 2.08 111.733 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 1.7 m -112.06 -172.55 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.6 -0.273 . . . . 0.45 111.553 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.529 HG13 ' HB2' ' A' ' 86' ' ' TRP . 29.2 pt -55.99 154.4 14.68 Favored Pre-proline 0 CA--C 1.528 0.13 0 CA-C-N 116.472 -0.331 . . . . 0.75 111.629 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -48.01 -53.67 6.33 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.651 2.234 . . . . 0.65 112.91 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.676 ' CA ' HD11 ' A' ' 32' ' ' LEU . . . -52.93 -49.69 53.9 Favored Glycine 0 CA--C 1.521 0.458 0 C-N-CA 120.802 -0.713 . . . . 0.31 113.112 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . 0.529 ' HB2' HG13 ' A' ' 83' ' ' ILE . 0.4 OUTLIER -59.49 -45.57 91.31 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.842 0.312 . . . . 0.78 111.842 -179.069 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 98.4 m -55.66 -37.49 68.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.442 -0.345 . . . . 1.4 111.689 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.64 -49.98 64.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.491 -0.322 . . . . 1.43 111.745 -179.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.642 ' HB2' HD22 ' A' ' 32' ' ' LEU . . . -64.39 -49.24 72.36 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.009 0.374 . . . . 0.33 112.009 -179.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -57.24 -26.72 61.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.423 -0.353 . . . . 0.39 111.72 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.712 ' HA ' HE21 ' A' ' 91' ' ' GLN . 0.0 OUTLIER -66.43 -24.55 66.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.836 0.35 . . . . 1.87 110.976 -179.89 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.412 ' O ' ' HD3' ' A' ' 94' ' ' PRO . 4.2 mm? -93.59 -7.51 43.85 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.168 -0.469 . . . . 1.31 111.134 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 69.3 mtp -88.32 108.44 22.15 Favored Pre-proline 0 CA--C 1.531 0.222 0 CA-C-N 116.47 -0.332 . . . . 1.66 111.891 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' A' ' 92' ' ' LEU . 99.0 Cg_endo -79.91 147.07 18.84 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.403 2.068 . . . . 0.44 110.582 178.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.495 ' HA ' HD13 ' A' ' 130' ' ' LEU . . . -45.58 126.59 6.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.779 0.323 . . . . 0.36 111.65 -179.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.563 ' H ' HD22 ' A' ' 130' ' ' LEU . . . 97.66 -7.8 63.53 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 120.549 -0.834 . . . . 0.34 113.281 178.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 38' ' ' ASN . 33.5 t -69.82 174.83 4.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.876 0.37 . . . . 1.41 111.264 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.452 HG22 HD12 ' A' ' 37' ' ' ILE . 24.5 m -147.31 90.82 1.91 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.987 -0.552 . . . . 0.23 110.471 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.702 ' HE1' ' HB2' ' A' ' 39' ' ' SER . 23.5 m0 -112.11 149.41 32.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.266 0.555 . . . . 0.53 112.189 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -119.59 107.78 13.69 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.311 -0.996 . . . . 1.37 108.311 177.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.604 HG22 ' HB3' ' A' ' 34' ' ' TYR . 48.7 pt -111.07 146.27 16.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 113.221 0.822 . . . . 0.25 113.221 -177.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.471 ' OH ' HG22 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -130.98 103.76 6.73 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.657 -1.156 . . . . 0.31 108.145 178.276 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 4.7 t -105.39 99.75 22.33 Favored Pre-proline 0 C--N 1.33 -0.265 0 N-CA-C 113.709 1.003 . . . . 0.52 113.709 -176.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.59 ' HG2' HD23 ' A' ' 107' ' ' LEU . 11.6 Cg_endo -58.73 151.15 65.78 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 121.701 1.601 . . . . 0.48 109.814 176.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -47.49 -31.87 4.67 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.544 0.572 . . . . 1.81 112.544 -178.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -56.97 -13.9 9.38 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.667 -0.778 . . . . 0.4 113.949 -178.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.59 HD23 ' HG2' ' A' ' 104' ' ' PRO . 2.8 mm? -115.19 -5.87 12.42 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 117.09 0.445 . . . . 2.35 111.788 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -109.41 -104.41 0.37 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.551 -0.295 . . . . 1.03 110.621 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -90.22 -17.24 27.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.96 0.41 . . . . 1.44 110.557 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 103.94 143.07 12.19 Favored Glycine 0 CA--C 1.522 0.471 0 CA-C-N 115.849 -0.614 . . . . 1.58 113.863 178.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.482 ' HA ' ' H ' ' A' ' 121' ' ' ASN . 18.8 Cg_endo -59.76 -8.43 7.51 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.542 2.828 . . . . 1.49 113.355 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.558 ' C ' ' H ' ' A' ' 114' ' ' VAL . 23.1 mtp180 -75.63 171.7 13.86 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.898 -0.321 . . . . 3.51 110.643 -178.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 38.1 t -55.9 3.12 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.059 -0.519 . . . . 1.63 112.244 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.558 ' H ' ' C ' ' A' ' 112' ' ' ARG . 31.0 m -96.52 19.67 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.75 0.309 . . . . 2.9 110.823 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -63.48 116.36 9.17 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.736 -0.745 . . . . 1.05 112.077 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -79.28 -115.38 0.24 Allowed Glycine 0 CA--C 1.521 0.448 0 C-N-CA 120.789 -0.72 . . . . 0.8 112.885 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -58.86 -35.43 98.62 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.283 1.989 . . . . 0.7 111.92 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.47 HG12 HD13 ' A' ' 124' ' ' LEU . 97.9 mt -91.07 124.65 43.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.993 -0.549 . . . . 1.25 110.273 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -45.55 155.21 0.5 Allowed Glycine 0 CA--C 1.522 0.481 0 CA-C-N 115.981 -0.554 . . . . 0.48 113.469 -179.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -62.11 131.02 32.73 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.282 1.988 . . . . 0.67 111.466 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.482 ' H ' ' HA ' ' A' ' 111' ' ' PRO . 1.8 m-80 47.92 35.32 4.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.073 0.463 . . . . 1.12 110.097 -178.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.452 ' HB3' HD11 ' A' ' 59' ' ' LEU . 11.3 mt-10 -115.6 135.39 54.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.044 -0.526 . . . . 1.73 110.904 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.525 ' O ' ' HB ' ' A' ' 60' ' ' ILE . 92.6 m -95.7 129.36 42.94 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.568 -0.53 . . . . 0.29 109.568 179.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.47 HD13 HG12 ' A' ' 118' ' ' ILE . 0.2 OUTLIER -117.45 150.48 38.84 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.168 0.509 . . . . 1.47 111.53 -178.593 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.536 ' N ' HD12 ' A' ' 125' ' ' ILE . 4.1 mp -113.48 140.56 33.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.567 -0.742 . . . . 0.2 110.08 179.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.413 ' CE1' HD22 ' A' ' 124' ' ' LEU . 74.9 m-85 -131.82 132.09 43.42 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.09 -0.505 . . . . 0.24 111.179 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -109.71 103.8 12.68 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.171 -0.677 . . . . 2.28 109.171 178.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 15.6 mt -102.81 122.58 55.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 112.634 0.605 . . . . 0.82 112.634 -177.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -118.26 100.09 7.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.243 -0.889 . . . . 0.26 108.74 178.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.6 ' HA ' HG12 ' A' ' 53' ' ' VAL . 0.8 OUTLIER -78.93 124.38 28.19 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.14 -0.482 . . . . 1.41 111.92 -178.047 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 35.3 mm -94.25 -50.52 11.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.642 -0.708 . . . . 1.17 110.09 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.463 ' HA ' ' HB1' ' A' ' 95' ' ' ALA . 51.9 p -164.5 165.12 21.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.922 -0.581 . . . . 1.17 110.244 179.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.65 HG22 HG12 ' A' ' 51' ' ' VAL . 96.8 t -130.72 117.86 40.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.803 0.335 . . . . 1.43 111.302 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 5.5 tmtp? 51.03 62.39 2.74 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.933 -0.576 . . . . 3.08 110.711 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 68.9 mttm 59.05 43.65 17.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.811 -0.631 . . . . 3.16 110.35 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 86.8 p 50.55 31.88 6.11 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.431 -0.804 . . . . 1.31 111.037 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 45.1 t . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.216 -0.897 . . . . 2.53 110.847 -179.873 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 . . . . . 0 N--CA 1.485 1.305 0 CA-C-O 120.81 0.338 . . . . 3.09 110.962 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -62.86 -21.73 66.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 2.08 111.153 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -61.52 -38.99 89.38 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.416 -0.587 . . . . 3.23 109.416 178.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -79.6 -34.74 40.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.557 -0.747 . . . . 2.63 109.622 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.485 ' HA ' ' ND2' ' A' ' 8' ' ' ASN . . . -57.65 -52.28 66.06 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.757 -0.656 . . . . 0.82 110.115 179.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -64.41 -36.15 83.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.784 -0.644 . . . . 2.57 109.484 178.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -55.68 -33.46 64.15 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.8 -0.815 . . . . 2.1 108.8 178.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.485 ' ND2' ' HA ' ' A' ' 5' ' ' ALA . 19.3 m-20 -69.1 -39.44 78.97 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 115.572 -0.74 . . . . 1.4 109.961 179.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -56.7 -32.4 65.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.709 -0.678 . . . . 2.67 111.037 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.8 t -78.03 -52.87 15.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.374 -0.375 . . . . 1.27 111.895 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.483 ' HG2' ' HA ' ' A' ' 8' ' ' ASN . 10.2 ptpp? -63.18 -26.06 68.63 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.895 0.379 . . . . 1.69 110.59 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.409 ' O ' ' HG ' ' A' ' 16' ' ' LEU . . . -75.76 -50.33 8.06 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.841 -0.695 . . . . 0.31 111.667 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.471 ' HA ' HD11 ' A' ' 16' ' ' LEU . 12.8 pt-20 -66.41 -27.56 67.94 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.873 0.368 . . . . 2.39 110.188 179.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.02 -34.19 61.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.096 -0.502 . . . . 0.23 110.491 179.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -63.75 -55.81 20.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.753 -0.658 . . . . 0.23 110.573 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.699 ' HA ' ' HB3' ' A' ' 19' ' ' ASN . 0.4 OUTLIER -64.16 -31.79 73.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.228 -0.442 . . . . 0.55 111.04 179.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.5 m -56.56 -47.65 79.01 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.607 -0.516 . . . . 0.27 109.607 179.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -73.61 -32.19 63.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.825 -0.625 . . . . 2.47 109.865 178.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.699 ' HB3' ' HA ' ' A' ' 16' ' ' LEU . 0.7 OUTLIER -59.09 -25.58 63.92 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.635 -0.711 . . . . 0.22 111.573 179.869 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -46.89 -20.21 0.13 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.536 -0.302 . . . . 2.45 111.605 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.712 HD22 ' N ' ' A' ' 21' ' ' ASN . 0.7 OUTLIER -68.67 -37.12 79.37 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.436 -0.347 . . . . 0.4 110.991 -179.482 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.805 ' O ' HG23 ' A' ' 25' ' ' VAL . 4.3 mptp? -50.53 118.83 10.2 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.067 -0.515 . . . . 1.4 110.251 179.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 22' ' ' LYS . 18.1 Cg_endo -57.06 147.06 77.48 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.33 2.02 . . . . 0.65 112.649 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.02 3.46 79.58 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.869 -0.681 . . . . 0.37 113.967 179.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.805 HG23 ' O ' ' A' ' 22' ' ' LYS . 38.1 t -55.09 106.43 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 117.563 0.681 . . . . 0.91 110.681 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.4 HG13 ' CE1' ' A' ' 34' ' ' TYR . 2.6 p -130.76 126.73 60.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.868 -0.605 . . . . 1.03 111.133 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.8 p -80.16 142.47 13.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.05 -0.523 . . . . 0.91 110.77 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.578 HD12 ' HB2' ' A' ' 32' ' ' LEU . 63.0 mt -101.73 167.85 9.95 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.476 -0.329 . . . . 0.4 110.673 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.46 ' HD2' ' HB3' ' A' ' 28' ' ' LEU . 71.4 Cg_exo -51.49 -31.95 41.3 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 121.923 1.748 . . . . 0.59 111.742 178.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.476 ' O ' HD22 ' A' ' 107' ' ' LEU . 30.3 t -86.44 -11.21 52.49 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.231 -0.44 . . . . 1.14 110.87 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.04 14.91 23.43 Favored Glycine 0 C--N 1.335 0.474 0 C-N-CA 120.563 -0.827 . . . . 0.34 114.298 178.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.748 HD11 ' CA ' ' A' ' 85' ' ' GLY . 6.8 mp -84.33 134.65 34.49 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.364 0.876 . . . . 1.35 113.364 -178.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.6 mp0 -114.28 142.54 46.17 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.082 -1.081 . . . . 1.75 108.082 177.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.484 ' CB ' HG22 ' A' ' 101' ' ' ILE . 27.8 p90 -158.97 175.18 13.87 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 113.173 0.805 . . . . 0.32 113.173 -178.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -122.48 117.3 25.61 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 114.768 -1.105 . . . . 2.15 109.536 179.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 66.6 t -77.3 126.25 37.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 113.424 0.898 . . . . 0.3 113.424 -178.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.405 ' HB ' ' O ' ' A' ' 98' ' ' THR . 78.0 mt -101.3 -65.99 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 115.408 -0.815 . . . . 0.65 109.872 178.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -129.84 95.54 3.99 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 116.394 -0.366 . . . . 1.03 110.094 178.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.713 ' HB3' ' HE1' ' A' ' 99' ' ' TRP . 68.2 p -105.15 145.88 29.97 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.262 0.467 . . . . 1.5 112.262 -178.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.92 103.18 0.07 OUTLIER Glycine 0 C--N 1.332 0.36 0 CA-C-N 115.686 -0.688 . . . . 1.09 113.168 179.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 54.6 m-80 -152.52 -82.56 0.09 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.691 0.282 . . . . 1.7 111.15 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.13 174.2 38.49 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 121.191 -0.528 . . . . 0.35 113.743 -179.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.619 ' O ' ' HB3' ' A' ' 44' ' ' LYS . 33.8 m -82.42 176.4 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 C-N-CA 123.401 0.68 . . . . 1.42 110.409 179.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.619 ' HB3' ' O ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER 165.1 156.54 0.08 OUTLIER Pre-proline 0 N--CA 1.471 0.591 0 CA-C-O 121.47 0.653 . . . . 2.18 112.33 -179.236 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.555 ' HD3' HG11 ' A' ' 133' ' ' VAL . 1.8 Cg_endo -85.36 173.47 7.63 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 125.082 3.854 . . . . 0.3 113.367 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' A' ' 48' ' ' SER . . . -68.28 -172.34 6.94 Favored Glycine 0 C--O 1.223 -0.572 0 CA-C-N 115.216 -0.902 . . . . 0.35 111.451 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -41.64 -13.48 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.763 1.023 . . . . 2.35 113.763 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 46' ' ' GLY . 50.5 m -86.16 7.51 24.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.46 0.647 . . . . 1.45 109.851 178.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.487 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 1.8 t70 -74.84 162.15 28.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.887 -1.051 . . . . 1.73 112.326 -179.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 90.3 m -125.56 133.85 52.16 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 108.752 -0.833 . . . . 0.44 108.752 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.636 HG12 HG22 ' A' ' 133' ' ' VAL . 30.1 m -131.74 140.37 48.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 112.807 0.669 . . . . 0.65 112.807 -178.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 89.4 m -112.98 119.86 39.39 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.083 -1.08 . . . . 0.32 108.083 177.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.568 HG12 ' HA ' ' A' ' 130' ' ' LEU . 5.0 m -146.4 -179.17 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.229 0.538 . . . . 0.24 111.943 -178.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -130.04 132.13 46.09 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.37 -0.832 . . . . 2.4 108.977 178.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -147.18 167.11 25.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.757 0.789 . . . . 0.26 112.412 -178.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 58.3 m -131.19 113.99 14.55 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.384 -1.28 . . . . 0.26 108.728 178.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.405 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -109.53 147.53 17.03 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 119.989 -1.1 . . . . 0.12 112.452 -178.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.34 145.93 31.4 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.046 0.451 . . . . 1.93 110.429 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.494 HD23 HD11 ' A' ' 124' ' ' LEU . 6.9 mt -79.9 153.39 29.04 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.688 -0.687 . . . . 1.21 110.255 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.497 ' HB ' ' O ' ' A' ' 123' ' ' THR . 0.4 OUTLIER -55.64 -14.35 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.401 0.619 . . . . 0.64 109.411 178.936 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -65.11 -10.87 34.07 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.266 -0.879 . . . . 2.01 110.93 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.02 0.03 75.14 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.547 -0.835 . . . . 0.45 113.837 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.0 t -121.64 131.53 54.15 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 117.646 0.723 . . . . 1.4 111.865 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 57' ' ' GLY . 3.9 p -61.68 134.35 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-N 115.709 -0.678 . . . . 0.28 110.049 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.69 ' HD1' ' H ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -97.66 -27.36 14.4 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.097 -0.501 . . . . 0.24 111.565 -179.882 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.69 ' H ' ' HD1' ' A' ' 65' ' ' PHE . 13.9 t70 -176.83 129.96 0.18 Allowed 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 120.619 0.247 . . . . 0.3 110.54 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 57.6 p -129.18 117.46 20.8 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.455 -0.339 . . . . 1.3 110.736 179.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 65.3 p -74.83 -12.35 60.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.065 0.459 . . . . 0.34 110.449 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -75.73 -46.91 28.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.632 -0.713 . . . . 2.11 111.25 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -71.18 -36.46 71.97 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.028 -0.533 . . . . 3.41 111.751 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 54.5 p -59.61 -12.62 7.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.788 0.327 . . . . 1.47 111.296 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 75.01 8.47 83.06 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.795 -0.717 . . . . 0.7 112.415 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -122.97 117.75 28.4 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.572 0.225 . . . . 3.05 110.875 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.09 153.18 16.54 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.667 2.245 . . . . 0.51 112.6 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -96.58 124.74 40.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.022 -0.535 . . . . 0.23 110.448 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.8 t -130.44 118.19 20.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.089 0.471 . . . . 1.26 111.297 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -158.54 161.82 37.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.022 -0.535 . . . . 0.36 111.108 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.54 HE21 ' H ' ' A' ' 80' ' ' SER . 0.0 OUTLIER -81.66 146.5 30.01 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.12 -0.491 . . . . 1.58 109.965 179.143 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 87' ' ' THR . 20.0 m -66.54 -30.88 51.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 112.771 0.656 . . . . 1.07 112.771 -178.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.54 ' H ' HE21 ' A' ' 78' ' ' GLN . 46.8 t -95.76 -6.39 39.82 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 112.438 0.533 . . . . 1.14 112.438 -178.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -84.92 5.66 28.13 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 111.89 0.33 . . . . 2.08 111.89 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.408 HG21 ' HB3' ' A' ' 86' ' ' TRP . 3.7 m -110.41 -173.37 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 111.749 0.277 . . . . 0.45 111.749 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.464 HG13 ' H ' ' A' ' 86' ' ' TRP . 45.4 pt -56.03 156.43 10.25 Favored Pre-proline 0 CA--C 1.53 0.2 0 CA-C-N 116.428 -0.351 . . . . 0.75 111.631 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -46.07 -59.56 1.16 Allowed 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.858 2.372 . . . . 0.65 113.262 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.748 ' CA ' HD11 ' A' ' 32' ' ' LEU . . . -50.9 -49.46 41.87 Favored Glycine 0 CA--C 1.521 0.454 0 C-N-CA 120.858 -0.686 . . . . 0.31 113.114 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . 0.464 ' H ' HG13 ' A' ' 83' ' ' ILE . 0.3 OUTLIER -61.72 -38.51 88.17 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.915 0.339 . . . . 0.78 111.915 -178.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' ' 79' ' ' VAL . 50.6 m -61.02 -35.55 77.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.721 0.296 . . . . 1.4 111.35 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -70.38 -42.64 71.46 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.279 -0.418 . . . . 1.43 111.798 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.544 ' HB2' HD22 ' A' ' 32' ' ' LEU . . . -75.51 -51.99 11.68 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.429 0.529 . . . . 0.33 112.429 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -54.93 -39.35 68.76 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.432 0.53 . . . . 0.39 112.432 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -67.23 -9.59 41.95 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.667 0.27 . . . . 1.87 111.443 -179.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 83.2 mt -103.42 -7.88 20.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.433 -0.349 . . . . 1.31 111.019 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.402 ' HE2' ' HE3' ' A' ' 99' ' ' TRP . 68.0 mtt -85.95 110.07 27.61 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.315 -0.402 . . . . 1.66 111.641 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.534 ' HG2' ' HB3' ' A' ' 97' ' ' SER . 74.3 Cg_endo -74.67 147.28 35.22 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.35 2.033 . . . . 0.44 111.477 179.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.594 ' HA ' HD23 ' A' ' 130' ' ' LEU . . . -50.02 126.72 15.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.505 -0.316 . . . . 0.36 111.594 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 94.97 -8.84 70.43 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 120.717 -0.754 . . . . 0.34 113.148 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.534 ' HB3' ' HG2' ' A' ' 94' ' ' PRO . 98.4 p -70.57 -176.52 1.29 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.926 0.393 . . . . 1.41 111.417 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.405 ' O ' ' HB ' ' A' ' 37' ' ' ILE . 24.3 m -159.03 97.44 1.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.762 -0.654 . . . . 0.23 110.605 -179.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.713 ' HE1' ' HB3' ' A' ' 39' ' ' SER . 34.9 m0 -115.11 149.06 38.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.233 0.54 . . . . 0.53 111.717 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.424 ' O ' ' HB2' ' A' ' 34' ' ' TYR . 27.0 tt0 -115.16 107.23 15.04 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.827 -1.175 . . . . 1.37 107.827 177.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.484 HG22 ' CB ' ' A' ' 34' ' ' TYR . 13.8 pt -114.58 140.57 34.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 113.602 0.964 . . . . 0.25 113.602 -177.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -120.58 104.33 9.86 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.959 -1.126 . . . . 0.31 107.959 177.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.59 HG13 HD12 ' A' ' 107' ' ' LEU . 52.9 t -93.35 98.23 2.37 Favored Pre-proline 0 C--N 1.329 -0.284 0 N-CA-C 113.563 0.949 . . . . 0.52 113.563 -177.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.458 ' HD2' ' HA ' ' A' ' 103' ' ' VAL . 6.9 Cg_endo -53.08 150.94 22.69 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.267 1.978 . . . . 0.48 111.407 177.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.555 ' HB2' ' HA3' ' A' ' 110' ' ' GLY . 3.5 p -48.02 -43.36 29.94 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.293 0.479 . . . . 1.81 112.293 -179.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -57.32 -9.14 4.14 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 115.384 0.914 . . . . 0.4 115.384 -177.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.59 HD12 HG13 ' A' ' 103' ' ' VAL . 46.3 mt -91.64 -19.27 22.86 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 118.244 1.022 . . . . 2.35 112.937 -178.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.429 ' HB2' HD12 ' A' ' 83' ' ' ILE . . . -130.05 -125.53 0.21 Allowed 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.761 -0.376 . . . . 1.03 111.769 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.406 ' HE2' HG22 ' A' ' 83' ' ' ILE . 88.5 m-85 -89.23 4.72 47.74 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.198 0.523 . . . . 1.44 110.147 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.555 ' HA3' ' HB2' ' A' ' 105' ' ' SER . . . -38.51 -79.0 0.04 OUTLIER Glycine 0 CA--C 1.524 0.628 0 CA-C-N 115.047 -0.978 . . . . 1.58 114.986 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -56.62 -9.86 4.44 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 123.339 2.692 . . . . 1.49 113.865 -177.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.409 ' C ' ' H ' ' A' ' 114' ' ' VAL . 40.6 mmt180 -79.48 139.71 37.53 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.897 -0.408 . . . . 3.51 109.897 179.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 79.6 p -63.12 -2.12 1.21 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.991 0.424 . . . . 1.63 111.193 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.429 HG13 ' O ' ' A' ' 114' ' ' VAL . 7.9 p -110.65 60.55 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.85 -0.613 . . . . 2.9 110.612 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -41.92 100.93 0.02 OUTLIER Glycine 0 C--N 1.334 0.457 0 CA-C-N 115.695 -0.684 . . . . 1.05 112.848 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -69.21 -128.87 0.05 OUTLIER Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.878 -0.677 . . . . 0.8 112.324 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_exo -60.46 -36.66 85.6 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 121.901 1.734 . . . . 0.7 111.093 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.59 HG23 HD12 ' A' ' 124' ' ' LEU . 94.8 mt -92.37 134.03 31.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.5 -0.773 . . . . 1.25 109.944 178.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -48.55 146.69 5.53 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.526 -0.845 . . . . 0.48 112.244 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -54.78 130.54 40.98 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.265 1.976 . . . . 0.67 111.861 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 42.75 35.16 0.66 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.033 -0.531 . . . . 1.12 110.65 -179.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.453 ' OE1' HD22 ' A' ' 59' ' ' LEU . 24.5 tt0 -116.54 142.86 46.33 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.826 -0.625 . . . . 1.73 111.074 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.54 HG21 HD23 ' A' ' 16' ' ' LEU . 92.7 m -95.66 129.53 42.83 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.548 -0.538 . . . . 0.29 109.548 178.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.59 HD12 HG23 ' A' ' 118' ' ' ILE . 0.1 OUTLIER -113.93 154.55 27.37 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.358 0.599 . . . . 1.47 112.279 -177.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.5 mp -113.92 140.75 32.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.174 -0.921 . . . . 0.2 109.585 178.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.457 ' CE1' HD22 ' A' ' 124' ' ' LEU . 82.2 m-85 -135.47 131.97 36.78 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.024 0.44 . . . . 0.24 111.445 -179.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.432 ' NZ ' ' HB3' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -114.4 102.8 10.44 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.189 -1.041 . . . . 2.28 108.189 177.87 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.441 HG23 HG21 ' A' ' 53' ' ' VAL . 12.2 mt -103.73 130.58 53.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 112.684 0.624 . . . . 0.82 112.684 -177.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -117.88 101.01 7.95 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.129 -0.941 . . . . 0.26 108.919 178.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.594 HD23 ' HA ' ' A' ' 95' ' ' ALA . 0.3 OUTLIER -78.5 123.29 26.9 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.119 0.485 . . . . 1.41 111.814 -178.274 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 58.6 mt -93.39 -53.13 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 115.518 -0.765 . . . . 1.17 110.92 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.469 ' HA ' ' HB1' ' A' ' 95' ' ' ALA . 60.7 p -164.53 165.57 21.12 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.055 0.455 . . . . 1.17 111.259 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.636 HG22 HG12 ' A' ' 51' ' ' VAL . 2.1 t -111.84 126.09 69.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.642 -0.708 . . . . 1.43 110.772 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 18.2 tttt 44.52 57.38 4.47 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.93 -0.577 . . . . 3.08 110.917 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm 60.85 34.5 19.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.572 -0.74 . . . . 3.16 111.336 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.439 ' HB2' ' HB2' ' A' ' 132' ' ' SER . 39.0 t 55.42 64.27 1.82 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.852 -0.613 . . . . 1.31 111.205 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 53.6 m . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.3 -0.857 . . . . 2.53 110.821 179.762 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 . . . . . 0 N--CA 1.485 1.306 0 CA-C-O 120.755 0.312 . . . . 3.09 110.841 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -67.45 -18.83 65.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 2.08 110.895 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -58.51 -40.32 82.52 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.663 -0.495 . . . . 3.23 109.663 179.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -78.78 -34.41 45.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.77 -0.65 . . . . 2.63 109.89 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.494 ' HB1' ' ND2' ' A' ' 121' ' ' ASN . . . -58.97 -52.43 65.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.875 -0.602 . . . . 0.82 110.127 179.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -63.96 -35.23 80.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.725 -0.671 . . . . 2.57 110.218 179.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -55.92 -32.58 63.9 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.334 -0.617 . . . . 2.1 109.334 178.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 13.7 m-20 -74.07 -37.46 64.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.445 -0.798 . . . . 1.4 110.826 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 52.6 tptt -63.9 -38.51 91.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 2.67 111.64 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.404 HG23 ' N ' ' A' ' 11' ' ' LYS . 16.1 m -71.58 -48.44 52.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 C-N-CA 121.189 -0.204 . . . . 1.27 111.514 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.497 ' HG3' HG21 ' A' ' 60' ' ' ILE . 18.1 ptpt -68.81 -25.71 64.82 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.835 0.35 . . . . 1.69 110.486 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.62 -53.26 8.63 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 121.066 -0.588 . . . . 0.31 112.143 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.412 ' HA ' HD11 ' A' ' 16' ' ' LEU . 43.8 tt0 -62.13 -27.89 69.25 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.096 0.474 . . . . 2.39 110.313 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.13 -30.63 49.43 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.951 -0.568 . . . . 0.23 110.423 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -65.94 -52.73 47.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.752 -0.658 . . . . 0.23 110.612 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.663 ' HA ' ' HB3' ' A' ' 19' ' ' ASN . 0.4 OUTLIER -67.62 -32.06 72.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.268 -0.424 . . . . 0.55 111.078 179.91 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.2 m -56.67 -47.58 79.5 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 109.748 -0.464 . . . . 0.27 109.748 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -73.05 -32.52 65.1 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.859 -0.61 . . . . 2.47 109.812 178.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.663 ' HB3' ' HA ' ' A' ' 16' ' ' LEU . 0.6 OUTLIER -59.46 -25.01 64.03 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.439 -0.8 . . . . 0.22 111.582 179.829 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -49.97 -20.35 0.91 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.518 -0.31 . . . . 2.45 111.722 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.745 HD22 ' N ' ' A' ' 21' ' ' ASN . 0.7 OUTLIER -68.96 -33.13 73.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.378 -0.374 . . . . 0.4 111.53 -178.98 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.663 ' O ' HG23 ' A' ' 25' ' ' VAL . 12.6 mptt -48.35 118.69 6.97 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 116.188 -0.46 . . . . 1.4 110.906 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.46 ' O ' ' HG2' ' A' ' 35' ' ' LYS . 32.1 Cg_exo -57.52 139.18 89.38 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.316 2.011 . . . . 0.65 112.651 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.83 3.39 80.27 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 120.863 -0.684 . . . . 0.37 114.025 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.663 HG23 ' O ' ' A' ' 22' ' ' LYS . 4.0 t -53.52 117.67 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.175 0 CA-C-N 117.425 0.613 . . . . 0.91 110.826 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 33' ' ' GLN . 4.3 p -129.87 128.16 64.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.064 -0.516 . . . . 1.03 111.061 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.3 p -85.69 141.97 13.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.459 . . . . 0.91 111.078 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.537 HD12 ' HB2' ' A' ' 32' ' ' LEU . 41.5 mt -104.1 165.34 13.57 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.011 -0.541 . . . . 0.4 110.609 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.45 ' HD2' ' HB3' ' A' ' 28' ' ' LEU . 72.2 Cg_exo -50.48 -38.34 53.64 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.179 1.919 . . . . 0.59 112.26 179.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.421 ' OG ' ' HG3' ' A' ' 88' ' ' GLU . 7.3 m -80.76 -9.59 59.79 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.2 -0.454 . . . . 1.14 111.368 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.3 14.52 27.99 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.331 -0.938 . . . . 0.34 113.48 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.537 ' HB2' HD12 ' A' ' 28' ' ' LEU . 0.4 OUTLIER -83.11 134.86 34.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.45 0.643 . . . . 1.35 112.168 -179.28 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.422 ' HA ' ' O ' ' A' ' 26' ' ' VAL . 47.4 mt-30 -123.34 143.0 50.38 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.984 -1.007 . . . . 1.75 108.636 178.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.799 ' HB3' HG22 ' A' ' 101' ' ' ILE . 48.3 p90 -157.83 175.39 13.93 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.809 0.67 . . . . 0.32 112.809 -178.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.46 ' HG2' ' O ' ' A' ' 23' ' ' PRO . 3.5 tmmm? -122.2 118.94 29.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.001 -0.999 . . . . 2.15 109.321 178.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.646 HG13 ' HE1' ' A' ' 99' ' ' TRP . 48.5 t -71.93 125.61 30.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 113.279 0.844 . . . . 0.3 113.279 -177.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.3 mp -98.81 -66.24 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.319 -0.855 . . . . 0.65 110.11 178.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.508 ' ND2' HD21 ' A' ' 41' ' ' ASN . 7.3 t30 -144.89 90.51 2.06 Favored 'General case' 0 CA--C 1.527 0.062 0 CA-C-N 116.471 -0.332 . . . . 1.03 110.166 179.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.637 ' HB3' ' HE1' ' A' ' 99' ' ' TRP . 94.9 p -105.32 145.98 30.0 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.932 0.396 . . . . 1.5 112.006 -178.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 91.59 94.4 1.33 Allowed Glycine 0 C--N 1.332 0.352 0 CA-C-N 115.854 -0.612 . . . . 1.09 112.764 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.508 HD21 ' ND2' ' A' ' 38' ' ' ASN . 35.4 m-80 -150.93 -81.89 0.1 Allowed 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 111.776 0.287 . . . . 1.7 111.776 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.09 178.53 42.01 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 121.088 -0.577 . . . . 0.35 114.161 -178.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.621 ' O ' ' HB3' ' A' ' 44' ' ' LYS . 27.3 m -90.32 176.89 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 123.729 0.812 . . . . 1.42 110.33 179.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.621 ' HB3' ' O ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER 165.08 156.6 0.08 OUTLIER Pre-proline 0 N--CA 1.472 0.668 0 CA-C-O 121.486 0.66 . . . . 2.18 112.172 -179.61 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.431 ' HD2' HG21 ' A' ' 133' ' ' VAL . 2.8 Cg_exo -77.72 173.52 14.0 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 124.752 3.634 . . . . 0.3 112.955 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.492 ' O ' ' N ' ' A' ' 48' ' ' SER . . . -67.54 -172.84 6.28 Favored Glycine 0 N--CA 1.448 -0.5 0 CA-C-N 115.368 -0.833 . . . . 0.35 111.037 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.432 ' HE3' ' NE2' ' A' ' 91' ' ' GLN . 9.2 ptpp? -41.88 -13.88 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.707 1.003 . . . . 2.35 113.707 -177.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 46' ' ' GLY . 84.5 p -86.54 7.37 26.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.065 0.459 . . . . 1.45 110.522 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.411 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 4.0 p30 -72.08 156.14 39.52 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.71 -0.677 . . . . 1.73 111.993 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 26.0 m -126.67 119.72 27.69 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 108.481 -0.933 . . . . 0.44 108.481 178.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.471 HG12 ' HA ' ' A' ' 133' ' ' VAL . 14.3 m -128.67 158.4 41.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.222 0.534 . . . . 0.65 112.326 -178.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 94.2 m -113.78 120.8 42.05 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.337 -0.847 . . . . 0.32 109.115 178.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.693 HG11 HD22 ' A' ' 130' ' ' LEU . 6.1 m -139.4 170.11 16.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.137 0.494 . . . . 0.24 111.6 -178.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -124.05 132.31 53.66 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.375 -0.83 . . . . 2.4 109.128 178.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.408 ' HB2' ' O ' ' A' ' 127' ' ' LYS . 14.7 p90 -144.05 164.6 30.17 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.683 0.754 . . . . 0.26 112.491 -178.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 37.9 m -123.56 113.39 18.64 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.426 -1.261 . . . . 0.26 108.565 178.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.467 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -110.02 143.81 16.79 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 119.684 -1.246 . . . . 0.12 112.677 -178.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.466 ' NH2' ' HA2' ' A' ' 62' ' ' GLY . 0.5 OUTLIER -147.62 147.0 29.57 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.004 0.431 . . . . 1.93 110.589 179.552 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.48 HD22 ' OE1' ' A' ' 122' ' ' GLU . 3.8 mt -78.83 158.03 28.24 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.858 -0.61 . . . . 1.21 110.254 179.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.497 HG21 ' HG3' ' A' ' 11' ' ' LYS . 0.4 OUTLIER -58.16 -14.21 3.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 108.957 -0.757 . . . . 0.64 108.957 178.64 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -63.64 -12.48 34.05 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.14 -0.936 . . . . 2.01 110.837 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.466 ' HA2' ' NH2' ' A' ' 58' ' ' ARG . . . 91.15 -0.31 75.31 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 120.634 -0.793 . . . . 0.45 113.673 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.3 t -119.85 132.46 55.58 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 117.374 0.587 . . . . 1.4 111.507 -178.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 57' ' ' GLY . 6.2 p -61.18 134.7 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 115.807 -0.633 . . . . 0.28 109.906 179.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.646 ' HD1' ' H ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -97.5 -26.54 14.79 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.241 -0.436 . . . . 0.24 111.266 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.646 ' H ' ' HD1' ' A' ' 65' ' ' PHE . 16.3 t70 -176.33 129.98 0.21 Allowed 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 120.809 0.338 . . . . 0.3 111.085 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 62.4 m -123.79 123.89 41.48 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.235 -0.439 . . . . 1.3 110.452 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.871 HG21 ' HB2' ' A' ' 75' ' ' ALA . 33.7 p -70.56 -8.41 51.2 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.94 0.4 . . . . 0.34 110.652 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -75.39 -46.85 30.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.861 -0.609 . . . . 2.11 110.794 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -61.94 -38.7 89.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.981 -0.554 . . . . 3.41 111.304 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 14.2 m -60.73 -13.54 15.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.143 0.496 . . . . 1.47 110.182 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 73.8 3.54 63.92 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.69 -0.687 . . . . 0.7 112.351 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -127.21 124.68 23.85 Favored Pre-proline 0 C--N 1.33 -0.262 0 C-N-CA 121.325 -0.15 . . . . 3.05 111.071 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -53.75 162.68 3.45 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.284 1.989 . . . . 0.51 111.517 179.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.871 ' HB2' HG21 ' A' ' 68' ' ' THR . . . -93.94 124.31 37.86 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.446 -0.343 . . . . 0.23 110.812 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 27.5 m -123.87 116.22 22.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.751 0.31 . . . . 1.26 111.079 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -158.72 159.46 35.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 0.36 111.34 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.608 HE21 ' H ' ' A' ' 80' ' ' SER . 0.0 OUTLIER -81.48 143.74 31.85 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 108.983 -0.747 . . . . 1.58 108.983 178.317 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.411 ' N ' HE21 ' A' ' 78' ' ' GLN . 10.8 m -70.83 -14.4 17.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 113.008 0.744 . . . . 1.07 113.008 -178.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.608 ' H ' HE21 ' A' ' 78' ' ' GLN . 66.0 m -95.49 -19.18 20.05 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.197 0.443 . . . . 1.14 112.197 -179.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.445 ' HG2' ' HB3' ' A' ' 78' ' ' GLN . 78.2 mm-40 -79.62 6.26 11.06 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.412 0.523 . . . . 2.08 112.412 -179.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.4 m -111.25 -175.7 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 112.685 0.624 . . . . 0.45 112.685 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.488 HD12 HD12 ' A' ' 107' ' ' LEU . 42.4 pt -56.12 160.45 4.75 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 115.836 -0.62 . . . . 0.75 112.595 -179.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.637 ' O ' HG22 ' A' ' 87' ' ' THR . 78.1 Cg_exo -47.86 -60.75 0.76 Allowed 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 123.102 2.535 . . . . 0.65 114.204 -178.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 1.004 ' H ' HD11 ' A' ' 107' ' ' LEU . . . -53.17 -48.3 59.28 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.759 -0.734 . . . . 0.31 113.386 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . 0.4 ' HB2' HG13 ' A' ' 83' ' ' ILE . 0.9 OUTLIER -54.81 -47.95 73.38 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.798 0.666 . . . . 0.78 112.798 -178.567 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.637 HG22 ' O ' ' A' ' 84' ' ' PRO . 11.6 t -62.68 -33.87 75.97 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.713 -0.395 . . . . 1.4 111.779 -179.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.486 ' O ' ' HG2' ' A' ' 91' ' ' GLN . 18.3 mm-40 -70.79 -40.85 72.3 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.924 0.342 . . . . 1.43 111.924 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.84 -49.45 17.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.871 0.367 . . . . 0.33 111.585 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.559 HD13 ' SD ' ' A' ' 93' ' ' MET . 3.5 mm? -55.87 -41.33 74.24 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.888 -0.596 . . . . 0.39 112.06 -179.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.486 ' HG2' ' O ' ' A' ' 88' ' ' GLU . 3.2 pt20 -65.41 -3.76 4.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.635 -0.257 . . . . 1.87 111.636 -179.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 94.7 mt -104.97 -29.61 10.35 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.713 0.264 . . . . 1.31 111.713 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.559 ' SD ' HD13 ' A' ' 90' ' ' LEU . 24.0 ptp -81.91 111.05 23.5 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-O 120.615 0.245 . . . . 1.66 111.537 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.87 147.18 61.59 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.227 1.952 . . . . 0.44 111.45 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.58 ' HB1' ' HA ' ' A' ' 132' ' ' SER . . . -46.35 127.15 8.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.469 -0.332 . . . . 0.36 111.115 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 103.56 -7.61 50.6 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.896 -0.669 . . . . 0.34 112.717 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 66.4 m -79.94 -175.47 4.96 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.845 0.355 . . . . 1.41 111.39 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 14.1 m -156.75 104.09 2.12 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.032 -0.531 . . . . 0.23 111.083 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.646 ' HE1' HG13 ' A' ' 36' ' ' VAL . 30.5 m0 -125.15 149.23 48.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.252 -0.431 . . . . 0.53 111.058 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.417 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 12.6 pt-20 -119.05 108.52 14.82 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.556 -0.905 . . . . 1.37 108.556 177.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.799 HG22 ' HB3' ' A' ' 34' ' ' TYR . 37.3 pt -108.17 139.67 29.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 112.963 0.727 . . . . 0.25 112.963 -177.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.416 ' OH ' HG22 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -113.95 103.91 11.63 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.783 -1.192 . . . . 0.31 107.783 177.886 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.492 HG11 HD12 ' A' ' 107' ' ' LEU . 40.7 t -94.57 102.04 7.98 Favored Pre-proline 0 C--N 1.329 -0.296 0 N-CA-C 113.78 1.03 . . . . 0.52 113.78 -176.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.46 ' HA ' HG23 ' A' ' 123' ' ' THR . 9.3 Cg_endo -56.07 149.89 50.75 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.192 1.928 . . . . 0.48 111.085 177.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.489 ' HB2' ' HA3' ' A' ' 110' ' ' GLY . 4.4 p -49.11 -43.26 41.23 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.247 0.462 . . . . 1.81 112.247 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -56.24 -8.42 2.45 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 115.19 0.836 . . . . 0.4 115.19 -177.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 1.004 HD11 ' H ' ' A' ' 85' ' ' GLY . 1.1 tm? -82.25 -31.75 30.02 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 117.863 0.831 . . . . 2.35 112.748 -178.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.439 ' HB2' ' HB ' ' A' ' 83' ' ' ILE . . . -129.45 -118.5 0.24 Allowed 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.375 -0.53 . . . . 1.03 112.382 -178.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -89.09 4.74 47.41 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 121.15 0.5 . . . . 1.44 110.567 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.489 ' HA3' ' HB2' ' A' ' 105' ' ' SER . . . -42.4 -76.78 0.1 OUTLIER Glycine 0 CA--C 1.524 0.607 0 CA-C-N 115.129 -0.941 . . . . 1.58 115.001 -179.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -55.81 -9.93 3.45 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 123.315 2.677 . . . . 1.49 113.904 -177.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.408 ' C ' ' H ' ' A' ' 114' ' ' VAL . 96.2 mtt180 -79.8 139.27 37.29 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.631 -0.507 . . . . 3.51 109.631 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 66.4 m -61.68 -6.35 2.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.247 0.546 . . . . 1.63 110.485 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.408 ' H ' ' C ' ' A' ' 112' ' ' ARG . 7.9 t -111.25 60.45 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.147 -0.933 . . . . 2.9 110.631 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -54.58 117.7 8.35 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.975 -0.631 . . . . 1.05 112.956 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -73.92 -115.38 0.08 OUTLIER Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.751 -0.738 . . . . 0.8 112.214 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.71 -35.8 35.31 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.127 1.885 . . . . 0.7 112.019 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.497 HG23 HD12 ' A' ' 124' ' ' LEU . 92.6 mt -91.45 135.66 26.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.069 -0.514 . . . . 1.25 110.322 179.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -46.97 148.3 2.88 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.748 -0.739 . . . . 0.48 112.087 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -56.05 130.03 38.09 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.119 1.88 . . . . 0.67 111.986 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.494 ' ND2' ' HB1' ' A' ' 5' ' ' ALA . 2.3 m-20 41.49 35.45 0.45 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.792 -0.64 . . . . 1.12 110.878 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.48 ' OE1' HD22 ' A' ' 59' ' ' LEU . 20.9 tt0 -116.89 145.86 43.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.881 -0.6 . . . . 1.73 111.258 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.468 ' O ' ' HB ' ' A' ' 60' ' ' ILE . 90.6 m -95.2 134.04 38.39 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.646 -0.501 . . . . 0.29 109.646 179.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.497 HD12 HG23 ' A' ' 118' ' ' ILE . 0.1 OUTLIER -120.55 156.54 31.36 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.342 0.592 . . . . 1.47 112.46 -178.249 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.406 HD12 ' N ' ' A' ' 125' ' ' ILE . 4.4 mp -113.85 148.17 16.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.128 -0.942 . . . . 0.2 109.467 178.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.459 ' CE1' HD22 ' A' ' 124' ' ' LEU . 81.2 m-85 -139.96 132.28 28.34 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.166 0.508 . . . . 0.24 111.761 -179.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.408 ' O ' ' HB2' ' A' ' 55' ' ' TYR . 2.2 tmtp? -110.91 104.04 12.6 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.575 -0.898 . . . . 2.28 108.575 178.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.534 ' N ' HD12 ' A' ' 128' ' ' ILE . 4.1 mp -102.12 127.19 55.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.377 0.608 . . . . 0.82 112.582 -177.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -118.38 99.97 7.18 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.036 -0.984 . . . . 0.26 108.492 177.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.693 HD22 HG11 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -77.94 120.95 23.52 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.122 -0.49 . . . . 1.41 111.135 -178.39 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 49.7 mm -94.9 -56.22 5.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.852 -0.613 . . . . 1.17 110.946 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.58 ' HA ' ' HB1' ' A' ' 95' ' ' ALA . 89.8 p -163.4 164.66 24.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.003 0.43 . . . . 1.17 111.351 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.471 ' HA ' HG12 ' A' ' 51' ' ' VAL . 7.1 p -107.93 127.24 64.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.904 -0.589 . . . . 1.43 111.054 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 12.8 tttp 45.34 -149.22 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.255 -0.43 . . . . 3.08 110.785 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -64.65 -5.4 5.6 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.226 -0.443 . . . . 3.16 110.979 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 32.9 t 65.42 82.6 0.18 Allowed 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.935 -0.575 . . . . 1.31 110.953 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 81.6 p . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.17 -0.919 . . . . 2.53 111.387 179.885 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.713 0.292 . . . . 3.09 110.84 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 26.2 p30 -63.61 -18.82 64.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.297 -0.411 . . . . 2.08 111.077 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -56.94 -40.88 77.22 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.614 -0.513 . . . . 3.23 109.614 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -79.76 -36.91 36.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.583 -0.735 . . . . 2.63 110.464 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -56.58 -51.94 66.7 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 116.145 -0.479 . . . . 0.82 110.386 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -67.59 -33.37 74.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.837 -0.62 . . . . 2.57 110.226 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.421 ' O ' ' HG2' ' A' ' 11' ' ' LYS . 41.3 tt0 -55.58 -33.53 64.0 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 109.096 -0.705 . . . . 2.1 109.096 178.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.496 ' HA ' ' HE2' ' A' ' 11' ' ' LYS . 10.1 m-20 -75.54 -38.42 59.31 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.371 -0.831 . . . . 1.4 110.286 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -56.24 -38.82 71.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.75 -0.659 . . . . 2.67 111.605 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.43 HG23 ' N ' ' A' ' 11' ' ' LYS . 18.6 m -78.33 -49.81 20.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 112.639 0.607 . . . . 1.27 112.639 -178.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.496 ' HE2' ' HA ' ' A' ' 8' ' ' ASN . 61.1 pttt -66.94 -26.25 66.75 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 120.861 -0.336 . . . . 1.69 111.445 -179.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.42 ' O ' ' HG ' ' A' ' 16' ' ' LEU . . . -76.41 -53.43 5.56 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.734 -0.746 . . . . 0.31 112.313 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.421 ' HA ' HD11 ' A' ' 16' ' ' LEU . 20.4 tp10 -61.86 -28.21 69.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.096 0.474 . . . . 2.39 110.604 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.3 -36.46 46.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.839 -0.619 . . . . 0.23 110.747 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -59.82 -53.71 54.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.076 -0.511 . . . . 0.23 110.617 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.684 ' HA ' ' HB3' ' A' ' 19' ' ' ASN . 0.4 OUTLIER -66.59 -33.77 76.4 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.737 -0.385 . . . . 0.55 111.101 -179.784 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.1 m -57.43 -45.96 84.08 Favored 'General case' 0 N--CA 1.456 -0.125 0 N-CA-C 109.622 -0.51 . . . . 0.27 109.622 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -74.35 -32.38 62.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.91 -0.586 . . . . 2.47 109.9 178.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.684 ' HB3' ' HA ' ' A' ' 16' ' ' LEU . 0.4 OUTLIER -57.58 -26.46 61.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.514 -0.767 . . . . 0.22 111.497 -179.822 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -49.19 -19.2 0.43 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.169 -0.469 . . . . 2.45 111.824 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.716 HD22 ' N ' ' A' ' 21' ' ' ASN . 0.8 OUTLIER -68.46 -31.87 71.47 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.192 0.441 . . . . 0.4 112.192 -178.482 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.643 ' O ' HG23 ' A' ' 25' ' ' VAL . 27.2 mmtm -52.97 119.21 15.66 Favored Pre-proline 0 CA--C 1.531 0.237 0 C-N-CA 121.322 -0.151 . . . . 1.4 110.619 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -57.86 143.64 95.34 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.189 1.926 . . . . 0.65 112.278 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.75 2.94 81.08 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.858 -0.687 . . . . 0.37 113.705 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 22' ' ' LYS . 5.9 t -59.73 120.86 6.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 117.167 0.483 . . . . 0.91 110.481 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.3 p -130.17 133.32 64.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 1.03 111.204 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.5 p -92.37 137.04 23.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.145 -0.479 . . . . 0.91 110.745 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.474 ' HB2' ' HB2' ' A' ' 32' ' ' LEU . 35.1 mt -100.94 162.94 19.05 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 0.4 110.751 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -53.26 -30.72 52.82 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.176 1.917 . . . . 0.59 112.309 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.531 ' O ' HD12 ' A' ' 107' ' ' LEU . 30.9 t -84.32 -10.08 57.91 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.175 -0.466 . . . . 1.14 111.551 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.27 15.49 25.48 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.367 -0.92 . . . . 0.34 112.595 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.506 HD21 ' HA2' ' A' ' 85' ' ' GLY . 2.6 mm? -80.86 133.54 35.6 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.222 0.535 . . . . 1.35 112.05 -178.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -126.07 138.27 53.69 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.329 -0.85 . . . . 1.75 109.175 178.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.751 ' HB3' HG22 ' A' ' 101' ' ' ILE . 38.6 p90 -160.84 174.81 13.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.269 0.557 . . . . 0.32 112.361 -178.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -121.71 117.51 26.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.198 -0.91 . . . . 2.15 109.3 178.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.472 HG13 ' HE1' ' A' ' 99' ' ' TRP . 86.9 t -72.56 125.53 31.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 113.081 0.771 . . . . 0.3 113.081 -178.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.411 HD12 HG22 ' A' ' 98' ' ' THR . 64.6 mt -102.3 -64.2 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.387 -0.824 . . . . 0.65 110.125 178.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.517 ' ND2' HD21 ' A' ' 41' ' ' ASN . 9.7 t30 -139.46 89.49 2.34 Favored 'General case' 0 CA--C 1.528 0.099 0 CA-C-N 116.37 -0.377 . . . . 1.03 110.192 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.796 ' HB2' ' HE1' ' A' ' 99' ' ' TRP . 31.9 t -105.37 146.2 29.75 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 112.334 0.494 . . . . 1.5 112.334 -178.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 87.31 95.65 0.9 Allowed Glycine 0 C--N 1.332 0.341 0 CA-C-N 115.684 -0.689 . . . . 1.09 112.936 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.517 HD21 ' ND2' ' A' ' 38' ' ' ASN . 43.3 m-80 -150.72 -83.65 0.09 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 111.675 0.25 . . . . 1.7 111.675 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.51 178.01 41.05 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 121.061 -0.59 . . . . 0.35 114.285 -178.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.742 HG22 ' H ' ' A' ' 44' ' ' LYS . 9.3 p -90.68 178.38 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 123.666 0.786 . . . . 1.42 109.688 178.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.742 ' H ' HG22 ' A' ' 43' ' ' VAL . 12.6 pttm 165.95 157.66 0.1 OUTLIER Pre-proline 0 N--CA 1.47 0.55 0 CA-C-O 121.482 0.658 . . . . 2.18 112.628 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.672 ' HD3' HG21 ' A' ' 133' ' ' VAL . 1.3 Cg_endo -85.03 173.79 7.75 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 125.061 3.841 . . . . 0.3 113.767 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.462 ' O ' ' N ' ' A' ' 48' ' ' SER . . . -68.05 -171.66 6.22 Favored Glycine 0 C--O 1.221 -0.714 0 CA-C-N 114.984 -1.007 . . . . 0.35 111.741 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.638 ' HG3' HE21 ' A' ' 91' ' ' GLN . 54.8 mtpt -41.22 -15.74 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.875 1.065 . . . . 2.35 113.875 -177.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.462 ' N ' ' O ' ' A' ' 46' ' ' GLY . 51.0 m -85.89 7.83 22.58 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.522 0.677 . . . . 1.45 109.677 178.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.579 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 0.0 OUTLIER -69.33 151.03 46.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.796 -1.093 . . . . 1.73 112.329 -179.073 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 48.4 m -126.86 119.74 27.52 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.71 -0.677 . . . . 0.44 109.257 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.609 HG12 ' HA ' ' A' ' 133' ' ' VAL . 34.9 m -133.24 154.98 40.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.26 0.553 . . . . 0.65 112.24 -178.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 90.3 m -111.12 121.24 44.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.339 -0.846 . . . . 0.32 109.148 178.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.514 HG12 ' HA ' ' A' ' 130' ' ' LEU . 4.2 m -141.28 -179.62 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.06 0.457 . . . . 0.24 111.833 -178.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -135.11 133.06 38.84 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.635 -0.712 . . . . 2.4 109.384 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -143.63 158.38 43.71 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.731 0.777 . . . . 0.26 112.124 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 63.2 m -125.37 113.26 17.32 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.353 -1.294 . . . . 0.26 108.582 178.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.468 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -109.69 145.15 16.85 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 119.914 -1.136 . . . . 0.12 112.756 -178.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.543 HH11 HD13 ' A' ' 125' ' ' ILE . 0.1 OUTLIER -148.07 146.48 28.86 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 120.891 0.377 . . . . 1.93 110.193 179.325 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.453 ' HA ' ' HG ' ' A' ' 124' ' ' LEU . 5.7 mt -76.27 156.64 33.29 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.989 -0.55 . . . . 1.21 109.744 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.475 HG21 ' HG3' ' A' ' 11' ' ' LYS . 0.4 OUTLIER -58.09 -11.17 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.199 -0.667 . . . . 0.64 109.199 179.021 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.41 ' N ' ' C ' ' A' ' 59' ' ' LEU . 19.5 t70 -65.0 -11.58 40.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.357 -0.838 . . . . 2.01 110.722 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.47 ' HA2' ' NH2' ' A' ' 58' ' ' ARG . . . 90.81 -0.72 77.08 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.544 -0.836 . . . . 0.45 113.511 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 40.7 p -118.94 128.36 54.35 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 117.277 0.538 . . . . 1.4 111.381 -178.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 57' ' ' GLY . 6.5 p -60.71 134.9 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-N 115.936 -0.574 . . . . 0.28 109.807 179.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.642 ' HD1' ' N ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -97.31 -26.24 14.97 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.185 -0.462 . . . . 0.24 110.888 -179.554 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.642 ' N ' ' HD1' ' A' ' 65' ' ' PHE . 21.4 t70 -177.29 134.46 0.18 Allowed 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.438 -0.346 . . . . 0.3 110.744 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 40.4 t -131.14 122.58 26.89 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.322 -0.399 . . . . 1.3 110.451 179.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.641 HG21 ' HB2' ' A' ' 75' ' ' ALA . 47.9 p -71.62 -17.88 62.24 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.007 0.432 . . . . 0.34 110.382 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -75.14 -45.58 39.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.916 -0.583 . . . . 2.11 110.508 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -62.55 -41.74 99.09 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.861 -0.609 . . . . 3.41 111.114 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 21.6 m -58.38 -17.63 21.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.315 -0.402 . . . . 1.47 110.662 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.42 3.61 88.43 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.821 -0.704 . . . . 0.7 112.46 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.455 ' NZ ' ' HB3' ' A' ' 73' ' ' LYS . 8.6 mtpm? -126.38 117.68 23.22 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.347 0.118 . . . . 3.05 111.039 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.43 163.38 3.67 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.476 2.117 . . . . 0.51 112.228 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.641 ' HB2' HG21 ' A' ' 68' ' ' THR . . . -96.33 124.72 40.43 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.207 -0.451 . . . . 0.23 110.511 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 61.8 m -124.79 111.44 15.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.922 0.391 . . . . 1.26 111.262 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -158.5 163.29 37.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.894 -0.594 . . . . 0.36 110.564 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.685 ' HG3' ' HB2' ' A' ' 81' ' ' GLN . 1.5 pt20 -89.7 147.49 23.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.385 0.612 . . . . 1.58 109.989 178.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 27.5 m -57.61 -23.36 19.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 N-CA-C 114.039 1.125 . . . . 1.07 114.039 -177.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 91.8 p -95.35 -2.55 48.94 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.515 0.561 . . . . 1.14 112.515 -178.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.685 ' HB2' ' HG3' ' A' ' 78' ' ' GLN . 6.6 tt0 -83.22 5.32 23.33 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.751 0.278 . . . . 2.08 111.751 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -112.87 -178.86 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.912 0.386 . . . . 0.45 111.977 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.629 HG13 ' H ' ' A' ' 86' ' ' TRP . 25.6 pt -56.1 154.46 15.02 Favored Pre-proline 0 C--O 1.231 0.102 0 CA-C-N 115.951 -0.568 . . . . 0.75 111.741 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -47.81 -44.67 26.32 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.483 2.122 . . . . 0.65 112.414 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.506 ' HA2' HD21 ' A' ' 32' ' ' LEU . . . -61.19 -49.26 79.95 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 120.622 -0.799 . . . . 0.31 113.024 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . 0.629 ' H ' HG13 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -63.03 -53.1 59.18 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.894 0.331 . . . . 0.78 111.894 -178.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.0 t -53.93 -34.23 59.02 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.006 0.373 . . . . 1.4 112.006 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.486 ' HG3' ' HB2' ' A' ' 30' ' ' SER . 0.6 OUTLIER -66.09 -51.09 61.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.6 -0.273 . . . . 1.43 111.076 -179.829 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.409 ' HB2' ' HG ' ' A' ' 32' ' ' LEU . . . -65.07 -44.41 89.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.512 -0.313 . . . . 0.33 111.549 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -57.42 -29.85 64.49 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.252 -0.431 . . . . 0.39 111.354 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.638 HE21 ' HG3' ' A' ' 47' ' ' LYS . 29.6 tt0 -62.24 -23.67 66.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.271 -0.422 . . . . 1.87 111.233 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.425 HD12 ' N ' ' A' ' 92' ' ' LEU . 8.3 mp -93.2 -7.66 44.62 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.153 0.427 . . . . 1.31 112.153 -178.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 2.9 ttm -92.21 107.81 26.01 Favored Pre-proline 0 C--N 1.33 -0.253 0 C-N-CA 120.99 -0.284 . . . . 1.66 111.512 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.419 ' HA ' ' HD3' ' A' ' 44' ' ' LYS . 69.6 Cg_endo -75.19 146.77 32.39 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.232 1.954 . . . . 0.44 110.496 178.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.56 ' HA ' HD13 ' A' ' 130' ' ' LEU . . . -45.81 124.96 5.67 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.917 -0.313 . . . . 0.36 111.363 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 102.38 -9.49 55.97 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 120.518 -0.848 . . . . 0.34 113.328 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.405 ' HA ' ' O ' ' A' ' 38' ' ' ASN . 31.2 t -72.74 175.0 6.85 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 117.005 0.403 . . . . 1.41 111.193 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.411 HG22 HD12 ' A' ' 37' ' ' ILE . 18.3 m -146.46 96.35 2.75 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.94 -0.573 . . . . 0.23 110.473 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.796 ' HE1' ' HB2' ' A' ' 39' ' ' SER . 30.8 m0 -119.57 149.79 41.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.192 0.52 . . . . 0.53 111.961 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.437 ' HB3' ' HD3' ' A' ' 127' ' ' LYS . 8.9 pt-20 -119.46 107.99 14.0 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.966 -1.124 . . . . 1.37 107.966 177.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.751 HG22 ' HB3' ' A' ' 34' ' ' TYR . 41.8 pt -108.14 142.75 20.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 113.53 0.937 . . . . 0.25 113.53 -177.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -123.45 103.63 8.58 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.498 -1.228 . . . . 0.31 108.228 177.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.415 ' HA ' ' HD2' ' A' ' 104' ' ' PRO . 2.2 t -107.55 96.89 17.63 Favored Pre-proline 0 C--N 1.329 -0.307 0 N-CA-C 113.219 0.822 . . . . 0.52 113.219 -176.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.552 ' HG2' HD23 ' A' ' 107' ' ' LEU . 9.5 Cg_endo -54.5 149.68 37.84 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 121.861 1.708 . . . . 0.48 110.484 177.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.5 p -48.63 -27.8 3.07 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.873 0.694 . . . . 1.81 112.873 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.429 ' N ' ' HD3' ' A' ' 111' ' ' PRO . . . -60.22 -10.46 15.76 Favored Glycine 0 CA--C 1.521 0.441 0 C-N-CA 120.799 -0.715 . . . . 0.4 113.754 -179.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.552 HD23 ' HG2' ' A' ' 104' ' ' PRO . 3.0 mm? -114.66 -0.94 13.45 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.242 0.46 . . . . 2.35 112.242 -178.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.487 ' HB2' HD12 ' A' ' 83' ' ' ILE . . . -109.3 -104.71 0.37 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 110.34 -0.244 . . . . 1.03 110.34 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -99.37 -2.25 36.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.341 0.591 . . . . 1.44 109.683 178.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 90.58 138.33 7.43 Favored Glycine 0 CA--C 1.522 0.518 0 CA-C-N 115.157 -0.928 . . . . 1.58 113.862 178.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.484 ' HB3' ' HA ' ' A' ' 121' ' ' ASN . 21.3 Cg_endo -59.97 -5.48 3.8 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.946 3.097 . . . . 1.49 113.265 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -75.04 161.33 29.54 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.735 0.302 . . . . 3.51 110.401 -177.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 81.2 p 53.97 -119.64 1.52 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.829 -0.623 . . . . 1.63 110.131 -178.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.505 ' HA ' ' HB3' ' A' ' 120' ' ' PRO . 2.5 t -114.14 17.28 7.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.764 0.316 . . . . 2.9 111.338 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 55.84 171.58 0.11 Allowed Glycine 0 CA--C 1.522 0.509 0 C-N-CA 120.833 -0.699 . . . . 1.05 112.861 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.402 ' HA3' ' HD2' ' A' ' 117' ' ' PRO . . . -80.77 -136.2 1.74 Allowed Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.768 -0.729 . . . . 0.8 111.918 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.402 ' HD2' ' HA3' ' A' ' 116' ' ' GLY . 19.4 Cg_endo -58.82 -23.93 69.49 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.072 1.848 . . . . 0.7 110.83 178.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.568 HG23 HD12 ' A' ' 124' ' ' LEU . 93.2 mt -90.09 135.57 26.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.311 -0.859 . . . . 1.25 110.031 179.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -42.88 152.0 0.3 Allowed Glycine 0 CA--C 1.52 0.386 0 C-N-CA 121.247 -0.501 . . . . 0.48 113.101 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.505 ' HB3' ' HA ' ' A' ' 114' ' ' VAL . 21.6 Cg_endo -60.33 130.88 35.78 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.436 2.091 . . . . 0.67 111.71 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.484 ' HA ' ' HB3' ' A' ' 111' ' ' PRO . 2.0 m-80 43.73 34.89 0.92 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.161 -0.472 . . . . 1.12 110.081 -178.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -115.72 136.37 53.13 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.914 -0.584 . . . . 1.73 111.495 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.474 HG21 HD23 ' A' ' 16' ' ' LEU . 96.7 m -95.53 134.08 38.81 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.02 -0.733 . . . . 0.29 109.02 178.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.568 HD12 HG23 ' A' ' 118' ' ' ILE . 0.1 OUTLIER -121.5 154.79 36.16 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.31 0.576 . . . . 1.47 112.413 -178.085 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.543 HD13 HH11 ' A' ' 58' ' ' ARG . 4.4 mp -113.81 141.22 30.62 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 CA-C-N 115.237 -0.892 . . . . 0.2 109.387 178.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.437 ' CE1' HD22 ' A' ' 124' ' ' LEU . 80.9 m-85 -133.83 132.06 39.97 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.173 0.511 . . . . 0.24 111.809 -179.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.437 ' HD3' ' HB3' ' A' ' 100' ' ' GLU . 42.6 mmtm -107.21 103.55 12.95 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.811 -0.811 . . . . 2.28 108.811 178.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 36.2 mt -102.68 119.03 50.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.047 0.451 . . . . 0.82 112.075 -178.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -114.99 99.97 7.85 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.655 -0.702 . . . . 0.26 109.327 178.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.56 HD13 ' HA ' ' A' ' 95' ' ' ALA . 0.6 OUTLIER -79.31 123.28 27.31 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.002 -0.545 . . . . 1.41 111.06 -178.838 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 48.3 mm -93.43 -56.77 4.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.067 -0.515 . . . . 1.17 111.012 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.484 ' HA ' ' HB1' ' A' ' 95' ' ' ALA . 13.6 m -163.45 165.23 24.03 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.976 0.417 . . . . 1.17 111.622 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.844 HG22 ' HG2' ' A' ' 134' ' ' LYS . 2.7 p -107.93 129.92 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 115.734 -0.666 . . . . 1.43 110.441 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.844 ' HG2' HG22 ' A' ' 133' ' ' VAL . 17.3 ptmt 34.55 55.25 0.67 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.036 0.446 . . . . 3.08 111.316 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm 61.62 42.94 10.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.764 -0.653 . . . . 3.16 110.929 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 43.5 t 52.5 61.14 3.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.78 -0.646 . . . . 1.31 110.993 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 71.2 m . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.2 -0.905 . . . . 2.53 111.139 -179.689 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.798 0.333 . . . . 3.09 110.893 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -66.09 -19.06 65.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.293 -0.412 . . . . 2.08 111.135 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -59.22 -40.98 87.55 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.675 -0.491 . . . . 3.23 109.675 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -79.82 -36.5 36.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.79 -0.641 . . . . 2.63 110.116 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.72 -52.52 62.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.739 -0.664 . . . . 0.82 110.179 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.408 ' O ' HG23 ' A' ' 10' ' ' VAL . 20.9 m-20 -67.4 -36.3 81.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.62 -0.718 . . . . 2.57 110.293 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -55.76 -32.99 63.91 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 109.335 -0.617 . . . . 2.1 109.335 178.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.565 ' HA ' ' HE2' ' A' ' 11' ' ' LYS . 21.4 m-20 -72.78 -38.84 67.14 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.494 -0.775 . . . . 1.4 110.471 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 8.3 tmtm? -59.8 -31.45 69.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.097 -0.501 . . . . 2.67 111.353 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 6' ' ' ASP . 11.8 t -77.81 -53.48 14.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 111.895 0.331 . . . . 1.27 111.895 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.565 ' HE2' ' HA ' ' A' ' 8' ' ' ASN . 58.9 pttt -66.1 -27.21 67.89 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.943 0.401 . . . . 1.69 110.523 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.95 -45.07 12.51 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.789 -0.72 . . . . 0.31 111.8 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.435 ' OE2' HD11 ' A' ' 16' ' ' LEU . 16.2 tp10 -68.07 -34.4 76.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.697 0.284 . . . . 2.39 110.767 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.47 -42.46 64.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.23 111.342 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -58.38 -56.28 24.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.541 -0.299 . . . . 0.23 110.496 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.549 ' HA ' ' HB3' ' A' ' 19' ' ' ASN . 4.1 pp -60.01 -33.06 71.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.262 -0.426 . . . . 0.55 110.482 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.8 m -58.09 -48.56 79.81 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.989 -0.551 . . . . 0.27 110.204 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -73.69 -32.01 63.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.934 -0.575 . . . . 2.47 110.034 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.549 ' HB3' ' HA ' ' A' ' 16' ' ' LEU . 0.4 OUTLIER -53.69 -32.45 51.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.408 -0.815 . . . . 0.22 111.478 179.934 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.58 ' HE2' HE22 ' A' ' 33' ' ' GLN . 35.6 mmtp -44.02 -20.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.996 -0.547 . . . . 2.45 112.332 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.664 HD22 ' N ' ' A' ' 21' ' ' ASN . 0.8 OUTLIER -68.49 -33.05 73.46 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.983 0.364 . . . . 0.4 111.983 -178.751 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.432 ' HD2' ' OD1' ' A' ' 19' ' ' ASN . 67.3 mttm -54.14 119.11 18.12 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.686 -0.234 . . . . 1.4 110.988 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.46 142.73 95.33 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.449 2.099 . . . . 0.65 112.258 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.14 -1.63 86.56 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.769 -0.729 . . . . 0.37 113.249 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' A' ' 34' ' ' TYR . 3.7 p -61.26 110.53 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 121.21 0.529 . . . . 0.91 110.58 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.0 p -130.04 130.94 66.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.838 -0.619 . . . . 1.03 111.508 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 9.7 p -82.89 138.38 19.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.91 110.861 179.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.53 HD12 ' HB2' ' A' ' 32' ' ' LEU . 55.3 mt -96.22 167.45 12.37 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.255 -0.429 . . . . 0.4 110.704 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.48 ' HD2' ' HB3' ' A' ' 28' ' ' LEU . 75.0 Cg_exo -51.06 -30.97 33.36 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.129 1.886 . . . . 0.59 112.265 179.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.479 ' HB2' HD23 ' A' ' 32' ' ' LEU . 31.9 m -89.25 -9.41 50.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.265 -0.425 . . . . 1.14 111.782 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.58 15.68 22.15 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.388 -0.91 . . . . 0.34 113.627 178.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.691 HD21 ' HA2' ' A' ' 85' ' ' GLY . 2.7 mm? -83.02 134.27 35.05 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.008 0.432 . . . . 1.35 111.92 -179.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.58 HE22 ' HE2' ' A' ' 20' ' ' LYS . 46.1 mt-30 -125.23 139.02 54.09 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.282 -0.636 . . . . 1.75 109.282 178.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.803 ' HB3' HG22 ' A' ' 101' ' ' ILE . 28.8 p90 -151.17 175.72 11.88 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.788 0.662 . . . . 0.32 112.788 -178.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -121.09 117.06 26.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.226 -0.897 . . . . 2.15 109.175 178.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.5 t -72.66 126.66 33.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 113.299 0.852 . . . . 0.3 113.299 -177.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.462 HD12 HG22 ' A' ' 98' ' ' THR . 76.8 mt -107.42 -66.75 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 115.401 -0.818 . . . . 0.65 110.131 178.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -142.59 82.86 1.79 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.19 -0.459 . . . . 1.03 110.157 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.417 ' OG ' ' NE1' ' A' ' 99' ' ' TRP . 17.8 m -106.03 146.38 30.18 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 112.515 0.561 . . . . 1.5 112.515 -178.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 92.43 83.65 1.5 Allowed Glycine 0 C--N 1.334 0.455 0 CA-C-N 115.755 -0.657 . . . . 1.09 113.038 178.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -150.61 -72.77 0.17 Allowed 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 111.681 0.252 . . . . 1.7 111.681 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.12 172.29 36.45 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 121.072 -0.585 . . . . 0.35 114.298 -178.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.598 HG12 ' H ' ' A' ' 44' ' ' LYS . 2.0 t -90.47 175.99 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 123.474 0.71 . . . . 1.42 110.022 179.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.598 ' H ' HG12 ' A' ' 43' ' ' VAL . 2.1 pptp? 164.96 156.53 0.07 OUTLIER Pre-proline 0 N--CA 1.472 0.657 0 CA-C-O 121.503 0.668 . . . . 2.18 112.028 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.471 ' HD2' ' HB2' ' A' ' 49' ' ' ASP . 1.2 Cg_endo -83.84 172.54 9.88 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 124.823 3.682 . . . . 0.3 113.692 -179.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 48' ' ' SER . . . -67.98 -172.93 6.92 Favored Glycine 0 C--O 1.223 -0.565 0 CA-C-N 115.096 -0.956 . . . . 0.35 111.237 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -41.63 -13.98 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.825 1.046 . . . . 2.35 113.825 -177.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.487 ' N ' ' O ' ' A' ' 46' ' ' GLY . 55.6 m -86.32 7.24 26.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.268 0.556 . . . . 1.45 110.092 178.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.471 ' HB2' ' HD2' ' A' ' 45' ' ' PRO . 3.0 p30 -74.79 166.23 23.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.267 -0.879 . . . . 1.73 111.676 -179.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 91.7 m -126.07 121.26 32.43 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 108.691 -0.855 . . . . 0.44 108.691 178.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.819 HG12 HG22 ' A' ' 133' ' ' VAL . 6.4 m -122.92 142.63 38.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 112.97 0.73 . . . . 0.65 112.97 -177.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 39.3 m -115.35 119.79 37.45 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.067 -1.086 . . . . 0.32 108.067 177.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.62 HG12 ' HA ' ' A' ' 130' ' ' LEU . 2.7 m -146.34 178.78 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.26 0.552 . . . . 0.24 111.961 -177.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -128.78 132.45 47.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.291 -0.868 . . . . 2.4 109.107 178.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -146.13 159.28 43.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.584 0.707 . . . . 0.26 112.345 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 57.0 m -121.84 112.89 18.9 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.483 -1.235 . . . . 0.26 108.223 178.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.473 ' O ' HG23 ' A' ' 64' ' ' VAL . . . -110.66 143.54 17.02 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 119.664 -1.255 . . . . 0.12 113.236 -178.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.543 ' O ' HD13 ' A' ' 124' ' ' LEU . 0.1 OUTLIER -148.43 145.61 28.07 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.566 -0.317 . . . . 1.93 110.176 179.266 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.538 HD23 HD11 ' A' ' 124' ' ' LEU . 2.3 mt -74.9 154.02 38.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.978 -0.555 . . . . 1.21 110.586 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.482 ' HB ' ' O ' ' A' ' 123' ' ' THR . 0.4 OUTLIER -56.55 -11.94 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.362 0.601 . . . . 0.64 109.621 179.001 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.402 ' N ' ' C ' ' A' ' 59' ' ' LEU . 21.4 t70 -71.11 -10.01 59.03 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.434 -0.803 . . . . 2.01 110.816 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.7 0.18 75.92 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.597 -0.811 . . . . 0.45 113.629 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 61.4 p -113.3 121.43 44.38 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 117.339 0.57 . . . . 1.4 111.724 -178.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 57' ' ' GLY . 5.9 p -60.61 132.4 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-N 115.889 -0.596 . . . . 0.28 109.819 179.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.701 ' HD1' ' H ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -97.79 -28.07 14.03 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.333 -0.394 . . . . 0.24 111.908 -179.4 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.701 ' H ' ' HD1' ' A' ' 65' ' ' PHE . 15.1 t70 -177.64 131.49 0.16 Allowed 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.606 0.241 . . . . 0.3 110.821 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.6 m -131.41 116.84 18.05 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.879 0.371 . . . . 1.3 110.487 178.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.544 HG21 ' HB2' ' A' ' 75' ' ' ALA . 80.4 p -74.84 -29.59 61.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.478 . . . . 0.34 111.323 -179.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -70.18 -39.45 75.26 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.199 -0.455 . . . . 2.11 110.654 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -71.02 -37.95 72.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.226 -0.443 . . . . 3.41 111.042 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 33.8 m -57.11 -22.75 42.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.233 -0.44 . . . . 1.47 110.794 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 95.21 2.15 62.33 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.869 -0.681 . . . . 0.7 112.618 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.449 ' HB2' ' NZ ' ' A' ' 73' ' ' LYS . 3.6 ttmp? -126.35 118.03 23.28 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.638 0.219 . . . . 3.05 111.111 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -52.65 150.25 22.39 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.62 2.213 . . . . 0.51 112.125 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.544 ' HB2' HG21 ' A' ' 68' ' ' THR . . . -94.73 125.02 39.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.39 -0.368 . . . . 0.23 110.811 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.7 t -123.85 113.97 19.24 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.952 0.406 . . . . 1.26 111.428 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -159.03 154.65 26.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.021 -0.536 . . . . 0.36 111.121 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.591 HE22 ' HB3' ' A' ' 80' ' ' SER . 0.0 OUTLIER -84.5 148.84 26.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.35 0.595 . . . . 1.58 109.871 178.487 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.4 ' CG1' ' HB3' ' A' ' 90' ' ' LEU . 2.5 m -68.79 -25.78 31.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 113.925 1.084 . . . . 1.07 113.925 -177.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.591 ' HB3' HE22 ' A' ' 78' ' ' GLN . 37.7 t -86.17 -2.35 58.27 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.616 0.599 . . . . 1.14 112.616 -178.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.422 ' HB2' ' HG3' ' A' ' 78' ' ' GLN . 7.8 tt0 -95.33 5.56 51.35 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.274 0.472 . . . . 2.08 112.274 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 1.7 m -113.63 -173.17 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 112.334 0.494 . . . . 0.45 112.334 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.593 HG13 ' H ' ' A' ' 86' ' ' TRP . 42.2 pt -56.14 158.95 6.52 Favored Pre-proline 0 CA--C 1.53 0.201 0 CA-C-N 115.906 -0.588 . . . . 0.75 112.268 -179.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.435 ' O ' HG22 ' A' ' 87' ' ' THR . 75.3 Cg_exo -51.38 -47.37 26.36 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.894 2.396 . . . . 0.65 113.043 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.691 ' HA2' HD21 ' A' ' 32' ' ' LEU . . . -59.85 -48.66 84.97 Favored Glycine 0 CA--C 1.521 0.407 0 C-N-CA 120.524 -0.846 . . . . 0.31 112.953 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . 0.593 ' H ' HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -64.06 -44.72 91.56 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.651 0.611 . . . . 0.78 112.651 -178.695 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.435 HG22 ' O ' ' A' ' 84' ' ' PRO . 10.0 t -60.25 -37.14 79.46 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.072 0.397 . . . . 1.4 112.072 -178.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.446 ' O ' ' HG2' ' A' ' 91' ' ' GLN . 10.3 tp10 -70.75 -40.2 72.85 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.008 0.373 . . . . 1.43 112.008 -179.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.495 ' HB2' ' HG ' ' A' ' 32' ' ' LEU . . . -76.09 -52.46 10.11 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.013 0.375 . . . . 0.33 112.013 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.691 HD11 HD13 ' A' ' 128' ' ' ILE . 4.6 mm? -57.38 -34.69 69.11 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.778 0.658 . . . . 0.39 112.778 -178.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.446 ' HG2' ' O ' ' A' ' 88' ' ' GLU . 18.1 pt20 -65.55 -4.79 6.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.635 0.255 . . . . 1.87 111.653 -179.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 82.6 mt -108.22 -7.85 15.89 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.564 -0.289 . . . . 1.31 111.207 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.553 ' HE3' ' N ' ' A' ' 99' ' ' TRP . 13.8 ttt -78.08 112.93 28.97 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.417 -0.356 . . . . 1.66 111.102 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.532 ' HA ' ' HG2' ' A' ' 44' ' ' LYS . 4.5 Cg_exo -77.04 142.37 21.85 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.761 2.307 . . . . 0.44 111.84 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.484 ' HB1' ' HA ' ' A' ' 132' ' ' SER . . . -50.41 128.28 19.46 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.372 -0.377 . . . . 0.36 111.499 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 92.25 2.27 68.56 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.689 -0.767 . . . . 0.34 113.292 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 19.8 m -92.85 -179.72 5.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.094 0.473 . . . . 1.41 111.776 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.462 HG22 HD12 ' A' ' 37' ' ' ILE . 3.9 m -144.63 120.4 10.55 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.658 -0.701 . . . . 0.23 110.084 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.553 ' N ' ' HE3' ' A' ' 93' ' ' MET . 4.9 m0 -132.36 150.65 52.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.23 0.538 . . . . 0.53 112.264 -178.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -122.46 106.85 11.4 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.715 -1.217 . . . . 1.37 107.715 177.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.803 HG22 ' HB3' ' A' ' 34' ' ' TYR . 41.0 pt -109.44 139.28 33.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 112.923 0.712 . . . . 0.25 112.923 -177.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -122.72 103.33 8.59 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.826 -1.079 . . . . 0.31 108.214 178.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.402 HG12 ' HB2' ' A' ' 107' ' ' LEU . 2.7 t -107.3 97.08 17.49 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 112.501 0.556 . . . . 0.52 112.501 -177.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.634 ' HA ' ' HA ' ' A' ' 123' ' ' THR . 9.9 Cg_endo -54.12 149.06 37.28 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 121.621 1.547 . . . . 0.48 110.528 177.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.567 ' HB3' ' HA3' ' A' ' 110' ' ' GLY . 3.3 m -48.15 -29.49 3.72 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.489 0.551 . . . . 1.81 112.489 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -56.64 -9.79 3.87 Favored Glycine 0 CA--C 1.521 0.444 0 C-N-CA 121.016 -0.611 . . . . 0.4 113.992 -178.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.488 HD23 ' HG2' ' A' ' 104' ' ' PRO . 3.4 mm? -110.6 1.98 18.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 117.251 0.526 . . . . 2.35 111.897 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.472 ' HB2' HD12 ' A' ' 83' ' ' ILE . . . -123.09 -111.01 0.32 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.715 -0.22 . . . . 1.03 111.586 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -130.92 4.17 4.48 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.793 0.33 . . . . 1.44 111.594 -179.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.687 ' N ' ' HD2' ' A' ' 111' ' ' PRO . . . -67.09 -36.44 90.5 Favored Glycine 0 CA--C 1.532 1.104 0 N-CA-C 115.836 1.095 . . . . 1.58 115.836 -178.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.687 ' HD2' ' N ' ' A' ' 110' ' ' GLY . 12.9 Cg_endo -56.52 -16.65 19.28 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.519 2.146 . . . . 1.49 112.969 -178.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -95.81 160.73 14.34 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.382 -0.372 . . . . 3.51 110.379 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 87.6 p -64.71 -2.33 2.41 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.063 0.458 . . . . 1.63 110.912 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 10.9 t -111.44 60.75 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.577 -0.738 . . . . 2.9 110.618 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -40.69 112.84 0.37 Allowed Glycine 0 C--N 1.333 0.401 0 CA-C-N 116.11 -0.496 . . . . 1.05 112.85 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.96 -145.13 0.07 OUTLIER Glycine 0 CA--C 1.52 0.373 0 C-N-CA 121.0 -0.619 . . . . 0.8 112.296 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.504 ' HB2' HD12 ' A' ' 118' ' ' ILE . 49.6 Cg_exo -54.76 -36.44 90.59 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 121.864 1.709 . . . . 0.7 111.453 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.539 HG23 HD23 ' A' ' 124' ' ' LEU . 4.0 mp -92.53 135.65 26.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.753 -0.658 . . . . 1.25 110.212 178.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -42.64 149.53 0.46 Allowed Glycine 0 C--N 1.335 0.493 0 C-N-CA 120.917 -0.658 . . . . 0.48 112.489 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -55.73 131.31 45.31 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.263 1.976 . . . . 0.67 112.282 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 42.99 37.68 1.2 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.311 -0.404 . . . . 1.12 110.862 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.462 ' OE1' HD22 ' A' ' 59' ' ' LEU . 30.8 tt0 -114.09 144.28 43.4 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.012 -0.54 . . . . 1.73 111.957 -179.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.634 ' HA ' ' HA ' ' A' ' 104' ' ' PRO . 70.0 m -97.0 129.3 44.49 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.369 -0.604 . . . . 0.29 109.369 178.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.543 HD13 ' O ' ' A' ' 58' ' ' ARG . 1.4 mm? -115.53 152.43 33.02 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.121 0.486 . . . . 1.47 111.838 -178.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.423 ' N ' HD12 ' A' ' 125' ' ' ILE . 4.8 mp -114.3 136.36 51.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.557 -0.747 . . . . 0.2 110.02 178.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -133.53 131.7 40.07 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.275 -0.42 . . . . 0.24 111.397 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -108.43 102.38 11.49 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.862 -1.162 . . . . 2.28 107.862 177.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.691 HD13 HD11 ' A' ' 90' ' ' LEU . 18.2 mt -102.83 126.56 57.03 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 CA-C-O 121.238 0.542 . . . . 0.82 112.148 -177.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.469 ' O ' ' HB ' ' A' ' 53' ' ' VAL . 1.3 t-160 -118.56 98.37 6.21 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.227 -0.897 . . . . 0.26 109.297 178.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.62 ' HA ' HG12 ' A' ' 53' ' ' VAL . 17.3 tp -80.25 113.61 18.54 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.187 -0.46 . . . . 1.41 111.113 -178.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 34.3 mm -81.98 -50.29 16.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.786 -0.643 . . . . 1.17 110.782 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.484 ' HA ' ' HB1' ' A' ' 95' ' ' ALA . 5.3 m -163.4 165.22 24.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 1.17 110.358 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.819 HG22 HG12 ' A' ' 51' ' ' VAL . 91.7 t -129.16 135.77 61.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.01 -0.541 . . . . 1.43 110.589 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.56 ' HE2' ' HB2' ' A' ' 137' ' ' SER . 21.4 ptmt 40.74 49.8 2.87 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.878 -0.601 . . . . 3.08 111.277 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt 63.77 41.21 7.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.345 -0.843 . . . . 3.16 111.507 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 33.9 t 48.03 32.61 2.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.71 -0.677 . . . . 1.31 111.477 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.56 ' HB2' ' HE2' ' A' ' 134' ' ' LYS . 69.8 m . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.213 -0.898 . . . . 2.53 110.894 179.902 . . . . . . . . 1 1 . 1 stop_ save_